note_id
stringlengths
13
15
subject_id
int64
10M
20M
hadm_id
int64
20M
30M
note_type
stringclasses
1 value
note_seq
int64
2
133
charttime
stringlengths
19
19
storetime
stringlengths
19
19
text
stringlengths
1.56k
52.7k
19971094-DS-14
19,971,094
27,853,347
DS
14
2187-03-12 00:00:00
2187-03-15 19:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Right rib pain Major Surgical or Invasive Procedure: None History of Present Illness: Patient is a ___ yo ___ male with a history of cholelithiasis, HTN, HL presenting with ruq pain. History is unclear, but daughter first noticed the patient was holding his right side yesterday, and complained of right sided abdominal/rib pain. Unclear when it started. Not associated with eating. Nonexertional. Had chest pain last ___ that reportedly resolved, sharp quality, woke up with it in the middle of the night. Apparently was having chest pain about a year or so ago when living in ___, which prompted a cardiac w/u at ___ with exercise stress test. This was about a year ago. She said that the results suggested a small blockage somewhere, but was medically managed. Has never had a catheterization. Denies shortness of breath, although daughter has noticed that he gets tired more easily with exertion, although doesn't seem more short of breath, although has noted wheezing at times. No recent fevers, chills, cough. Denies n/v/d. Daughter also notes Of note, per discussion with cardiologist Dr. ___, had pharmacologic nuclear stress test in ___ showing mild inferolateral defect but with normal EF. Treated medically as he was asymptomatic. Subsequently had a SAH with a R supraclinoid aneurysm, so decision was made with patient, family and providers to stop treatment with antiplatelet agents. Had myalgias with atorvastatin, so has been managed medically with lovastatin and metoprolol. Scheduled for follow-up appointment with Dr. ___ tomorrow to discuss elective cholecystectomy. In the ED, initial vitals were: 5 97.5 64 139/99 16 100% RA Labs notable for WBC 5.9, H/H 12.8/38.4, BUN/CR ___, LFTs WNL, Trop-T: <0.01. Imaging notable for RUQ with Cholelithiasis with a gallstone seen at the gallbladder neck. No other evidence of acute cholecystitis. CXR w/ no acute cardiopulmonary process. Vitals on transfer: 3 70 112/50 16 96% RA On the floor, he continues to endorse pain that is very localized to the lateral right lower rib. Past Medical History: - hypertension - CAD (nuclear stress test ___ at ___: mild inferolateral defect, normal EF) - Subarachnoid hemorrhage related to R supraclinoid aneurysm (___) - H/o TIA - hypothyroidism - anxiety - left hip replacement ___ - bilateral cataract surgery Social History: ___ Family History: Family history is negative for coronary artery disease or cancer. Physical Exam: ON ADMISSION: VS: 97.3 126/73 74 18 97% on RA General: Pleasant elderly gentleman laying comfortably in bed in NAD HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Mild expiratory wheeze in the mid to upper lung fields bilaterally, otherwise clear to auscultation bilaterally. CV: Somewhat distant heart sounds, but regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops appreciated. Point tenderness over the lateral right lower rib. Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly. Neg murhpys sign. Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: No notable rashes or lesions Neuro: Moving all extremities equally with purpose. ON DISCHARGE: VS: afebrile ___ 138/36 (94-138/59-86) 18 97%RA General: Pleasant elderly gentleman laying comfortably in bed in NAD HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Mild expiratory wheeze in the mid to upper lung fields bilaterally, otherwise clear to auscultation bilaterally. CV: RRR. II/VI systolic ejection murmur heard best at the right ___ ICS. Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly. Neg murhpys sign. Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: No notable rashes or lesions Neuro: Moving all extremities equally with purpose. Pertinent Results: ADMISSION LABS: ___ 03:45PM BLOOD WBC-5.9 RBC-4.33* Hgb-12.8* Hct-38.4* MCV-89 MCH-29.6 MCHC-33.3 RDW-13.9 RDWSD-44.6 Plt ___ ___ 03:45PM BLOOD Neuts-50.0 ___ Monos-10.2 Eos-5.8 Baso-0.3 Im ___ AbsNeut-2.95 AbsLymp-1.96 AbsMono-0.60 AbsEos-0.34 AbsBaso-0.02 ___ 03:45PM BLOOD ___ PTT-32.1 ___ ___ 03:45PM BLOOD Glucose-96 UreaN-21* Creat-1.1 Na-138 K-4.3 Cl-103 HCO3-27 AnGap-12 ___ 03:45PM BLOOD ALT-11 AST-19 AlkPhos-53 TotBili-0.6 ___ 03:45PM BLOOD Lipase-34 ___ 03:45PM BLOOD Albumin-4.1 PERTINENT LABS: ___ 03:45PM BLOOD cTropnT-<0.01 ___ 12:26AM BLOOD cTropnT-<0.01 ___ 05:56AM BLOOD cTropnT-<0.01 ___ 07:11PM BLOOD cTropnT-<0.01 ___ 03:00PM BLOOD cTropnT-<0.01 DISCHARGE LABS: ___ 03:00PM BLOOD WBC-6.5 RBC-4.42* Hgb-12.9* Hct-39.4* MCV-89 MCH-29.2 MCHC-32.7 RDW-13.8 RDWSD-44.7 Plt ___ ___ 03:00PM BLOOD Glucose-167* UreaN-20 Creat-1.2 Na-137 K-4.7 Cl-101 HCO3-26 AnGap-15 ___ 03:00PM BLOOD Calcium-9.8 Phos-3.5 Mg-2.0 IMAGING/STUDIES: RUQUS ___ IMPRESSION: Cholelithiasis with a gallstone seen at the gallbladder neck. No other evidence of acute cholecystitis. CXR PA+LAT ___ FINDINGS: There is evidence of right apical scarring and possible calcified node at the right hilum. Opacity at the right cardiophrenic angle is felt most likely to be a fat pad as seen on the lateral view. Elsewhere, lungs are clear. The cardiomediastinal silhouette is within normal limits. No acute osseous abnormalities. IMPRESSION: No acute cardiopulmonary process. Pharmacologic Stress test ___ RESTING DATA EKG: SR, LEFTWARD AX, ERWP HEART RATE: 62BLOOD PRESSURE: 164/100 PROTOCOL / STAGETIMESPEEDELEVATIONWATTSHEARTBLOODRPP (MIN)(MPH)(%) RATEPRESSURE ___ ___ TOTAL EXERCISE TIME: 4% MAX HRT RATE ACHIEVED: 63 SYMPTOMS:NONE ST DEPRESSION:NONE INTERPRETATION: This ___ year old man with hx of HTN and HL was referred to the lab for evaluation of chest discomfort. He was infused with 0.142/mg/kg/min of dipyridamole over 4 minutes. He did not report any chest, arm, neck or back discomfort throughout the study. No ST segment changes were seen throughout the test. Rhythm was sinus with no ectopy. Baseline HTN with appropriate hemodynamic response to the infusion. The dipyridamole reversed with 125 mg aminophylline IV. IMPRESSION : No anginal type symptoms or ST segment changes. Nuclear report sent separately. Pharmacologic perfusion study ___: TECHNIQUE: ISOTOPE DATA: (___) 10.7 mCi Tc-99m Sestamibi Rest; (___) 31.6 mCi Tc-99m Sestamibi Stress; DRUG DATA: (Non-NM admin) Dipyridamole. Resting images were obtained approximately 45 minutes following the intravenous injection of tracer. Stress images were obtained after resting images and approximately 30 minutes following the intravenous injection of tracer. Imaging protocol: Gated SPECT. This study was interpreted using the 17-segment myocardial perfusion model. FINDINGS: Left ventricular cavity size is normal Rest and stress perfusion images reveal uniform tracer uptake throughout the left ventricular myocardium. Gated images reveal normal wall motion. The calculated left ventricular ejection fraction is 56%. IMPRESSION: Normal myocardial perfusion study including the inferolateral wall. Normal wall motion with an estimated ejection fraction of 56%. Brief Hospital Course: ___ yo male with a history of cholelithiasis, HTN, HL presenting with one day of right sided rib/right upper quadrant pain. #Costochondritis: Pain localized to lower right rib and reproduced with palpation. ECG on presentation with no acute ischemic changes. Trop neg x 3. CXR with no acute process. RUQ US showed cholelithiasis with stone in the gallbladder neck, but no e/o cholecystitis. Likely musculoskeletal/rib pain from costochrondritis. Pain improved on standing tylenol. Had episode of new vague chest discomfort the day prior to discharge. ECG unchanged. Trop neg x 1. Low concern for cardiac etiology, but given previous abnormal stress test and consideration of elective cholecystectomy, pt underwent pharm nuclear stress test to assist with pre-op cardiac risk assessment. No anginal type symptoms or ST segment changes with stress and normal myocardial perfusion study with normal wall motion and EF 56%. Discharged with PCP, cardiology and surgery follow-up. #Cholelithiasis: On presentation RUQUS with stone noted in the gall bladder neck, no e/o cholecystitis. Symptoms on presentation thought unlikely to be related to biliary colic. Seen by surgery team while inpatient to discuss option of elective cholecystectomy, with plan on discharge to follow-up in several weeks with Dr. ___ in clinic. #HTN: continued home metoprolol #HL: continued home statin =================== TRANSITIONAL ISSUES: =================== - Cholelithiasis: gallstone seen in neck of gallbladder this admission, but current symptoms unlikely related. Will require further discussion of benefits versus risk of elective cholecystectomy. Plan for outpatient follow-up with cardiology and surgery. -CAD: Continued on home metoprolol and lovastatin for medical management, without ASA per prior discussion with outpatient providers given history of SAH and decision to avoid treatment with anticoagulants/antiplatelet agents. Pharm nuclear stress test showed no evidence of reversible ischemia. Recommend formal preoperative evaluation by PCP prior to proceeding with surgery. - CONTACT: ___ (daughter, HCP): ___ - CODE: Full code (confirmed) Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lovastatin 20 mg oral DAILY 2. OxycoDONE (Immediate Release) 2.5-5 mg PO Q6H:PRN pain 3. Levothyroxine Sodium 75 mcg PO DAILY 4. Metoprolol Succinate XL 25 mg PO BID 5. FLUoxetine 20 mg PO DAILY Discharge Medications: 1. FLUoxetine 20 mg PO DAILY 2. Levothyroxine Sodium 75 mcg PO DAILY 3. Metoprolol Succinate XL 25 mg PO BID 4. Lovastatin 20 mg oral DAILY 5. OxycoDONE (Immediate Release) 2.5-5 mg PO Q6H:PRN pain Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: Costochondritis SECONDARY DIAGNOSIS: cholelithiasis, HTN, HL, CAD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, You came into the hospital because you were having right sided chest wall pain. You had blood tests and an EKG done which showed that this pain was not from a heart attack. It is most likely pain from a rib or muscle strain. Because you had an episode of chest pain recently, you had a stress test which was negative. You should continue to talk with your family, cardiologist and primary care provider to decide on whether to proceed with surgery to remove the gall bladder. It was a pleasure being involved in your care! Your ___ Care Team Followup Instructions: ___
19971290-DS-7
19,971,290
21,456,551
DS
7
2122-03-05 00:00:00
2122-03-05 22:00:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Fall, broken rib, found to have pulmonary embolism Major Surgical or Invasive Procedure: None History of Present Illness: ============================================================ MEDICINE ADMISSION NOTE Date of admission: ___ =========================================================== PRIMARY CARE PHYSICIAN: ___ CHIEF COMPLAINT: Fall, rib fracture, found to have bilateral PE. HISTORY OF PRESENT ILLNESS: ___ is a ___ year old veteran from ___ with past medical history of hypertension, hyperlipidemia, PTSD, left total knee replacement in ___ who presents after fall with rib fracture found to have incidental bilateral pulmonary embolism. Patient reports he was in his usual state of health when on ___ his foot slipped on the carpet of his stairs as he walked down the stairs. Patient states he fell backwards onto his back down 3 stairs. He states he did not hit his head and was able to protect his head as he was falling down. He endorses this was a mechanical fall and denies room spinning or passing out. He denies palpitations or chest pain. Patient went to urgent care on ___ due to pain associated with fall. He reports that due to findings on chest x ray (?fluid, ?hemothorax)he was sent to ___ where he underwent CT scan of head, chest abdomen. CT chest with contrast demonstrated right subsegmental and left main pulmonary emboli. He was transferred to ___ for management of possible hemothorax. Upon presentation to ___, patient was noted to have BPs in the 160s/70s with HRs in the ___ and satting high ___ on 2L NC (93% on RA). His exam was notable for crackles in the right base extending half way up the lung fields and large ecchymosis on the left flank. A second opinion read of the CT chest was requested and is still pending (per ___ -- "left PE in left main pulm art into segmental and subsegmental, on right a segmental PE. Density of effusion is simple and not c/w hemothorax"). Trauma surgery was also consulted who did not think this was consistent with hemothorax. A CXR showed moderately extensive left lower lobe infarction or atelectasis and small pleural effusion unchanged with new abnormality at the right lung base, which may represent atelectasis, developing infarction, or coincidental pneumonia. Labs were notable for Hgb 11.5, INR 1.2, proBNP 904, and trop < 0.01. He received IV morphine, acetaminophen, and oxycodone for pain. He was also started on a heparin gtt. Upon arrival to the floor, the patient describes above story. In regards to risk factors for PE, patient had left knee replacement in ___. He reports he took warfarin for 3 weeks after the surgery and that he has had some swelling of left leg attributed to surgical changes. He underwent colonoscopy ___ years ago when he had polyps. He states he is due for repeat colonoscopy. He denies recent air travel. He denies prior blood clots. REVIEW OF SYSTEMS: Endorses night sweat x 1 week ago, denies weight loss, denies nausea, denies vomiting, denies chest pain, denies shortness of breath, denies abdominal pain. Review of systems otherwise negative, except as reviewed above. Past Medical History: Hypertension Hyperlipidemia Post traumatic Stress disorder Osteoarthritis s/p left total knee replacement Cataract surgery bilaterally Deviated septum Obstructive sleep apnea not on home CPAP Social History: ___ Family History: Father died of MI in his ___ Mother with HCV from blood transfusion, died of complications No family history of PE or DVT. Multiple family members with cerebral aneurysms. Physical Exam: ADMISSION PHYSICAL EXAM: VITALS: ___ 1540 Temp: 97.4 PO BP: 169/80 R Sitting HR: 62 RR: 16 O2 sat: 97% O2 delivery: 2L Dyspnea: 0 RASS: 0 Pain Score: ___ General: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear, PERRL, neck supple, JVP 8cm, no LAD, bilateral supraclavicular fullness CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Rales on right side from lower lobe to middle back, left is clear to air; no wheezing Abdomen: Soft, non-tender, mildly distended, bowel sounds present, no organomegaly, no rebound or guarding Back: tenderness to palpation of left midline back, large bruise of left flank that is mildly indurate Ext: Warm, well perfused, Left leg slightly larger than right, has midline well healed incision over left patella Skin: Warm, dry, no rashes or notable lesions. Neuro: CNII-XII intact, ___ strength of bilateral biceps, triceps, hip flexion, hip extension, knee flexion, knee extension, plantarflexion, dorsiflexion DISCHARGE PHYSICAL EXAM: ___ 0000 Temp: 98.2 PO BP: 164/85 HR: 62 RR: 20 O2 sat: 97% O2 delivery: 2l General: Alert, oriented, appears his age, conversant, interactive, but very anxious CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Rales on right side from lower lobe to middle back, left is clear to air; no wheezing Abdomen: Soft, non-tender to light and deep palpation, mildly distended, bowel sounds present, no hepatosplenomegaly, no rebound or guarding Back: tenderness to palpation of left midline back, large bruise of left flank that is mildly indurated Ext: Warm, well perfused, left leg slightly more swollen than right with mild pitting edema, has midline well healed incision over left patella Skin: Warm, dry, no rashes or notable lesions Pertinent Results: ADMISSION LABS: ___ 02:56AM GLUCOSE-83 UREA N-15 CREAT-0.9 SODIUM-143 POTASSIUM-3.8 CHLORIDE-107 TOTAL CO2-24 ANION GAP-12 ___ 02:56AM cTropnT-<0.01 proBNP-904* ___ 02:56AM WBC-5.1 RBC-4.17* HGB-11.5* HCT-35.8* MCV-86 MCH-27.6 MCHC-32.1 RDW-14.8 RDWSD-46.4* ___ 02:56AM NEUTS-69.6 ___ MONOS-7.7 EOS-2.2 BASOS-0.6 IM ___ AbsNeut-3.54 AbsLymp-0.98* AbsMono-0.39 AbsEos-0.11 AbsBaso-0.03 ___ 02:56AM PLT COUNT-156 ___ 02:56AM ___ PTT-39.6* ___ IMAGING: CXR ___: FINDINGS: The large area of peripheral consolidation at the left lung base, accompanied by small left pleural effusion, comparable to the appearance on chest CTA ___, is in the area of greatest arterial thrombosis and could be a large pulmonary infarction. Peribronchial opacification at the right lung base is new. This could be atelectasis, early infarction, or even early pneumonia. Heart size may be slightly larger today than on the chest CTA but there is abundant mediastinal fat making at determination difficult. The upper lungs are clear and there is no pulmonary edema. No pneumothorax. IMPRESSION: Moderately extensive left lower lobe infarction or atelectasis and small pleural effusion unchanged. New abnormality at the right lung base could be atelectasis, developing infarction or coincidental pneumonia. Duplex ultrasound of lower extremities ___ FINDINGS: There is normal compressibility, flow, and augmentation of the bilateral common femoral, femoral, and popliteal veins. Normal color flow and compressibility are demonstrated in the posterior tibial and peroneal veins. There is normal respiratory variation in the common femoral veins bilaterally. There is a right popliteal ___ cyst which measures 1.9 x 1.2 x 1.1 cm. IMPRESSION: 1. No evidence of deep venous thrombosis in the right or left lower extremity veins. 2. 1.9 cm right popliteal ___ cyst. Transthoracic echo ___: The left atrial volume index is mildly increased. The right atrium is mildly enlarged. There is no evidence for an atrial septal defect by 2D/color Doppler. The estimated right atrial pressure is ___ mmHg. There is normal left ventricular wall thickness with a normal cavity size. There is suboptimal image quality to assess regional left ventricular function. There is no resting left ventricular outflow tract gradient. No ventricular septal defect is seen. Normal right ventricular cavity size with normal free wall motion. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. The aortic arch diameter is normal with a normal descending aorta diameter. There is no evidence for an aortic arch coarctation. The aortic valve leaflets (?#) appear structurally normal. There is no aortic valve stenosis. There is no aortic regurgitation. The mitral valve leaflets appear structurally normal with no mitral valve prolapse. There is trivial mitral regurgitation. The tricuspid valve leaflets appear structurally normal. There is physiologic tricuspid regurgitation. The pulmonary artery systolic pressure could not be estimated. There is a moderate loculated pericardial effusion. There are no 2D or Doppler echocardiographic evidence of tamponade. IMPRESSION: Suboptimal image quality. Moderate loculated, predominantly posterior pericardial effusion without echocardiographic evidence of tamponade. Normal biventricular cavity sizes, and global systolic function (cannot rule out regional wall motion abnormalities due to suboptimal image quality). No valvular pathology or pathologic flow identified. DISCHARGE LABS: ___ 04:52AM BLOOD WBC-5.3 RBC-3.95* Hgb-11.1* Hct-33.9* MCV-86 MCH-28.1 MCHC-32.7 RDW-14.7 RDWSD-46.3 Plt ___ ___ 04:52AM BLOOD Glucose-107* UreaN-14 Creat-0.9 Na-143 K-3.6 Cl-105 HCO3-25 AnGap-13 ___ 05:56AM BLOOD calTIBC-324 Ferritn-53 TRF-249 Brief Hospital Course: ___ is a ___ year old man with past medical history of HTN, HLD, PTSD who presented after fall and found to have rib fracture, submassive pulmonary embolism, pleural effusion and pericardial effusion. ACUTE ISSUES #Submassive Pulmonary Embolism Hemodynamically stable with no hypoxia, normotension, no tachycardia. Clot burden involved left main pulmonary artery and right subsegmental arteries on CT angiogram. EKG with no evidence of right heart strain, troponin negative though mildly elevated BNP to 900. Echo performed that did not demonstrate right heart strain, but was significant for moderate loculated pericardial effusion, discussed below. Patient managed with heparin initially and transitioned to rivaroxaban. #Loculated pericardial effusion Measured as 1.8 cm on ultrasound. No tamponade on exam. Cardiology consulted who felt given position and size it was not amenable to drainage. Pulsus paradoxus not elevated and with elevated systolic blood pressures. Unclear etiology, but could represent occult malignancy vs. post infectious. #Left pleural effusion Seen on CT at OSH with initial concern for hemothorax. Seen by thoracic surgery in the ED and radiology reviewed imaging with low suspicion for hemothorax. Patient with no hypoxemia while in house. Patient evaluated by interventional pulmonology, who did not tap effusion due to small size. #Rib fracture In setting of mechanical fall. Pain control managed with standing Tylenol and lidocaine patch. Oxycodone 5mg PO PRN severe pain. #Normocytic anemia #Thrombocytopenia Hgb 11.1 from 11.5. Iron studies within normal limits, though iron borderline low. Unclear etiology of mild anemia, though malignancy vs. other underlying inflammatory process is on the differential. CHRONIC ISSUES #Hypertension Continued home Lisinopril. #Hyperlipidemia Continued home simvastatin. #GERD Continued home pantoprazole. #PTSD Continued home buproprion, sertraline, lorazepam. TRANSITIONAL ISSUES: [ ] Patient being discharged on rivaroxaban with plan for possibly indefinite anticoagulation pending further workup of effusions, as this may be unprovoked [ ] Pulmonary embolism appears to be unprovoked given orthopedic surgery was 7 months ago; will need further workup as above and below [ ] Given fluid collections (pleural, pericardial) with Pulmonary embolism alongside symptoms of night sweats does warrant additional outpatient work up for occult cause (malignancy or otherwise), including colonoscopy [ ] Would recommend hematology/hypercoag workup if no occult provocation of PE found [ ] Patient being discharged with 12 tablets of oxycodone for pain associated with rib fracture, patient prescription history reviewed on ___ with no concerns [ ] Patient needs repeat echocardiogram (TTE) within one week to evaluate interval change of loculated pericardial effusion; should be scheduled via PCP at ___ [ ] Patient has an appointment to follow up with ___ clinic on ___ to evaluate for interval increase in pleural effusion. [ ] Discharge anti-coagulation: rivaroxaban 15mg BID for 21 days, then 20mg daily indefinitely [ ] Discharge Hgb: 11.1 #Code status: Full, Confirmed #Emergency Contact: Daughter ___, Nurse at ___, ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 20 mg PO DAILY 2. Simvastatin 20 mg PO QPM 3. LORazepam 1 mg PO BID 4. Sodium Chloride Nasal ___ SPRY NU QID:PRN nasal congestion 5. Zolpidem Tartrate 5 mg PO QHS 6. Sertraline 100 mg PO QHS 7. BuPROPion 150 mg PO BID 8. Sucralfate 1 gm PO BID 9. Pantoprazole 40 mg PO Q12H Discharge Medications: 1. Acetaminophen 650 mg PO Q6H RX *acetaminophen 650 mg 1 tablet(s) by mouth Every 6 hours Disp #*120 Tablet Refills:*0 2. Lidocaine 5% Patch 1 PTCH TD QPM RX *lidocaine [Lidocaine Pain Relief] 4 % Apply 1 patch for 12 hours daily Disp #*12 Patch Refills:*0 3. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Severe RX *oxycodone 5 mg 1 capsule(s) by mouth PRN Q8H Disp #*12 Capsule Refills:*0 4. Rivaroxaban 15 mg PO DAILY RX *rivaroxaban [Xarelto] 15 mg (42)- 20 mg (9) 1 tablets(s) by mouth Twice daily Disp #*1 Dose Pack Refills:*0 5. BuPROPion 150 mg PO BID 6. Lisinopril 20 mg PO DAILY 7. LORazepam 1 mg PO BID 8. Pantoprazole 40 mg PO Q12H 9. Sertraline 100 mg PO QHS 10. Simvastatin 20 mg PO QPM 11. Sodium Chloride Nasal ___ SPRY NU QID:PRN nasal congestion 12. Sucralfate 1 gm PO BID 13. Zolpidem Tartrate 5 mg PO QHS Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis Pulmonary embolism Pleural effusion Pericardial effusion Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___! Why was I admitted to the hospital? - You were admitted because you were found to have blood clots in your lungs What happened while I was in the hospital? - We treated your blood clots with a blood thinner - Tests of your legs did not show evidence of blood clot - You underwent imaging of your heart which demonstrated normal function, but did demonstrate some fluid around your heart - We continued your home medications - We treated the pain associated with your rib fracture What should I do now that I am leaving the hospital? - You should take the blood thinner medication rivaroxaban twice a day for the first 3 weeks; you will then take this medication daily - You should continue to take Tylenol for rib pain and oxycodone as needed for severe pain - Do not take zolpidem sleep aide if you require oxycodone for pain - You should continue to take your other medications as prescribed - Please continue to use the incentive spirometer to help with your breathing - Please make sure to go to your primary care appointment on ___ - You will need a repeat echocardiogram (ultrasound of the heart) in the next week; your primary care doctor should coordinate this - Please go to your appointment with the lung doctor on ___ at 1pm - If you have fevers, chills, chest pain, problems breathing, or generally feel unwell, please call your doctor or go to the emergency room Sincerely, Your ___ Treatment Team Followup Instructions: ___
19972355-DS-6
19,972,355
25,983,396
DS
6
2114-03-16 00:00:00
2114-03-27 15:35:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: s/p fall, back and chest wall pain Major Surgical or Invasive Procedure: none History of Present Illness: ___ sustained fall from approximately 10 feet from attic door today. Fell onto left side, no LOC, immediately complained of L-sided pain and was assisted by friend. Taken to OSH and films identified rib fractures and L2-L4 lumbar transverse process fractures; she was transferred to ___ for further management. On arrival to ___ ED she is complaining of left rib pain but otherwise denies complaints. Her husband accompanies her and states she appears to have normal speech and affect. On ROS she denies headache, visual changes, shortness of breath, weakness or numbness in the extremeties. Past Medical History: scoliosis, HTN, hypothyroidism, right piriformis syndrome (s/p steroid injection to R hip by PCP), IBS Social History: ___ ___ History: nc Physical Exam: O: T: 99 BP: 140/90 HR: 88 R 18 O2Sats 100 2L Gen: WD/WN, comfortable, NAD. HEENT: Pupils: PERRLA, EOMs intact b/l Neck: Supple. Lungs: CTA bilaterally. Cardiac: RRR. S1/S2. Chest: + chest wall tenderness to left side, + midline tenderness to L spine Abd: Soft, NT, BS+ Extrem: Warm and well-perfused. Neuro: CN2-12 intact, UEs and LEs ___ strength b/l, sensation equal and intact b/l, proprioception intact, cerebellar intact to finger-nose-finger Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Sensation: Intact to light touch, propioception, pinprick and vibration bilaterally. Reflexes: B T Br Pa Ac Right + + + + + Left + + + + + Propioception intact Toes downgoing bilaterally Pertinent Results: ___ 10:14PM PH-7.40 COMMENTS-GREEN TOP ___ 10:14PM GLUCOSE-122* LACTATE-1.4 NA+-143 K+-3.7 CL--106 TCO2-24 ___ 10:14PM freeCa-1.13 ___ 10:07PM UREA N-24* CREAT-0.7 ___ 10:07PM estGFR-Using this ___ 10:07PM LIPASE-39 ___ 10:07PM ASA-NEG ETHANOL-NEG ACETMNPHN-5* bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 10:07PM WBC-12.2* RBC-4.27 HGB-13.6 HCT-39.1 MCV-92 MCH-31.9 MCHC-34.9 RDW-12.5 ___ 10:07PM PLT COUNT-248 ___ 10:07PM ___ PTT-24.3* ___ ___ 10:07PM ___ CT Torso: 1. Anterolateral left 4, ___ acute rib fractures. 2. Left L2 and L3 transverse process fractures, better delineated on the same day lumbar spine CT scan. 3. 6mm cavitary nodule in the left upper lobe anterior segment with vague surrounding ground-glass opacity. Recommend ___ month followup. 4. Small bleb at the left lung with no evidence of pneumothorax. 5. Bilateral renal hypodensities, some of which are too small to characterize but likely representing renal cysts; the largest in the left interpolar region measures 16 mm. 6. Right kidney angiomyolipoma. Renal cysts. 7. Hepatic hypodensity within the left lobe of the liver is too small to characterize but statistically likely represents a simple cyst or hemangioma. MR C-spine: No evidence of ligamentous disruption seen but mild increased signal in the posterior soft tissues and interspinous ligaments indicate mild traumatic injury. No evidence of spinal cord compression or intrinsic spinal cord signal abnormalities or intraspinal hematoma seen. Mild multilevel degenerative changes noted. Brief Hospital Course: Pt was admitted to the ACS service for multiple rib fx/transverse process fractures. Her pain was well controlled, and neurosurgery was consulted for spine evaluation. An MRI of her C-spine revealed no evidence of acute pathology. Pt's pain was well controlled in house, and she remained stable, with good breath sounds b/l and O2 sats >95% throughout. Pt is comfortable on day of discharge. She was kept in a c-collar until cleared by neurosurgery on day of discharge. She will follow up with her primary care physician and in ___ clinic for follow-up of rib fractures. Medications on Admission: levoxyl 750mcg PO daily, Toprol XL 25mg PO daily, meloxicam 15mg PO daily, cymbalta 60mg PO daily, prempro 0.45/1.5mg PO daily, HCTZ 12.5mg PO daily Discharge Medications: levoxyl 750mcg PO daily, Toprol XL 25mg PO daily, meloxicam 15mg PO daily, cymbalta 60mg PO daily, prempro 0.45/1.5mg PO daily, HCTZ 12.5mg PO daily 1. oxycodone 5 mg Tablet Sig: ___ Tablets PO every ___ hours as needed for pain for 1 weeks. Disp:*40 Tablet(s)* Refills:*0* 2. acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q 8H (Every 8 Hours). 3. tramadol 50 mg Tablet Sig: One (1) Tablet PO QID (4 times a day) as needed for pain. Disp:*45 Tablet(s)* Refills:*0* Discharge Disposition: Home Discharge Diagnosis: L2-4 Left transverse process fractures, ___ and 5th rib fractures Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: It was a pleasure taking care of you here at ___ ___. You were admitted to the hospital here after having a fall, during which you fractured ribs and extensions of your vertebrae in your lumbar spine. We performed multiple imaging tests, and you were evaluated by our neurosurgeouns. You are now safe to return home. Please return to the ER if you have: * Your pain gets worse. *worsening cough *difficulty breathing *fever over ___ * You develop pain, numbness, tingling or weakness in your arms or legs. * You lose control of your bowels or urine ("passing water"). * Trouble walking. * Your pain is not getting better after 2 days. * Anything else that worries you. Followup Instructions: ___
19972371-DS-5
19,972,371
26,223,444
DS
5
2155-08-19 00:00:00
2155-08-22 23:41:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: hypotension, fever Major Surgical or Invasive Procedure: none History of Present Illness: HPI: Pt is a ___ Y F with a history of progressive, metastatic melanoma presents to the ER with acute encephalopathy , fever and hypotension. History is obtained via the ER physicians and the patient's husband. The patient was in her usual state of health until 2 days prior to admission when she attended an event with her husband; she felt fatigued and was warm to the touch. This progressed and the day of admission, she also was very fatigued, hot to thr touch, and difficult to aurouse. She was taken to the ER where initial vitals: 102.1 80 90/52 16 96% ra. She was treated for sepsis with Vancomycin, Cefepime, Hydrocortisone (for Hx of adrenal insufficiency), Tylenol, and 6L IVF. Her SBP fell to the ___ with a MAP in the ___ as she was being prepared to travel to the ICU. When the team informed the husband that she she would need to be intubated, have a line placed, and started on pressors, he stated that these decisions would not produce a quality of life that she would want. After husband's discussion with the ER resident and Attending the decision was made to have her be CMO. . ROS: unable to obtain secondary to encephalopathy.Per husabnd, had no complaints up to a few days prior to admission. Past Medical History: ONCOLOGIC HISTORY: 1980s melanoma that was excised from the right upper thigh, sentinel lymph nodes ___ negative ___ transvaginal ultrasound showed a 4.7 x 4 x 4.4 cm echogenic mass in the right external iliac chain, concerning for malignant adenopathy, enlarged on ___ ___, CT abdomen and pelvis reportedly showed two masses, one in the right lower pelvis, abutting the inferior vena cava and right common iliac vein measuring 3.6 cm in size; as well as a large lobular mixed heterogeneous mass measuring 3-4 cm in size in the lower pelvis. ___, ultrasound-guided biopsy revealed cells that were positive for S-100, MART-1, and HMB-45, most compatible with melanoma. ___ PET CT scan showed multiple hypermetabolic masses in the retroperitoneum, R iliac, and right pelvis also concerning for soft tissue/nodal metastases from melanoma. ___ MRA of the pelvis showed an extensive enlarged confluent adenopathy in the retroperitoneum ___, she underwent exploratory laparotomy with resection of right pelvic mass and exposure of retroperitoneal paracaval mass by Dr. ___. The surgery also involved resection of the distal inferior vena cava and proximal right and left common iliac vein with reconstruction ___ PET CT remaining sites of hypermetabolism at the right pericaval retroperitoneum with soft tissue mass measuring 2.8 cm in diameter. The left periaortic 1.5 cm diameter nodule was slightly decreased in size compared to previous. There were two subcentimeter nodular foci along the right common iliac nodal chain. There were no new suspicious pulmonary nodules. ___ MRI of the brain did not show any evidence of metastatic disease. ___: 3 doses of ipilimumab 3 mg/kg (200 mg dose) ___: received ___ Target Now results for patient's tested melanoma: BRAF mutant (V600E), c-Kit wild type; additional microarray data available in patient's paper chart ___: Hold any further doses of ipilimumab due to concern for pituitary hypophysitis. ___: Pituitary MRI: Partially empty sella turcica, unchanged since ___. No evidence of pituitary abnormality. No evidence of metastatic disease. ___: Torso CT: Multiple enlarged retroperitoneal lymph nodes. Iliac vein stents in place. No evidence of metastasis spreading beyond the noted lymphadenopathy, which per prior oncology progress notes, appears stable to slightly smaller in size. PAST MEDICAL HISTORY: 1. Status post open heart surgery for patent ductus arteriosus when she was ___ years old, done at ___, stable; she is not followed by a cardiologist 2. History of left knee pain 3. Hypertension 4. Status post IVC artificial graft on ___, with subsequent chronic warfarin use, stable. 5. Pituitary failure secondary to ipilimumab ___ Social History: ___ Family History: Mother had ___, Father had CVA Physical Exam: GEN: NAD, somnlent but will mildly arouse to voice. HEENT: conjunctivae clear, OP dry and without lesion NECK: Supple, no JVD CV: Reg rate and rhythm, no heaves. CHEST: Resp unlabored, no accessory muscle use. no wheezes or rhonchi. ABD: Soft, NT, ND, no HSM MSK: normal muscle tone and bulk EXT: No c/c/e, normal perfusion SKIN: No rash, warm skin NEURO: aurosable to voice at times but very somnlent PSYCH: comfortable . Pertinent Results: ___ 08:00PM URINE COLOR-Yellow APPEAR-Hazy SP ___ ___ 08:00PM URINE BLOOD-SM NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG ___ 08:00PM URINE RBC-0 WBC-<1 BACTERIA-MOD YEAST-NONE EPI-1 ___ 08:00PM URINE HYALINE-24* ___ 08:00PM URINE MUCOUS-RARE ___ 06:17PM LACTATE-0.9 ___ 06:00PM GLUCOSE-97 UREA N-42* CREAT-2.0* SODIUM-132* POTASSIUM-3.3 CHLORIDE-91* TOTAL CO2-22 ANION GAP-22* ___ 06:00PM estGFR-Using this ___ 06:00PM ALT(SGPT)-78* AST(SGOT)-109* LD(LDH)-1350* ALK PHOS-152* TOT BILI-1.2 ___ 06:00PM LIPASE-24 ___ 06:00PM ALBUMIN-4.0 CALCIUM-8.9 PHOSPHATE-3.9 MAGNESIUM-2.4 ___ 06:00PM WBC-19.7*# RBC-4.38 HGB-12.6 HCT-37.8 MCV-86 MCH-28.8 MCHC-33.4 RDW-14.1 ___ 06:00PM NEUTS-88.9* LYMPHS-5.0* MONOS-5.5 EOS-0.2 BASOS-0.3 ___ 06:00PM PLT COUNT-469* ___ 06:00PM ___ PTT-33.9 ___ . CXR ___: No evidence of acute disease. . Brief Hospital Course: . ___ yo woman with met melanoma s/p ipilimumab and currently on vemurafenib with mixed response presented to the ED unresponsive with fever and hypotension. . #MS changes: Pt was unresponsive on admission, however, the morning after admission pt awoke and was back to her baseline.MS changes likely due to infection/low blood pressure. . #Fever: Source unclear. CXR and u/a negative. Blood and urine cultures remained sterile. Pt completed empiric vancomycin and ___ hrs and was switched to oral cipro and augmentin.Pt remained afebrile and wbc trending down during hospital stay. . #Acute renal failure:Resolved with IVF.Likely pre-renal due to hypotension/dehydration. . #Hypotension: Likely due infection and hypoadrenalism.Pt was started on stress doses of hydrocortisone and which was decreased to 50 mg TID and then back prednisone 5 mg. HCTZ was discontinued and not restarted on discharge. Blood pressure was normotensive throughout hospital stay. . #Pan-hypopit.As above-stress doses of hydrocortisone. Outpt dose of levothyroxine was continued . TSH level wnl. . #H/O IVC artificial graft/chronic antocoagulation: INR therapeutic at 2.9 on admission . INR was followed daily and warfarin dosed based on INR. Lower dose of warfarin was need while pt on ciprofloxacin. . Medications on Admission: (per OMR) HYDROCHLOROTHIAZIDE - (Prescribed by Other Provider) - 25 mg Tablet - 1 Tablet(s) by mouth daily IPILIMUMAB [___] - (Prescribed by Other Provider) (On Hold from ___ to unknown for hypophysitis) - 200 mg/40 mL (5 mg/mL) Solution - 3mg/kg IV every 3 weeks LEVOTHYROXINE - 75 mcg Tablet - 1 tablet by mouth daily PREDNISONE - 5 mg Tablet - 1 Tablet(s) by mouth every morning VEMURAFENIB [___] - (On Hold from ___ to unknown for severe rash) - 240 mg Tablet - 5 Tablet(s) per day WARFARIN - (Prescribed by Other Provider) - 1 mg Tablet - 1 Tablet(s) by mouth daily as directed ; undergoing active adjustment; currently ___ per day . Medications - OTC CAMPHOR-MENTHOL [ANTI-ITCH] - 0.5 %-0.5 % Lotion - apply to affected area twice daily as needed for rash CETIRIZINE - 10 mg Tablet - 1 Tablet(s) by mouth daily as needed for allergy symptoms, itchy skin ; may cause drowsiness DIPHENHYDRAMINE HCL - 2 % Cream - apply to affected skin four times a day as needed for itchy skin . Discharge Medications: 1. levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. guaifenesin 100 mg/5 mL Syrup Sig: ___ MLs PO Q6H (every 6 hours) as needed for coughing. 3. ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 3 days. Disp:*6 Tablet(s)* Refills:*0* 4. warfarin 2 mg Tablet Sig: 1.5 Tablets PO Once Daily at 4 ___: dose needs to be adjusted based on INR. Follow-up INR on ___. 5. prednisone 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Discharge Disposition: Home Discharge Diagnosis: Hypotension Fever Acute renal failure Adrenal insufficiency Hypothyroidism Melanoma Chronic anticoagulation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms ___ , you presented to the emergency room with fever adn very low blood pressure. You were treated with IV fluids , IV antibiotics and stress doses of steroids.Blood and urine cultures remained without growth. You were evaluaetd by endocrinology adn transitioned back to your home dose of prednisone.You were also transitioned to oral antibiotics. Changes in medications: 1.Ciprofloxacin 500mg po bid x 3 days 2.Warfarin (coumadin) decreased to 3 mg daily 9 because of ciprofloxacin) until ___ morning and adjusments to be doen by coagulation clinic at ___. Ciprofloxacin can change. 3.Hydrochlorthiazide discontinued 4. If you are feeling weak and fatigued than usual you should contact Dr ___ as you may need to increase your prednisone dose. Followup Instructions: ___
19972786-DS-20
19,972,786
24,256,499
DS
20
2199-12-10 00:00:00
2199-12-10 15:49:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Lisinopril Attending: ___. Chief Complaint: Nausea Major Surgical or Invasive Procedure: None History of Present Illness: ___ hx HTN, HLD, DMII who presented with the chief complaint of continous nausea w/o vomiting for the past ___ days, unrelieved by tums. He has not had associated chest pain, abdominal pain, fevers, chills, diaphoresis. No dietary changes. His appetite remains good and he's eating as he usually does; even endorses feeling hungry during our interview.Patient also denies any changes in his bowel habit-- his last BM was yesterday morning and looked dark brown without any coating of blood. Endorses an associated sensation of bloating. No recent changes in meds. Hx of appendectomy. At the ED, his initial vitals were 98.6 65 161/53 18 96% RA. CXR w/o acute process and negative CT A/P with contast. EKG showed ~1mm ST elevation in V2. Cardiology was consulted and it was thought that his EKG was largely unchanged. ETT was performed, which showed ischemic EKG changes and poor exercise capacity. Trops were negative x 2. He was given ASA 325mg, Zofran, HCTZ, amlodipine, and metformin. On review of systems, he denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools. ROS as above. Cardiac review of systems is notable for absence of chest pain, dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, palpitations, syncope or presyncope. Past Medical History: HTN DM type 2 Dyslipidemia GERD Peripheral neuropathy h/o gout Colonic polyps Dizziness Social History: ___ Family History: Father and mother both passed away from an MI; mother was ___ and father was ___. Physical Exam: VS: Wt=72.8 kg T=97.9 BP=146/57 HR=69 RR=16 O2 sat= 97 RA General: well appearing gentleman who appears stated age; in no apparent distress. Laughing and joking through entire interview. HEENT: Sclerae are anicteric. Pupils are equal, round and reactive to light and accommodation. Oropharynx is clear. Neck: No JVP, no LAD Chest: Clear to auscultation bilaterally, though decreased breath sounds. No wheezes, rales or rhonchi. HEART: Regular rate and rhythm. ___ systolic murmur at the left upper sternal border ABDOMEN: Soft, nontender and nondistended. Normoactive bowel sounds. No hepatosplenomegaly. PULSES: 2+ radial and DP bilaterally Pertinent Results: ADMISSION LABS ___ 06:21PM BLOOD cTropnT-<0.01 ___ 12:05AM BLOOD cTropnT-<0.01 ___ 06:21PM BLOOD Lipase-97* ___ 06:21PM BLOOD ALT-18 AST-34 AlkPhos-65 TotBili-0.2 ___ 06:21PM BLOOD Glucose-106* UreaN-20 Creat-1.1 Na-136 K-4.6 Cl-98 HCO3-25 AnGap-18 ___ 06:21PM BLOOD Plt ___ ___ 06:21PM BLOOD Neuts-55.2 ___ Monos-5.4 Eos-1.7 Baso-0.7 ___ 06:21PM BLOOD WBC-5.6 RBC-3.88* Hgb-12.9* Hct-39.7* MCV-102* MCH-33.2* MCHC-32.5 RDW-12.9 Plt ___ DISCHARGE LABS ___ 06:30AM BLOOD Calcium-10.0 Phos-3.5 Mg-1.9 ___ 06:30AM BLOOD Glucose-100 UreaN-16 Creat-1.2 Na-135 K-4.5 Cl-99 HCO3-29 AnGap-12 ___ 06:30AM BLOOD Plt ___ ___ 06:30AM BLOOD WBC-4.6 RBC-4.02* Hgb-13.0* Hct-40.4 MCV-100* MCH-32.3* MCHC-32.2 RDW-13.7 Plt ___ STUDIES: ___ ETT TOTAL EXERCISE TIME: 4.5 % MAX HRT RATE ACHIEVED: 86 ST DEPRESSION: ISCHEMIC PEAK INTENSITY: 1MM ONSET: 4.5 MINUTES EX ___ RESOLUTION: 5 MINUTES REC 69 164/64 ___ INTERPRETATION: ___ history of hypertension, hyperlipidemia and diabetes was referred to evaluate an atypical chest pain. The patient completed 4 minutes and 34 seconds of a Gervino protocol representing a poor exercise tolerance for his age; approximately ___ METS. The exercise test was stopped due to fatigue. No chest, back, neck, or arm discomforts were reported during exercise. During recovery the patient reported the lower abdominal discomfort that prompted his initial emergency department evaluation. At peak exercise, 0.5-1mm horizontal ST-segment depression was noted inferiorly and in the lateral precordial leads. The rhythm was sinus with rare isolated ABPs and VPBs. The hemodynamic response to exercise was appropriate. IMPRESSION: Poor exercise tolerance in the setting of ischemic ECG changes and atypical symptoms. Appropriate hemodynamic response to exercise. ___ CXR FINDINGS: PA and lateral chest radiographs. There is no focal consolidation, pleural effusion, or pneumothorax. Subsegmental areas of atelectasis in the right lung base can be seen on CT Abdomen from same date. Eventration of the right hemidiaphragm and tortuosity of the thoracic aorta are unchanged from multiple priors. The heart size is top normal. IMPRESSION: No acute cardiopulmonary process. ___ CT ABDOMEN/PELVIS WITH CONTRAST CT ABDOMEN: The lung bases are clear. The heart is enlarged and there are dense coronary artery calcifications and aortic valve calcifications. The liver enhances homogeneously and there is no focal liver lesion. The hepatic and portal veins are patent. The gallbladder, pancreas, spleen, and adrenals are normal. The kidneys enhance symmetrically and excrete contrast without evidence of hydronephrosis or mass. No bowel obstruction or bowel wall thickening. There is no portacaval, mesenteric and retroperitoneal lymphadenopathy. There is no free air or free fluid. There are dense calcifications of the abdominal aorta and its major branches. CT PELVIS: The appendix is not visualized, but there are no secondary signs of inflammation. The colon, rectum, urinary bladder and prostate are normal. Soft tissue densities in the bilateral inguinal canals are stable from prior CT and likely represent undescended testes. There is no pelvic lymphadenopathy or free fluid. OSSEOUS STRUCTURES: There is no lytic or blastic lesion worrisome for malignancy. IMPRESSION: No acute CT findings to explain patient's abdominal pain. Brief Hospital Course: ___ gentleman with history of T2DM, hypertension and hyperlipidemia who presented to ED for persistent nausea, which resolved after receiving IV Zofran. given the posibility that his nausea may have been an anginal equivalent, after detecting a ___epression in V2, the patient underwent a stress test that elicited ischemic changes in his inferolateral leads. His overall problems during this hospitalization were managed as follows: #Nausea: there was initial concern for abdominal source v. anginal equivalent. Pt had a negative CT, negative UA, and lack of fevers ruling out infectious abdominal/urinary source. Despite the coronary artery disease detected by his stress test, his nausea did not seem to be an anginal equivalent given that he denied experiencing this sx with exertion previously, and did not even have recurrence during the stress test (it resolved with zofran prior to ETT). Before discharge, patient has been started on pantoprazole, since he endorsed a previous history of ulcerative disease treated with maalox and symptoms of reflux after eating large meals. #Coronary artery disease: +ETT, with decreased exercise capacity and ischemic changes. Patient opted to pursue optimized medical therapy over cardiac catheterization. His 325 mg of aspirin was changed to 81 mg, his 20 mg simvastatin was switched to 80 mg atorvastatin, his amlodipine was discontinued and 25 mg metoprolol succinate was started. #Macrocytic anemia: Pt is asymptomatic (no SOB, CP, palpitations, fatigue). Not on any medications that would cause macrocytosis and he does not have known liver dz. This may have developed ___ nutritional deficiency. CHRONIC MEDICAL PROBLEMS #Type 2 DM - last A1C this ___ is 6.3; patient continued to take metformin. #Hypertension - adequately controlled on home regimen. However, given likely CAD with positive stress test, amlodipine was discontinued for beta-blockade with metoprolol. #Hyperlipidemia - Last lipid panel of Cholest Triglyc HDL CHOL/HD LDLcalc 182 ___. Simvastatin 20 changed to atorvastatin 80 TRANSITIONAL ISSUES -check folate and thiamine -monitor blood pressure control during next PCP visit Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Amlodipine 10 mg PO DAILY 3. Aspirin 325 mg PO DAILY 4. Hydrochlorothiazide 12.5 mg PO DAILY 5. MetFORMIN (Glucophage) 500 mg PO BID 6. Simvastatin 20 mg PO DAILY 7. Simethicone 120 mg PO QID:PRN gas Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY RX *aspirin [Adult Low Dose Aspirin] 81 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 3. Hydrochlorothiazide 12.5 mg PO DAILY 4. MetFORMIN (Glucophage) 500 mg PO BID 5. Simethicone 120 mg PO QID:PRN gas 6. Atorvastatin 80 mg PO DAILY RX *atorvastatin 80 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 7. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 8. Metoprolol Succinate XL 25 mg PO DAILY RX *metoprolol succinate 25 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Coronary artery disease Nausea, resolved HTN HLD T2DM (last A1C of 6.3) Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure to provide you with care during your stay at ___. You came to the hospital after you had several days of nausea, which we treated with a medication called zofran; we also started a medication that will reduce your stomach acid. To make sure there was no infectious disease, you had imaging and blood work that was very reassuring. Since some patients will complain of nausea when they have heart disease, you also had a stress test of your heart. This revealed that you likely have some blockages of the arteries of your heart. We talked about the possibility of either cardiac catheterization (w/ possible stenting) to treat you or medical optimization. You ultimately chose to be on medication only treatment. Please take your medications as prescribed and follow-up with your primary care doctor and cardiologist. We wish you the best, Your team at ___ Followup Instructions: ___
19972786-DS-21
19,972,786
29,611,193
DS
21
2200-02-17 00:00:00
2200-02-18 14:08:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Lisinopril Attending: ___ Chief Complaint: 1.) Abdominal Pain 2.) Shortness of breath Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ with a hx of HTN, HLD, T2DM who presents with acute onset of abdominal pain. He says the pain started last night without any inciting factor. It is a ___, burning, non-radiating pain in his left lower quadrant that is intermittent. He is unsure of what inciting or alleviating factors are - he does not believe it is related to eating although he has been eating little due to the pain. He took Maalox to no effect. He had a normal bowel movment this morning with no bright red blood or dark stool. He has not taken any medications for his symptoms and denies ever having this pain before. His only other abdominal history includes an appendectomy several years ago. Additionally he endorses shortness of breath during exertion for the last ___ days. Has cough productive of sputum. Denies leg swelling, or chest pain. No f/c/n/v, headaches, dysphagia, melena, diarrhea, constipation, BRBPR, joint pain, dysuria, changes in his diet. Of note, he was admitted ___ for nausea during which time a workup included poor exercise tolerance in the setting of ischemic EKG on ETT, neg CT abd pelvis. A cardiology consult at that time did not attribute his nausea to angina. He was discharged on pantoprazole, aspirin reduce to 81mg, 20mg simvastatin increased to 80mg atorvastatin, and amlodipine changed to 25mg metoprolol. In the ED, initial vitals: T 98.5 HR 81 BP 164/85 RR 14 O2Sat 99% 2L NC Vitals prior to transfer: HR 75 BP 153/70 RR 16 O2 98%RA At time of admission, patient is resting comfortably and has no pain. Is hungry and asking to eat a sandwich. Has no complaints. Past Medical History: HTN DM type 2 Dyslipidemia GERD Peripheral neuropathy h/o gout Colonic polyps Dizziness Social History: ___ Family History: Father and mother both passed away from an MI; mother was ___ and father was ___. Physical Exam: ADMISSION PHYSICAL: Vitals- 97.8 150/70 75 20 97% RA General- Alert, oriented, no acute distress HEENT- Sclerae anicteric, MMM, oropharynx clear. Has dentures Neck- supple, JVP elevated, no LAD, no thyromegaly Lungs- CTAB no wheezes, rales, rhonchi CV- RRR, Nl S1, S2, No MRG. Tachypneic when lying flat. Abdomen- soft, NT/ND bowel sounds present, no rebound tenderness or guarding, no organomegaly. Healed surgical scar in RLQ GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, motor function grossly normal DRE - soft stool in rectal vault - no gross blood noticeable. No palpable masses. LABS: See below. Significant for ___ 126 ALT 93 AST 105 proBNP 4744 (no prior baseline value). Guiac negative. DISCHARGE PHYSICAL: Vitals: 98.3 136/63 68 18 95%RA I/O: Since MN ___ 24HR 1200/1700 Wgt 70.5 kg GENERAL - Laying in bed in NAD. Alert and interactive. HEENT - PERRLA, EOMI, sclerae anicteric, MMM, OP clear, JVP not elevated HEART - RRR, nl S1-S2, no MRG LUNGS - CTAB ABDOMEN - NABS, soft/NT/ND, no masses or HSM EXTREMITIES - WWP, no c/c, trace edema, 2+ peripheral pulses NEURO - awake, A&Ox3, CNs II-XII grossly intact Pertinent Results: ADMISSION LABS AND IMAGING: ___ 08:50AM WBC-4.2 RBC-3.82* HGB-12.2* HCT-36.7* MCV-96 MCH-32.0 MCHC-33.3 RDW-14.3 ___ 08:50AM NEUTS-73.8* LYMPHS-16.2* MONOS-6.7 EOS-2.7 BASOS-0.7 ___ 08:50AM ALBUMIN-4.3 ___ 08:50AM proBNP-4744* ___ 08:50AM ALT(SGPT)-93* AST(SGOT)-105* ALK PHOS-101 TOT BILI-0.5 ___ 08:50AM LIPASE-25 ___ 08:50AM GLUCOSE-153* UREA N-14 CREAT-1.0 SODIUM-127* POTASSIUM-4.3 CHLORIDE-91* TOTAL CO2-23 ANION GAP-17 ___ 09:03AM LACTATE-1.8 ___ 10:10AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 10:10AM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 01:55PM cTropnT-<0.01 ___ 01:55PM GLUCOSE-119* UREA N-12 CREAT-0.9 SODIUM-126* POTASSIUM-4.9 CHLORIDE-93* TOTAL CO2-23 ANION GAP-15 DISCHARGE LABS: ___ 07:55AM BLOOD WBC-4.3 RBC-3.99* Hgb-12.9* Hct-39.0* MCV-98 MCH-32.2* MCHC-33.0 RDW-14.3 Plt ___ ___ 07:55AM BLOOD Glucose-102* UreaN-14 Creat-1.1 ___ K-4.6 Cl-96 HCO3-27 AnGap-15 ___ 07:55AM BLOOD Calcium-9.7 Phos-3.5 Mg-1.9 IMAGING: ___ ECHO (TTE): The left atrium is mildly dilated. There is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>55%). Doppler parameters are indeterminate for left ventricular diastolic function. There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Mild (1+) mitral regurgitation is seen. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. There is an anterior space which most likely represents a prominent fat pad. ___ Chest Pa Lat: Moderate cardiomegaly with mild pulmonary edema, small bilateral pleural effusions, and bibasilar atelectasis. ___ CT Abd Pelvis: Small bilateral pleural effusions with mild pulmonary edema, new from ___. New mild stranding and fluid along the second portion of the duodenum and anterior right pararenal space is non-specific but could represent duodenitis. Pancreatitis is unlikely given the normal lipase value. No small bowel obstruction or mesenteric ischemia. Severe atherosclerosis. Brief Hospital Course: Mr. ___ is a ___ with a hx of HTN, HLD, T2DM who presented with acute onset of abdominal pain of one day and shortness of breath for ___ days. Upon admission his abdominal pain quickly resolved with administration of a PPI and sucralfate - his pain was most likely to indigestion and gas. His shortness of breath was concerning for congestive heart failure given his medical history as well as findings on chest x-ray concerning for pulmonary edema and pleural effusions. He was evaluated while in patient and was found to have LVH, mild atrial and mitral regurgitation on ECHO. #Congestive heart failure, preserved ejection fraction, new diagnosis / acute exacerbation: Reported a ___ day history of shortness of breath with cough productive of sputum. Has no other signs, symptoms of acute process such as f/c/n/v or elevated WBC. CXR is remarkable for bilateral pleural effusions and pulmonary edema. Given his history of HTN it is most likely that this shortness of breath is due to congestive heart failure. An ECHO revealed that mild symmetric left ventricular hypertrophy with preserved global and regional biventricular systolic function, mild aortic regurgitation, and mild mitral regurgitation. He was diuresed with IV furosemide, then transitioned to a stable oral regimen. #Electrolyte Abnormalities: Mr. ___ at admission was 126 and he was asymptomatic. His hyponatremia most likely due HCTZ and hypervolemic hyponatremia due to CHF and CKD. We held his hydrochlorothiazide which can worsen hyponatremia and intitiated losartan instead. On Day 1 of his hospitalization, his K continued to trend upwards so he was diuresed with the intention of both addressing his hyperkalemia and hyponatremia. His hyperkalemia resolved, and had improved hyponatremia. #Abdominal pain: Acute onset abdominal pain with no other associated symptoms such as nausea, vomiting, diarrhea, BRBPR, or melena. Notable findings are elevated AST/ALT and potential duodenitis on CT. It is unlikely that his pain is due to small bowel obstruction, pancreatitis, AAA, or mesenteric ischemia. Given duodenitis found on CT ordered H.Pylori stool antigen but he was unable to produce a sample before discharge. Ultimately, he was treated for gas and indigestion with double doses of his home pantoprazole, sucralfate, and simethicone. Overall, he had good oral intake and bowel movements without issue. CHRONIC ISSUES #HTN - Held HCTZ (see above) and initiated losartan. Also continued him on his home metoprolol. #T2DM - Held metformin while inpatient, maintained SSI. #CKD - Cr is 0.9, baseline for patient. #Hypercholesterolemia - Held home atorvastatin given elevated LFTs, changed to pravastatin upon discharge. #Gout - Continued home allopurinol. TRANSITIONAL ISSUES - Will potentially follow-up with cardiologist (Dr. ___ ___ given CHF symptomology this hospitalization. - Follow-up with PCP (Dr. ___ - Recommend outpatient H. pylori stool study given finding of duodenitis on CT scan. - Daily weights Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Atorvastatin 80 mg PO DAILY 3. Hydrochlorothiazide 12.5 mg PO DAILY 4. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 5. Metoprolol Succinate XL 25 mg PO DAILY 6. Pantoprazole 40 mg PO Q24H 7. Aspirin 81 mg PO DAILY 8. Simethicone 166 mg PO QID:PRN gas Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Metoprolol Succinate XL 25 mg PO DAILY 4. Pantoprazole 40 mg PO Q24H 5. Simethicone 166 mg PO QID:PRN gas 6. Losartan Potassium 25 mg PO DAILY RX *losartan 25 mg 1 tablet(s) by mouth DAILY Disp #*30 Tablet Refills:*0 7. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 8. Furosemide 10 mg PO DAILY RX *furosemide 20 mg 0.5 (One half) tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 9. Pravastatin 40 mg PO DAILY RX *pravastatin 40 mg 1 tablet(s) by mouth DAILY Disp #*30 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ ___: PRIMARY: - Congestive Heart Failure with preserved ejection fraction, with acute exacerbation SECONDARY: - Abdominal pain / Duodenitis - Abnormal liver function tests Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, Thank you for choosing ___ for your care. You were admitted for abdominal pain of one day and shortness of breath that you were experiencing for several days. In terms of your abdominal pain, your labs and tests indicated that you had a mild duodenitis (inflammation of a part of your bowel). Your pain resolved quickly after admission and we concluded given how you presented that it was most likely due to indigestion and gas. We provided you with pantoprazole (a medication you were already taking at home), sucralfate, and simethicone. Your abdominal pain improved. In terms of your shortness of breath, this is most likely due to a condition called congestive heart failure. Your blood tests and an ultrasound of your heart showed that you have mild dysfunction of two valves in your heart and thickening of the wall of your heart, which are contributing to congestive heart failure. You will need close follow-up with a cardiologist to address your symptoms of congestive heart failure and your ECHO findings. You should weigh yourself every day and if your weight increases by more than 3lbs in one day, contact your PCP. It was a pleasure to be a part of your care. We wish you the very best. Sincerely, Your ___ Team Followup Instructions: ___
19972786-DS-22
19,972,786
27,486,130
DS
22
2200-05-16 00:00:00
2200-05-17 20:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Lisinopril Attending: ___. Chief Complaint: chest pain Major Surgical or Invasive Procedure: cardiac catheterization ___ History of Present Illness: ___ with pmhx of HTN, DM, HL and presents with 4 days of exertional shortness of breath. Patient reports that he has also had epigastric discomfort radiating from his abdomen up through his chest with associated belching. He is presenting today because he is having difficulty sleeping due to the aforementioned symptoms and that they have not improved and SOB is worse with lying down. The patient has been evaluated in the past for chest pain most recently with a stress test that was abnormal. Since that time has been followed by cardiology. He saw them most recently 2 days ago where her these results were discussed and the patient preferred not to have a cardiac catheterization, however, his cardiologist indicated that this may be an option of the road if he again had chest pain. She denies any fever, chills, bowel or bladder changes. In the ED initial vitals were: 97.4 65 165/78 16 99% ra - Labs were significant for Na 131, trop <0.01 - Patient was given On the floor, patient continued to have worsening SOB with lying down as well as mild abdominal pain Review of Systems: (+) per HPI (-) fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. Past Medical History: HTN DM type 2 Dyslipidemia GERD Peripheral neuropathy h/o gout Colonic polyps Dizziness Social History: ___ Family History: Father and mother both passed away from an MI; mother was ___ and father was ___. Physical Exam: ADMISSION PHYSICAL EXAM: ======================== Vitals - T:98.2 BP:165/82 HR:75 RR:18 02 sat:96/RA GENERAL: NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM, good dentition NECK: nontender supple neck, no LAD, mild JVD elevation to about 9cm CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG:mild bibasilar crackles ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: trace edema b/l NEURO: AOx3 SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM: ======================== Vitals - 98.5 124/55-144/70 50-63 16 100% RA Weight: 68.7 kg (69.5 kg ___ GENERAL: NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM, good dentition NECK: nontender supple neck, no LAD, no JVD CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: TAB ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: trace edema b/l. ___ with 2+ ___ NEURO: AOx3 SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: ADMISSION LABS: =============== ___ 03:40AM BLOOD WBC-3.7* RBC-3.78* Hgb-12.5* Hct-36.5* MCV-97 MCH-33.1* MCHC-34.2 RDW-15.1 Plt ___ ___ 09:34AM BLOOD ___ PTT-33.2 ___ ___ 03:40AM BLOOD Glucose-124* UreaN-23* Creat-1.1 Na-131* K-4.3 Cl-97 HCO3-25 AnGap-13 ___ 03:00PM BLOOD ALT-95* AST-79* AlkPhos-82 TotBili-0.7 ___ 05:43PM BLOOD Calcium-9.9 Phos-3.5 Mg-1.8 CARDIAC LABS: ============= ___ 03:40AM BLOOD proBNP-9240* ___ 03:40AM BLOOD cTropnT-<0.01 ___ 06:00AM BLOOD CK-MB-4 cTropnT-<0.01 ___ 06:30AM BLOOD CK-MB-3 cTropnT-0.01 IMAGING/STUDIES: ================ ___ Cardiac Cath: Coronary angiography: right dominant LMCA: 60% smooth distal left main LAD: The LAD had an 80% stenosis in the mid portion with post-stenotic aneurysmal dilation. The mid LAD was 100% occluded (filled by right to left collaterals). A large diagonal branch arose just distal to the stenosis and was a medium-large vessel without additional significant disease. LCX: The LCX was a large vessel with a 60-70% stenosis in its proximal portion. The LCX terminated in a large posterolateral branch. RCA: The RCA was tortuous and had a 40% stenosis in the mid segment. The distal RCA had a 80-90% stenosis prior to a large PDA. The RCA gave prominent collaterals to the LAD - which appeared to be a diffusely diseased vessel. Interventional details The patient presented with angina and an early positive stress test for hypotension after 2.5 mins exercise. Given the three vessel coronary artery disease with total occlusion of the LAD and focal stenoses in the RCA and LCx - the patient will be evaluated for CABG. Assessment & Recommendations 1.Three vessel coronary artery disease 2.Consideration for CABG ___ CXR: No acute cardiopulmonary process. Chronic changes of pleural thickening at the bilateral lung bases and moderate cardiomegaly. DISCHARGE LABS: =============== ___ 06:00AM BLOOD WBC-3.7* RBC-4.01* Hgb-13.2* Hct-39.2* MCV-98 MCH-32.8* MCHC-33.6 RDW-15.3 Plt ___ ___ 06:00AM BLOOD ___ PTT-32.8 ___ ___ 06:30AM BLOOD Glucose-107* UreaN-18 Creat-1.1 Na-132* K-4.3 Cl-97 HCO3-26 AnGap-13 ___ 06:30AM BLOOD ALT-63* AST-36 AlkPhos-71 TotBili-0.6 ___ 06:30AM BLOOD Calcium-9.4 Phos-3.7 Mg-2.0 ___ 03:00PM BLOOD %HbA1c-6.4* eAG-137* Brief Hospital Course: ___ with pmhx of HTN, DM, HL and presents with 4 days of exertional shortness of breath, found to have multivessel disease on cath as well as acute diastolic CHF exacerbation. Patient was discharged with plan for return on ___ for CABG. ACTIVE MEDICAL ISSUES: # Unstable Angina: CAD previously stable on medical therapy. Patient now presented with CP and cath showed mutivessel disease. Troponins negative. His lesions were felt to be too high risk and not amenable to stent placement. Patient was evaluated for CABG while in-patient. Patient was scheduled to return to the ___ Lobby at 6 AM on ___. Patient was continued on aspirin, metoprolol and losartan. Home atorvastatin was increased to 80mg daily from 40mg daily. #acute diastolic CHF exacerbation: Patient presented with worsening SOB and elevated BNP. Presentation most likely due to CHF exacerbation, possibly secondary to ischemia. He was gently diuresed with improvement in symptoms and discharged on home lasix. #HTN: continued metoprolol and losartan #transaminitis: Patient presented with mildly elevated LFTs at AST 79, ALT 63. They were felt to be possibly related to CHF exacerbation and downtrended during hospitalization with diuresis. CHRONIC MEDICAL ISSUES: #DM: held home metformin and maintained on sliding scale during hospitalization #HL: increased atorvastatin to 80mg daily #GERD: continued ranitidine, pantoprazole #Gout: continued allopurinol TRANSITIONAL ISSUES: -CABG plan: Patient instructed to return to ___ Lobby at 6 AM on ___ for CABG. -home atorvastatin increased to 80mg daily -discharged on furosemide 10 daily. -discharge weight: 98.7 kg Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Losartan Potassium 25 mg PO DAILY 2. Simethicone 166 mg PO QID:PRN gas 3. Allopurinol ___ mg PO DAILY 4. Metoprolol Succinate XL 25 mg PO DAILY 5. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 6. Ranitidine 150 mg PO BID 7. Atorvastatin 40 mg PO QPM 8. Furosemide 10 mg PO DAILY 9. Pantoprazole 40 mg PO Q24H 10. Aspirin 81 mg PO DAILY Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet Refills:*0 4. Pantoprazole 40 mg PO Q24H 5. Ranitidine 150 mg PO BID 6. Simethicone 166 mg PO QID:PRN gas 7. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 8. Losartan Potassium 25 mg PO DAILY 9. Metoprolol Succinate XL 25 mg PO DAILY 10. Furosemide 10 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: Unstable angina Coronary Artery Disease acute diastolic congestive heart failure Secondary: hypertension diabetes GERD hyperlipidemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to ___ with chest pain and shortness of breath. You were found to have obstructions in the vessels around you heart that could not be fixed with stents. You were evaluated by our surgeons who recommended bypass surgery, which has been scheduled for ___. Please plan to arrive at the ___ Lobby at 6 AM on ___. While you were in the hospital, you also had a little fluid buildup in your lungs. This responded well to IV medication. You should continue taking your home Lasix 10 mg daily. We have increased the dose of your atorvastatin from 40 mg to 80 mg. You should continue to take your other medications as prescribed and follow up with your doctors as directed. Please weigh yourself daily and call your doctor if you gain more than 3 pounds. It has been a pleasure taking care of you and we wish you all the best, Your ___ Care Team Followup Instructions: ___
19972786-DS-26
19,972,786
25,671,888
DS
26
2201-02-16 00:00:00
2201-02-28 10:11:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Lisinopril Attending: ___. Chief Complaint: Shortness of breath, nausea Major Surgical or Invasive Procedure: Right heart catheterization. History of Present Illness: Mr. ___ is a ___ yo gentleman with CAD s/p CABG, global systolic dysfunction, HTN, HLD, CKD, DMII who presents with shortness of breath and abdominal pain. Patient has had 3 days of abdominal discomfort and nausea improved with eating but associated cough w/ white sputum, SOB and bilateral ___ swelling. No orthopnea, PND, CP, palpitations, fever, emesis, diarrhea,sick contacts, ___ pain, N/V, or dysuria. In the ED initial vitals were: ___, 90, 167/90, 16, 99% RA EKG: None Labs/studies notable for: BNP 13452, Na 129, Cr 1.3, WBC 3.7, Hgb 10.8 Social History: ___ Family History: Premature coronary artery disease- Father and mother both passed away from an MI; mother was ___ and father was ___. Physical Exam: Admission: GENERAL: Well appearing male in NAD HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple. CARDIAC: RRR, normal S1, S2. Soft systolic murmur (II/VI) in RLSB. No rubs/gallops. No thrills, lifts. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No TTP/rebound/guarding. EXTREMITIES: 2+ pedal edema. No clubbing or cyanosis. Moving all extremities. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Distal pulses palpable and symmetric Neuro: AOX3, CNII-XII intact Discharge PHysical Exam: VS: 98.1 123/63 57 18 100%RA I/O: 300+/750 (spent much of yesterday off floor at RHC) Wt 61.6 Dry weight: on last discharge weighed 66kg. GENERAL: Thin, slightly wasted-looking male in NAD; HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple. JVP: 3cm above clavicle @ 30degrees CARDIAC: RRR, normal S1, S2. systolic murmur (II/VI) in RLSB. No rubs/gallops. No thrills, lifts. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No TTP/rebound/guarding. EXTREMITIES: No ___ today. No clubbing or cyanosis. Moving all extremities. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Distal pulses palpable and symmetric Neuro: AOX3 Pertinent Results: Admission Labs: ============ ___ 01:02PM GLUCOSE-140* UREA N-17 CREAT-1.1 SODIUM-129* POTASSIUM-4.0 CHLORIDE-93* TOTAL CO2-26 ANION GAP-14 ___ 01:02PM CALCIUM-9.5 PHOSPHATE-3.5 MAGNESIUM-1.7 ___ 05:00AM LACTATE-1.1 ___ 01:02PM cTropnT-0.01 ___ 02:42AM cTropnT-<0.01 ___ 04:50AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG ___ 04:50AM URINE RBC-<1 WBC-<1 BACTERIA-NONE YEAST-NONE EPI-<1 ___ 04:50AM URINE HYALINE-1* ___ 04:50AM URINE MUCOUS-RARE ___ 02:42AM GLUCOSE-104* UREA N-19 CREAT-1.3* SODIUM-129* POTASSIUM-5.0 CHLORIDE-93* TOTAL CO2-25 ANION GAP-16 ___ 02:42AM ALT(SGPT)-58* AST(SGOT)-60* ALK PHOS-122 TOT BILI-0.4 ___ 02:42AM LIPASE-33 ___ 02:42AM ___ ___ 02:42AM ALBUMIN-3.9 ___ 02:42AM WBC-3.7* RBC-3.36* HGB-10.8* HCT-31.4* MCV-94 MCH-32.1* MCHC-34.4 RDW-13.2 RDWSD-45.6 ___ 02:42AM NEUTS-55.7 ___ MONOS-9.7 EOS-3.2 BASOS-1.4* IM ___ AbsNeut-2.06 AbsLymp-1.10* AbsMono-0.36 AbsEos-0.12 AbsBaso-0.05 Discharge Labs: ============ ___ 07:30AM BLOOD WBC-4.4 RBC-3.81* Hgb-12.0* Hct-35.5* MCV-93 MCH-31.5 MCHC-33.8 RDW-13.2 RDWSD-44.6 Plt ___ ___ 07:30AM BLOOD Plt ___ ___ 07:30AM BLOOD Glucose-105* UreaN-20 Creat-1.1 Na-132* K-4.8 Cl-97 HCO3-26 AnGap-14 ___:35AM BLOOD ALT-37 AST-38 AlkPhos-76 TotBili-0.6 ___ 07:30AM BLOOD Calcium-10.2 Phos-3.5 Mg-2.0 Studies: ======= CXR: ___ FINDINGS: MILD TO MODERATE CARDIOMEGALY AND PULMONARY VASCULAR CONGESTION ARE CHRONIC. THERE IS NO GOOD EVIDENCE FOR PULMONARY EDEMA LEFT PLEURAL THICKENING AND ASSOCIATED LOWER LOBE ATELECTASIS ARE LONG-STANDING. SMALL RIGHT PLEURAL EFFUSION HAS RECURRED. NO PNEUMOTHORAX. IMPRESSION: 1. PERSISTENT LEFT LOWER LOBE ATELECTASIS ASSOCIATED WITH CHRONIC LEFT PLEURAL SCARRING. 2. Pulmonary vascular congestion AND MILD TO MODERATE CARDIOMEGALY OR CHRONIC. ALTHOUGH THERE IS RECURRENT SMALL RIGHT PLEURAL EFFUSION THERE IS NO PULMONARY EDEMA. Right Heart Catheterization ___: High normal filling pressures, CI of 2.17, pulmonary HTN See full report for details. Brief Hospital Course: Mr. ___ is a ___ yo gentleman with CAD s/p CABG, global systolic dysfunction, HTN, HLD, CKD, DMII who presents with shortness of breath, nausea and dyspepsia. Admitted for heart failure. #Acute on chronic systolic heart failure exacerbation Most likely due to medication non-compliance - Diuresed to euvolemia; right heart cath prior to admission showed RA mean 3; Wedge 10; mean PA pressure mid ___. Discharged on 20mg PO torsemide. #Hyponatremia: Somewhat hyponatremic at baseline; likely hypervolemic hyponatremia in setting of heart failure; this improved with diuresis. #Indigestion and belching Patient has had long-standing complaint of indigestion and belching which improves with eating. Reports that he still has good PO intake; no vomiting, diarrhea, or constipation. Discomfort is attributed in part to abdominal congestion due to CHF. Responds to famotidine and tums. Consider outpatient GI work-up if symptoms persist even once euvolemic. #Hypertension: Patient hypertensive on admission, but has low pressures on home antihypertensives (Hydralazine 25mg PO bid, Imdur 30 qday, Amlodipine 2.5mg qday). Most likely a problem of medication compliance. #CAD: continue ASA 81mg, Atorvastatin 80, Metoprolol # DM: written for insulin sliding scale, but had no elevated blood sugars. #Gout: Allopurinol ___ mg PO DAILY Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Metoprolol Succinate XL 25 mg PO DAILY 5. HydrALAzine 25 mg PO BID 6. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 7. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 8. Vitamin D 50,000 UNIT PO DAILY 9. Furosemide 10 mg PO DAILY Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. HydrALAzine 25 mg PO BID 5. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 6. Metoprolol Succinate XL 25 mg PO DAILY 7. Vitamin D 50,000 UNIT PO DAILY 8. Famotidine 20 mg PO Q24H RX *famotidine 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 9. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 10. Torsemide 10 mg PO DAILY RX *torsemide 10 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Acute on chronic systolic heart failure Hyponatremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, You were admitted to the hospital for heart failure. We gave you IV lasix and your symptoms of cough and shortness of breath and some of your nausea improved. You were also treated for indigestion. We have prescribed famotidine for your stomach symptoms. If you continue to have stomach symptoms we recommend that you follow up with your primary care provider or ___ gastroenterologist. You were started on a new medications called torsemide. You will take this instead of your Lasix (furosemide). All of your medications are detailed in your discharge medication list. You should review this carefully and take it with you to any follow up appointments. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Your dry weight (last weight here in the hospital) is 61.6 kg ( The details of your follow up appointments are given below. It was a pleasure taking care of you. Sincerely, Your ___ Cardiology Team Followup Instructions: ___
19972786-DS-27
19,972,786
29,171,452
DS
27
2201-02-25 00:00:00
2201-02-28 10:25:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Lisinopril Attending: ___. Chief Complaint: Nausea, Shortness of breath Major Surgical or Invasive Procedure: Cardiac Cath. History of Present Illness: Mr. ___ is a ___ yo gentleman with CAD s/p CABG, global systolic dysfunction, HTN, HLD, CKD, DMII who presents with shortness of breath and abdominal pain. He was recently admitted for CHF exacerbation with similar symptoms. He was discharged ___ (4 days ago) and went home feeling ok, though with persistent nausea and belching which was made better by eating. He did not have any SOB until yesterday evening when he was sitting, watching television, when he suddenly felt like he could not breathe. He also has had some difficulty lying down flat, though he denies this is due to shortness of breath. Denies chest pain, palpitations, lower extremity edema, lightheadedness, dizziness, fevers, sweats, chills, vomiting, diarrhea, constipation (last BM yesterday), hematochezia, difficulty urinating, joint pain, or rashes. He states that he does take his medications though he cannot say what they are. Per records his discharge weight was 61.6 kg, however he has not been tracking his weight. Past Medical History: 1. CARDIAC RISK FACTORS: +hypertension, +dyslipidemia, +diabetes 2. CARDIAC HISTORY: - CABG: ___ - LIMA-LAD, SVG-dLAD, RI, OM, dRCA; post-op Afib - PERCUTANEOUS CORONARY INTERVENTIONS: None - PACING/ICD: None - LV global systolic dysfunction (___) 3. OTHER PAST MEDICAL HISTORY: -HTN -Type 2 DM -Dyslipidemia -GERD -Peripheral neuropathy -H/O gout -Colonic polyps Social History: ___ Family History: Premature coronary artery disease- Father and mother both passed away from an MI; mother was ___ and father was 75. Physical Exam: Admission Physical Exam: =================== GENERAL: Well appearing male in NAD HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple. CARDIAC: RRR, normal S1, S2. Soft systolic murmur (II/VI) in RLSB. No rubs/gallops. No thrills, lifts. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No TTP/rebound/guarding. EXTREMITIES: 2+ pedal edema. No clubbing or cyanosis. Moving all extremities. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Distal pulses palpable and symmetric Neuro: AOX3, CNII-XII intact Discharge Physical Exam: =================== VS: 98.8 125/56 (99-143/50s) 50s-60s 18 100%RA Weight 60.4 kg I/O= 8hr: ___ 24hr: ___ GENERAL: WDWN in NAD. Oriented x2. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. NECK: Supple with JVP at clavicle at 45 degrees CARDIAC: RRR. III/VI systolic murmur loudest at apex, II/VI DM loudest at LUSB LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Distal pulses palpable and symmetric Pertinent Results: Admission Labs: ============ ___ 07:25PM GLUCOSE-178* UREA N-29* CREAT-1.5* SODIUM-131* POTASSIUM-3.7 CHLORIDE-94* TOTAL CO2-26 ANION GAP-15 ___ 07:25PM CALCIUM-10.2 PHOSPHATE-3.4 MAGNESIUM-1.8 ___ 07:25PM PTT-92.8* ___ 05:34AM ___ PTT-29.3 ___ ___ 05:20AM cTropnT-0.02* ___ 05:00AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 01:45AM D-DIMER-1300* ___ 12:56AM CK-MB-4 ___ 12:56AM ALT(SGPT)-31 AST(SGOT)-40 ALK PHOS-112 TOT BILI-0.4 ___ 11:02PM cTropnT-0.02* ___ 11:02PM proBNP-8741* ___ 11:02PM WBC-4.8 RBC-4.02* HGB-12.8* HCT-37.9* MCV-94 MCH-31.8 MCHC-33.8 RDW-13.4 RDWSD-46.3 ___ 11:02PM NEUTS-40.0 ___ MONOS-11.2 EOS-6.4 BASOS-1.7* AbsNeut-1.92 AbsLymp-1.96 AbsMono-0.54 AbsEos-0.31 AbsBaso-0.08 ___ 11:02PM PLT COUNT-280 Discharge Labs: ============= ___ 07:30AM BLOOD WBC-4.6 RBC-3.64* Hgb-11.4* Hct-34.9* MCV-96 MCH-31.3 MCHC-32.7 RDW-13.5 RDWSD-47.8* Plt ___ ___ 07:30AM BLOOD Plt ___ ___ 07:30AM BLOOD Glucose-102* UreaN-30* Creat-1.3* Na-134 K-5.1 Cl-97 HCO3-30 AnGap-12 ___ 07:55AM BLOOD ALT-20 AST-31 AlkPhos-61 ___ 07:30AM BLOOD Calcium-10.4* Phos-4.0 Mg-2.0 Iron-41* ___ 07:30AM BLOOD calTIBC-346 Ferritn-61 TRF-266 Studies: Cardiac Catheterization (___) The LMCA had tubular 40% stenosis. The only supply from the LMCIA was an OM branch that has mild disease with 40-50% stenosis and the SVG was seen to retrogradely fill from this vessel back to the rams touchdown. The rams itself was a 0.5mm vessel. The LAD filled via a LIMA and had mild disease the LIMA itself was free of disease. The RCA was a tortuous vessel with diffuse 40% stenosis proximally and 60% stenosis distally. The SVG-RAMUS-OM was a diffusely diseased 2.0mm graft with long diffused 70% disease touching down to the 0.5 mm Ramus and the OM described previously that had mild disease. The SVG to LAD, SVG to RCA were occluded. Impression: 1. Moderate residual coronary disease 2. Occluded SVG RCA, SVG LAD. 3. SVG-RAMUS-OM not suitable for PCI. Brief Hospital Course: Mr. ___ is a ___ yo gentleman with CAD s/p CABG, global systolic dysfunction (LVEF: 40-45%) repeat ECHO: LVEF 30%, HTN, HLD, CKD, DMII who presents with shortness of breath and abdominal pain. He was found to have a slightly increased troponin as well as marked t-wave inversions in the anterolateral leads; concern for ___. #Troponinemia with t-wave inversions. Received loading dose of ___ in ED and heparin gtt, trops trended down. Repeated EKG with improving T waves but still change from baseline. Coronary angiography revealed disease of his SVG to RCA graft but good flow to the RCA; no stentable lesion; medical management was recommended. Continued daily ___. #Dyspnea. Improved. History of CHF but does not appear to be having an acute CHF exacerbation on physical exam. D-dimer was elevated but CTA (final read) read as no PE. No tachycardia. Appears euvolemic today. Continued home dose of torsemide and spironolactone. #Chronic systolic CHF (LVEF: 40-45% at last adimssion, most recent LVEF is 30%) Not currently volume overloaded; BNP elevated but lower than previous admission; was euvolemic to dry on discharge 4 days prior to this admission (had RHCath on previous admission). Cont metoprolol, torsemide, spironolactone, losartan. Had previously stopped Imdur/Hydral due to hypotension; Now restarting imdur 30 mg daily for after load reduction and treatment of anginal symptoms. #HTN Has been hypertensive on past admissions and improved with home medication regimen. BPs were in fact on the low side so we discontinued Imdur/Hydral. Then restarted Imdur for angina/afterload reduction. BP in good range on current discharge regimen metoprolol, losartan, imdur. (See med list for discharge dosing) #Persistent dyspepsia Nausea and belching that improves with eating. Concern that this is anginal equivalent vs separate GI problem. GI work-up recommended in past but not done. Seen by Gastroenterology inpatient. EGD showed two antral nodules and an 8mm duodenal mass. Biopsies were done and showed normal tissue in antrum and chronic duodenitis. Hpylori testing was positive in early ___ and treated at that time; repeat Hpylori testing was pending at discharge. Follow up with GI in ___ months is recommended. Restarted pantoprazole (stopped famotidine); #CAD: ___ 81mg, Atorvastatin 80 #CKD: monitor Cr; still stable at 1.3 #Hyponatremia: Hyponatremic at baseline and on previous admissions due to obvious hypervolemia. Improved to 134 today. #DM: Hemoglobin A1C in 6s since ___ on last admission documented BG never over 140s; no fingersticks/ ISS required on this admission. cont to monitor AM BG on Chemistries # Gout: Allopurinol ___ mg PO DAILY Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. HydrALAzine 25 mg PO Frequency is Unknown 5. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 6. Vitamin D ___ UNIT PO DAILY 7. Famotidine 20 mg PO DAILY 8. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 9. Torsemide 10 mg PO DAILY 10. Metoprolol Succinate XL 25 mg PO DAILY Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Torsemide 10 mg PO DAILY 5. Clopidogrel 75 mg PO DAILY RX *clopidogrel 75 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 6. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 7. Losartan Potassium 25 mg PO DAILY RX *losartan 25 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 8. Metoprolol Succinate XL 25 mg PO DAILY 9. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 10. Vitamin D ___ UNIT PO DAILY 11. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary: Unstable Angina Secondary: Duodenitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, You were admitted to the hospital for shortness of breath. We found that you had EKG changes and other evidence that blood flow to your heart was being blocked. We put you on a medication that prevents blood from clotting and you improved. We did a cardiac catheterization to determine which blood vessels to your heart were blocked. No stents were placed and we have decided to manage you with medicines. You also have been having nausea, belching and belly pain that improves when you eat. We consulted GI specialists to assess your stomach problems and they recommended a test to look at your esophagus and stomach called an EGD. The EGD showed duodenitis. We also put you on pantoprazole, a medication that can help with stomach symptoms. You were started on new medications including pantoprazole, ___ and losartan. It is very important that you continue to take these. All of your medications are detailed in your discharge medication list. You should review this carefully and take it with you to any follow up appointments. Because of your heart failure, please weigh yourself every morning, call MD if weight goes up more than 3 lbs. The details of your follow up appointments are given below. It was a pleasure taking care of you. Sincerely, Your ___ Cardiology Team Followup Instructions: ___
19972786-DS-28
19,972,786
20,400,012
DS
28
2201-05-04 00:00:00
2201-06-03 00:19:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Lisinopril Attending: ___. Chief Complaint: dizziness Major Surgical or Invasive Procedure: none History of Present Illness: Mr ___ is an ___ yo M with h/o CAD s/p CABG, sCHF (EF 30%), HTN, HLD, CKD, DMII and peripheral neuropathy who presents with recurrent, positional "dizziness". Denies vertigo; dizziness has worsened over the past few days and today he has felt unsteady on his feet as well. He was recently admitted to the neurology service with similar symptoms; at that time his MRI was negative for stroke and his symptoms were felt likely due to a combination of orthostatis, hypovolemic hyponatremia, and diabetic autonomic neuropathy. Endorses nausea, but at his baseline; no vomiting, diarrhea. Denies fevers/chills, URI-like symptoms. In the ED, initial VS were 97.8 62 142/58 16 99% RA. Patient evaluated by neurology for dizziness; neurology felt he was at his baseline (naming difficulty, no cerebellar signs, + peripheral neuropathy) and that dizziness was likely ___ orthostatic hypotesion; orthostatics were indeed positive. Labs notable for bland UA, baseline anemia, normal chem10. CT Head showed no acute process; chronic small vessel disease and maxillary sinus disease. CXR showed pulmonary vascular congestion and stable left pleural effusion. Patient was given 2 L IVF as well as Zofran, however persistently symptomatic, so patient was admitted for further management. On arrival to the floor, patient reports feeling better - able to stand and walk from stretcher with only a little unsteadiness. Past Medical History: 1. CARDIAC RISK FACTORS: +hypertension, +dyslipidemia, +diabetes 2. CARDIAC HISTORY: - CABG: ___ - LIMA-LAD, SVG-dLAD, RI, OM, dRCA; post-op Afib - PERCUTANEOUS CORONARY INTERVENTIONS: None - PACING/ICD: None - LV global systolic dysfunction (___) 3. OTHER PAST MEDICAL HISTORY: -HTN -Type 2 DM -Dyslipidemia -GERD -Peripheral neuropathy -H/O gout -Colonic polyps Social History: ___ Family History: Premature coronary artery disease- Father and mother both passed away from an MI; mother was ___ and father was ___. Physical Exam: ADMISSION PHYSICAL EXAM: VS - 97.8 153/74 76 16 100% RA 139.7lbs (bed weight) GENERAL: NAD HEENT: PERRL, MMM NECK: JVP at 2cm above clavicle at 45 degree CARDIAC: RRR, S1/S2, II/VI systolic murmur loudest at apex, II/VI DM loudest at LUSB LUNG: CTAB, no wheezes, rales, rhonchi ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 extremities with purpose NEURO: CN II-XII intact DISCHARGE VS - 97.8 78 117/52 18 100%/RA Weight: 61.3 kg standing General: thin, well appearing, NAD HEENT: anicteric sclera, PERRL, EOMI, dry OM, OP clear Neck: supple, prominent arterial pulsations, no JVD, no LAD CV: Regular rate, II/VI LUSB SEM, II/VI Apex SEM, no rubs/gallops Lungs: NLB, CTAB Abdomen: soft, NT, ND, hypoactive BS Ext: warm and well perfused, no cyanosis or edema Neuro: A&O, CN II-XII intact, SILT, no weakness, ataxia, BLE brisk reflexes Pertinent Results: ADMISSION ========= ___ 12:45PM WBC-4.2 RBC-3.47* HGB-10.8* HCT-33.2* MCV-96 MCH-31.1 MCHC-32.5 RDW-14.8 RDWSD-51.8* ___ 12:45PM NEUTS-57.7 ___ MONOS-7.4 EOS-1.7 BASOS-0.7 IM ___ AbsNeut-2.41 AbsLymp-1.35 AbsMono-0.31 AbsEos-0.07 AbsBaso-0.03 ___ 12:45PM PLT COUNT-222 ___ 12:45PM GLUCOSE-105* UREA N-19 CREAT-1.1 SODIUM-133 POTASSIUM-5.0 CHLORIDE-97 TOTAL CO2-24 ANION GAP-17 ___ 12:45PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 12:45PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-NEG PERTINENT ========= LABS: ___ 06:00AM BLOOD WBC-4.2 RBC-3.79* Hgb-11.9* Hct-36.3* MCV-96 MCH-31.4 MCHC-32.8 RDW-14.9 RDWSD-52.8* Plt ___ ___ 06:00AM BLOOD Glucose-94 UreaN-21* Creat-1.1 Na-135 K-4.8 Cl-99 HCO3-27 AnGap-14 ___ 06:00AM BLOOD Calcium-10.2 Phos-3.4 Mg-2.2 ___ 06:50AM BLOOD ALT-17 AST-25 LD(LDH)-167 AlkPhos-71 TotBili-0.5 ___ 06:50AM BLOOD proBNP-6844* ___ 06:50AM BLOOD VitB12-472 Folate-12.2 ___ 06:50AM BLOOD %HbA1c-6.4* eAG-137* ___ 06:50AM BLOOD Cortsol-10.7 MICRO: ___ 12:45 pm URINE SOURCE: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. IMAGING: ___ ___: 1. No acute intracranial abnormality. 2. Extensive chronic small vessel ischemic disease. 3. Bilateral maxillary sinus disease, a component of which is chronic on the left. CXR ___: Mild pulmonary vascular engorgement and unchanged small left pleural effusion. Continued bibasilar atelectasis. Brief Hospital Course: Mr. ___ is an ___ year old man with a history of CAD s/p 5v CABG ___, ___ (EF 30%), CKD, DM2 who presents for second admission for symptom of lightheadedness without vertigo. He was found to have orthostatic vital signs. We believe this may be due to autonomic neuropathy (history of diabetes, though fairly well controlled) and medications (valsartan, metoprolol, isosorbide, torsemide) contributing to impaired ability to vasoconstrict adequately. His symptoms did not resolve with IVF, suggesting he was not actually hypovolemic and supporting autonomic dysfunction. Imdur was held on discharge and patient was prescribed compression stockings. He was deemed to be safe for discharge home. # Orhtostatic Hypotension: likely ___ diabetic autonomic neuropathy, though currently well controlled with A1c 6.4. Neurology evaluated patient and though it was not likely an alternative neurologic process; CT head notable only for chronic cerebral vascular disease. Alternate etiologies include medication related (on diuretic as well as ___ and arterial dilators). Adrenal insufficiency considered but unlikely as cortisol was 10.4 in early AM. B12/folate levels WNL. Patient was ambulating with improved but not resolved symptoms s/p IVF. Imdur was held and patient prescribed compression stockings on discharge. Will F/U with neurology and cardiology. # Chronic systolic CHF: LVEF is 30%, last ECHO ___. S/p 2L IVF in ED. Last discharge dry weight 60.4 kg; appeared relatively dry to euvolemic and near dry weight with BNP down from last admission. Continued home metoprolol, spironolactone, losartan, torsemide. CHRONIC #GERD: continued home pantoprazole #CAD: s/p CABG: continued home ASA 81mg, Atorvastatin 80mg #CKD: Cr at baseline of 1.0 #DM: Hemoglobin A1C in 6s since ___ on metformin at home: low dose ISS while admitted #Gout: continued home allopurinol ___ #Anemia: chronic, normocytic: stable TRANSITIONAL []repeat EGD ___ per last GI note and ___ EGD recommendations []consider stopping clopidogrel when deemed medically appropriate (on since ___ []follow up to see if patient has angina symptoms off of ISMN []follow up with neurology as outpatient Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Torsemide 10 mg PO DAILY 5. Clopidogrel 75 mg PO DAILY 6. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 7. Losartan Potassium 25 mg PO DAILY 8. Metoprolol Succinate XL 12.5 mg PO DAILY 9. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 10. Vitamin D ___ UNIT PO 1X/WEEK (___) 11. Pantoprazole 40 mg PO Q24H Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Clopidogrel 75 mg PO DAILY 5. Losartan Potassium 25 mg PO DAILY 6. Metoprolol Succinate XL 12.5 mg PO DAILY 7. Pantoprazole 40 mg PO Q24H 8. Torsemide 10 mg PO DAILY 9. Vitamin D ___ UNIT PO 1X/WEEK (___) 10. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 11. Compression stalkings Compression stockings ___. ICD10 ___.1 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSES: #Orthostatic hypotension #Probable diabetic autonomic neuropathy SECONDARY DIAGNOSES: #Coronary artery disease #Chronic systolic congestive heart failure #Type 2 diabetes probable dehydration and medication effect Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure participating in your care at the ___ ___. You were admitted for feeling dizzy with walking. Your symptoms improved but did not resolve with intravenous fluids. You were seen be neurologists who felt that you 1) did not have any evidence of a stroke 2) your dizziness is likely due to orthostatic hypotension (low blood pressure when changing from sitting to standing). At home, you should get up from bed and sitting very slowly. We stopped your isosorbide mononitrate which can lower blood pressure as your blood pressures in the hospital were reasonable 140s-150s. We are going to prescribe compression stockings to prevent blood from pooling in your legs. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Please follow your new medication list. Followup Instructions: ___
19972786-DS-32
19,972,786
23,470,157
DS
32
2204-09-03 00:00:00
2204-09-04 08:48:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Lisinopril / tizanidine Attending: ___. Chief Complaint: Back Pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ w/ PMHx of HFrEF (EF 30%), CAD s/p CABG (LIMA-LAD, SVG-OM), and HTN, CKD (1.2-1.3), mild dementia who presented to the ED for hip/back pain, found to have volume overload on exam, elevated BNP, CXR with pulm edema, ___ c/w acute decompensated HFrEF. Pt states that for the last several weeks he has noticed more fluid. He went to his outpt cardiologist on ___ where he was found to be volume overloaded. TTE showed EF 28% similar to prior. Torsemide increased to 80 mg daily. In the ED, VS: 98.0 80 ___ 96% RA EKG: SR, no ischemic changes LABS: - CBC: WBC 4.6, Hgb 9.6, plt 212 - Chem: Na 132, BUN 46, Cr 1.6 - Trop T: 0.04 - LFTs ALT 503, AST 357, Tb 0.5 - UA: Tr prot, otherwise unremarkable - BNP 19000 IMAGING/STUDIES: - CXR: Mild pulmonary vascular congestion. Low lung volumes. Patchy basilar opacities could be due to atelectasis, but infection or aspiration is not excluded. - CT A&P: 1. Acute fracture through the anterior inferior base of the L4 vertebral body. 2. Small amount of perihepatic and pelvic ascites. In the presence of gynecomastia, Findings may represent underlying liver disease. Correlation with liver function tests is recommended. 3. No acute intraabdominal process identified. 4. No fracture, dislocation, or radiographic evidence of steomyelitis or necrosis of the left hip. - Pelvis XR: No acute fracture or dislocation of the left hip or left femur. Acute fracture of the anterior, inferior L4 vertebra was better assessed on preceding CT. CONSULTS: - Spine consult: There is no spinal intervention for this and no bracing needed. The patient can follow up in spine clinic with Dr. ___. MEDS: 11:29 PO Acetaminophen 1000 mg ___ ___ 12:25 IV HYDROmorphone (Dilaudid) .25 mg ___ Partial Administration ___ 13:30 IV HYDROmorphone (Dilaudid) .25 mg ___ Partial Administration ___ 15:33 IV Furosemide 120 mg ___ ___ 15:33 PO/NG OxyCODONE (Immediate Release) 2.5 mg ___ ED COURSE: ___ 16:45: VOID. ___ mL On the floor, endorses the hx above. Denies dyspnea, orthopnea, PND. Does endorse ___ Lt back/hip pain. REVIEW OF SYSTEMS: Positive per HPI. Remaining 10 pt ROS reviewed and negative. Past Medical History: 1. CARDIAC RISK FACTORS: +hypertension, +dyslipidemia, +diabetes 2. CARDIAC HISTORY: - CAD s/p CABG: ___ - LIMA-LAD, SVG-dLAD, RI, OM, dRCA; - CHF, chronic systolic: Amyloid heart disease and ischemic cardiomyopathy. 3. OTHER PAST MEDICAL HISTORY: -HTN -Type 2 DM -Dyslipidemia -GERD -Peripheral neuropathy -H/O gout -Colonic polyps Family History: Premature coronary artery disease- Father and mother both passed away from an MI; mother was ___ and father was ___. Physical Exam: ADMISSION PHYSICAL EXAM: ====================== VS: ___ ___ Temp: 97.4 PO BP: 155/69 L Lying HR: 92 RR: 18 O2 sat: 98% O2 delivery: RA Wt: 147 lb GENERAL: Confused in NAD. HEENT: EOMI, PERRLA, MMM NECK: Supple. JVP of 15 cm. CARDIAC: RRR, no m/r/g LUNGS: Crackles throughout, no wheezing ABDOMEN: Soft, NT, ND Back: Lt flank/hip pain with movement, associated tender paraspinal muscle spasm GU: No foley EXTREMITIES: WWP, 2+ pitting edema b/l to knees. SKIN: No significant skin lesions or rashes. PULSES: Distal pulses palpable and symmetric. NEURO: CN II-XII intact, MAE DISCHARGE PHYSICAL EXAM: ====================== 24 HR Data (last updated ___ @ 736) Temp: 98.2 (Tm 98.5), BP: 135/68 (97-142/53-68), HR: 74 (71-80), RR: 20 (___), O2 sat: 98% (97-100), O2 delivery: RA Fluid Balance (last updated ___ @ 922) Last 8 hours Total cumulative -90ml IN: Total 360ml, PO Amt 360ml OUT: Total 450ml, Urine Amt 450ml Last 24 hours Total cumulative -318ml IN: Total 1057ml, PO Amt 1057ml OUT: Total 1375ml, Urine Amt 1375ml GENERAL: alert and conversational, confused at baseline HEENT: EOMI, MMM NECK: JVP 8cm CARDIAC: RRR, no m/r/g LUNGS: Lungs clear ABDOMEN: Soft, NT, ND EXTREMITIES: WWP, no edema NEURO: Moving all extremities with purpose Pertinent Results: ADMISSION LABS: ============== ___ 11:50AM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 11:50AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR* GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 11:50AM URINE RBC-0 WBC-1 BACTERIA-NONE YEAST-NONE EPI-<1 ___ 11:50AM URINE HYALINE-2* ___ 11:35AM GLUCOSE-133* UREA N-46* CREAT-1.6* SODIUM-132* POTASSIUM-4.5 CHLORIDE-93* TOTAL CO2-24 ANION GAP-15 ___ 11:35AM estGFR-Using this ___ 11:35AM ALT(SGPT)-503* AST(SGOT)-357* ALK PHOS-126 TOT BILI-0.5 ___ 11:35AM LIPASE-23 ___ 11:35AM cTropnT-0.04* ___ 11:35AM ALBUMIN-3.4* ___ 11:35AM WBC-4.6 RBC-3.07* HGB-9.6* HCT-28.6* MCV-93 MCH-31.3 MCHC-33.6 RDW-15.9* RDWSD-54.4* ___ 11:35AM WBC-4.6 RBC-3.07* HGB-9.6* HCT-28.6* MCV-93 MCH-31.3 MCHC-33.6 RDW-15.9* RDWSD-54.4* ___ 11:35AM NEUTS-73.3* LYMPHS-10.9* MONOS-12.6 EOS-2.6 BASOS-0.2 IM ___ AbsNeut-3.37 AbsLymp-0.50* AbsMono-0.58 AbsEos-0.12 AbsBaso-0.01 ___ 11:35AM PLT COUNT-212 ___ 11:35AM ___ PTT-28.5 ___ DISCHARGE LABS: =============== ___ 07:15AM BLOOD WBC-4.4 RBC-3.49* Hgb-10.9* Hct-33.6* MCV-96 MCH-31.2 MCHC-32.4 RDW-16.4* RDWSD-55.6* Plt ___ ___ 07:15AM BLOOD Glucose-118* UreaN-47* Creat-1.4* Na-139 K-4.6 Cl-95* HCO3-27 AnGap-17 ___ 07:23AM BLOOD ALT-65* AST-48* AlkPhos-87 TotBili-0.8 IMAGING: ======== ___ (PA & LAT) IMPRESSION: Mild pulmonary vascular congestion. Low lung volumes. Patchy basilar opacities could be due to atelectasis, but infection or aspiration is not excluded. ___ PELVIS & FEMUR IMPRESSION: No acute fracture or dislocation of the left hip or left femur. Acute fracture of the anterior, inferior L4 vertebra was better assessed on preceding CT. Left knee chondrocalcinosis. ___ ABD & PELVIS W/O CON IMPRESSION: 1. Acute fracture through the anterior, inferior base of the L4 vertebral body. 2. Small amount of perihepatic and pelvic ascites. In the presence of gynecomastia, Findings may represent underlying liver disease. Correlation with liver function tests is recommended. 3. No fracture of the left hip identified. MICROBIOLOGY: ============= ___ 11:50 am URINE **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. Brief Hospital Course: SUMMARY: ___ w/ PMHx of HFrEF (EF 30%), CAD s/p CABG (LIMA-LAD, SVG-OM), and HTN, CKD (1.2-1.3), mild dementia who presented to the ED for hip/back pain, found to have L4 vertebral fracture. Neurosurgery saw him and recommended conservative management. He was also found to be volume overload on exam, elevated BNP, CXR with pulm edema, ___ c/w acute decompensated HFrEF. He was admitted to the CHF service and diuresed with IV lasix gtt @ 40. He was transitioned to PO Torsemide and titrated to maintain euvolemia. he was discharged at dry wt of 127 lbs with close follow up with cardiology for continued management TRANSITIONAL ISSUES: ================== [] Post-Discharge Follow-up Labs Needed: Repeat chemistry ___ to ensure Cr and electroyltes stable on diuretic [] F/u appts: ___ clinic, Cardiology, Neurosurgery CHF: [] Discharge weight: 127 lbs [] Discharge diuretic: Torsemide 100 [] Discharge Cr: 1.4 [] Please weigh the patient every day. Should his weight increase by ___ lbs above his dry wt, please give an extra dose of Torsemide 100 mg and repeat chem OTHER: [] Follow up with spine for L4 vertebral fracture. [] Patient evaluated by speech and swallow as inpatient who suggested that patient be discharged on ground diet with thin liquids. Recommend repeat in ___ weeks. [] Patient with significant belching causing emotional distress in the setting of constipation. Please ensure patient is having ___ BM per day. Patient requiring suppositories as inpatient. # CODE: Full (presumed) # CONTACT: ___ (grand-daughter) ___ CORONARIES: CAD s/p CABG ___ (LIMA-LAD, SVG-dLAD, RI, OM, dRCA), last LHC ___ with non-flow limiting stenosis of RCA PUMP: Last TTE ___ EF 28% global HK RHYTHM: SR ACUTE ISSUES: =============== # Acute on Chronic HFrEF: # Ischemic/amyloid CMP Hx of mixed iCMP and amyloid CMP. Presents with wt 147 up from dry wt of 135, elevated JVP and edema on exam. proBNP now 20K, CXR with congestion. Unclear precipitant of decompensation at this time. Possibly represents natural progression of underlying amyloid heart disease vs problems with med administration. Started on lasix gtt to remove fluid requiring dose as high as 40cc. NHBK: No metop iso amyloid. Afterload: continued home Isordil 20/Hydral 10 TID, losartan 12.5 mg. Repleted iron with 4 days of IV iron. # L4 vertebral fracture: New, found on CT. Spine consulted who rec non-op management. Tylenol ___ q8h. Lidocaine patch x2. Low dose oxycodone as needed. Pt was given TIZANIDINE, but became hypotensive and was discontinued. Will need F/u w/ spine as outpt #Choking Patient noted to be choking while eating on several occasions per nursing notes. Concerned that patient may be aspirating. S&S evaluation including video swallow showed that despite food intermittently entering the trachea, patient had good cough so did not aspirate. Speech and swallow recommended that patient continue on ground diet with thin liquids. # CAD s/p CABG x5 # Elevated Troponin: CAD s/p CABG ___ (LIMA-LAD, SVG-dLAD, RI, OM, dRCA), last LHC ___ with non-flow limiting stenosis of RCA. Trop T 0.04 on admission, mild near his baseline. No significant ECG changes. Suspect demand iso of CHF exacerbation. Continued home DAPT and atorvastatin for ischemic CM. Patient was continued on DAPT because per discussion with outpatient cardiologist, patient has tolerated regimen thus far. # ___ on CKD: Cr 1.6 from baseline 1.3-1.4. Suspect cardiorenal. Cr at discharge 1.6. # Transaminitis: Elevated in past with CHF exacerbations. Likely congestive hepatopathy. LFTs on discharge had continued to downtrend. CHRONIC ISSUES: =============== # HTN: Continued Hydral + Imdur as above. Losartan as above # Type 2 DM: Held home metformin. ISS in house # GERD: Continued pantoprazole 40mg BID # CODE: Full (presumed) # CONTACT: ___ (grand-daughter) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Clopidogrel 75 mg PO DAILY 5. HydrALAZINE 10 mg PO TID 6. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 7. Losartan Potassium 12.5 mg PO DAILY 8. Pantoprazole 40 mg PO Q12H 9. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 10. Torsemide 80 mg PO DAILY 11. Simethicone 40-80 mg PO TID abd pain/gas Discharge Medications: 1. Polyethylene Glycol 17 g PO DAILY Please hold for loose stools. 2. Senna 8.6 mg PO BID 3. Torsemide 100 mg PO DAILY 4. Allopurinol ___ mg PO DAILY 5. Aspirin 81 mg PO DAILY 6. Atorvastatin 80 mg PO QPM 7. Clopidogrel 75 mg PO DAILY 8. HydrALAZINE 10 mg PO TID 9. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 10. Losartan Potassium 12.5 mg PO DAILY 11. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 12. Pantoprazole 40 mg PO Q12H 13. Simethicone 40-80 mg PO TID abd pain/gas Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: PRIMARY: ======== Heart failure with reduced ejection fraction L4 vertebral fracture Acute kidney injury in the setting of chronic kidney disease SECONDARY: ========== Coronary artery disease Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a privilege caring for you at ___. Please see below for more information on your hospitalization. WHY WERE YOU ADMITTED TO THE HOSPITAL? - You had a back fracture - You had extra fluid in your body WHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL? - Neurosurgery was consulted for your back. No intervention was needed. - We gave you medication to remove fluid from your body - You were also seen by the speech and swallow team who suggested you eat a ground diet to lower your risk of food entering your lung. WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - Take all of your medications as prescribed (listed below) - Follow up with your doctors as listed below - Weigh yourself every morning, seek medical attention if your weight goes up more than 3 lbs from your discharge weight of 127.2 - Seek medical attention if you have new or concerning symptoms or you develop swelling in your legs, abdominal distention, or shortness of breath at night. It was a pleasure taking part in your care here at ___! We wish you all the best! - Your ___ Care Team Followup Instructions: ___
19972786-DS-34
19,972,786
21,739,538
DS
34
2205-02-21 00:00:00
2205-02-23 15:38:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Lisinopril / tizanidine Attending: ___. Major Surgical or Invasive Procedure: None attach Pertinent Results: ADMISSION LABS: =============== ___ 09:00PM BLOOD WBC-4.8 RBC-3.09* Hgb-10.0* Hct-31.0* MCV-100* MCH-32.4* MCHC-32.3 RDW-15.9* RDWSD-57.6* Plt ___ ___ 09:00PM BLOOD Neuts-78.0* Lymphs-13.8* Monos-5.7 Eos-1.3 Baso-0.6 Im ___ AbsNeut-3.72 AbsLymp-0.66* AbsMono-0.27 AbsEos-0.06 AbsBaso-0.03 ___ 07:04AM BLOOD ___ PTT-29.4 ___ ___ 09:00PM BLOOD Glucose-164* UreaN-32* Creat-1.3* Na-142 K-3.7 Cl-99 HCO3-30 AnGap-13 ___ 09:00PM BLOOD Calcium-10.1 Phos-2.4* Mg-2.0 PERTINENT LABS: =============== ___ 07:04AM BLOOD ALT-93* AST-37 LD(LDH)-241 AlkPhos-98 TotBili-1.0 ___ 09:00PM BLOOD CK-MB-3 cTropnT-0.08* ___ ___ 03:10AM BLOOD CK-MB-3 cTropnT-0.08* ___ 06:15AM BLOOD cTropnT-0.06* DISCHARGE LABS: =============== ___ 07:20AM BLOOD WBC-5.0 RBC-3.46* Hgb-11.1* Hct-34.2* MCV-99* MCH-32.1* MCHC-32.5 RDW-15.9* RDWSD-57.1* Plt ___ ___ 07:20AM BLOOD Glucose-109* UreaN-49* Creat-1.4* Na-138 K-4.3 Cl-90* HCO3-33* AnGap-15 ___ 07:20AM BLOOD Calcium-10.3 Phos-2.7 Mg-2.3 IMAGING: ======== NONE Brief Hospital Course: Mr. ___ is an ___ year old male with past medical history significant for CAD s/p CABG ___ (LIMA-LAD, SVG-dLAD, RI, OM, dRCA; cath ___ w/severe stenosis of SVG-RCA not amenable to PCI), HFrEF ___ (infarct-mediated iso fixed perfusion defects, and TTR amyloid cardiomyopathy), HTN, DM2, HLD, CKD stage 3, GERD, gout, and dementia (MMS ___ in ___ who presents with two weeks of increasing shortness of breath and is being admitted to ___ service for HF exacerbation. He was volume overloaded and diuresed well with IV Lasix boluses. His SOB improved and he was discharged on Torsemide 100 BID. ==================== TRANSITIONAL ISSUES: ==================== Discharge Cr: 1.4 Discharge Weight: 113.98lb Discharge diuretic: Torsemide 100mg BID, metolazone 5mg daily:PRN for weight gain greater than 3 lbs [ ] We increased his home diuretic dosing from Torsemide 80mg QAM and 60mg QPM to 100mg BID [ ] Patient should be weighed daily. If his weight increases by 3 lbs, he should receive po metolazone 5mg and KCl 40 mEq. [ ] We discussed his condition with his granddaughter, who is his HCP, and they made the decision to enroll in hospice upon discharge. In my discussions with the patient he does not seem to grasp the severity of his condition or be able to engage in conversations about overall prognosis due to this limited understanding. =============== ACTIVE ISSUES: =============== # Acute on chronic decompensated heart failure # HFrEF 28% (infarct-mediated iso fixed perfusion defects, and TTR amyloid cardiomyopathy; global biventricular dysfunction) # Moderate TR: The patient presented with evidence of heart failure exacerbation after recent HF admission. Potential triggers include recent URI/pneumonia given cough, although afebrile and no white count. Reports med and diet compliance. PE unlikely given history, however, recently hospitalized patient w/o anticoagulation. ACS less likely based on troponins and EKG. Most likely this represents progression of his heart failure. We discussed with his HCP/granddaughter who reports that they have started palliative care discussions with doctors at his nursing home about goals of care. We diuresed him with IV Lasix boluses, and his SOB symptoms improved, although he continued to complain of belching, likely due to abdominal congestion from his volume overload. He was transitioned to Torsemide 100mg BID prior to discharge, which is increased from his home dose of Torsemide 80AM, 60PM. He is also being discharged on metolazone 5mg daily:PRN for weight gain greater than 3 lbs which should be taken with potassium chloride 40 mEq. We continued him on his home hydralazine 10mg TID and isosorbide mononitrate ER 30mg BID. # CAD s/p CABG ___ (LIMA-LAD, SVG-dLAD, RI, OM, dRCA; cath ___ w/severe stenosis of SVG-RCA not amenable to PCI) He was continued on his home aspirin 81, Plavix 75, atorvastatin 80, and Imdur 30mg BID #CKD His Cr was stable during the admission at his baseline of 1.3-1.6. # Macrocytic anemia: His Hgb was stable at his baseline of ___. ================ CHRONIC ISSUES: ================ # Gout: He was continued on home allopurinol ___ daily. # HLD: He was continued on home atorvastatin 80mg qhs. # DM2: His home metformin was held and he was given sliding scale insulin. # GERD: He was continued on his home PO pantoprazole 40 daily. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild/Fever 2. Allopurinol ___ mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 80 mg PO QPM 5. Bisacodyl 10 mg PO DAILY:PRN Constipation - Second Line 6. Calcium Carbonate 500 mg PO QID:PRN indigestion 7. Clopidogrel 75 mg PO DAILY 8. HydrALAZINE 10 mg PO TID 9. Torsemide 80 mg PO QAM 10. Torsemide 60 mg PO QPM 11. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 12. Benzonatate 100 mg PO TID:PRN Cough 13. Pantoprazole 40 mg PO Q24H 14. Senna 8.6 mg PO BID:PRN Constipation - First Line 15. Simethicone 80 mg PO QID:PRN gas 16. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Third Line 17. GuaiFENesin ___ mL PO Q6H:PRN Cough 18. Isosorbide Dinitrate 30 mg PO BID Discharge Medications: 1. MetOLazone 5 mg PO DAILY:PRN weight gain of 3lbs in one day 2. Potassium Chloride 40 mEq PO DAILY:PRN when taking metolazone Hold for K > 3. Torsemide 100 mg PO BID RX *torsemide 100 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*2 4. Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild/Fever 5. Allopurinol ___ mg PO DAILY 6. Aspirin 81 mg PO DAILY 7. Atorvastatin 80 mg PO QPM 8. Benzonatate 100 mg PO TID:PRN Cough 9. Bisacodyl 10 mg PO DAILY:PRN Constipation - Second Line 10. Calcium Carbonate 500 mg PO QID:PRN indigestion 11. Clopidogrel 75 mg PO DAILY 12. GuaiFENesin ___ mL PO Q6H:PRN Cough 13. HydrALAZINE 10 mg PO TID 14. Isosorbide Dinitrate 30 mg PO BID 15. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 16. Pantoprazole 40 mg PO Q24H 17. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Third Line 18. Senna 8.6 mg PO BID:PRN Constipation - First Line 19. Simethicone 80 mg PO QID:PRN gas Hyperkalemia precludes the use of ___. Beta blockers not prescribed due to intolerance in the setting of biopsy confirmed cardiac amyloidosis. Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: -acute on chronic systolic heart failure -chronic kidney disease -type 2 diabetes mellitus Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. WHY WAS I ADMITTED TO THE HOSPITAL? - You were feeling short of breath because you had fluid in your lungs. - This was caused by a condition called heart failure, where your heart does not pump hard enough and fluid backs up into your lungs. WHAT HAPPENED WHILE I WAS IN THE HOSPITAL? - You were given medications to help get the fluid out. - Your breathing got better and were ready to leave the hospital. WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - Take all of your medications as prescribed (listed below) - Follow up with your doctors as listed below - Weigh yourself every morning. Your weight on discharge is 113.98lb. Call your doctor if your weight goes up or down more than 3 pounds (increases to a weight of 117lb) in one day or 5 lb in one week. - Call you doctor if you notice any of the "danger signs" below. We wish you the best! Your ___ Care Team Followup Instructions: ___
19973083-DS-5
19,973,083
20,741,363
DS
5
2123-10-20 00:00:00
2123-10-21 07:05:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Shortness of breath, dyspnea on exertion Major Surgical or Invasive Procedure: s/p Aortic valve replacement with a 25 mm Onyx mechanical valve on ___ (Dr ___ Transesophageal ECHO ___ History of Present Illness: Ms. ___ is a ___ yo woman with a history of aortic insufficiency and congestive heart failure status post aortic valve replacement with On-X valve on ___. She was discharged home on POD 6 on Coumadin for mechanical valve/ atrial ___ syndrome. Cardiac surgery office received call ___ from patient complaining of intermittent SOB. Patient reports she felt fine when she woke this am and became acutely short of breath about 2300 ___. She had a bedside echo by cardiology in the ED which showed no pericardial effusion and severe MR, which was unchanged from an echo 1 week prior. In the ED she had worsening dyspnea and hypoxia ___ on NRB and was placed on bipap with significant improvement in symptoms. She was given Lasix with brisk response. She is transferred to ___ for further care. Past Medical History: Anemia ___ Syndrome Aortic Insufficiency Breast Mass, left Cerebrovascular Accident Congestive Heart Failure, acute diastolic Hypertension Lupus Nocturnal Polyuria Non-specific reaction to PPD without tuberculosis Pre-diabetes Surgical History: Cesarean-section, ___ Hysterectomy, ___ Social History: ___ Family History: Mother- HTN Father- HTN ** no premature coronary artery disease Physical Exam: ========================== ADMISSION PHYSICAL EXAM ========================== Temp 98.6 137/96 HR 76 16 92% NRB Height: 65" Weight: General: Awake, alert in moderate distress, tachypnic, leaning forward, ___ word dyspnea Skin: Dry [x] intact [x] HEENT: PERRLA [] EOMI []-not examined due to patient discomfort Neck: Supple [x] Full ROM [x] Chest: Lungs-crackles ___ way up posteriorly, scattered wheezes, sputum productive white/creamy Heart: RRR [x] + mech click unable to assess for murmur due to patient positioning Abdomen: Soft [x] non-distended [x] non-tender [x] bowel sounds + [x] Extremities: Warm [x], well-perfused [x] Edema L>R Varicosities: None [x] Neuro: Grossly intact [x] sternal incision clean, dry, sternum stable Pulses: DP Right:+ Left:+ ___ Right:+ Left:+ ========================== DISCHARGE PHYSICAL EXAM ========================== Well-developed, well-nourished. NAD. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with JVP not elevated above the clavicle at 90 degrees. CARDIAC: RRR, normal S1, prominent S2. ___ click heard diffusely. ___ holosystolic murmur hear best at apex No rubs/gallops. No thrills, lifts. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. WWP SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Midline sternotomy with dressing CDI. Pertinent Results: ====================== ADMISSION LAB RESULTS ====================== ___ 02:19AM BLOOD WBC-7.1 RBC-3.92 Hgb-8.2* Hct-28.5* MCV-73* MCH-20.9* MCHC-28.8* RDW-18.6* RDWSD-47.3* Plt ___ ___ 02:19AM BLOOD Neuts-69.7 Lymphs-13.6* Monos-14.3* Eos-1.6 Baso-0.4 Im ___ AbsNeut-4.91 AbsLymp-0.96* AbsMono-1.01* AbsEos-0.11 AbsBaso-0.03 ___ 02:19AM BLOOD Neuts-69.7 Lymphs-13.6* Monos-14.3* Eos-1.6 Baso-0.4 Im ___ AbsNeut-4.91 AbsLymp-0.96* AbsMono-1.01* AbsEos-0.11 AbsBaso-0.03 ___ 02:19AM BLOOD ___ PTT-52.7* ___ ___ 02:19AM BLOOD Glucose-112* UreaN-50* Creat-2.2* Na-137 K-5.1 Cl-101 HCO3-22 AnGap-14 ___ 02:19AM BLOOD proBNP-5530* ___ 02:19AM BLOOD cTropnT-0.03* ___ 02:19AM BLOOD Calcium-9.0 Phos-4.3 Mg-2.2 ___ 02:25AM BLOOD ___ pO2-36* pCO2-42 pH-7.42 calTCO2-28 Base XS-2 ___ 02:25AM BLOOD Lactate-2.1* ====================== DISCHARGE LAB RESULTS ====================== ___ 07:15AM BLOOD WBC-3.5* RBC-3.93 Hgb-8.2* Hct-28.1* MCV-72* MCH-20.9* MCHC-29.2* RDW-17.9* RDWSD-45.3 Plt ___ ___ 07:10AM BLOOD ___ PTT-51.3* ___ ___ 07:10AM BLOOD Glucose-103* UreaN-52* Creat-2.1* Na-145 K-4.3 Cl-102 HCO3-26 AnGap-17 ___ 07:10AM BLOOD Glucose-103* UreaN-52* Creat-2.1* Na-145 K-4.3 Cl-102 HCO3-26 AnGap-17 ___ 07:10AM BLOOD ALT-27 AST-24 AlkPhos-134* TotBili-0.2 ___ 07:10AM BLOOD Calcium-9.1 Phos-4.5 Mg-2.0 ======================= IMAGING AND REPORTS ======================= Transthoracic Echocardiogram ___ There is mild symmetric left ventricular hypertrophy with a normal cavity size. There is normal regional and global left ventricular systolic function. The visually estimated left ventricular ejection fraction is 55%. There is no resting left ventricular outflow tract gradient. No ventricular septal defect is seen. Diastolic parameters are indeterminate. Normal right ventricular cavity size with moderate global free wall hypokinesis. There is post-thoracotomy interventricular septal motion. A mechanical aortic valve prosthesis is present. There is no aortic regurgitation. The mitral valve leaflets are mildly thickened with no mitral valve prolapse. There is moderate to severe [3+] mitral regurgitation. The pulmonic valve leaflets are normal. The tricuspid valve leaflets appear structurally normal. There is moderate to severe [3+] tricuspid regurgitation. There is moderate pulmonary artery systolic hypertension. In the setting of at least moderate to severe tricuspid regurgitation, the pulmonary artery systolic pressure may be UNDERestimated. There is a small to moderate loculated pericardial effusion. There is normal respiratory variation in transmitral or transtricuspid inflow, suggesting absence of tamponade physiology. Bilateral pleural effusions are present. IMPRESSION: Focused study. Mild symmetric left ventricular hypertrophy with preserved left ventricular systolic function. Moderately hypokinetic right ventricle. Well-seated, mechanical aortic valve (gradients not assessed). Moderate to severe mitral and tricuspid regurgitation. Moderate pulmonary hypertension. Small to moderate (from 0.8 up to 1.4 cm) focal pericardial effusion anterior to the right atrium without echocardiographic evidence of tamponade. Bilateral pleural effusions. Transthoracic Echocardiogram ___ The left atrial volume index is SEVERELY increased. The right atrium is moderately enlarged. The estimated right atrial pressure is ___ mmHg. There is normal left ventricular wall thickness with a normal cavity size. There is normal regional and global left ventricular systolic function. The visually estimated left ventricular ejection fraction is >=60%. Due to severity of mitral regurgitation, intrinsic left ventricular systolic function is likely lower. Left ventricular cardiac index is normal (>2.5 L/min/m2). There is no resting left ventricular outflow tract gradient. Normal right ventricular cavity size with mild global free wall hypokinesis. Tricuspid annular plane systolic excursion (TAPSE) is depressed. There is post-thoracotomy interventricular septal motion. The aortic sinus diameter is normal for gender. A bileaflet mechanical aortic valve prosthesis is present. The prosthesis is well seated with normal disc motion and transvalvular gradient. The effective orifice area index is moderately reduced (0.65-0.85 cm2/m2). There is trace (normal for prosthesis) aortic regurgitation. The mitral valve leaflets appear structurally normal with no mitral valve prolapse. There is moderate to severe [3+] mitral regurgitation. The tricuspid valve leaflets appear structurally normal. There is an eccentric, interatrial sepal directed jet of mild to moderate [___] tricuspid regurgitation. There is mild pulmonary artery systolic hypertension. There is a small pericardial effusion anterior to the right atriuim (clip 31). A left pleural effusion is present. IMPRESSION: Well seated, normal functioning bileaflet mechanical AVR with normal gradient and trace aortic regurgitation. Moderate to severe mitral regurgitation with normal valve morphology. Mild pulmonary artery systolic hypertension. Mild-moderate tricuspid regurgitation. TRANSESOPHAGEAL ECHO ___ There is no spontaneous echo contrast or thrombus in the body of the left atrium/left atrial appendage. Theleft atrial appendage ejection velocity is normal. No spontaneous echo contrast or thrombus is seen in thebody of the right atrium/right atrial appendage. The right atrial appendage ejection velocity is normal. There isno evidence for an atrial septal defect by 2D/color Doppler. Overall left ventricular systolic function is normal.Due to severity of mitral regurgitation, intrinsic left ventricular systolic function is likely lower. The rightventricle has depressed free wall motion. Intrinsic right ventricular systolic function is likely lower due to theseverity of tricuspid regurgitation. There are simple atheroma in the descending aorta to 40cm from theincisors. A bileaflet mechanical aortic valve prosthesis is present. The prosthesis is well seated with normaldisc motion and transvalvular gradient. No masses or vegetations are seen on the aortic valve. No abscess isseen. There is no aortic regurgitation. The mitral valve leaflets are mildly thickened with no mitral valveprolapse. No masses or vegetations are seen on the mitral valve. No abscess is seen.There is a central jet ofmoderate to severe mitral regurgitation [3+].The tricuspid valve leaflets appear structurally normal. Nomass/vegetation are seen on the tricuspid valve. No abscess is seen. There is mild to moderate ___ regurgitation. There is moderate pulmonary artery systolic hypertension. There is a trivial pericardialeffusion. IMPRESSION: Moderate to severe functional mitral regurgitation. Well seated mechanical bileafletOn-X aortic valve with normal disc motion and transvalvular gradients. Grossly normal leftventricular systolic function with depressed right ventricular systolic function. Mild to moderatetricuspid regurgitation. At least moderate pulmonary artery systolic hypertension. Brief Hospital Course: ___ yo female with a past medical history of CVA, antiphospholipid syndrome on warfarin, and AI s/p AVR ON-X on ___ who upon discharge has been experiencing recurrent progressive SOB requiring inpatient diuresis (___) now with progressive SOB. TTE on admission showed 3+ MR, EF 54%. She was admitted to the cardiac surgery service where she was diuresed with steady improvement in her symptoms and volume status on exam. Once euvolemic a TTE continued to demonstrate moderate to severe MR; TEE ___ performed showing 3+ MR with ___ central jet of MR. ___ was maintained on 40mg of torsemide. ===================== Transitional issues: ===================== [ ] ___ to draw labs on ___ for appointment with Dr. ___ ___ on ___. This will include BMP and INR. The INR will be followed up by her primary care physician, ___. [ ] Discharge creatinine: 2.1 [ ] Discharge weight: 150 pounds [ ] Discharge diuretic: 40mg of torsemide [ ] Patient is completing a reload of amiodarone for persistent atrial fibrillation (despite being on amiodarone postoperatively). She will continue on 200 bid until ___. Then, she should be on 200 mg daily. [ ] Please consider referral to nephrology for establishment of care given likely new CKD # CORONARIES: No artherosclerosis # PUMP: LVEF >60% (visual estimate) # RHYTHM: NSR with short lasting pAfib ACUTE PROBLEMS: =============== #Valvular heart disease #Severe MR Ms. ___ has been experiencing recurrent exacerabations of her valvular heart disease. She initially underwent aortic valve replacement in on ___. Her aortic insufficiency was thought to be a consequence of remote endocarditis. Post operatively, she was found to have new moderate mitral regurgitation. On subsequent TTE, the regurgitation was worsening. She was discharged on oral diuretics, but became dyspneic at home. On this admission, her TTE showed 3+ MR, EF 54%. This was on ___. She responded well to aggressive diuresis. Echo on ___, with Ms. ___ at near ___, demonstrated moderate to severe MR increasing the concern for a primary valvulopathy (SLE) or structural cause of her MR possibly secondary to the aortic valve replacement. TEE ___ continued to demonstrate 3+ MR with ___ central jet of MR, no prolapse, no valvular lesions. This did not reveal an etiology for her MR. ___ weight remained stable on PO diuretics and it was felt that it was safe to discharge her home on an oral regimen of torsemide 40 mg daily. with close follow up. D/c Weight 150.57 lbs #AOCKI Looking at creatinine in BI system. It appears that in early ___ Ms. ___ had a baseline creatinine of 1.0. Following her AVR, creatinine rose to 3.9. This raises concern for perioperative kidney injury/ATN. It does not appear that Ms. ___ renal function has fully recovered since that time. It appears that her new baseline creatinine is 1.6. Given chronicity of 1 month, does not meet criteria for CKD. She was aggressively diuresed this admission, with creatinine peaking to 2.2. She remained stable on PO torsemide. Discharge creatinine was 2.1. Patient should see a nephrologist after discharge. #pAfib Ms. ___ first experience afib perioperatively. A fib this hospitalization, 1 month out from procedure, was paroxysmal. She continued to experience paroxysmal afib while on amiodarone 200 mg. Amiodarone was reloaded by increase to 200 mg BID for two weeks ___ - ___ and then to amiodarone 200 mg QD. With amiodarone increased, Ms. ___ rate returned to ___ with first degree AV block. Warfarin was continued with a goal INR of 2.5 - 3.5 (confirmed with cardiac surgery: higher goal given history of CVA, pAFIB, and AVR). Her next INR check will be two days after discharge, ___ and her labs will be sent to PCP for dose adjustments. #SLE #Anti phospholipid syndrome APLS diagnosed in ___. Records not available to investigate further work up or reason for testing. No work up mentioned in available records since that time. New onset valvular heart disease requiring AVR along with moderate to sever MR at ___ are concerning for SLE valvulopathy. SLE valvulopathy is more commonly seen in individuals with high antiphospholipid titers. Denied any signs/symptoms of Lupus, denies prior flares, and does not know when she was diagnosed. Given low diagnostic accuracy of antibody titers for SLE valvular disease, which does not correlate with SLE flares, and provided other plausible structural causes of MR, further testing was deferred this hospitalization. #Pre-diabetes A1c 5.8 ___. BSG was within normal range this hospitalization. Continued to monitor. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amiodarone 200 mg PO DAILY 2. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 3. Aspirin EC 81 mg PO DAILY 4. Atorvastatin 80 mg PO QPM 5. HydrALAZINE 25 mg PO Q6H 6. Metoprolol Tartrate 75 mg PO BID 7. Potassium Chloride 20 mEq PO DAILY 8. Furosemide 20 mg PO DAILY 9. Ranitidine 150 mg PO DAILY 10. ___ MD to order daily dose PO DAILY16 Mechanical AVR ___. TraMADol 50 mg PO Q4H:PRN Pain - Moderate Discharge Medications: 1. CARVedilol 6.25 mg PO BID 2. Torsemide 40 mg PO DAILY 3. Valsartan 40 mg PO BID 4. Amiodarone 200 mg PO BID 5. TraMADol 50 mg PO Q6H:PRN Pain - Moderate 6. Warfarin 3 mg PO DAILY16 Duration: 1 Dose Target INR: 2.5 - 3.5 7. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 8. Aspirin EC 81 mg PO DAILY 9. Atorvastatin 80 mg PO QPM 10. Ranitidine 150 mg PO DAILY 11.Outpatient Lab Work Nonrheumatic aortic (valve) insufficiency. ICD 10: I35.1 INR, BMP to be drawn on ___ Fax results to Dr. ___: ___ and Dr. ___: ___ Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Heart failure exacerbation PMH: Aortic Insufficiency, s/p Aortic valve replacement with a 25 mm Onyx mechanical valve on ___ by Dr ___ ___ Lupus ___ syndrome History of CVA Anemia prediabetes mobile left breast mass in ___ non-specific reaction to PPD without tuberculosis nocturnal polyuria diastolic heart failure Discharge Condition: Alert and oriented x3, non-focal Ambulating, gait steady Sternal pain managed with oral analgesics Sternal Incision - healing well, no erythema or drainage ___ trace Edema Discharge Instructions: Please shower daily -wash incisions gently with mild soap, no baths or swimming, look at your incisions daily Please - NO lotion, cream, powder or ointment to incisions Each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart No driving for approximately one month and while taking narcotics Clearance to drive will be discussed at follow up appointment with surgeon No lifting more than 10 pounds for 10 weeks Encourage full shoulder range of motion, unless otherwise specified **Please call cardiac surgery office with any questions or concerns ___. Answering service will contact on call person during off hours** Females: Please wear bra to reduce pulling on incision, avoid rubbing on lower edge Followup Instructions: ___
19973133-DS-12
19,973,133
20,578,132
DS
12
2189-04-06 00:00:00
2189-04-07 19:42:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Atenolol / adhesive tape / Niaspan Starter Pack / Neosporin Scar Solution / Lipitor / Crestor / Nexium Packet / tramadol / vicryl sutures / steri strips Attending: ___ ___ Complaint: Fever, shortness of breath Major Surgical or Invasive Procedure: None History of Present Illness: ___ F with hx of COPD, HTN, HLD, hypothyroidism presents with 2 weeks of URI symptoms and 2 days of fever, found to have influenza A and anemia. The patient reports developing non-productive cough, rhinorrhea, and malaise about 2 weeks prior, after she received her second influenza shot. She says a cold has been going around her family--her husband and son have also had similar symptoms. However, 2 days ago she developed fevers to 102, chills, weakness and myalgias with decreased PO intake. She also reports increased shortness of breath with exertion, not at rest. Says it feels like her COPD flaring up. She denies any chest pain, palpitations, nausea, vomiting, abdominal pain, sore throat, ear ache, dysuria. She also reports black stools for about 10 days since starting oral ferrous sulfate. Has been having loose stools for about 2 weeks, soft not watery, about 2x/day. Denies any lightheadedness/dizziness. No prior GI bleed. Reports hx of iron deficiency anemia. Had colonoscopy ___ years prior. In the ED, initial vitals: 98.6 88 125/78 16 97% RA. Labs were significant for hct 30.4->25.9, creatinine 1.3->1.1, positive influenza A. CXR showed no acute cardiopulmonary process. She was given 2L IVF, albuterol and ipratropium nebs, 1g tylenol, and home levothyroxine, citalopram, aspirin and protonix. Rectal exam showed guaiac positive brown stool. She was admitted for influenza, anemia. Vitals prior to transfer: 97.8 79 120/55 20 96% RA. Currently, the patient feels fatigued. Some abdominal/chest pain from coughing. Past Medical History: - Chronic iron deficiency anemia without known source of bleeding. - Hypertension. - Hypothyroidism. - Osteoarthritis. - Hyperlipidemia. - GERD. - COPD/asthma - Skin cancers. - Severe back pain due to sarcoid sacroiliac dysfunction, now much improved after injection. -___ ___ neuropathy - Cataracts - Nephrolithiasis s/p lithotripsy x3 (calcium stones) - s/p Appendectomy - Positive PPD - s/p Bladder suspension - s/p TAH - s/p spinal fusion ___ -cervical rib resection ___ -no DM Social History: ___ Family History: mother - ___ disease, DM, breast cancer, valvular heart disease, pernicious anemia Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VS: 98.0 123/53 84 18 97% RA GEN: Alert, lying in bed, no acute distress HEENT: MMM, anicteric sclerae, no conjunctival pallor NECK: Supple without LAD PULM: Generally CTA b/l without wheeze or rhonchi COR: RRR (+)S1/S2 no m/r/g ABD: Soft, non-tender, non-distended EXTREM: Warm, well-perfused, no edema NEURO: CN II-XII grossly intact, motor function grossly normal DISCHARGE PHYSICAL EXAM: ======================== VITALS: 98.3, 126/73, 96, 18, 92% RA GEN: Alert, lying in bed, no acute distress HEENT: MMM, anicteric sclerae, no conjunctival pallor NECK: Supple without LAD PULM: Generally CTA b/l without wheeze or rhonchi COR: RRR (+)S1/S2 no m/r/g ABD: Soft, non-tender, non-distended EXTREM: Warm, well-perfused, no edema NEURO: CN II-XII grossly intact, motor function grossly normal Pertinent Results: ADMISSION LABS: ================ ___ 02:00PM BLOOD WBC-6.2 RBC-4.32 Hgb-9.7* Hct-30.4* MCV-70* MCH-22.4* MCHC-31.9 RDW-19.4* Plt ___ ___ 02:00PM BLOOD Neuts-75.0* ___ Monos-5.3 Eos-0.6 Baso-0.3 ___ 02:00PM BLOOD Glucose-91 UreaN-17 Creat-1.3* Na-137 K-5.2* Cl-99 HCO3-25 AnGap-18 ___ 02:00PM BLOOD ALT-26 AST-51* AlkPhos-79 TotBili-0.3 ___ 02:00PM BLOOD Albumin-4.2 OTHER LABS: ============ ___ 03:33PM BLOOD Ret Aut-1.5 ___ 03:33PM BLOOD LD(LDH)-190 TotBili-0.2 ___ 03:33PM BLOOD calTIBC-390 ___ Ferritn-27 TRF-300 ___ 03:33PM BLOOD Iron-16* ___ 06:06AM BLOOD Glucose-124* UreaN-5* Creat-0.9 Na-137 K-4.2 Cl-101 HCO3-29 AnGap-11 DISCHARGE LABS: ================ ___ 05:30AM BLOOD WBC-7.5 RBC-3.82* Hgb-8.3* Hct-29.2* MCV-76* MCH-21.6* MCHC-28.3*# RDW-21.0* Plt ___ MICRO: ======= ___ BLOOD CULTURE x2 -- NGTD, FINAL RESULT PENDING ___ STOOL C DIFFICILE ASSAY -- Positive for toxigenic C. difficile IMAGING: ======== ___ CHEST (PA & LAT) IMPRESSION: No acute cardiopulmonary process. Brief Hospital Course: ___ F with hx of COPD, HTN, HLD, hypothyroidism presents with 2 weeks of URI symptoms and 2 days of fever, found to have influenza A and anemia. # Influenza A: Patient with fever, chills, weakness, and cough on presentation, and tested positive for influenza A. Likely upper respiratory infection 2 weeks ago with superimposed influenza for 2 days with fevers. Although patient likely 48 hours after onset of influenza, treated with tamiflu given comorbidities (COPD) as she is at risk for decompensation. She was also treated supportively with cough medications, zofran, and tylenol. She improved and by discharge was feeling better. # Anemia: Patient with hct in the upper ___ during admission, with stable blood counts. Slightly lower than recent baseline of low ___. Pt c/o dark stools, but difficult to interpret in setting of recent iron use. Stool in ED was brown and guaiac positive. Iron studies reveal low iron and ferritin, consistent with iron deficiency. Last colonoscopy and EGD done in ___. Hemolysis w/u negative. She has a history of iron deficiency anemia and was previously evaluated by hematology; last saw them ___. Possibly due to slow GIB vs. iron deficiency from malabsorption or poor intake. No hx of prior GIBs. She was given IV iron infusions and restarted on oral ferrous sulfate. She will need colonoscopy and EGD for further evaluation. # Diarrhea: Patient reporting mild amount of small volume diarrhea, mostly mucus and nonbloody beginning a couple of days into her hospital course. She remained afebrile with the onset of the diarrhea and was without abdominal pain. She tested positive for C difficile and was started on treatment with PO metronidazole 500mg TID for a 14 day course to end ___. This is her first episode of c diff. # COPD: Patient with non-O2 dependent COPD, with worsening shortness of breath. No evidence of COPD exacerbation. She was given standing duonebs, albuterol prn, advair and cough medications. She improved clinically by the day of discharge. # ___: Resolved. Creatinine on admission 1.3, then improved to baseline. Likely pre-renal in setting of acute infection and poor PO intake. # HTN: Initially held amlodipine and lisinopril given acute infection, however, were restarted by discharge. # Depression: Continued citalopram # Hypothyroidism: Continued levothyroxine # Chronic pain: Held vicodin as non-formulary, instead gave oxycodone prn # GERD: continued protonix TRANSITIONAL ISSUES: ==================== - Will need colonoscopy and EGD for further evaluation of iron deficiency anemia Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheezing 2. Alendronate Sodium 70 mg PO QMON 3. Amlodipine 5 mg PO BID 4. Benzonatate 100 mg PO TID:PRN cough 5. budesonide-formoterol 160-4.5 mcg/actuation 2 puffs BID 6. Citalopram 20 mg PO QHS 7. Fluticasone Propionate NASAL 1 SPRY NU DAILY:PRN allergies 8. Hydrocodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H:PRN pain 9. Levothyroxine Sodium 75 mcg PO DAILY 10. Lisinopril 20 mg PO DAILY 11. Pantoprazole 40 mg PO Q24H 12. Tiotropium Bromide 1 CAP IH DAILY 13. Aspirin 81 mg PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Benzonatate 100 mg PO TID:PRN cough 3. Citalopram 20 mg PO QHS 4. Fluticasone Propionate NASAL 1 SPRY NU DAILY:PRN allergies 5. Levothyroxine Sodium 75 mcg PO DAILY 6. Pantoprazole 40 mg PO Q24H 7. Ferrous Sulfate 325 mg PO DAILY RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 8. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheezing 9. Alendronate Sodium 70 mg PO QMON 10. Amlodipine 5 mg PO BID 11. budesonide-formoterol 160-4.5 mcg/actuation 2 PUFFS BID 12. Hydrocodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H:PRN pain 13. Lisinopril 20 mg PO DAILY 14. Tiotropium Bromide 1 CAP IH DAILY 15. Dextromethorphan Polistirex ___ mg PO Q12H RX *dextromethorphan polistirex ___ mg/5 mL 5 mL by mouth every twelve (12) hours Refills:*0 16. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H DO NOT use alcohol while taking this medication. Concurrent alcohol use will cause severe GI upset RX *metronidazole 500 mg 1 tablet(s) by mouth every eight (8) hours Disp #*40 Tablet Refills:*0 17. OSELTAMivir 75 mg PO Q12H RX *oseltamivir [Tamiflu] 75 mg 1 capsule(s) by mouth once a day Disp #*1 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Influenza A infection Iron deficiency anemia Discharge Condition: Activity Status: Ambulatory - Independent. Level of Consciousness: Alert and interactive. Mental Status: Clear and coherent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you during your stay. You were admitted for fever and shortness of breath, and were found to have the flu. You were started on tamiflu and were given supportive medications, such as cough medications and tylenol. You improved and by discharge were feeling better. In addition, you were found to have iron deficiency anemia. Your blood counts remained stable during your stay and you were given a few doses if IV iron infusions. Please follow up with your PCP after discharge; you will likely need a colonoscopy and possibly upper endoscopy for further evaluation. You were also found to have an intestinal infection called Clostridium difficile (or C diff). We treated you with an antibiotic called metronidazole. Please take this medication as prescribed. It is very important that you DO NOT use alcohol while taking this medication as it can cause very severe GI upset (nausea, vomiting etc). Please take all of the pills and do not skip doses or shorten your antibiotic course without speaking to your doctor. Your follow up appointments are listed below. Please take all of your medications a prescribed. We wish you the best! Your ___ care team Followup Instructions: ___
19973133-DS-14
19,973,133
20,505,308
DS
14
2192-08-28 00:00:00
2192-08-29 20:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Atenolol / adhesive tape / Niaspan Starter Pack / Neosporin Scar Solution / Lipitor / Crestor / Nexium Packet / tramadol / vicryl sutures / steri strips Attending: ___. Chief Complaint: Fall Major Surgical or Invasive Procedure: Right femoral neck fracture s/p right hip hemiarthroplasty on ___ History of Present Illness: ___ female history of severe COPD (on 3 L home O2), hypertension, aortic stenosis, HFpEF, pulmonary hypertension, dyslipidemia who presents with right hip pain status post mechanical fall. The patient was ambulating in her home without a walker when she got tangled in her oxygen tubing and tripped and fell directly onto her right side. Noticed immediate pain and deformity. Was unable to bear any weight on the right side. She presented to the hospital for further evaluation. Denies any numbness tingling or pain elsewhere. Past Medical History: - Chronic iron deficiency anemia without known source of bleeding. - Hypertension. - Hypothyroidism. - Osteoarthritis. - Hyperlipidemia. - GERD. - COPD/asthma - Skin cancers. - Severe back pain due to sarcoid sacroiliac dysfunction, now much improved after injection. -___ ___ neuropathy - Cataracts - Nephrolithiasis s/p lithotripsy x3 (calcium stones) - s/p Appendectomy - Positive PPD - s/p Bladder suspension - s/p TAH - s/p spinal fusion ___ -cervical rib resection ___ -no DM Social History: ___ Family History: mother - ___ disease, DM, breast cancer, valvular heart disease, pernicious anemia Physical Exam: ADMISSION EXAM ============== General: Well-appearing female in no acute distress. Right lower extremity: Leg shortened and externally rotated Unable to tolerate log roll or axial compression - Fires ___ - SILT S/S/SP/DP/T distributions - 1+ ___ pulses, WWP DISCHARGE EXAM ============== VITALS: Stable, satting mid-90's on 3L NC GENERAL: Resting comfortably in bed in no acute distress. HEENT: Anicteric. CV: Regular rate and rhythm. Grade ___ systolic murmur. heard loudest at left sternal border. PULM: Reduced breath sounds at lung bases. No wheezing or rales. ABD: +Bowel sounds, soft, non-tender, non-distended. SKIN: Dressed wound right hip. Bruising over nasal bridge. PSYCH: A&O x3, moving all limbs with purpose Pertinent Results: ADMISSION LABS ============== ___ 10:00PM BLOOD WBC-9.5 RBC-4.38 Hgb-14.2 Hct-41.8 MCV-95 MCH-32.4* MCHC-34.0 RDW-13.2 RDWSD-47.0* Plt ___ ___ 10:00PM BLOOD Neuts-78.7* Lymphs-12.1* Monos-5.6 Eos-2.1 Baso-0.7 Im ___ AbsNeut-7.50* AbsLymp-1.15* AbsMono-0.53 AbsEos-0.20 AbsBaso-0.07 ___ 10:00PM BLOOD Plt ___ ___ 10:00PM BLOOD Glucose-123* UreaN-14 Creat-1.3* Na-136 K-5.8* Cl-92* HCO3-28 AnGap-16 ___ 10:00PM BLOOD estGFR-Using this DISCHARGE LABS ============== ___ 03:36AM BLOOD WBC-11.7* RBC-2.93* Hgb-9.4* Hct-28.7* MCV-98 MCH-32.1* MCHC-32.8 RDW-12.9 RDWSD-46.5* Plt ___ ___ 03:36AM BLOOD Plt ___ ___ 03:36AM BLOOD Glucose-116* UreaN-23* Creat-1.1 Na-134* K-4.2 Cl-93* HCO3-30 AnGap-11 ___ 03:36AM BLOOD cTropnT-<0.01 ___ 03:36AM BLOOD Calcium-8.4 Phos-2.8 Mg-2.0 NOTABLE LABS ============ ___ 10:00PM BLOOD ASA-NEG ___ Acetmnp-NEG Tricycl-NEG NOTABLE IMAGING =============== ___ FEMUR XR IMPRESSION: Limited study due to underpenetration. Right femoral neck fracture, likely basicervical, with impaction. Right femoral head articulates with the acetabulum. ___ PELVIC XR Limited study due to underpenetration. Right femoral neck fracture, likely basicervical, with impaction. Right femoral head articulates with the acetabulum. ___ CTA CHEST IMPRESSION: 1. No evidence of pulmonary embolism or aortic abnormality. 2. Small bilateral pleural effusions. 3. Moderate to severe pulmonary emphysema. 4. Biapical pleuroparenchymal scarring and calcifications are unchanged and likely sequela of prior infection. ___ TTE IMPRESSION: Normal global and regional biventricular systolic function. Mild aortic stenosis. Mild mitral regurgitation. Moderate pulmonary hypertension. Compared with the prior TTE (images reviewed) of ___, the findings are similar. Brief Hospital Course: HOSPITAL COURSE =============== ___ is an ___ female with a past medical history significant for severe COPD (on 3 L home O2), hypertension, aortic stenosis, HFpEF, pulmonary hypertension, and dyslipidemia who presented to the ___ ED after a fall, found to have right femoral neck fracture s/p right hip hemiarthroplasty on ___, transferred to medicine due to hypoxia and delirium. ACUTE ISSUES ============ # HYPOXIA / HFpEF / COPD Patient developed increasing O2 requirements following her right hip hemiarthroplasty, improved w/ IV Lasix, CXR with mild pulmonary vascular congestion without overt pulmonary edema. CTA showing severe emphysema but no PE. On ___, back on baseline 3L O2. Discharged on Lasix 60mg PO QD (was on ___ alternating doses at home). # FEMORAL NECK FRACTURE Patient sustained a femoral neck fracture following a mechanical fall at her home. s/p right hip hemiarthoplasty on ___. Patient's surgical site is healing well and the surgery was uncomplicated. - Activity: WBAT & ROMAT RLE - Anticoagulation: heparin 5000 U sc tid - Pain Control: tylenol ___ TID, Oxycodone 5mg PO q 4 hours while awake, Oxycodone 2.5mg PO q 6 hours PRN, Lidocaine Patch # DELIRIUM The patient has evidence of delirium evolving in in the setting of a high risk patient with multiple triggers. She was noted overnight to have some signs and features of sun-downing. Resumed home Alprazolam 0.25mg QHS. Analgesia as detailed above. Stable at discharge. # EtOH USE DISORDER Significant alcohol use along with chronic prescription opioid use, likely major contributor to recent falls. Started on MVI, thiamine, folate. Should continue to encourage alcohol cessation. CHRONIC ISSUES ============== # HFpEF No current signs of volume overload on exam. Intermittently hypoxic. No frank pulmonary edema on CXR or exam. TTE done ___ with LVEF of 76%. On lasix 60mg/80mg alternating daily doses at home. No signs of acute decompensation at this time. # HTN - Continued home amLODIPine 5 mg PO DAILY - Held home Lisinopril 20 mg PO DAILY given recent procedure, normotension # COPD # Pulmonary Hypertension (WHO class II/III): On 3L NC O2 at baseline. - Continued home Tiotropium Bromide 1 CAP IH DAILY - Continued home Symbicort inhalation DAILY - Continued home Albuterol Inhaler 1 PUFF IH Q4H:PRN wheezing # GERD - Continued home Pantoprazole 40 mg PO Q24H # HYPOTHYROIDISM - Continued home Levothyroxine Sodium 50 mcg PO DAILY # DEPRESSION/ ANXIETY - Continued home Citalopram 30 mg PO QHS - Continued home ALPRAZolam 0.25 mg PO DAILY:PRN severe anxiety TRANSITIONAL ISSUES =================== [] Medication changes - Lasix changed from alternating ___ every other day to 60mg PO DAILY - Started subq heparin to be continued at least 4 weeks post-op - Stopped HYDROcodone-Acetaminophen, replaced with oxycodone and APAP - Stopped Lisinopril 20 mg PO DAILY as not hypertensive - Started on folate, multivitamin, thiamine given alcohol use [] Please call ___ to schedule orthopedics follow-up with ___ within ___ weeks [] Please call ___ to make appointment with patient's PCP/gerontologist ___ at time of discharge. [] Patient with significant alcohol use; this along with chronic prescription opioid use has likely been large contributor to recent falls and trauma. Would continue to strongly encourage alcohol cessation [] Please titrate down oxycodone amount as possible once patient's post-surgical pain resolves [] Obtain daily weights and monitor respiratory status, if significant weight increase or increase oxygen requirements (baseline 3 liters) would consider increasing Lasix dose # CODE: FULL # CONTACT: - Name of health care proxy: ___ - Relationship:daughter - Phone ___, Cell phone: ___ 42 minutes was spent seeing, examining and supervising/coordinating the discharge of Ms. ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Docusate Sodium 100 mg PO DAILY 2. GuaiFENesin ER 600 mg PO Q12H 3. Tiotropium Bromide 1 CAP IH DAILY 4. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation DAILY 5. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheezing 6. ALPRAZolam 0.25 mg PO DAILY:PRN severe anxiety 7. amLODIPine 5 mg PO DAILY 8. Citalopram 30 mg PO QHS 9. Fexofenadine 180 mg PO DAILY 10. Furosemide 60 mg PO EVERY OTHER DAY 11. Furosemide 80 mg PO EVERY OTHER DAY 12. HYDROcodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN Pain - Moderate 13. Levothyroxine Sodium 50 mcg PO DAILY 14. Lisinopril 20 mg PO DAILY 15. Pantoprazole 40 mg PO Q24H Discharge Medications: 1. Acetaminophen 1000 mg PO TID 2. FoLIC Acid 1 mg PO DAILY 3. Heparin 5000 UNIT SC TID 4. Lidocaine 5% Patch 1 PTCH TD QAM pain 5. Lidocaine 5% Patch 2 PTCH TD QPM 6. Multivitamins 1 TAB PO DAILY 7. OxyCODONE (Immediate Release) 5 mg PO Q4H do not give overnight, do not wake up to give 8. OxyCODONE (Immediate Release) 2.5 mg PO Q6H:PRN BREAKTHROUGH PAIN 9. Thiamine 100 mg PO DAILY 10. ALPRAZolam 0.25 mg PO QHS severe anxiety 11. Furosemide 60 mg PO DAILY 12. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheezing 13. amLODIPine 5 mg PO DAILY 14. Citalopram 30 mg PO QHS 15. Docusate Sodium 100 mg PO DAILY 16. Fexofenadine 180 mg PO DAILY 17. GuaiFENesin ER 600 mg PO Q12H 18. Levothyroxine Sodium 50 mcg PO DAILY 19. Pantoprazole 40 mg PO Q24H 20. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation DAILY 21. Tiotropium Bromide 1 CAP IH DAILY 22. HELD- Lisinopril 20 mg PO DAILY This medication was held. Do not restart Lisinopril until found to be hypertensive Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary diagnosis - Right femoral neck fracture s/p right hip hemiarthroplasty on ___ Secondary diagnoses - Heart failure with preserved EF - COPD - Alcohol use disorder Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms ___, You were admitted to the hospital after you fell and broke your hip. You underwent surgery to repair your hip. You developed some breathing difficulties and required higher levels of oxygen for a while, but this improved and you were back to your home O2 requirement. You have had multiple falls recently, and your alcohol use is likely a strong contributor to this. We STRONGLY encourage you to cut down or stop your alcohol intake to prevent further serious health problems. It was a privilege to care for you in the hospital, and we wish you all the best. Sincerely, Your ___ Health Team Followup Instructions: ___
19973133-DS-17
19,973,133
23,458,544
DS
17
2193-08-17 00:00:00
2193-08-19 15:30:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Atenolol / adhesive tape / Niaspan Starter Pack / Neosporin Scar Solution / Lipitor / Crestor / Nexium Packet / tramadol / vicryl sutures / steri strips Attending: ___. Chief Complaint: Weakness, recent fall Major Surgical or Invasive Procedure: EGD/colonoscopy History of Present Illness: Ms. ___ is a ___ yo F with hx of COPD on 3 L O2 at baseline, HTN, HFpEF, HLD, hypothyroidism, back pain, who presents to the ED following a fall and continued UTI symptoms that was previously treated at urgent care on a course of 10 days cefpodoxime. Per history obtained in the ED, she states was diagnosed with a UTI 10 days ago and treated with cefpodoxime x10 days. She was on her last dose of cefpodoxime but presented to the ED with continued dysuria, increased urinary frequency, and right flank pain. She feels that her symptoms have not resolved and she feels less well and more fatigued. She also has new incontinence. She also reports a fall forward 4 days ago onto her knees and then her side with headstrke on the wall. She denies LOC and no residual headache. She denied fevers, chest pain, SOB, syncope, LOC or dizziness. In the ED, initial vitals were: 159/80, HR 95, 97.7, 100% on 3L NC, pain ___ Exam was notable for: - soft, nontender abdomen, stool brown but guaiac positive, normal rectal tone Labs were notable for: - WBC 7.8, Hb 5.5, HCT 21, plt 335 - repeat WBC 8.0, Hb 7.4, HCT 27, Plt 354 - repeat WBC 6.8, Hb 7.1, HCT 25.7, Plt 318 - ALT 9, AST 22, Tbili 0.2, Alb 4.3, AP 64 - Na 135, K 4.7 Cr 1.2, BG 107 Na 139, K 4.6, Cr 0.9, BG 101 - UA with straw colored urine, neg bood, neg nitrite, trace leuks, RBC <1, WBC 1, bact none, yeast none, epi 0 - lactate 0.6 Studies were notable for: - CT abd/pelvis -- findings concerning for right rectus sheath hematoma measuring 2.3 x 5.7 x 6.7 cm, nonobstructing 4 mm left upper pole renal calculi, diverticulosis without evidence of diverticulitis - no active extravasation on imaging and ___ deferred intervention - CXR with no evidence of pulmonary edema or pneumonia - EKG: sinus rhythm, ?left atrial enlargement The patient was given: - morphine sulfate 4 mg, morphine 2 mg x2 - LR 1 L - citalopram 20 mg - levothyroxine 50 mcg - 1 neb ipratroprium-albuterol Consults: - ___ -- right rectus hematoma post fall, Hb 10 --> 5 over 3 months, no extravasation, no ___ intervention planned for now - SW for patient's husband who cannot go home alone -- patient and husband live at ___ - ___ allowing husband to remain at bedside with patient overnight - SW to coordinate with ___ staff On arrival to the floor, she says she has been feeling lousy and tired for the past ~10 days. She states that she fell about 10ish days ago by tripping up on some wires while getting off the couch. She says she fell to her knees, hit her right side on the couch, and smacked her head against the wall. She denies any headaches, lightheadedness, dizziness, or loss of consciousness after the fall. It was a bit unclear if this fall happened 10 days ago or just 4 days ago because she thinks she was feeling lousy before the fall which prompted her to present to urgent care. On ___, she presented to urgent care with right sided back pain and urinary frequency and was treated with cefpodoxime for 10 days. She nearly finished her course except for 1 pill. She did not feel that the treatment helped with her symptoms at all. She says the pain on her right side feels like someone kicked her and rates it as ___. She is not sure if the pain started gradually or all of a sudden. She has been taking motrin and aleve every day for >1 month and sometimes up to 6 pills a day. She also used voltaren gel which does not help. She also endorses leg weakness and increase in urinary frequency. She is having normal bowel movements (last BM yesterday). She endorses chronic cough and she wears 3 L O2 at home but 2 L when she goes out because there isn't enough oxygen. She feels short of breath when she is out running errands. She also endorses weakness in her legs that has been getting worse over the last month. She says she was seeing ___ and doing really well. She walks with a cane when outside but otherwise walks without any support. Otherwise, she denies headache, lightheadedness, dizziness, sore throat, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, numbness or tingling. Past Medical History: PAST PSYCHIATRIC HISTORY: -Prior diagnoses: Depression, anxiety -Hospitalizations: Denies -Partial hospitalizations: Denies -Psychiatrist: Denies -Therapist: Denies -Medication trials: Celexa, Prozac -___ trials: Denies -Suicide attempts: Denies -Self-injurious behavior: Denies -Harm to others: Denies -Trauma: Denies -Access to weapons: Denies . PAST MEDICAL HISTORY: - Chronic iron deficiency anemia - Hypertension. - Hypothyroidism. - Osteoarthritis. - Hyperlipidemia. - GERD. - COPD/asthma - Skin cancer. - sarcoid sacroiliac dysfunction, - ___ ___ neuropathy - Cataracts - Nephrolithiasis s/p lithotripsy x3 (calcium stones) - s/p Appendectomy - s/p Bladder suspension - s/p TAH - s/p spinal fusion ___ . Social History: ___ Family History: Mother -- valvular heart disease, breast cancer Father -- leukemia Physical ___: ADMISSION PHYSICAL EXAM: ======================== VITALS: 147/76, HR 94, 97% on 3 L NC, 97.9 GENERAL: Alert and interactive. In no acute distress. Wearing NC O2. HEENT: EOMI. Sclera anicteric and without injection. MMM. Conjunctiva pale. NECK: No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. Systolic ejection murmur, heard ___ at RUSB. LUNGS: Clear to auscultation bilaterally but some minimal expiratory wheezes on anterior exam only. No increased work of breathing. BACK: No CVA tenderness bilaterally. Well healed scars in thoracic and lumbar area. ABDOMEN: Normal bowels sounds, non distended, non-tender to deep palpation in all four quadrants. Possibly with central umbilical hernia that is soft. Tenderness to palpation on right side/front of flank (but no CVA tenderness), no skin changes or erythema. EXTREMITIES: No clubbing, cyanosis, or edema. Pulses DP/Radial 2+ bilaterally. SKIN: Warm. No rashes. NEUROLOGIC: AOx3. CN2-12 intact. Moving all 4 limbs spontaneously. Otherwise grossly intact. DISCHARGE PHYSICAL EXAM: =================== PHYSICAL EXAM: VS: 128/66, HR 95, RR 18, 100% on 3L GENERAL: NAD, lying in bed. HEENT: Anicteric sclerae. Pale conjunctiva. MMM. NECK: No JVD. No cervical/clavicular LAD. CV: RRR. S1/S2. Systolic ejection murmur at RUSB. PULM: Clear to auscultation bilaterally. ABD: BS+, soft, ND, mildly tender to palpation in RLQ/right back EXTR: WWP, no edema, clubbing, jaundice Pertinent Results: ADMISSION LABS: =========== ___ 07:52PM BLOOD WBC-7.8 RBC-2.80* Hgb-5.5* Hct-21.1* MCV-75* MCH-19.6* MCHC-26.1* RDW-16.5* RDWSD-45.2 Plt ___ ___ 07:52PM BLOOD Glucose-107* UreaN-32* Creat-1.2* Na-135 K-4.7 Cl-97 HCO3-24 AnGap-14 ___ 07:52PM BLOOD Albumin-4.3 Calcium-9.3 Phos-3.8 Mg-2.1 Interim labs: ___ 04:36AM BLOOD calTIBC-536* VitB12-349 Folate->20 Ferritn-13 TRF-412* REPORTS: ======= ___ CXR Apical scarring is noted bilaterally. No evidence of focal consolidation, pleural effusion or pneumothorax. Minimal bibasal atelectasis. No pulmonary edema. Cardiac and hilar silhouettes are normal. Prominent aortic arch calcifications are noted. ___ CT abd/pelvis 1. Findings concerning for a right rectus sheath hematoma measuring 2.3 x 5.7 x 6.7 cm. 2. Nonobstructing 4 mm left upper pole renal calculi 3. Diverticulosis without evidence of diverticulitis. ___: colonoscopy - normal mucosa in whole colon - diverticulosis of descending colon and sigmoid colon - colon was tortuous, requiring use of rescue colonoscope to transverse sigmoid - grade 2 internal hemorrhoids ___ EGD - normal mucosa of whole esophagus - esophageal hiatal hernia - polyps (3 mm to 5 mm) in antrum and fundus (biopsy) - erosions in fundus in hiatal hernia - normal mucosa in whole examined duodenum - erythema in antrum DISCHARGE LABS: =========== ___ 06:20AM BLOOD WBC-7.3 RBC-3.18* Hgb-7.2* Hct-25.3* MCV-80* MCH-22.6* MCHC-28.5* RDW-19.5* RDWSD-55.6* Plt ___ ___ 06:20AM BLOOD Glucose-103* UreaN-13 Creat-1.1 Na-145 K-3.5 Cl-102 HCO3-23 AnGap-20* Brief Hospital Course: SUMMARY ============================================================= Mrs. ___ is an ___ woman with COPD on 3L O2, HFpEF, HTN, HLD, and hypothyroidism who presents with fatigue and R torso pain after a fall ___ days ago and recent UTI, found to have a R rectal sheath hematoma and guaiac positive stools, c/f GI bleed. She received 2 units PRBC due to low Hb (down to 5.5 in the ED). However, her Hb remained low at 7.3 on ___. Pt originally wanted to leave AMA due to concern for ongoing care of husband with ___ at the ___ living facility, but the team convinced her to stay in the hospital for further evaluation given the risk of decompensation despite transfusion. GI was consulted, EGD was performed on ___ which revealed the presence of non bleeding erosions in fundus of hiatal hernia suggestive of ___ lesions. Pt was discharged in stable condition, w/ Hb 7.2. TRANSITIONAL ISSUES: = = = ================================================================ PCP: [] Please get repeat CBC at PCP ___ appointment [] Patient had a stable right rectus sheath hematoma. Please evaluate location to make sure there is no concerning findings. [] Per patient, she tripped which precipitated her fall. Please consider home safety evaluation for fall risk. [] Please ensure that patient has started omeprazole 20mg BID and stopped taking pantoprazole. She should continue 20 mg BID for ___ weeks and then transition to daily 20 mg. [] Consider starting ferrous sulfate every other day (has been shown to be better than daily iron) New meds: pantoprazole Stopped meds: amlodipine, lisinopril Changed meds: None ACTIVE ISSUES: = = = ================================================================ #Acute on chronic anemia, fatigue: Etiology of acute anemia ___ GI bleed vs. rectus sheath hematoma (less likely given it is stable w/o signs of extravasation per ___, w/ underlying chronic iron deficiency anemia. In working up, GI was consulted and EGD was performed which found the presence of non bleeding erosions in fundus of hiatal hernia suggestive of ___ lesions for which she is to be managed with omeprazole twice a day. Pt is also caretaker for her husband with ___, and presentation may have an element of caretaker fatigue. # Right rectus sheath hematoma 2.3 x 5.7 x 6.7 cm hematoma from recent fall, possibly exacerbated by chronic cough from COPD and HTN. Women and older patients are also at higher risk due to small rectus abdominis muscle mass and therefore less likely to be able to tamponade the rectus sheath hematoma. Pt not on systemic anticoagulation, and coags normal. ___ consulted and did not see any active extravasation. # Urinary frequency Recent presumed UTI treated with cefpodoxime x 10d. Patient still reports increased frequency and new incontinency, but UA negative with only trace leuk esterase. Possible etiologies also include urinary tract atrophy (common in postmenopausal women). # Fall multifactorial with multiple comorbidities: weakness with recent acute on chronic anemia, hypothyroidism, possible UTI, and COPD wearing oxygen and could have tripped on wires (per patient report). Pt also has history of chronic alcohol use, which could be contributing to weakness in legs. Continued home levothyroxine, folate and thiamine. # Pain Per review of old records, patient was on Vicodin and Xanax in the past (refer to ___ gerontology note) though there was concern for over use. Patient has hx of chronic back pain and receives nerve blocks for shoulder pain. She is seen in chronic pain clinic. # ___ Patient presented with ___ that resolved prior to discharge, likely in the setting of dehydration given poor PO intake and increased urinary frequency with recent UTI CHRONIC/STABLE ISSUES ===================== # Chronic hypoxic respiratory failure -- COPD on home O2 3L: continued O2 3L with goal O2 >88%, albuterol 1 puff PO q4 hr PRN for wheeze, sybmicort 2 puffs BID, and tiotropium 1 puff daily # HTN: held home amlodipine 5 mg daily and lisinopril 2.5 daily in case of hypotension with GI bleed # Hypothyroidism: continued home 50 mcg tablet daily # HFpEF:continued home Lasix 60 mg daily # Depression: continued mirtazapine 7.5 mg qhs and citalopram 30 mg qhs # Allergies: continued fexofenadine 180 mg daily Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 2. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheezing 3. amLODIPine 5 mg PO DAILY 4. Citalopram 30 mg PO QHS 5. Docusate Sodium 100 mg PO DAILY 6. Fexofenadine 180 mg PO DAILY 7. Tiotropium Bromide 1 CAP IH DAILY 8. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation DAILY 9. Mirtazapine 7.5 mg PO QHS 10. Lidocaine 5% Patch 2 PTCH TD QPM 11. Levothyroxine Sodium 50 mcg PO DAILY 12. Lisinopril 2.5 mg PO DAILY 13. Pantoprazole 40 mg PO Q24H 14. FoLIC Acid 1 mg PO DAILY 15. Furosemide 60 mg PO DAILY 16. Thiamine 100 mg PO DAILY 17. Ibuprofen 200 mg PO Q8H:PRN Pain - Mild 18. GuaiFENesin ER 600 mg PO Q12H 19. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation BID:PRN Discharge Medications: 1. Omeprazole 20 mg PO BID RX *omeprazole 20 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*1 2. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 3. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheezing 4. amLODIPine 5 mg PO DAILY 5. Citalopram 30 mg PO QHS 6. Docusate Sodium 100 mg PO DAILY 7. Fexofenadine 180 mg PO DAILY 8. FoLIC Acid 1 mg PO DAILY 9. Furosemide 60 mg PO DAILY 10. GuaiFENesin ER 600 mg PO Q12H 11. Levothyroxine Sodium 50 mcg PO DAILY 12. Lidocaine 5% Patch 2 PTCH TD QPM 13. Lisinopril 2.5 mg PO DAILY 14. Mirtazapine 7.5 mg PO QHS 15. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation DAILY 16. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation BID:PRN Wheezing 17. Thiamine 100 mg PO DAILY 18. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home Discharge Diagnosis: PRIMARY: ============================= Acute on chronic anemia Right rectus sheath hematoma SECONDARY: ============================= Urinary frequency Fall ___ COPD HTN Hypothyroidism HFpEF Depression Allergies Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure caring for you here at ___ ___! WHY WAS I IN THE HOSPITAL? ================================ - You were admitted to the ___ due to a fall, followed by a low red blood count, concerning for a bleed. WHAT HAPPENED IN THE HOSPITAL? ================================ - We performed a series of blood tests and imaging studies to evaluate for sites of bleeding. - You received blood transfusion in the hospital due to your decreasing red blood count. - You were evaluated by the GI doctor and ****they performed a procedure to check for sites of active bleeding in your stomach and intestines*** - You were also started on a medication called pantoprazole to alleviate the symptoms. WHAT SHOULD I DO WHEN I LEAVE THE HOSPITAL? ================================ - You should follow up with your doctors at the ___ appointment below. - If your symptoms worsen acutely (such as dizziness, bright red blood in your stool), you should see a doctor in the emergency department immediately. We wish you all the ___! Your ___ care team Followup Instructions: ___
19973133-DS-18
19,973,133
25,361,247
DS
18
2193-08-23 00:00:00
2193-08-24 13:26:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Atenolol / adhesive tape / Niaspan Starter Pack / Neosporin Scar Solution / Lipitor / Crestor / Nexium Packet / tramadol / vicryl sutures / steri strips Attending: ___. Chief Complaint: Melena Major Surgical or Invasive Procedure: Capsule Endoscopy History of Present Illness: Ms. ___ is a ___ female with medical history notable for COPD on ___ L O2, HFpEF, recent admission for anemia and rectus sheath hematoma, hypertension, hyperlipidemia, hypothyroidism who presents for evaluation of dark stools. Of note, she was recently hospitalized from ___ to ___. She initially presented after a fall, was found to have a rectal sheath hematoma, as well as anemia with guaiac positive stools requiring 2 units PRBCs. During admission, she had an EGD on ___ demonstrating nonbleeding erosions consistent with Camerons lesions and a colonoscopy with diverticulosis and internal hemorrhoids. She was discharged home on oral PPI. She reports feeling well after discharge and then woke up in the morning on ___ feeling unwell and lightheaded. She thought that she was just feeling the effects of being in bed in the hospital for 5 days. She made herself homemade waffles and bacon and then went to go to clean the litter box when she broke out in a sweat and had to use the bathroom urgently. She had a large black stool that is consistent with her prior episodes of bleeding. She denies any nausea or vomiting. She has only had one stool in total today. She still feels unsteady on her feet but denies dizziness when laying down. On arrival to ED, initial vitals were stable: T 97.4, heart rate 94, BP 123/66, respiratory rate 18 satting 96% on 2 L nasal cannula. ED exam notable for diffuse tenderness to palpation worse in the left upper quadrant. Rectal exam demonstrating melena with positive guaiac. Initial ED labs notable for H/H 8.5/30.9 from 7.2/25.3 at discharge. BMP with serum creatinine 1.3, from baseline 0.9-1.1; otherwise CBC, chemistries, LFTs, coags, urinalysis unremarkable. Repeat CBC 6 hours later 7.8/27.9 In the ED she was started on IV PPI twice daily and received some of her home medications. On arrival to the floor she endorses the above and reports back pain which is chronic. She otherwise has no acute concerns. ROS: 10 point review of systems otherwise negative Past Medical History: PAST PSYCHIATRIC HISTORY: -Prior diagnoses: Depression, anxiety -Hospitalizations: Denies -Partial hospitalizations: Denies -Psychiatrist: Denies -Therapist: Denies -Medication trials: Celexa, Prozac -___ trials: Denies -Suicide attempts: Denies -Self-injurious behavior: Denies -Harm to others: Denies -Trauma: Denies -Access to weapons: Denies . PAST MEDICAL HISTORY: - Chronic iron deficiency anemia - Hypertension. - Hypothyroidism. - Osteoarthritis. - Hyperlipidemia. - GERD. - COPD/asthma - Skin cancer. - sarcoid sacroiliac dysfunction, - ___ ___ neuropathy - Cataracts - Nephrolithiasis s/p lithotripsy x3 (calcium stones) - s/p Appendectomy - s/p Bladder suspension - s/p TAH - s/p spinal fusion ___ . Social History: ___ Family History: Mother -- valvular heart disease, breast cancer Father -- leukemia Physical ___: ADMISSION PHYSICAL EXAM ===================== VS: 97.9 F, 154 / 75, HR 89, RR 18, 972l GENERAL: Alert and interactive. In no acute distress. HEENT: EOMI. Sclera anicteric and without injection. MMM. Conjunctiva pale. NECK: No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. Systolic ejection murmur, heard best at ___. LUNGS: Clear to auscultation bilaterally. No increased work of breathing. ABDOMEN: Normal bowels sounds, non distended, non-tender to deep palpation in all four quadrants. Round mass-like structure palpated to the right of the umbilicus EXTREMITIES: No clubbing, cyanosis, or edema. Pulses DP/Radial 2+ bilaterally. SKIN: Warm. Fluid filled blister approx 2cm in length on the anterior chest NEUROLOGIC: AOx3. CN2-12 intact. Moving all 4 limbs spontaneously. Otherwise grossly intact. DISCHARGE PHYSICAL EXAM ======================= VS: 98.4 PO 140 / 67 90 18 96% on 2L GENERAL: Alert and interactive. In no acute distress. HEENT: EOMI. Sclera anicteric and without injection. MMM. Conjunctiva pale. NECK: No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. Systolic ejection murmur, heard best at RUSB. LUNGS: Clear to auscultation bilaterally. No increased work of breathing. ABDOMEN: Normal bowels sounds, non distended, non-tender to deep palpation in all four quadrants. Easily reducible hernia palpated to right of umbilicus EXTREMITIES: No clubbing, cyanosis, or edema. Pulses DP/Radial 2+ bilaterally. SKIN: WWP. NEUROLOGIC: AOx3. CN2-12 intact. Moving all 4 limbs spontaneously. Otherwise grossly intact. Pertinent Results: ADMISSION LABS ============= ___ 03:04PM WBC-8.9 RBC-3.81* HGB-8.5* HCT-30.9* MCV-81* MCH-22.3* MCHC-27.5* RDW-20.1* RDWSD-58.9* ___ 03:04PM NEUTS-78.5* LYMPHS-9.7* MONOS-9.2 EOS-0.9* BASOS-1.1* IM ___ AbsNeut-7.00* AbsLymp-0.86* AbsMono-0.82* AbsEos-0.08 AbsBaso-0.10* ___ 03:04PM PLT COUNT-418* ___ 03:04PM ___ PTT-23.9* ___ ___ 03:04PM ALBUMIN-4.3 IRON-204* ___ 03:04PM ALT(SGPT)-10 AST(SGOT)-26 ALK PHOS-74 TOT BILI-0.2 ___ 03:04PM GLUCOSE-97 UREA N-18 CREAT-1.3* SODIUM-143 POTASSIUM-4.3 CHLORIDE-100 TOTAL CO2-26 ANION GAP-17 DISCHARGE LABS ============= ___ 08:10AM BLOOD WBC-7.2 RBC-3.62* Hgb-8.2* Hct-29.3* MCV-81* MCH-22.7* MCHC-28.0* RDW-19.7* RDWSD-57.9* Plt ___ ___ 08:10AM BLOOD Glucose-94 UreaN-12 Creat-0.8 Na-145 K-4.2 Cl-104 HCO3-27 AnGap-14 ___ 08:10AM BLOOD Calcium-9.5 Phos-4.1 Mg-1.8 IMAGING ======= ___: Capsule Endoscopy Report Summary/Impression: 1. Mild patchy gastric erythema in keeping with known gastritis 2. One punctate non-bleeding angioectasia in proximal jejunum of unlikely clinical importance. 3. Isolated region of mild non-specific erythema in proximal ileum of unlikely clinical importance. 4. Three small to medium-sized non-bleeding angioectasias in the colon. No stigmata of recent bleeding. 5. Known non-bleeding colonic diverticulosis. 6. No active bleeding in the small bowel. 7. No melenic stool in the observed colon. Brief Hospital Course: ___ female with medical history notable for COPD on ___ L O2, HFpEF, recent admission for anemia and rectus sheath hematoma, hypertension, hyperlipidemia, hypothyroidism who presents with one episode of melena. ============= ACUTE ISSUES: ============= # Acute on chronic anemia # Melena EGD during last admission with medium sized hiatal hernia and ___ erosions, also with several polyps in the antrum and fundus that were biopsied. Req'd 2uPRBCs. Current bleeding may be secondary either of these or post-biopsy bleeding from polyps (though this would be a late presentation). She also had a colonoscopy that showed diverticulosis and internal hemorrhoids. GI was consulted and felt the bleeding was likely due to known ___ erosions but recommended capsule endoscopy given biopsies taken on endoscopy. Results demonstrated mild patchy erythema consistent with known gastritis. One punctate non-bleeding angioectasias in proximal jejunum, unlikely clinical importance. No stigmata of recent bleeding of three small-medium angioectasias. Non-bleeding colonic diverticulosis, no active bleeding in small bowel, no melenic stool in observed colon. Patient placed on BID PPI and started on Carafate four times daily per GI. On discharge was continued on BID PPI and Carafate BID with GI f/u in one-two months per GI. Patient will also need CBC in one week and one month. # ___. Patient presenting with Cr 1.3, up from a baseline of around 1.0. Likely in the setting of bleeding. Home diuretics and lisinopril were held and she received 50cc LR for fluid resuscitation. Home Lasix and Lisinopril restarted prior to discharge. CHRONIC/STABLE ISSUES: ====================== # COPD on home ___ - Continued O2 3L with goal O2 >88% - albuterol 1 puff PO q4 hr PRN for wheeze - sybmicort nonformulary, treated with advair instead - tiotropium 1 puff daily # HTN Held home amlodipine 5 mg and lisinopril 2.5 in the setting of bleeding. Restarted upon discharge. # Hypothyroidism - continued home 50 mcg levothyroxine daily # HFpEF - Held home Lasix 60 mg daily in the setting of bleeding, restarted on discharge. # Depression - Continued mirtazapine 7.5 mg qhs and citalopram 30 mg qhs # Allergies - Continued fexofenadine 180 mg daily CORE MEASURES: ============== # CODE: Full code, limited trial of resuscitation for 24 hours # CONTACT: ___) -- ___ TRANSITIONAL ISSUES: ================= [] f/u with PCP for repeat CBC in one week and another in one month per GI. [] f/u with gastroenterology in ___ months. [] Medications: Pt instructed to take omeprazole BID and Carafate BID until GI f/u, Iron supplementation until f/u with PCP. Pt instructed to take Senna and uptitrate to Miralax if needed as well as to call PCP office if no bowel movement by ___. New Medications Carafate twice daily Senna once to twice daily Changed Medications Please take your omeprazole twice per day rather than once per day Stopped Medications None Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheezing 2. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 3. amLODIPine 5 mg PO DAILY 4. Citalopram 30 mg PO QHS 5. Docusate Sodium 100 mg PO DAILY 6. Fexofenadine 180 mg PO DAILY 7. FoLIC Acid 1 mg PO DAILY 8. Furosemide 60 mg PO DAILY 9. GuaiFENesin ER 600 mg PO Q12H 10. Levothyroxine Sodium 50 mcg PO DAILY 11. Lisinopril 2.5 mg PO DAILY 12. Mirtazapine 7.5 mg PO QHS 13. Thiamine 100 mg PO DAILY 14. Tiotropium Bromide 1 CAP IH DAILY 15. Lidocaine 5% Patch 2 PTCH TD QPM 16. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation DAILY 17. Pantoprazole 40 mg PO Q12H The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheezing 2. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 3. amLODIPine 5 mg PO DAILY 4. Citalopram 30 mg PO QHS 5. Docusate Sodium 100 mg PO DAILY 6. Fexofenadine 180 mg PO DAILY 7. FoLIC Acid 1 mg PO DAILY 8. Furosemide 60 mg PO DAILY 9. GuaiFENesin ER 600 mg PO Q12H 10. Levothyroxine Sodium 50 mcg PO DAILY 11. Lisinopril 2.5 mg PO DAILY 12. Mirtazapine 7.5 mg PO QHS 13. Thiamine 100 mg PO DAILY 14. Tiotropium Bromide 1 CAP IH DAILY 15. Lidocaine 5% Patch 2 PTCH TD QPM 16. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation DAILY 17. Pantoprazole 40 mg PO Q12H Discharge Medications: 1. Senna 8.6 mg PO BID:PRN Constipation - First Line RX *sennosides [Evac-U-Gen (sennosides)] 8.6 mg 1 ml by mouth once a day Disp #*30 Tablet Refills:*0 2. Sucralfate 1 gm PO BID RX *sucralfate 1 gram 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 3. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 4. Albuterol Inhaler 1 PUFF IH Q4H:PRN wheezing 5. amLODIPine 5 mg PO DAILY 6. Citalopram 30 mg PO QHS 7. Docusate Sodium 100 mg PO DAILY 8. Fexofenadine 180 mg PO DAILY 9. FoLIC Acid 1 mg PO DAILY 10. Furosemide 60 mg PO DAILY 11. GuaiFENesin ER 600 mg PO Q12H 12. Levothyroxine Sodium 50 mcg PO DAILY 13. Lidocaine 5% Patch 2 PTCH TD QPM 14. Lisinopril 2.5 mg PO DAILY 15. Mirtazapine 7.5 mg PO QHS 16. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 17. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation DAILY 18. Thiamine 100 mg PO DAILY 19. Tiotropium Bromide 1 CAP IH DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Upper GI Bleed Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: ====================== DISCHARGE INSTRUCTIONS ====================== Dear Ms. ___, It was a privilege caring for you at ___ ___! WHY WAS I IN THE HOSPITAL? - You were admitted to the hospital out of concern for bleeding from your stomach or intestines after passing stool with blood in it. WHAT HAPPENED TO ME IN THE HOSPITAL? - We completed laboratory tests to evaluate for bleeding and monitored you to ensure you were stable. - We consulted our gastroenterology team who used a small capsule to evaluate for any bleeding in your stomach and intestines which did not show any signs of overt bleeding. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Please continue to take all of your medications and follow-up with your appointments as listed below. I was unable to make these appointments for you as it is a ___. - Please make a followup appointment to see Dr ___ this week or early next week by calling her office at ___ to get a repeat CBC. You will also need another followup CBC in one month. - Please make an appointment in the ___ clinic at ___ to make an appointment in one month. Medications: - Please take your omeprazole twice per day rather than once per day. - Please take iron supplementation until you follow up with your PCP, ___ - ___ start taking Senna once per day to help with your bowel movements. You may also try Miralax to help move your bowels if the Senna does not work. If you do not have a bowel movement by ___ please call your PCP's office. New Medications Carafate twice daily Senna once to twice daily Changed Medications Please take your omeprazole twice per day rather than once per day Stopped Medications None We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
19973404-DS-14
19,973,404
27,326,628
DS
14
2163-11-27 00:00:00
2163-11-27 16:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal pain and diarrhea Major Surgical or Invasive Procedure: None History of Present Illness: Mrs. ___ is a ___ year old woman with a history of type I diabetes c/b gastroparesis, nephropathy, retinopathy who presents with 5 days of abdominal pain and diarrhea. Her symptoms began after eating a large meal at ___ which she knows she isn't supposed to eat. And thereafter she began her symptoms. Regarding her diarrhea, she's had about 10 watery bowel movements a day. She reports no associated hematochezia, melena, and denies other inciting triggers such as recent antibiotic usage, recent travel, camping, exposure to sick contacts, young children. No recent GI illness among her family/friends. Her abdominal pain is left and right upper quadrant sharp, radiating from left to right, about 30 minutes after a meal. Some mild nausea and vomitting but not as prominent. Pain feels similar to gastroparesis but lack of vomitting and diarrhea is unusual. . Initial VS in the ED: ___ 133/86 12 100% r/a. Patient was given 2L NS and morphine 5mg IV x 2. She was admitted for pain control. . On the floor, the patient complains of persistent abdominal pain and diarrhea. . Review of systems: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denied cough, shortness of breath. Denied chest pain or tightness, palpitations. Denied constipation. No recent change in bladder habits. No dysuria. Denied arthralgias or myalgias. Past Medical History: 1) Ventriculomegaly, not felt to have increased ICP 2) Bipolar Disorder 3) Diabetes Type I followed at ___ with retinopathy, nephropathy/proteinuria, and gastroparesis 4) Glaucoma 5) Hepatitis B per notes 6) S/p cholecystectomy ___ 7) S/p uterine polyp removal ___ and uterine laser . Social History: ___ Family History: She has a family history significant for asthma in her father. Her father is also a type-2 diabetic and has cardiac disease. She has a sister who is a type 2 diabetic and is schizophrenic and died of a heart attack in ___. Physical Exam: Vitals: 97.9 120/70 98 18 100%RA ___ 194 57kg General: Alert, oriented, no acute distress HEENT: Sclera anicteric, dry MM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, mild RUQ and LUQ tenderness, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Pertinent Results: ADMISSION: ___ 12:59PM BLOOD WBC-8.1# RBC-4.14* Hgb-12.9 Hct-36.9 MCV-89 MCH-31.2 MCHC-35.0 RDW-12.2 Plt ___ ___ 12:59PM BLOOD Neuts-76.3* Lymphs-13.8* Monos-4.2 Eos-5.6* Baso-0.2 ___ 12:59PM BLOOD ___ PTT-27.9 ___ ___ 12:59PM BLOOD Glucose-250* UreaN-14 Creat-0.6 Na-130* K-4.2 Cl-99 HCO3-21* AnGap-14 ___ 12:59PM BLOOD ALT-21 AST-17 AlkPhos-55 TotBili-0.3 ___ 08:10AM BLOOD Calcium-7.4* Phos-3.3# Mg-1.4* ___ 12:59PM BLOOD TSH-1.7 ___ 12:59PM BLOOD Carbamz-12.8* ___ 09:15PM BLOOD Carbamz-8.7 ___ 12:59PM BLOOD Glucose-229* Lactate-0.9 K-4.3 DISCHARGE: ___ 07:05AM BLOOD WBC-5.6 RBC-3.72* Hgb-11.8* Hct-33.0* MCV-89 MCH-31.8 MCHC-35.9* RDW-12.3 Plt ___ ___ 07:05AM BLOOD Glucose-68* UreaN-5* Creat-0.6 Na-141 K-3.8 Cl-105 HCO3-30 AnGap-10 ___ 07:05AM BLOOD Calcium-8.6 Phos-3.9 Mg-1.8 REPORTS: CT ABD & PELVIS WITH CONTRAST Study Date of ___ 2:04 ___ 1. Dilated, fluid-filled stomach, which may be related to the patient's known history of gastroparesis. 2. Scattered fluid-filled small bowel loops can be seen with gastroenteritis, though this is a nonspecific finding and must be correlated with the patient's n.p.o. status. 3. Prominence of the common bile duct, little changed from prior studies, and likely reflecting prior cholecystectomy. Brief Hospital Course: Assessment and Plan: ___ year old woman with a history of type I diabetes c/b gastroparesis, nephropathy, retinopathy who presents with 5 days of abdominal pain and diarrhea thought to be secondary to a gastroparesis flare. . # Abdominal pain and diarrhea: Clinical picture and CT abdomen showing retained fluid in the stomach is highly suggestive of gastroparesis. Normal LFTs and lipase made hepatitis and pancreatitis unlikely. Concominant gastroenteritis possible given diarrhea but patient without any other viral prodrome such as fever, body aches, etc other than abdominal pain and diarrhea. Diabetic enteropathy is a possibility but unlikely as this usually presents with incontinence which she lacked. Medications possible but most doses stable. TSH wnl here and TtG wnl in ___. Diarrhea resolved upon admission making infectious diarrhea highly unlikely. The patient significantly improved with fluids, reglan (only 5mg to mitigate the risk of tardive dyskinesia given her concominant seroquel, risks were discussed with the patient). The patient tolerated a regular diabetic diet the day prior as well as the day of discharge with minimal pain, no diarrhea or vomitting. Patient was instructed to adhere to small frequent meals, as meal size indiscretions were behind the likely trigger for this flare. She expressed an understanding of the plan moving forward. . # Type I diabetes: Patient very savvy and last A1C 6.3, but control is actually in reality worse because she is brittle with lots of highs and lots of lows. Lantus 19 units HS was continued, she unfortunately developed AM hypoglycemia to the ___ with sx. Per the patient, this happens frequently as an outpatient because her gastroparesis makes aborption of food and carb counting unpredictable. ___ was consulted who recommended cutting down to 16 of lantus and cutting back significantly her sliding scale. Upon discharge, the patient was lowered further to even 14 units lantus HS given her persistent hypoglycemia (although improving by admission). Her outpatient ___ Dr. ___ was contacted to check in on the patient ___ to assess her glucose control. The patient was also instructed to only take her insulin upon successful completion of a meal in order to make carb counting more predictable. The patient will set up a sooner follow up with her ___ doctors and ___ be in touch with Dr. ___. . # Seizure disorder: Continued carbamazapine 800mg PO QAM and 1000mg PO QPM (discussed with pharmacy as her confirmed dosage). Her carbamazapine level (the second one was correctly timed as 12 hours after her dose) was in the therapeutic range. . # Bipolar: Continued seroquel 200mg PO QAM, 400mg PO QPM (discussed with pharmacy). ___ rec attempted 3 times with 3 different pharmacies without success, per inpatient pharm, these are correct dosages . # Prophylaxis: Subcutaneous heparin, bowel regimen . # Code: presumed full TRANSITIONAL ISSUES: Sugar checks by Dr. ___ next week. Medications on Admission: Confirmed: 1. Metoclopramide 10 mg Tablet Sig: One (1) Tablet PO QIDACHS (4 times a day (before meals and at bedtime)). Disp:*120 Tablet(s)* Refills:*0* 2. Quetiapine 200 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. Quetiapine 200 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime). 4. Carbamazepine 200 mg Tablet Sig: Four (4) Tablet PO DAILY (Daily). 5. Carbamazepine 200 mg Tablet Sig: Three (3) Tablet PO HS (at bedtime). 6. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 7. Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. Latanoprost 0.005 % Drops Sig: One (1) Drop Ophthalmic HS (at bedtime). 9. Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: One (1) Puff Inhalation Q4H (every 4 hours) as needed for wheezing. 10. Ibuprofen 600 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) as needed for abdominal pain. Disp:*15 Tablet(s)* Refills:*0* 11. Zolpidem 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed for sleep. 12. Lantus 19 units qhs 13. Novolog sliding scale Discharge Medications: 1. carbamazepine 200 mg Tablet Sig: Four (4) Tablet PO QAM (once a day (in the morning)). 2. carbamazepine 200 mg Tablet Sig: Five (5) Tablet PO QPM (once a day (in the evening)). 3. quetiapine 200 mg Tablet Sig: One (1) Tablet PO QAM (once a day (in the morning)). 4. quetiapine 200 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime). 5. metoclopramide 10 mg Tablet Sig: 0.5 Tablet PO QIDACHS (4 times a day (before meals and at bedtime)). Disp:*12 Tablet(s)* Refills:*0* 6. insulin glargine 100 unit/mL Cartridge Sig: Fourteen (14) UNITS Subcutaneous at bedtime. 7. Novolog 100 unit/mL Solution Sig: One (1) Subcutaneous once a day: Per home carb-counting scale. 8. lisinopril 10 mg Tablet Sig: One (1) Tablet PO once a day. 9. simvastatin 40 mg Tablet Sig: One (1) Tablet PO once a day. Discharge Disposition: Home Discharge Diagnosis: Diabetic gastroparesis Type 1 diabetes poorly controlled (ie brittle) Hypoglycemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted for gastroparesis causing abdominal pain, vomitting, and some diarrhea. Your symptoms resolved with fluids, reglan, and other supportive measures. Your stay was complicated by hypoglycemia, which is a chronic issue for you. In discussion with ___ consultants, we have decided on a modified regimen for you for the next few days while your gastroparesis resolves. We will communicate this with Dr. ___ will also check in with you next week. Remember, the key to controlling your gastroparesis is small frequent meals. We have made the following changes to your medications: DECREASE your lantus to 14 units every night until you speak with Dr. ___ week CONTINUE your original carb counting insulin scale but take the insulin after meals to ensure good absorption while you gastroparesis is resolving START metoclopromide 5mg by mouth 30 minutes before each meal for the next 3 days Please call Dr. ___ if you develop any further low blood sugars. Please contact your PCP for any other concerning symptoms. Followup Instructions: ___
19973404-DS-17
19,973,404
23,868,350
DS
17
2166-01-02 00:00:00
2166-01-02 15:57:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: vomiting and abdominal pain Major Surgical or Invasive Procedure: none History of Present Illness: ___ y/o Female with past medical history including Hep B, bipolar disorder, seizure disorder, IDDM and gastroparesis developed severe nausea, vomiting, and abdominal pain at 11pm last night (___). She reports that she has had episodes of gastroparesis in the past, and that this episode is distinct by the rapid onset of abdominal pain after vomiting but is otherwise similar to past episodes of gastroparesis. Notably she denies bloody or bilious vomiting, only food, secretions, and then dry heaving. She was complaining of constipation however had a large non bloody bm prior to coming to the ED. She had been on a "light fast" of a diet consisting of vegetables and chicken prior to eating a ___ hamburger for dinner yesterday evening. Feels well otherwise. S/p Botox injection of pylorus in ___, has not had any episodes of gastroparesis since that time. Last BM was yesterday evening; she denies conspitation at present. In the ED, initial vitals: 97.6 133/78 96 16 98%RA. Labs were notable for glucose of 236 and magnesium of 1.5 but were otherwise unremarkable. She received metoclopramide, hydromorphone, lorazepam, and ondansetron in the ED. Vitals prior to transfer: 98.7 124/85 100 14 98%RA On the floor the patient endorsed ___ abdominal pain, severe nausea and she continued to vomit nonbilious nonbloody emesis. Vitals were 97.8 135/71 10 16 100%RA FSBG 184. ROS: No fevers, chills, night sweats, or weight changes. No changes in vision or hearing, no changes in balance. No cough, no shortness of breath, no dyspnea on exertion. No chest pain or palpitations. No diarrhea or constipation. No dysuria or hematuria. No hematochezia, no melena. No numbness or weakness, no focal deficits. Past Medical History: BIPOLAR DISORDER DIABETES MELLITUS - insulin dependent. Pt reports proteinuria, nephropathy, and retinopathy in addition to gastroparesis. GLAUCOMA RIGHT BUNDLE BRANCH BLOCK SEIZURE DISORDER - currently treated with Carbamazepine to which Pt attributes vertigo/dizziness, self-changed evening dose to 800mg from 1000mg yesterday (___) ALCOHOL ABUSE ASTHMA HEPATITIS B HEP C GASTROPARESIS - s/p Botox injection in ___ Past Surgical History: CHOLECYSTECTOMY ___ FROZEN SHOULDER ___ UTERINE POLYPS PRIOR CESAREAN SECTION G3P1 MIS2 BILATERAL TUBAL LIGATION Social History: ___ Family History: Extensive family history of Diabetes Mellitus with both parents still living. Heart disease in father. ___ family history of cancer. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals- 97.8 135/71 10 16 100%RA FSBG 184 General- Alert, oriented, no acute distress. Sitting on bed consuming ice chips. HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- CTAB no wheezes, rales, rhonchi CV- RRR, Nl S1, S2, Systolic murmur. No rubs/gallops. Abdomen- soft, nondistended. Diffusely tender, worst at umbilicus. Diminished bowel sounds. No rebound tenderness, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 grossly intact, motor function grossly normal DISCHARGE EXAM Vitals (7:15am) 97.6 114/71 80 18 100%RA General- Alert, oriented, no acute distress. HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- Clear to auscultation bilateratlly. CV- Regular rate and rhythm, normal S1 + S2, grade II systolic flow murmur, rubs, gallops Abdomen- soft, non-tender, non-distended, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- moving all extremities, motor function grossly normal Pertinent Results: Admission labs: ___ 09:35AM GLUCOSE-236* UREA N-13 CREAT-0.5 SODIUM-142 POTASSIUM-4.0 CHLORIDE-104 TOTAL CO2-22 ANION GAP-20 ___ 09:35AM estGFR-Using this ___ 09:35AM ALT(SGPT)-18 AST(SGOT)-21 ALK PHOS-62 TOT BILI-0.4 ___ 09:35AM LIPASE-12 ___ 09:35AM ALBUMIN-4.1 CALCIUM-8.9 PHOSPHATE-3.3 MAGNESIUM-1.5* ___ 09:35AM WBC-7.7# RBC-4.07* HGB-12.8 HCT-38.1 MCV-94 MCH-31.5 MCHC-33.7 RDW-11.8 ___ 09:35AM NEUTS-89.8* LYMPHS-6.6* MONOS-2.4 EOS-1.0 BASOS-0.2 ___ 09:35AM PLT COUNT-187 ___ 09:15AM ALT(SGPT)-19 KUB ___: Normal bowel gas pattern without obstruction. Discharge labs: ___ 06:45AM BLOOD WBC-10.0 RBC-3.66* Hgb-11.5* Hct-34.2* MCV-94 MCH-31.5 MCHC-33.7 RDW-11.8 Plt ___ ___ 06:45AM BLOOD Glucose-163* UreaN-15 Creat-0.6 Na-137 K-3.8 Cl-103 HCO3-16* AnGap-22* Brief Hospital Course: ___ F with PMH of seizure disorder, bipolar disorder,hepatitis B, IDDM and history of gastroparesis s/p pyloric Botox injection presents with acute onset nausea, vomiting, and abdominal pain several hours after consuming her first fatty meal in several weeks. #Nausea and Vomiting: Pt has a history of gastroparesis and reports that this episode is nearly identical to gastroparesis episodes in the past. While she has not suffered severe nausea and vomiting since the pyloric Botox injection in ___, her abrupt change in diet (fatty meal after a period of "light fasting") may have contributed to the present episode. KUB demonstrated normal bowel gas pattern which was reassuring that she did not have ileus or obstruction leading to nausea and vomiting. She was initially made NPO and then advanced to sips. She had several episodes of nonbloody, nonbilious emesis. After administration of metoclopromide and toradal, she felt her symptoms were improved and diet was advanced to full liquids in the AM. This was well tolerated and she was advanced to regular diabetic diet. She has continued to take her home domperidone during this admission. She was discharged on her home regimen. Of note the patient self tapered her carbamazepine. We recommeded she share this change with her providers. Additionally as carbamazepine and seroquel may be contributing to decreased gastric motility would consider tapering this medications as an outpatient if appropriate. #Diabetes mellitus - The patient was continued on sliding scale and fixed dose insulin. Her fixed dose was reduced overnight to 9 units Glargine due to reduced PO intake and returned to ___ Glargibe on ___ after she began to eat again. #Exposure - Due to needlestick exposure in ED, patient was ordered for HCV viral load, Hep C Ab, HIV Chronic issues: #BIPOLAR DISORDER - continued home quetiapine. #GLAUCOMA - continued home latanoprost #RIGHT BUNDLE BRANCH BLOCK - EKG unchanged #SEIZURE DISORDER - continued home carbamazepine at 800mg BID. The patient had been prescribed for 800mg QAM and 1000mg QPM but had self-decreased to 800mg QPM due to vertigo/dizziness. #HEPATITIS B - continued Viread 300mg daily Transitional Issues - Would consider taper of seroquel and carbamezepine if able - Bicarb low on date of discharge, patient appears well would recommend repeat electrolytes at follow-up - Patient was full code throughout this admission Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Betamethasone Valerate 0.1% Cream 1 Appl TP APPLY TWICE A DAY FOR UP TO TWO WEEKS AT A TIME 2. Carbamazepine 800 mg PO BID 3. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS 4. Lisinopril 10 mg PO DAILY 5. Simvastatin 40 mg PO DAILY 6. Docusate Sodium 100 mg PO BID 7. Glargine 18 Units Bedtime 8. Insulin SC Sliding Scale Insulin SC Sliding Scale using REG Insulin 9. DiCYCLOmine 20 mg PO QID 10. Tenofovir Disoproxil (Viread) 300 mg PO DAILY 11. QUEtiapine Fumarate 300 mg PO BID Discharge Medications: 1. Carbamazepine 800 mg PO BID 2. Docusate Sodium 100 mg PO BID 3. Glargine 18 Units Bedtime 4. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS 5. Lisinopril 10 mg PO DAILY 6. Simvastatin 40 mg PO DAILY 7. Tenofovir Disoproxil (Viread) 300 mg PO DAILY 8. Domperidone 10 mg PO QID 9. QUEtiapine Fumarate 300 mg PO BID 10. Betamethasone Valerate 0.1% Cream 1 Appl TP APPLY TWICE A DAY FOR UP TO TWO WEEKS AT A TIME 11. DiCYCLOmine 20 mg PO QID 12. NovoLOG (insulin aspart) 100 unit/mL subcutaneous QID continue your current sliding scale Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: gastroparesis Secondary: diabetes mellitus Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital because of nausea, vomiting, and abdominal pain. The physicians who took care of you believed that this was another episode of gastroparesis which was triggered by eating a fatty meal after eating a low fat diet for several weeks. Your pain and nausea were treated, and you were restarted on food which you have been able to eat without nausea, vomiting, or pain. You will need to follow-up with your primary care doctor as well as your gastroenterologist. Followup Instructions: ___
19973404-DS-18
19,973,404
22,452,588
DS
18
2166-01-08 00:00:00
2166-01-08 14:32:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: nausea, abdominal pain Major Surgical or Invasive Procedure: none History of Present Illness: ___ with a history of chronic Hep B, bipolar disorder, seizure disorder, IDDM and gastroparesis presents with nausea associated with ABD pain. She has had generalized malaise since d/c from hospital (was here ___ and treated for gastroparesis with improvement). She states that she was still nauseas at the time of discharge but that she said she felt fine in order to avoid getting another IV placed. She went directly to bed when she went home and has only eaten a waffle and ham sandwich due to severe nausea. Has been able to tolerate liquid intake despite nausea. She developed abdominal pain after being home one day, and did attempt PO zofran per her outpatient gastroenterologist Dr. ___. She denies any emesis since discharge. Has not had a bowel movement in 5 days and is beginning to feel bloated. Also insists she has not passed gas in 5 days. In the ED intial vitals were: 99.0 96 157/78 20 99% RA There, she was unable to take p.o. Zofran and Compazine did not help her. Also got morphine x2 without relief. Labs were notable for Hct of 36.9 which is at her baseline. She also had FSBG of 72 and then 79 for which she was given sips of orange juice with improvement to the , EKG demonstrated RBB which is old, with question of mild ST depressions in V4 and V5 leads. QTc of 425, compared to 457 on ___. Vitals prior to transfer:98.2 121/67 77 16 98%RA pain ___ On the floor she continues to endorse nausea and abomdinal pain, though it is improved since presentation to the ED. She feels thirsty and has ___ abdominal pain. No vomiting. She has continued to take her home domperidone while waiting for a bed in the ED. Has some headache. Denies chest pain, shortness of breath. ROS: No fevers, chills, night sweats, or weight changes. No changes in vision or hearing, no changes in balance. No cough, no shortness of breath, no dyspnea on exertion. No chest pain or palpitations. No diarrhea. No dysuria or hematuria. No hematochezia, no melena. No numbness or weakness, no focal deficits. Past Medical History: BIPOLAR DISORDER DIABETES MELLITUS - insulin dependent. Pt reports proteinuria, nephropathy, and retinopathy in addition to gastroparesis. GLAUCOMA RIGHT BUNDLE BRANCH BLOCK SEIZURE DISORDER - currently treated with Carbamazepine to which Pt attributes vertigo/dizziness, self-changed evening dose to 800mg from 1000mg yesterday (___) ALCOHOL ABUSE ASTHMA HEPATITIS B HEP C GASTROPARESIS - on domperidone, s/p Botox injection in ___ . Past Surgical History: CHOLECYSTECTOMY ___ FROZEN SHOULDER ___ UTERINE POLYPS PRIOR CESAREAN SECTION G3P1 BILATERAL TUBAL LIGATION Social History: ___ Family History: Extensive family history of Diabetes Mellitus with both parents still living. Heart disease in father. ___ family history of cancer. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals- 97.9 122/75 82 18 97%RA ___ pain FSBG 48 General- Alert, oriented, no acute distress. HEENT- Sclera anicteric, MMM with some white coating on tongue, oropharynx clear Neck- supple Lungs- CTAB no wheezes, rales, rhonchi CV- RRR, Nl S1, S2, Grade 3 Systolic flow murmur. No rubs/gallops. Abdomen- soft, nondistended. Periumbical TTP. Bowel sounds present. No rebound tenderness, no organomegaly. ___ sign negative. Ext- warm, well perfused, palpable pulses, no clubbing, cyanosis or edema Neuro- Moving all extremities, motor function grossly normal . DISCHARGE PHYSICAL EXAM: Vitals- 98.1 120/75 78 18 99%RA ___ pain FSBG 59 at 4:45am, 150 at 5:40am General- Alert, oriented, no acute distress. HEENT- Sclera anicteric, moist MM, oropharynx clear Neck- supple Lungs- CTAB no wheezes, rales, rhonchi CV- RRR, Nl S1, S2, Grade 3 Systolic flow murmur. No rubs/gallops. Abdomen- soft, nondistended. No TTP. No rebound tenderness, no organomegaly. Ext- warm, well perfused, palpable pulses, no clubbing, cyanosis or edema Neuro- Moving all extremities, motor function grossly normal Pertinent Results: Admission labs: ___ 09:20PM BLOOD WBC-6.2 RBC-3.89* Hgb-12.3 Hct-34.9* MCV-90 MCH-31.7 MCHC-35.3* RDW-12.3 Plt ___ ___ 09:20PM BLOOD Neuts-62.7 ___ Monos-8.1 Eos-3.0 Baso-0.4 ___ 09:20PM BLOOD Plt ___ ___ 09:20PM BLOOD Glucose-256* UreaN-8 Creat-0.5 Na-134 K-3.6 Cl-94* HCO3-24 AnGap-20 ___ 09:20PM BLOOD ALT-28 AST-27 AlkPhos-55 TotBili-0.3 ___ 10:15PM BLOOD CK(CPK)-52 ___ 09:20PM BLOOD Lipase-18 ___ 10:15PM BLOOD CK-MB-2 cTropnT-<0.01 ___ 09:20PM BLOOD cTropnT-<0.01 ___ 09:20PM BLOOD Albumin-4.0 Calcium-8.3* Phos-3.6 Mg-1.7 . Discharge labs: ___ 05:15AM BLOOD Glucose-90 UreaN-4* Creat-0.5 Na-143 K-4.3 Cl-105 HCO3-30 AnGap-12 ___ 05:15AM BLOOD Calcium-8.9 Phos-4.7* Mg-1.8 . Imaging: ___ KUB: IMPRESSION: Frontal upright and supine views of the abdomen show no pathologic distention of large or small bowel. There is formed stool in the transverse and left colon, and no free subdiaphragmatic gas. Vascular clips denote prior right upper quadrant surgery. Brief Hospital Course: ___ h/o chronic Hep B, bipolar disorder, seizure disorder, IDDM and gastroparesis p/w N/V associated with abd pain consistent with gastroparesis flare. . #Nausea, Abdominal pain / Gastroparesis Flare: This patient's presentation is most c/w unresolved gastroparesis from last admission. Her carbamazepine and Seroquel may be contributing to decreased gastric motility, and we would encourage her outpt psychiatrist to consider tapering this medications as an outpatient if appropriate. Additionally, her KUB was not concerning for obstruction/flatus but showed much stool, making it likely that constipation was also contributing to nausea. Although her presenting symptoms were unlikely to have been cardiac in nature, due to an isolated ST depressionin V4 in ED, we ruled out cardiac etioloty with trop/repeat EKG/tele. She was initially placed on sips with IVF and IV metoclopromide standing, IV Zofran prn, IV Toradol and Tylenol for pain prn, as well as her home domperidone. Her bowel regimen was also increased to include senna, bisacodyl PR, and Miralax. Her symptoms improved and her diet was slowly advanced to clears and then a regular diabetic diet. She was able to tolerate each advancement. GI was consulted on ___ for ? of repeat Botox injection via EGD but they indicated that any endoscopic procedure should be completed as an outpatient. At discharge, she had eaten a full breakfast and denied any nausea, vomiting, or abdominal pain. She reported many bowel movements during her admission with simultaneous improvement in her abdominal pain. She was discharged on her home domperidone. . #Hypoglycemia/Diabetes Mellitus- Patient has a history of Type I diabetes and has become hypoglycemic during this admission requiring close monitoring. In ED FSBG was 72 and 79, treated with sips of orange juice. Pt FSBG down to 48 on her first overnight on the floor. The initial hypoglycemic events were likely due to receiving full 18 unit Lantus dose evening of ___ in setting of persistent reduced oral intake. We reduced her ___ Lantus dose to 9 given her poor oral intake. ___ Diabetes was consulted on ___ and suggested adjusting her Lantus dose to 14 while maintaining her home sliding/scale + carb correction. She received ___ NS at rate of 50cc/hour while she had poor PO intake. This was discontinued the evening of ___ after she tolerated a small evening meal and clear liquids. Early morning ___, she had another FSB to 59 which improved to 150 after apple juice. This was most likely due to a small dinner, and we anticipate that the hypoglycemic episodes will cease given that she is able to eat full meals starting today. She was discharged on her home insulin regimen, glargine 18 units qhs plus insulin SS and carb counting. She was not hypoglycemic on discharge. . CHRONIC ISSUES: #BIPOLAR DISORDER - continued home quetiapine. #GLAUCOMA - continued home latanoprost #RIGHT BUNDLE BRANCH BLOCK - aside from one isolated ST depression on her ED EKG, this patient's EKG was unchanged during admission. #SEIZURE DISORDER - continued home carbamazepine #HEPATITIS B - continued Viread 300mg daily Transitional issues: - This patient will need to follow-up with her outpatient gastroenterologist to discuss how to prevent gastroparesis flares in the future. This may involve altering her diet or receiving another pyloric Botox injection - She will require outpatient follow-up with her PCP. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Carbamazepine 800 mg PO BID 2. Docusate Sodium 100 mg PO BID 3. Glargine 18 Units Bedtime 4. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS 5. Lisinopril 10 mg PO DAILY 6. Simvastatin 40 mg PO DAILY 7. Tenofovir Disoproxil (Viread) 300 mg PO DAILY 8. Domperidone 10 mg PO QID 9. QUEtiapine Fumarate 300 mg PO BID 10. Betamethasone Valerate 0.1% Cream 1 Appl TP APPLY TWICE A DAY FOR UP TO TWO WEEKS AT A TIME 11. DiCYCLOmine 20 mg PO QID 12. NovoLOG (insulin aspart) 100 unit/mL subcutaneous QID 13. Ondansetron Dose is Unknown PO Frequency is Unknown Discharge Medications: 1. Betamethasone Valerate 0.1% Cream 1 Appl TP APPLY TWICE A DAY FOR UP TO TWO WEEKS AT A TIME 2. DiCYCLOmine 20 mg PO QID 3. NovoLOG (insulin aspart) 100 unit/mL subcutaneous QID 4. Carbamazepine 800 mg PO BID 5. Docusate Sodium 100 mg PO BID 6. Domperidone 10 mg PO QID 7. Glargine 18 Units Bedtime 8. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS 9. Lisinopril 10 mg PO DAILY 10. QUEtiapine Fumarate 300 mg PO BID 11. Simvastatin 40 mg PO DAILY 12. Tenofovir Disoproxil (Viread) 300 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: gastroparesis, hypoglycemia, insulin-dependent diabetes mellitus Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure participating in your care while you were admitted to the ___. As you know you were admitted because you were having continued symptoms of your gastroparesis. You were treated with a restricted diet and medications, in particular medicine that made you feel less naseous and that would help you move your bowels. You should follow up with your gastroenterologist and primary care doctor after you leave the hospital. Followup Instructions: ___
19973404-DS-19
19,973,404
29,788,438
DS
19
2167-09-12 00:00:00
2167-09-13 12:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Nausea/Vomiting Major Surgical or Invasive Procedure: EGD with botox injections History of Present Illness: ======================================================= MEDICINE NIGHTFLOAT ADMISISON NOTE Date of admission: ___ ======================================================= ___. CC:nausea/vomiting and epigastric pain HISTORY OF PRESENT ILLNESS: ___ year old woman with a history of type I diabetes c/b gastroparesis/nephropathy/retinopathy, bipolar, who presents with vomiting and nausea and abdominal pain Ms ___ reports that this morning she awoke with ___ abdominal pain that was associated with non-bloody, mildly bilious vomiting. She reports that her symptoms were exactly the same as her previous gastroparesis episodes. Her last flare was one year ago and required hospitalization for IV pain meds and anti-emetics. In the ED, initial vs were: 18:45 10 97.6 101 151/84 20 99% RA Exam notable for: pt awake and alert, speaking in full clear sentences, pleasant and cooperative, abd was soft tender throughout, +bs. Labs were remarkable for: UA with 1000 glucose, Chem panel with glucose of 300 and white blood cell count of 12.4. Patient was given: 1000ml NS, reglan, Ativan, dilaudid with improvement of symptoms. She is admitted for further pain and nausea control. Vitals on transfer were: sleeping 98.2 101 127/64 18 97% RA On arrival to the floor, she is feeling much better and abdominal pain is now ___. Nausea is improving and she would like to try drinking gingerale. She has a history of gastroparesis and says this feels "exactly the same". Denies fever, chills, sweats, HA, rhinnorhea, cough, melena, BRBPR, CP, SOB. Endorses recent episode of hyperglycemia. She reports that she has obtained good control of her gastroparesis with Domperidone 10 mg PO QID, which she has to obtain in ___ and which is not FDA approved in the ___. She reports that she has difficulty with the expense and has recently cut back on how often she takes it over the past week. She is concerned that it was decreasing this med that lead to this flare. Review of sytems: (+) Per HPI PAST MEDICAL HISTORY: 1) Ventriculomegaly, not felt to have increased ICP 2) Bipolar Disorder 3) Diabetes Type I followed at ___ with retinopathy, nephropathy/proteinuria, and gastroparesis 4) Glaucoma 5) Hepatitis B per notes 6) S/p cholecystectomy ___ 7) S/p uterine polyp removal ___ and uterine laser MEDICATIONS AT HOME: The Preadmission Medication list is accurate and complete 1. NovoLOG (insulin aspart) 100 unit/mL subcutaneous QID 2. Carbamazepine 800 mg PO BID 3. Domperidone 10 mg PO QID 4. Lisinopril 10 mg PO DAILY 5. Simvastatin 40 mg PO DAILY 6. Tenofovir Disoproxil (Viread) 300 mg PO DAILY 7. Glargine 18 Units Bedtime 8. QUEtiapine Fumarate 200 mg PO BID 9. Fexofenadine 180 mg PO DAILY 10. Polyethylene Glycol 17 g PO DAILY:PRN constipation 11. Vitamin D 1000 UNIT PO DAILY ALLERGIES: NKDA SOCIAL HISTORY: ___ FAMILY HISTORY: She has a family history significant for asthma in her father. Her father is also a type-2 diabetic and has cardiac disease. She has a sister who is a type 2 diabetic and is schizophrenic and died of a heart attack in ___. PHYSICAL EXAM: Vitals: 97.9 121/54 107 18 97RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally CV: Regular rate, normal rhythm, normal S1S2. Has II/VI crescendo SEM at LUSB and holosytolic murmur at apex. Abdomen: soft, mild tenderness over epigastric region, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: no rashes appreciated Neuro: CN ___ grossly intact, ___ strength in all extremities, no peripheral sensory deficits. ACCESS: #20 ___ LABS: ========================= 137 97 11 ---------------< 305 AGap=24 4.2 20 0.6 Ca: 9.7 Mg: 1.7 P: 4.1 94 12.4 \ 12.7 / 223 / 36.9 \ N:92.8 L:4.1 M:2.3 E:0.1 Bas:0.3 ___: 0.4 MICRO:None pending STUDIES: ============================ + EGD (___): Normal mucosa in the whole esophagus Normal mucosa in the whole stomach (injection) Normal mucosa in the whole duodenum Otherwise normal EGD to third part of the duodenum ASSESSMENT AND PLAN: ___ year old woman with a history of type I diabetes c/b gastroparesis, nephropathy, retinopathy, bipolar, cholecystectomy, C-section who presents with vomiting and nausea and abdominal pain. #Gastroparesis: Current nausea and epigastic pain most likely secondary to gastroparesis given history of recurrent gastroparesis. Pt notes this feels exactly like similar episodes and she has been diagnosed in past by gastric emptying study. Pancreatitis or liver pathology less likely given negative in past but will check - check LFTs, lipase - Zofran, Ativan, Hydromorphone overnight - Sips with plan to ADAT a clear diet - Consider GI consult in AM - In AM, attending will need to write note in chart authorizing use of domperidone. # Mild Leukocytosis: Patient with WBC of 12.4. Suspect this is stress reaction for recurrent vomiting. She denies fevers, chills, dysuria or cough. - continue to monitor. CHRONIC ISSUES: ==================== # DM Type 1: Patient is very well educated regarding management and current dosing. Humalog sliding scale calorie based. - Continue with 18U qhs lantus and Humalog sliding scale # Nephropathy: Continue lisinopril # Bipolar: stable. Not currently promoting any manic or depressed mood. Continue with seroquel. # Hepatitis B: continue tenofovir. CORE MEASURES: ==================== # FEN: No IVF, replete electrolytes, regular diet # PPX: Subcutaneous heparin, senna/colace, pain meds # ACCESS: peripherals # CODE: Full # CONTACT: Husband ___ # DISPO: CC7, pending above Past Medical History: BIPOLAR DISORDER DIABETES MELLITUS - insulin dependent. Pt reports proteinuria, nephropathy, and retinopathy in addition to gastroparesis. GLAUCOMA RIGHT BUNDLE BRANCH BLOCK SEIZURE DISORDER - currently treated with Carbamazepine to which Pt attributes vertigo/dizziness, self-changed evening dose to 800mg from 1000mg yesterday (___) ALCOHOL ABUSE ASTHMA HEPATITIS B HEP C GASTROPARESIS - on domperidone, s/p Botox injection in ___ . Past Surgical History: CHOLECYSTECTOMY ___ FROZEN SHOULDER ___ UTERINE POLYPS PRIOR CESAREAN SECTION G3P1 BILATERAL TUBAL LIGATION Social History: ___ Family History: Extensive family history of Diabetes Mellitus with both parents still living. Heart disease in father. ___ family history of cancer. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals: 97.9 121/54 107 18 97RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally CV: Regular rate, normal rhythm, normal S1S2. Has II/VI crescendo SEM at LUSB and holosytolic murmur at apex. Abdomen: soft, mild tenderness over epigastric region, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: no rashes appreciated Neuro: CN ___ grossly intact, ___ strength in all extremities, no peripheral sensory deficits. DISCHARGE PHYSICAL EXAM: Vitals: afebrile, BP baseline here in 130's/70's (currently 111/65)HR: , 100% RA General: Alert, oriented, in no acute distress HEENT: mmm, no vertical nystagmus noted. Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rhythm, normal S1 + S2, no murmurs noted. Abdomen: soft, non-distended, tender in RLQ, no rebound Ext: Warm, well perfused Skin: No rash. Neuro: moving all extremities, distal sensation intact. Pertinent Results: ADMISSION LABS: ___ 08:51PM WBC-12.4*# RBC-3.93 HGB-12.7 HCT-36.9 MCV-94 MCH-32.3* MCHC-34.4 RDW-11.9 RDWSD-41.1 ___ 08:51PM NEUTS-92.8* LYMPHS-4.1* MONOS-2.3* EOS-0.1* BASOS-0.3 IM ___ AbsNeut-11.47*# AbsLymp-0.51* AbsMono-0.29 AbsEos-0.01* AbsBaso-0.04 ___ 08:51PM GLUCOSE-305* UREA N-11 CREAT-0.6 SODIUM-137 POTASSIUM-4.2 CHLORIDE-97 TOTAL CO2-20* ANION GAP-24* ___ 08:51PM ALT(SGPT)-21 AST(SGOT)-23 ALK PHOS-75 TOT BILI-0.4 ___ 08:51PM LIPASE-18 ___ 08:51PM CALCIUM-9.7 PHOSPHATE-4.1 MAGNESIUM-1.7 ___ 08:56PM URINE MUCOUS-RARE ___ 08:56PM URINE RBC-1 WBC-2 BACTERIA-FEW YEAST-NONE EPI-1 ___ 08:56PM URINE BLOOD-SM NITRITE-NEG PROTEIN-TR GLUCOSE-1000 KETONE-150 BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-NEG ___ 08:56PM URINE COLOR-Straw APPEAR-Clear SP ___ DISCHARGE LABS: ___ 05:49AM BLOOD WBC-5.5 RBC-3.52* Hgb-11.2 Hct-34.8 MCV-99* MCH-31.8 MCHC-32.2 RDW-12.4 RDWSD-44.4 Plt ___ ___ 05:49AM BLOOD Plt ___ ___ 05:49AM BLOOD Glucose-142* UreaN-3* Creat-0.5 Na-135 K-4.0 Cl-98 HCO3-23 AnGap-18 ___ 05:49AM BLOOD Calcium-8.8 Phos-3.3 Mg-1.7 ___ 06:29AM BLOOD VitB12-1559* PERTINENT IMAGING: ___ ABDOMEN XR (SUPINE ONLY): Nonobstructive bowel gas pattern. ___ CTA HEAD W&W/O C & RECONS: final read pending, study sent for possible stroke and was unrevealing. ___ MR HEAD W/O CONTRAST: There is no acute infarct or intracranial hemorrhage. ___ TTE: The left atrium is normal in size. No thrombus/mass is seen in the body of the left atrium. No atrial septal defect or patent foramen ovale is seen by 2D, color Doppler or saline contrast with maneuvers. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). No masses or thrombi are seen in the left ventricle. There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. No masses or vegetations are seen on the aortic valve. The mitral valve leaflets are mildly thickened. No mass or vegetation is seen on the mitral valve. Trivial mitral regurgitation is seen. There is mild pulmonary artery systolic hypertension. ___ CT HEAD W/O CONTRAST: No evidence of acute intracranial hemorrhage or large vascular territorial infarction. Brief Hospital Course: Ms. ___ is a ___ year old woman with a history of type I diabetes c/b gastroparesis, nephropathy, retinopathy, bipolar, cholecystectomy, C-section who presents with vomiting and nausea and abdominal pain. Vomiting, nausea and abdominal pain occured in the setting of trying to cut back on domiperidone dose from QID to BID due to cost of medication. Patient had no signs of infection and her lipase was normal. Domiperidone was restarted and patient was advanced to regular diabetic diet. Patient continued to have nausea and vomiting which was felt in part to be due to her elevated blood sugars. ___ was consulted who titrated her inpatient insulin regimen with subsequent improvement in her blood sugars. By the time of discharge, patient noted resolution of her nausea, vomiting, and abdominal pain and was tolerating po intake well. Since the patient reported having an insufficient amount of domperidone available before the arrival of her next shipment of domperidone from ___, she was prescribed Ativan to take in the meantime. She had an EGD with botox injection which she tolerated well with improvement of symptoms. Patient was noted to develop new vertical nystagmus during her hospital stay. A code stroke was called, however no evidence of stroke was noted on CT/CTA/MRI and TTE was performed demonstrating no defects including PFO. Neurology was consulted but ultimately etiology of nystagmus remained unclear and nystagmus improved by day of discharge. ACTIVE ISSUES ============= #Gastroparesis: Thought to be triggered by patient attempting to decrease domperidone dose frequency to save on cost. Domperidone restarted at old regimen. However, patient initially with persistent nausea and vomiting despite restarting domiperidone that was thought to be related to concomitant poor blood sugar control. S/p EGD with botox injections in pylorus. She was seen by nutrition with recommendations for a gastroparesis diet and she ultimately able to tolerate small meals and liquids. She discharged with Ativan for nausea and an anxiety component of her gastroparesis with instructions to take the Ativan 30 minutes prior to meals. #Vertical Nystagmus: Code stroke called ___ in absence of other symptoms with negative imaging for posterior stroke (CT/CTA/MRI), TTE also neg for PFO. Neurology re-consulted given acute change of nystagmus with vertigo and gait instability c/f central process. Per Neuro, vertical nystagmus similiar from prior assessment. Unlikely pontine stroke or seziure. Consider carbamazepime toxicity; nystagmus worsened by low magnesium. Repeat CTH negative. She was treated with Meclizine and magnesium repleted with improvement in her symptoms and was set-up with follow-up with Neurology. # DM Type 1: Managed per ___ recommendations, discharged on her home 18 units of Lantus. CHRONIC ISSUES: ==================== # Nephropathy: Lisinopril 10 mg PO/NG DAILY # Bipolar: stable. Not currently promoting any manic or depressed mood. Restarted on Lithium Carbonate 900 mg PO QHS per her home medications. Continued with QUEtiapine Fumarate 200 mg PO/NG BID, CarBAMazepine 800 mg PO/NG BID # Hepatitis B: continued tenofovir. # Hyperlipidemia: held Simvastatin 40 mg PO/NG DAILY while inpatient, restarted as outpatient. # GERD: Fexofenadine 180 mg PO DAILY Transitional Issues: ===================== #) Magnesium: Patient started on oral magnesium due to low Mg and because she is on multiple QTc prolonging medications. Please follow up and titrate as clinically warranted. #) QTc: Patient on multiple QTc prolonging medications including domperidone and quetiapine. Please repeat EKG at next appointment and repeat as clinically warranted. #) Domiperidone: Patient tried to cut back due to cost. Planning to go back to QID dosing. Consider trialing taper to TID if clinically warranted to help with cost. At time of discharge, patient reported having insufficient amount of domperidone to make it until arrival of next shipment. Consequently was discharged on Zofran and advised to change back to domperidone once the next shipment arrived. #) Type 1 DM: Reports difficulty controlling BS due to gastroparesis and resultant difficulty in predicing required insulin dose. Reports hypoglycemia at home to ___ and hyperglycemia to 200s. Please follow up. # Diabetes: She should follow up in ___ as well. To schedule please contact (___) and/or ask for ___ or leave a voice message for her. #) Nystagmus: Worked up by neurology with no evidence of stroke. Follow up in neurology outpatient clinic if this persists and is symptomatic. #) Code status: Full #) CONTACT: ___ (Husband) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. NovoLOG (insulin aspart) 100 unit/mL subcutaneous QID 2. Carbamazepine 800 mg PO BID 3. Domperidone 10 mg PO QID 4. Lisinopril 10 mg PO DAILY 5. Simvastatin 40 mg PO DAILY 6. Tenofovir Disoproxil (Viread) 300 mg PO DAILY 7. Glargine 18 Units Bedtime 8. QUEtiapine Fumarate 200 mg PO BID 9. Fexofenadine 180 mg PO DAILY 10. Polyethylene Glycol 17 g PO DAILY:PRN constipation 11. Vitamin D 1000 UNIT PO DAILY 12. Lithium Carbonate 900 mg PO QHS 13. Psyllium Powder 1 PKT PO TID:PRN constipation Discharge Medications: 1. Carbamazepine 800 mg PO BID 2. Domperidone 10 mg PO QID 3. Fexofenadine 180 mg PO DAILY 4. Lisinopril 10 mg PO DAILY 5. Polyethylene Glycol 17 g PO DAILY:PRN constipation 6. QUEtiapine Fumarate 200 mg PO BID 7. Simvastatin 40 mg PO DAILY 8. Tenofovir Disoproxil (Viread) 300 mg PO DAILY 9. Vitamin D 1000 UNIT PO DAILY 10. Magnesium Oxide 400 mg PO DAILY RX *magnesium oxide 400 mg 1 capsule(s) by mouth daily Disp #*30 Capsule Refills:*0 11. NovoLOG (insulin aspart) 100 unit/mL subcutaneous QID 12. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 13. Lithium Carbonate 900 mg PO QHS 14. Psyllium Powder 1 PKT PO TID:PRN constipation 15. Glargine 18 Units Bedtime 16. Meclizine 12.5 mg PO Q6H:PRN vertigo RX *meclizine 12.5 mg 1 tablet(s) by mouth every six (6) hours Disp #*45 Tablet Refills:*0 17. Lorazepam 0.5 mg PO QAC RX *lorazepam 0.5 mg 1 tablet(s) by mouth before meals Disp #*21 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary diagnoses: ================== 1. Gastroparesis 2. Type 1 Diabetes Mellitus 3. Nystagmus Secondary diagnoses: ===================== 1. Nephropathy 2. Bipolar disorder 3. Hepatitis B 4. Hyperlipidemia 5. Gastroesophageal reflux disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was our pleasure caring for you during your admission to ___ ___. You were admitted due to nausea/vomiting and epigastric pain. This was felt to be due to your gastroparesis. We restarted your domiperidone at its prescribed dose of four times per a day. Unfortunately, you continued to have nausea and vomiting on this regimen. This was thought to be due to your high blood sugars. We changed your insulin regimen while you were in the hospital and your blood sugars then improved. You also saw your gastroenterologist and you had a procedure to inject botox into your stomach. You also had developed some eye movements while you were in the hospital that were concerning for a stroke. The neurology team evaluated you and performed a number of imaging tests that did not show any evidence of a stroke. It is unclear what caused these eye movements. Please follow up with neurology for continued management. You may take meclizine for your symptoms of vertigo. You should continue your domiperidone at your prescribed dose of four times a day. You stated that you did not have a sufficient quantity of domperidone to take until you received your next shipment. Thus, we have prescribed you some Ativan to take in the meantime. You should restart your dopmeridone at your usual dose once you get more domperidone. You should follow up with your GI doctor, a neurologist and your PCP. You should follow up with ___ clinic. You should follow up with Neurology if your eye symptoms continue. We wish you a speedy recovery! - Your ___ Care Team Followup Instructions: ___
19973404-DS-20
19,973,404
22,873,532
DS
20
2167-09-17 00:00:00
2167-09-17 17:09:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: abdominal pain, vomiting, diarrhea Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old woman with a history of type I diabetes c/b gastroparesis/nephropathy/retinopathy, bipolar, who presents with recurrent vomiting and nausea and abdominal pain. Pt was discharged 3 days ago for the same issues, recieved an EGD with botox injection. She was doing well, tolerating food until today at 9:30, when her symptoms suddenly returned. She had acute onset abdominal pain, diarrhea, and nausea/NBNB vomiting. She denies hematochezia or hematemesis. Denied fever, sick contacts or eating out. EKG: SR 98, RBBB QTc 491, no ST changes, similar to prior In the ED, initial vitals were: 97.4 109 126/69 16 100% RA - Labs were significant for WBC 18.7, H/H 14.8/43.8, BUN/Cr ___, blood glucose 338, negative u/a, normal lactate. - CT abd/pelvis showed small bowel inflammation c/w enteritis. - The patient was given 3L NS in ED, as well 1mg IV dilaudid x3, 4 mg Zofran IV x3, 6U insulin and 400 mg IV cipro and 500mg IV flagyl. Vitals prior to transfer were: 98.5 ___ 18 98% RA Upon arrival to the floor, VS were 97.8, 125/65, HR 106, RR 14, 97% RA. Patient reported her nausea/vomiting had resolved with the IV dilaudid and Zofran. Continued to endorse mild abdominal pain. Past Medical History: BIPOLAR DISORDER DIABETES MELLITUS - insulin dependent. Pt reports proteinuria, nephropathy, and retinopathy in addition to gastroparesis. GLAUCOMA RIGHT BUNDLE BRANCH BLOCK SEIZURE DISORDER - currently treated with Carbamazepine to which Pt attributes vertigo/dizziness, self-changed evening dose to 800mg from 1000mg yesterday (___) ALCOHOL ABUSE ASTHMA HEPATITIS B HEP C GASTROPARESIS - on domperidone, s/p Botox injection in ___ . Past Surgical History: CHOLECYSTECTOMY ___ FROZEN SHOULDER ___ UTERINE POLYPS PRIOR CESAREAN SECTION G3P1 BILATERAL TUBAL LIGATION Social History: ___ Family History: Extensive family history of Diabetes Mellitus with both parents still living. Heart disease in father. ___ family history of cancer. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals: T97.8, 125/65, HR 106, RR 14, 97% RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated, no LAD CV: tachycardic, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, mild mid-epigastric/RUQ ttp, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, moving all extremities, speech fluent, gait deferred. DISCHARGE PHYSICAL EXAM: Vital Signs: T: 98.1 BP: 108/59 HR: 83 RR: 18 Sp02: 98 RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, neck supple, Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Normal S1,S2, regular rate, no m/r/g. Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: Without rashes or lesions Neuro: CN II-XII intact, no vertical nystagmus noted, distal sensation intact. Pertinent Results: ADMISSION LABS: ___ 03:15PM BLOOD WBC-18.7*# RBC-4.61# Hgb-14.8# Hct-43.8# MCV-95 MCH-32.1* MCHC-33.8 RDW-12.1 RDWSD-42.1 Plt ___ ___ 03:15PM BLOOD Neuts-91.7* Lymphs-2.1* Monos-5.4 Eos-0.1* Baso-0.3 Im ___ AbsNeut-17.11* AbsLymp-0.40* AbsMono-1.00* AbsEos-0.01* AbsBaso-0.05 ___ 03:15PM BLOOD Plt ___ ___ 03:15PM BLOOD Glucose-338* UreaN-12 Creat-0.7 Na-135 K-4.5 Cl-95* HCO3-22 AnGap-23* ___ 03:15PM BLOOD ALT-34 AST-39 AlkPhos-68 TotBili-0.5 ___ 03:15PM BLOOD Lipase-25 ___ 03:15PM BLOOD Albumin-4.1 Calcium-10.2 Mg-1.6 ___ 03:15PM BLOOD Lactate-1.8 DISCHARGE LABS: ___ 06:55AM BLOOD WBC-5.4 RBC-3.24* Hgb-10.1* Hct-30.7* MCV-95 MCH-31.2 MCHC-32.9 RDW-12.1 RDWSD-41.6 Plt ___ ___ 06:55AM BLOOD Plt ___ ___ 06:55AM BLOOD Glucose-81 UreaN-6 Creat-0.5 Na-140 K-3.4 Cl-103 HCO3-27 AnGap-13 ___ 06:55AM BLOOD Calcium-8.8 Phos-3.2 Mg-1.5* PERTINENT IMAGING: ___ CT ABD/PELVIS W/ CONTRAST IMPRESSION: 1. Multiple focal regions of small bowel wall thickening with surrounding inflammatory changes, raise concern for enteritis. 2. Mild descending colonic wall thickening and edema. While these findings may be secondary to underdistention, the associated adjacent inflammatory changes and mesenteric fluid suggest colitis. Findings may be secondary to infectious, ischemic, or inflammatory causes. 3. Moderate axial hiatal hernia. 4. 2.2 cm left adnexal cyst may be physiologic if patient is premenopausal. If patient is postmenopausal, recommend follow-up pelvic ultrasound for further assessment. MICROBIOLOGY: Blood Culture- pending Stool Culture- pending Brief Hospital Course: ___ year old woman with a history of type I diabetes c/b gastroparesis recently admitted for nausea/vomiting in the setting of self-discontinuation of domperidone represents with acute onset sharp abdominal pain with diarrhea/nausea/vomiting. Clinical picture most concerning for gastroenteritis. She improved with hydration and was able to eat and drink normally on the day after admission. Stool cultures were sent but were pending at the time of discharge. ACTIVE ISSUES: ============== # Gastroenteritis: Nausea and diarrhea on day of admission. Was started on IV abx in Emergency Department. She was afebrile and hemodynamically stable. CT Abdomen/Pelvis showed enteritis/colitis. Most likely this is viral gastroenteritis, however bacterial could not be ruled out. C Diff was unlikely given no recent antibiotics. She improved with hydration and was able to eat without issue. Stool cultures were sent and are pending at discharge. #Gastroparesis: Gastroparesis was resolving as an outpatient and aside from some vomiting with her initial presentation, she was able to tolerate small meals on a low fiber, low fat diet. Controlled with Domperidone and Lorazepam 0.5 prior to meals for nausea. # DM Type 1: Recent high sugar to 480's as outpatient in the setting of eating canned fruit. Blood sugar was well controlled as an inpatient with home regimen of 18 ___ and sliding scale. CHRONIC ISSUES: =============== # Nephropathy: Lisinopril 10 mg PO/NG DAILY continued # Bipolar: stable. Not currently promoting any manic or depressed mood. Continued on Lithium Carbonate 900 mg PO QHS, QUEtiapine Fumarate 200 mg PO/NG BID, Lorazepam and CarBAMazepine 800 mg PO/NG BID # Hepatitis B: continue tenofovir. # Hyperlipidemia: hold Simvastatin 40 mg PO/NG DAILY Transitional Issues: ===================== [] consider alternative magnesium repletion as mg oxide is not well tolerated. [] f/u stool Yersinia, EHEC, Campylobacter, Shigella [] Recommendation from CT Abdomen/Pelvis: 2.2 cm left adnexal cyst may be physiologic if patient is premenopausal. If patient is postmenopausal, recommend follow-up pelvic ultrasound for further assessment. (From most recent d/c on ___ #) QTc: Patient on multiple QTc prolonging medications including domperidone and quetiapine. Please repeat EKG at next appointment and repeat as clinically warranted. #) Domiperidone: Patient tried to cut back due to cost. Planning to go back to QID dosing. Consider trialing taper to TID if clinically warranted to help with cost. At time of discharge, patient reported having insufficient amount of domperidone to make it until arrival of next shipment. Consequently was discharged on Zofran and advised to change back to domperidone once the next shipment arrived. #) Type 1 DM: Reports difficulty controlling BS due to gastroparesis and resultant difficulty in predicting required insulin dose. Reports hypoglycemia at home to ___ and hyperglycemia to 200s. Please follow up. # Diabetes: She should follow up in ___ as well. To schedule please contact (___) and/or ask for ___ or leave a voice message for her. #) Nystagmus: Worked up by neurology with no evidence of stroke. Follow up in neurology outpatient clinic if this persists and is symptomatic. CODE STATUS: Full Code CONTACT: ___ (husband) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Carbamazepine 800 mg PO BID 2. Domperidone 10 mg PO QID 3. Fexofenadine 180 mg PO DAILY 4. Lisinopril 10 mg PO DAILY 5. Polyethylene Glycol 17 g PO DAILY:PRN constipation 6. QUEtiapine Fumarate 200 mg PO BID 7. Simvastatin 40 mg PO DAILY 8. Tenofovir Disoproxil (Viread) 300 mg PO DAILY 9. Vitamin D 1000 UNIT PO DAILY 10. Aspirin 81 mg PO DAILY 11. Lithium Carbonate 900 mg PO QHS 12. Psyllium Powder 1 PKT PO TID:PRN constipation 13. Meclizine 12.5 mg PO Q6H:PRN vertigo 14. Lorazepam 0.5 mg PO QAC 15. Glargine 18 Units Bedtime Insulin SC Sliding Scale using HUM Insulin Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Carbamazepine 800 mg PO BID 3. Domperidone 10 mg PO QID 4. Fexofenadine 180 mg PO DAILY 5. Glargine 18 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 6. Lisinopril 10 mg PO DAILY 7. Lithium Carbonate 900 mg PO QHS 8. Lorazepam 0.5 mg PO QAC 9. Meclizine 12.5 mg PO Q6H:PRN vertigo 10. Polyethylene Glycol 17 g PO DAILY:PRN constipation 11. QUEtiapine Fumarate 200 mg PO BID 12. Simvastatin 40 mg PO DAILY 13. Tenofovir Disoproxil (Viread) 300 mg PO DAILY 14. Vitamin D 1000 UNIT PO DAILY 15. Psyllium Powder 1 PKT PO TID:PRN constipation Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis: Gastroenteritis Secondary Diagnoses: Gastroparesis Diabetes Type I Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms. ___, You came in after you had severe abdominal pain with diarrhea and vomiting. In the Emergency Department, you were found to have a high white blood cell count concerning for possible infection. Your symptoms are likely due to gastroenteritis. This is likely viral and will get better on its own without antibiotics. You should follow-up with your PCP. It was as pleasure taking care of you. -Your ___ Team Followup Instructions: ___
19973404-DS-25
19,973,404
25,995,277
DS
25
2170-07-19 00:00:00
2170-07-19 20:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: morphine Attending: ___ Chief Complaint: abdominal pain, n/v Major Surgical or Invasive Procedure: n/a History of Present Illness: Ms. ___ is a ___ female with the past medical history of DM c/b gastroparesis, bipolar d/o, seizure d/o, Hep B who presents with abdominal pain, n/v, admitted for presumed gastroparesis flare. Patient recently seen by GI/gastroparesis specialist. Outpatient gastric emptying study ordered and patient instructed to hold domperidone for 5 days prior to exam. Test was scheduled for ___ however on ___ patient developed severe and acute abdominal pain. She was advised by her GI physician to present to ER for evaluation. Patient states the pain was ___, located in epigastric area, sharp and at times cramping, associated with NBNB emesis, currently down to ___ with dilaudid. Her last BM was yesterday, feels more constipated due to using Zofran. Denies f/c, states pain is consistent with her usual gastroparesis flares, has been unable to tolerate much food without pain or n/v. Denies CP, SOB, light-headedness and dizziness. Also notes glucose at home has been more labile since stopping domperidone which she attributes in part to inconsistent PO intake. Has had several hypoglycemic episodes at home as well as in ED. In the ED, patient's vitals were as follows: T 97.5, HR 86, BP 148/92, RR 16, SpO2 98% on RA. CMP wnl, CBC wnl. She had a RUQUS which did not show any acute abnormalities. She was given 0.5 mg IV dilaudid x 2, Zofran 4 mg x2, LR 1L x 2. Patient had an episode of hypoglycemia in ED to ___ requiring IV dextrose. She was admitted to medicine for further work up and monitoring. ROS: Pertinent positives and negatives as noted in the HPI. All other systems were reviewed and are negative. Past Medical History: - Diabetes Mellitus: insulin dependent. Pt reports proteinuria, nephropathy, and retinopathy in addition to gastroparesis. - Gastroparesis - on domperidone, s/p Botox injections - Bipolar Disorder - Seizure Disorder - currently treated with Carbamazepine - EtOH Use Disorder - Right Bundle Branch Block - Asthma - Hepatitis B - Hepatitis C - Glaucoma - G3P1 Past Surgical History: - Cholecystectomy ___ - Frozen shoulder ___ - Uterine Polyps - Cesarean Section - Bilateral tubal ligation Social History: ___ Family History: Extensive family history of Diabetes Mellitus with both parents still living. Heart disease in father. ___ family history of cancer. Physical Exam: GENERAL: Alert and in no apparent distress CV: Heart regular, no murmur, no S3, no S4. No JVD. RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, slightly TTP in epigastric area. Bowel sounds present. No HSM GU: No suprapubic fullness or tenderness to palpation SKIN: No rashes or ulcerations noted NEURO: Alert, oriented, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs, sensation to light touch grossly intact throughout PSYCH: pleasant, appropriate affect Pertinent Results: ___ 02:03PM GLUCOSE-115* UREA N-10 CREAT-0.5 SODIUM-140 POTASSIUM-4.2 CHLORIDE-101 TOTAL CO2-29 ANION GAP-10 ___ 02:03PM ALT(SGPT)-21 AST(SGOT)-21 ALK PHOS-82 TOT BILI-<0.2 ___ 02:03PM WBC-5.8 RBC-4.09 HGB-13.0 HCT-37.4 MCV-91 MCH-31.8 MCHC-34.8 RDW-11.9 RDWSD-39.4 RUQ US ___ FINDINGS: Limited views of the pancreas appear unremarkable. Distal CBD measures up to 1 cm, unchanged from prior. Gallbladder is surgically absent. Minimal prominence of the intrahepatic biliary tree is unchanged from prior. The liver is normal in appearance and echotexture. No ascites. Main portal vein is patent with hepatopetal flow. Right kidney measures 9.6 cm and appears normal without hydronephrosis or worrisome lesion. Left kidney measures 9.7 cm and is normal in grayscale appearance without worrisome lesion. The spleen is normal in size at 9.5 cm in length. IMPRESSION: Status post cholecystectomy. Stable prominence of the biliary tree. FINDINGS: Residual tracer activity in the stomach is as follows: At 45 mins 97% of the ingested activity remains in the stomach At 2 hours 83% of the ingested activity remains in the stomach At 3 hours 65% of the ingested activity remains in the stomach At 4 hours 33% of the ingested activity remains in the stomach The majority of the residual tracer activity remains in the gastric fundus throughout the study. The gastric emptying curve demonstrates a plateau over the first 45 minutes then gradually slopes more steeply downward. IMPRESSION: Markedly delayed gastric emptying. Brief Hospital Course: Ms. ___ is a ___ female with the past medical history of DM c/b gastroparesis, bipolar d/o, seizure d/o, Hep B who presents with abdominal pain, n/v, admitted for presumed gastroparesis flare. ACUTE/ACTIVE PROBLEMS: #Abdominal pain #Nausea/vomiting #Gastroparesis flare - occurred in setting of discontinuation of domperidone in preparation for gastric emptying study. Have instructed patient that narcotics should be used sparingly as this may also affect gastric emptying study. -NM gastric emptying study ___ showed Markedly delayed gastric emptying. I discussed with Dr. ___. The pt will likely need pyloroplasty. His office will call her to refer her to a surgeon for this procedure. -Pt can resume her domperidone at discharge. #DM1 c/b hypoglycemia and hyperglycemia - labile BS with one documented hypoglycemic episode in ED and several at home per patient. Likely in setting of inconsistent PO intake from gastroparesis -___ consult appreciated. -Per ___ recs, pt advised to take Lantus 10U in AM and 16U in ___ along with current sliding scale and carb counting (1U per every 18g carbohydrates) CHRONIC/STABLE PROBLEMS: #Hep B - continue viread #Bipolar d/o - continue asenapine #Seizure d/o - continue carbamazepine Medications on Admission: The Preadmission Medication list is accurate and complete. 1. ASENapine 5 mg SL QHS 2. Aspirin 81 mg PO DAILY 3. CarBAMazepine 800 mg PO BID 4. Lisinopril 15 mg PO DAILY 5. Omeprazole 40 mg PO DAILY 6. Polyethylene Glycol 17 g PO DAILY 7. Tenofovir Disoproxil (Viread) 300 mg PO DAILY 8. domperidone maleate Study Med 10 mg PO QACHS 9. Carbamide Peroxide 6.5% ___ DROP BOTH EARS BID 10. linaCLOtide 72 mcg oral DAILY 11. Multivitamins 1 TAB PO DAILY 12. Simvastatin 40 mg PO QPM 13. Cetirizine 10 mg PO DAILY Discharge Medications: 1. Glargine 10 Units Breakfast Glargine 16 Units Dinner Insulin SC Sliding Scale using HUM Insulin 2. ASENapine 5 mg SL QHS 3. Aspirin 81 mg PO DAILY 4. CarBAMazepine 800 mg PO BID 5. Carbamide Peroxide 6.5% ___ DROP BOTH EARS BID 6. Cetirizine 10 mg PO DAILY 7. domperidone maleate Study Med 10 mg PO QACHS 8. linaCLOtide 72 mcg oral DAILY 9. Lisinopril 15 mg PO DAILY 10. Multivitamins 1 TAB PO DAILY 11. Omeprazole 40 mg PO DAILY 12. Polyethylene Glycol 17 g PO DAILY 13. Simvastatin 40 mg PO QPM 14. Tenofovir Disoproxil (Viread) 300 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Gastroparesis Type 1 diabetes mellitus Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You presented with a flare up of gastroparesis which caused nausea, vomiting and abdominal pain. You underwent a gastric emptying study which showed that you have marked delayed emptying. You will be contacted by the Gastrointestinal follow upw with regards to appropriate follow up. You were also seen by ___ specialists and your insulin was adjusted. Lantus 10U in the morning, 16U in the evening Sliding scale with meals as directed. Carbohydrate counting (1U for every 18g of carbs). Followup Instructions: ___
19973404-DS-29
19,973,404
27,142,177
DS
29
2171-09-13 00:00:00
2171-09-13 20:09:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: morphine Attending: ___ Major Surgical or Invasive Procedure: None attach Pertinent Results: LAB RESULTS ON ADMISSION: ========================= ___ 03:55PM BLOOD WBC-5.8 RBC-3.92 Hgb-12.1 Hct-36.7 MCV-94 MCH-30.9 MCHC-33.0 RDW-12.1 RDWSD-41.7 Plt ___ ___ 03:55PM BLOOD Plt ___ ___ 09:22PM BLOOD D-Dimer-462 ___ 03:55PM BLOOD Glucose-75 UreaN-16 Creat-0.5 Na-139 K-4.2 Cl-103 HCO3-26 AnGap-10 ___ 03:55PM BLOOD ALT-10 AST-18 AlkPhos-91 TotBili-<0.2 ___ 03:55PM BLOOD Lipase-15 ___ 03:55PM BLOOD cTropnT-<0.01 ___ 04:35AM BLOOD Calcium-8.7 Phos-3.5 Mg-1.6 ___ 03:55PM BLOOD Albumin-4.3 LAB RESULTS ON DISCHARGE: ========================= ___ 04:30AM BLOOD WBC-3.9* RBC-3.42* Hgb-10.6* Hct-31.7* MCV-93 MCH-31.0 MCHC-33.4 RDW-12.1 RDWSD-41.3 Plt ___ ___ 04:30AM BLOOD Glucose-186* UreaN-17 Creat-0.5 Na-139 K-4.3 Cl-102 HCO3-25 AnGap-12 ___ 04:30AM BLOOD Calcium-8.5 Phos-4.4 Mg-1.6 IMAGING: ======== ___ CXR No acute cardiopulmonary abnormality. ___ PORTAL ABDOMEN Moderate to severe colonic fecal burden with a nonobstructive bowel gas pattern. Brief Hospital Course: ___ with hx of DM1, gastroparesis s/p laparoscopic converted to open pyloroplasty (___) c/b infected seroma, ___ disease, HLD, bipolar disorder, chronic abdominal pain presenting with recurrent abdominal pain likely ___ constipation and gastroparesis in combination, which resolved with increased bowel regimen. # RUQ/epigastric pain: # Nausea: Patient described progressive constipation in the setting of known gastroparesis with moderate to severe colonic fecal burden with a nonobstructive bowel gas pattern seen on CXR. Abdominal pain resolved with increasing bowel regimen, suspect primarily driven by constipation, potentially triggering gastroparesis symptoms. Throughout hospitalization, patient has been very upset, insisting that our gastroenterology colleagues see her while in the hospital, with vociferous vocalizations at nursing staff repeatedly. We increased her lactulose to daily dosing and also provided her with miralax upon discharge. # Type 1 DM: Home regimen is Levemir 12u qAM and 20u qHS, patient reports that in the hospital she uses glargine 20u qHS, without am dose. While she was here with us, we dose reduced basal insulin to 14u qHS with Humalog SS sliding scale 2+1 50>150. She preferred to carb count while with us. There was episode of hypoglycemia to ___ in setting of over correction. In discussion with ___, patient will be discharged on her home insulin regimen without change. # Bipolar disorder: - Continue home asenapine 5 mg PO daily # ___: - Continue carbidopa/levodopa ___ TID # Hepatitis B: - Continue home tenofovir 300 mg PO daily # Seizure disorder: - Continue home carbamazepine 800 mg PO BID # HLD: - Continue home simvastatin 40 mg PO daily # Hypertension: While in house, held patient's home lisinopril 15 mg as SBP 100s off this medication. Discussed holding it on discharge, but patient preferred to continue. In this case, discussed she should monitor blood pressures at home closely and call PCP should BP be low or should she have symptoms such as dizziness/weakness. TRANSITIONAL ISSUES: ==================== [] Increased bowel regimen to lactulose 15 mL daily + PRN miralax, patient instructed to titrate as needed - No changes made to home insulin regimen [] Discussed holding home lisinopril given SBP 100s in house off this medication, she strongly preferred to continue, please titrate as needed Medications on Admission: The Preadmission Medication list is accurate and complete. 1. LORazepam 1 mg PO DAILY:PRN nausea, anxiety 2. ASENapine 5 mg SL DAILY 3. Tenofovir Disoproxil (Viread) 300 mg PO DAILY 4. Aspirin 81 mg PO DAILY 5. CarBAMazepine 800 mg PO BID 6. Simvastatin 40 mg PO QPM 7. Lisinopril 15 mg PO DAILY 8. Cetirizine 10 mg PO DAILY 9. Omeprazole 40 mg PO DAILY 10. Carbidopa-Levodopa (___) 1 TAB PO TID 11. Lactulose 15 mL PO EVERY OTHER DAY 12. Levemir 12 Units Breakfast Levemir 20 Units Bedtime Insulin SC Sliding Scale using Novolog Insulin Discharge Medications: 1. Lactulose 15 mL PO DAILY RX *lactulose 10 gram/15 mL 15 ml by mouth once a day Refills:*0 2. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Third Line RX *polyethylene glycol 3350 17 gram/dose 1 dose by mouth once a day Refills:*0 3. ASENapine 5 mg SL DAILY 4. Aspirin 81 mg PO DAILY 5. CarBAMazepine 800 mg PO BID 6. Carbidopa-Levodopa (___) 1 TAB PO TID 7. Cetirizine 10 mg PO DAILY 8. Levemir 12 Units Breakfast Levemir 20 Units Bedtime 9. Lisinopril 15 mg PO DAILY Would prefer to hold as SBP 100s while off, please monitor BP carefully 10. LORazepam 1 mg PO DAILY:PRN nausea, anxiety 11. Omeprazole 40 mg PO DAILY 12. Simvastatin 40 mg PO QPM 13. Tenofovir Disoproxil (Viread) 300 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Constipation History of gastroparesis Type 1 diabetes Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted for abdominal pain, thought secondary to constipation and your gastroparesis. While you were here, you were given medications to help you have a bowel movement and you subsequently felt better. You were seen by our diabetes doctors and also our gastroenterologists per your request. No changes were made to your insulin. We have increased your bowel regimen and you can titrate it as needed to make sure you have bowel movements which will help prevent further episodes. Please take care and take all your medications as prescribed. We did temporarily hold your blood pressure medication because your systolic blood pressure was in the 100 range while here. You preferred to continue to take this on discharge, hence we discussed monitoring your blood pressure very carefully while at home and to call your primary care doctor if you feel dizzy. Sincerely, Your ___ Care Team Followup Instructions: ___
19973580-DS-13
19,973,580
27,373,602
DS
13
2161-11-22 00:00:00
2161-11-24 15:54:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: ___ / ___ Attending: ___ Chief Complaint: Dyspnea Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old woman with PMH of GERD, depression, former tobacco use, and no known pulmonary history with recent admission for respiratory distress and wheezing, diagnosed with likely COPD. 2 weeks prior to that she had been admitted with community acquired pneumonia. She was discharged on ___ with inhalers, and a ___ outpatient note states that she was using them incorrectly, and felt immediate relief once instructed on correct usage. Of note, sputum culture from ___ shows sparse growth of GNRs. The patient received azithromycin only at this recent admission. In the evening yesterday the patient started feeling short of breath, but thought it would pass. She tried her inhalers without much effect. After continuing SOB by 3AM she decided to come to the ED. Since leaving the hospital on ___ her breathing has been ok, but she has been wheezy and has had a cough, mostly dry but sometimes productive of green sputum. She has also had runny nose. Otherwise she denies fevers/chills or muscle aches. In ED initial VS: 98.4 ___ 32 Placed on BiPAP Patient was given: Duonebs, IV methylprednisolone 125mg, azithromycin 500mg IV Imaging notable for: CXR showing pulmonary vascular congestion and mild pulmonary edema. VS prior to transfer: 98.6 108 118/67 20 100% bipap On arrival to the MICU, patient was on BiPAP and felt much improved in terms of SOB. REVIEW OF SYSTEMS: Positive per HPI. Otherwise ROS negative. Past Medical History: BREAST CANCER DEPRESSION BENIGN POSITIONAL VERTIGO KNEE PAIN OSTEOARTHRITIS TKR ___ Lumpectomy TAH/BSO Social History: ___ Family History: No family history of lung disease. Mother deceased at ___ (melanoma). Father deceased at ___ (___). Physical Exam: ADMISSION: GENERAL: Anxious and mildly distressed, but speaking in full sentences, alert, interactive HEENT: Sclera anicteric, MMM, oropharynx clear LUNGS: Diffuse wheezing, with good air movement throughout, fine crackles heard at the bases b/l CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: 1+ non-pitting edema b/l; Warm, well perfused, 2+ pulses NEURO: Moving all extremities with purpose DISCHARGE: VITALS: 98.1 158/88 80 20 94/RA GENERAL: Anxious and mildly distressed, but speaking in full sentences, alert, interactive HEENT: Sclera anicteric, MMM, oropharynx clear LUNGS: Faint wheezing improved from prior, with good air movement throughout, fine crackles heard at the bases b/l CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: 1+ non-pitting edema b/l; Warm, well perfused, 2+ pulses NEURO: Moving all extremities with purpose Pertinent Results: Admission labs: ___ 04:55AM BLOOD Neuts-59 Bands-0 ___ Monos-3* Eos-1 Baso-1 Atyps-2* ___ Myelos-0 AbsNeut-16.70* AbsLymp-10.19* AbsMono-0.85* AbsEos-0.28 AbsBaso-0.28* ___ 04:55AM BLOOD WBC-28.3*# RBC-5.01 Hgb-13.3 Hct-43.9 MCV-88 MCH-26.5 MCHC-30.3* RDW-15.8* RDWSD-50.4* Plt ___ ___ 04:55AM BLOOD ___ PTT-32.7 ___ ___ 04:55AM BLOOD Glucose-170* UreaN-23* Creat-0.6 Na-139 K-5.3* Cl-100 HCO3-25 AnGap-19 ___ 04:55AM BLOOD ALT-23 AST-31 AlkPhos-110* TotBili-0.3 ___ 04:55AM BLOOD Albumin-4.3 Calcium-9.2 Phos-6.5* Mg-2.1 ___ 05:43AM BLOOD ___ pO2-49* pCO2-80* pH-7.18* calTCO2-31* Base XS-0 ___ 05:10AM BLOOD Lactate-1.6 ___ 08:02AM BLOOD Lactate-3.7* K-3.6 ___ 05:43AM BLOOD O2 Sat-74 PERTINENT/DISCHARGE LABS: ___ 06:20AM BLOOD WBC-15.0* RBC-4.27 Hgb-11.5 Hct-36.5 MCV-86 MCH-26.9 MCHC-31.5* RDW-15.9* RDWSD-49.1* Plt ___ ___ 06:40AM BLOOD Glucose-85 UreaN-16 Creat-0.6 Na-139 K-4.1 Cl-99 HCO3-24 AnGap-20 ___ 06:15AM BLOOD LD(LDH)-269* CK(CPK)-41 ___ 06:15AM BLOOD proBNP-507* ___ 06:40AM BLOOD IgG-749 IgA-134 IgM-237* ___ 01:44PM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE Micro: ___ 1:51 pm URINE **FINAL REPORT ___ Legionella Urinary Antigen (Final ___: NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. (Reference Range-Negative). Performed by Immunochromogenic assay. A negative result does not rule out infection due to other L. pneumophila serogroups or other Legionella species. Furthermore, in infected patients the excretion of antigen in urine may vary. Time Taken Not Noted Log-In Date/Time: ___ 1:45 pm Rapid Respiratory Viral Screen & Culture Source: Nasopharyngeal swab. **FINAL REPORT ___ Respiratory Viral Culture (Final ___: No respiratory viruses isolated. Culture screened for Adenovirus, Influenza A & B, Parainfluenza type 1,2 & 3, and Respiratory Syncytial Virus.. Detection of viruses other than those listed above will only be performed on specific request. Please call Virology at ___ within 1 week if additional testing is needed. Respiratory Viral Antigen Screen (Final ___: Negative for Respiratory Viral Antigen. Specimen screened for: Adeno, Parainfluenza 1, 2, 3, Influenza A, B, and RSV by immunofluorescence. Refer to respiratory viral culture and/or Influenza PCR (results listed under "OTHER" tab) for further information.. ___ 11:14 am URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: < 10,000 CFU/mL. ___ 5:20 am BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH x2 Imaging: CXR ___ Right basal consolidation has increased concerning for progression of infectious process. Cardiomegaly is mild, unchanged. Mediastinum is stable. Lungs overall clear. TTE ___: The left atrium is normal in size. No atrial septal defect is seen by 2D or color Doppler. Left ventricular wall thicknesses and cavity size are normal. There is mild regional left ventricular systolic dysfunction with focal hypokinesis of the basal to mid inferior wall and inferoseptum. The remaining segments contract normally (LVEF = 50-55 %). Overall left ventricular systolic function is mildly depressed. Tissue Doppler imaging suggests a normal left ventricular filling pressure (PCWP<12mmHg). There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are structurally normal. There is no mitral valve prolapse. Mild (1+) mitral regurgitation is seen. There is mild pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Suboptimal image quality. Regional left ventricular systolic dysfunction c/w possiblCAD. Normal right ventricular cavity size and systolic function. Mild mitral regurgitation. Mild pulmonary hypertension. PFTs ___: FVC 1.77 (58%) FEV1 1.17 (50%) FEV1/FVC 65 (85%) no change with bronchodilators VC 2.08 (69%) TLC 4.34 (85%) Brief Hospital Course: ___ year old with significant remote smoking history and recent diagnosis of likely COPD (PFTs scheduled but not yet performed) presenting with hypercarbic respiratory failure likely ___ COPD exacerbation. ================= ACTIVE ISSUES ================= # Hypercarbic respiratory failure: She had been admitted ___ for PNA and found to have wheezing treated with steroids and nebs, which was thought to represent reactive airways in setting of new PNA and no known diagnosis of COPD. She was then readmitted ___ for dyspnea and hypoxemia, and treated with short steroid burst and azithromycin. Per patient, she was discharged home and felt well while on prednisone, but had worsening dyspnea once the burst completed. She presented to ED for dyspnea, VBG ___ suggesting acute CO2 retention. She was started on BiPAP and given IV solumedrol 125 x1 and nebs, with improvement in her breathing and normalization of her pH. Given prior, though remote smoking history and substantive wheezing on exam, it was thought this may represent underlying COPD. However, picture is not entirely clear, and last CT Chest on ___ showed tree in ___ lesions. She should have pulmonary follow up with PFTs and repeat CT scan prior to discharge. Long steroid taper as she has had rebound dyspnea after 2 prior shorter bursts. Of note, CXR did show a RLL opacity so she was started on CTX/azithro for a 5 day course of CAP treatment. PFTs demonstrated obstructive disease most consistent with COPD, no significant improvement with bronchodilators. NIF -45. Ambulatory sats >90 on RA. BNP slightly elevated to 507. Immunoglobins, aldolase pending on discharge. SLP consulted with no c/f aspiration. Patient significantly improved on discharge # Lactic acidosis: Patient had a mild lactic acidosis with max lactate of 4, without hypotension or evidence of poor organ perfusion. Etiology remained unclear but her lactate improved slowly. She was started on thiamine for possible deficiency. # Hypertension: Patient with no previous history of HTN. BP 140-170s/80-100s on the floor. Improved on amlodipine to 140s-150s. Discharged on Amlodipine 5 mg PO QDaily # CAD: Presumed diagnosis based on regional hypokinesis on recent TTE. She was unable to complete her recent stress test due to dyspnea. Should reschedule after discharge. She was continued on ASA81mg, simvastatin 40mg. Also consider starting B-blocker. #Depression: continued fluoxetine #GERD: continued esomeprazole TRANSITIONAL ISSUES -Prednisone taper over 10 days -Started on Advair/Spiriva -follow up CT likely in 6 months, but will defer to outpatient pulm -Should get repeat stress test as outpatient -Will defer decision to connect to cardiology to PCP -___ be started on b-blocker and ACEi as an outpatient given her cardiac disease -per discussion with pulm, cardio-selective BB should not have a significant effect on her airway disease -Pulm to follow pending laboratory studies -___ WBC count at PCP ___ - was 15.0 on discharge, downtrending. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Ipratropium-Albuterol Inhalation Spray 1 INH IH Q6H Wheezing 2. Esomeprazole Magnesium 40 mg oral DAILY 3. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg calcium- 200 unit oral DAILY 4. FLUoxetine 10 mg PO DAILY 5. Aspirin 81 mg PO DAILY 6. Simvastatin 40 mg PO QPM Discharge Medications: 1. Albuterol Inhaler ___ PUFF IH Q4H:PRN shortness of breath / wheezing RX *albuterol sulfate [ProAir HFA] 90 mcg ___ puffs inhaled every ___ hours as needed Disp #*1 Inhaler Refills:*0 2. amLODIPine 5 mg PO DAILY RX *amlodipine 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 3. Atorvastatin 20 mg PO QPM RX *atorvastatin 20 mg 1 tablet(s) by mouth every evening Disp #*30 Tablet Refills:*0 4. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID RX *fluticasone-salmeterol [Advair Diskus] 500 mcg-50 mcg/dose 1 dose inhaled twice a day Disp #*1 Disk Refills:*0 5. PredniSONE 50 mg PO DAILY Duration: 2 Doses This is dose # 1 of 5 tapered doses RX *prednisone 10 mg ___ tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 6. PredniSONE 40 mg PO DAILY Duration: 2 Doses Start: After 50 mg DAILY tapered dose This is dose # 2 of 5 tapered doses 7. PredniSONE 30 mg PO DAILY Duration: 2 Doses Start: After 40 mg DAILY tapered dose This is dose # 3 of 5 tapered doses 8. PredniSONE 20 mg PO DAILY Duration: 2 Doses This is dose # 4 of 5 tapered doses 9. PredniSONE 10 mg PO DAILY Duration: 2 Doses Start: After 20 mg DAILY tapered dose This is dose # 5 of 5 tapered doses 10. Tiotropium Bromide 1 CAP IH DAILY RX *tiotropium bromide [Spiriva with HandiHaler] 18 mcg 1 capsule inhaled daily Disp #*30 Capsule Refills:*0 11. Aspirin 81 mg PO DAILY 12. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg calcium- 200 unit oral DAILY 13. Esomeprazole Magnesium 40 mg oral DAILY 14. FLUoxetine 10 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: PRIMARY Hypercarbic respiratory failure SECONDARY Reactive airway disease Hypertension Leukocytosis Lactic acidosis Coronary artery disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, Thank you for choosing to receive your care at ___. You were admitted with respiratory failure, and briefly required intensive breathing treatments. You subsequently improved with medications that help open up your airways, and underwent testing which demonstrated that you have an obstructive airway disease, which is likely a combination of underlying COPD from previous smoking with inflammation from your respiratory infections you've experienced recently. You were started on steroids for treatment, which you should take for 10 more days through ___. You were also started on new inhaled medications to prevent further exacerbations. You have follow up appointments listed below for further management with lung disease specialists. Please see below for an updated list of your medications and upcoming appointments. We wish you the best with Followup Instructions: ___
19973587-DS-19
19,973,587
23,312,973
DS
19
2143-07-18 00:00:00
2143-07-18 12:31:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Tetracycline Analogues Attending: ___ Chief Complaint: Weakness, chest pain and shortness of breath Major Surgical or Invasive Procedure: None History of Present Illness: HPI: The patient is an ___ year old female ___ metastatic ovarian cancer x ___ year s/p chemo who presented with weakness, pleuritic chest pressure along with shortness of breath x 4 day. As the week went on her weakness worsened but her shortness of breath and chest pain got better. She felt so weak that all she wanted to do was lay in bed. She has a cat a home and she felt too weak to even care for her cat. Pain has improved but continues to worsen with breathing. She does not wake up short of breath. She does have report worsening dyspnea on exertion but none at rest. She sleeps in a recliner because of her L hip operation ___ years ago. She reports anorexia and decreased po intake. She feels like her cancer is getting to her and that she is failing. When she urinates she gets a body chill but no dysuria. In ER: (Triage Vitals:4 98.2 72 131/53 16 98% ra ) Meds Given: ceftriaxone Fluids given: 2L Radiology Studies: CTA- large pericardial effusion/pulmonary edema/pleural effusion consults called: cardiology PAIN SCALE: ___ ________________________________________________________________ REVIEW OF SYSTEMS: 10 or 2 with "all otherwise negative" CONSTITUTIONAL: [] All Normal [ -] Fever [+] Chills [ ] Sweats [ ] Fatigue [ ] Malaise [ ]Anorexia [ ]Night sweats [ +] __15___ lbs. weight loss over ___ year ____ Eyes [X] All Normal [ ] Blurred vision [ ] Loss of vision [] Diplopia [ ] Photophobia ENT [+ ] Dry mouth [ ] Oral ulcers [ ] Bleeding gums [ ] Sore throat [] Sinus pain [ ] Epistaxis [ ] Tinnitus [ ] Decreased hearing [ ] Other: RESPIRATORY: [] All Normal [ +] Shortness of breath [+] Dyspnea on exertion [ ] Can't walk 2 flights [ ] Cough [ ] Wheeze [ ] Purulent sputum [ ] Hemoptysis [ ]Pleuritic pain [ ] Other: CARDIAC: [] All Normal [ +] Palpitations - x 1 week [ ] Edema [ ] PND [ ] Orthopnea [ ] Chest Pain [ ] Dyspnea on exertion [ ] Other: GI: [] All Normal [ +] Nausea - improved with nausea pill [+] Vomiting- gatorade, no blood, no bile x 1 [] Abd pain [] Abdominal swelling [ -] Diarrhea [ -] Constipation [ ] Hematemesis [ ] Blood in stool [ ] Melena [ ] Dysphagia: [ ] Solids [ ] Liquids [ ] Odynophagia [ ] Anorexia [ ] Reflux [ ] Other: GU: [] All Normal [- ] Dysuria- but chill with urination [ ] Incontinence or retention [ ] Frequency [ ] Hematuria []Discharge []Menorrhagia SKIN: [] All Normal [ ] Rash [ ] Pruritus [+]dry skin on her hands MS: [X] All Normal [ ] Joint pain [ ] Jt swelling [ ] Back pain [ ] Bony pain NEURO: [X] All Normal [ ] Headache [ ] Visual changes [ ] Sensory change [ ]Confusion [ ]Numbness of extremities [ ] Seizures [ ] Weakness [ ] Dizziness/Lightheaded [ ]Vertigo [ ] Headache ENDOCRINE: [] All Normal [ +] Skin changes [ ] Hair changes [ ] Heat or cold intolerance [ ] loss of energy HEME/LYMPH: [X] All Normal [ ] Easy bruising [ ] Easy bleeding [ ] Adenopathy PSYCH: [] All Normal [ +] depression and feeling overwhelmed- she has thought about suicide but reassures me that she would never take her own life. [-]Suicidal Ideation [ ] Other: ALLERGY: [X ]Medication allergies Confirms tetracycline - thinks it gave her a rash but she is not sure. [ ] Seasonal allergies [X]all other systems negative except as noted above Past Medical History: PAST ONCOLOGY HISTORY: - ___: admitted with fatigue and abdominal pain. A CT abdomen and pelvis (___) showed multiple areas consistent with metastatic ovarian carcinoma, including omental metastases, retroperitoneal lymphadenopathy, moderate ascites, an indeterminate 9 mm liver lesion, and a 10 mm pulmonary nodule at the right lung base. - ___: a CT chest showed left side pleural effusion, a right lower lobe 1.1 cm nodule, mediastinal lymphadenopathy, moderate pericardial effusion and nodularity of the right breast with a right axilla lymphnode. A mammogram and breast US ruled out breast malignancy. An head CT was negative for metastases. - ___ thoracentesis. The cytology on the pleural fluid was negative for malignancy. On ___ she also underwent paracentesis, the pathology examination on the cell block obtained from the ascitic fluid showed adenocarcinoma with immunohistochemistry consistent with ovarian cancer (CK7, WT-1, p53 and MOC31 positive, CK20, CDX2 and calretinin negative). . ___ cycle 1 Carboplatin (AUC 5) D1 q21d ___ cycle 2 Carboplatin (AUC 5) D1 q21d ___ cycle 3 Carboplatin (AUC 5) D1 complicated by thrombocytopenia, cycle 4 delayed of 1 week ___ cycle 4 Carboplatin (AUC 5) D1 q28d ___ cycle 5 Carboplatin (AUC 5) D1 q28d ___ cycle 6 Carboplatin (AUC5) ___ restaging CT of Torso shows partial response to chemotherapy ___ clinical disease progression ___ start chemotherapy with Doxil 30 mg/m2 q28d . OTHER PAST MEDICAL HISTORY: PAST MEDICAL HISTORY: - Pericardial effusion small to moderate sized, no tamponade on Echo ___ and CT Torso ___. - Chronic afib s/p pacer for sick sinus syndrome - H/o mesenteric thromboembolism - HTN - Hyperlipidemia - Type II diabetes - Pulmonary artery hypertension (moderate on ECHO ___ - Possible MI ___ - Gait instability - Hypothyroidism - H/o C.diff - ___ Left hip replacement s/p fall/fracture - ___ Ventral hernia repair with mesh c/b c. diff - ___ ___ thromboembolectomy - ___ Exploratory laparotomy for hemoperitoneum (possible pancreatic laceration) s/p MVA Social History: ___ Family History: No family history of cancer, except breast cancer in 1 niece (daughter of her brother)- confirmed on admission. Dad/brother/half siblings died of heart disease. Physical Exam: 1. VS T = 97.5 P 83 BP = 163/69 RR = 18 O2Sat on __97% RA __ GENERAL: Thin female laying in bed Nourishment: OK Grooming: very good, + makeup Mentation: alert speaks in full sentence 2. Eyes: [] WNL EOMI without nystagmus, Conjunctiva: slightly injected 3. ENT [] WNL [] Moist [] Endentulous [] Ulcers [] Erythema [] JVD ____ cm [X] Dry [] Poor dentition [] Thrush [] Swelling [] Exudate 4. Cardiovascular [X] WNL Elevated JVP with + HJR [X] Regular [] Tachy [X] S1 [X] S2 [-] Systolic Murmur /6, Location: [] Irregular []Brady []S3 [] S4 [] Diastolic Murmur /6, Location: [X] Edema RLE None [] Bruit(s), Location: [X] Edema LLE None [] PMI [X] Vascular access [] Peripheral [] Central site: 2+ DPP b/l 5. Respiratory [ ] Crackles at the bases 6. Gastrointestinal [X] WNL [X] Soft [] Rebound [] No hepatomegaly [X] Non-tender [] Tender [] No splenomegaly [] Non distended [] distended [] bowel sounds Yes/No [] guiac: positive/negative 7. Musculoskeletal-Extremities [] WNL RLE ___ strength LLE - ___ stength which she states is baseline since her hip surgery ___ strength dorsiflexion b/l 8. Neurological [X WNL [ X] Alert and Oriented x 3 [ ] Romberg: Positive/Negative [ ] CN II-XII intact [ ] Normal attention [ ] FNF/HTS WNL [] Sensation WNL [ ] Delirious/confused [ ] Asterixis Present/Absent [ ] Position sense WNL [ ] Demented [ ] No pronator drift [] Fluent speech 9. Integument [] WNL Petechiae at the L ankle [X] Warm [X] Dry [] Cyanotic [] Rash: none/diffuse/face/trunk/back/limbs [ ] Cool [] Moist [] Mottled [] Ulcer: None/decubitus/sacral/heel: Right/Left 10. Psychiatric [] WNL [] Appropriate [] Flat affect [+] Anxious [] Manic [] Intoxicated [] Pleasant [] Depressed [] Agitated [] Psychotic [] Combative Pertinent Results: ___ 06:30PM URINE COLOR-Yellow APPEAR-Hazy SP ___ ___ 06:30PM URINE BLOOD-TR NITRITE-POS PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-MOD ___ 06:30PM URINE RBC-1 WBC-27* BACTERIA-MANY YEAST-NONE EPI-0 TRANS EPI-<1 ___ 06:30PM URINE HYALINE-4* ___ 06:30PM URINE MUCOUS-RARE ___ 04:20PM GLUCOSE-153* UREA N-16 CREAT-0.9 SODIUM-138 POTASSIUM-5.0 CHLORIDE-104 TOTAL CO2-22 ANION GAP-17 ___ 04:20PM estGFR-Using this ___ 04:20PM ALT(SGPT)-21 AST(SGOT)-50* ALK PHOS-80 TOT BILI-0.5 ___ 04:20PM LIPASE-17 ___ 04:20PM cTropnT-0.06* proBNP-___* ___ 04:20PM ALBUMIN-3.7 ___ 04:20PM WBC-10.3 RBC-4.30 HGB-13.0 HCT-39.7 MCV-92 MCH-30.2 MCHC-32.7 RDW-14.6 ___ 04:20PM NEUTS-79.9* LYMPHS-11.4* MONOS-5.6 EOS-2.5 BASOS-0.6 ___ 04:20PM PLT COUNT-390 ------------------- Admission CTA 1. No pulmonary embolism or aortic dissection. Large pericardial effusion, worse since prior study. 2. Bilateral small effusions, with pulmonary edema. 3. Mediastinal and axillary adenopathy are larger since prior study --------------- ECG: atrial fib Q in V1 and V2, - Q in V2 is new. --------------- ___ TTE: IMPRESSION: Prominent pericardial effusion without echocardiographic evidence of tamponade physiology. Serial evaluation is suggested. Compared with the prior study (images reviewed) of ___, the effusion is larger inferolateral and the estimated PA systolic pressure is higher. --------------- **FINAL REPORT ___ URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 ORGANISMS/ML.. PRESUMPTIVE IDENTIFICATION. Piperacillin/tazobactam sensitivity testing available on request. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ 16 I AMPICILLIN/SULBACTAM-- 4 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- 64 I TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- =>16 R Brief Hospital Course: The patient is a ___ year old female with HTN, HLD, know metastatic ovarian cancer s/p 6 cycles of carboplatin and 4 cycles of doxin who presents with shortness of breath, chest pain found to have increase pericardial effusion, pulmonary edema and elevated BNP. . Shortness of breath, chest pain with pericardial effusion - the etiology of these symptoms was not clear but improved to nearly her baseline just with treatment of her UTI - she was initially thought to have mild heart failure, but her symptoms improved without significant diuresis and she was nearly at her baseline at discharge - she was evaluated by Cardiology given the pericardial effusion, who found no clinical evidence of tamponade, and recommended a non-urgent TTE - the TTE was done, showing increased pericardial effusion without tamponade and it was recommended to follow this as an outpatient - I and the on-call Oncology fellow talked with her and her daughter ___ about the possibility that this effusion was due to her cancer, and suggested that she and her Oncologist discuss this further in the outpatient setting - in addition, her imaging showed that her disease burden in her lungs may be spreading -- defer to Oncology in the outpatient setting to discuss the risks and benefits of further treatment - her discomfort was easily managed with her home dose of oxycodone SR during this admission . Chills, weakness and urinary tract infection - the weakness was ultimately attributed to a urinary tract infection - she was found to have UA ___ WBCs, and UCx with >100,000 E. Coli UTI sensitive to cefazolin (so cephalexin by extension), resistant to cipro and TMP/SMX and intermediate to nitrofurantoin - as a result she was given 2 days of ceftriaxone in the hospital, remained afebrile and her symptoms improved -- this was transitioned to an additional 10 days of cephalexin at discharge - she and her family noted she has failed this antibiotic before -- but I emphasized it should be susceptible given the culture data, and that we did not have many other good options (Augmentin may be a possibility), and encouraged her to call or return if she began to feel worse -- they understood - she and her family noted that she has had recurrent infections -- we reviewed the importance of staying hydrated, and I think the idea of suppressive therapy would be good to touch on in the outpatient setting . HTN, HL with persistent afib and sinus node dysfunction, S/P SJM PPM implanted in ___ - she was continued on her home amlodipine, isosorbide mononitrate, ASA, dabigatran . Other - she was continued on her home mirtazapine, and sertraline was increased to 25mg daily from 12.5mg daily given her anxiety - continued docusate, pantoprazole and levothyroxine . Diabetes - she is on no agents at home and was given only sliding scale insulin as needed as an inpatient . Code Status - She was kept full code this admission. Per the admitting physician, she "at first said that she did not want resuscitation but then seemed unsure. During her last admission she was DNR/DNI." This should be addressed in the outpatient setting with her Oncologist in light of her possible disease progression despite chemotherapy (see above). Medications on Admission: Preadmission medications listed are correct and complete. Information was obtained from Patient. 1. Amlodipine 5 mg PO DAILY 2. Dabigatran Etexilate 150 mg PO BID 3. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 4. Sertraline 12.5 mg PO DAILY 5. Levothyroxine Sodium 100 mcg PO DAILY 6. Pantoprazole 40 mg PO Q24H 7. Docusate Sodium 100 mg PO BID 8. Aspirin 81 mg PO DAILY 9. Multivitamins 1 TAB PO DAILY 10. Mirtazapine 15 mg PO HS 11. Oxycodone SR (OxyconTIN) 10 mg PO HS:PRN pain Discharge Medications: 1. Amlodipine 5 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Dabigatran Etexilate 150 mg PO BID 4. Docusate Sodium 100 mg PO BID 5. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 6. Levothyroxine Sodium 100 mcg PO DAILY 7. Mirtazapine 15 mg PO HS 8. Multivitamins 1 TAB PO DAILY 9. Oxycodone SR (OxyconTIN) 10 mg PO HS:PRN pain 10. Pantoprazole 40 mg PO Q24H 11. Sertraline 25 mg PO DAILY RX *sertraline 25 mg 1 tablet(s) by mouth DAILY Disp #*30 Tablet Refills:*0 12. Cephalexin 500 mg PO Q12H Duration: 10 Days RX *cephalexin 500 mg 1 capsule(s) by mouth twice a day Disp #*20 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Urinary tract infection, complicated Pericardial effusion, gradually enlarging, unknown etiology Metastatic ovarian cancer, on monthly chemotherapy Atrial fibrillation with sinus node dysfunction, with a pacer Hypertension Hyperlipidemia Hypothyroidism Discharge Condition: Mental Status: Clear and coherent. (hard of hearing at baseline) Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted with weakness, shortness of breath and chest pain. You were found to have a urinary tract infection, and were given antibiotics. Your symptoms improved greatly after this, as they have with treatment of your prior infections. You were also found to have an increased pericardial effusion (fluid around the heart). You were seen by the cardiologists for this (heart doctors) and it was determined that this should be observed, and no further diagnostic testing or treatment was indicated at this time. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Followup Instructions: ___
19973795-DS-9
19,973,795
23,822,974
DS
9
2194-11-06 00:00:00
2194-11-06 08:51:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: Codeine / morphine Attending: ___. Chief Complaint: Back and leg pain Major Surgical or Invasive Procedure: amterior /posterior L3-S1 decompression and fusion History of Present Illness: Patient had progressive inability to ambulate secondary to neurogenic claudication Past Medical History: Hypertension/ scoliosis/ spinal stenosis Social History: ___ Family History: Non-contributory Physical Exam: Awake and alert/ vss Lungs clear to ausc. Abdomen soft, NT Extremities - moderate bilateral pedal swelling Calves soft, NT weakness diffusely ___ throughout both lower extremities Pertinent Results: ___ 12:42AM GLUCOSE-96 UREA N-17 CREAT-0.7 SODIUM-137 POTASSIUM-3.7 CHLORIDE-96 TOTAL CO2-27 ANION GAP-14 ___ 12:42AM estGFR-Using this ___ 12:42AM CRP-0.7 ___ 12:42AM WBC-6.0 RBC-4.05 HGB-13.3 HCT-39.9 MCV-99* MCH-32.8* MCHC-33.3 RDW-11.8 RDWSD-42.7 ___ 12:42AM NEUTS-58.5 ___ MONOS-11.4 EOS-4.0 BASOS-1.3* IM ___ AbsNeut-3.53 AbsLymp-1.48 AbsMono-0.69 AbsEos-0.24 AbsBaso-0.08 ___ 12:42AM ___ PTT-29.3 ___ ___ 12:42AM PLT COUNT-344 Brief Hospital Course: Patient was admitted and underwent an anterior and posterior lumbar decompression and fusion procedure in a staged fashion. She had post-operative atelectasis and was given an incentive spirometer. Her strength and sensation improved in both legs. at the time of discharge she was able to stand for short periods of time and had a bowel movement. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. DULoxetine 60 mg PO DAILY 2. Furosemide 20 mg PO DAILY 3. Gabapentin 300 mg PO TID 4. Methadone 10 mg PO DAILY 5. OxyCODONE--Acetaminophen (5mg-325mg) 1 TAB PO TID:PRN Pain - Moderate 6. Potassium Chloride 40 mEq PO DAILY 7. TraZODone 200 mg PO QHS:PRN insomnia Discharge Medications: 1. Cyclobenzaprine 5 mg PO TID:PRN spasms RX *cyclobenzaprine 10 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*0 2. Docusate Sodium 100 mg PO BID 3. Hydrochlorothiazide 50 mg PO DAILY diuretic RX *hydrochlorothiazide 50 mg 1 tablet(s) by mouth once a day Disp #*25 Tablet Refills:*0 4. Nitrofurantoin Monohyd (MacroBID) 100 mg PO Q12H RX *nitrofurantoin monohyd/m-cryst [Macrobid] 100 mg 1 capsule(s) by mouth every twelve (12) hours Disp #*14 Capsule Refills:*0 5. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Moderate RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*90 Tablet Refills:*0 6. Senna 17.2 mg PO HS RX *sennosides [senna] 8.6 mg 1 package by mouth once a day Disp #*60 Tablet Refills:*0 7. Gabapentin 600 mg PO TID 8. Methadone 10 mg PO QHS 9. potassium chloride 40 meq oral BID 10. TraZODone 100 mg PO QHS:PRN insomnia 11. DULoxetine 60 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Scoliosis/ spinal stenosis Discharge Condition: Awake and alert/ vss/ Incision clean and dry/ moving both legs well Discharge Instructions: Keep incisions clean and dry/ ambulate as tolerated with brace Physical Therapy: Ambulate as tolerated / use corset for comfort Treatments Frequency: Keep incisions clean and dry/ Followup Instructions: ___
19974480-DS-2
19,974,480
23,201,377
DS
2
2147-03-29 00:00:00
2147-03-29 17:10:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROSURGERY Allergies: tramadol / Pneumovax 23 / Penicillins / Sulfa (Sulfonamide Antibiotics) / ibuprofen Attending: ___ Chief Complaint: Brain Mass Major Surgical or Invasive Procedure: ___ biospy of brain tumor History of Present Illness: ___ yo F presented for outpatient work up of altered mental status. Pt's husband first felt like she wasn't herself 3 weeks ago. She seemed withdrawn and depressed at that time. Over the last two days pt has become more confused, unable to make meals, laughing at inappropriate times. Husband brought her to ___ who ordered MRI which was done today and shows a large frontal lesion that crosses midline with associated vasogenic edema. Pt denies HA, vision changes, numbness, weakness or tingling. "I don't have any symptoms." Past Medical History: HTN, hyperlipidemia, osteoporosis, s/p left knee replacement, s/p right hip replacement, chronic sinusitis, panic disorder Social History: ___ Family History: unable to obtain Physical Exam: On Admission: O: T: 98.9 HR:84 BP:121/65 RR:16 Sat:100% RA Gen: WD/WN, comfortable, NAD. HEENT: normocephalic, atraumatic Neck: Supple. Extrem: Warm and well-perfused. Neuro: Mental status: Inattentive, Awake and alert, cooperative with exam, depressed mood, laughs inappropriately at times Orientation: Oriented to person, "hospital" and ___ with choices Language: paucity of speech Difficulty with multi step commands Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 4 to 3 mm bilaterally. Visual fields unable to test due to inattention III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout. No pronator drift Sensation: Intact to light touch bilaterally. Coordination: + ataxia on on finger-nose-finger On Discharge: Pertinent Results: MR HEAD W & W/O CONTRAST ___ Large heterogeneously enhancing mass, approximately 6.5AP x 4.7CCx4.7TR cm, likely intra-axial, with extensive surrounding vasogenic edema centered in the bifrontal region, left more than right and causing effacement and exerting local mass effect as described above. Correlation with noncontrast CT can be helpful for hemorrhage versus mineralization. Differential diagnosis includes GBM, lymphoma, metastasis, etc. Neurosurgery consult, further workup and followup as needed. CT ABD & PELVIS W & W/O CONTRAST, ADDL SECTIONS ___ 1. No evidence of malignancy in the abdomen or pelvis. 2. Simple hepatic cysts. CT CHEST W/CONTRAST ___ No evidence of intrathoracic malignancy. MR HEAD W/ CONTRAST ___ Rim enhancing mass involving bilateral medial frontal lobes on the corpus callosum is again demonstrated for surgical planning. Diagnostic considerations include glioblastoma, or lymphoma if the patient is immunocompromised. Metastasis less likely. Brief Hospital Course: ___ y/o F with headaches and AMS who presented for an outpatient MRI which showed a large bifrontal tumor. She was seen in the ED and admitted to neurosurgery for further evaluation and management. She was alert and oriented x3 and full strength throughout. She was started on decadron and keppra. On ___, she remained stable on exam. OR planning was intitiated and husband was consented. On ___, patient remained stable. MRI WAND was done and she was NPO for OR. Patient was taken to the OR for a Frameless image-guided stereotactic brain biopsy (See Operative report for further details). Patient had a postoperative Non-contrast Head CT which was showed expected postoperative changes. She was transferred to the PACU and transferred to step-down once stable. She remained neurologically stable on exam. Patient was also evaluated by Radiation Oncology for further treatment planning On ___, patient remained stable on exam, she was transitioned to q4 neuro checks and telemetry was discontinued. On ___, the patient was at her baseline neurologically. ___ cleared her for home with rehab but her family wished that she be re-screened to see if she would qualify for rehab. On ___, the patient was doing well with no issues over night. She was discharged to home in stable condition. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Reclast (zoledronic acid-mannitol-water) 5 mg/100 mL injection yearly 2. Hydrocodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN pain 3. Atorvastatin 40 mg PO QPM 4. azelastine 137 mcg nasal BID 5. Losartan Potassium 50 mg PO DAILY 6. ClonazePAM 0.5 mg PO BID 7. Fluticasone Propionate NASAL 2 SPRY NU BID 8. Milk of Magnesia 30 mL PO PRN constipation Discharge Medications: 1. Atorvastatin 40 mg PO QPM 2. ClonazePAM 0.5 mg PO BID 3. Fluticasone Propionate NASAL 2 SPRY NU BID 4. Losartan Potassium 50 mg PO DAILY 5. Milk of Magnesia 30 mL PO PRN constipation 6. azelastine 137 mcg nasal BID 7. Reclast (zoledronic acid-mannitol-water) 5 mg/100 mL injection yearly 8. Senna 17.2 mg PO QHS RX *sennosides [senna] 8.6 mg 1 capsule by mouth daily as needed Disp #*20 Capsule Refills:*0 9. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth Daily while on steroids Disp #*30 Tablet Refills:*0 10. OxycoDONE (Immediate Release) ___ mg PO Q6H:PRN Pain RX *oxycodone 5 mg ___ tablet(s) by mouth Every ___ hours as needed for pain Disp #*50 Tablet Refills:*0 11. LeVETiracetam 500 mg PO BID RX *levetiracetam 500 mg 1 tablet(s) by mouth Twice a day Disp #*60 Tablet Refills:*2 12. Dexamethasone 4 mg PO Q6H RX *dexamethasone 4 mg 4 tablet(s) by mouth Every 8 hours Disp #*21 Tablet Refills:*0 13. Dexamethasone 2 mg PO Q8H 2mg PO q8h x 1 week 2mg PO Q12h x 1 week 2mg PO Daily x 1 week Off Tapered dose - DOWN RX *dexamethasone 2 mg 1 tablet(s) by mouth Every 8 hours Disp #*42 Tablet Refills:*0 Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: bilateral frontal lobe tumor Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Surgery brain. •*** You underwent a biopsy. A sample of tissue from the lesion in your brain was sent to pathology for testing. •Please keep your incision dry until your sutures/staples are removed. •You may shower at this time but keep your incision dry. •It is best to keep your incision open to air but it is ok to cover it when outside. •Call your surgeon if there are any signs of infection like redness, fever, or drainage. Activity •We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. •You make take leisurely walks and slowly increase your activity at your own pace once you are symptom free at rest. ___ try to do too much all at once. •No driving while taking any narcotic or sedating medication. •If you experienced a seizure while admitted, you are NOT allowed to drive by law. •No contact sports until cleared by your neurosurgeon. You should avoid contact sports for 6 months. Medications •***Please do NOT take any blood thinning medication (Aspirin, Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon. •***You have been discharged on Keppra (Levetiracetam). This medication helps to prevent seizures. Please continue this medication as indicated on your discharge instruction. It is important that you take this medication consistently and on time. •You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. What You ___ Experience: •You may experience headaches and incisional pain. •You may also experience some post-operative swelling around your face and eyes. This is normal after surgery and most noticeable on the second and third day of surgery. You apply ice or a cool or warm washcloth to your eyes to help with the swelling. The swelling will be its worse in the morning after laying flat from sleeping but decrease when up. •You may experience soreness with chewing. This is normal from the surgery and will improve with time. Softer foods may be easier during this time. •Feeling more tired or restlessness is also common. •Constipation is common. Be sure to drink plenty of fluids and eat a high-fiber diet. If you are taking narcotics (prescription pain medications), try an over-the-counter stool softener. When to Call Your Doctor at ___ for: •Severe pain, swelling, redness or drainage from the incision site. •Fever greater than 101.5 degrees Fahrenheit •Nausea and/or vomiting •Extreme sleepiness and not being able to stay awake •Severe headaches not relieved by pain relievers •Seizures •Any new problems with your vision or ability to speak •Weakness or changes in sensation in your face, arms, or leg Call ___ and go to the nearest Emergency Room if you experience any of the following: •Sudden numbness or weakness in the face, arm, or leg •Sudden confusion or trouble speaking or understanding •Sudden trouble walking, dizziness, or loss of balance or coordination •Sudden severe headaches with no known reason Followup Instructions: ___
19974520-DS-19
19,974,520
23,580,334
DS
19
2152-01-20 00:00:00
2152-01-22 17:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Novocain / Asparagus Attending: ___. Chief Complaint: COUGH and FEVER Major Surgical or Invasive Procedure: None History of Present Illness: ___ with hx bronchiectasis presenting with ongoing purulent cough, fevers and weakness for one month failing a 10-day course of Augment. She has had a productive cough since the beginning of ___ which is continuing to worsen. She reports greenish/yellow sputum with no blood ___ sputum. Notes that her ribs on the right hurt "from coughing". Has been taking guaifenesin (Mucinex) and Tylenol and not feeling better. Has had reduced PO because she feels globally weak. Queasy feeling but no bowel movement changes and no vomiting. Notes her ankles are more swollen than usual. She also endorses fatigue and night sweats. She reports her symptoms of fever (as high as 102), sputum, cough, and SOB began ___ ___. She began a course of Augmentin on ___ after visiting her PCP but the script was changed to levofloxacin when a CXR showed multifocal pneumonia. However, she reports not taking the levofloxacin and choosing to finish the Augment course instead. Her symptoms improved slightly on antibiotics, but resumed when her course finished. She presented to her pulmonologist Dr. ___ on ___ with worsening purulent sputum, fever to 102, chest pain and fatigue. On exam she was tachycardic, sat 96%RA, afebrile, coughing thick green sputum, decreased breath sounds ___ lower left lobe and rhonchi diffusely, and edema ___ legs bilaterally to mid shins. CXR obtained at the visit (___) showed LLL and lingular infiltrates with effusion concerning. Also of note is that bronchoalveolar lavage ___ ___ grew aspergillus. She was sent to ED by her pulmonologist for further evaluation. Past Medical History: 1. Osteoporosis. 2. Basal cell carcinoma of the right forehead, surgically removed 3. Gastroesophageal reflux. 4. Weight loss. 5. Tinnitus. 6. Vertigo 7. Bronchiectasis chest CT scan. 8. Heart murmur (MVP) 9. Panic disorder Social History: ___ Family History: Father died of brain tumor ___ his ___. Mother died ___ ___ of heart disease. She does not have any siblings. Physical Exam: ADMISSION PHYSCIAL EXAM: ========================= VS - 98.5 114/58 90 18 100% RA GENERAL: NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM, good dentition NECK: nontender supple neck, no LAD, no JVD CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: Decreased BS on L base, soft rales at the right base ABDOMEN: nondistended, +BS, nontender ___ all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: 1+ pitting edema to mid-shin PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM: ========================= VS - Tc 97.6 Tm 98.3 BP 115/61 HR 95 RR 18 O297%RA GENERAL: woman lying ___ bed ___ NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM, good dentition, mild fissuring ___ tongue along central sulcus, OP clear CARDIAC: RRR, S1/S2, ___ systolic murmur radiating to left apex, gallops, or rubs LUNG: basilar crackles on left side, high-pitched end-inspiratory sound heard inconsistently bilaterally ___ along upper and lower lung fields ABDOMEN: nondistended, +BS EXTREMITIES: trace edema to mid-shin NEURO: CN II-XII intact SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: ADMISSION LABS: ================= ___ 10:55AM BLOOD WBC-10.2*# RBC-3.42* Hgb-9.6* Hct-30.6* MCV-90 MCH-28.1 MCHC-31.4* RDW-14.6 RDWSD-46.7* Plt ___ ___ 10:55AM BLOOD Neuts-79.1* Lymphs-10.1* Monos-9.4 Eos-0.5* Baso-0.3 Im ___ AbsNeut-8.11* AbsLymp-1.03* AbsMono-0.96* AbsEos-0.05 AbsBaso-0.03 ___ 02:48PM BLOOD Glucose-91 UreaN-11 Creat-0.4 Na-132* K-6.1* Cl-90* HCO3-30 AnGap-18 ___ 02:48PM BLOOD Albumin-3.2* ___ 02:54PM BLOOD Lactate-1.6 Na-133 K-4.6 DISCHARGE LABS: ================= ___ 06:15AM BLOOD WBC-7.0 RBC-3.29* Hgb-9.2* Hct-29.1* MCV-88 MCH-28.0 MCHC-31.6* RDW-14.6 RDWSD-46.9* Plt ___ ___ 06:15AM BLOOD Glucose-109* UreaN-13 Creat-0.4 Na-135 K-4.6 Cl-94* HCO3-35* AnGap-11 ___ 06:15AM BLOOD Calcium-8.7 Phos-3.9 Mg-2.0 PERTINENT FINDINGS: ==================== Labs: ------ ___ 06:40AM BLOOD calTIBC-293 VitB12-735 Folate-15.7 Ferritn-67 TRF-225 ___ 02:48PM BLOOD Albumin-3.2* Micro: ------ ___ 05:00PM URINE Color-Straw Appear-Clear Sp ___ ___ 05:00PM URINE Blood-TR Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-8.0 Leuks-NEG ___ 05:00PM URINE RBC-2 WBC-2 Bacteri-NONE Yeast-NONE Epi-2 ___ 05:00PM URINE Mucous-RARE ___ 05:00PM URINE Hours-RANDOM UreaN-280 Creat-26 Na-154 ___ 2:42 pm BLOOD CULTUREx2 Blood Culture, Routine (Pending): ___ 11:39 am SPUTUM Source: Expectorated. GRAM STAIN (Final ___: >25 PMNs and <10 epithelial cells/100X field. 4+ (>10 per 1000X FIELD): GRAM POSITIVE COCCI. ___ PAIRS AND CHAINS. 4+ (>10 per 1000X FIELD): GRAM NEGATIVE ROD(S). 2+ ___ per 1000X FIELD): GRAM POSITIVE ROD(S). RESPIRATORY CULTURE (Final ___: MODERATE GROWTH Commensal Respiratory Flora. HAEMOPHILUS INFLUENZAE, BETA-LACTAMASE NEGATIVE. MODERATE GROWTH. Beta-lactamse negative: presumptively sensitive to ampicillin. Confirmation should be requested ___ cases of treatment failure ___ life-threatening infections.. FUNGAL CULTURE (Preliminary): NO FUNGUS ISOLATED. LEGIONELLA CULTURE (Preliminary): NO LEGIONELLA ISOLATED. ___ 5:15 pm Rapid Respiratory Viral Screen & Culture Source: Nasopharyngeal swab. Respiratory Viral Culture (Preliminary): Respiratory Viral Antigen Screen (Final ___: Negative for Respiratory Viral Antigen. Specimen screened for: Adeno, Parainfluenza 1, 2, 3, Influenza A, B, and RSV by immunofluorescence. Refer to respiratory viral culture and/or Influenza PCR (results listed under "OTHER" tab) for further information. Legionella Urinary Antigen (Final ___: NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. (Reference Range-Negative). Performed by Immunochromogenic assay. A negative result does not rule out infection due to other L. pneumophila serogroups or other Legionella species. Furthermore, ___ infected patients the excretion of antigen ___ urine may vary. ___ 2:38 am MRSA SCREEN Source: Nasal swab. **FINAL REPORT ___ MRSA SCREEN (Final ___: No MRSA isolated Imaging: ---------- ___ Sinus tachycardia. Low limb lead voltage. Biatrial abnormality. Delayed R wave transition. Compared to the previous tracing of ___ the rate has increased. Otherwise, no diagnostic interim change. Read by: ___ ___ Axes Rate PR QRS QT QTc (___) P QRS T 107 171 80 ___ 70 -10 35 CXR ___ Compared to chest radiographs since ___, most recently ___. Large scale pneumonia ___ the left lower lobe and lingula is new, a smaller region of consolidation ___ the right lung base has a different distribution than before. Previous right upper lobe pneumonia left a region of bronchiectatic scarring. Moderate left pleural effusion is new. Multifocal pneumonia could be due to bronchiectasis, chronic aspiration, or even cryptogenic organizing pneumonia. Volume of left pleural effusion must be followed for any indication that the patient may be developing empyema. Heart size normal. No pneumothorax. CTA Chest ___: 1. Irregular inferior lingular, right upper lobe and bilateral lower lobe consolidations with areas of peribronchial nodularity compatible with multifocal pneumonia. 2. Small left-sided pleural effusion. 3. Worsening widespread bronchiectasis with bilateral lower lobe predominance with multiple areas of mucous impaction. 4. Mild hilar and mediastinal adenopathy, increased since ___, potentially reactive. 5. No evidence of pulmonary embolism or aortic abnormality. TTE ___: The left atrium is normal ___ size. The estimated right atrial pressure is ___ mmHg. Normal left ventricular wall thickness, cavity size, and global systolic function (3D LVEF = 63 %). The estimated cardiac index is normal (>=2.5L/min/m2). Tissue Doppler imaging suggests an increased left ventricular filling pressure (PCWP>18mmHg). The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. The mitral valve leaflets are mildly thickened. There is mild bileaflet leaflet mitral valve prolapse. Trivial mitral regurgitation is seen. A late systolic jet of The estimated pulmonary artery systolic pressure is normal. There is a trivial/physiologic pericardial effusion. Normal biventricular cavity sizes with preserved global and regional biventricular systolic function. Mild mitral valve prolapse with trivial mitral regurgitation. Compared with the report of the prior study (images unavailable for review) of ___, the estimated LV filling pressure is elevated; other findings are similar. Brief Hospital Course: ___ hx bronchiectasis presenting with ongoing purulent cough, fevers, and weakness for one month failing a 10-day course of Augmentin. She visited her pulmonologist Dr. ___ collected a sputum sample and a CXR. The CXR showed bronchiectasis and left lower and lingular lobe infiltrates concerning for a multifocal pneumonia as well as a left pleural effusion. She was referred to the ED, where a CTA was performed. There was no evidence of PE and the left-sided pleural effusion was revealed to be minimal. Influenza and respiratory viral antigen screens were also performed and were negative. Legionella urinary antigen was performed and was negative. Blood cultures were also drawn and the results are still pending, though no growth has been noted after 3 days. Because the patient presented with an apparent multifocal pneumonia that had lasted several weeks and failed a course of Augmentin, she was started on broad-spectrum antibiotics of Cefepime/Levofloxacin/vancomycin to cover typical causes of community-acquired pneumonia as well as Pseudomonas, MRSA, and atypical causes of pneumonia. Furthermore, she received acapella and incentive spirometry to promote pulmonary hygiene. She received three days of IV vancomycin, cefepime, and levofloxacin. Her finalized sputum cultures grew beta-lactamase negative Haemophilus influenzae and normal respiratory flora, so she is being discharged on a 7-day course of levofloxacin 750MG PO, which should have sufficient coverage against H. influenzae and other typical causes of community-acquired pneumonia. Laboratory tests also revealed an albumin of less than 3 and hemoglobin ___ the ___ range. The patient reported a history of poor PO intake during the past few months and reports a primarily vegetarian diet. This finding was concerning for poor nutrition. She was seen by a nutritionist and was recommended meal supplementation, for example, with Ensure. The patient also reported some uncertainty ___ going home to live independently and met with one of our social workers to explore options that may lend her some help at home. Finally, she was also evaluated by ___ and was deemed fit and able to go home without the need for physical therapy. She was discharged with regular diet. TRANSITIONAL ISSUES: ====================== [ ] Complete 7 day course of PO Levofloxacin 750mg Qdaily (Last ___. [ ] Follow up with PCP office, esp. regarding anemia and fatigue. Consider Iron supplementation and dietary modification ___ the future. [ ] Follow up with pulmonologist Dr. ___ antibiotic course finishes for PFTs and repeat CXR [ ] Osteoporosis, not currently on Calcium supplementation, may want to consider. #Full code ___ (Friend) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. ALPRAZolam 0.25 mg PO DAILY:PRN anxiety 2. estradiol 0.01 % (0.1 mg/gram) vaginal unknown 3. Omeprazole 40 mg PO BID 4. Vitamin B Complex 1 CAP PO DAILY 5. Vitamin D ___ UNIT PO DAILY 6. Magnesium Citrate 300 mL PO ONCE Discharge Medications: 1. ALPRAZolam 0.25 mg PO DAILY:PRN anxiety 2. Omeprazole 40 mg PO BID 3. Vitamin B Complex 1 CAP PO DAILY 4. Vitamin D ___ UNIT PO DAILY 5. estradiol 0.01 % (0.1 mg/gram) vaginal unknown 6. Magnesium Citrate 300 mL PO ONCE 7. Levofloxacin 750 mg PO Q24H Pneumonia Duration: 4 Days RX *levofloxacin 750 mg 1 tablet(s) by mouth daily Disp #*5 Tablet Refills:*0 8. Lidocaine 5% Ointment 1 Appl TP ONCE Duration: 1 Dose Apply to areas of chest pain, 12 hours on, 12 hours off. RX *lidocaine 5 % Apply thin layer over affected area once a day Refills:*0 9. Guaifenesin-Dextromethorphan 5 mL PO Q6H:PRN cough RX *dextromethorphan-guaifenesin [Guaifenesin-DM] 100 mg-10 mg/5 mL 10 mg by mouth every six (6) hours Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY --------- -Pneumonia -Anemia SECONDARY ------------ -Bronchiectasis -Hyponatremia -Osteoporosis -GERD -Panic Disorder Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to ___ for shortness of breath and concern for pneumonia. WHAT WAS DONE DURING YOUR HOSPITAL STAY? ========================================== - An x-ray and CAT scan of your chest showed signs of pneumonia ___ addition to your known diagnosis of bronchiectasis. - You were started on IV antibiotics. - Sputum cultures as well as blood and urine cultures were sent off. - Sputum cultures grew a likely source of infection, a bacteria called Haemophilus influenzae. - A blood count test revealed you have moderate anemia. - You were transitioned to oral antibiotics, called Levofloxacin. - You were deemed to be stable for discharge. WHAT SHOULD YOU DO FOLLOWING DISCHARGE? ========================================= - Please take your medications as regularly prescribed. -- Finish your 7 day course of Levaquin antibiotics (LAST DAY = ___ - Follow up with your ___ at your PCP's office on ___ at 10:45 AM - Follow up with your pulmonologist, Dr. ___ on ___ at 9:10. You may call to make a new appointment if you prefer later time. It was a pleasure taking care of you during your hospital stay. If you have any questions about the care you received, please do not hesitate to ask. We wish you the best ___ health ___ the future. Sincerely, Your Inpatient ___ Care Team Followup Instructions: ___
19974576-DS-12
19,974,576
20,930,639
DS
12
2122-03-20 00:00:00
2122-03-20 17:17:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: vomiting, diarrhea, fever Major Surgical or Invasive Procedure: None History of Present Illness: ___ with metastatic intraperitoneal mucinous adenocarcinoma of presumed appendiceal primary s/p 3 cycles of carbotaxol targeting presumed gynecologic primary tumor without significant response, then with exlap (___) concerning for appendiceal primary presenting now with acute onset nausea/vomiting/diarrhea/fever. Interview conducted in ___ w/ family at bedside. She was in USOH until yesterday AM when she rather suddently developed watery diarrhea (nonbloody) and nonbloody nonbilious emesis and has been unable to keep down fluids for 24 hrs. She had chills at home and diffuse abdominal pain and was unable to keep down fluids so came to the ED. No sick contacts. No headache. No body aches. No dysuria, no CP/SOB. Regarding onc history: she saw her oncologist ___ and per notes it seems that they discussed that treatment would be palliative; with that in mind and evidence of disease progression despite therapy at the time, she had previously expressed to them that she would not want more chemo if the intent is palliative. They planned to see her in 4 weeks for follow up. ED course: T 100.0 HR 102 BP 97/50 RR 18 98%RA. 3L IVF given along with 5mg IV morphine and 4mg IV Zofran. CT a/p with contrast showing significant worsening of metastatic disease burden in the abd and pelvis with large predominattly cystic masses in pelvis and widespread omental caking and peritoneal mets. parenchymal cystic lesions in the liver spleen of also enlarged since prior study. No e/o SBO or intraperitoneal free air. Labs with WBC 16 up from 10 in ___, Hct stable at 33 Plts 343. 80% pmns. Chem with na of 132 and bun/cr ___. LFTs normal lipase 15. uA not consistent with infectious process. lactate 2.2. HR down to 77 prior to transfer. Past Medical History: PMH: - Asthma - Osteoporosis - Denies hypertension, diabetes, thromboembolic disease PSH: - Abdominal surgery to remove her placenta post-partum (pt unclear re details, occurred after vaginal delivery, via small infraumbilical 4cm vertical incision) - Ex lap, drainage of ascites, omental bx, peritoneal bx, ovarian bx, ___, ___ ___: - ___ (4 deceased in neonatal period) - SVD x 11 - One pregnancy c/b ? retained placenta, requiring abdominal surgery via vertical 4cm infraumbilical incision PGYN: - Menopausal, late ___ - Denies postmenopausal bleeding - Not currently sexually active - Denies hormonal replacement therapy or history of OCPs - Never had a Pap smear (pt denies and nothing in CHA records since ___ - Denies history of pelvic infections or sexually transmitted infections - Denies history of fibroids or cysts Social History: ___ Family History: - Sister died of liver cancer - No known family history of breast, uterine, ovarian, cervical or colon cancer - No known history of bleeding or clotting disorder Physical Exam: PHYSICAL EXAM: VITAL SIGNS: T afeb 110/60 64 18 94-96% RA General: NAD HEENT: MMM, no OP lesions, no cervical, supraclavicular, or axillary adenopathy, no thyromegaly CV: RR, NL S1S2 no S3S4 MRG PULM: CTAB GI: BS+, soft, NTND, no masses or hepatosplenomegaly, nontender. Large midline well healed scar LIMBS: 1+ edema, clubbing, tremors, or asterixis; no inguinal adenopathy SKIN: No rashes or skin breakdown NEURO: Oriented x3. Cranial nerves II-XII are within normal limits excluding visual acuity which was not assessed Pertinent Results: ___ 06:30AM BLOOD Glucose-107* UreaN-9 Creat-0.6 Na-133 K-4.0 Cl-102 HCO3-25 AnGap-10 ___ 06:30AM BLOOD Calcium-8.3* Phos-2.2* Mg-1.6 CT abdomen IMPRESSION: 1. Significant worsening of metastatic disease burden in the abdomen and pelvis, with large predominantly cystic masses in the pelvis and widespread omental caking and peritoneal metastases. 2. Parenchymal cystic lesions in the liver spleen of also enlarged since the prior study. 3. No evidence of bowel obstruction or intraperitoneal free air. Brief Hospital Course: ___ with metastatic intraperitoneal mucinous adenocarcinoma of presumed appendiceal primary s/p 3 cycles of carbotaxol targeting presumed gynecologic primary tumor without significant response, then with exlap (___) concerning for appendiceal primary presenting admitted with acute onset nausea/vomiting/diarrhea/fever. # nausea/vomiting/diarrhea/chills - concerning for infectious process given acute onset the day of ED presentation and absence of concerning acute pathology on abdominal exam. WBC elevated at 16 c/w infectious process also. Viral gastroenteritis seemed most likely explanation. CT with significant worsening of metastatic disease burden in the abd and pelvis likely contributor, but worsening disease alone should not cause this constellation of sx (vomiting/diarrhea) unless some obstructive process which is not suggested by imaging. LFTS/lipase reassuring. fevers up to 102.4 during hospitalization. Over course of her hospitalization diarrhea improved, appetite returned (though still weak), and had no vomiting. WBC improved also. C diff/norovirus negative. # Hypotension - resolved after hydration # Hypoxia - developed hypoxia on HD#2 in context of a fever 102.6. CXR normal. Exam unrevealing and so a CTA was obtained. BNP elevated. With stopping of IVF and one dose of Lasix, hypoxia improved. Did not obtain an echocardiogram in light of overall prognosis and this was in setting of very aggressive hydration #Metastatic intraperitoneal mucinous adenocarcinoma of presumed appendiceal primary. Discussed with patient and her daughters several times. It was clear that they understood that the patient did not want any more chemotherapy and that her prognosis was grim. We had difficulty with conversations regarding code status as discussed in palliative care note and my notes. The only thing that patient discussed was the desire to die at home.We did try and facilitate home hospice enrollment with ___, but this was not set up before discharge due to holiday. Did not set up home health nurse given insurance issues. TRANSITIONAL ISSUES: - continue to engage family regarding hospice and code status - potentially pursue echocardiogram if pulm edema becomes an issue again Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H pain 2. Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB 3. Docusate Sodium 100 mg PO BID 4. Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID 5. Lorazepam 0.5 mg PO QHS:PRN insomnia/agitation/anxiety/nausea 6. Fentanyl Patch 12 mcg/h TD Q72H 7. OxycoDONE (Immediate Release) 10 mg PO Q4H:PRN pain 8. Venlafaxine XR 75 mg PO DAILY 9. Prochlorperazine 10 mg PO Q6H:PRN nausea Discharge Medications: 1. Acetaminophen 650 mg PO Q6H pain 2. Albuterol Inhaler ___ PUFF IH Q4H:PRN SOB 3. Fentanyl Patch 12 mcg/h TD Q72H 4. Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID 5. Lorazepam 0.5 mg PO QHS:PRN insomnia/agitation/anxiety/nausea 6. OxycoDONE (Immediate Release) 10 mg PO Q4H:PRN pain 7. Prochlorperazine 10 mg PO Q6H:PRN nausea 8. Venlafaxine XR 75 mg PO DAILY ONLY MEDICATION STOPPED WAS COLACE Discharge Disposition: Home Discharge Diagnosis: Gastroenteritis Metastatic intraperitoneal mucinous adenocarcinoma of presumed appendiceal primary Pulmonary edema Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: ___, it was a pleasure to care for you during this hospitalization. We believe you picked up a viral illness and you have improved with fluids. We expect that your diarrhea will slowly improve for the next few days Followup Instructions: ___
19974576-DS-13
19,974,576
24,449,283
DS
13
2123-03-18 00:00:00
2123-03-19 16:02:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / Dilaudid Attending: ___. Chief Complaint: nausea, vomiting, abdominal pain Major Surgical or Invasive Procedure: NGT History of Present Illness: ___ M with advanced metastatic intraperitoneal mucinous adenocarcinoma of presumed appendiceal primary presents with worsening of abdominal pain, nausea, vomiting. Per review of records, initially presented for care in ___ in ___. At that point, she was having abdominal pain, diarrhea, bloating, decreased appetite, early satiety, and a 25-pound weight loss over the preceding few months. She underwent a CT scan, which showed a right adnexal hypodense lesion. A pelvic ultrasound showed a multiseptated cystic lesion without vascularization. On ___, she underwent an exploratory laparotomy and drainage of 20 mL of ascites that showed malignancy on pathology. There was a biopsy of a right ovarian mass, which showed inflammation but no evidence of malignancy. A biopsy of an omental mass was positive for metastatic adenocarcinoma. She had elevated CEA and CA-125. She subsequently moved to the ___ area where she presented for care. An omental biopsy on ___, showed metastatic mucinous adenocarcinoma. The differential diagnosis included a GI or appendiceal primary, pancreaticobiliary, ovarian, or uterine/cervical primary. She underwent a thorough GI evaluation, which was negative. She was started on neoadjuvant chemotherapy with carboplatin and paclitaxel with the assumption that this represented a gynecologic malignancy. The patient was last seen at ___ ___ for similar symptoms, s/p chemo most recently last year with carbotaxol but did not elect to pursue further chemotherapy if intent was purely palliative. Underwent ex-lap in ___ for planned surgical debulking, extensive tumor burden at that time resulted in failure of debulking procedure, pt was advised to pursue HIPEC at ___, unclear if she established care. She did elect to return to ___ to spend time with family; developed worsening abdominal distension approximately 3 weeks ago with some serous leakage of fluid around her umbilicus. This was managed with an ostomy appliance, has not noted any drainage for past 4 days. Now having worsening abd pain, nausea, vomiting, and inability to tolerate PO. Last BM 4 days ago, underwent CT scan in ED that showed concern for mass effect from tumor on small bowel. In the ED, initial vitals were: 97.6 82 106/67 16 100% RA. Exam notable for cachectic woman, with distended abdomen, hypoactive bowel sounds, with ostomy in place without output in the bag, severe tenderness to light palpation, with diffuse guarding. Labs showed WBV of 11.8, H/H of 11.7/37.3, Plt 645. BMP notable for Na of 131, K 3.9, Cl 95, HCO3 23, BUN 11, Cr of 0.6. LFTS unremarkable with an alk phos of 150. Lactate 1.2. Imaging showed marked progression of primary and metastatic tumor burden. Received 2 mg IV morphine and was started on LR. ACS was consulted and recommended NG tube decompression. Decision was made to admit to medicine for further management. On the floor, patient reports the history above and c/o abdominal pain. Review of systems: 10-point ROS was performed and is negative except as noted in the HPI. Past Medical History: PMH: - Asthma - Osteoporosis - Denies hypertension, diabetes, thromboembolic disease PSH: - Abdominal surgery to remove her placenta post-partum (pt unclear re details, occurred after vaginal delivery, via small infraumbilical 4cm vertical incision) - Ex lap, drainage of ascites, omental bx, peritoneal bx, ovarian bx, ___, ___ ___: - ___ (4 deceased in neonatal period) - SVD x 11 - One pregnancy c/b ? retained placenta, requiring abdominal surgery via vertical 4cm infraumbilical incision PGYN: - Menopausal, late ___ - Denies postmenopausal bleeding - Not currently sexually active - Denies hormonal replacement therapy or history of OCPs - Never had a Pap smear (pt denies and nothing in CHA records since ___ - Denies history of pelvic infections or sexually transmitted infections - Denies history of fibroids or cysts Social History: ___ Family History: - Sister died of liver cancer - No known family history of breast, uterine, ovarian, cervical or colon cancer - No known history of bleeding or clotting disorder Physical Exam: UPON ADMISSION: Vital Signs: 98.7 PO 94 / 60 79 16 95 RA General: ___ woman crying, in moderate distress HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRLA CV: RRR, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, decreased breath sounds at the bases bilaterally Abdomen: moderately distended, TTP, focal guarding in the LUQ, +rebound tenderness GU: No foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally, gait deferred. UPON DISCHARGE: VS: 98.2 100 / 56 80 16 95% ra General: ___ female, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRLA CV: RRR, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, decreased breath sounds at the bases bilaterally Abdomen: moderately distended, TTP, focal guarding in the LLQ, +rebound tenderness, area of localized hyperpigmented skin overlying umbilicus with no drainage GU: foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Pertinent Results: LABS UPON ADMISSION: ___ 10:05PM BLOOD WBC-11.8* RBC-4.63 Hgb-11.7 Hct-37.3 MCV-81* MCH-25.3* MCHC-31.4* RDW-15.1 RDWSD-43.9 Plt ___ ___ 10:05PM BLOOD Glucose-113* UreaN-11 Creat-0.6 Na-131* K-3.9 Cl-95* HCO3-23 AnGap-17 ___ 10:05PM BLOOD ALT-11 AST-20 AlkPhos-150* TotBili-0.4 ___ 10:05PM BLOOD Albumin-2.9* LABS UPON DISCHARGE ___ 08:00AM BLOOD WBC-9.6 RBC-3.74* Hgb-9.4* Hct-30.4* MCV-81* MCH-25.1* MCHC-30.9* RDW-15.3 RDWSD-44.8 Plt ___ ___ 08:00AM BLOOD Glucose-78 UreaN-4* Creat-0.4 Na-136 K-3.8 Cl-101 HCO3-26 AnGap-13 ___ 07:50AM BLOOD ALT-6 AST-12 AlkPhos-103 TotBili-0.3 ___ 08:00AM BLOOD Calcium-7.8* Phos-3.3 Mg-1.5* EKG on admission: Sinus rhythm. There is an early transition that is non-specific. Low voltage in the precordial leads. Non-specific ST-T wave changes. The Q-T interval is prolonged. Compared to the previous tracing of ___ these findings are new. CT abdomen and pelvis w/contrast: IMPRESSION: 1. Markedly increased primary and metastatic tumor burden. Metastatic deposits extend through the anterior wall defect into the "ostomy". 2. Distention of proximal loops of small bowel with relative decompression but node discrete transition point in the distal ileum, compatible with partial obstruction likely due to mass effect by the large intra-abdominal cystic mass. Abdominal KUB: IMPRESSION: No intraperitoneal free air. Normal bowel gas pattern. CXR: IMPRESSION: In comparison with the study of ___, there are lower lung volumes. No evidence of vascular congestion or acute focal pneumonia. There has been placement of a nasogastric tube that extends to the lower body of the stomach. Residual contrast material is seen in the colon. Brief Hospital Course: ___ with metastatic intraperitoneal mucinous adenocarcinoma of presumed appendiceal primary not currently receiving treatment who presented with abdominal pain, abdominal distension, emesis found to have partial small bowel obstruction. Patient had CT scan upon admission that showed increased primary and metastatic tumor burden as well as a partial bowel obstruction. Surgery was consulted and recommended no surgical intervention. NGT was placed to intermittent suction with minimal output. NGT placed to gravity and pt had nausea and abdominal pain. NGT was then placed back on to suction with relief of symptoms. NGT was to gravity prior to discharge and patient's pain was stable. Imaging noteable for worsening of patient's malignancy. Pt has been out of the country (___) for nearly a year and has received some medical treatment there (antibiotics per her family). Patient reported that she would not want chemotherapy or surgery. Palliative care was consulted and met with the patient. After an extensive goals of care discussion, pt was made DNR/DNI and is going home with hospice services. **TRANSITIONAL ISSUES** -Patient was discharged with "Hospice comfort kit contents"- acetaminophen 650 suppository, atropine 1% oral drops, bisacodyl 10 mg suppository, haloperidol 5 mg/1 ml oral solution, lorazepam 5 mg/1ml oral solution, senna-s -Also wrote script for fentanyl patch if needed -Please maintain patient's comfort -MOLST form was signed on ___. DNR/DNI, do not hospitalize Medications on Admission: The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications Discharge Medications: 1. Fentanyl Patch 12 mcg/h TD Q72H RX *fentanyl 12 mcg/hour Place on skin every three days Disp #*3 Patch Refills:*0 2. Polyethylene Glycol 17 g PO DAILY RX *polyethylene glycol 3350 17 gram/dose 1 powder(s) by mouth daily Disp #*170 Gram Refills:*0 ALSO DISCHARGED WITH PRESCRIPTIONS FOR: "Hospice comfort kit contents"- acetaminophen 650 suppository, atropine 1% oral drops, bisacodyl 10 mg suppository, haloperidol 5 mg/1 ml oral solution, lorazepam 5 mg/1ml oral solution, senna-s Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSES: Metastatic intraperitoneal mucinous adenocarcinoma Partial small bowel obstruction Hypotension Thrombocytosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms ___, **WHY DID YOU COME TO THE HOSPITAL?** -You came to the hospital with belly pain **WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?** -We took a picture of your belly (CT scan) and it showed that you have a small blockage in your bowels and growing size of your cancer -We placed a tube through your nose in your belly to help with your bloating, nausea and pain **WHAT SHOULD YOU DO WHEN YOU LEAVE THE HOSPITAL?** -You will be going home with hospice care. You and your family will receive help from nurses. -___ have an appointment with your oncologist at ___ on ___ (see below for more details). It was a pleasure taking care of you. Your ___ Team Followup Instructions: ___
19975602-DS-16
19,975,602
28,809,966
DS
16
2181-06-18 00:00:00
2181-06-18 18:59:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ Attending: ___. Chief Complaint: Head injury after fall Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old man with PMhx DM2, HTN, CKD, BPAD presents with SAH after a syncopal episode. Patient is amnestic to event. Patient's son witnessed him stumbling backwards and hitting his head with laceration but no loss of consciousness. He was brought to ___ where CT head shows 5mm parafalcine vessel hemorrhage, without edema or shift. Labs were notable for WBC 5.9, Hgb 13.2, Cr 1.0, TropT < 0.03, U/A unremarkable. He was given Keppra IV and transferred to ___. Patient currently has no symptoms whatsoever and denies pain. In the ED, initial VS were: 98.9 76 190/111 16 98% RA Exam notable for: depression in the posterior occiput with 3 cm horizontal laceration, wound is explored with no evidence of fracture underneath, ___ clear bilaterally no battle signs. No tenderness to palpation over the midline of the back but abrasions over the mid thoracic spine. Regular rate and rhythm, Clear to auscultation bilateral with normal chest rise bilaterally, abdomen soft, nontender nondistended, pelvis is stable, moving all extremities with no tenderness to palpation Labs showed: - WBC 10.4 PMN 84.9 - Hgb 13.2 - normal Plt, ___ - Cr 0.8 Imaging showed: - NCHCT: 5mm right parafalcine SAH, no skull or cervical fractures Patient received: no medications or fluids Neurosurgery was consulted: Likely syncopal fall. The patient is neurologically intact on exam. Reviewed imaging and consulted with Dr. ___. Bleed meets ED obs criteria and there are no acute neurosurgical needs. Recommending possible medicine admission for syncopal workup. Hold aspirin, may resume in 3 days if needed. Transfer VS were: 98.1 69 121/78 14 100% RA On arrival to the floor, patient reports that he felt queasy and dizzy immediately before the fall without chest pain, SOB, light headedness, blurred vision. He denies post fall loss of bowel / bladder control, headache, blurred vision, dysarthria, focal numbness, weakness. Last fall was "a few months ago," while shopping, preceeded by leg weakness, no trauma, no medical attention. Leg weakness lasted ___ minutes, he was able to get up under his own power. He denies other antecedent symptoms or post fall symptoms. He also has chronic stable occasional urinary incontinence described as dripping without sensation of need to void. This has been present for years and has not changed. Denies straining, dribbling, hesitancy, need for diapers. Denies fever, cough, sore throat, chills, chest pain, SOB, abd pain, N/V/D, bloody stools, dysuria, hematuria, swollen joints, rash, focal numbness, weakness, other recent falls. Past Medical History: DM2 HTN CKD HLD Bipolar Anemia Social History: ___ Family History: Does not know too much about his family history, father had a stroke, no known aneurysms. Physical Exam: =========================== ADMISSION PHYSICAL EXAM: =========================== VS: 98.6 161/83 57 18 98% RA Weight: 75.52 kg GENERAL: WNWD man in NAD HEENT: 3in curvilinear horizontal occipital laceration, s/p staples, c/d/i, flattened occiput, tender, anicteric sclera, PERRL, EOMI, MOM, OP clear NECK: supple, no elevated JVD HEART: RRR, normal S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: soft, nondistended, nontender in all quadrants, no rebound/guarding, +BS EXTREMITIES: no cyanosis, clubbing, or edema PULSES: 2+ DP pulses bilaterally NEURO: A&O, CN II-XII intact, SILT, ___ strength BUE/BLE, no clonus, dysmetria, HKS normal SKIN: warm and well perfused ======================= DISCHARGE PHYSICAL EXAM: ======================= Vitals: 98.1 PO 131 / 81 96 16 98 RA GENERAL: Sitting in bed, NAD HEENT: 3in curvilinear horizontal occipital laceration, s/p staples, c/d/i, flattened occiput, tender, anicteric sclera, PERRL, EOMI, MOM, OP clear NECK: supple, no elevated JVD HEART: RRR, normal S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: soft, nondistended, nontender in all quadrants EXTREMITIES: no cyanosis, clubbing, or edema PULSES: 2+ DP pulses bilaterally NEURO: A&O, CN II-XII intact, ___ strength BUE/BLE, no clonus, dysmetria. Reflexes present in biceps and knees bilaterally, slightly diminished left patellar reflex. Cerebellar function intact. SKIN: warm and well perfused Pertinent Results: ADMISSION LABS: ___ 03:53PM GLUCOSE-130* UREA N-10 CREAT-0.8 SODIUM-145 POTASSIUM-3.7 CHLORIDE-104 TOTAL CO2-27 ANION GAP-14 ___ 03:53PM estGFR-Using this ___ 03:53PM CK(CPK)-125 ___ 03:53PM CK-MB-4 cTropnT-0.01 ___ 03:53PM WBC-10.4* RBC-4.35* HGB-13.2* HCT-39.1* MCV-90 MCH-30.3 MCHC-33.8 RDW-13.2 RDWSD-43.5 ___ 03:53PM NEUTS-84.9* LYMPHS-8.6* MONOS-5.6 EOS-0.2* BASOS-0.1 IM ___ AbsNeut-8.84* AbsLymp-0.90* AbsMono-0.58 AbsEos-0.02* AbsBaso-0.01 ___ 03:53PM PLT COUNT-222 ___ 03:53PM ___ PTT-24.7* ___ PERTINENT IMAGING: CT HEAD SECOND OPINION (___): 1. 5 mm hyperdense extra-axial focus along the right parafalcine region, compatible with provided history of small subarachnoid hemorrhage. 2. No evidence of calvarial fracture. Soft tissue swelling and a small subgaleal hematoma noted along the posterior occiput. 3. No evidence of cervical spinal fracture or traumatic malalignment. 4. Moderate cervical spinal degenerative changes, as above. TRANSTHORACIC ECHOCARDIOGRAM (___): The left atrium is normal in size. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity is mildly dilated. There is mild regional left ventricular systolic dysfunction with basal to mid inferior and inferolateral hypokinesis. Right ventricular chamber size and free wall motion are normal. The ascending aorta is mildly dilated. The aortic arch is mildly dilated. The number of aortic valve leaflets cannot be determined. There is no aortic valve stenosis. No aortic regurgitation is seen. The mitral valve appears structurally normal with trivial mitral regurgitation. There is no mitral valve prolapse. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. LVEF 45%. IMPRESSION: Mild regional LV systolic dysfunction c/w prior myocardial infarction in the RCA territory. DISCHARGE LABS: ___ 06:25AM BLOOD Glucose-109* UreaN-17 Creat-0.9 Na-145 K-3.2* Cl-105 HCO___-27 AnGap-13 ___ 06:15AM BLOOD ASA-NEG Ethanol-NEG Carbamz-4.7 Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG Brief Hospital Course: ___ year old man with PMhx DM2, HTN, CKD, BPAD presents with SAH after a syncopal episode. Seen by neurosurgery (with no recommendations for surgery at this time), admitted to the floor for observation and further workup of syncope. Patient was stable and doing well during admission. ACUTE ISSUES: ============= # ___ # Fall with headstrike # Syncope and # New diagnosis of HFrEF: Patient presented with a right parafalcine SAH (diagnosed on a head CT at OSH) after a falling episode, where he landed and hit the back of his head. Preceded by a prodrome of lightheadedness; his fall most consistent with neurocardiogenic syncope of unclear trigger. Pt did not have any preceding chest pain or exertional symptoms to suggest ischemia, nor has he had any throughout his hospital course. Pt was neurologically intact on admission with no urgent surgical intervention recommended by a neurosurgical consult. Patient was evaluated with EKG, telemetry, orthostatic vitals, cardiac enzymes, and an echocardiogram that demonstrated the presence of a right bundle branch block (EKG). Transthoracic echocardiogram performed on ___ demonstrated evidence of a prior RCA MI, with inferior wall akinesis and a depressed EF at 45%. His cardiac biomarkers remained negative throughout admission. Patient was given routine neurological exams (q4) that showed no neurological changes. Per neurosurgery recommendations, interval imaging was not performed; nor was any further antiepileptic medication started. Pt recommended to follow up at the concussion clinic ___ weeks after his presentation. Angiography (to evaluate for the presence of aneurysms) was considered as well, however given the traumatic nature of the patient's presentation, neurosurgery did not believe this to be necessary. Patient will follow up with neurology, cardiology, and his PCP in the outpatient setting once leaving the hospital. - Recommended holding ASA until ___ in setting of recent ___ - Staple removal from occipital wound to be performed 10d after placement at ___ ___ (on ___. # Urinary incontinence Patient without bladder obstructive symptoms and history of carbamazepine, lithium and risperidone presents with chronic stable urinary incontinence. Patient is also taking a diuretic for BP control. Likely a medication effects as these medications are associated with urinary incontinence but given clinical scenario of ___, this urinary incontinence was monitored closely during his hospital stay. CHRONIC ISSUES: =============== # DM2 Last A1c 5.7 ___, not on any medications. Presented without overt hyperglycemia. A1c is 5.4 on ___, obtained for risk stratification purposes. # HTN: hypertensive I/s/o. Continued valsartan, amlodipine, and HCTZ. Was giving metoprolol to further control pressures. # CKD: presents below prior readings of 1.3-1.6 in ___. # HLD: stable. Continued pravastatin and held home potassium chloride. # Bipolar: mood stable. Continued home Carbamazepine 200 mg QAM / 400 mg QPM and risperidone 2 mg QD. Carbamazepine level at discharge was 4.7, within the therapeutic range. # Anemia: presents above prior baseline of ___ in ___. Stably at baseline at time of discharge. TRANSITIONAL ISSUES: ==================== #CODE: Full (presumed) #CONTACT: ___ (son/HCP) ___ [ ] MEDICATION CHANGES: - Added: Atorvastatin 40mg (if tolerates can increase to 80mg) - Held: Aspirin 81mg. Do not restart until at least ___ given recent subarachnoid hemorrhage. [ ] NEW DIAGNOSIS OF HEART FAILURE WITH REDUCED EJECTION FRACTION: - Pt euvolemic at time of discharge. - Discharge weight: 76.98kg - Discharge creatinine: 0.9 - Recommend Pt follow up with cardiology as scheduled for further consideration of outpatient stress test, possible cardiac catheterization. [ ] SUBARACHNOID HEMORRHAGE: - Pt to hold on aspirin until ___. - Maintain blood pressure control with sBP < 160. He was under this threshold without PRN hydralazine by discharge; consider uptitrating home medicines as needed to achieve this effect. - To follow up in Cognitive Neurology clinic by calling the follow-up number. Mr. ___ is clinically stable for discharge today. The total time spent today on discharge planning, counseling and coordination of care was greater than 30 minutes. Medications on Admission: 1. Aspirin 81 mg PO DAILY 2. Pravastatin 40 mg PO QPM 3. CarBAMazepine 200 mg PO QAM 4. Potassium Chloride 20 mEq PO BID 5. RisperiDONE 2 mg PO DAILY 6. Valsartan 160 mg PO DAILY 7. Metoprolol Succinate XL 100 mg PO DAILY 8. amLODIPine 10 mg PO DAILY 9. Hydrochlorothiazide 12.5 mg PO DAILY 10. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 11. CarBAMazepine 400 mg PO QPM Discharge Medications: 1. Atorvastatin 40 mg PO QPM RX *atorvastatin 40 mg 1 tablet(s) by mouth QPM Disp #*30 Tablet Refills:*0 2. amLODIPine 10 mg PO DAILY 3. CarBAMazepine 200 mg PO QAM 4. CarBAMazepine 400 mg PO QPM 5. Hydrochlorothiazide 12.5 mg PO DAILY 6. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 7. Metoprolol Succinate XL 100 mg PO DAILY 8. Potassium Chloride 20 mEq PO BID Hold for K > 4.5 9. Pravastatin 40 mg PO QPM 10. RisperiDONE 2 mg PO DAILY 11. Valsartan 160 mg PO DAILY 12. HELD- Aspirin 81 mg PO DAILY This medication was held. Do not restart Aspirin until at least ___. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSES: - Subarachnoid hemorrhage - New diagnosis of heart failure with reduced ejection fraction (EF 45%) SECONDARY DIAGNOSIS: - Right bundle branch block Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at the ___ ___. WHY WAS I SEEN IN THE HOSPITAL? - You had a fall and a small brain bleed. WHAT WAS DONE WHILE I WAS IN THE HOSPITAL? - We looked at the electrical activity of your heart and the squeeze of your heart. This showed that your heart was not squeezing as well as it should. - Our neurosurgeons did not recommend any further evaluation for your brain bleed. WHAT SHOULD I DO WHEN I AM OUT OF THE HOSPITAL? - Please call the cognitive neurology clinic for ___ week follow up. - Please go to your appointments as scheduled. - Weigh yourself every day, and call your doctor if your weight goes up more than three pounds in a day. We wish you the best, Your ___ Care Team Followup Instructions: ___
19975710-DS-21
19,975,710
20,266,816
DS
21
2129-11-30 00:00:00
2129-12-04 11:33:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Allergies/ADRs on File Attending: ___. Chief Complaint: shortness of breath Major Surgical or Invasive Procedure: Intubated ___ History of Present Illness: ___ year old female with a history of diabetes, hypertension, hyperlipidemia and obesity discharged from ___ ___ today following total right hip replacement for osteoarthritis three days ago presenting with shortness of breath and found to have sats of 60% requiring intubation. In ED initial VS: HR 63 BP 110/58 RR 18 SO2 100% while intubated Labs significant for: WBC 17.3 (86% neutrophils) Hbg 8.1 Hct 26.2 ___ 14103 (was 287 on ___ Trop-T 0.27 Lactate 1.1 -> 0.7 Arterial blood gas with pH 7.27, pCO2 51, pO2 198, HCO3 24 UA: Moderate leuks, negative nitrates, 23 ___ Patient was given: Heparin for concern of DVT and started on vancomycin, cefepime and azithromycin due to concern of pneumonia Imaging notable for: Bedside echo revealing RV with good function and no evidence of RH strain and no pericardial effusion. Good AS EKG showing normal sinus rhythm with TWI in V3, no ST changes or Q waves Consults: Orthopedics On arrival to the FICU, unable to obtain additional history as patient was intubated and sedated. REVIEW OF SYSTEMS: Unable to obtain as patient was intubated and sedated. Past Medical History: Essential Hypertension Hypothyroidism Aortic Valve Stenosis Body Mass Index ___ - Severely Obese Chronic Kidney Disease, Stage 3 Diabetes Mellitus Type 2 in Obese Endometrial Carcinoma Gastroesophageal Reflux Disease Hyperlipidemia Iron Deficiency Anemia Osteoarthritis Social History: ___ Family History: Mother passed away at the age of ___ due to cancer. Physical Exam: Admission Physical Exam ======================== GENERAL: intubated and sedated LUNGS: Course breath sounds bilaterally CV: Regular rate and rhythm with holosystoic murmur ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, with mild lower extremity edema SKIN: incision on right hip with mild erythema and scant drainage, inferior portion of incision with surrounding Discharge Physical Exam ======================== GENERAL: NAD, well appearing HEENT: AT/NC, anicteric sclera, MMM NECK: supple, no LAD, JVP not appreciated CV: RRR, S1/S2, loud III/VI systolic murmur over RUSB, no gallops or rubs PULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles GI: obese abdomen, soft, nondistended, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing, 1+ edema to knees bilaterally (reports baseline from amlodipine) PULSES: 2+ radial pulses bilaterally NEURO: Alert, moving all 4 extremities with purpose, ___ strength in upper extremities, face symmetric, sensation grossly intact, PERRL Pertinent Results: Admission Labs =============== ___ 07:00PM BLOOD WBC-17.3* RBC-3.01* Hgb-8.1* Hct-26.2* MCV-87 MCH-26.9 MCHC-30.9* RDW-17.7* RDWSD-55.8* Plt ___ ___:00PM BLOOD Neuts-86.0* Lymphs-6.4* Monos-6.2 Eos-0.4* Baso-0.2 Im ___ AbsNeut-14.86* AbsLymp-1.10* AbsMono-1.07* AbsEos-0.07 AbsBaso-0.03 ___ 07:00PM BLOOD ___ PTT-26.0 ___ ___ 07:00PM BLOOD Glucose-143* UreaN-30* Creat-1.1 Na-136 K-5.3 Cl-102 HCO3-21* AnGap-13 ___ 07:00PM BLOOD ___ ___ 07:00PM BLOOD cTropnT-0.27* ___ 07:00PM BLOOD Calcium-7.9* Phos-3.6 Mg-1.8 ___ 07:40PM BLOOD Type-ART pO2-198* pCO2-51* pH-7.27* calTCO2-24 Base XS--3 ___ 07:08PM BLOOD Lactate-1.1 Micro/Other Pertinent Labs =========================== ___ 11:06 am URINE Source: Catheter. **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. ___ 10:10 am Mini-BAL GRAM STAIN (Final ___: 2+ ___ per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. RESPIRATORY CULTURE (Preliminary): NO GROWTH, <1000 CFU/ml. ___ 8:11 am SPUTUM Source: Endotracheal. **FINAL REPORT ___ GRAM STAIN (Final ___: ___ PMNs and <10 epithelial cells/100X field. NO MICROORGANISMS SEEN. RESPIRATORY CULTURE (Final ___: SPARSE GROWTH Commensal Respiratory Flora. ___ 9:08 am MRSA SCREEN Source: Nasal swab. **FINAL REPORT ___ MRSA SCREEN (Final ___: No MRSA isolated. ___ 02:14PM BLOOD Ret Aut-1.8 Abs Ret-0.05 ___ 07:00PM BLOOD ___ ___ 07:00PM BLOOD cTropnT-0.27* ___ 02:25AM BLOOD CK-MB-9 cTropnT-0.29* ___ 07:30AM BLOOD CK-MB-8 cTropnT-0.30* ___ 11:57AM BLOOD CK-MB-9 cTropnT-0.25* ___ 02:02PM BLOOD cTropnT-0.49* ___ 10:15PM BLOOD cTropnT-0.45* ___ 05:23AM BLOOD cTropnT-0.94* ___ 02:14PM BLOOD calTIBC-160* ___ Hapto-357* Ferritn-97 TRF-123* ___ 02:14PM BLOOD Iron-20* Imaging ======== CTA CHEST ___ 1. No evidence of pulmonary embolism or aortic abnormality. 2. Cardiomegaly and diffuse bilateral ground-glass opacities and paraseptal thickening, suggestive of pulmonary edema. 3. Moderate right pleural effusion and small left pleural effusion. TTE ___ The left atrial volume index is normal. The right atrial pressure could not be estimated. There is normal left ventricular wall thickness with a normal cavity size. There is mild-moderate left ventricular regional systolic dysfunction with severe hypokinesis of the distal half of the anterior and anterior septum, distal inferior and apical walls (see schematic) and preserved/normal contractility of the remaining segments. Quantitative biplane left ventricular ejection fraction is 37 %. Left ventricular cardiac index is normal (>2.5 L/min/m2). There is no resting left ventricular outflow tract gradient. Normal right ventricular cavity size with normal free wall motion. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. The aortic valve leaflets are moderately thickened. There is severe aortic valve stenosis (valve area less than 1.0 cm2). There is trace aortic regurgitation. The mitral valve leaflets are mildly thickened with no mitral valve prolapse. There is moderate mitral annular calcification. There is mild to moderate [___] mitral regurgitation. Due to acoustic shadowing, the severity of mitral regurgitation could be UNDERestimated. The tricuspid valve leaflets appear structurally normal. There is physiologic tricuspid regurgitation. There is moderate pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Suboptimal image quality. Severe aortic valve stenosis. Normal left ventricular cavity size with regional systolic dysfunction most c/w CAD (mid-LAD distribution). Moderate pulmonary artery systolic hypertension. Mild-moderate mitral regurgitation. CXR ___ Increased pulmonary edema and right pleural fluid. CXR ___ 1. Interval improvement of bilateral airspace opacities consistent with improved aeration. 2. Mild to moderate bilateral pleural effusions right worse than left, that are unchanged from prior exam. 3. Support lines and tubes are unchanged CORONARY ANGIOGRAPHY ___ LM- The left main coronary artery has no angiographically apparent disease. LAD- The left anterior descending coronary artery. The vessel is diffusely calcified. There is a proximal 90% stenosis. The lesion is is a culprit stenosis. Circ- The circumflex coronary artery has no angiographically apparent disease. OM1- The first obtuse marginal coronary artery. The vessel is small in diameter. There is a 90% stenosis. RI- The ramus intermedius has no angiographically apparent disease. RCA- The right coronary artery. There is a proximal 40% steno **A 6 ___ EBU3.5 guide provided adequate support. Crossed with a Prowater wire into the distal LAD. Predilated with a 2.5 mm balloon and then deployed a 3.0 mm x 12 mm DES at 16 atm. Final angiography revealed normal flow, no dissection and 0% residual stenosis CXR ___ Support lines and tubes unchanged. Bilateral effusions right greater than left are stable. Pulmonary edema has slightly worsened. Cardiomediastinal silhouette is stable. No pneumothorax is seen. Discharge Labs =============== ___ 06:01AM BLOOD WBC-12.7* RBC-3.73* Hgb-10.8* Hct-34.1 MCV-91 MCH-29.0 MCHC-31.7* RDW-17.8* RDWSD-55.8* Plt ___ ___ 06:01AM BLOOD ___ PTT-22.2* ___ ___ 06:01AM BLOOD Glucose-167* UreaN-18 Creat-0.9 Na-141 K-4.3 Cl-102 HCO3-25 AnGap-14 ___ 06:01AM BLOOD Calcium-8.2* Phos-2.1* Mg-1.4* Brief Hospital Course: ___ year-old female with a history of diabetes, HTN, HLD, recently discharged from ___ on ___ following total right hip replacement, who presented with shortness of breath found to be in acute hypoxic respiratory failure in setting of fluid overload likely due to NSTEMI and severe AS, now s/p DES to LAD, with course c/b possible HAP. #CORONARIES: s/p DES to LAD, 90% occlusion OM1, 40% RCA #PUMP: EF 37% #RHYTHM: NSR ACTIVE ISSUES: =============== #NSTEMI: Two vessel disease (LAD, OM1) now s/p DES to LAD with new apical akinesis. Continued patient on atorvastatin 80mg daily, ASA daily, and Plavix daily. Given apical akinesis, plan for treatment with triple therapy for the next three months with INR goal ___. Will need repeat TTE at that time with consideration of discontinuation of warfarin. #CHF EF 37%: #Severe AS New heart failure (TTE in Atrius system from earlier this year without contractile dysfunction) secondary to NSTEMI. Patient volume overloaded on arrival, now 7.2L negative and grossly euvolemic. Started torsemide 10mg daily. Will continue metoprolol succinate 12.5mg daily, amlodipine 10mg daily, and valsartan 160mg BID. #Severe AS: Follow up for TAVR v SAVR eval in the outpatient setting. #Respiratory failure: Now resolved, likely in setting of volume overload and possible pneumonia. Initially was treated with antibiotics for HAP, but discontinued given signs of infection. She was treated with vanc/cefepime from ___ and ceftriaxone to ___. ___ Baseline creatinine 0.9 on admission, then developed ___ to 1.6, likely in setting of contrast load from cardiac catheterization and diuresis. Resolved. #Iron-deficiency anemia: s/p pRBC ___ for hgb 7, ___ for hgb<10 study, ___ for hgb<10 study, ___ for hgb<10 study. Received course of IV iron. She was transfused to Hb 10 for study in which she was entered. #s/p hip replacement Orthopedics aware of patient but not actively following. No acute issues. She will follow up with orthopedics at ___ ___. #Fungal rash: Continued miconaozole powder. CHRONIC/STABLE ISSUES: ======================= # Insulin Dependent Diabetes: Placed on ISS. # Hypothyroidism: Continued levothyroxine 88mcg PO daily # HLD: Continued home dose of 20 mg simvastatin # GERD: Continued home omeprazole 20 mg BID # HTN: hypotensive while in ICU in setting of NSTEMI - Consider restarting home metoprolol tartrate 50 bid and valsartan-hydrochlorothiazide 320-25 as pressures tolerate TRANSITIONAL ISSUES: ==================== Discharge weight: 102.2kg Discharge Cr: 0.9 Medication changes [] Started warfarin for apical akinesis after MI. Will continue with warfarin with goal INR ___. [] Started aspirin 81mg daily and Plavix 75mg daily. Will need to continue on DAPT for 12 months. Can consider discontinuation of Plavix at that time. [] Started torsemide 10mg daily [] Started irbesartan 150mg BID for hypertension (given issues with valsartan purity). Adjust based on BP. [] Stopped simvastatin and replaced with atorvastatin Other issues: [] Please recheck Chem10 in ___ days to assess for stable Cr on torsemide 10mg daily. If loses or gains more than ___ lbs, readjust dosing or discontinue. [] Repeat INR on ___ and adjust warfarin dosing accordingly. Goal INR ___. [] Repeat TTE in 3 months to assess for improvement in apical akinesis and ability to stop anticoagulation as well as aortic stenosis [] Arrange for outpatient follow-up for evaluation for TAVR vs SAVR [] Discharged on DAPT for 12 months. Should not stop for any reason without consulting cardiologist. Can discontinue Plavix at that time. [] f/u anemia and iron studies. Patient received IV iron [] Consider switching to metoprolol and amlodipine to carvedilol given possible contribution to fluid retention. [] Consider adding spironolactone if tolerated for HFrEF. [] Arrange for orthopedic follow up with Dr. ___ at NEB ___ or ___ *** #CONTACT: ___, ___ ___, Daughter, ___ #CODE: Full code (discussed with next of kin by CCU team) Medications on Admission: 1. amLODIPine 10 mg PO DAILY 2. Vitamin D 1000 UNIT PO DAILY 3. Cyanocobalamin 100 mcg PO DAILY 4. Ferrous Sulfate 325 mg PO DAILY 5. FoLIC Acid 0.8 mg PO DAILY 6. Gabapentin 300 mg PO BID 7. GlipiZIDE 5 mg PO BID 8. aspart 15 Units Breakfast aspart 18 Units Bedtime 9. Levothyroxine Sodium 88 mcg PO DAILY 10. MetFORMIN (Glucophage) 500 mg PO BID 11. Omeprazole 20 mg PO BID 12. Simvastatin 20 mg PO QPM 13. LORazepam 1 mg PO PRN prior to flying 14. Acetaminophen 325 mg PO Q6H:PRN Pain - Mild 15. Bisacodyl 5 mg PO DAILY:PRN Constipation - First Line 16. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate 17. Polyethylene Glycol 17 g PO DAILY 18. Senna 8.6 mg PO BID:PRN Constipation - First Line 19. Enoxaparin Sodium 30 mg SC Q12H Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 80 mg PO QPM 3. Clopidogrel 75 mg PO DAILY to prevent stent thrombosis 4. Docusate Sodium 100 mg PO BID 5. irbesartan 150 mg oral BID 6. Metoprolol Succinate XL 100 mg PO DAILY 7. Torsemide 10 mg PO DAILY 8. Warfarin 2 mg PO DAILY16 Goal INR ___ 9. aspart 15 Units Breakfast aspart 18 Units Bedtime 10. Acetaminophen 325 mg PO Q6H:PRN Pain - Mild 11. amLODIPine 10 mg PO DAILY 12. Bisacodyl 5 mg PO DAILY:PRN Constipation - First Line 13. Cyanocobalamin 100 mcg PO DAILY 14. Ferrous Sulfate 325 mg PO DAILY 15. FoLIC Acid 0.8 mg PO DAILY 16. Gabapentin 300 mg PO BID 17. GlipiZIDE 5 mg PO BID 18. Levothyroxine Sodium 88 mcg PO DAILY 19. LORazepam 1 mg PO PRN prior to flying 20. MetFORMIN (Glucophage) 500 mg PO BID 21. Omeprazole 20 mg PO BID 22. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours Disp #*18 Tablet Refills:*0 23. Polyethylene Glycol 17 g PO DAILY 24. Senna 8.6 mg PO BID:PRN Constipation - First Line 25. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS: ================== Acute systolic heart failure ___ to NSTEMI SECONDARY DIAGNOSIS: ==================== Aortic stenosis Hypertension Hypothyroidism DM2 CKD3 GERD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you at the ___ ___! WHY WAS I IN THE HOSPITAL? ========================== - You were admitted to the hospital because you had been feeling short of breath and had swelling in your legs. This was felt to be due to a condition called heart failure, where your heart does not pump hard enough and fluid backs up into your lungs. - You were found to have had a heart attack and it was thought to be the cause of your new heart failure. WHAT HAPPENED IN THE HOSPITAL? ============================== - You were found to have fluid in your lungs with low oxygen levels in your blood. You had a temporary breathing tube placed (intubation) to support your breathing while in the ICU. You were given a diuretic medication through the IV to help get the fluid out. - Your heart arteries were examined (cardiac catheterization) which showed a blockage of one of the arteries, the left anterior descending (LAD). This was opened by placing a tube called a stent in the artery. You were given medications to prevent future blockages. - You received an ultrasound of your heart (echocardiogram) which showed that parts of your heart were found to be moving less than normal. This increases your risk of forming clots within your heart that can spread throughout the body and also cause a stroke. , and you were started WHAT SHOULD I DO WHEN I GO HOME? ================================ - It is very important to take your aspirin and clopidogrel (also known as Plavix) every day. These two medications keep the stents in the vessels of the heart open and help reduce your risk of having a future heart attack. If you stop these medications or miss ___ dose, you risk causing a blood clot forming in your heart stents and having another heart attack. Please do not stop taking either medication without taking to your heart doctor. - It is also very important to take your warfarin (also known as Coumadin) to reduce the risk of developing clots within your heart that can then cause strokes. - Please follow-up with your doctor to have your INR level checked to make sure your warfarin is at appropriate levels. - You are also on other new medications to help your heart, such as atorvastatin, metoprolol, valsartan, and torsemide (replaces your hydrochlorothiazide). - Your weight at discharge is 102.2kg. Please weigh yourself today at home and use this as your new baseline - Please weigh yourself every day in the morning. Call your doctor if your weight goes up by more than 3 lbs. Thank you for allowing us to be involved in your care, we wish you all the best! Your ___ Healthcare Team Followup Instructions: ___
19975747-DS-15
19,975,747
28,362,274
DS
15
2148-08-29 00:00:00
2148-08-29 13:51:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal pain, nausea, vomiting Major Surgical or Invasive Procedure: None History of Present Illness: ___ female presenting with epigastric and back pain. Patient notes that her pain started yesterday at 6:30 ___ after dinner. Specifically, she describes an epigastric pain that is burning in character. It radiates around the right upper and left upper quadrants around to the back. The pain is constant and severe. Pain is accompanied with nausea as well as vomiting. Patient has had multiple episodes of emesis. She describes no fever or chills. Patient does not have any urinary changes. Patient continues to have normal bowel movements. Patient does not have any red flags with regards to her back pain. She does not describe any stool incontinence. She has no urinary retention. She has no saddle anesthesia. Patient's past medical history significant for breast cancer status post mastectomy and C-section x2. She also has GERD. Patient drinks alcohol only occasionally. She is a family history significant for ulcerative colitis. Past Medical History: PMH breast cancer ___ years ago s/p mastectomy GERD PSH 2 c sections Social History: ___ Family History: family history significant for ulcerative colitis. Physical Exam: Physical Exam on Admission: 98 110 149/87 18 97% RA gen: NAD CV: regular, mildly tachycardic pulm: nonlabored breathing on room air abd: soft, mildly distended, mildly tender to palpation in epigastric region Physical Exam on Discharge: Vitals: 24 HR Data (last updated ___ @ 2347) Temp: 98.3 (Tm 98.8), BP: 154/93 (129-168/71-93), HR: 87 (80-98), RR: 18, O2 sat: 97% (97-99), O2 delivery: Ra Fluid Balance (last updated ___ @ 1456) Last 8 hours No data found Last 24 hours Total cumulative 2055ml IN: Total 2155ml, PO Amt 735ml, IV Amt Infused 1420ml OUT: Total 100ml, Urine Amt 0ml, NGT 100ml Physical exam: Gen: NAD, AxOx3, NGT with bilious output Card: RRR Pulm: no respiratory distress Abd: Soft, non-tender, non-distended Ext: No edema, warm well-perfused Pertinent Results: Labs on Admission: ___ 01:30PM BLOOD WBC-11.8* RBC-4.61 Hgb-14.2 Hct-43.3 MCV-94 MCH-30.8 MCHC-32.8 RDW-12.0 RDWSD-41.3 Plt ___ ___ 01:30PM BLOOD Glucose-142* UreaN-15 Creat-0.9 Na-142 K-4.6 Cl-96 HCO3-29 AnGap-17 ___ 01:30PM BLOOD ALT-15 AST-36 AlkPhos-61 TotBili-0.3 ___ 01:30PM BLOOD Lipase-25 Labs on Discharge: ___ 07:55AM BLOOD WBC-7.2 RBC-4.03 Hgb-12.4 Hct-38.4 MCV-95 MCH-30.8 MCHC-32.3 RDW-12.1 RDWSD-42.1 Plt ___ ___ 07:55AM BLOOD Glucose-111* UreaN-11 Creat-0.7 Na-142 K-3.5 Cl-104 HCO3-25 AnGap-13 ___ 07:55AM BLOOD Calcium-8.7 Phos-2.8 Mg-2.0 IMAGING: =============================== ___: CTA CHEST ; CT ABD & PELVIS WITH CONTRAST IMPRESSION: 1. High-grade small-bowel obstruction with transition point in the low mid abdomen. Small volume pelvic free fluid. No pneumoperitoneum or organized fluid collections. 2. Marked distension of the stomach for which enteric tube decompression is recommended. 3. Distal esophageal wall thickening likely reflective of esophagitis from recent vomiting. 4. No pulmonary embolism or acute aortic pathology. 5. 4 mm left upper lobe pulmonary nodule. See recommendations below. 6. Evidence of prior granulomatous disease in the chest. 7. Mild cylindrical bronchiectasis and mild airway wall thickening suggestive of chronic bronchitis. Brief Hospital Course: ___ in good health, PMHx breast cancer s/p mastectomy ___ y/a and 2 c sections, presented with abdominal pain, nausea, and vomiting. A CT abd/pelvis demonstrated a SBO with transition point. A nasogastric tube was placed for decompression on admission and she was started on IVF and made NPO. She continued to have regular bowel movements. On the morning of ___, her abdominal pain and nausea were significantly improved. She had an abdominal X-ray with PO contrast that showed contrast passing through the colon without any signs of a small bowel obstruction. Her NG tube was removed on the morning of ___. She was started on a clear liquid diet, which she tolerated well, and then was advanced to a regular diet without any issues. She continued to have regular bowel movements. At the time of discharge, the patient was doing well, afebrile and hemodynamically stable. The patient was tolerating a diet, ambulating, voiding without assistance, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Gabapentin 300 mg PO TID 2. Omeprazole Dose is Unknown PO DAILY Discharge Medications: 1. Omeprazole 20 mg PO DAILY 2. Gabapentin 300 mg PO TID Discharge Disposition: Home Discharge Diagnosis: Small bowel obstruction Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, ___ was a pleasure providing care for you during your stay at ___. WHY I CAME TO THE HOSPITAL? - You came to the hospital because you were vomiting, feeling nauseas, and having abdominal pain. WHAT HAPPENED WHEN I WAS IN THE HOSPITAL? - A CT scan showed that you had a small bowel obstruction, which was causing your symptoms. We placed a nasogastric tube to relieve the pressure in your stomach, which provided significant relief of your pain and nausea. We started you on IV fluids and kept you from eating until your symptoms improved. We got x-rays that showed improved in the small bowel obstruction and removed your nasogastric tube. WHAT SHOULD I DO WHEN I LEAVE THE HOSPITAL? - You should follow up with your primary care provider within one week of discharge from the hospital - You should take your usual medications as prescribed - You should continue to eat your regular diet We wish you the best of luck! Sincerely, Your ___ Care Team Followup Instructions: ___
19975898-DS-13
19,975,898
25,531,568
DS
13
2159-12-12 00:00:00
2159-12-13 14:35:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Dilaudid / Demerol / ribavirin / venlafaxine Attending: ___. Chief Complaint: SI Major Surgical or Invasive Procedure: None History of Present Illness: ___ hx of liver transplant went to ___ with anxiety/AMS. Transferred to ___ for further w/u given h/o transplant and due to lack of psychiatry at ___. No f/c, CP, SOB, N/V/D, abdominal pain. Patient arrived from ___ on ___ and endorsed SI. Of note patient had inpatient psych admission in early ___ for SI. He was seen by psychiatry in the ED due to SI - ___ was placed, pt unable to leave AMA. Psych bed search was initiated. Patient was also started on olanzapine 15 mg daily and ativan 1 mg PO TID. Per psych recs, his home imipramine and remeron were held given concern that his anxiety / SI may have been med related mood disorder. In the ED: - Labs were significant for normal white count, BUN/Cr 34/1.1, INR 1.1, normal LFTs, negative utox, negative serum tox; tacroFK 6.6. - Imaging revealed patent hepatic vasculature. Unremarkable liver Doppler examination - The patient was started on his home medications as well as psych medications per psych recs. Vitals prior to transfer were: 97.2 64 107/67 18 98% RA Upon arrival to the floor, VS were 97.5, 134/94, HR 81, RR 10, SaO2 99% RA. Patient denied SI, but reported ongoing intermittent anxiety. Denied fever, sob, cough, abd pain, n/v, diarrhea. REVIEW OF SYSTEMS: (+) Per HPI (-) Denies fever, chills, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Past Medical History: PAST PSYCHIATRIC HISTORY: Hospitalizations: possible hospitalization ___ years ago for 'mental break' ___ drug use Current treaters and treatment: no mental health providers ___ and ECT trials: trialed multiple SSRIs, SNRIs and benzodiazepines; patient uncertain as to exact names; most recently started Venlafaxine XR; also on Mirtazapine for unclear indication since OLT Self-injury: denied; however, ideation with research for plan Harm to others: asked to be restrained Access to weapons: denied PMH: -HCV cirrhosis s/p OLT with HCV in donor liver s/p treatment with Harvoni and ribaviron -nephrolithiasis -Chronic lower back pain -HTN Social History: ___ Family History: FAMILY PSYCHIATRIC HISTORY: mother ___, EtOH dependence, Alzheimer's Dementia), father (EtOH ___, sister and son (___) Physical Exam: ADMISSION: Vitals: 97.5, 134/94, HR 81, RR 10, SaO2 99% RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: well healed surgical scars from prior transplant, soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII grossly intact, ___ strength upper/lower extremities, grossly normal sensation, gait deferred. PSYCH: denies SI DISCHARGE: VS:98.0 109/67 66 16 98%RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, normal thyroid exam, no JVD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly, large RUQ healed scar Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: no jaundice Neuro: no asterixis, AAOx3, denies active SI/HI Pertinent Results: ADMISSION ___ 04:40AM ___ PTT-36.7* ___ ___ 04:40AM WBC-4.7# RBC-4.28*# HGB-12.3*# HCT-36.8* MCV-86 MCH-28.7 MCHC-33.4 RDW-12.7 RDWSD-39.5 ___ 04:40AM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 04:40AM tacroFK-6.6 ___ 04:40AM ALBUMIN-5.1 CALCIUM-9.7 PHOSPHATE-3.0 MAGNESIUM-2.1 ___ 04:40AM LIPASE-12 ___ 04:40AM ALT(SGPT)-18 AST(SGOT)-18 ALK PHOS-115 TOT BILI-0.7 ___ 04:50AM LACTATE-1.0 ___ 04:40AM GLUCOSE-106* UREA N-34* CREAT-1.1 SODIUM-139 POTASSIUM-4.3 CHLORIDE-103 TOTAL CO2-25 ANION GAP-15 ___ 01:50PM URINE bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG oxycodn-NEG mthdone-NEG INTERIM ___ 06:45AM BLOOD tacroFK-7.4 DISCHARGE ___ 06:35AM BLOOD WBC-4.0 RBC-3.85* Hgb-11.2* Hct-32.7* MCV-85 MCH-29.1 MCHC-34.3 RDW-12.6 RDWSD-38.0 Plt ___ ___ 06:35AM BLOOD Plt ___ ___ 06:35AM BLOOD Glucose-91 UreaN-32* Creat-1.0 Na-141 K-4.0 Cl-107 HCO3-23 AnGap-15 ___ 06:45AM BLOOD ALT-19 AST-16 AlkPhos-101 TotBili-0.6 ___ 06:35AM BLOOD Calcium-9.4 Phos-3.6 Mg-2.0 ___ 06:35AM BLOOD tacroFK-7.8 IMAGING: RUQ U/S (___): -IMPRESSION: 1. Patent hepatic vasculature. Unremarkable liver Doppler examination. 2. Unchanged 9 mm right upper pole nonobstructing renal calculus. No hydronephrosis. 3. Stable mild splenomegaly. STUDIES: -Urine cx: negative -Blood cx: Brief Hospital Course: ___ hx of liver transplant and depression presented to ED with suicidal ideation, admitted to medicine for further monitoring while awaiting safe transfer. # Suicidal Ideation: patient presented to ___ with anxiety / SI. Transferred for further mgmt given receives care at ___. He was seen in the ED and wassectioned by psychiatry, may not leave AMA. He remained medically stable in the ED x3 days without placement in psychiatry. Although medically cleared, patient was transferred to medicine floor. Per psych notes, patients may have had some component of med-related mood disorder causing manic symptoms from imipramine and remeron. The imipramine and remeron were discontinued and patient was started on olanzapine 15mg qHS with Ativan 1mg TID for breakthrough anxiety and vistaril 25mg PRN for anxiety. On arrival to the floor patient reported no active suicidal ideation. His 1:1 and section were discontinued after being cleared by psychiatry. He was discharged on olanzapine 15mg qHS with olanzapine 5mg qHS PRN if unable to fall asleep within x1 hour and vistaril 25mg PRN for anxiety. He was provided with the contact information for social work at the ___ and the social worker for the Liver Transplant service was contacted to further assist the patient in establishing psychiatric care. An appointment was made for him with his PCP ___ 2 days from discharge. # Liver transplant: s/p OLTx ___omplicated by HCV recurrence s/p treatment with harvoni/RBV as well as mild ACR ___. RUQ in ED showed patent hepatic vasculature. Tacro level on ___ was 6.6. He was evaluated by hepatology in the ED who reported he was doing well. He was continued on tacrolimus 2mg q12hours, mycophenolate 500mg BID, asa 81mg/Plavix 75mg daily for common hepatic stent. He will follow-up with his Hepatologist as an outpatient. # Hypertension: he was continued on his home amlodipine, metoprolol # Chronic back pain: he was continued on his home gabapentin, cyclobenzaprine TI: [] f/u w/psychiatry - will need to call insurance company to find out which providers he is eligible for, will likely need referral from PCP [] f/u w/social work # CODE STATUS: Full Code # CONTACT: ___ (son) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amlodipine 10 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Clopidogrel 75 mg PO DAILY 4. Cyclobenzaprine ___ mg PO HS 5. Metoprolol Tartrate 25 mg PO BID 6. Mirtazapine 30 mg PO QHS 7. Mycophenolate Mofetil 500 mg PO BID 8. Tacrolimus 2 mg PO Q12H 9. OLANZapine 5 mg PO BID 10. Imipramine 10 mg PO QHS 11. Gabapentin 600 mg PO QHS Discharge Medications: 1. Amlodipine 10 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Clopidogrel 75 mg PO DAILY 4. Cyclobenzaprine ___ mg PO HS 5. Gabapentin 600 mg PO QHS 6. Metoprolol Tartrate 25 mg PO BID 7. Mycophenolate Mofetil 500 mg PO BID 8. OLANZapine 15 mg PO QHS You may take an additional 5mg at night if difficulty falling asleep RX *olanzapine 15 mg 1 tablet(s) by mouth at bedtime Disp #*30 Tablet Refills:*0 9. Tacrolimus 2 mg PO Q12H 10. OLANZapine 5 mg PO QHS:PRN insomnia ___ take in addition to nighttime dose if difficulty falling asleep after 1 hour RX *olanzapine 5 mg 1 tablet(s) by mouth at bedtime Disp #*30 Tablet Refills:*0 11. HydrOXYzine 25 mg PO QHS:PRN insomnia, anxiety Please take only as needed for anxiety or insomnia RX *hydroxyzine HCl 25 mg 1 tablet by mouth at bedtime Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSES: Medication-induced mood disorder Suicidal ideation SECONDARY DIAGNOSES: OLT HTN Chronic lower back pain Discharge Condition: Appearance: Clean and casual Behavior: Cooperative, engaged in interview, appropriate eye contact Mood: 'Fine' Affect: Euthymic, mood congruent Thought process: Linear, logical, goal directed. Thought Content: Devoid of any delusional thoughts or paranoia, denies AH/VH, SI, or HI. Judgment: Improving Insight: Improving Discharge Instructions: Dear Mr. ___, You were admitted to the hospital due to concern about hurting yourself and anxiety. You were evaluated by the Psychiatry team who stopped your imipramine and mirtazapine and started you on olanzapine 15mg which you should take every night. It is very important that you follow-up with your Psychiatrist. If you begin to feel suicidal or not in control of your feelings please immediately return to the ED. Thank you for letting us be a part of your care! Your ___ Team -Please avoid abusing alcohol and any drugs--whether prescription drugs or illegal drugs--as this can further worsen your medical and psychiatric illnesses. -Please contact your outpatient psychiatrist or other providers if you have any concerns. -Please call ___ or go to your nearest emergency room if you feel unsafe in any way and are unable to immediately reach your health care providers. Followup Instructions: ___
19975981-DS-2
19,975,981
25,927,585
DS
2
2157-09-16 00:00:00
2157-09-17 16:53:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: OBSTETRICS/GYNECOLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Prolapsed fibroid Major Surgical or Invasive Procedure: total abdominal hysterectomy History of Present Illness: ___ premenopausal female with long hx of menorrhagia and newly diagnosed fibroids presenting initially to ___ ___ this AM and then transferred to ___ with episode of heavy vaginal bleeding. She reports monthly menses up until ___ when she began having daily bleeding requiring pad or tampon changes nearly hourly. She reports two days of no bleeding in ___ when she noted heavy watery discharge followed by resumption of bleeding. She denies vaginal pain and pelvic pain although she endorses taking Aleve sometimes for cramping. She did not know she had fibroids until her evaluation by pelvic ultrasound today. She has not had any medical care in ___ years due to insurance issues. She went to the ED today because she noted a large gush of blood and began to feel lightheaded and dizzy. She denies CP, SOB and palpitations. Patient found to have hct of 22 around noon followed by hct 18 at CHA after IV hydration. She received half a unit of blood prior to transfer to ___. A transfusion of an additional 2 units has started in the ED. Pelvic ultrasound shows a 22cm multifibroid uterus as well as a large fibroid prolapsing into the vagina. The endometrium is thickened with fluid and clot and ?polyp. The patient reports she is still having some ongoing bleeding, but less than before. Of note, pt reports approx. 50lbs of unintentional weight loss since ___ while caring for her mother who was dying with dementia. She reports she had less of an appetite and "wasn't really eating." Past Medical History: POb: - TAB X ___ (___) - SVD x 1 - HTN in preg - SAB x 1 - no D&C PGyn: - menarche at ___ -> regular monthly ___ with ___ days of bleeding - menorrhagia bleeding through a pad or super tampon every hour for the first 3 days at least - denies hx of abnl paps and STIs - hx of ovarian cyst removed in pregnancy at ___ - benign - open PMH: - obesity PSH: - open ovarian cystectomy as above - D&E x ___ Meds: aleve for cramps occasionally Allergies: NKDA Social History: ___ Family History: ___: denies hx of gyn CA, colon CA, diabetes Physical Exam: Admission physical exam: O: T 97.6 HR 78 BP 171/87 RR 18 O2 100%RA - bps 160S-170S/70S-80S NAD, well-appearing, obese RRR CTAB Abd soft, obese, ND, well-healed midline incision inferior to umbilicus Upon discharge physical exam VSS, AF Gen: NAD, A&O x 3 ENT: large neck CV: RRR, S1 S2 Pulm: CTAB, no r/w/c Abd: soft, appropriately tender, ND, no r/g/d Ext: no c/c/e Incision: c/d/i Pertinent Results: ___ 08:00PM ALT(SGPT)-12 AST(SGOT)-15 ___ 08:00PM %HbA1c-5.2 eAG-103 ___ 08:00PM WBC-6.9 RBC-3.86* HGB-7.5* HCT-26.2* MCV-68* MCH-19.5* MCHC-28.7* RDW-23.9* ___ 08:00PM PLT COUNT-296 ___ 01:10PM WBC-5.3 RBC-3.42* HGB-6.5* HCT-23.0* MCV-67* MCH-19.1* MCHC-28.4* RDW-23.6* ___ 01:10PM PLT COUNT-301 ___ 11:21AM TSH-1.0 ___ 11:21AM HCG-<5 ___ 11:21AM WBC-5.2 RBC-3.61* HGB-6.8*# HCT-23.8* MCV-66* MCH-18.7*# MCHC-28.4*# RDW-23.6* ___ 11:21AM PLT COUNT-307 ___ 11:21AM ___ PTT-31.0 ___ ___ 11:21AM ___ 10:06PM ___ PTT-29.1 ___ ___ 10:06PM ___ 10:00PM GLUCOSE-84 UREA N-7 CREAT-0.6 SODIUM-142 POTASSIUM-3.3 CHLORIDE-111* TOTAL CO2-24 ANION GAP-10 ___ 10:00PM estGFR-Using this ___ 10:00PM NEUTS-65.3 ___ MONOS-7.9 EOS-2.9 BASOS-0.6 ___ 10:00PM PLT COUNT-336 Final Report INDICATION: History of fibroid prolapsing and vaginal bleeding. COMPARISONS: Pelvic ultrasound from outside hospital from ___. TECHNIQUE: Transabdominal and transvaginal exam was performed, the latter to better assess the uterus and adnexa. FINDINGS: The uterus measures 22.7 x 10.3 x 14.2 cm and is markedly enlarged. Multiple fibroids are noted, the largest in the left aspect of the fundus measuring 10.9 x 9.0 x 9.1 cm. The endometrium is markedly distorted. A focal echogenic lesion measuring approximately 2.9 cm has focal vascular flow and may represent a polyp or submucosal fibroid. There is echogenic material within the endometrium that is likely hemorrhage and blood clot as well as fluid. Transvaginal exam was limited due to a large prolapsed fibroid which was reportedly visualized on direct inspection. This is probably demonstrated as a structure prolapsing through the cervix on image 26. The ovaries are not visualized. IMPRESSION: 1. Markedly enlarged fibroid uterus. 2. Distorted endometrium with hemorrhage, fluid and a vascularized intraluminal structure that could represent a polyp or submucosal fibroid. 3. A prolapsed fibroid, reportedly visualized on direct inspection, is partially imaged. 4. Non-visualization of the ovaries. The study and the report were reviewed by the staff radiologist Brief Hospital Course: On ___, Ms. ___ was admitted to the gynecology service for observation of her prolapsed uterus. The patient initially presented with a hematocrit of 18 from the outside hospital where she received ___ unit of PRBC. The patient then received a total of 5 units of PRBC for pre-op optimization. On ___. she then underwent a total abdominal hysterectomy, along with 3 additional units of PRBCs intraop as well as 1 unit of FFP. Please see the operative report for full details. Her post-operative course was uncomplicated. Immediately post-op, her pain was controlled with IV pain medications. On post-operative day 1, her urine output was adequate so her foley was removed and she voided spontaneously. Her diet was advanced without difficulty and she was transitioned to oral pain meds. On POD #2, the patient experienced some abdominal discomfort ___ gas pain. Her diet was backed down, and she was ultimately able to transition her diet. A goiter was noted on a physical exam, though her TSH was normal, we recommend an outpatient follow-up with a thyroid ultrasound. Also, the patient had blood pressures that were elevated, though she did not receive any anti-hypertensives. We also recommend that she follow-up with her primary care doctor as well. By post-operative day 3, she was tolerating a regular diet, voiding spontaneously, ambulating independently, and pain was controlled with oral medications. Her hematocrit was 30 upon discharge. She was then discharged home in stable condition with outpatient follow-up scheduled. Medications on Admission: Aleve prn pain Discharge Medications: 1. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*60 Capsule Refills:*2 2. Ibuprofen 600 mg PO Q6H:PRN pain RX *ibuprofen 600 mg 1 tablet(s) by mouth every six (6) hours Disp #*40 Tablet Refills:*2 3. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4H:PRN pain Do not take more than 4000mg acetaminophen in 24 hours RX *oxycodone-acetaminophen 5 mg-325 mg ___ tablet(s) by mouth every four (4) hours Disp #*40 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Prolapsed fibroid Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to the Gynecology service at ___ ___ for your prolapsed fibroid and have since received a total abdominal hysterectomy. You have recovered well, and met all of your post-operative milestones, including, pain controlled with medications, walking independently, urinating spontaneously and tolerating a regular diet. We have determined that you are in a stable condition to go home. Please follow-up as scheduled, and follow the instructions below. General instructions: * Take your medications as prescribed. * Do not drive while taking narcotics. * Take a stool softener such as colace while taking narcotics to prevent constipation * Do not combine narcotic and sedative medications or alcohol * Do not take more than 4000mg acetaminophen (APAP) in 24 hrs * No strenuous activity until your post-op appointment * Nothing in the vagina (no tampons, no douching, no sex) for 3 months * No heavy lifting of objects >10 lbs for 6 weeks. * You may eat a regular diet Incision care: * You may shower and allow soapy water to run over incision; no scrubbing of incision. No bath tubs for 6 weeks. * Your staples will be removed at your follow-up appointment on ___. Call your doctor for: * fever > 100.4 * severe abdominal pain * difficulty urinating * vaginal bleeding requiring >1 pad/hr * abnormal vaginal discharge * redness or drainage from incision * nausea/vomiting where you are unable to keep down fluids/food or your medication To reach medical records to get the records from this hospitalization sent to your doctor at home, call ___. Followup Instructions: ___
19975995-DS-10
19,975,995
26,284,923
DS
10
2111-03-18 00:00:00
2111-03-18 23:19:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: RLQ pain, fever, and vomiting Major Surgical or Invasive Procedure: Laparoscopic appendectomy ___ ___ placement of three drains into pelvic abscesses ___ History of Present Illness: Mr. ___ is a ___ previously health M presented with three-day -old migratory RLQ pain, fever, and vomiting. He reports after having Chipotle on ___ evening (three days prior to presentation), he woke up from an excruciating LLQ pain and had an episode of non-bloody, non-bilious emesis. He went to the ___ ED, and got an KUB, which was unremarkable according to patient. He was cleared and discharged after having some Zofran and Tylenol. While nausea and vomiting has subsided, the pain migrated to supraumbilicus. Patient reports that he woke up feeling feverish yesterday morning (temp unmeasured), which resolved with Tylenol. Appetite has been poor since symptom occurred and he only had a few crackers since pain onset. Early this AM, the pain migrated to RLQ and has worsen. Pain exacerbates with movement. He reports haven't had any bowel movement in 3 days, deviating from his normal BM habit of ___ times a day. Pain has become unbearable this morning and he came to the ___ ED. At the ___ ED, he was febrile ___. He was given NS bolus, Morphine 4mg IV, Acetaminophen 1000mg, and Zofran 4mg. Patient reports pain and nausea are alleviated after IV meds. Basic labs were ordered, and CT has yet to be performed. ACS is consulted for abdominal pain. Patient denies chills, diarrhea, hematochezia, lightheadedness, vertigo, cough, SOB, chest pain, and change in urination. Patient denies recent travels, sick contacts, or antibiotic use. Past Medical History: PMHx: None PSHx: None Social History: ___ Family History: Father - HTN No known inflammatory bowel disease Physical Exam: Admission Physical Exam: Discharge Physical Exam: GEN: NAD, resting comfortably reclined in bed. Soeaking in clear and fluent sentences CTAB, RRR Abd: obese, soft, slight tenderness to palpation around drain insertion sites and lateral abdomen bilaterally; nontender at lap appy sites with steristrips in place on midline low abdomena nd periumbilical, no staining n lower set, min shatining anguine on umbilical steris; 3 ir drains- LLQ, Rmid lateral, midline low abd-- all dry dressings, ir drains in place, serosang out of right lateral, clear serous in left lat and midline 2+ DP Pertinent Results: ___ 05:39AM BLOOD WBC-14.5* RBC-4.25* Hgb-12.6* Hct-38.9* MCV-92 MCH-29.6 MCHC-32.4 RDW-13.5 RDWSD-45.3 Plt ___ ___ 11:48AM BLOOD Neuts-88.6* Lymphs-2.9* Monos-7.0 Eos-0.3* Baso-0.4 Im ___ AbsNeut-25.27* AbsLymp-0.83* AbsMono-1.99* AbsEos-0.08 AbsBaso-0.10* ___ 05:39AM BLOOD Plt ___ ___ 05:39AM BLOOD Glucose-115* UreaN-7 Creat-0.6 Na-135 K-3.9 Cl-100 HCO3-25 AnGap-14 ___ 11:48AM BLOOD ALT-10 AST-15 AlkPhos-83 TotBili-0.9 ___ 05:39AM BLOOD Calcium-8.3* Phos-4.5 Mg-2.1 Brief Hospital Course: Following initial surgical evaluation in the ED, the patient was sent for a CT of his Abdomen and Pelvis which demonstrated acute appendicitis with two appendicoliths and extensive surrounding soft tissue stranding. The patient was started on Flagyl and Ancef and was not deemed to be a non-operative candidate. He was consented for a Laparoscopic Appendectomy brought back to the operating room. During the procedure, the appendix was noted to be liquefied in the midportion and disintegrated with manipulation releasing multiple large fecaliths into the peritoneum, which were retrieved and extracted. Otherwise, he tolerated the procedure well and was sent to the PACU post-operatively. For further details on the operation, please refer to the operative note on ___. Over the ensuing three days, Mr. ___ progressed well; he was tolerating a regular diet and given PO pain control. On POD 3 however, he began to develop nausea, vomiting and sustained leukocytosis concerning for a developing intra-abdominal infection. Subsequent CT demonstrated numerous rim enhancing collections that were drained by ___ on ___. Three drains were left in place and the patient progressed well over the next several days. His diet was progressed in a step-wise fashion. By the time of discharge, he was tolerating a regular diet, voiding and stooling normally, pain was controlled with PO medications and he was independently ambulating with no issues. He is to follow up with Dr. ___ in 10 days and will receive a CT scan at that point. He was discharged on the aforementioned antibiotic regimen and was discharged home with ___ services to help with his 3 JP drains that were left in place. ___ will help with drain care, recoding output total 14 days antibiotics, will dc with another 6 days ct scan ___- pt made aware call dr ___- will call him, discussed drain care and ___ Medications on Admission: None Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H 2. Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin HCl [Cipro] 500 mg 1 (One) tablet(s) by mouth every twelve (12) hours Disp #*12 Tablet Refills:*0 3. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 (One) capsule(s) by mouth twice a day Disp #*30 Capsule Refills:*1 4. MetroNIDAZOLE 500 mg PO Q8H RX *metronidazole 500 mg 1 (One) tablet(s) by mouth every eight (8) hours Disp #*18 Tablet Refills:*0 5. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Moderate RX *oxycodone 5 mg 1 to 2 tablet(s) by mouth every four (4) to six (6) hours Disp #*40 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Perforated gangrenous appendicitis postop ileus Intra-abdominal abscesses Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to ___ with ruptured appendicitis and underwent a laparoscopic (minimally invasive) removal of your appendix. Because your appendix was ruptured, you developed fluid collections in your abdomen that were drained by our interventional radiologist. Your infection has since improved and you are ready for discharge home to continue your recovery. ACTIVITY: o Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. Do not drive until your pain no longer limits your motion- make sure you can make quick moves without stopping because of pain. o You may climb stairs. o You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. o Don't lift more than ___ lbs for 4 weeks. (This is about the weight of a briefcase or a bag of groceries.) This applies to lifting children, but they may sit on your lap. o You may start some light exercise when you feel comfortable. o You will need to stay out of bathtubs or swimming pools for a time while your incision is healing. Ask your doctor when you can resume tub baths or swimming. HOW YOU MAY FEEL: o You may feel weak or "washed out" for a couple of weeks. You might want to nap often. Simple tasks may exhaust you. o You may have a sore throat because of a tube that was in your throat during surgery. o You might have trouble concentrating or difficulty sleeping. You might feel somewhat depressed. o You could have a poor appetite for a while. Food may seem unappealing. o All of these feelings and reactions are normal and should go away in a short time. If they do not, tell your surgeon. YOUR INCISION: Your visiting nurses should help you with your drains and their care. The nurses ___ go over with you how to take care of your drains. Please record how much comes out of your drains and what it looks like, and record this on a paper log. ****General Drain Care:*** *Please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody discharge, warm to touch, fever). *If the drain is connected to a collection container, please note color, consistency, and amount of fluid in the drain. Call the doctor, ___, or ___ nurse if the amount increases significantly or changes in character. Be sure to empty the drain frequently. Record the output, if instructed to do so. *Wash the area gently with warm, soapy water. *Keep the insertion site clean and dry otherwise. *Avoid swimming, baths, hot tubs; do not submerge yourself in water. *Make sure to keep the drain attached securely to your body to prevent pulling or dislocation. o Your incisions may be slightly red. This is normal. o You may gently wash away dried material around your incision. o Avoid direct sun exposure to the incision area. o Do not use any ointments on the incision unless you were told otherwise. o You may see a small amount of clear or light red fluid staining your dressing or clothes. If the staining is severe, please call your surgeon. o You may shower. As noted above, ask your doctor when you may resume tub baths or swimming. YOUR BOWELS: o Constipation is a common side effect of narcotic pain medications. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. o If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. PAIN MANAGEMENT: o It is normal to feel some discomfort/pain following abdominal surgery. This pain is often described as "soreness". o Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. o You will receive a prescription for pain medicine to take by mouth. It is important to take this medicine as directed. o Do not take it more frequently than prescribed. Do not take more medicine at one time than prescribed. o Your pain medicine will work better if you take it before your pain gets too severe. o Talk with your surgeon about how long you will need to take prescription pain medicine. Please don't take any other pain medicine, including non-prescription pain medicine, unless your surgeon has said its okay. o If you are experiencing no pain, it is okay to skip a dose of pain medicine. o Remember to use your "cough pillow" for splinting when you cough or when you are doing your deep breathing exercises. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain MEDICATIONS: Take all the medicines you were on before the operation just as you did before, unless you have been told differently. If you have any questions about what medicine to take or not to take, please call your surgeon. ___ Drain Care: -Please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody discharge, warm to touch, fever). -Note color, consistency, and amount of fluid in the drain. Call the doctor, ___, or ___ nurse if the amount increases significantly or changes in character. -Be sure to empty the drain bag or bulb frequently. Record the output daily. You should have a nurse doing this for you. -You may shower; wash the area gently with warm, soapy water. -Keep the insertion site clean and dry otherwise. -Avoid swimming, baths, hot tubs; do not submerge yourself in water. - If you develop worsening abdominal pain, fevers or chills please call Interventional Radiology at ___ at ___ and page ___. -When the drainage total is LESS THAN 10cc/ml for 2 days in a row, please have the ___ call Interventional Radiology at ___ at ___ and page ___. This is the Radiology fellow on call who can assist you. Followup Instructions: ___
19975995-DS-11
19,975,995
29,336,309
DS
11
2111-03-29 00:00:00
2111-03-29 18:39:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Change in ___ Drain output Major Surgical or Invasive Procedure: ___ drain placement History of Present Illness: Mr. ___ is a ___ M s/p lap appendectomy ___ for acute appendicitis c/b multiple intrabdominal abscesses s/p ___ drain placement ___. He was discharged home on ___ on course of oral cipro/flagyl which he completed ___. He presents today with complaint of increased purulent drain output. He reports that over the preceding 4 days, all 3 JP drains were putting out minimal serosanguinous fluid (<10cc total daily from all 3 drains). He reports that this morning, however, he noted the drainage from drains #2 and #3 was thick, cheese-like and foul-smelling. He reports approximately 20cc purulent output from drains #2 and #3 with minimal output from drain #1. He also reports that drain ___ have become dislodged as he felt it moved. He denies fevers/chills, worsening abdominal pain, diarrhea/constipation, nausea/vomiting, or any other abdominal symptoms. Past Medical History: Past Medical History: None Past Surgical History: ___ Laparoscopic appendectomy ___ ___ drain placement x3 Social History: ___ Family History: Father - HTN No known inflammatory bowel disease Physical Exam: GEN: NAD, well appearing HEENT: NCAT CV: RRR RESP: breathing comfortably on room air GI: multiple well healing incisions (in the mid abdomen, suprapubic region and LLQ) used for previous ___ drains and appropriately covered with bandages, RLQ ___ Drain appropriate and bandaged pulling white-yellow fluid to bulb suction, right buttock ___ drain pulling serosanguinous fluid to bulb suction, abdomen soft, appropriately TTP, no masses or hernia, no guarding distension or rebound tenderness EXT: well perfused Pertinent Results: ___ 06:03AM BLOOD WBC-9.8 RBC-4.23* Hgb-12.5* Hct-38.6* MCV-91 MCH-29.6 MCHC-32.4 RDW-12.6 RDWSD-41.6 Plt ___ ___ 04:15AM BLOOD Neuts-72.9* Lymphs-12.6* Monos-12.4 Eos-0.9* Baso-0.6 Im ___ AbsNeut-10.43* AbsLymp-1.81 AbsMono-1.78* AbsEos-0.13 AbsBaso-0.09* ___ 06:03AM BLOOD Plt ___ ___ 06:03AM BLOOD Glucose-93 UreaN-5* Creat-0.6 Na-136 K-4.0 Cl-97 HCO3-25 AnGap-18 ___ 06:03AM BLOOD Calcium-8.9 Phos-4.4 Mg-2.0 Brief Hospital Course: Mr. ___ returned to ___ several weeks ago following an episode of Acute Appendicitis s/p Laparoscopic Appendenctomy c/b gangrenous and perforated appendix. Upon return to hospital following his procedure, he was found to have 3 abdominal fluid collections and abscesses that were subsequently drained by ___. He was discharged with the drains and ___ services but noticed that the output changed substantially in one of the drains. As directed, he returned to the ED most recently on ___ for further workup and management. During this admission, repeat CT imaging demonstrated a large pelvic fluid collection that was subsequently drained by ___ via a posterior approach. He tolerated the procedure well. For the procedure report, please see the note in the OMR. In the several days following the procedure, the patient's diet was advanced and pain was appropriately controlled. By the time of discharge, the patient was independently ambulatory, tolerating a PO diet, voiding and passing flatus. He was discharged with the appropriate follow up and given a course of oral antibiotics. CT: 1. Interval increase in size of midline pelvic abscess, now measuring 8.3 x 7.3 cm which extends to the left anterior pelvis. 2. Three pigtail catheters in place with interval resolution of the left-sided fluid collection and marked decrease in size of the two remaining collections. No new fluid collections identified. 3. New mild right-sided hydroureteronephrosis, with transition point in the distal right ureter as it courses in the region of phlegmonous changes in the right lower quadrant. 4. Wedge-shaped area of hyperdensity surrounding a hypodense tubular structure in segment VIII, more pronounced compared to prior study, which could represent a potentially thrombosed branch of the middle hepatic vein with thrombophlebitis, or less likely, cholangitis surrounding a dilated duct. This could be further assessed with MRCP. Medications on Admission: None Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild RX *acetaminophen 500 mg ___ tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills:*0 2. Ciprofloxacin HCl 750 mg PO Q12H RX *ciprofloxacin HCl 750 mg 1 tablet(s) by mouth twice a day Disp #*11 Tablet Refills:*0 3. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*20 Capsule Refills:*0 4. MetroNIDAZOLE 500 mg PO TID RX *metronidazole [Flagyl] 500 mg 1 tablet(s) by mouth three times a day Disp #*17 Tablet Refills:*0 5. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Severe RX *oxycodone 5 mg 1 capsule(s) by mouth every four (4) hours Disp #*30 Capsule Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Pelvic Abscess Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, You were admitted to the hospital for management of your abdominal discomfort and a workup to determine the cause of your changing drain output. Upon evaluation with CT imaging, it was determined that you had a large pelvic fluid collection consistent with an abscess; a collection of infected material in your abdomen. You were re-started on IV antibiotics and you received a drain that was placed in the fluid collection via radiologic intervention. The drain entered your abdomen via your backside. Two of your previously placed abdominal drains were removed during this admission; thus, you will return home with 1 drain exiting in your abdomen, and 1 drain exiting from your backside. A visiting nurse service will be helping you maintain your drains as they did previously. You will return to clinic for a follow up appointment in one week. You will continue on an oral antibiotic regimen until ___. You recovered well from this process and you are ready to return home to finish your recovery. Please remain in ___ until at least ___ so you are nearby the hospital should any issues arise. If you notice any change in the color or consistency in the output of your drains, have increasing abdominal pain, experience nausea, vomiting, fever, chills or increasing redness around the drain sites, please call the number listed below or return to the ER. Followup Instructions: ___
19976024-DS-13
19,976,024
29,806,870
DS
13
2135-11-30 00:00:00
2135-11-30 20:54:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: right lower quadrant pain Major Surgical or Invasive Procedure: laparscopic appendectomy History of Present Illness: ___ with no significant PMH presenting with 2 days of RLQ pain. Patient states symptoms have been localized to the RLQ for the past day, desribes the pain as 'sharp' and 'crampy.' Pain radiates somewhat to right flank with slight testicular pain. Denied nausea, vomiting, fevers or chills. Denied dysuria, diarrhea or hematochezia. Denied a history of renal stones, penile discharge or other genitourinary complaints. Past Medical History: none Social History: ___ Family History: NC Physical Exam: PE: VS:97.9 68 130/55 16 100% General: in no acute distress, lying comfortably in bed HEENT: mucus membranes moist, nares clear, trachea at midline CV: regular rate, rhythm. No appreciable murmurs, rubs, gallops Pulm: clear to auscultation bilaterally Abd: + bowel sounds, tender to palpation in RLQ, slight right flank tenderness non-distended. No hernias, masses or scars. Equivocal psoas/obturator signs. Negative Rosving's. MSK: warm, well perfused Neuro: alert, oriented to person, place, time Physical examination upon discharge: ___ vital signs: t=98.2, hr=68, bp=126/72, rr=18, oxygen saturation 96% General: NAD CV: ns1, s2, -s3, -s4 LUNGS; clear ABDOMEN: soft, tender, port sites with DSD EXT: no pedal edema bil., no calf tenderness MENTATION: alert and oriented x 3, speech clear Pertinent Results: ___ 05:30AM BLOOD WBC-12.8* RBC-4.56* Hgb-14.1 Hct-41.3 MCV-90 MCH-30.9 MCHC-34.2 RDW-12.9 Plt ___ ___ 05:30AM BLOOD Neuts-80.9* Lymphs-12.0* Monos-4.5 Eos-1.9 Baso-0.6 ___ 05:30AM BLOOD Glucose-98 UreaN-21* Creat-0.8 Na-140 K-4.1 Cl-105 HCO3-27 AnGap-12 ___ 05:30AM BLOOD ALT-20 AST-27 AlkPhos-51 TotBili-0.6 ___ 05:30AM BLOOD Albumin-4.7 ___ 05:43AM BLOOD Lactate-1.3 ___: cat scan of abdomen and pelvis: Acute appendicitis. Brief Hospital Course: The patient was admitted to the hospital with right lower quadrant pain. Upon admission, he was made NPO, given intravenous fluids, and underwent imaging. On cat scan he was reported to have a dilated, hyperemic appendix surrounded by fat stranding. There was no evidence of perforation. Based on these findings, he was taken to the operating room where he underwent a laparoscopic appendectomy. The operative course was stable with minimal blood loss. He was extubated after the procedure and monitored in the recovery room. His post-operative course has been stable. His incisional pain has been controlled with intravenous analgesia with conversion to oral agents. He has been tolerating a regular diet and voiding without difficulty. His vital signs have been stable and he has been afebrile. On POD #1, he was discharged home in stable condition. Follow-up appointment was made with the acute care service. Medications on Admission: none Discharge Medications: 1. Docusate Sodium 100 mg PO BID 2. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain avoid driving while on this medication,may cause drowsiness RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*30 Tablet Refills:*0 3. Senna 1 TAB PO BID:PRN constipation 4. Acetaminophen 650 mg PO Q6H Discharge Disposition: Home Discharge Diagnosis: Acute Appendicitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital with right lower quadrant pain. You underwent a cat scan which showed appendicitis. You were taken to the operating room to have your appendix removed. You are slowly recovering from your surgery and preparing for discharge home with the following instructions: You were admitted to the hospital with acute appendicitis. You were taken to the operating room and had your appendix removed laparoscopically. You tolerated the procedure well and are now being discharged home with the following instructions: Please follow up at the appointment in clinic listed below. We also generally recommend that patients follow up with their primary care provider after having surgery. We have scheduled an appointment for you listed below. ACTIVITY: Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. You may climb stairs. You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. Don't lift more than ___ lbs for ___ weeks. (This is about the weight of a briefcase or a bag of groceries.) This applies to lifting children, but they may sit on your lap. You may start some light exercise when you feel comfortable. You will need to stay out of bathtubs or swimming pools for a time while your incision is healing. Ask your doctor when you can resume tub baths or swimming. HOW YOU MAY FEEL: You may feel weak or "washed out" a couple weeks. You might want to nap often. Simple tasks may exhaust you. You may have a sore throat because of a tube that was in your throat during surgery. You could have a poor appetite for a couple days. Food may seem unappealing. All of these feelings and reactions are normal and should go away in a short time. If they do not, tell your surgeon. YOUR INCISION: Tomorrow you may shower and remove the gauzes over your incisions. Under these dressings you have small plastic bandages called steristrips. Do not remove steri-strips for 2 weeks. (These are the thin paper strips that might be on your incision.) But if they fall off before that that's okay. Your incisions may be slightly red around the stitches. This is normal. You may gently wash away dried material around your incision. Avoid direct sun exposure to the incision area. Do not use any ointments on the incision unless you were told otherwise. You may see a small amount of clear or light red fluid staining your dressing or clothes. If the staining is severe, please call your surgeon. You may shower. As noted above, ask your doctor when you may resume tub baths or swimming. YOUR BOWELS: Constipation is a common side effect of narcotic pain medicaitons. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. PAIN MANAGEMENT: It is normal to feel some discomfort/pain following abdominal surgery. This pain is often described as "soreness". Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. You will receive a prescription for pain medicine to take by mouth. It is important to take this medicine as directed. Do not take it more frequently than prescribed. Do not take more medicine at one time than prescribed. Do not drink alcohol or drive while taking narcotic pain medication. Your pain medicine will work better if you take it before your pain gets too severe. Talk with your surgeon about how long you will need to take prescription pain medicine. Please don't take any other pain medicine, including non-prescription pain medicine, unless your surgeon has said its okay. If you are experiencing no pain, it is okay to skip a dose of pain medicine. Remember to use your "cough pillow" for splinting when you cough or when you are doing your deep breathing exercises. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain MEDICATIONS: Take all the medicines you were on before the operation just as you did before, unless you have been told differently. If you have any questions about what medicine to take or not to take, please call your surgeon. DANGER SIGNS: Please call your surgeon if you develop: - worsening abdominal pain - sharp or severe pain that lasts several hours - temperature of 101 degrees or higher - severe diarrhea - vomiting - redness around the incision that is spreading - increased swelling around the incision - excessive bruising around the incision - cloudy fluid coming from the wound - bright red blood or foul smelling discharge coming from the wound - an increase in drainage from the wound Followup Instructions: ___
19976911-DS-9
19,976,911
27,576,166
DS
9
2139-10-17 00:00:00
2139-10-21 22:57:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: lightheadedness Major Surgical or Invasive Procedure: ___: Dual-Chamber Pacemaker Placement History of Present Illness: Mr. ___ is a ___ y/o man with a PMH of cirrhosis c/b ascites from hemochromatosis, HTN, gout, peripheral vascular disease, and polyneuropathy, who presents with lightheadedness. He was recently seen in his PCP's office two days prior to admission with a one week history of pre-syncope and dizziness. Was hypertensive to 170/70 mmHg standing (158/54 mmHg) bradycardic at the time to 46 (baseline in the ___. He was thought to have orthostatic hypotension and instructed to hold his Lasix for 3 days and return if his symptoms worsened. He subsequently reported that he was feeling more dizzy and weak and that he felt as though he were going to fall despite using his cane. In the ED, initial vitals were: T 97.9F P 35 BP 157/54 RR 16 O2 98% RA Labs were notable for: Na+ 131, K+ 5.3, Cl- 97, HCO3- 25, BUN 12, Cr 0.9, Gluc 122. WBC 10.6, H/H 13.2/37.9, Plt 131. Diff: 73.8% Neut, 11.7% Lymph, 11.6% Monos, 1.2% Eos. ___ 13.9, PTT 34.5, INR 1.3. Trop-T <0.01. EKG was notable for complete heart block with escape rhythm of 38 bpm and no ischemic changes. In the unit, he reported that these symptoms occurred suddenly three days prior to admission (___) while he was making his morning tea. He felt dizzy and "lousy" and said that he had never felt this way before. He had no syncope, no loss of consciousness, no chest pain, palpitations, shortness of breath, orthopnea, or PND. Denied fevers, chills, nausea, vomiting, diarrhea, constipation, abdominal pain, hematuria, hematochezia, melena, hearing loss, tinnitus, or visual changes. No history of recent travel and no significant time spent outdoors (other than time spent reading the newspaper on his deck). Past Medical History: Hemochromatosis Cirrhosis (c/b ascites and pleural effusion) Gouty arthritis Hypertension PVD (peripheral vascular disease) Obesity Polyneuropathy Macrocytosis without anemia Cholecystectomy Ventral hernia Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. Physical Exam: =============== ADMISSION EXAM: =============== VS: P 40 BP 153/43 mmHg O2 97% RA General: Pleasant, elderly man, in NAD. HEENT: Anicteric sclera. MMM, OP clear. PERRL. Neck: Supple, JVP 8 cm. Normal carotid upstroke. CV: Bradycardic and regular, normal S1/S2. III/VI harsh early systolic murmur, with no thrills or heaves. Abd: Obese, soft, non-tender. NABS. Large mid-line abdominal scar. No ascites. Ext: Warm and well-perfused. 2+ pitting edema. 2+ DP pulses. Skin: No rashes or lesions. Neuro: A&Ox3. Distal sensation intact to light touch. Gait deferred. =============== DISCHARGE EXAM: =============== VS: per Metavision General: Pleasant, elderly man, in NAD. HEENT: Anicteric sclera. MMM, OP clear. PERRL. Neck: Supple, no JVD. Normal carotid upstroke. CV: RRR, normal S1/S2. III/VI harsh early systolic murmur, with no thrills or heaves. Pacer dressing site c/d/i. Abd: Obese, soft, non-tender. NABS. Large mid-line abdominal scar. No ascites. Ext: L arm in sling. Warm and well-perfused. 1+ pitting edema. 2+ DP pulses. Skin: No rashes or lesions. Neuro: A&Ox3. Distal sensation intact to light touch. Gait deferred Pertinent Results: =============== ADMISSION LABS: =============== ___ 04:36PM ___ PTT-34.5 ___ ___ 04:36PM PLT COUNT-131* ___ 04:36PM NEUTS-73.8* LYMPHS-11.7* MONOS-11.6 EOS-1.2 BASOS-0.8 IM ___ AbsNeut-7.80* AbsLymp-1.24 AbsMono-1.23* AbsEos-0.13 AbsBaso-0.09* ___ 04:36PM WBC-10.6* RBC-3.69* HGB-13.2* HCT-37.9* MCV-103* MCH-35.8* MCHC-34.8 RDW-14.1 RDWSD-53.3* ___ 04:36PM cTropnT-<0.01 ___ 04:36PM estGFR-Using this ___ 04:36PM GLUCOSE-122* UREA N-12 CREAT-0.9 SODIUM-131* POTASSIUM-5.3* CHLORIDE-97 TOTAL CO2-25 ANION GAP-14 ================== PERTINENT RESULTS: ================== Echocardiogram (___): Conclusions The left atrium is moderately dilated. The estimated right atrial pressure is ___ mmHg. There is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>55%). Right ventricular chamber size and free wall motion are normal. The ascending aorta is mildly dilated. The aortic valve is not well seen. There is severe aortic valve stenosis (valve area <1.0cm2). The transvalvular mean and peak gradient does not meet severe aortic stenosis severity. However, by continuity equation there is severe aortic stenosis. The stroke volume index is low at 37 ml/m2 using Teicholz and also LVOT Doppler assessment possibly indicating paradoxical low flow low gradient physiology in setting of normal left ventricular ejection fraction. Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Trivial mitral regurgitation is seen. There is no pericardial effusion. IMPRESSION: Suboptimal image quality. Likely severe aortic stenosis (see details above). Mild symmetric left ventricular hypertrophy with normal biventricular regional/global systolic function. The patient has a mildly dilated ascending aorta. Based on ___ ACCF/AHA Thoracic Aortic Guidelines, if not previously known or a change, a follow-up echocardiogram is suggested in ___ year; if previously known and stable, a follow-up echocardiogram is suggested in ___ years. CXR (___): Moderate left pleural effusion and left lower lobe atelectasis are unchanged and pre see the insertion of new left trans subclavian right atrial ventricular pacer leads, continuous from the left pectoral generator. Thereis no pneumothorax or mediastinal widening. Right lung is clear. CXR (___): No unfavorable change, stable appearance of the pacer leads and moderate left effusion. ___ 5:18 am MRSA SCREEN Source: Nasal swab. **FINAL REPORT ___ MRSA SCREEN (Final ___: No MRSA isolated. ___ 5:18 am SEROLOGY/BLOOD Source: Venipuncture. **FINAL REPORT ___ LYME SEROLOGY (Final ___: NO ANTIBODY TO B. BURGDORFERI DETECTED BY EIA. Reference Range: No antibody detected. Negative results do not rule out B. burgdorferi infection. Patients in early stages of infection or on antibiotic therapy may not produce detectable levels of antibody. Patients with clinical history and/or symptoms suggestive of lyme disease should be retested in ___ weeks. =============== DISCHARGE LABS: =============== ___ 05:40AM BLOOD WBC-8.0 RBC-3.37* Hgb-11.9* Hct-34.4* MCV-102* MCH-35.3* MCHC-34.6 RDW-14.2 RDWSD-54.0* Plt ___ ___ 05:40AM BLOOD Plt ___ ___ 05:40AM BLOOD Glucose-107* UreaN-17 Creat-0.8 Na-132* K-3.9 Cl-97 HCO3-25 AnGap-14 ___ 05:40AM BLOOD Calcium-8.3* Phos-3.5 Mg-1.8 Brief Hospital Course: Mr. ___ is a ___ y/o man with a PMH of HTN and hemochromatosis complicated by decompensated cirrhosis (ascites), who presented with a one week history of lightheadedness and dizziness without chest pain and syncope, found to be in complete heart block. ACUTE ISSUES: ============= # Complete heart block: Patient presented with a history of lightheadedness over the past week prior to presentation. Denied worsening of symptoms with exertion. The patient was without chest pain, orthopnea, PND, or oxygen requirement to suggest heart failure, and was hemodynamically stable. The patient was found to be in complete heart block; Lyme serologies were negative and electrophysiology was consulted, with recommendation for permanent pacemaker. A permanent dual chamber pacemaker was successfully placed on ___. The patient received 3 doses of IV Vancomycin as ___ prophylaxis, without complications. Follow-up with electrophysiology was arranged at the time of discharge. # Severe aortic stenosis. The patient has a history of aortic stenosis, for which he states that he has not had cardiology workup for in the past. He was discharged with instructions to follow-up with both electrophysiology and cardiology for further evaluation and monitoring on an outpatient basis. He will be called with an appointment date and time for cardiology follow-up. # Urinary difficulty: The patient reported difficulty urinating after Foley catheter was removed. He was prescribed tamsulosin 0.4mg qhs with improvement in symptoms. He was given a prescription to continue on tamsulosin for concern of BPH, which can be addressed during his follow-up appointment with his primary care physician. #Hypertension: The patient had a history of hypertension, and presented to the hospital taking both atenolol and spironolactone. He was restarted on spironolactone while admitted, but beta-blocker was held at the time of discharge. CHRONIC ISSUES # Cirrhosis. In the setting of known hemochromatosis. No ascites or stigmata of cirrhosis on examination. The patient continued on his home doses of diuretics, without worsening LFTs. # Gout: Continued home-dose allopurinol ___ mg daily. # B12 deficiency: Continued home-dose cyanocobalamin 50 mcg daily. TRANSITIONAL ISSUES: ==================== - The patient has a mildly dilated ascending aorta. Based on ___ ACCF/AHA Thoracic Aortic Guidelines, if not previously known or a change, a follow-up echocardiogram is suggested in ___ year; if previously known and stable, a follow-up echocardiogram is suggested in ___ years. - Re-assess need for tamsulosin at the time of follow-up; patient had urinary retention after discontinuing Foley catheter during hospitalization - Patient completed 3-day course of ___ Vancomycin prior to discharge - discontinued home atenolol on discharge # Code Status: FULL # Emergency Contact: Cousin ___ (___) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Spironolactone 25 mg PO DAILY 2. Atenolol 50 mg PO DAILY 3. Allopurinol ___ mg PO DAILY 4. Furosemide 40 mg PO DAILY 5. Cyanocobalamin 50 mcg PO DAILY Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Cyanocobalamin 50 mcg PO DAILY 3. Furosemide 40 mg PO DAILY 4. Spironolactone 25 mg PO DAILY 5. Tamsulosin 0.4 mg PO QHS Your primary care physician ___ determine if you need to continue to take this medication RX *tamsulosin 0.4 mg 1 capsule(s) by mouth at bedtime Disp #*30 Capsule Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary Diagnosis: Bradycardia Complete Heart Block Secondary Diagnosis: Aortic Stenosis, Severe Hypertension Cirrhosis Gout Vitamin B12 Deficiency Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure providing care for you at ___ ___. You were admitted to the hospital for lightheadedness which was caused by a slow heart rate. Testing showed that your heart's electrical activity wasn't as good as it should be, and you needed a pacemaker as a result. The pacemaker was placed on ___, which you tolerated well. Your heart rate improved after you received your pacemaker. You had some difficulty urinating at first, for which you were started on a medication called tamsulosin. Your primary care doctor ___ determine whether you need to stay on this medication long-term or not. It is important that you take all of your medications as prescribed, and that you attend all of your follow-up appointments as scheduled. We wish you the best of health, Your cardiology team at ___ Followup Instructions: ___
19977310-DS-17
19,977,310
22,535,910
DS
17
2152-01-22 00:00:00
2152-01-22 13:47:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Catapres Attending: ___. Chief Complaint: fever Major Surgical or Invasive Procedure: Hemodialysis Blood transfusion Tunnelled dialysis line removal History of Present Illness: ___ year old male with ESRD recently started on HD, hypertension, hyperlipidemia presented from HD with rigors. . Pt in USOH at home and through his HD session yesterday until the end, when he spiked a fever to 101.8 and rigors. Blood cultures were obtained and he was sent to the ED. This morning, he denies cough/SOB/rhinorrhea, abdominal pain, diarrhea, neck stiffness, dysuria or urinary frequency but reports "stinky, concentrated urine" and intermittent sharp pain at HD line site. . In the ED, initial VS T 100.5, HR- 97, BP- 147/91, RR- 24, SaO2- 100% 2L NC. Another set of blood cultures were drawn and he was given vancomycin, gentamicin and tylenol. Renal fellow alerted, and the patient was admitted for further work-up. . On arrival to the floor, vital signs were Temp 100.1 F, BP 173/78, HR 92, R 18, O2-sat 93% RA. The patient was asymptomatic and comfortable. He confirmed the above story this morning, again reporting no symptoms beyond some line site tenderness and purulent urine. Renal fellow examined his RIJ tunnelled line and reported that it appears infected, request ___ line removal and temporary line placement Past Medical History: ESRD -diabetic nephropathy -hypertensive nephrosclerosis -started HD ___ ___ Hypertension Hyperlipidemia COPD Diabetes mellitus, on insulin Gastroesophageal reflux disease Anemia Hernia repair Osteoarthritis s/p right knee replacement Dishydrotic eczema Social History: ___ Family History: Multiple family members with diabetes and hypertension. Physical Exam: ADMISSION VS - T 100.1 F, BP 173/78, HR 92, R 18, O2-sat 93% RA GENERAL - Alert, interactive, well-appearing in NAD HEENT - EOMI, sclerae anicteric, MMM, OP clear NECK - Supple, no JVD. HD line in place R chest, minimally tender, dressing c/d/i (purulence and erythema per Renal fellow eval) HEART - PMI non-displaced, RRR, nl S1-S2, no MRG LUNGS - CTAB, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use ABDOMEN - Obese, NABS, soft/NT/ND, no masses or HSM EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses SKIN - no open ulcers noted on lower extremities LYMPH - no cervical LAD NEURO - awake, A&Ox3 . DISCHARGE VS T 98.2 152/77 78 18 100/RA ___ 107 ___ low 34/24h) GENERAL - Alert, interactive, well-appearing, walking around slowly in NAD HEENT - EOMI, sclerae anicteric, MMM, OP clear NECK - Supple, no JVD. HD line site nontender, no erythema, dressing c/d/i HEART - PMI non-displaced, RRR, nl S1-S2, II-III/VI holosystolic murmur throughout precordium, best LUSB LUNGS - CTAB, no r/rh/wh, good air movement, resp unlabored ABDOMEN - Obese, NABS, soft/NT/ND, no masses EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses SKIN - dry; desquamating plaques across dorsal hands LYMPH - no cervical LAD NEURO - awake, A&Ox3, gait slow but narrow-based and stable without assistance Pertinent Results: ADMISSION LABS ___ 08:15PM WBC-9.0 RBC-3.21* HGB-8.5* HCT-25.8* MCV-80* MCH-26.4* MCHC-32.8 RDW-18.2* ___ 08:15PM NEUTS-81.1* LYMPHS-8.0* MONOS-3.6 EOS-7.1* BASOS-0.2 ___ 08:15PM PLT COUNT-188 ___ 08:15PM GLUCOSE-45* UREA N-34* CREAT-5.1*# SODIUM-140 POTASSIUM-4.1 CHLORIDE-100 TOTAL CO2-30 ANION GAP-14 ___ 08:23PM LACTATE-1.4 . DISCHARGE LABS ___ 07:50AM BLOOD WBC-9.6 RBC-3.38* Hgb-8.9* Hct-27.0* MCV-80* MCH-26.2* MCHC-32.9 RDW-18.5* Plt ___ ___ 07:50AM BLOOD Glucose-97 UreaN-34* Creat-5.5*# Na-135 K-4.5 Cl-97 HCO3-30 AnGap-13 ___ 07:50AM BLOOD Calcium-8.9 Phos-3.5 Mg-2.1 ___ 01:53AM URINE Color-Yellow Appear-Clear Sp ___ ___ 01:53AM URINE Blood-SM Nitrite-NEG Protein-300 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-TR ___ 01:53AM URINE RBC-1 WBC-8* Bacteri-FEW Yeast-NONE Epi-<1 TransE-<1 ___ 01:53AM URINE CastHy-3* . MICRO . ___ BLOOD CULTURE - NEGATIVE (FINAL) ___ URINE CULTURE - NEGATIVE (FINAL) ___ BLOOD CULTURE - NGTD ___ BLOOD CULTURE - NGTD ___ 6:20 pm SWAB CVC EXIT SITE. **FINAL REPORT ___ GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. WOUND CULTURE (Final ___: STAPH AUREUS COAG +. SPARSE GROWTH. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ STAPH AUREUS COAG + | CLINDAMYCIN-----------<=0.25 S ERYTHROMYCIN----------<=0.25 S GENTAMICIN------------ <=0.5 S LEVOFLOXACIN----------<=0.12 S OXACILLIN-------------<=0.25 S TRIMETHOPRIM/SULFA---- <=0.5 S . IMAGING . ___ CXR FINDINGS: PA and lateral views of the chest were obtained. A right IJ dialysis catheter is seen with its tip in the expected location of the cavoatrial junction. There is mild pulmonary venous congestion with probable mild pulmonary edema. No large pleural effusions are seen. In the presence of pulmonary edema the possibility of a superimposed mild/early pneumonia is impossible to exclude, though none is clearly seen. No pneumothorax. Heart size is top normal though stable. Aortic calcifications are noted. Bony structures appear intact though there are degenerative spurs along the mid thoracic spine. IMPRESSION: Mild pulmonary edema without definite signs of pneumonia though post-diuresis films may be obtained to further assess if clinically warranted. . ___ TTE Conclusions The left atrium is mildly dilated. The estimated right atrial pressure is ___ mmHg. There is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>55%). Tissue Doppler imaging suggests an increased left ventricular filling pressure (PCWP>18mmHg). Right ventricular chamber size and free wall motion are normal. The aortic root is mildly dilated at the sinus level. The ascending aorta is moderately dilated. The aortic arch is mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No masses or vegetations are seen on the aortic valve. Trace aortic regurgitation is seen. The mitral valve appears structurally normal with trivial mitral regurgitation. There is no mitral valve prolapse. No mass or vegetation is seen on the mitral valve. The pulmonary artery systolic pressure could not be determined. There is a very small pericardial effusion. IMPRESSION: Aortic valve sclerosis. Mild symmetric left ventricular hypertrophy with preserved global and regional biventricular systolic function. Trace aortic regurgitation. Dilated thoracic aorta. Increased PCWP. No discrete vegetation identified. CLINICAL IMPLICATIONS: The patient has a moderately dilated ascending aorta. Based on ___ ACCF/AHA Thoracic Aortic Guidelines, if not previously known or a change, a follow-up echocardiogram is suggested in 6 months; if previously known and stable, a follow-up echocardiogram is suggested in ___ year. Based on ___ AHA endocarditis prophylaxis recommendations, the echo findings indicate prophylaxis is NOT recommended. Clinical decisions regarding the need for prophylaxis should be based on clinical and echocardiographic data. Brief Hospital Course: ___ with ESRD presents from HD w/rigors and fever, found to have infected-appearing HD line site; symptoms resolved with IV antibiotics qHD. . 1. MSSA HD Line infection Patient presented with fever and rigors. Line site appeared infected, was pulled. Patient initially received vancomycin (___), then cefazolin (___) after entry site swab and catheter tip both grew MSSA. Blood cultures all negative or NGTD at time of discharge (note: two sets drawn on ___ were drawn at HD and in ED, before initiating vancomycin in the ED). Patient afebrile and without rigors within 12h of line pull. Possible new systolic murmur auscultated on exam and not previously documented, but no evidence of vegetations on TTE. Discharged w/plan for 2 weeks cefazolin qHD (___ alerted by Renal fellow). . 2. CKD/HD access Stage V ESRD, recently initiated on HD (started on ___. Some access difficulties with fistula at ___ since last discharge led patient to have additional RIJ tunnelled line placed at ___ outpatient center (this is the line that was affected, above). Renal and transplant teams assessed his fistula and felt it was sufficiently mature & ready for dialysis; HD nurses found access to be positional but possible and were able to access it using a smaller gauge needle during 3 HD sessions here. . 3. Hypertension Some elevated BPs to the 160s-180s here; his qHD labetolol and amlodipine were increased in frequency to QD, with better BP control. . 4. DM Longstanding DM2, on long-acting + sliding-scale insulin at home. Reports recent difficulty with early AM symptomatic hypoglycemia. Home regimen of 75U lantus qAM was decreased to 40U qAM here - even with this dose reduction he experienced symptomatic hypoglycemia to the ___ here (responded to juice). Discharged on 40U w/instructructions to log ___ use at home for discussion at PCP ___ appt next week. . 5. Hyperlipidemia Continued home simvastatin. . 6. COPD Patient was breathing comfortably on room air. Noted to be no longer smoking. . 7. Chronic low back pain Patient on oxycodone PRN at home but reports he minimizes use because it clouds his thinking. Honored patient request to hold oxycodone here; pain control w/tylenol PRN was sufficient. . 8 Dishydrotic eczema Continued home regimen (confirmed in most recent dermatology note): clobetasol 0.05% ointment BID + aquaphor w/gloves to hands qHS. . TRANSITIONAL ISSUES 1. Follow-up fingerstick/blood sugar log, adjust insulin scale PRN. 2. Address chronic back pain medication needs/side effects. 3. Check-in re: any ongoing difficulties w/HD access at outpatient HD center. 4. BP check (losartan/amlodipine now QD). Medications on Admission: 1. sevelamer carbonate 800 mg Tablet Sig: Three (3) Tablet PO TID W/MEALS (3 TIMES A DAY WITH MEALS). 2. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily): please take after dialysis on the days that you have dialysis. 3. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap PO DAILY (Daily). 4. losartan 50 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily): Please take after dialysis on the days that you have dialysis. 5. aspirin 325 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO DAILY (Daily). 6. clobetasol 0.05 % Ointment Sig: One (1) Appl Topical BID (2 times a day): Apply to hands and forearms twice a day for two weeks per month maximum. Do not apply elsewhere. 7. hydrocortisone valerate 0.2 % Cream Sig: One (1) Appl Topical BID (2 times a day) as needed for itchy skin: apply to itchy skin on groin twice daily for two weeks per month maximum. Do not apply elsewhere. (STOPPED ALREADY AS OUTPATIENT AT LAST DERM APPT) 8. halobetasol propionate 0.05 % Ointment Sig: One (1) application Topical twice a day: Apply to back of hands twice a day. Avoid use on face, armpits, and groin. (STOPPED ALREADY AS OUTPATIENT AT LAST DERM APPT) 9. oxycodone 5 mg Capsule Sig: ___ Capsules PO every six (6) hours as needed for CHRONIC LOW BACK pain. (PATIENT WEANED SELF OFF RECENTLY) 10. simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day. 11. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO twice a day. 12. NPH insulin human recomb 100 unit/mL Suspension Sig: Seventy Five (75) units Subcutaneous once a day: Please take in the morning. Discharge Medications: 1. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). Disp:*60 Tablet(s)* Refills:*2* 2. sevelamer carbonate 800 mg Tablet Sig: Three (3) Tablet PO TID W/MEALS (3 TIMES A DAY WITH MEALS). 3. losartan 50 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). Disp:*60 Tablet(s)* Refills:*2* 4. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap PO DAILY (Daily). 5. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 7. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 8. NPH insulin human recomb 100 unit/mL Suspension Sig: AS DIRECTED Subcutaneous once a day: please continue your home insulin regimen unchanged. 9. cefazolin 10 gram Recon Soln Sig: One (1) Recon Soln Injection HD PROTOCOL (HD Protochol). 10. acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for pain. Disp:*100 Tablet(s)* Refills:*0* 11. camphor-menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical QID (4 times a day) as needed for itching. Disp:*1 bottle* Refills:*0* 12. clobetasol 0.05 % Ointment Sig: One (1) application Topical twice a day: apply to hands and forearms twice a day for two weeks per month maximum. Do not apply elsewhere. 13. Aquaphor Ointment Sig: One (1) application Topical once a day: apply to hands under cotton gloves at least once daily, especially after bathing. Disp:*1 100 cc tube or closest equivalent* Refills:*2* Discharge Disposition: Home Discharge Diagnosis: Dialysis line infection Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure to care for you at ___. You were admitted to the hospital with fever and rigors. We found you had an infection of your dialysis line. We started you on antibiotics and pulled the line. Your symptoms resolved within 24 hours. We are able to perform dialysis here through your fistula, so no additional line was needed. We kept you in the hospital for more intravenous antibiotics and to perform an echocardiogram (ultrasound of your heart) because we heard a new heart murmur. The echo showed no evidence of bacteria on the heart valve, which is good. We made the following changes to your medications: 1. STARTED CEFAZOLIN - YOU WILL RECEIVE ___ GRAMS AT EACH DIALYSIS SESSION FOR TWO WEEKS 2. INCREASED AMLODIPINE TO *EVERY DAY* 3. INCREASED LOSARTAN TO *EVERY DAY* 4. STOPPED OXYCODONE (YOU HAD ALREADY WEANED YOURSELF OFF AT HOME) . Please review the attached medication list with Dr. ___ at your next appointment. Followup Instructions: ___
19978119-DS-15
19,978,119
20,178,379
DS
15
2189-04-28 00:00:00
2189-04-29 20:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: amiodarone / gemcitabine / Abraxane Attending: ___. Chief Complaint: lethargy Major Surgical or Invasive Procedure: none History of Present Illness: ___ with hx of CAD s/p PCI (___), metastatic pancreatic cancer s/p ___ on FOLFOX, Afib on enoxaparin, chronic urinary retention, and current C Diff colitis on fidaxomicin who p/w lethargy and hypotension c/f infection found to have elevated troponins and pancolitis. Of note, the patient was recently admitted from ___ for E.coli bacteremia s/p ceftriaxone and urinary Retention/bilateral hydronephrosis, for which he was discharged with a foley. He is currently receiving fidaxomicin for C.diff colitis. At rehab on ___, the patient had increasing lethargy. At the OSH he has soft pressures to the systolics ___. Labs showed leukocytosis to 22, Trop I 1.5, creatinine 2.2 (baseline 1.0), positive UA. CXR showed infiltrate vs. atelectasis. He received Flagyl, 3+ L crystalloid. He was then transferred to ___. In the ED, initial vitals: 97.9 72 108/68 16 97% RA. - Labs were significant for Lactate: 1.4, Trop-T: 0.76, CK: 63 MB: 2, Cr 1.8, Na 128, Wbc 22.2 (N:88.0 L:3.0 M:6.7 E:0.8 Bas:0.2), UA with rare bacteria. - EKG w/o ischemic changes - CXR showed patchy opacities in lung bases c/w atelectasis but cannot exclude infection. - CT abd/pelvis showed diffuse pancolitis most severely affecting the descending and rectosigmoid colon, most consistent with ischemia. It also showed new splenic hypodensity c/w infarct and stable metastases. - Pt received IVF 1000 mL, IV CefePIME 2 g, IV Vancomycin 1000 mg and was started on IV Norepinephrine - Cardiology consulted and thought his high troponin was a trop leak due to hypoperfusion/demand ischemia. Recommended to trend cardiac enzymes; no indication for heparin gtt. - Surgery consulted, and recommended nothing to do. On arrival to the MICU, patient is significantly lethargic but no acute distress. He was somewhat confused, but ultimately oriented x3. He initially reported some lower abdominal pain but then denied. He also denied shortness of breath or chest pain. Past Medical History: PAST ONCOLOGIC HISTORY: Reconciled in OMR. Pancreatic cancer stage IIB (T3N1M0) now with progressive metastatic disease - ___ Admitted to the ___ with 2-week history of gradual onset of generalized malaise, dark urine, acoholic stools, and eventual painless jaundice. Found to have obstructive LFTS (AST 211, ALT 215, AP 741, TB 26.7) and subsequent US/CT showed moderate intrahepatic and extrahepatic biliary ductal dilatation to the level of the pancreatic head without overt mass seen (lack of IV contrast). US showed, "Moderate intrahepatic and extrahepatic biliary ductal dilatation to the level of the pancreatic head. The CBD measures 17 mm at the hilum. Limited evaluation of the pancreas does not demonstrate any pancreatic head mass. Cholelithiasis without evidence of acute cholecystitis. Borderline splenomegaly." Follow up CT showed, "Dilated intrahepatic and extrahepatic bile ducts. No obvious mass but evaluation is limited without contrast. Markedly dilated urinary bladder with mild left hydroureteronephrosis and distal right ureter dilatation possibly from obstructive uropathy. No calculus. There is an enlarged prostate gland with a suspected TURP defect." - ___ ERCP for stent placement, brushings negative for malignancy. He was discharged on ___. - ___ Seen by his PCP who arranged for EUS at ___. TB down to 3.8 at that point with improved symptoms. - ___ EUS performed by Dr. ___ showed, "No celiac adenopathy was seen. Reactive gastrohepatic ligament adenopathy seen. Two SB-IPMNs noted; one in the body and the larger one in the head. A solid mass was seen surrounding the distal CBD, measuring 1.2 cm. The CBD was dilated proximal to the mass up to 1.2 cm in size. A small, suspicious-appearing lymph node was seen around the distal CBD. FNA performed, prelim results show neoplastic ___ final pathology positive for malignant cells, CONSISTENT WITH ADENOCARCINOMA. - ___ ___ resection revealed pancreatic adenocarcinoma pT3N1 with 1 of 14 nodes involved with carcinoma, LVI negative, extensive perineural invasion present, margins clear by 2 mm at the SMV. - ___ Signed consent for APACT Trial ___ ___ - ___ CT torso showed celiac adenopathy and a possible new liver met - ___ MR liver showed likely liver met and adenopathy - ___ Began discussion of HALO trial - ___ FNA of the liver lesion via EUS showed metastatic adenocarcinoma - ___ Signed consent for HALO, randomized to control arm - ___ C1D1 gemcitabine 1000 mg/m2 Abraxane 125 mg/m2 D1,8,15 - ___ C2D1 gemcitabine 1000 mg/m2 Abraxane 125 mg/m2 D1,8,15 - ___ CT torso showed response to therapy - ___ C3D1 gemcitabine 1000 mg/m2 Abraxane 125 mg/m2 D1,8,15 - ___ C4D1 gemcitabine 1000 mg/m2 Abraxane 125 mg/m2 D1,8,15 - ___ CT torso showed further reduction in liver mets, new pneumomitis - ___ Holding chemo for pneumonitis. Start steroids. Off study ___ ___ control arm of the HALO trial. - ___ Much improved on steroids. - ___ CT torso showed progression of liver mets and development of numerous new liver mets as well as progression of portal adenopathy. - ___ C1D1 FOLFOX6 - ___ C2D1 FOLFOX6 - ___ CT torso showed progression of known disease and some increased pulmonary nodules. Rising tumor markers. - ___ C3D1 FOLFOX6 - ___ C3D15 dose of FOLFOX held for admission to OSH for MI - ___ CT torso showed stable lung nodules and enlargement of multiple hepatic metastatic lesions and the local recurrence in the tumor bed. - PLANNED ___ Resume chemotherapy with C4D1 FOLFOX6 PAST MEDICAL HISTORY: - Metastatic Pancreatic Cancer - CAD s/p PCI (___) - pAFib ___, converted to sinus spontaneously) - HTN - HLD - Obstructive Uropathy with BPH - followed by Dr. ___ ___ - ___ (baseline Cr 1.5) - Agent Orange exposure during ___ - Biceps tendon rupture - Cataracts PSH: - Whipple (___) - TURP - Left inguinal hernia repair (___) - Cholecystectomy - Bicept tendon repair - b/l cataract surgery Social History: ___ Family History: 1. Mother died of a ruptured abdominal aortic aneurysm. 2. Father was healthy until his ___. 3. Son died young of coronary artery disease. 4. No family history of malignancies that he is aware of. Physical Exam: ADMISSION: Vitals: T:97.2 BP: 101/48 P: 101 R: 18 O2: GENERAL: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear NECK: supple, JVP not elevated, no LAD LUNGS: Clear to auscultation bilaterally, faint bibasilar crackles, but no significant wheezes, rales, rhonchi CV: irreg irreg, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-tender, non-distended, hypoactive bowel sounds, no rebound tenderness or guarding, no organomegaly. EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema SKIN: no rashes or other lesions. port in place. NEURO: no facial droop, moving extremities, but unable to participate in formal neurologic exam. DISCHARGE: Physical Exam Vitals- Resting comfortable not febrile to touch, no tachypnea General- NAD HEENT- Anicteric sclera, dry MM Pertinent Results: ADMISSION/IMPORTANT LABS: ========================= ___ 05:33AM BLOOD WBC-27.1* RBC-3.80* Hgb-11.2* Hct-33.9* MCV-89 MCH-29.5 MCHC-33.0 RDW-15.7* RDWSD-50.9* Plt ___ ___ 04:50AM BLOOD WBC-20.8* RBC-3.42* Hgb-10.0* Hct-29.9* MCV-87 MCH-29.2 MCHC-33.4 RDW-15.6* RDWSD-49.5* Plt ___ ___ 09:10PM BLOOD Neuts-88.0* Lymphs-3.0* Monos-6.7 Eos-0.8* Baso-0.2 Im ___ AbsNeut-19.57*# AbsLymp-0.66* AbsMono-1.48* AbsEos-0.18 AbsBaso-0.04 ___ 09:10PM BLOOD Glucose-104* UreaN-58* Creat-1.8* Na-128* K-3.8 Cl-97 HCO3-17* AnGap-18 ___ 09:10PM BLOOD ALT-27 AST-44* CK(CPK)-63 AlkPhos-321* TotBili-0.4 ___ 09:10PM BLOOD cTropnT-0.76* ___ 05:33AM BLOOD cTropnT-0.81* ___ 02:58PM BLOOD cTropnT-0.71* ___ 08:13AM BLOOD Lactate-1.4 LABS AT DISCHARGE: ================= ___ 05:51AM BLOOD WBC-13.6* RBC-3.33* Hgb-9.7* Hct-30.8* MCV-93 MCH-29.1 MCHC-31.5* RDW-18.3* RDWSD-58.7* Plt ___ ___ 05:51AM BLOOD Glucose-87 UreaN-21* Creat-0.9 Na-144 K-3.1* Cl-120* HCO3-18* AnGap-9 ___ 05:51AM BLOOD ALT-30 AST-95* AlkPhos-526* TotBili-0.5 MICROBIOLOGY: ============= C. difficile DNA amplification assay (Final ___: Reported to and read back by ___ AT 10:49 AM ___. CLOSTRIDIUM DIFFICILE. Positive for toxigenic C. difficile by the Illumigene DNA amplification. (Reference Range-Negative). URINE CULTURE (Final ___: NO GROWTH. IMAGING: ======= CT Abdomen/Pelvis w/o contrast ___. Diffuse pancolitis, most severely affecting the descending and rectosigmoid colon. Given the degree of wall thickening and fat stranding surrounding the distal colon, although nonspecific and limited in the absence of IV contrast, there is high concern for ischemia given this appearance. No portal venous gas or pneumatosis identified. 2. Small amount of ascites is primarily perihepatic and perisplenic. 3. New apparent wedge-shaped hypodensity in the spleen is nonspecific, possibly infarction, less likely metastasis. 4. Stable severe thoracolumbar spine degenerative change. 5. Stable multifocal hepatic hypodensities consistent with known metastatic prostate cancer. 6. Trace pericardial and bilateral layering pleural effusions. CXR ___ Limited study as result of low lung volumes. Patchy opacities in the lung bases may reflect atelectasis but infection or aspiration cannot be excluded in the correct clinical setting. CT ABD/PELVIS ___ 1. Splenic infarcts. 2. Numerous hypodense masses in the liver are consistent with history of metastatic pancreatic cancer. 3. Thrombus within the main portal vein and left portal vein branches. 4. Colonic wall thickening consistent with colitis is persistent but improved compared to ___. 5. Small to moderate amount of nonhemorrhagic ascites is slightly increased KUB ___ Comparison to ___. Three views of the abdomen are provided. Clips are projecting over the middle abdomen. Mild colonic distension at the level of the transverse and the descending colon. Colonic air-fluid levels are visualized on the cross-table view. No evidence of free intra-abdominal air. Several phleboliths projecting over the pelvis. ECHO ___ The left atrial volume index is normal. No atrial septal defect is seen by 2D or color Doppler. Normal left ventricular wall thickness, cavity size, and regional/global systolic function (biplane LVEF = 58 %). Right ventricular chamber size and free wall motion are normal. The aortic root is mildly dilated. The aortic valve leaflets are mildly thickened (?#). There is no aortic valve stenosis. Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are structurally normal. Mild (1+) mitral regurgitation is seen. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. IMPRESSION: Suboptimal image quality. Normal biventricular cavity sizes with preserved regional and global biventricular systolic function. Mild aortic regurgitation. Mild mitral regurgitation. Compared with the prior study (images reviewed) of ___, the severity of aortic regurgitation and mitral regurgitation are slighlty increased. Left ventricular regional and global systolic function are similar. The ventricular rate is now higher with frequent extrasystoles. LEFT UE US ___ There is normal flow with respiratory variation in the left subclavian vein. The left internal jugular and axillary veins are patent, show normal color flow and compressibility. The left brachial, basilic, and cephalic veins are patent, compressible and show normal color flow and augmentation. IMPRESSION: No evidence of deep vein thrombosis in the left upper extremity. Brief Hospital Course: PLEASE ADMIT TO INPATIENT HOSPICE BRIEF HOSPITAL COURSE ===================== Mr. ___ is a ___ with hx of CAD s/p PCI (___), metastatic pancreatic cancer s/p Whipple (___) on FOLFOX, Afib on enoxaparin, chronic urinary retention, who presented with severe C Diff colitis on fidaxomicin and troponemia. #GOC: Patient has poor prognosis and is extremely weak given c-diff and metastatic pancreatic cancer. One month ago patient was quite functional and had actually driven himself to his oncology appointments. He has declined quite rapidly and is now unable to move his limbs against gravity. Since patient's mental status did not allow for a goals of care discussion, an in depth discussion was held with HCP, and decision was made to change care to comfort based care. Receiving comfort focused medications only. Other medical issues before transition to comfort based care: # Shock: Patient with hypotension and evidence of end-organ dysfunction with lethargy and ___. Given leukocytosis, thought to be septic shock. Although patient had positive troponin, he was without chest pain or significant changes on ECG. Thus, troponinemia is likely a type II demand event. Initial suspected sources of infection included C.diff given pancolitis and reported history (although C.diff negative on last admission) as well as potential PNA based on CXR findings. However, he denied any respiratory symptoms. Initially, patient was treated with broad spectrum antibiotics to cover both colitis and pneumonia with IV vanc, cefepime, flagyl, and PO vanc. C.diff was sent and returned positive. IV vanc, cefepime was discontinued. He remained on PO vanc and IV flagyl for treatment of severe C.diff until transfer to the floor. He was weaned off pressors and his leukocytosis was downtrending at the time of discharge from the ICU. #Severe C-diff colitis: As above he was transferred to the floor on both IV flagyl and high dose vancomycin. He was evaluated by speech and swallow who recommended initially that he be made NPO due to aspiration. He progressed to pureed solids and nectar thick liquids but had not progressed to meet his nutritional needs sufficiently. During that time he was started on tube feeds and the rate was gradual increased without residuals or worsening of his colitis symptoms. Was initially evaluated by surgery but no intervention with improvement in symptoms. His leukocytosis remained somewhat stable. Patient did not improve but remained stable. On ___ antibiotics were discontinued and tubefeeds were stopped per above goals of care discussion. # NSTEMI: Per cardiology, likely type 2 NSTEMI given absence of symptoms and no EKG changes. Had not been on beta blocker at home, therefore after troponins trended down and blood pressures improved patient was started on metoprolol tartrate 12.5 BID. He had been on an aspirin 81 every other day at home. Aspirin was restarted daily. Patient already anticoagulated with enoxaparin, however, this was held in setting ___ and concern for possible need for surgical intervention. It was restarted shortly thereafter without issue. Continued atorvastatin. All cardiac medications were discontinued as per above goals of care. # Acute on chronic renal injury: Likely prerenal given hypotension/sepsis. Creatinine initially 2.1 but downtrended appropriately in response to fluid resuscitation and resolution of hypotension. Cr prior to discharge was 0.9 # Hyponatremia: RESOLVED Likely hypovolemic. Patient asymptomatic. Na improved after fluids. # Metabolic acidosis: Lactate WNL. Non anion gab acidosis Likely due to diarrhea, as patient is noted to have chronic diarrhea since ___. Urine electrolytes with a pH of 6 and no AG in conjunction with patient normal potassium make RTA unlikely. # Afib on enoxaparin: Rate controlled throughout, on lovenox for anti-coagulation as previously decided by cardiologist given hx of metastatic pancreatic cancer. # Metastatic pancreatic cancer: Chemotherapy with FOLFOX from oncologist, Dr. ___. No chemotherapy given on this admission. Dr. ___ met with patient and family and communicated extremely poor prognosis, and that patient was not candidate for any chemo given poor functional status. # Urinary retention: continued indwelling foley which patient had on transfer from rehab to ___. Attempted voiding trial with high post void residuals. foley placed back. No UTI. # Depression: continued citalopram # GERD: Discontinued omeprazole in light of increasing risk of C-diff recurrence, changed to famotidine. TRANSITIONAL ISSUES =================== -Consider completely liberalizing diet, patient likely aspirating even on nectar thick liquids. -#DNR/DNI -#CONTACT GRANDSON ___ ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 40 mg PO QPM 2. Citalopram 20 mg PO DAILY 3. Enoxaparin Sodium 120 mg SC DAILY Start: ___, First Dose: Next Routine Administration Time 4. Gabapentin 400 mg PO BID:PRN shingles 5. Lidocaine 5% Patch 1 PTCH TD QAM 6. LOPERamide ___ mg PO QID:PRN diarreha 7. Omeprazole 40 mg PO DAILY 8. Ondansetron 8 mg PO Q8H:PRN nausea 9. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain 10. lidocaine HCl 3 % topical TID:PRN pain 11. Prochlorperazine 10 mg PO Q6H:PRN nausea 12. CeftriaXONE 2 gm IV Q 24H 13. Sarna Lotion 1 Appl TP TID:PRN pruritis 14. Tamsulosin 0.4 mg PO QHS 15. Creon 12 3 CAP PO TID W/MEALS 16. Acetaminophen 325 mg PO Q6H:PRN pain 17. Dificid (fidaxomicin) 200 mg oral Q12H 18. Oyster Shell Calcium (calcium carbonate) 500 mg calcium (1,250 mg) oral BID 19. Ibuprofen 400 mg PO BID:PRN pain 20. Ferrous Sulfate 325 mg PO DAILY Discharge Medications: 1. Citalopram 20 mg PO DAILY 2. Lidocaine 5% Patch 1 PTCH TD QAM 3. lidocaine HCl 3 % topical TID:PRN pain 4. Ondansetron 8 mg PO Q8H:PRN nausea 5. Prochlorperazine 10 mg PO Q6H:PRN nausea 6. Sarna Lotion 1 Appl TP TID:PRN pruritis 7. Miconazole Powder 2% 1 Appl TP BID groin 8. Acetaminophen 325 mg PO Q6H:PRN pain 9. Glycopyrrolate 0.1 mg IV Q6H:PRN excess secretions 10. LORazepam 0.5-2 mg IV Q2H:PRN anxiety/distress 11. Morphine Sulfate ___ mg IV Q15MIN:PRN Pain or respiratory distress 12. Ondansetron ___ mg IV Q6H:PRN nausea/vomiting Discharge Disposition: Extended Care Facility: ___. Discharge Diagnosis: Primary: Septic Shock Severe C-diff Colitis Aspiration Secondary: chronic systolic heart failure HTN HLD ___ Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, You were admitted to ___ after being found to have low blood pressures because of a severe c-diff. We gave you special medication to support your blood pressures and treated your c-diff with antibiotics. As your c-diff improved we were able to wean off the blood pressure medications. You had a swallow assessment which showed that your swallowing muscles were weak and so we started you on tube feeds to support your nutrition. After discussion with you and your HCP it was decided not to continue to pursue treatment and your care became focused on comfort only. All of your non-comfort medications were discontinued and you were discharged to hospice. Sincerely, Your ___ Care Team Followup Instructions: ___
19978265-DS-21
19,978,265
23,713,862
DS
21
2157-05-22 00:00:00
2157-05-23 19:48:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Fall Major Surgical or Invasive Procedure: Open reduction internal fixation of left mandibular angle fracture and extraction of multiple teeth, 15, 16, 18, 5, 30, 29, and 31. History of Present Illness: ___ PMHx for alcoholism, heroin use who presents to the ED s/p fall with displaced left mandibular fracture. Of note, patient states that she has a hx of alcohol use and was planning to check into an alcohol detoxification center in the near future. However, she had 4 pints of Whiskey and stumbled off the train, and fell on the ground landing on her left mandible. She did not have LOC, denies nausea/vomiting. Patient was brought into the ED by her BF and was evaluated by OMFS. Past Medical History: Alcohol use Hepatitis C Social History: ___ Family History: non-contributory Physical Exam: Admission Physical Exam: Vitals: Stable General: AAOx3, appears stressed and threatened to leave AMA HEENT: pupils equal and reactive, EOMI intact, no midface deformities, pain with biting down, swelling of left mandible. Cardiac: WNL Respiratory: Breathing comfortably on room air, right sided chest wall tenderness Abdomen: Soft, non-tender, no rebound or guarding, prior midline laparotomy scar Skin: Scar over right lip from bar fight last week, bruise over right eye brow, prior burn. Discharge Physical Exam: Gen: Alert, sitting up in bed. HEENT: bruising around left mandible, slightly swollen. trachea midline. neck supple. Cardiac: RRR Resp: Breath sounds clear to auscultation bilaterally Abd: Soft, non-tender, non-distended Ext: Warm and dry. 2+ ___ pulses. Neuro: A&Ox3. PERRL. Follows commands, moves all extremities equal and strong. Pertinent Results: ___ 09:00AM BLOOD WBC-11.0* RBC-3.61* Hgb-11.2 Hct-36.5 MCV-101* MCH-31.0 MCHC-30.7* RDW-17.1* RDWSD-62.9* Plt ___ ___ 11:16AM BLOOD WBC-9.3 RBC-3.16* Hgb-9.7* Hct-32.2* MCV-102* MCH-30.7 MCHC-30.1* RDW-15.8* RDWSD-59.2* Plt ___ ___ 12:36PM BLOOD WBC-11.9* RBC-3.00* Hgb-9.4* Hct-30.3* MCV-101* MCH-31.3 MCHC-31.0* RDW-16.1* RDWSD-59.7* Plt ___ ___ 04:10AM BLOOD WBC-10.0 RBC-3.24* Hgb-10.1* Hct-32.6* MCV-101* MCH-31.2 MCHC-31.0* RDW-15.9* RDWSD-58.4* Plt ___ ___ 09:00AM BLOOD Glucose-113* UreaN-6 Creat-0.6 Na-135 K-4.4 Cl-100 HCO3-26 AnGap-13 ___ 04:20AM BLOOD Glucose-100 UreaN-4* Creat-0.5 Na-131* K-4.2 Cl-98 HCO3-27 AnGap-10 ___ 11:16AM BLOOD Glucose-131* UreaN-2* Creat-0.5 Na-134 K-4.0 Cl-100 HCO3-24 AnGap-14 ___ 12:36PM BLOOD Glucose-102* UreaN-4* Creat-0.4 Na-136 K-3.6 Cl-100 HCO3-26 AnGap-14 ___ 04:10AM BLOOD Glucose-105* UreaN-7 Creat-0.6 Na-144 K-3.6 Cl-107 HCO3-26 AnGap-15 ___ 09:00AM BLOOD Calcium-9.3 Phos-3.9 Mg-1.8 ___ 04:20AM BLOOD Calcium-8.8 Phos-2.9 Mg-1.8 ___ 11:16AM BLOOD Calcium-8.4 Phos-2.2* Mg-1.8 ___ 12:36PM BLOOD Calcium-7.6* Phos-3.1 Mg-1.2* ___ CT Sinus/Mandible 1. Mildly displaced left mandibular fracture. 2. Mild irregularity of the right nasal bone may indicate a fracture. 3. Multiple dental caries. Periapical lucencies right mandibular third molar. ___ CT Head 1. No acute intracranial process. 2. Mild irregularity of the right nasal bones may indicate a fracture. ___ CT C-Spine 1. Moderately limited by motion artifact. No convincing evidence for acute fracture. 2. Left mandibular fracture. ___ Lumbar Sacral Spine No fracture. ___ Chest PA/Lat No acute cardiopulmonary process. ___ CT Chest/Abdomen/Pelvis 1. No evidence of acute injury in the torso. No fractures. 2. Small filling defect in the right external iliac vein concerning for a small thrombus. 3. Status post cholecystectomy and splenectomy. 4. Hepatic steatosis. ___ Unilat lower extremity veins 1. No evidence of deep venous thrombosis in the right lower extremity veins. 2. 4.0 cm fluid collection in the right popliteal fossa, which does not definitely connect to the joint space. ___ Mandible series Left mandibular angle fracture. ___ MRV Pelvis Small nonocclusive, nonenhancing thrombus in the right external iliac vein, as seen previously. ___ Mandible Series In comparison with the study of ___, there is a fixation device about the distracted fracture in the region of the angle of the mandible on the left. ___ Unilat lower extremity vein No evidence of deep venous thrombosis in the left lower extremity veins. Brief Hospital Course: Ms. ___ is a ___ yo female admitted to the acute care trauma surgery service on ___own 4 stairs. Her past medical history is significant for alcoholism and heroin use. CT imaging showed a left mandibular fracture, a mildly displaced nasal bone, and a filling defect in the right external iliac vein. OMFS was consulted and recommended surgical repair. On ___ informed consent was obtained and she was taken to the OR for an open reduction internal fixation of left mandibular angle fracture and extraction of multiple teeth, 15, 16, 18, 5, 30, 29, and 31. She was extubated and taken to the PACU until stable then transferred to the floor for further management. On POD 1 her diet was advanced to full liquids which she tolerated well and her pain was controlled with PO pain medications. An MRV confirmed a small nonocclusive, nonenhancing thrombus in the right external iliac vein. On POD 2 vascular surgery was consulted for the thrombus and recommended lower extremity non-invasive studies which were negative for DVT. On POD 3 a heparin drip was started. On POD 4 coumadin therapy was initiated. Case management and social work were involved in the patients care plan throughout the hospitalization. Her discharge plan was complicated by her need for anticoagulation and limited insurance coverage in ___. Several options were discussed with the patient such as returning to ___ to be followed by her primary care provider. She did not want to do that at this time. The decision was made with the patient to start Xarelto therapy since she would not have frequent blood draws. She was given a 2 week supply of medication from the care plus pharmacy. She plans to go back to ___ to see her primary care provider and further discuss treatment within the month. Her primary care was made aware of the plan and agreed to assist her in obtaining continued therapy. The risks associated with her diagnosis of deep vein thrombosis and anticoagulation treatment were discussed and the patient verbalized agreement and understanding with the plan. Please see case management note for further details. At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a full liquid diet, ambulating, voiding without assistance, and pain was well controlled. The patient was discharged and reports having a safe place to stay. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Follow up appointments were made. Medications on Admission: none Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN pain Not to exceed 4,000 mg in 24 hours RX *acetaminophen 325 mg ___ tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills:*0 2. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID RX *chlorhexidine gluconate 0.12 % swish and spit twice a day Refills:*0 3. Docusate Sodium 100 mg PO BID hold for diarrhea RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*30 Capsule Refills:*0 4. Nicotine Patch 14 mg TD DAILY DO NOT smoke while wearing this patch. Only wear 1 patch at a time. RX *nicotine 14 mg/24 hour apply to skin once a day Disp #*14 Patch Refills:*0 5. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*40 Tablet Refills:*0 6. Rivaroxaban 15 mg PO BID Duration: 21 Days RX *rivaroxaban [___] 15 mg 15 tablet(s) by mouth twice a day Disp #*21 Tablet Refills:*0 7. Rivaroxaban 20 mg PO DAILY DVT Duration: 10 Weeks Please start this dose/frequency after initial 21 days therapy (on ___. RX *rivaroxaban [Xarelto] 20 mg 1 tablet(s) by mouth once a day Disp #*7 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Right external iliac DVT Mildly displaced nasal bone Left angle mandible fracture and multiple retained roots. Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to ___ on ___own stairs. Imagining revealed that you fractured several bones in your face and jaw. The oral, maxillofacial surgery team was consulted and repaired these fractures in the operating room and removed 7 teeth. You were found to have a deep vein thrombosis (blood clot) in a vein near your right hip that is partially blocking blood flow. You are being treated for this with a blood thinning medication called Coumadin. It is very important that you take this medication as prescribed and have blood levels drawn as ordered by your doctor. You are now ready to be discharged from the hospital to continue your recovery. Please note the following discharge instructions. Wound care: Do not disturb or probe the surgical area with any objects. The sutures placed in your mouth are usually the type that self dissolve. If you have any sutures on the skin of your face or neck, your surgeon will remove them on the day of your first follow up appointment. SMOKING is detrimental to healing and will cause complications. Bleeding: Intermittent bleeding or oozing overnight is normal. Placing fresh gauze over the area and biting on the gauze for ___ minutes at a time may control the bleeding. If you had nasal surgery, you may have occasional slow oozing from your nostril for the first ___ days. Bleeding should never be severe. If bleeding persists or is severe or uncontrollable, please call our office immediately. If it is after normal business hours, please come to the emergency room and request that the oral surgery resident on call be paged. ___: Normal healing after oral surgery should be as follows: the first ___ days after surgery, are generally the most uncomfortable and there is usually significant swelling. After the first week, you should be more comfortable. The remainder of your postoperative course should be gradual, steady improvement. If you do not see continued improvement, please call our office. Physical activity: It is recommended that you not perform any strenuous physical activity for a few weeks after surgery. Do not lift any heavy loads and avoid physical sports unless you obtain permission from your surgeon. Swelling & Ice applications: Swelling is often associated with surgery. Swelling can be minimized by using a cold pack, ice bag or a bag of frozen peas wrapped in a towel, with firm application to face and neck areas. This should be applied 20 minutes on and 20 minutes off during the first ___ days after surgery. If you have been given medicine to control the swelling, be sure to take it as directed. Hot applications: Starting on the ___ or ___ day after surgery, you may apply warm compresses to the skin over the areas of swelling (hot water bottle wrapped in a towel, etc), for 20 minutes on and 20 min off to help soothe tender areas and help to decrease swelling and stiffness. Please use caution when applying ice or heat to your face as certain areas may feel numb after surgery and extremes of temperature may cause serious damage. Tooth brushing: Begin your normal oral hygiene the day after surgery. Soreness and swelling may nor permit vigorous brushing, but please make every effort to clean your teeth with the bounds of comfort. Any toothpaste is acceptable. Please remember that your gums may be numb after surgery. To avoid injury to the gums during brushing, use a child size toothbrush and brush in front of a mirror staying only on teeth. Mouth rinses: Keeping your mouth clean after surgery is essential. Use 1 teaspoon of salt dissolved in an 8 ounce glass of warm water and gently rinse with portions of the solution, taking 5 min to use the entire glassful. Repeat as often as you like, but you should do this at least 4 times each day. If your surgeon has prescribed a specific rinse, use as directed. Showering: You may shower ___ days after surgery, but please ask your surgeon about this. If you have any incisions on the skin of your face or body, you should cover them with a water resistant dressing while showering. DO NOT SOAK SURGICAL SITES. This will avoid getting the area excessively wet. As you may physically feel weak after surgery, initially avoid extreme hot or cold showers, as these may cause some patients to pass out. Also it is a good idea to make sure someone is available to assist you in case if you may need help. Sleeping: Please keep your head elevated while sleeping. This will minimize swelling and discomfort and reduce pain while allowing you to breathe more easily. One or two pillows may be placed beneath your mattress at the head of the bed to prop the bed into a more vertical position. Pain: Most facial and jaw reconstructive surgery is accompanied by some degree of discomfort. You will usually have a prescription for pain medication. Some patients find that stronger pain medications cause nausea, but if you precede each pain pill with a small amount of food, chances of nausea will be reduced. The effects of pain medications vary widely among individuals. If you do not achieve adequate pain relief at first you may supplement each pain pill with an analgesic such as Tylenol or Motrin. If you find that you are taking large amounts of pain medications at frequent intervals, please call our office. If your jaws are wired shut with elastics, you may have been prescribed liquid pain medications. Please remember to rinse your mouth after taking liquid pain medications as they can stick to the braces and can cause gum disease and damage teeth. Diet: Unless otherwise instructed, only a cool, clear liquid diet is allowed for the first 24 hours after surgery. After 48 hours, you can increase to a full liquid diet, but please check with your doctor before doing this. Avoid extreme hot and cold. If your jaws are not wired shut, then after one week, you may be able to gradually progress to a soft diet, but ONLY if your surgeon instructs you to do so. It is important not to skip any meals. If you take nourishment regularly you will feel better, gain strength, have less discomfort and heal faster. Over the counter meal supplements are helpful to support nutritional needs in the first few days after surgery. A nutrition guidebook will be given to you before you are discharged from the hospital. Remember to rinse your mouth after any food intake, failure to do this may cause infections and gum disease and possible loss of teeth. Nausea/Vomiting: Nausea is not uncommon after surgery. Sometimes pain medications are the cause. Precede each pill with a small amount of soft food. Taking pain pills with a large glass of water can also reduce nausea. Try taking clear fluids and minimizing taking pain medications, but call us if you do not feel better. If your jaws are wired shut with elastics and you experience nausea/vomiting, try tilting your head and neck to one side. This will allow the vomitus to drain out of your mouth. If you feel that you cannot safely expel the vomitus in this manner, you can cut elastics/wires and open your mouth. Inform our office immediately if you elect to do this. If it is after normal business hours, please come to the emergency room at once, and have the oral surgery on call resident paged. ___: Depending on the type of surgery, you may have elastics and/or wires placed on your braces. Before discharge from the hospital, the doctor ___ instruct you regarding these wires/elastics. If for any reason, the elastics or wires break, or if you feel your bite is shifting, please call our office. Medications: You will be given prescriptions, some of which may include antibiotics, oral rinses, decongestants, nasal sprays and pain medications. Use them as directed. A daily multivitamin pill for ___ weeks after surgery is recommended but not essential. If you have any questions about your progress, please call our office at ___. Followup Instructions: ___
19978454-DS-20
19,978,454
26,077,022
DS
20
2176-06-08 00:00:00
2176-06-12 06:32:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: melena and abdominal pain Major Surgical or Invasive Procedure: EGD History of Present Illness: ___ year old female with cirrhosis and HCC and history of uncomplicated diverticulitis reporting abdominal pain and melena. Patient reported sharp abdominal pain for about 3 days gradulaly building and is currently ___. Patient reported her pain started as a band across her whole abdomen and now also includes her RUQ. This pain started similarly as her bout of uncomplicated diverticulitis ___ years ago. Patient's melena started yesterday, hx of ascities new abd pain and chills. No ascities. In the ED, initial vitals: T 99.0 HR 80 BP 118/68 RR 18 SpO2 100 RA Labs were significant for Hgb 10 Hct 31.1 and Plt 62 (all three values within her reccent outpatient baseline). Alk Phos 140 and Lipase 80 Imaging showed no free air or acute pulmonary process on CXR PA and lateral. In the ED, patient was given three 1mg doses of dilaudid, 1L NS, a one time 40mg dose of pantoprazole, and 4mg zofran. Past Medical History: - Anemia - Diveticulitis - ___ years ago at ___ - Liver Cancer - HCC - Cirrhosis - HepC - s/p curative therapy (___ trial) - Rheumatoid Arthritis - Bunionectomy ~ ___ years ago Social History: ___ Family History: Patient has no family history of liver cancer, diverticular disease, or bleeding or clotting disorders. Physical Exam: VS: T 95 BP 129/64 HR 94 RR 16 O2Sat: 94% on RA GEN: Alert, lying in bed, no acute distress HEENT: Pinpoint pupils, Dry MM, anicteric sclerae, no conjunctival pallor NECK: Supple without LAD, JVP Not-elevated PULM: Generally CTA b/l without wheeze or rhonchi COR: RRR (+)S1/S2 with normal respophasic variation no m/r/g ABD: Soft, tender to palpation in epigastrium, mildly-distended EXTREM: Warm, well-perfused, no edema, palpaple pulses bilaterally: radial, dorsal pedis, posterior tibial NEURO: CN II-XII grossly intact, motor function grossly normal DISCHARGE EXAM: Vitals: T 97.9 HR ___ BP 109-131/51-69 RR 16 SaO2 97% on RA General: alert, oriented, no acute distress HEENT: sclera anicteric, MMM, oropharynx clear, pinpoint pupils bilaterally Lungs: clear to auscultation bilaterally, no wheezes, rales, ronchi CV: regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Soft, mildly tender to palpation in RLQ, mildly-distended bowel sounds present, no rebound tenderness or guarding Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Pertinent Results: ___ 05:15PM BLOOD WBC-4.0 RBC-3.84* Hgb-9.0* Hct-28.5* MCV-74* MCH-23.4* MCHC-31.5 RDW-20.2* Plt Ct-57* ___ 02:08PM BLOOD Neuts-65.9 ___ Monos-5.9 Eos-2.6 Baso-0.4 ___ 05:15PM BLOOD Plt Ct-57* ___ 06:41AM BLOOD ___ PTT-31.8 ___ ___ 06:41AM BLOOD Glucose-79 UreaN-5* Creat-0.8 Na-140 K-3.7 Cl-109* HCO3-21* AnGap-14 ___ 06:41AM BLOOD Calcium-8.5 Phos-3.2 Mg-1.9 ___ 12:57PM BLOOD AFP-4.5 ___ 06:40PM BLOOD Lactate-1.8 ___ 04:45PM URINE Color-Yellow Appear-Hazy Sp ___ ___ 04:45PM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-TR ___ 04:45PM URINE RBC-1 WBC-2 Bacteri-FEW Yeast-NONE Epi-2 ___ 04:45PM URINE Mucous-RARE ___ - CT Abdomen Pelvis PO IV Contrast: Preliminary Report1. Mild non-specific fat stranding in the right lower quadrant inferior to Preliminary Reportthe cecum, without evidence of colonic wall thickening, may be seen in Preliminary Reportmild/early cecal colitis. No appendicitis or diverticulitis. Preliminary Report2. 3 mm heterogeneous focus along the lateral aspect of segment VI, Preliminary Reportcorresponding to the ___ better evaluated on recent MRI dated ___. Preliminary ReportPreviously described suspicious segment III lesion is not well visualized on Preliminary Reportthis single-phase study. Preliminary Report3. Sequela of portal hypertension including patent umbilical vein, splenic Preliminary Reportvarices, and a splenorenal shunt with resulting downstream left renal vein Preliminary Reportdilation. Preliminary Report4. Large hiatal hernia. Preliminary Report5. Cholelithiasis without evidence of cholecystitis. Preliminary Report6. Interval enlargement of an 8 mm, likely pleural based, pulmonary nodule at Preliminary Reportthe right lung base. ___ - Abdominal US - No ascites seen. Paracentesis was therefore canceled. ___ - Chest XRay PA n Lateral- There is no focal consolidation, effusion, or pneumothorax. The cardiomediastinal silhouette is normal. Imaged osseous structures are intact. No free air below the right hemidiaphragm is seen. ___ 1. Mild non-specific fat stranding in the right lower quadrant inferior to the cecum, without evidence of colonic wall thickening, may be seen in mild/early cecal colitis. No appendicitis or diverticulitis. 2. 3 mm heterogeneous focus along the lateral aspect of segment VI, corresponding to the ___ better evaluated on recent MRI dated ___. Previously described suspicious segment III lesion is not well visualized on this single-phase study. 3. Sequela of portal hypertension including patent umbilical vein, splenic varices, and a splenorenal shunt with resulting downstream left renal vein dilation. 4. Large hiatal hernia. 5. Cholelithiasis without evidence of cholecystitis. 6. Interval enlargement of an 8 mm, likely pleural based, pulmonary nodule at the right lung base. Brief Hospital Course: Ms. ___ presented to the ___ ED on ___ with three days of abdominal pain and one day history of melena. In the ED, initial vitals were normal T 99.0 HR 80 BP 118/68 RR 18 SpO2 100 RA Labs were significant for Hgb 10 Hct 31.1 and Plt 62 (all three values within her recent outpatient baseline). Alk Phos 140 and Lipase 80. Imaging showed no free air or acute pulmonary process on CXR PA and lateral. Patient was given three 1 mg doses of Dilaudid, 1L NS, a one time 40mg dose of pantoprazole, and 4mg zofran. Patient was transferred to ___ 7 inpatient medicine floor. On the night of presentation, patient was put on ceftriaxone for concern for spontaneous bacterial peritonitis or other intraabdominal infectious process. The next morning, Ms. ___ abdominal pain was greatly improved and she was continued on ceftriaxone. U/S was negative for ascites and no para was performed. CT abd/pelvis absent for ascites as well, but noted subtle cecal enhancement c/w early colitis, no evidence of diverticulitis or appendicitis. She was transitioned to PO cipro with plan for outpatient colonoscopy. She had no bloody bowel movements, crits were stable. EGD was negative for acute findings, grade I varicies were again noted with no evidence of acute bleed. She was maintained on her home medications for chronic issues. No evidence of decompensation of cirrhosis. TRANSITIONAL ISSUES - Outpatient colonoscopy - Complete course of ciprofloxacin - Short course of oxycodone prescribed Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lactulose 15 mL PO BID:PRN confusoin 2. Lorazepam 0.5 mg PO QHS:PRN insomnia 3. TraZODone 50 mg PO QHS:PRN insomnia 4. Hydroxychloroquine Sulfate 400 mg PO DAILY 5. FoLIC Acid 1 mg PO DAILY 6. Vitamin D 1000 UNIT PO DAILY 7. Ferrous Sulfate 325 mg PO DAILY Discharge Medications: 1. Hydroxychloroquine Sulfate 400 mg PO DAILY 2. Lactulose 15 mL PO BID:PRN confusoin 3. Lorazepam 0.5 mg PO QHS:PRN insomnia 4. TraZODone 50 mg PO QHS:PRN insomnia 5. Ciprofloxacin HCl 500 mg PO Q12H Duration: 5 Days 6. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN Pain 7. FoLIC Acid 1 mg PO DAILY 8. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Home Discharge Diagnosis: Colitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure participating in your care at ___ ___. You were admitted because you had evidence of bleeding from your bowel, as well as bad abdominal pain. You had an endoscopy the did not evidence a bleeding cause. A cat scan showed a small amount of inflammation in your large bowel that may have caused your symptoms. You improved with antibiotics and pain control. It is important that you complete the course of antibiotics. In addition, you will need a colonoscopy to evaluate your colitis. Followup Instructions: ___
19978630-DS-9
19,978,630
21,940,751
DS
9
2152-08-14 00:00:00
2152-08-14 19:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: left distal ___ femoral shaft fracture Major Surgical or Invasive Procedure: left retrograde femoral nail placement History of Present Illness: This is a ___ with hx of Alzheimers and who is non-ambulatory who presents s/p fall at home with a left mid-shaft femur fracture. She was being transferred from her wheelchair to her bed by her daughter and health care worker when they lost grip on her and she fell to the ground. She was crying in pain and taken to ___ where xrays showed the aforementioned fracture. She is very hard of hearing and confused. Past Medical History: Alzheimers Social History: ___ Family History: Non contributory Physical Exam: Exam on discharge: Vitals: AVSS General: Well-appearing, breathing comfortably on RA. Neuro: A&Ox1-2, at baseline CV: RRR by palp Pulm: nonlabored breathing, no audible wheezes or crackles MSK: -Appropriately tender to palpation -Dressings c/d/I -Left Thigh compartments soft -Sensorimotor exam intact -Left foot WWP Pertinent Results: see OMR for pertinent results Brief Hospital Course: The patient presented as a same day admission for surgery. The patient was taken to the operating room on ___ for left retrograde femoral nail, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The ___ hospital course was otherwise unremarkable. In discussion of dispo planning, multiple conversations involving the family, medicine, palliative care, and case management teams were had. Ultimately given the family's goals of care regarding the patient, it was decided that comfort measures only would be in the patient's best interest. Given the frequent demands and needs for care of the patient, it was thought that nursing home with hospice would be the best setting for the patient. However, the family wanted the patient to be brought home with hospice services despite the demands including wound care, dressing changes, assistance with transfers and ambulation, and administration for subcutaneous heparin on a daily basis. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is weight-bearing as tolerated in the left lower extremity, and will be discharged on Subcutaneous Heparin twice daily for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: None Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 2. Docusate Sodium 100 mg PO BID 3. Heparin 5000 UNIT SC BID 4. Senna 8.6 mg PO BID 5. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL QID Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: left distal ___ femoral shaft fracture Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - weight-bearing as tolerated left lower extremity MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take Subcutaneous heparin three times daily for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - Please remain in your dressing and do not change unless it is visibly soaked or falling off. Physical Therapy: -weight-bearing as tolerated left lower extremity Treatments Frequency: -staples to remain in place until follow up visit Followup Instructions: ___
19978766-DS-10
19,978,766
21,880,865
DS
10
2165-03-28 00:00:00
2165-03-28 13:00:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: atenolol / Serax / Neurontin Attending: ___. Chief Complaint: Increased abdominal pain Fever Major Surgical or Invasive Procedure: None History of Present Illness: ___ y/o male with history of pancreatitis, gastric ulcers, UGIB. He presents to ED today with 4 days history of increasing LUQ pain decrease PO intakes and fevers. Of note the etiology of his pancreatitis is ETOH abuse and he has an impressive history of ETOH intake. The patient is well known to Dr. ___ was planning to operate on him on ___. He endorsed nausea but he denies emesis SOB, CP, hematemesis, hematochezia or acholic stools. Past Medical History: Alcohol abuse Alcohol withdrawal Delirium tremens Alcohol pancreatitis pancreatic pseudocyst anxiety and depression hypertension gastric ulcers UGIB polysubstance abuse GERD Tobacco abuse withdrawal seizures from stopping Xanax Social History: ___ Family History: Noncontributory Physical Exam: On Admission: Vitals: 99.6 129/72 86 99% RA GEN: A&O, NAD HEENT: NCAT,No scleral icterus, mucus membranes moist CV: RRR, No M/G/R PULM: Clear to auscultation b/l, No W/R/R ABD: Soft, nondistended, TTP of RUQ and LUQ however, more tender in LUQ. no rebound or peritonitis Ext: No ___ edema, ___ warm and well perfused On Discharge: VS: 98.7, 64, 102/64, 16, 99% RA GEN: NAD, A&O x 3 HEENT: NC/AT, PERRL, EOMI CV: RRR Pulm: CTAB Abd: Soft, NT/ND Extr: Warm, no c/c/e Pertinent Results: ___ 05:50AM BLOOD WBC-21.3* RBC-3.87* Hgb-11.2* Hct-35.0* MCV-90 MCH-28.8 MCHC-31.9 RDW-13.9 Plt ___ ___ 05:50AM BLOOD Glucose-129* UreaN-12 Creat-0.7 Na-137 K-4.2 Cl-98 HCO3-28 AnGap-15 ___ 12:45PM BLOOD Lipase-16 ___ 12:45 pm URINE Site: CLEAN CATCH **FINAL REPORT ___ URINE CULTURE (Final ___: GRAM POSITIVE BACTERIA. 10,000-100,000 ORGANISMS/ML.. Alpha hemolytic colonies consistent with alpha streptococcus or Lactobacillus sp. ___ BLOOD CULTURE: Pending ___ ABD CT: IMPRESSION: 1. Interval development of irregular fluid collection between the body of the pancreas and lesser curvature of the stomach concerning for an infected pancreatic pseudocyst. 2. Healing splenic infarcts, chronic splenic vein thrombosis, extensive portosystemic collaterals in the left upper quadrant. 3. 12-mm hypodensity within segment VI of the liver previously characterized as hemangioma on an ultrasound from ___. Findings discussed with the surgical team at the time of initial review. 4. Several stable renal cysts. ___ CXR: IMPRESSION: No acute findings including no sign of pneumoperitoneum. Brief Hospital Course: The patient well known for Dr. ___ scheduled for elective surgical resection on ___ was admitted to the General Surgical Service for evaluation of fevers and increased abdominal pain. The abdominal CT was concerning for infected pancreatic pseudocyst. The patient was started on broad-spectrum antibiotics. On HD# 2, patient's abdominal pain subsided, he was afebrile, and his diet was advanced to regular. On HD # 3, patient was afebrile, his antibiotics were changed to oral, he tolerated regular diet. The patient underwent preoperative evaluation by anesthesiology and was discharged home in stable condition. At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Medications on Admission: Omeprazole Discharge Medications: 1. nicotine 21 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr Transdermal DAILY (Daily). Disp:*30 Patch 24 hr(s)* Refills:*2* 2. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 3. oxycodone 5 mg Tablet Sig: ___ Tablets PO every eight (8) hours as needed for pain. Disp:*10 Tablet(s)* Refills:*0* 4. sulfamethoxazole-trimethoprim 800-160 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) for 1 weeks. Disp:*14 Tablet(s)* Refills:*0* 5. fluconazole 200 mg Tablet Sig: Two (2) Tablet PO Q24H (every 24 hours) for 1 weeks. Disp:*14 Tablet(s)* Refills:*0* Discharge Disposition: Home Discharge Diagnosis: 1. Chronic pancreatitis 2. Pancreatic pseudocyst 3. Chronic splenic vein thrombosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Please resume all regular home medications , unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. Avoid driving or operating heavy machinery while taking pain medications. Please follow-up with your surgeon and Primary Care Provider (PCP) as advised. Please call your doctor or nurse practitioner if you experience the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain is not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Followup Instructions: ___
19978774-DS-16
19,978,774
20,876,246
DS
16
2132-08-31 00:00:00
2132-08-31 12:50:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: CARDIOTHORACIC Allergies: Penicillins Attending: ___ Chief Complaint: Worsening Chest pain,nausea, vomiting, left arm numbness and left jaw pain for the past month. Major Surgical or Invasive Procedure: none History of Present Illness: Mr. ___ is ___ old gentleman with h/o CABG in ___ with Dr ___, SVG->Diag/Ramus/OM). He had recurrent chest pain, chest "numbness" in ___ and cath at that time showed 80% stenosis of the mid LMCA leading into the proximal LCX, which was stented was a Promus DES by Dr. ___. He was soon afterward again readmitted on that same ___ with recurrent chest pain/numbness repeat cath showed that all vessels and stent were patent. Coronary spasm was suspected and his meds were optimized. Recent routine f/u cath was done 4 months ago at the ___ which according to the patient was "negative". He admits to doing well up until one month ago when he began developing recurrent chest pain radiating into his left arm and left jaw associated with occasional nausea/vomiting. He was recently treated with erythromycin and steroid pack for throat infection that he completed 2 weeks ago. He has also been experinceing difficulty breathing at night waking up SOB. His paxil was increased for possible anxiety attacks. He has been on paxil for one year. He arrived in the ER today with complaints or worsen left sided chest pains and upper back pain. His CTA revealed 4x6cm anterior mediastinum hematoma anterior to the ascending aorta. No PE or dissection noted, sternal wires intact. CT surgery was consulted regarding the hematoma. Past Medical History: 1. CARDIAC RISK FACTORS: +Diabetes, +Dyslipidemia 2. CARDIAC HISTORY: -CABG: ___ with Dr. ___->LAD, SVG->Diag/Ramus/OM -PERCUTANEOUS CORONARY INTERVENTIONS: ___ Promus DES to LMCA into LCx -PACING/ICD: 3. OTHER PAST MEDICAL HISTORY: GERD kidney stones surgery ___ Social History: ___ Family History: Father + CABG and multiple stents paternal Grand Father +CAD History of valvular disease in father and breast cancer in sister. Physical Exam: Pulse: Resp:18 O2 sat: RA 100% B/P Right: 139/70 Left: 142/91 Height: 6ft Weight:200lbs Five Meter Walk Test #1_______ #2 _________ #3_________ General: Skin: Dry [x] intact [x] flushed chest and neck HEENT: PERRLA [x] EOMI [] Neck: Supple [x] Full ROM [x] Chest: Lungs clear bilaterally [x] Heart: RRR [xx] Irregular [] Murmur [] grade ______ Abdomen: Soft [] non-distended [x] non-tender [x] bowel sounds + [] Extremities: Warm [x], well-perfused [] Edema [] _none____ Varicosities: None [c] Neuro: Grossly intact [x] Pulses: Femoral Right:+1 Left:+1 DP Right: doppler Left:absent ___ Right: palp Left:doppler Radial Right: +1 Left:absent Carotid Bruit Right: None Left:None Pertinent Results: ___ 03:49AM BLOOD WBC-8.0 RBC-4.77 Hgb-15.3 Hct-44.4 MCV-93 MCH-32.1* MCHC-34.6 RDW-13.8 Plt ___ ___ 03:49AM BLOOD Glucose-194* UreaN-20 Creat-0.9 Na-140 K-4.2 Cl-107 HCO3-26 AnGap-11 ___ 03:49AM BLOOD CK-MB-2 cTropnT-<0.01 ___ 04:24PM BLOOD CK-MB-2 cTropnT-<0.01 ___ 03:49AM BLOOD CK(CPK)-37* ___ 04:24PM BLOOD CK(CPK)-60 ECHO The left atrium and right atrium are normal in cavity size. The estimated right atrial pressure is ___ mmHg. There is mild symmetric left ventricular hypertrophy with normal cavity size. There is mild regional left ventricular systolic dysfunction with mild inferior wall hypokinesis. The remaining segments contract normally (LVEF = 50-55%). Transmitral and tissue Doppler imaging suggests normal diastolic function, and a normal left ventricular filling pressure (PCWP<12mmHg). The aortic root is mildly dilated at the sinus level. The ascending aorta is mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve appears structurally normal with trivial mitral regurgitation. There is no mitral valve prolapse. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. IMPRESSION: Mild symetric left ventricular hypertrophy with mild regional systolic dysfunction c/w CAD. Dilated ascending aorta. Compared with the prior study (images reviewed) of ___, mild regional systolic dysfunction is now seen. CLINICAL IMPLICATIONS: The patient has a mildly dilated ascending aorta. Based on ___ ACCF/AHA Thoracic Aortic Guidelines, a follow-up echocardiogram is suggested in ___ years. Based on ___ AHA endocarditis prophylaxis recommendations, the echo findings indicate prophylaxis is NOT recommended. Clinical decisions regarding the need for prophylaxis should be based on clinical and echocardiographic data. Electronically signed by ___, MD, Interpreting physician ___ ___ 11:47 CTA: Contrast bolus timing is adequate for assessment of the pulmonary arteries to the subsegmental level. There is no pulmonary embolism. The aorta is normal caliber appearance throughout its length. There is no aortic aneurysm or dissection. CHEST CT: There is a hematoma in the anterior mediastinum. Hyperdense tissue density is seen in the anterior mediastinum forming an ill-defined collection measuring approximately 3 cm AP x 6 cm TV x 8 cm CC. A focal hyperdensity along the anterior wall of the ascending aorta is shown to be calcified on the non-contrast scan. There are numerous surgical clips from prior CABG. The lungs are well expanded and clear. There is no focal consolidation, effusion, nodule, mass, or pneumothorax. Subsegmental basilar atelectasis is mild. The airways are patent to the subsegmental level. The thyroid gland enhances homogeneously. There is no supraclavicular adenopathy. A prominent precarinal lymph node measures 11 cm in short axis. There is no additional mediastinal, hilar, or axillary adenopathy. The size of the heart is normal. Coronary artery calcifications are extensive. There is no pericardial effusion. This exam is not tailored to evaluate subdiaphragmatic structures. The adrenal glands and visualized abdominal viscera are unremarkable. There are no concerning lytic or sclerotic bony lesions. The sternotomy is incompletely fused at the level of the manubrium (3: 43, 3: 56). The sternotomy wires are intact. The margins of the bone fragments are sclerotic indicating that this is likely an incomplete fusion rather than a dehiscence. IMPRESSION: 1. Anterior mediastinal hematoma of unknown chronicity. No active extravasation. 2. No pulmonary embolism, aortic dissection or aneurysm. 3. Incomplete fusion of the manubrium. The study and the report were reviewed by the staff radiologist. Brief Hospital Course: Mr. ___ was admitted for shortness of breath and chest pain to the CVICU after undergoing a CTA which revealed the following: CHEST CT: There is a hematoma in the anterior mediastinum. Hyperdense tissue density is seen in the anterior mediastinum forming an ill-defined collection measuring approximately 3 cm AP x 6 cm TV x 8 cm CC. A focal hyperdensity along the anterior wall of the ascending aorta is shown to be calcified on the non-contrast scan. There are numerous surgical clips from prior CABG. The lungs are well expanded and clear. There is no focal consolidation, effusion, nodule, mass, or pneumothorax. Subsegmental basilar atelectasis is mild. The airways are patent to the subsegmental level. The thyroid gland enhances homogeneously. There is no supraclavicular adenopathy. A prominent precarinal lymph node measures 11 cm in short axis. There is no additional mediastinal, hilar, or axillary adenopathy. The size of the heart is normal. Coronary artery calcifications are extensive. There is no pericardial effusion. This exam is not tailored to evaluate subdiaphragmatic structures. The adrenal glands and visualized abdominal viscera are unremarkable. There are no concerning lytic or sclerotic bony lesions. The sternotomy is incompletely fused at the level of the manubrium (3: 43, 3: 56). The sternotomy wires are intact. The margins of the bone fragments are sclerotic indicating that this is likely an incomplete fusion rather than a dehiscence. IMPRESSION: 1. Anterior mediastinal hematoma of unknown chronicity. No active extravasation. 2. No pulmonary embolism, aortic dissection or aneurysm. 3. Incomplete fusion of the manubrium. His troponins were negative and pain was controlled with toradol. He did have complaints of nausea which he had prior to admission and states it occurs after taking his medications. A cardiac cath was performed in ___ ( see OMR for results). Echo was done at the request of cardiology and was without significant findings as discussed with Dr. ___ Mr. ___ was discharged to home with script for nicotine patch and counseled to discuss smoking cessation with his PCP. A script was also given for ultram for pain. Medications on Admission: Lisinopril 2.5mg daily,Norvasc 2.5mg daily,Plavix 75mg daily lipitor 80mg daily,Asa 81mg daily,Carafate 1gm q 12hrs, paxil 40mg daily, Humalog ___ 40units bid Discharge Medications: 1. Amlodipine 2.5 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO DAILY 4. Clopidogrel 75 mg PO DAILY 5. Lisinopril 2.5 mg PO DAILY 6. Nicotine Patch 14 mg TD DAILY 7. Aluminum-Magnesium Hydrox.-Simethicone 30 mL PO QID:PRN indigestion 8. Docusate Sodium (Liquid) 100 mg PO BID 9. Ranitidine 150 mg PO BID 10. Humalog ___ 40 Units Breakfast Humalog ___ 40 Units Bedtime 11. Paroxetine 40 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: muscle strain related to recent physical activity Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Contact your primary care doctor and or cardiologidt if you develop chest pain or shortness of breath at rest or with exertion or any other symptoms that concern you. Take motrin and tylenol for muscle soreness Followup Instructions: ___
19978842-DS-5
19,978,842
26,698,803
DS
5
2113-05-29 00:00:00
2113-05-29 09:58:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROSURGERY Allergies: Sulfa (Sulfonamide Antibiotics) / prednisone / Norvasc / Adhesive tape / Penicillins / vancomycin Attending: ___. Chief Complaint: wound drainage Major Surgical or Invasive Procedure: none History of Present Illness: ___ is a ___ yo woman s/p C5 corpectomy and C4-6 ACDF ___ who has been having minimal wound drainage since ___. No fevers, chills or sweats at home. Past Medical History: C5 corpectomy with C4-6 ACDF ___ with Dr. ___ aneurysm clipping ___ Spinal meningitis Appendectomy Lumpectomy Cervical stenosis Social History: ___ Family History: Mother had ___ cancer, past smoker. Denies alcohol or drug use. Physical Exam: Upon admission: Gen: WD/WN, comfortable, NAD. HEENT: Neck: Anterior neck incision: area of erythema and induration at the medial pole of incision, kidney bean size palpable induration, no active drainage Extrem: Warm and well-perfused. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Language: Speech fluent Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout. No pronator drift Sensation: decreased in right finger tips digits ___ Upon discharge: a&o x3 full strength incision- no active drainage Pertinent Results: ___ 11:40PM WBC-8.7 RBC-4.10* HGB-13.5 HCT-37.1 MCV-91 MCH-33.0* MCHC-36.5* RDW-13.4 ___ 11:40PM NEUTS-64 BANDS-0 ___ MONOS-2 EOS-0 BASOS-0 ___ MYELOS-0 ___ 06:30AM BLOOD WBC-12.2* RBC-3.89* Hgb-12.1 Hct-34.6* MCV-89 MCH-31.2 MCHC-35.1* RDW-13.1 Plt ___ ___ 06:30AM BLOOD Glucose-128* UreaN-13 Creat-0.7 Na-141 K-3.4 Cl-102 HCO3-26 AnGap-16 ___ CT Neck: Status post C5 corpectomy and C4 through 6 anterior spinal fusion without evidence of postoperative fluid collection. No evidence of hardware complication. ___ CXR As compared to the previous image, there is a new parenchymal opacity at the right lung bases, projecting over the basal and lateral parts of the right costophrenic sinus. Adjacent to this opacity and located more proximally, between the hilus and the opacity, are several airways with thickened walls. Although the abnormality is seen in 1 projection only, the presence of pneumonia must be is strongly suspected. Normal size of the cardiac silhouette. Normal hilar and mediastinal structures. No pneumothorax. Status post vertebral fixation. At the time of dictation and observation, 08:33, on the ___, the referring physician ___ was not ___. Therefore, the findings were posted to the radiology dashboard. In addition, a high priority email was sent to the referring physician and the attending ___ CXR Heart size is mild mildly enlarged, similar to ___. Mediastinum is unremarkable. Lobulations of both hemidiaphragms are present. No definitive evidence of pleural effusion or pneumothorax is seen. Linear atelectasis in the right lower lung is present but no definitive evidence of pneumonia demonstrated. Brief Hospital Course: Pt was admitted to neurosurgery floor where an attempted aspiration of small medial collection was unsuccesful though a swab cx sent of minimal expressed purulent material was sent. She was started on Losartan for BP control. A CT of her C-Spine did not show any fluid collection. On ___ T spiked to 101.4 WBC 12.2, re-sent blood, urine cultures. Her CRP and ESR were with in normal range. A CXR showed concern for right lower lobe pneumonia on ___. On ___ A ID consult was obtained due to pneumonia versus wound infection versus superficial wound infection. Given wound cultures were growing staph auresis they recommended IV vancomycin while senstivies were pending . Regarding possible pneumonia, she denies all clinical symptoms of respiratory infection and the chest x-ray was a portible one. Repeat CXR with PA/lateral views revealed no definitive evidence of pneumonia On ___ Patient continued on IV vancomycin. She remained stable. Final wound cultures were pending On ___ ID made final antibiotic recommendations for 14 day course of moxifloxicin. She was planned for discharge but this was postponed secondary to transportation issues. On ___ she was deemed fit for dsicharge and was given prescriptions for required medications, instructions for followup, and all questions were answered prior to discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Losartan Potassium 100 mg PO DAILY 2. Atenolol 25 mg PO BID Discharge Medications: 1. Losartan Potassium 50 mg PO DAILY 2. Acetaminophen ___ mg PO Q6H:PRN pain 3. Atenolol 25 mg PO BID 4. moxifloxacin 400 mg oral DAILY Duration: 14 Days RX *moxifloxacin 400 mg 1 tablet(s) by mouth DAILY Disp #*14 Tablet Refills:*0 5. Outpatient Physical Therapy Balance training Discharge Disposition: Home Discharge Diagnosis: Wound infection Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted for a wound infection. You will be discharged home on oral antibiotics •Do not smoke. •Keep your wound(s) clean and dry / No tub baths or pool swimming for two weeks from your date of surgery. •No pulling up, lifting more than 10 lbs., or excessive bending or twisting. •Limit your use of stairs to ___ times per day. •Have a friend or family member check your incision daily for signs of infection. •wear your cervical collar as instructed. •You may shower briefly without the collar or back brace; unless you have been instructed otherwise. •Take your pain medication as instructed; you may find it best if taken in the morning when you wake-up for morning stiffness, and before bed for sleeping discomfort. •Do not take any medications such as Aspirin unless directed by your doctor. •Increase your intake of fluids and fiber, as pain medicine (narcotics) can cause constipation. We recommend taking an over the counter stool softener, such as Docusate (Colace) while taking narcotic pain medication. CALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE FOLLOWING: •Pain that is continually increasing or not relieved by pain medicine. •Any weakness, numbness, tingling in your extremities. •Any signs of infection at the wound site: redness, swelling, tenderness, and drainage. •Fever greater than or equal to 101° F. •Any change in your bowel or bladder habits (such as loss of bowl or urine control). Followup Instructions: ___
19978886-DS-8
19,978,886
25,887,347
DS
8
2183-11-11 00:00:00
2183-11-11 18:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: lower back pain Major Surgical or Invasive Procedure: None History of Present Illness: Condensed history per ED HPI and further discussion with patient: ___ man with PMH herniated disc s/p L5 through S1 discectomy in ___, hyperlipidemia, HTN who presents ___ of mildly worsening LBP but ___ experienced excruciating left low back pain radiating into his L mid-calf when rising from his car. He was able to stand upright and "walk it off" but the symptoms repeated when rising from the dinner table and was debilitating. He says this is very similar to prior episode when he needed the discectomy. He presented to an ___ and was transferred to ___ due to multiple prior spinal surgeries performed here. In the ED, initial vitals were: T 97.2 BP 126/65 HR 96 RR 16 Sat96% RA Exam notable for: Neuro: A&Ox3, CN II-XII intact ___ strength in b/lUE RLE: ___ strength in hip flexion and extension; ___ knee flexion and extension; ___ dorsiflexion and plantarflexion with normal sensation throughout LLE: ___ strength in hip flexion and extension; ___ knee flexion and extension; ___ dorsiflexion and plantarflexion with decreased sensation on plantar aspect of the L foot with normal sensation over the legs and thighs Psych: Normal mentation Rectal tone: normal with normal perirectal sensation - Labs notable for: - Imaging was notable for: CT Lumbar W&W/O Contrast (myelogram) ****************** - Patient was given: IV Dilaudid (2.5g total), Ketorolac 15mg, started on Solmedrol 8mg Upon arrival to the floor, patient reports ongoing stabbing sharp backpain that starts in the middle of his back and radiates down his left leg, also on the side of the leg, and is associated with numbness on the top of the left foot. He also experiences left back and leg pain when he moves his right leg, but does not have any pain or numbness in right leg. He denies any incontinence of urine or stool. Past Medical History: L5-S1 Disectomy Cerebral aneurysm with subarachnoid hemorrhage and frontal contusions, s/p 2 aneurysm clips in brain - ___ HTN HLD past smoker chronic lower back pain depression (d/t subarachnoid hemorrhage and concussions) hx of testicular CA s/p orchiectomy Social History: ___ Family History: Non contributory Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VITAL SIGNS: T 97.2 BP 126/65 HR 96 RR 16 Sat96% RA GENERAL: well-nourished, pleasant man who appears uncomfortable HEENT: PERRLA, nystagmus noted with horizontal eye movement NECK: supple with no LAD CARDIAC: RRR, no m/r/g LUNGS: CTAB, no wheezes or ronchi ABDOMEN: soft, NT/ND, BS+ EXTREMITIES: Pulses 2+, ___, ___ strength in UE and ___ bilaterally NEUROLOGIC: CN2-12 intact, straight-leg positive on left leg; decreased sensation on dorsal aspect of left foot and mildly decreased on interior plantar aspect of left foot SKIN: no rashes, lesions DISCHARGE PHYSICAL EXAM: ========================= ___ 1227 Temp: 97.3 PO BP: 135/76 HR: 68 RR: 20 O2 sat: 97% O2 delivery: Ra General: Pleasant, alert, oriented and in no acute distress but significant amount of pain with movement HEENT: NCAT. PERRLA, no icterus or injection bilaterally. EOMI. No erythema or exudate in posterior pharynx; uvula midline; MMM. Neck: neck veins flat with full ROM Resp: Breathing comfortably on RA. No incr WOB, CTAB with no crackles or wheezes. CV: RRR. Normal S1/S2. NMRG. 2+ radial and DP pulses bilateral. Abd: Soft, Nontender, Nondistended with no organomegaly; no rebound tenderness or guarding. MSK: ___ without edema bilaterally; paraspinal tenderness to palpation Skin: No rash, Warm and dry, No petechiae Neuro: A&Ox3, CNII-XII intact. Decreased sensation to light touch and cold on dorsum of left foot, strength of toe dorsiflexion slightly limited by pain on left. Pertinent Results: ___ 02:00PM GLUCOSE-119* UREA N-15 CREAT-0.8 SODIUM-137 POTASSIUM-4.7 CHLORIDE-100 TOTAL CO2-21* ANION GAP-16 ___ 02:00PM estGFR-Using this ___ 02:00PM WBC-7.8 RBC-4.04* HGB-12.8* HCT-39.0* MCV-97 MCH-31.7 MCHC-32.8 RDW-12.5 RDWSD-44.8 ___ 02:00PM NEUTS-79.0* LYMPHS-12.6* MONOS-4.5* EOS-2.4 BASOS-1.0 IM ___ AbsNeut-6.12* AbsLymp-0.98* AbsMono-0.35 AbsEos-0.19 AbsBaso-0.08 ___ 02:00PM PLT COUNT-261 ___ 02:00PM ___ PTT-30.9 ___ Brief Hospital Course: ==================== Summary ==================== ___ man with PMH herniated disc s/p L5 through S1 discectomy in ___, hyperlipidemia, HTN who presents ___ of mildly worsening LBP but ___ experienced excruciating left low back pain radiating into his L mid-calf when rising from his car. He presented to an ___ and was transferred to ___ due to multiple prior spinal surgeries performed here. CT and myelogram imaging revealed notable for stable disc bulge at L4-L5 level; Ortho Spine determined there was no need for surgical intervention. Pts pain was controlled and will be discharged on oral pain control regimen. =============== ACUTE ISSUES: =============== #Acute on chronic lower back pain with radiculopathy Has had multiple lower back procedures including herniated disc s/p L5 through S1 discectomy in ___, presents with acutely worsened LBP that radiates down l leg and associated L foot numbness that started the day prior to discharge while getting out of his car at work and became unbearable that evening as he stood up from seated position. CT non-contrast and myelogram notable only for: "At L4-L5, there is a diffuse disc bulge causing mild anterior thecal sac deformity and moderate bilateral neural foraminal narrowing, facet joint arthropathy and ligamentum flavum hypertrophy. Findings are relatively stable when compared with the prior examination in ___ There was no evidence of any hardware complications. Per ortho, no surgical intervention needed. Acute pain episode thought to be caused by bulging or irritated spinal disc causing radicular pain and muscle strain with spasms based on paraspinal muscle tenderness on exam. Initially pain controlled with IV Dilaudid and IV Ketorolac. Steroids were not given due to lack of sufficient evidence for their efficacy in this clinical context. Discharged on Ibuprofen 800mg Q8 hours for 3 days, capsaicin topical, cyclobenzaprine 10mg QHS PRN, and prescription for outpatient physical therapy. #Pain control Pt is followed by Dr. ___ in ___ for chronic LBP that is normally well controlled with home Gabapentin and Duloxetine, and PRN Advil. Continued home Gabapentin & Duloxetine. For acute episode of LBP, regimen is as stated above. ================== CHRONIC ISSUES: ================== #Depression Patient followed by neuropsychiatrist as outpatient and has recently been weaned off Eszopiclone (Lunesta) and transitioned to Mirtazepine QHS for help with sleeping. Subarachnoid hemorrhage and concussions have contributed to depression since ___. Continued home Duloxetine 90mg QDaily, Mirtazepine 7.5mg QHS, and Amantadine 200mg QAM and 100mg QPM. #Hypertension Well controlled on home regimen. Continued home atenolol 50mg Qdaily, Lisinopril 60mg QDaily, and Chlorthalidone 12.5mg QDaily. #Hyperlipidmia: Continued atorvastatin 40mg QDaily. ========================= TRANSITIONAL ISSUES: ========================= [ ] Of note, the patient's CNS clips are MRI compatible: per the ___ ___, the craniotomy and clipping was performed on ___, and he then had an MRI Brain on ___, which showed the residual aneurysm (1mm) below the clips along-- these are MRI compatible clips per the ___ Notes the bifurcation. Therefore, if further imaging is needed, MRI can be done. [ ] Discharged with prescription for physical therapy. Can follow up with outpatient PCP regarding need for ongoing ___. [ ] Patient previously on oxydocone in the past, he received ___ doses of this on this admission but our goal was to discharge off of opiates so he was sent with ibuprofen instead Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amantadine 200 mg PO QAM 2. Amantadine 100 mg PO LUNCH 3. Atenolol 50 mg PO DAILY 4. Chlorthalidone 12.5 mg PO DAILY 5. DULoxetine 90 mg PO DAILY 6. Gabapentin 300 mg PO BID 7. Lisinopril 60 mg PO DAILY 8. Mirtazapine 7.5 mg PO QHS Discharge Medications: 1. Atorvastatin 10 mg PO QPM 2. Capsaicin 0.025% 1 Appl TP TID RX *capsaicin [Capzasin-HP] 0.1 % apply cream to lower back up to three times daily, as needed Refills:*0 3. Cyclobenzaprine 10 mg PO HS:PRN Back pain RX *cyclobenzaprine 10 mg 1 tablet(s) by mouth evenings before bed, as needed Disp #*10 Tablet Refills:*0 4. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day as needed Disp #*30 Capsule Refills:*0 5. Ibuprofen 800 mg PO Q8H Duration: 3 Days RX *ibuprofen [IBU] 800 mg 1 tablet(s) by mouth every 8 hours Disp #*9 Tablet Refills:*0 6. Lidocaine 5% Patch 1 PTCH TD QAM Alternate the lidocaine patch with the topical capsaicin ointment. RX *lidocaine [Lidocaine Pain Relief] 4 % apply patch to affected area may remain up to 12 hrs in 24-hour period Disp #*12 Patch Refills:*0 7. Amantadine 200 mg PO QAM 8. Amantadine 100 mg PO LUNCH 9. Atenolol 50 mg PO DAILY 10. Chlorthalidone 12.5 mg PO DAILY 11. DULoxetine 90 mg PO DAILY 12. Gabapentin 300 mg PO BID 13. Lisinopril 60 mg PO DAILY 14. Mirtazapine 7.5 mg PO QHS 15.Outpatient Physical Therapy Physical therapy to reduce lower back pain, paraspinal muscle spasms, and treat radiculopathy. ICD10: M54.4 Duration: ongoing Discharge Disposition: Home Discharge Diagnosis: Primary: ----------- Acute left LBP w/ sciatica Paraspinal muscular spasm Secondary: ----------- Depression Chronic LBP Hypertension Hyperlipidemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a privilege caring for you at ___. WHY WAS I IN THE HOSPITAL? - You had severe lower back pain and there was concern for a herniated disk or more serious issue due to your prior spine surgeries. WHAT HAPPENED TO ME IN THE HOSPITAL? - You had CT imaging of your spine, which showed no spinal cord impingement and no issues with your existing hardware. - Your back pain is thought to be due to an irritated spinal disc as well as surrounding muscular spasms. - Your pain was managed with anti-inflammatory and analgesic medications. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
19979081-DS-14
19,979,081
22,763,407
DS
14
2179-02-05 00:00:00
2179-02-05 23:54:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: simvastatin / lisinopril / Penicillins Attending: ___. Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: EGD w/ EUS and gastric mass bx History of Present Illness: Mrs. ___ is an ___ year old woman with a history of colonic adenoma in ___, and remote TAH/BSO who presents with 1 day of acute, sudden onset epigastric pain on ___. She reports feeling generally at her baseline and suddenly after lunch, she felt acute epigastric pain that radiated down to her lower abdomen. She also reports ___ years of progressively worsening early satiety and nausea and vomiting every time she eats too large of a meal. The vomiting is nonbilious and nonbloody and occurs once or twice a month, again with eating too large of a meal (she reports she never mentioned these symptoms to her physicians because she did feel them to be abnormal). She does not report any recent vomiting associated with the pain, however. She also denies fevers, chills, black or bloody stools,in fact her stools have been normal and brown. She denies any chest pain, shortness of breath, coughing, dysuria, calf pain, weight loss (she has remained at her baseline of about 130 lbs for the past few years), or night sweats. Of note she was reminded to follow up with GI for a repeat colonoscopy in ___ ___ after adenoma found in ___, per protocol) but she decided against it because she felt her first one was normal and she did not need one. Given the severity of her abdominal symptoms she decided to come to the ED. In the ED, her vital signs were 97.8 161/68 92 16 99%RA. She was given morphine 5mg IV once for pain with resolution of her symptoms. LFTs notable for ALT 230, AST 513, AP 131, TB 1.3,Lipase 83, HCT 30 (baseline mid ___. RUQ U/S showed CBD dilation (1.1cm) but no stone. Perhepatic GB thickening also seen. ERCP was consulted and she was admitted to the ___ ___ service for further work up. Past Medical History: #) Colonic adenoma in ___ #) TAH/BSO #) Hyperlipidemia Social History: ___ Family History: No family history of GI disease or cancer Physical Exam: EXAM: VS 98.4 (Tm 99) 130/63 95 18 100%RA GEN: NAD, well-appearing elderly woman in NAD EYES: PERRL EOMI conjunctiva clear anicteric ENT: Dry mucous membranes NECK: supple CV: RRR s1s2 no s3 or s4. JVP wnl. PULM: CTA, no WRR. GI: normal BS, ND, soft, mild RUQ tenderness, mild lower abdominal tenderness. No rebound or guarding, negative ___ sign. EXT: warm, no edema SKIN: no rashes NEURO: alert, oriented x 3, answers ? appropriately, follows commands PSYCH: appropriate ACCESS: PIV FOLEY: none present Pertinent Results: ___ 10:45PM BLOOD WBC-10.7 RBC-4.76 Hgb-9.2* Hct-30.1* MCV-63* MCH-19.2* MCHC-30.4* RDW-19.5* Plt ___ ___ 10:45PM BLOOD Neuts-91.3* Lymphs-4.9* Monos-3.6 Eos-0.1 Baso-0.1 ___ 10:45PM BLOOD Plt ___ ___ 10:45PM BLOOD Glucose-174* UreaN-18 Creat-0.8 Na-142 K-3.7 Cl-104 HCO3-22 AnGap-20 ___ 10:45PM BLOOD ALT-230* AST-513* AlkPhos-131* TotBili-1.3 ___ 10:45PM BLOOD Lipase-83* ___ 07:59AM BLOOD GGT-92* ___ 07:59AM BLOOD Calcium-8.5 Phos-2.7 Mg-2.1 Iron-13* ___ 07:59AM BLOOD calTIBC-363 Ferritn-48 TRF-279 RUQ U/S ___ IMPRESSION: 1. Extra-hepatic biliary ductal dilatation, CBD measures 1.1 cm. 2. Asymmetric gallbladder wall thickening on hepatic surface. Given this patient's elevated LFTs, this may be secondary to hepatitis. Colonoscopy report ___ (Atrius): FINDINGS Diverticulosis in the left colon 4mm polyp at 30 Polypectomy performed with hot snare. 7mm polyp on a stalk at 20cm. Polypectomy performed with hot snare Polyp retrieved. Histology revealed adenoma. Internal hemorrhoids. Repeat colonscopy in ___ years. EKG: NSR, ST depressions are upsloping, diffuse, mild, and nonspecific. RSR pattern, unchanged per prior report in ___ (Atrius). ___ 07:59AM BLOOD WBC-6.6 RBC-4.56 Hgb-8.8* Hct-29.5* MCV-65* MCH-19.3* MCHC-30.0* RDW-20.0* Plt ___ ___ 06:32AM BLOOD WBC-4.6 RBC-4.29 Hgb-8.4* Hct-28.1* MCV-65* MCH-19.5* MCHC-29.9* RDW-19.2* Plt ___ ___ 07:45AM BLOOD WBC-5.6 RBC-4.89 Hgb-9.2* Hct-31.1* MCV-64* MCH-18.8* MCHC-29.5* RDW-20.0* Plt ___ ___ 07:59AM BLOOD Calcium-8.5 Phos-2.7 Mg-2.1 Iron-13* ___ 07:59AM BLOOD calTIBC-363 Ferritn-48 TRF-279 ___ 07:59AM BLOOD HCV Ab-NEGATIVE ___ 07:59AM BLOOD HBsAb-POSITIVE HBcAb-NEGATIVE HAV Ab-POSITIVE IgM HBc-NEGATIVE IgM HAV-NEGATIVE ___ 09:27AM BLOOD HERPES SIMPLEX VIRUS 1 AND 2 (IGG)-PND ___ 06:32AM BLOOD CEA-2.9 ___ 07:59AM BLOOD ALT-354* AST-289* AlkPhos-150* TotBili-1.6* ___ 06:32AM BLOOD ALT-247* AST-134* AlkPhos-151* TotBili-0.5 ___ 07:45AM BLOOD ALT-190* AST-74* AlkPhos-165* TotBili-0.5 ___ EBV IgG (+), IgM (-) ___ CMV IgG (+) at 90 AU/ml (normal <4, if >6 considered positive) ___ MRCP: 1. No biliary dilation. Diffuse, homogeneous gallbladder wall edema, without evidence of acute cholecystitis. These findings are likely secondary to the known hepatitis. 2. Multiple subcapsular renal cortical cysts, relate to glomerular cystic disease. ___ HIDA SCAN: IMPRESSION: Essentially normal hepatobiliary scan. There is no evidence of acute cholecystitis. Note is made of slow filling of the gallbladder in the setting of somewhat unusual bilobed gallbladder anatomy. ___ EGD: Impression: Mass in the stomach body on the lesser curvature, just beyond the GE junction. Polyp in the stomach body on the greater curvature near the antrum. Multiple biopsies taken with a large capacity biopsy forceps. Otherwise normal EGD to third part of the duodenum ___ EUS: Impression: 1.Normal ampulla. 2.Radial EUS of gastric mass: The lesion measured 1.5 cm in length and 0.3 cm in maximum depth. The lesion was hypoechoic and heterogenous with well defined borders. The lesion involved the mucosa and submucosa. There was no evidence of invasion beyond the submucosa. This was staged as T1b by EUS criteria. No ___ lymphadenopathy was found. 3. Linear EUS of bile duct: The bile duct was imaged at the level of the porta-hepatis, head of the pancreas, and ampulla. The maximum diameter of the bile duct was 8 mm. The bile duct was otherwise normal. 4. Otherwise normal upper EUS to second part of the duodenum. ___ ABD/PELV CT: IMPRESSION: 1. In this patient with known mass along the lesser curvature of the stomach, evaluation for gastric mass is limited due to underdistension. 2. No evidence of metastatic disease otherwise noted. 3. Simple hepatic cysts and multiple sub-cm renal cysts are again noted. Brief Hospital Course: ASSESSMENT & PLAN ___ year old woman with a history of colonic adenoma in ___, and remote TAH/BSO who presents with 1 day of acute, sudden onset epigastric pain consistent with cholestatic hepatitis. #) Cholestatic hepatitis: Unclear cause, but possible spontaneously passed stone without CBD dilation. No evidence of cholecystitis. LFTs normalizing dialy prior to discharge. Will need to be followed as outpatient. PCP ___. Labs indicate EBV exposure, and chronic CMV, neither of which are likely culprits here. Her pain dissipated on admission, and patient tolerated a diet prior to discharge. #) Gastric Mass: concerning for malignancy, but if so, all imaging so far would suggest early stage. Surgery ACS team saw her in house in consultation and will follow up with her in near future to review pathology, which is pending at discharge. Patient aware of possibility of cancer and potential need for surgery. #) Anemia: HCT to 30, and patient with guiac positive brown stool in ED. She also has a markedly low MCV, with low iron, suggesting iron deficiency and perhaps a component of hemoglobinopathy such as Thallesemia trait. She should receive oupatient colonoscopy in the future, and especially if the gastric mass biopsy is benign. She was started on oral iron therapy. #) HLP: She was not interested in statin Transitional issues: 1) Gastric mass biospy results pending -- surgery and PCP aware, patient to f/u with PCP and outpatient surgery ACS (___) 2) Iron deficiency anemia +/- ___ trait -- recommend hemoglobin elecrophoresis outpatient, iron therapy and outpatient colonoscopy 3) LFTS should be repeated at next PCP appointment ___ spoke with PCP coverage on day of discharge with update about patient's condition. Medications on Admission: #) Omeprazole 20mg PO BID (just started on ___ Discharge Medications: 1. Omeprazole 20 mg PO BID 2. Ferrous Sulfate 325 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Cholestatic hepatitis - ?passed stone? Gastric mass 1.5cm lesser curvature of stomach Iron deficiency anemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted with RUQ pain and liver test abnormalities which suggested temporary bile duct obstruction with liver inflammation Fortunately, your pain quickly improved, as did you labs. A scan of the gallbladder was normal. A MRCP of the liver did not demonstrate biliary problems. An endoscopy showed a 1.5cm gastric nodule suspicious for possible cancer. Endoscopic ultrasound and CT scan of the abdomen/pelvis did not suggested any spread. A Biopsy of the mass is pending. Followup Instructions: ___
19979239-DS-14
19,979,239
26,031,061
DS
14
2117-04-14 00:00:00
2117-04-14 10:35:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: ___ year old female with L4-L5 left disc herniation and LLE radicular pain. Major Surgical or Invasive Procedure: Revision left L4-L5 microdiscectomy by Dr. ___ on ___ History of Present Illness: ___ year old female with Left L4-L5 disc herniation and LLE radiculopathy who has failed conservative therapies. Patient had h/o previous L4-L5 microdiscectomy by Dr. ___ in ___. Past Medical History: depression Social History: ___ Family History: nc Physical Exam: NAD, A&Ox4 nl resp effort RRR Sensory: ___ L2 L3 L4 L5 S1 S2 (Groin) (Knee) (Med Calf) (Grt Toe) (Sm Toe) (Post Thigh) R SILT SILT SILT SILT SILT SILT L SILT SILT SILT SILT SILT SILT Motor: ___ Flex(L1) Add(L2) Quad(L3) TA(L4) ___ ___ R 5 5 5 5 5 5 5 L 5 5 5 5 5 5 5 Pertinent Results: ___ 09:17PM WBC-6.4 RBC-4.53 HGB-13.5 HCT-40.0 MCV-88 MCH-29.8 MCHC-33.8 RDW-13.0 RDWSD-42.2 ___ 09:17PM GLUCOSE-82 UREA N-16 CREAT-0.9 SODIUM-142 POTASSIUM-4.5 CHLORIDE-102 TOTAL CO2-27 ANION GAP-13 Brief Hospital Course: Patient was admitted to the ___ Spine Surgery Service and taken to the Operating Room for the above procedure. Refer to the dictated operative note for further details. The surgery was without complication and the patient was transferred to the PACU in a stable condition. TEDs/pnemoboots were used for postoperative DVT prophylaxis. Intravenous antibiotics were continued for 24hrs postop per standard protocol. Initial postop pain was controlled with a IV and PO pain medications. Diet was advanced as tolerated. The patient was transitioned to oral pain medication when tolerating PO diet. Foley was removed postoperatively without issue. Physical therapy was consulted for mobilization OOB to ambulate. Hospital course was otherwise unremarkable. On the day of discharge the patient was afebrile with stable vital signs, comfortable on oral pain control and tolerating a regular diet. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Gabapentin 600 mg PO TID 2. Sertraline 100 mg PO DAILY Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H Please obtain over the counter. 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*14 Capsule Refills:*1 3. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate Reason for PRN duplicate override: Alternating agents for similar severity RX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours Disp #*36 Tablet Refills:*0 4. Gabapentin 600 mg PO TID 5. Sertraline 100 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Left L4-L5 disc herniation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You have undergone the following operation: Revision Microdiscectomy Immediately after the operation: Activity: You should not lift anything greater than 10 lbs for 2 weeks. You will be more comfortable if you do not sit or stand more than ~45 minutes without moving around. Rehabilitation/ Physical Therapy: ___ times a day you should go for a walk for ___ minutes as part of your recovery. You can walk as much as you can tolerate. Limit any kind of lifting. Diet: Eat a normal healthy diet. You may have some constipation after surgery. Brace: You do not need a brace. Wound Care: Remove the dressing in 2 days. If the incision is draining cover it with a new sterile dressing. If it is dry then you can leave the incision open to the air. Once the incision is completely dry (usually ___ days after the operation) you may take a shower. Do not soak the incision in a bath or pool. If the incision starts draining at anytime after surgery, do not get the incision wet. Cover it with a sterile dressing. Call the office. You should resume taking your normal home medications. You have also been given Additional Medications to control your pain. Please allow 72 hours for refill of narcotic prescriptions, so please plan ahead. You can either have them mailed to your home or pick them up at the clinic located on ___. We are not allowed to call in narcotic prescriptions (oxycontin, oxycodone, percocet) to the pharmacy. In addition, we are only allowed to write for pain medications for 90 days from the date of surgery. Follow up: Please Call the office and make an appointment for 2 weeks after the day of your operation if this has not been done already. At the 2-week visit we will check your incision, take baseline X-rays and answer any questions. We may at that time start physical therapy. We will then see you at 6 weeks from the day of the operation and at that time release you to full activity. Please call the office if you have a fever>101.5 degrees Fahrenheit and/or drainage from your wound Physical Therapy: No heavy lifting, twisting or bending for 6 weeks. Treatments Frequency: Wound Care: Remove the dressing in 2 days. If the incision is draining cover it with a new sterile dressing. If it is dry then you can leave the incision open to the air. Once the incision is completely dry (usually ___ days after the operation) you may take a shower. Do not soak the incision in a bath or pool. If the incision starts draining at anytime after surgery, do not get the incision wet. Cover it with a sterile dressing. Call the office. Followup Instructions: ___
19979275-DS-17
19,979,275
20,033,240
DS
17
2126-04-24 00:00:00
2126-04-24 18:17:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Depakote / gabapentin / morphine / naproxen Attending: ___. Chief Complaint: Seizure-Like Episodes Major Surgical or Invasive Procedure: None this hospitalization. History of Present Illness: Mr. ___ is a ___ with a history of right occipital gliosarcoma s/p resection with residual left field defect, non-small cell carcinoma, and chronic dizziness who presented with seizure like episodes. He (with help from his family - wife, son, daughter at bedside) describes the episodes as left arm shaking, which evolves into to full-body tremulousness. He never loses consciousness and remembers the events, but he feels poorly for a few minutes prior. He notices that the events spontaneously happen when he lifts his left arm, just about every time he lifts it today, corroborated by his family. He feels like he has no control over it and that moving the arm exacerbates it. Per report, he had multiple episodes over the week prior to admission (1 on ___ and ___, at which time Dr. ___ his lamictal to 125mg twice daily, in addition to Vimpat 100mg twice daily. This initially resolved the issue for about 1 week. On ___, he was noted by his wife to have hand clenching and arching of his back; the episode lasted a minute or so. Based on this, Dr. ___ increased ___ to 150mg twice daily and started dexamethasone 2mg daily for concern for progression of his gliosarcoma. His MRI was moved up. However, he was then brought into the ED because of ongoing shaking and family concern for seizures. He is chronically dizzy with vertigo for which he has been going to vestibular ___ and getting Epley maneuvers, which he feels makes things worse. He has nausea with the vertigo but no vomiting. He reports double vision today but his family was very surprised by this. His left leg has been colder than the right for 4 days, but per family this is a baseline and people have compared pulses before. He has had chronic neck pain on the right side which is ongoing, perhaps worse over the past few days. He did have some chest pain on the drive in to the hospital, left and right sided, difficult to describe which resolved when he had settled down in the ED. Notably, his prior seizure episodes were staring episodes, on EEG found to arise from the right central parasagital region. In the ED, initial vitals were: 73 | 111/76 | 19 | 97% RA . His neuro exam was noted to be nonfocal, notable for "some difficulties with memory and recounting event, tangential speech, left inferior quadrantanopia, decreased pinprick in the hands," and his family reportedly felt him to be at his baseline. Labs were notable for: 142 | 102 | 24 9.8 ---------------< 102 1.9 4.8 | 24 | 1.5 3.7 6.7 > 13.1/41.3 <229 N 75.2 AST 13, ALT 8, AP 89, Tbili 0.2, Alb4.4, Lipase 21 Neg serum tox Trio 0.01 ___ 11.6, PTT 36.4, INR 1.1 UA: Neg Imaging notable for an MR head with no acute findings. The patient was given IV lorazepam. Vitals prior to transfer: 98.8 | 68 | 128/79 24 | 96% RA. Past Medical History: PAST ONCOLOGIC HISTORY, per primary oncologist note: (1) blurry vision and headache on ___, (2) ___ ___ head CT showed intracranial hemorrhage in the right occipital brain, (3) started on ___ levetiracetam 500 mg twice daily and dexamethasone 4 mg TID, (4) reportedly gross total resection on ___ ___. ___ by Dr. ___ (4) began ___ IMRT + temozolomide by Dr. ___, (5) dexamethasone reduced to 2 mg TID for insomnia in ___, (6) developed strange behavior on ___ with difficulty buttoning his shirt and word-finding difficulty, (7) developed right upper extremity tremor on ___, (8) ___ ED on ___ seizures, (9) admission to ___ ___ general neurology for seizures (10) EEG ___ to ___ showed 8 electrographic seizures in the right central parasagittal region lasting ___ minutes, (11) lacosamide 100 mg IV BID, fosphenytoin 100 mg IV Q8H added, (12) EEG ___ to ___ showed bursts of focal slowing at the right hemisphere, (13) resumed IMRT + TMZ on ___ at ___ to ___, (14) monthly TMZ x 11 cycles ended in ___, (15) both dexamethasone and Bactrim stopped in ___, 916) Pt noted to struggle with low mood in ___, which seemed to improve. PAST MEDICAL HISTORY: - NSCLC: a long standing smoker; developed a chronic cough. PCP sent him for a chest X-ray which revealed a LUL mass on ___. Staging scans were negative except for the lung. CT guided biopsy on ___ revealed non-small cell lung cancer consistent with squamous cell carcinoma. Power port was inserted ___. He was treated with chemo-irradiation at ___ Cancer radiation. Chest irradiation was applied to 6300 cGy and it ended ___. - CAD - HTN - HLD - Asthma - Anxiety - Degenerative disk disease PAST SURGICAL HISTORY - ___ CABG x3 vessel - ___ AAA repair Social History: ___ Family History: Father with alcohol use disorder and lung cancer. Mother with pancreatitis. Physical Exam: ======================== Admission Physical Exam: ======================== VS: 98.3 | 131/79 | 58 | 19 | 97%Ra GENERAL: Appears cachectic and fatigued. Laying in bed, looks uncomfortable, partially covering face with sheet, intermittently deferring to his wife ___ mucous membranes. Pupils 4mm and equally reactive to light (to 2mm). NECK: No concerning lymphadenopathy. Can turn neck complete to left, somewhat limited by pain (only about 45* on right) CV: RRR, no murmurs. PULM: CTAB without adventitious sounds. ABD: Scaphoid, soft, nontender, nondistended. EXT: WWP without edema. SKIN: No visible rashes. NEURO: Oriented to year, month; date "___ but knows his birthday is coming up. Somewhat confused on details of recent history (per family) and perseverating a bit on older history (eg, used to be strong enough to lift water buckets for work; now weaker than that). Face is grossly symmetric though beard may obscure a slight left lip droop. Strength and sensation on face are intact and symmetric. Tongue is midline with some jerking movmements intermittently. No dysarthria. Can follow two-step commands: use your left pointer finger to point at your son. Can name high and low frequency objects (though does steth-es-cope by syllables). He has large-amplitude jerking movement when he moves either his left shoulder or his left elbow, which can evolve into a whole body jerking movement during which he is still conscious; however, this can be suppressed by distraction, or by helping him get into position (eg, left arm outstretched) and then removing supporting hand. He has no cogwheel rigditiy. He has no asterixis or jerking on prolonged finger grip. His strength is grossly ___ in large muscle groups Sensation to light touch is grossly symmetric in upper extremities; lower extremities "left feels a little different." No pronator drift. Gait not assessed. Pertinent Results: =============== Admission Labs: =============== ___ 09:37PM BLOOD WBC-6.8 RBC-4.36* Hgb-13.1* Hct-41.3 MCV-95 MCH-30.0 MCHC-31.7* RDW-14.1 RDWSD-48.7* Plt ___ ___ 09:37PM BLOOD Neuts-75.2* Lymphs-15.7* Monos-7.3 Eos-0.6* Baso-0.9 Im ___ AbsNeut-5.12 AbsLymp-1.07* AbsMono-0.50 AbsEos-0.04 AbsBaso-0.06 ___ 09:39PM BLOOD ___ PTT-36.4 ___ ___ 09:37PM BLOOD Glucose-102* UreaN-24* Creat-1.5* Na-142 K-4.8 Cl-102 HCO3-24 AnGap-16 ___ 09:37PM BLOOD ALT-8 AST-13 AlkPhos-89 TotBili-0.2 ___ 09:37PM BLOOD Lipase-21 ___ 09:37PM BLOOD cTropnT-<0.01 ___ 09:37PM BLOOD Albumin-4.4 Calcium-9.8 Phos-3.7 Mg-1.9 ___ 09:37PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Tricycl-NEG ___ 09:39PM BLOOD Lactate-1.5 ======================== Discharge Physical Exam: ======================== ___ 06:19AM BLOOD WBC-6.4 RBC-4.38* Hgb-13.2* Hct-41.1 MCV-94 MCH-30.1 MCHC-32.1 RDW-14.0 RDWSD-49.1* Plt ___ ___ 06:19AM BLOOD Glucose-91 UreaN-19 Creat-1.2 Na-141 K-4.1 Cl-99 HCO3-31 AnGap-11 ___ 06:19AM BLOOD Calcium-9.8 Phos-4.2 Mg-2.1 ============= Microbiology: ============= ___ Urine Culture < 10,000 CFU/mL ======== Imaging: ======== 1. Redemonstrated postsurgical changes related to resection of previously noted right temporoparietal mass. 2. Thin linear enhancement along the inferolateral margin of the resection cavity appears unchanged. 3. The extent of FLAIR hyperintense signal surrounding the resection cavity and involving the splenium of the corpus callosum and white matter along the left occipital horn appears unchanged. 4. Interval decrease in size of a rounded nonenhancing focus within the dependent resection cavity, mild measuring 9 mm, previously measuring 17 mm on ___. Findings likely reflect clotted blood products with interval partial resorption. 5. No new region of FLAIR signal abnormality or enhancement is seen. Brief Hospital Course: ___ with a history of right occipital gliosarcoma s/p resection with residual left field defect, non-small cell carcinoma, and chronic dizziness who presented with seizure like episodes of left arm myoclonus and whole-body jerking, not associated with an aura or post-ictal state, which is suppressible on exam, but nonetheless potentially concerning for seizure activity. # Non-Epileptic Convulsions/Seizures: # Gliosarcoma: MRI brain was unchanged. Monitored on EEG without true seizures. He was continued on lamictal (recently increased as outpatient) and lacosamide. Continued dexamethasone. His symptoms were improved at discharge. He will follow-up with Dr. ___. # Acute Kidney Injury: Resolved with fluids. # Depression: His sertraline was increased to 100mg daily. He was continued on his other home medications. # Chronic Back Pain: Continued home oxycodone and oxycontin. # Hypertension: Continued home metoprolol. # Hyperlipidemia: Continued home pravastatin. # BILLING: 35 minutes were spent in preparation of discharge summary, coordination with outpatient providers, and counseling with patient/family. ==================== Transitional Issues: ==================== - Sertraline increased to 100mg daily. - Continued Lamictal 150mg BID and dexamethasone 2mg daily. - Please follow-up final EEG report from ___ and ___. - Please ensure follow-up with Dr. ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Dexamethasone 2 mg PO DAILY 2. LACOSamide 100 mg PO BID 3. LamoTRIgine 150 mg PO BID 4. ALPRAZolam 0.5-1 mg PO BID:PRN anxiety 5. Metoprolol Succinate XL 25 mg PO BID 6. Pravastatin 20 mg PO QPM 7. OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Moderate 8. OxyCODONE SR (OxyCONTIN) 20 mg PO Q12H 9. Omeprazole 20 mg PO DAILY 10. Aspirin 81 mg PO DAILY 11. Sertraline 50 mg PO DAILY 12. Albuterol Inhaler ___ PUFF IH Q6H:PRN shortness of breath/wheezing 13. Ipratropium Bromide MDI 2 PUFF IH BID:PRN shortness of breath/wheezing 14. ALPRAZolam 2 mg PO DAILY Discharge Medications: 1. Sertraline 100 mg PO DAILY RX *sertraline 100 mg Take 1 tablet by mouth daily. Disp #*30 Tablet Refills:*2 2. Albuterol Inhaler ___ PUFF IH Q6H:PRN shortness of breath/wheezing RX *albuterol sulfate 90 mcg Take ___ puffs IH every six (6) hours Disp #*1 Inhaler Refills:*2 3. ALPRAZolam 0.5-1 mg PO BID:PRN anxiety 4. ALPRAZolam 2 mg PO DAILY 5. Aspirin 81 mg PO DAILY 6. Dexamethasone 2 mg PO DAILY RX *dexamethasone 2 mg Take 1 tablet by mouth daily. Disp #*30 Tablet Refills:*0 7. Ipratropium Bromide MDI 2 PUFF IH BID:PRN shortness of breath/wheezing 8. LACOSamide 100 mg PO BID 9. LamoTRIgine 150 mg PO BID RX *lamotrigine 150 mg Take 1 tablet by mouth twice daily. Disp #*60 Tablet Refills:*2 10. Metoprolol Succinate XL 25 mg PO BID 11. Omeprazole 20 mg PO DAILY 12. OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Moderate 13. OxyCODONE SR (OxyCONTIN) 20 mg PO Q12H 14. Pravastatin 20 mg PO QPM Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis: - Non-Epileptic Convulsions/Seizures - Acute Kidney Injury - Gliosarcoma - Depression Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at the ___ ___. You were admitted with concern for seizure. You had a brain MRI that did not show any changes. You had an EEG that did show any true seizure activity. Your symptoms improved. Your lamictal and sertraline dose was increased. You will follow-up with Dr. ___. All the best, Your ___ Team Followup Instructions: ___
19979469-DS-16
19,979,469
20,045,455
DS
16
2201-06-09 00:00:00
2201-06-09 22:08:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Lightheadedness Major Surgical or Invasive Procedure: EGD, colonoscopy History of Present Illness: Mr. ___ is a ___ yo male with history of Hepatitis C c/b cirrhosis with prior hx varices, & obstructive jaundice s/p , unresectable stage IIB ampullary adenocarcinoma s/p operative resection ___, ERCP and stent placement who presents with lightheadedness for 2 days in the setting of red diarrhea. Patient reports 2 day history of diarrhea with reddish color but no gross blood. Never had GI bleeding before. Diarrhea continued day of admission w/ some mild, intermittent periumbilical abdominal pain. On day of admission, patient became lightheaded and had to lay on floor. Denies LOC or head trauma. Patient then slept for 2 hours, came down stairs, and was noted by wife to have 2 separate episodes of sweating, lightheadedness, hyperventilation while fading out. Denies chest pain, shortness of breath, nausea, vomiting, fevers, chills. No recent surgery or prolonged immobilization. Denies leg swelling, worsening DOE in last couple of days preceding. No PND/orthopnea. In the ED, initial VS were: 97.9 94 93/52 16 99% Patient found to have Hct drop of 10 pts, transfused 2 units, thought likely LGIB. Started on pantoprazole BID. BP 100s-110s/60s-70s; mentating fine. GI saw patient. Neg NG lavage per pt. On arrival to the MICU, patient denies any discomfort. 125/67 87 sat 97% on RA REVIEW OF SYSTEMS: no chest pain, dyspnea, fevers, chills, nausea, vomiting, PND or orthopnea. Past Medical History: Pancreatic mass as detailed in Oncology notes Chronic Hep C Cirrhosis (varices noted in past) Asthma ERCP/CBD stent ___ Social History: ___ Family History: Maternal aunt colon cancer in her ___. Maternal uncles had cancer NOS in their old age. Mother: living at age ___ ___VA Father: living at age ___ Siblings: brother deceased of ___ in ___, 2 other brothers and 1 sister living Children: healthy No family history of pancreaticoduodenal cancer. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals: 125/67 87 sat 97% on RA General: NAD HEENT: clear oropharynx Neck: supple CV: NR, RR, no murmur Lungs: CTAB, good air movement Abdomen: NT, ND, soft, well-healed post-surgical scar on RUQ, no ascites appreciated GU: no Foley Ext: no peripheral edema Skin: no lesions noted Neuro: A&O, no gross deficits, moving all ext Psych: appropriate affect DISCHARGE PHYSICAL EXAM: Vitals: 98.0 126/73 65 18 97RA General: alert, oriented x3, NAD HEENT: clear oropharynx Neck: supple CV: NR, RR, no murmur Lungs: CTAB, good air movement Abdomen: NT, ND, soft, well-healed post-surgical scar on RUQ, no ascites appreciated GU: no Foley Ext: no peripheral edema Skin: no lesions noted Neuro: A&O, no gross deficits, moving all ext Pertinent Results: ADMISSION LABS: ___ 05:06PM WBC-5.5 RBC-2.21*# HGB-7.2*# HCT-21.3*# MCV-96 MCH-32.8* MCHC-34.1 RDW-22.5* ___ 05:06PM NEUTS-78.2* LYMPHS-13.8* MONOS-4.8 EOS-2.9 BASOS-0.3 ___ 05:06PM ___ PTT-21.5* ___ ___ 05:06PM GLUCOSE-111* UREA N-33* CREAT-0.9 SODIUM-141 POTASSIUM-4.5 CHLORIDE-109* TOTAL CO2-22 ANION GAP-15 ___ 05:06PM ALT(SGPT)-32 AST(SGOT)-56* ALK PHOS-62 TOT BILI-0.3 ___ 05:06PM LIPASE-92* ___ 05:06PM ALBUMIN-3.1* CALCIUM-8.3* PHOSPHATE-3.3 MAGNESIUM-2.0 ___ 06:03PM LACTATE-1.2 DISCHARGE LABS: ___ 01:00PM BLOOD Hct-26.6* ___ 07:00AM BLOOD WBC-3.8* RBC-2.69* Hgb-8.7* Hct-24.9* MCV-93 MCH-32.2* MCHC-34.8 RDW-21.8* Plt Ct-94* IMAGING: CXR: FINDINGS: Two views were obtained of the chest. Right Port-A-Cath terminates with tip in the upper right atrium. The lungs appear well expanded and clear without pleural effusion or pneumothorax. The heart is normal in size with normal cardiomediastinal contours. IMPRESSION: No acute intrathoracic process. EKG:Sinus rhythm. Left axis deviation. Otherwise, within normal limits. No previous tracing available for comparison. EGD: Distal esophagitis was seen. There were no varices. Antral gastritis was seen. (biopsy) Duodenal erosions. Medium hiatal hernia. Otherwise normal EGD to third part of the duodenum Colonoscopy: Normal colon to cecum. Brief Hospital Course: Mr. ___ is a ___ yo male with history of Hepatitis C c/b cirrhosis with prior hx varices, obstructive jaundice, unresectable stage IIB ampullary adenocarcinoma s/p operative resection ___, ERCP and stent placement who presents with lightheadedness for 2 days in the setting of hematochezia and significant hematocrit drop. # GI BLEED: He presented with 2 days of dark bloody stools, and his Hct dropped from baseline of 30 to 21. This is likely lower GI given presence of red/maroon colored stools, however source not entirely clear. Differential included upper source from local extension of tumor vs. lower source (diverticular, AV malformation, ischemic). He received 3 units of pRBCs on admission to the ICU, and his hematocrit remained stable thereafter. He was treated with IV protonix, and received an upper endoscopy and colonoscopy which showed esophagitis, gastritis and duodenitis with duodenal erosions. There were no active sites of bleeding. At the time of discharge, his hematocrit was stable at 26.6 and he was started on daily PPI. There was no need for GI follow-up or further work-up. # Lightheadedness: He presented with lightheadedness, likely orthostatic dizziness due to his GIB. His blood pressures remained stable after his transfusions, however his home amlodipine was held. At the time of discharge, he did not have lightheadedness, and his hematocrit was stable. His Amlodipine was held on discharge, with the instructions that this could be restarted after being seen by his PCP for HCT check and vitals. # Ampullary Adenocarcinoma, stage IIB: s/p operative resection ___ however, stage IIB ampullary found intraoperatively to have unresectable disease secondary to regional lymph node metastases. Hx obstructive jaundice s/p ERCP and stent placement. He was previously on capecitabine, however this was held during this admission given his GI bleed. # Hepatitis C / Cirrhosis: MELD score 6. Child's ___ class A. Reported hx of varices, however EGD ___ neg for varices. No ascites was appreciated on exam, so there was no need for diuresis or SBP prophylaxis. His mental status was clear and there was no concern for encephalopathy. # MOOD: stable, continued his home fluoxetine TRANSITIONAL ISSUES: 1. Pending labs: biopsy results of gastric mucosa during EGD 2. Hct check: on ___ at Dr. ___ (visit ___/ ___ ___ NP.) 3. Amlodipine: was held on discharge as BPs remained well controlled without this med. Would advise restarting Amlodipine only if needed after HCT/vitals check 4. For analgesia in the future: please encourage him to use Tylenol (<3g daily) or low dose oxycodone that he has at home already. Please remind him to avoid Motrin and aspirin. 5. His chemotherapy (capecitabine) for his ampullary adenocarcinoma was held during this admission given his GI bleed. He will follow up with heme-onc on ___ to resume treatment. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ondansetron 8 mg po Q8H:PRN nausea 2. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain, headache hold for sedation or confusion 3. Gabapentin 300 mg PO TID hold for sedation 4. Fluoxetine 30 mg PO DAILY 5. Amlodipine 5 mg PO DAILY Discharge Medications: 1. Fluoxetine 30 mg PO DAILY 2. Gabapentin 300 mg PO TID hold for sedation 3. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain, headache hold for sedation or confusion 4. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. Outpatient Lab Work CBC ICD-9-CM 578.9 Please fax results to Dr. ___: ___ 6. Ondansetron 8 mg PO Q8H:PRN nausea Discharge Disposition: Home Discharge Diagnosis: Gastrointestinal bleeding Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you while you were admitted to ___. You were admitted with gastrointestinal bleeding and you received blood transfusions which you tolerated well. You were also seen by the gastroenterology specialists who performed an upper endoscopy and colonoscopy. They found areas of inflammation in the esophagus, stomach and small intestine, but no sites of active bleeding. At this time, you do not require further gastrointestional follow-up or imaging studies. It is important that you stop taking medications that may lead to bleeding, such as Motrin (ibuprofen) and aspirin. You should also refrain from ingesting hydrogen peroxide solution as you were recently doing. You will also need to have blood work done on ___, to check your hematocrit level (blood level). If in the future you notice bleeding, weakness/dizziness, shortness of breath, or chest pain, please call your PCP or come to the emergency room. Followup Instructions: ___
19979469-DS-21
19,979,469
23,317,669
DS
21
2202-08-29 00:00:00
2202-08-29 16:24:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: GI bleeding Major Surgical or Invasive Procedure: EGD ___ History of Present Illness: ___ h/o recurrent upper GI bleeding in the setting of an ulcerated stage IIB ampullary adenocarcinoma, ___ ulcer, and gastric angioectasias s/p recent arterial embolization to ampulla blood supply presents from clinic for severe anemia. Pt came to clinic today and was found to be orthostatic and hypotensive. Pt c/o one day of weakness, fatigue and associated dark stools. He denies n/v/d/abd pain. He denies fever though did have an episode of chiils today. Labs in clinic showed Hct of 22.5 down from 23 on ___ despite having had 2 units prbcs. He was sent to the ___ and given 1U of prbcs before transferred to ___ for further management. . In the ___: T98.3, bp 104/68, hr 90, 20 98% ra. HCT 22, plt 70. Admitted to ___ for further management. . ROS: as above. otherwise complete ROS negative Past Medical History: PAST ONCOLOGIC HISTORY: ___: developed obstructive jaundice for which he underwent an ERCP at ___ which was complicated by self-limited pancreatitis. ___: felt well until developed jaundice. ERCP was again performed at ___ with stent placement and his jaundice resolved. ___: EUS revealing enlarged tumor-like ampulla and mass at the head of the pancreas. FNA of the mass revealed ampullary adenocarcinoma. ___: presented to the ___ with fever and obstructive jaundice and underwent ERCP with previous plastic stent which had migrated being removed and pigtail biliary stent placed at the distal CBD stricture. ___: he underwent surgery with Dr. ___ with intention to perform Whipple, but intraoperatively he was noted to have a nodule/cirrhotic liver and several hard regional lymph nodes near the celiac axis and mesenteric artery/para-aortic region such that Whipple was abandoned and Pt had cholecystectomy, liver biopsies and lymph node biopsies. 1 lymph node retro-pancreatic was positive for adenocarcinoma consistent with ampullary primary. ___: Gemcitabine started. Dose reduction for C2 by 25% secondary to neutropenia and thrombocytopenia C1D15 requiring dose to be held. ___: C2D15 once again held for cytopenias; regimen changed to 21d cycle with treatment on D1, D8. ___: completed C3 with neulasta support on ___, day 9 ___: completed 6.5 cycles of gemcitabine, stopped due to increasing ___: started capecitabine alone for cycle 1 ___: ___ cycle 1 dose reduced oxaliplatin to 100mg/m2 ___: ___ 130mg/m2 cycle 2 ___: ___ reduced to 100mg/m2 ox. Cycle 6 reduced to 85mg/m2 as had been delayed 2 weeks due to thrombocytopenia. Cycle 7 was delayed and on ___ he started capecitabine alone. Cycle 9 was postponed 1 week due to borderline platelets and being on antibiotics. ___ single agent capecitabine was started at 1000mg BID. ___ restaging CT showed stable disease ___ Xeloda held due to hand and foot syndrome. ___ hospitalized due to upper GI bleeding, replacement of stent, complicated by sepsis. ___ restaging CT showed local progression of ampullary cancer. ___ radiation to biliary area with concurrent Xeloda ___ admitted to medicine service for GI bleed requiring ___ embolization of arterial supply to ampulla ___ admitted for recurrent GI bleed, no further ___ intervention given risk for necrosis, EGDx2 with APC to areas of bleeding. continued to have slow bleeding at ___, plan for palliative transfusions at ___ PAST MEDICAL HISTORY: # Chronic HCV w/ Class A Cirrhosis: - Per OMR has had varices in the past but none seen on EGD on ___ - HCV VL 782,757 IU/mL on ___ # Prior GIB, ___: Source unidentified # Distal esophagitis on EGD ___ # Antral gastritis on EGD ___ # Duodenal erosions on EGD ___ # Medium hiatal hernia on EGD ___ # Asthma - Recent history notable for bronchitis # HTN Social History: ___ Family History: Maternal aunt colon cancer in her ___. Maternal uncles had cancer (unknown type) in their old age. Mother: living at age ___ ___VA Father: living at age ___ Siblings: brother deceased of ___ in ___, 2 other brothers and 1 sister (alcoholic) living Children: healthy No family history of pancreaticoduodenal cancer Physical Exam: PHYSICAL EXAM: VITALS: 98.1 106/58 78 18 97%RA GENERAL: NAD, appears pale HEENT: MMM CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: clear to ausculation bilaterally, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: moderately distended, positive bowel sounds, non-tender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: trace edema bilaterally in lower extremities, warm and well perfused NEURO: ___ strength throughout, no asterixis SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: ================================== Labs ================================== ___ 12:30PM BLOOD WBC-3.9* RBC-2.31* Hgb-7.1* Hct-21.65* MCV-94 MCH-30.6 MCHC-32.7 RDW-16.1* Plt Ct-70* ___ 06:50PM BLOOD WBC-3.5* RBC-2.61* Hgb-7.8* Hct-24.6* MCV-94 MCH-30.0 MCHC-31.8 RDW-16.7* Plt Ct-76* ___ 04:26AM BLOOD WBC-2.8* RBC-2.45* Hgb-7.6* Hct-23.4* MCV-96 MCH-30.9 MCHC-32.3 RDW-16.2* Plt Ct-69* ___ 06:00AM BLOOD WBC-3.5* RBC-2.39* Hgb-7.4* Hct-22.5* MCV-94 MCH-31.0 MCHC-32.9 RDW-16.8* Plt Ct-59* ___ 01:00PM BLOOD WBC-3.6* RBC-2.58* Hgb-8.1* Hct-24.3* MCV-94 MCH-31.5 MCHC-33.5 RDW-16.5* Plt Ct-71* ___ 04:30AM BLOOD ___ PTT-30.3 ___ ___ 01:00PM BLOOD Glucose-110* UreaN-17 Creat-0.8 Na-133 K-3.5 Cl-102 HCO3-27 AnGap-8 ___ 03:29AM BLOOD ALT-38 AST-100* AlkPhos-326* TotBili-4.6* ___ 06:02AM BLOOD ALT-33 AST-73* AlkPhos-309* TotBili-2.5* ___ 07:29AM BLOOD TotBili-1.4 ___ 04:30AM BLOOD TotBili-1.3 ___ 04:26AM BLOOD ALT-23 AST-39 AlkPhos-206* ___ 06:00AM BLOOD ALT-10 AST-19 AlkPhos-110 TotBili-0.5 ___ 01:00PM BLOOD ALT-20 AST-33 AlkPhos-177* TotBili-1.8* ___ 03:29AM BLOOD Calcium-7.2* Phos-2.9 Mg-2.0 ___ 06:00AM BLOOD Albumin-1.1* Calcium-4.3* Phos-2.0* Mg-1.1* ___ 01:00PM BLOOD Albumin-2.0* Calcium-7.4* Phos-3.8# Mg-1.8 ___ 01:00PM BLOOD Albumin-2.0* Calcium-7.4* Phos-3.8# Mg-1.8 ================================== Procedures ================================== EGD ___ Impression: A medium size paraesophageal hernia was seen. Grade B esophagitis was seen; no varices were noted Patchy petechiae and abnormal vascularity of the mucosa without stigmata of recent bleeding were noted in the antrum (improved from previous s/p RFA). Diffuse continuous friability, congestion and abnormal vascularity of the mucosa with contact bleeding were noted in the first and second part of the duodenum up until the ampullary metal stent. There were multiple frank ulcers without high risk stigmata. RFA was applied for hemostasis successfully using a flexible HALO TTS catether in the duodenum (bulb and D1/2 turn). Overall successful RFA of ongoing/worsening duodenitis. paracentesis ___ FINDINGS: Initial four quadrant ultrasound demonstrated a large pocket of free fluid consistent with ascites. PROCEDURE: The procedure, risks, benefits and alternatives were discussed with the patient and written informed consent was obtained. A preprocedure time-out was performed discussing the planned procedure, confirming the patient's identity with 3 identifiers, and reviewing a checklist per ___ protocol. Under ultrasound guidance, an entrance site was selected and the skin was prepped and draped in the usual sterile fashion. 1% lidocaine buffered with sodium bicarbonate was instilled for local anesthesia. A 5 ___ catheter was advanced into the largest fluid pocket in the right lower quadrant and 4.95 L of clear, straw-fluidwas removed. The patient tolerated the procedure well without immediate complication. Estimated blood loss was minimal. Dr. ___ attending radiologist, was present throughout the critical portions of the procedure. IMPRESSION: Technically successful ultrasound-guided therapeutic paracentesis with 4.95 L of ascites removed. The study and the report were reviewed by the staff radiologist. Brief Hospital Course: ___ year old man h/o stage IIb ampullary carcinoma and recurrent GIBs s/p ___ embolization and endoscopy with APC, who presented with ongoing GI bleeding, requiring maintenance transfusions. also with symptomatic ascites s/p 5L paracentesis 1. GI Bleed- ongoing issue with several recent hospitalizations. after last hospitalization DCed with plan for palliative transfusions which he was getting at ___. s/p 1 unit ___ at ___ and 6 units here over the course of his 1 weeks stay. He has been evaluated extensively by ___ and GI. - previously seen by ___, no plan for further intervention given risk for necrosis - endoscopy with GI shows similar findings of some oozing angioectasias and friable mucosa. may be related to radiation to the area. despite multiple attempts with APC and RFA he continues to lose blood and is requiring blood transfusions every ___ days. He was transfused to a goal hct >24. plt goal was >50 though he did not require platelet transfusion. 2. Ascites: malignant versus related to liver cirrhosis. s/p paracentesis ___, approx 5L removed, with improvement in discomfort and hiccups. started on lasix and aldactone. will need f/u electrolytes in the next few days. repeat paracentesis will be based on reaccumulation and development of symptoms. outpatient paracentesis can be arranged through Dr. ___ ___ if needed. 3. Stage IIb Ampullary Carcinoma - Deemed not a surgical candidate. Cannot have further chemotherapy at this point due to his continued GI bleeds and thrombocytopenia. CT abd/pelvis on last admission suggests slight increase in tumor burden. given his ongoing bleeding and cytopenias he will likely not be able to get any further tumor directed therapy. pt and his wife are aware of this, and of the fact that his tumor will likely progress over the next few weeks to months and eventually cause some kind of new medical problem. 4. Depression - he continued his home dose of Prozac 5. Pain - controlled on home regimen: - Continue OxyCODONE SR (OxyconTIN) 20 mg PO Q12H - OxycoDONE (Immediate Release) 10 mg PO/NG Q4H:PRN pain 6. Pancytopenia -likely ___ malignancy and cirrhosis/splenomegaly. stable, no intervention was required. FEN: regular diet ACCESS: PIV, port-a-cath PROPHYLAXIS: - DVT ppx with compression stockings, holding anticoagulation given bleeding concerns -Pain management with Oxycodone, Oxycontin -Bowel regimen with colace, senna CODE: Full code EMERGENCY CONTACT: ___ ___ # Dispo: [x] Discharge documentation reviewed, pt is stable for discharge. [x] Time spent on discharge activity was greater than 30min. [ ] Time spent on discharge activity was less than 30min. ____________________________________ ___, MD, pager ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Docusate Sodium 100 mg PO BID 2. Dronabinol 2.5 mg PO DAILY 3. Fluoxetine 40 mg PO DAILY 4. Gabapentin 300 mg PO DAILY 5. Multivitamins 1 TAB PO DAILY 6. OxycoDONE (Immediate Release) 10 mg PO Q4H:PRN pain 7. OxyCODONE SR (OxyconTIN) 20 mg PO Q12H 8. Senna 8.6 mg PO BID:PRN constipation 9. Ascorbic Acid ___ mg PO DAILY 10. Omeprazole 20 mg PO BID 11. Ondansetron 4 mg PO Q8H:PRN n/v Discharge Medications: 1. Ascorbic Acid ___ mg PO DAILY 2. Docusate Sodium 100 mg PO BID 3. Dronabinol 2.5 mg PO DAILY 4. Fluoxetine 40 mg PO DAILY 5. Gabapentin 300 mg PO DAILY 6. Multivitamins 1 TAB PO DAILY 7. Ondansetron 4 mg PO Q8H:PRN n/v 8. OxycoDONE (Immediate Release) 10 mg PO Q4H:PRN pain 9. OxyCODONE SR (OxyconTIN) 20 mg PO Q12H 10. Senna 8.6 mg PO BID:PRN constipation 11. Baclofen 15 mg PO TID hiccups 12. Omeprazole 20 mg PO BID 13. Furosemide 20 mg PO DAILY 14. Spironolactone 50 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: ampullary carcinoma GI bleed ascites Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: You were admitted because you were having persistent GI bleeding. You had a repeat endoscopy and some small areas of bleeding were stopped, but you continue to have persistent oozing and are requiring blood transfusions every ___ days. It was noticed that your abdomen was getting more and more distended. Therefore, a paracentesis was performed to remove fluid from your abdomen. You were then discharged to ___ ___ where you will continue being monitored. Followup Instructions: ___
19979529-DS-14
19,979,529
27,918,561
DS
14
2167-09-20 00:00:00
2167-09-20 16:14:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Benzocaine Attending: ___. Chief Complaint: PCP: ___ GI: ___ CC: ___ pain x 2 months Major Surgical or Invasive Procedure: EGD/colonoscopy History of Present Illness: HPI(4): Ms. ___ is a ___ female with a PMH of multinodular goiter (euthyroid), dysphonia, anxiety, and multiple orthopedic surgeries after an escalator accident who presents with two months of constant abdominal pain. She was referred here by her gastroenterologist, Dr. ___ expedited workup. The abdominal pain is diffuse, difficult to localize and feels like an gnawing pain. It is aggravated by having an empty stomach and sometimes wakes her up at night from sleep. Sometimes drinking hot tea with milk alleviates the pain. Tensing her abdomen does not make the pain worse. She denies associated nausea/vomiting and has not had any bladder or bowel issues. History of a cholecystectomy years ago but no other abdominal surgeries. Has had a lot of recent stressors including interpersonal issues with people at her group home and a stalled lawsuit over an escalator accident. On ___, patient called Dr. ___ at ___ with with persistent severe abdominal pain. Passing gas and having BMs. No nausea and vomiting. No fever. Patient very irritable and unable to provide further details of character of pain. Given severity they advised her to come to ED for expedited CT scan. However she did not want to come to ER and hung up. She did not want to try any medications such as tylenol/Bentyl. Per Dr. ___, pain seemed c/w some kind of ulcer or gastritis or possibly Gerd and may require egd, omeprazole and h pylori testing. ED Course: VS, PE, belly labs and CT unremarkable. GI consulted. Admitted for expedited workup. ROS: Pertinent positives and negatives as noted in the HPI. All other systems were reviewed and are negative Past Medical History: PAST MEDICAL/SURGICAL HISTORY: MULTINODULAR GOITER - euthyroid, has recent benign biopsy for a nodule HYPERTENSION DYSPHONIA PSYCHIATRIC ILLNESS, ? TYPE -see ___ social service note- living in group home, no primary care, in process of changing- no records yet available - not sure who gave her her anti anxiety meds originally or who other than pcp is regulating SURGICAL HISTORY KNEE SURGERY - bilat tkr last ___ CHOLECYSTECTOMY ? when MULTIPLE ORTHOPEDIC OPERATIONS ON KNEES AND L SHOULDER escalator accident ___ unavailable Social History: ___ Family History: Father died of MI and had ulcers Physical Exam: EXAM(8) VITALS: Afebrile and vital signs stable (see eFlowsheet) GENERAL: Alert and in no apparent distress EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate CV: Heart regular, no murmur, no S3, no S4. No JVD. RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: nondistended, tender in focal areas in mid ax line lug and mid rectus to l and slightly below umbilicus, both hardly tender when pt relaxed or tenses. Negative ___. no lumps or masses appreciated. No rebound GU: No suprapubic fullness or tenderness to palpation MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs SKIN: No rashes or ulcerations noted NEURO: Alert, oriented, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs, sensation to light touch grossly intact throughout PSYCH: pleasant, appropriate affect Pertinent Results: DATA: I have reviewed the relevant labs, radiology studies, tracings, medical records, and they are notable for: ___ 06:15AM BLOOD WBC: 7.5 Hgb: 13.___* ___ 06:15AM BLOOD Glucose: 98 UreaN: 20 Creat: 1.1 Na: 141 K: 5.1 Cl: 103 HCO3: 27 AnGap: 11 ___ 06:15AM BLOOD Lipase: 34 GGT: 13 ___ 06:15AM BLOOD 25VitD: 15* ___ 06:15AM BLOOD Hpy IgG: Pending ___ 06:20AM BLOOD Lactate: 1.0 ___ 10:00AM URINE Blood: NEG Nitrite: NEG Protein: NEG Glucose: NEG Ketone: NEG Bilirub: NEG Urobiln: NEG pH: 6.0 Leuks: LG* ___ 10:00 am URINE URINE CULTURE (Pending): ___ 6:15 am BLOOD CULTURE Blood Culture, Routine (Pending): # Abd CT (___): 1. Mild intrahepatic biliary dilation and slightly increased CBD diameters are new since ___. No evidence of stones on CT however choledocholithiasis cannot be excluded. Correlation with hepatic function is recommended. 2. No bowel obstruction or ascites. # EGD/colonoscopy (___): prelim read. EGD showed nodular inflammation of the antrum. Mult biopsies taken. Colonoscopy was negative. Brief Hospital Course: ASSESSMENT & PLAN: ___ F h/o goiter, anxiety and multiple orthopedic injuries who presents from her group home with poorly localized abd pain of unclear etiology x 2 mos. Pain worse when tensing abd at ___ clinic, concerning for abdominal wall pain. ACUTE/ACTIVE PROBLEMS: #Abdominal pain. Ms. ___ was admitted with abdominal pain over the past 2 months. Extensive tests here were performed - including HPylori serologies, LFTS, and abd/pelvic CT scan were unremarkable. The thought was that this most c/w gastritis. She underwent EGD/colonoscopy which showed evidence of nodular inflammation of the antrum - c/w gastritis but could not rule out cancer. Multiple biopsies were taken. PPI was increased to 40 mg BID and sucralfate was added to her regimen. Colonoscopy was negative. Of note, her symptoms/complaints were out of proportion from objective markers and she was noted to be sleeping well, not tachycardic, fully mobile, and without distress otherwise. She was seen by her gastroenterologist - who will follow up with the results and follow up as outpt. #Anxiety- pt has had behavioral issues in the past and gotten agitated with staff. will work on getting social work involved to both get some history, figure out prior care, and to work with patient get old records from prior ___ care environment CHRONIC/STABLE PROBLEMS: #Anx: CLONAZEPAM - clonazepam 1 mg tablet. 1 tablet(s) by mouth three times a day - (Prescribed by Other Provider) #HTN: LISINOPRIL - lisinopril 40 mg tablet. 1 tablet(s) by mouth daily - (Prescribed by Other Provider) #GERD: OMEPRAZOLE - omeprazole 20 mg capsule,delayed release. 1 capsule(s) by mouth at 4 pm #Urinary retention: OXYBUTYNIN CHLORIDE - oxybutynin chloride ER 5 mg tablet,extended release 24 hr. 1 tablet(s) by mouth twice a day - (Prescribed by Other Provider) GENERAL/SUPPORTIVE CARE: # Nutrition/Hydration: clears tomorrow, moviprep. # Functional status: can complete ADLs # Bowel Function: miralax, moviprep # Lines/Tubes/Drains: PIV # Precautions: none # VTE prophylaxis: HSQ # Consulting Services: GI # Code: presumed full # Disposition: - Anticipate discharge to: assisted living home Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 40 mg PO DAILY 2. Oxybutynin 5 mg PO BID 3. ClonazePAM 1 mg PO TID 4. Omeprazole 20 mg PO DAILY gerd Discharge Medications: 1. Sucralfate 1 gm PO QID RX *sucralfate 1 gram/10 mL 1 ml by mouth four times a day Disp #*1 Bottle Refills:*2 2. Omeprazole 40 mg PO BID gerd RX *omeprazole 40 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 3. ClonazePAM 1 mg PO TID RX *clonazepam 1 mg 1 tablet(s) by mouth three times a day Disp #*6 Tablet Refills:*0 4. Lisinopril 40 mg PO DAILY 5. Oxybutynin 5 mg PO BID Discharge Disposition: Home Discharge Diagnosis: abdominal pain -- gastritis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, As you know, you were admitted with abdominal pain. Extensive workup here was performed - including CT scan, blood tests, and endoscopy (EGD and colonoscopy). These studies revealed showed gastritis which is likely to respond to the acid suppressant medication, Prilosec and sucralfate (which coats the stomach). We anticipate that your pain will improve over time with this medication. There were biopsies taken of the stomach which will be followed up by Dr. ___. Please continue to take these 2 medications until your visit with Dr. ___. Your other medications otherwise remain unchanged. We wish you good health. Your ___ team Followup Instructions: ___
19979532-DS-21
19,979,532
26,713,659
DS
21
2116-11-05 00:00:00
2116-11-05 18:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Haldol Attending: ___. Chief Complaint: Tachycardia and malaise Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ man with a past medical history of IVDU, hypertension, asthma, and PTSD, who presents for the evaluation of flu-like symptoms, cough, abdominal pain, nausea and vomiting. The patient is homeless, and states that for about the past ___ days, he has felt chills and muscle aches. A few days ago, he developed a cough without hemoptysis. He also notes RUQ abdominal discomfort over the last few days associated with nausea and vomiting, and inability to keep anything down for the last ___ days. He also states that about 4 days ago, he developed a rash spreading over his whole body. He states he has been feeling like he is having a panic attack "all day." As a result, he was having shortness of breath and chest pain during this attack. He states he normally sees a psychiatrist, but lost this provider as result of missing too many appointments. He states he has anxiety and PTSD from childhood trauma. Of note the patient was admitted to ___ for MSSA bacteremia about ___ year ago. He has been sober from IV drug use for about 2 months. ED Course notable for: Initial vital signs: T 97.1, HR 145, BP 156/99, RR 24, O2 sat 99% RA Exam notable for: Appears anxious and slightly diaphoretic. HEENT exam unremarkable. Cardiac exam with regular tachycardia; no murmurs, rubs, or gallops. Lungs are clear to auscultation bilaterally. Abdomen is mildly tender to palpation in the periumbilical and right lower quadrant regions. Lower extremities are warm well perfused. The patient has a faint blanching petechial rash over his torso and extremities. Labs notable for: WBC 12.9, AST 85, ALT 133, Cr 1.1, lactate 2.6, utox positive for amphetamines Imaging notable for: CT A/P- No acute findings in the abdomen or pelvis to explain the patient's abdominal pain, nausea or vomiting. Specifically, the appendix is normal. EKG: Sinus rhythm 131. Normal PR, QRS, and QTc intervals. Normal axis. No clear ST segment deviation or T-wave inversion to suggest ischemia. Peaked T waves in the lateral precordial leads V3-V5 are new from his prior exam. The patient received 3L IVF, lorazepam, and was started on vancomycin and Zosyn for concern for endocarditis prior to transfer to the MICU. Vital signs prior to transfer: HR 135, BP 129/66, RR 19, O2 sat 98% RA On arrival to the MICU, the patient confirmed the above history. He states that he is beginning to feel better. He currently does not report fevers, chills, chest pain, shortness of breath, nausea, and vomiting. He still notes RUQ abdominal pain. Past Medical History: HTN Asthma PTSD IVDU Social History: ___ Family History: Non-contributory. Physical Exam: ADMISSION PHYSICAL EXAM: ========================== VITALS: T 97.7 BP 108 / 64 HR 94 RR 19 O2 Sat 96 RA GENERAL: Alert, oriented, no acute distress, appears anxious, pacing around the room HEENT: Sclera anicteric, MMM, oropharynx clear NECK: supple, JVP not elevated, no LAD LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Tachycardic, regular rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, RUQ tenderness on palpation, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema SKIN: red macular lesions on face and abdomen NEURO: A&Ox3, moving all 4 extremities with purpose DISCHARGE PHYSICAL EXAM: ========================== VS: T 97.4 BP 150 / 76 HR 81 RR 16 O2 Sat 93 Ra GENERAL: Well-appearing, eyes closed, in NAD HEENT: NC/AT, EOMI, MMM NECK: Supple, JVP not elevated, no LAD LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: RRR, normal S1/S2, no murmurs ABD: Soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing SKIN: no rashes appreciated, no diaphoresis NEURO: A&Ox3, moving all 4 extremities with purpose Pertinent Results: ADMISSION LABS: ================ ___ 02:10AM WBC-12.9* RBC-4.97 HGB-15.4 HCT-45.2 MCV-91 MCH-31.0 MCHC-34.1 RDW-13.7 RDWSD-45.4 ___ 02:10AM NEUTS-73.3* LYMPHS-18.4* MONOS-7.3 EOS-0.1* BASOS-0.4 IM ___ AbsNeut-9.44* AbsLymp-2.37 AbsMono-0.94* AbsEos-0.01* AbsBaso-0.05 ___ 02:10AM cTropnT-<0.01 ___ 02:10AM LIPASE-19 ___ 02:10AM ALT(SGPT)-133* AST(SGOT)-85* ALK PHOS-81 TOT BILI-0.5 ___ 02:17AM LACTATE-2.6* PERTINENT LABS: ================ ___ Trend: ___ 04:40AM BLOOD WBC-9.7 Hgb-12.7* Hct-38.8* Plt ___ ___ 08:15AM BLOOD WBC-7.1 Hgb-13.7 Hct-41.8 Plt ___ ___ 09:54AM BLOOD WBC-6.6 Hgb-14.0 Hct-41.1 Plt ___ ___ 04:40AM BLOOD Neuts-59.9 ___ Monos-5.6 Eos-2.6 Baso-0.6 Im ___ AbsNeut-5.80 AbsLymp-2.99 AbsMono-0.54 AbsEos-0.25 AbsBaso-0.06 LFTs: ___ 04:40AM BLOOD ALT-90* AST-60* LD(LDH)-261* AlkPhos-66 TotBili-0.7 ___ 08:15AM BLOOD ALT-88* AST-56* AlkPhos-64 TotBili-0.3 ___ 04:40AM BLOOD HBsAg-NEG HBsAb-POS HBcAb-NEG ___ 04:40AM BLOOD HCV Ab-POS* ___ 04:40AM BLOOD HCV VL-PND ___ 04:40AM BLOOD TSH-3.3 ___ 04:40AM BLOOD Free T4-1.3 ___ 04:40AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Tricycl-NEG ___ 10:48AM BLOOD Lactate-1.5 DISCHARGE LABS: ================ ___ 06:30AM BLOOD WBC-7.5 Hgb-13.6* Hct-40.6 Plt ___ ___ 06:30AM BLOOD Glucose-94 UreaN-12 Creat-0.7 Na-140 K-4.4 Cl-102 HCO3-24 AnGap-14 IMAGING/STUDIES: ================= CXR ___ No focal consolidation or other acute cardiopulmonary abnormality. CT A/P ___ No acute findings in the abdomen or pelvis to explain the patient's abdominal pain, nausea or vomiting. Normal appendix. TTE ___ Normal biventricular cavity sizes, regional/global systolic function. No valvular pathology or pathologic flow identified. Normal estimated pulmonary artery systolic pressure. No 2D echocardiographic evidence for endocarditis. MICROBIOLOGY: ============== MRSA SCREEN (Final ___: No MRSA isolated. URINE CULTURE (Final ___: < 10,000 CFU/mL. ___ 1:50 am BLOOD CULTURE Blood Culture, Routine (Pending): No growth to date (as of ___ at 6PM) Brief Hospital Course: Mr. ___ is a ___ man with a past medical history of IVDU, hypertension, asthma, and PTSD, who presents for the evaluation of flu-like symptoms, cough, abdominal pain, nausea and vomiting, initially admitted to the MICU for sinus tachycardia to 140's, now with resolution of tachycardia and improvement in presenting symptoms. ACTIVE ISSUES: ============== # Tachycardia, resolved The etiology of his tachycardia was unclear but likely related to dehydration or viral infection. Other infection was ruled out, and although his lactate at presentation was 2.6, this resolved with fluids. He was briefly maintained on broad-spectrum antibiotics from ___. Of note, the patient had been missing a couple of dose of his psychiatric medications, so he may have had withdrawal sympathetic response. He did have a skin rash on presentation but this is likely a viral exanthema. # Abdominal pain/malaise # Transaminitis The etiology of his transaminases unclear but could be related to hepatitis C infection versus viral gastroenteritis. His hepatitis C viral load was pending at discharge. His liver labs trended down. LFTs at discharge: ALT 106 AST 68 LDH 226 Alk Phos 67 Tbili 0.2. # Homelessness: Importantly, the patient has been homeless for months. He has had multiple admissions to and from ___ and has not had good follow-up. Social worker helped with resources as inpatient, and patient decided to go to shelter today upon discharge. He continues to be on an expedited waiting list for ___. Patient is unable to return home to stay with his parents. # Normocytic anemia: Unclear etiology. Hgb fluctuating between 13 and 15 over past few days. No evidence of active bleeding on exam. No reason to suspect hemolysis and tbili normal. Concern for nutritional deficiency given history vs. anemia of inflammation. Discharge Hgb 13.6. CHRONIC ISSUES: ============== # Hx of IVDU: Reportedly sober for past 2 months. Serum tox positive only for amphetamines (on Adderall which was discontinud on discharge). He was continued on his Suboxone. # PTSD Continued home meds as confirmed by psychiatry. He was maintained on buspirone, gabapentin, Benadryl, clonidine as needed, Vistaril as needed, Effexor and Suboxone as above. He should follow-up with Bridge clinic at ___. TRANSITIONAL ISSUES: =============== [] HELD MEDICATION: Adderall given sinus tachycardia. Patient did well without Adderall while in-house. Restart as clinically indicated. [] Patient is willing to go to ___ today for ongoing assistance seeking substance use treatment. ___ will assign clinician work with him to identify appropriate treatment programs. ___ [] Please follow-up with LFTs at discharge. They were elevated, and HCV viral load was also pending at discharge. Patient will like to discuss hepatitis C treatment, but he should require close follow-up with his PCP prior to initiating HCV treatment. We set up an appointment with a PCP that he has not seen in years, Dr. ___. [] Patient should continue to follow up with Dr. ___ at the ___ clinic. Phone number for Dr. ___ is ___. [] No new medications or antibiotics Medications on Admission: The Preadmission Medication list is accurate and complete. 1. CloNIDine 0.1 mg PO BID:PRN anxiety 2. Amphetamine-Dextroamphetamine 30 mg PO BID 3. Gabapentin 800 mg PO TID 4. BusPIRone 10 mg PO BID 5. Buprenorphine-Naloxone (8mg-2mg) 1 TAB SL BID 6. DiphenhydrAMINE 50 mg PO QHS 7. HydrOXYzine 50 mg PO BID:PRN anxiety 8. Venlafaxine XR 75 mg PO DAILY Discharge Medications: 1. Buprenorphine-Naloxone (8mg-2mg) 1 TAB SL BID 2. BusPIRone 10 mg PO BID 3. CloNIDine 0.1 mg PO BID:PRN anxiety 4. DiphenhydrAMINE 50 mg PO QHS 5. Gabapentin 800 mg PO TID 6. HydrOXYzine 50 mg PO BID:PRN anxiety 7. Venlafaxine XR 75 mg PO DAILY 8. HELD- Amphetamine-Dextroamphetamine 30 mg PO BID This medication was held. Do not restart Amphetamine-Dextroamphetamine until your doctor tells you to Discharge Disposition: Home Discharge Diagnosis: Sinus tachycardia related to dehydration Discharge Condition: Mental Status: Clear and coherent. Activity Status: Ambulatory - Independent. Level of Consciousness: Alert and interactive. Discharge Instructions: Dear Mr. ___, Thank you for coming to ___! WHY WERE YOU ADMITTED? - You were admitted with a fast heart rate and were looking very sick WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL? - You were briefly in the ICU (Intensive Care Unit) to control your heart rate. Your heart rate improved with IV fluids - We gave you antibiotics for 2 days due to concern for infection. We did not find any infection so we stopped your antibiotics - We had our social worker see you. They offered some resources for addiction as well as shelters. WHAT SHOULD YOU DO WHEN YOU LEAVE THE HOSPITAL? - It is important for you to follow up with a doctor. We set up an appointment with ___ MD for follow-up. They can also talk to you about hepatitis C treatment. - It is also important for you to follow up with your psychiatrist. - For housing, you agreed to go to a shelter today. We believe that this is very important for you, and if you should any other resources, please see below for other shelters that you can go to. - It is important for you to continue refraining from using any IV drugs. You can ask for a Homeless Outreach Team (HOT) when you stay at any emergency shelter in ___. They will continue to work with you to identify stable housing in the community. You can also walk in to the below clinics for psychiatric and substance use treatment: ___ for the Homeless Program (___) Address: ___ Phone: ___ Walk in hours: M-F 7a-11p Or ___ has a clinic at ___ (___): ___ at ___ offers primary care each weekday in the Medical Walk-in Unit, and coordinates and assists with care and discharge planning for homeless patients throughout ___. ___ You can walk in to ___ if you want help getting placement for substance use treatment Providing Access to Addictions Treatment, Hope and Support Address: ___ Walk in M-F 7:30AM-6PM Walk in S/S: 8AM-3PM Phone: ___re located at the Dr. ___ ___ ___ at ___ ___ Floor, ___ Or at the ___ ___. ___ Floor ___ Homeless Support Services ___ ___ ___ ___ ___ ___ ___ Floor ___ Walk-ins are welcome for enrollment (no appointment needed) – Intakes: ___. – ___., 9:00am – 3:00pm (note: ___ until 1:00pm). Programs: ___. – ___., 8:00am – 4:00pm (note: ___ until 2:00pm). It was a pleasure taking care of you! We wish you all the best. - Your ___ Team Followup Instructions: ___
19979651-DS-9
19,979,651
27,852,917
DS
9
2187-08-01 00:00:00
2187-08-02 17:34:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: L wrist pain Major Surgical or Invasive Procedure: L wrist ORIF History of Present Illness: ___ RHD woman was leaving the ___ at ___ this evening and tripped on the sidewalk, landed on outstretched left hand. Had immediate pain and obvious deformity. Presented with husband to ___. ED staff performed hematoma block and closed reduction, sugartong splinting and consulted Orthopedic surgery for evaluation of reduction acceptability. Patient denies any numbness, tingling, head strike, LOC, syncope, previous osteoporotic fracture. Past Medical History: Osteoporosis (recent diagnosis), no surgical hx Social History: ___ Family History: nc Physical Exam: PHYSICAL EXAMINATION: General: NAD, AOx3 RRR on peripheral vascular exam Regular WOB, Symmetric chest rise bilaterally, no audible wheezing Vitals: AVSS Right upper extremity: - Skin intact - No deformity, erythema, edema, induration or ecchymosis - Soft, non-tender arm and forearm - Full, painless AROM/PROM of shoulder, elbow, wrist, and digits - EPL/FPL/DIO (index) fire - SILT axillary/radial/median/ulnar nerve distributions - 2+ radial pulse Left upper extremity: - Splint c//di - Soft, non-tender arm and forearm - Full AROM/PROM of shoulder, elbow, and digits - EPL/FPL/DIO (index) fire - SILT axillary/radial/median/ulnar nerve distributions - 2+ radial pulse, BCR distally all digits Right lower extremity: - Skin intact - No deformity, erythema, edema, induration or ecchymosis - Soft, non-tender thigh and leg - Full, painless AROM/PROM of hip, knee, and ankle - ___ fire - SILT SPN/DPN/TN/saphenous/sural distributions - 1+ ___ pulses, foot warm and well-perfused Left lower extremity: - Skin intact - No deformity, erythema, edema, induration or ecchymosis - Soft, non-tender thigh and leg - Full, painless AROM/PROM of hip, knee, and ankle - ___ fire - SILT SPN/DPN/TN/saphenous/sural distributions - 1+ ___ pulses, foot warm and well-perfused Pertinent Results: ___ 02:30AM GLUCOSE-117* UREA N-22* CREAT-0.5 SODIUM-139 POTASSIUM-4.0 CHLORIDE-103 TOTAL CO2-25 ANION GAP-15 ___ 02:30AM estGFR-Using this ___ 02:30AM WBC-9.2# RBC-4.51 HGB-13.9 HCT-42.0 MCV-93 MCH-30.8 MCHC-33.1 RDW-12.6 RDWSD-42.9 ___ 02:30AM NEUTS-83.9* LYMPHS-9.1* MONOS-5.9 EOS-0.4* BASOS-0.3 IM ___ AbsNeut-7.73* AbsLymp-0.84* AbsMono-0.54 AbsEos-0.04 AbsBaso-0.03 ___ 02:30AM PLT COUNT-255 ___ 02:30AM ___ PTT-29.0 ___ Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have L wrist fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for L wrist ORIF, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to home was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is nonweightbearing in the left upper extremity, and will be discharged on aspirin for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: Nasacort, Fosamax Discharge Medications: 1. Acetaminophen 650 mg PO Q6H RX *acetaminophen [8 HOUR PAIN RELIEVER] 650 mg 1 tablet(s) by mouth every 6 hours as needed for pain Disp #*120 Tablet Refills:*0 2. Aspirin 325 mg PO DAILY RX *aspirin 325 mg 1 tablet(s) by mouth once a day Disp #*14 Tablet Refills:*0 3. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation RX *bisacodyl [Dulcolax (bisacodyl)] 5 mg 2 tablet(s) by mouth daily as needed for constipation Disp #*60 Tablet Refills:*0 4. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day as needed for constipation Disp #*60 Capsule Refills:*0 5. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Severe RX *oxycodone [Oxaydo] 5 mg ___ tablet(s) by mouth every 4 hours as needed for pain Disp #*70 Tablet Refills:*0 6. Pantoprazole 40 mg PO Q24H Discharge Disposition: Home Discharge Diagnosis: left volar bartons fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - independent Discharge Instructions: Ms. ___, - ___ were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Nonweight bearing in the left upper extremity MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so ___ should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take aspirin 325 mg at bedtime daily for two weeks WOUND CARE: - ___ may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining. DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if ___ experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever > 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns FOLLOW UP: Please follow up with your Orthopaedic Surgeon, Dr. ___. ___ will have follow up with ___, NP in the Orthopaedic Trauma Clinic 14 days post-operation for evaluation. Call ___ to schedule appointment upon discharge. Please follow up with your primary care doctor regarding this admission within ___ weeks and for and any new medications/refills. Followup Instructions: ___
19979849-DS-10
19,979,849
21,842,247
DS
10
2135-02-05 00:00:00
2135-08-11 14:59:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: UROLOGY Allergies: pitted fruit Attending: ___. Chief Complaint: 2 obstructing right distal ureteral stones, acute kidney injury Major Surgical or Invasive Procedure: ___ Cystoscopy, right ureteroscopy, laser lithotripsy, right ureteral stent placement History of Present Illness: HPI: Patient is a ___ male who known to urology for a small right renal mass and nephrolithiasis s/p R PCNL by Dr. ___ in ___, who presents with right sided flank pain since ___. He has had nausea but no vomiting, no fevers or chills. He presented to the ER overnight a CT showed 2 distal right ureteral stones with hydronephrosis. His Cr was 1.8 from 0.9, and he was observed overnight. His Cr only improved to 1.6 with fluids and he required more morphine overnight. Past Medical History: PMH/PSH: - nephrolithiasis - renal mass Social History: Country of Origin: ___ Marital status: Significant Other Name of ___ ___: Children: Yes: 1 son and 1 daughter Work: ___ Sexual Abuse: Denies Domestic violence: Denies Tobacco use: Never smoker Alcohol use: Present Alcohol use rarely comments: Recreational drugs Past (marijuana, heroin, crack pills or other): Recreational drugs marijuna up to ___ comments: Depression: Based on a PHQ-2 evaluation, the patient does not report symptoms of depression Exercise: None Diet: not always healthy Family History: Father ___ ___ HEART DISEASE ALCOHOL ABUSE Brother ___ ___ DIABETES MELLITUS Physical Exam: WdWn male, NAD, AVSS Interactive, cooperative Abdomen soft, Nt/Nd Lower extremities w/out edema or pitting and no report of calf pain Pertinent Results: ___ 05:40AM BLOOD WBC-12.5* RBC-4.55* Hgb-13.3* Hct-41.0 MCV-90 MCH-29.2 MCHC-32.4 RDW-14.0 RDWSD-46.3 Plt ___ ___ 07:15PM BLOOD WBC-13.5* RBC-4.75 Hgb-13.9 Hct-42.5 MCV-90 MCH-29.3 MCHC-32.7 RDW-14.3 RDWSD-46.5* Plt ___ ___ 07:15PM BLOOD Neuts-74.3* Lymphs-13.8* Monos-10.2 Eos-1.0 Baso-0.3 Im ___ AbsNeut-10.05* AbsLymp-1.87 AbsMono-1.38* AbsEos-0.13 AbsBaso-0.04 ___ 07:15PM BLOOD ___ PTT-26.7 ___ ___ 05:40AM BLOOD Glucose-95 UreaN-23* Creat-1.6* Na-140 K-4.7 Cl-103 HCO3-24 AnGap-13 ___ 07:15PM BLOOD Glucose-83 UreaN-29* Creat-1.8* Na-140 K-4.6 Cl-100 HCO3-26 AnGap-14 ___ 07:15PM BLOOD ALT-51* AST-35 AlkPhos-83 TotBili-0.6 ___ URINE URINE CULTURE-FINAL INPATIENT ___ URINE URINE CULTURE-FINAL INPATIENT ___ URINE URINE CULTURE-FINAL EMERGENCY WARD Brief Hospital Course: ___ was admitted to Dr. ___ for nephrolithiasis management with a known obstructing stone, from the ED. He was given pain control and Flomax and consented for urgent cystoscopy with right ureteral stent insertion. He underwent cystoscopy, right ureteroscopy, laser lithotripsy, right ureteral stent placement for known right ureteral stones, right renal stone and acute kidney injury. See the dictated operative note for full details. Overnight, the patient was hydrated with intravenous fluids and received appropriate perioperative prophylactic antibiotics. On POD1, catheter was removed and he was prepped for discharge home. At discharge on POD1, patient’s pain was controlled with oral pain medications, tolerating regular diet, ambulating without assistance, and voiding without difficulty. Patient was explicitly advised to follow up as directed as the indwelling ureteral stent must be removed and or exchanged. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Phenazopyridine 100 mg PO Q8H:PRN pain 2. potassium citrate 15 mEq oral TID W/MEALS 3. Tamsulosin 0.4 mg PO DAILY 4. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild Discharge Medications: 1. Cephalexin 500 mg PO ONCE Duration: 1 Dose RX *cephalexin 500 mg 1 capsule(s) by mouth once Disp #*1 Capsule Refills:*0 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg one capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 3. OxyCODONE--Acetaminophen (5mg-325mg) 1 TAB PO Q4H:PRN Pain - Severe RX *oxycodone-acetaminophen 5 mg-325 mg 1 tablet(s) by mouth every four hours Disp #*20 Tablet Refills:*0 4. Tamsulosin 0.4 mg PO DAILY RX *tamsulosin [Flomax] 0.4 mg ONE capsule(s) by mouth Daily Disp #*30 Capsule Refills:*0 5. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 6. potassium citrate 15 mEq oral TID W/MEALS Discharge Disposition: Home Discharge Diagnosis: Nephrolithiasis, right distal ureteral Acute kidney injury (creat to 1.6) Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: -You can expect to see occasional blood in your urine and to possibly experience some urgency and frequency over the next month; this may be related to the passage of stone fragments or the indwelling ureteral stent . -The kidney stone may or may not have been removed AND/or there may fragments/others still in the process of passing. -You may experience some pain associated with spasm of your ureter.; This is normal. Take the narcotic pain medication as prescribed if additional pain relief is needed. -Ureteral stents MUST be removed or exchanged and therefore it is IMPERATIVE that you follow-up as directed. -Do not lift anything heavier than a phone book (10 pounds) -You may continue to periodically see small amounts of blood in your urine--this is normal and will gradually improve -Resume your pre-admission/home medications EXCEPT as noted. You should ALWAYS call to inform, review and discuss any medication changes and your post-operative course with your primary care doctor. HOLD ASPIRIN and aspirin containing products for one week unless otherwise advised. -IBUPROFEN (the ingredient of Advil, Motrin, etc.) may be taken even though you may also be taking Tylenol/Acetaminophen. You may alternate these medications for pain control. For pain control, try TYLENOL FIRST, then ibuprofen, and then take the narcotic pain medication as prescribed if additional pain relief is needed. -Ibuprofen should always be taken with food. Please discontinue taking and notify your doctor should you develop blood in your stool (dark, tarry stools) -You MAY be discharged home with a medication called PYRIDIUM that will help with the "burning" pain you may experience when voiding. This medication may turn your urine bright orange. -You may be given “prescriptions” for a stool softener and/or a gentle laxative. These are over-the-counter medications that may be “health care spending account reimbursable.” -Colace (docusate sodium) may have been prescribed to avoid post-surgical constipation or constipation related to use of narcotic pain medications. Discontinue if loose stool or diarrhea develops. Colace is a stool-softener, NOT a laxative. -Senokot (or any gentle laxative) may have been prescribed to further minimize your risk of constipation. -Do not eat constipating foods for ___ weeks, drink plenty of fluids to keep hydrated -No vigorous physical activity or sports for 4 weeks and while Foley catheter is in place. Followup Instructions: ___
19980241-DS-9
19,980,241
23,739,999
DS
9
2137-12-21 00:00:00
2137-12-25 07:12:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: UROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: NEPHROLITHIASIS, ACUTE KIDNEY INJURY, BACTEREMIA Major Surgical or Invasive Procedure: ___: LEFT PERCUTANEOUS NEPHROSTOMY by Interventional Radiology ___: MIDLINE placed for IV Antibiotics History of Present Illness: ___ with no significant PMH who presents from an OSH with left flank pain, fevers, and evidence of an obstructing left UPJ stone. Labs are remarkable for WBC 20.4 and Cr 2.5. The patient is currently afebrile, hemodynamically stable, and comfortable. The patient proceeded from the ED to ___ for L PCN placement, which was uncomplicated. Past Medical History: Mr ___ reports that he has had no medical care for over ___ years and since his last known PCP ___. He reports no medical problems or use of medications. Morbid obesity Social History: ___ Family History: No family history of kidney stones Maternal uncle with DM and kidney disease. Mother with DM and afib. Paternal grandfather with HTN. No family hx of renal stones. Physical Exam: WDWN Caucasian male obese NT/ND LEFT PCN w/ clear yellow UOP lower extremities w/out edema, pitting, pain Pertinent Results: ___ 06:05AM BLOOD WBC-10.4 RBC-4.67 Hgb-13.6* Hct-41.8 MCV-90 MCH-29.1 MCHC-32.5 RDW-14.5 Plt ___ ___ 05:50AM BLOOD WBC-12.9* RBC-4.27* Hgb-12.5* Hct-37.3* MCV-87 MCH-29.3 MCHC-33.5 RDW-14.3 Plt ___ ___ 02:35AM BLOOD WBC-20.4* RBC-4.18* Hgb-12.6* Hct-35.6* MCV-85 MCH-30.2 MCHC-35.5* RDW-15.0 Plt ___ ___ 02:35AM BLOOD Neuts-89.0* Lymphs-5.5* Monos-5.1 Eos-0.2 Baso-0.2 ___ 06:05AM BLOOD Plt ___ ___ 02:35AM BLOOD Plt ___ ___ 02:35AM BLOOD ___ PTT-34.2 ___ ___ 06:05AM BLOOD Glucose-128* UreaN-39* Creat-2.5* Na-141 K-3.6 Cl-104 HCO3-22 AnGap-19 ___ 05:50AM BLOOD Glucose-128* UreaN-36* Creat-2.8* Na-138 K-3.7 Cl-103 HCO3-21* AnGap-18 ___ 04:58PM BLOOD Glucose-155* UreaN-33* Creat-2.7* Na-135 K-4.4 Cl-102 HCO3-17* AnGap-20 ___ 02:00AM BLOOD Glucose-181* UreaN-29* Creat-2.5* Na-134 K-3.8 Cl-98 HCO3-21* AnGap-19 ___ 02:00AM BLOOD ALT-34 AST-61* AlkPhos-89 TotBili-1.5 ___ 06:05AM BLOOD Calcium-8.5 Phos-3.5 Mg-2.3 ___ 05:50AM BLOOD Calcium-7.7* Phos-3.1 Mg-2.1 ___ 02:00AM BLOOD Albumin-3.3* ___ 05:50AM BLOOD %HbA1c-6.3* eAG-134* ___ 05:50AM BLOOD TSH-5.2* ___ 05:50AM BLOOD PTH-157* ___ 02:44AM BLOOD Lactate-2.1* ___ 05:50AM BLOOD VITAMIN D ___ DIHYDROXY-PND ___ 02:24PM URINE Hours-RANDOM Creat-89 Na-37 K-23 Cl-42 TotProt-148 Prot/Cr-1.7* ___ 02:24PM URINE Osmolal-340 ___ 2:00 am BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: ESCHERICHIA COLI. IDENTIFICATION AND SENSITIVITIES PERFORMED ON CULTURE # ___ ___. Aerobic Bottle Gram Stain (Final ___: Reported to and read back by ___ @ 0204 ON ___ - ___. GRAM NEGATIVE ROD(S). Anaerobic Bottle Gram Stain (Final ___: GRAM NEGATIVE ROD(S). ___ 2:00 am BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: ESCHERICHIA COLI. FINAL SENSITIVITIES. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ <=2 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S Aerobic Bottle Gram Stain (Final ___: GRAM NEGATIVE ROD(S). Reported to and read back by ___ ___ @ 8:12 ___. Anaerobic Bottle Gram Stain (Final ___: GRAM NEGATIVE ROD(S). ___ 5:20 am URINE CATHETER. **FINAL REPORT ___ URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 ORGANISMS/ML. OF TWO COLONIAL MORPHOLOGIES. PRESUMPTIVE IDENTIFICATION. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ 8 S AMPICILLIN/SULBACTAM-- 4 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S ___ BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT ___ BLOOD CULTURE Blood Culture, Routine-PENDING INPATIENT Brief Hospital Course: Mr. ___ is a ___ obese male with no significant past medical or surgical history who presented from an OSH with fevers, left flank pain, and evidence of an obstructing left UPJ stone. He had previously been in his usual state of health when he experienced left flank pain radiating to his LUQ. He also reported fevers to 104.9. He took Tylenol for the fevers and pain. He denied dysuria, hematuria, nausea, and vomiting. He presented to an OSH, where a CT scan showed a 9mm obstructing left UPJ stone with associated hydronephrosis. He had a temp of 104, WBC 18.5, Cr 2.2, Lactate 5.6, UA c/w infection and was subsequently transferred to ___ ED as there was no urology at the OSH. Mr. ___ was admitted and urgently taken to the interventional radiology theater for urgent decompression. A left percutaneous nephrostomy was placed and he was recovered and transferred to the general surgical floor. He was placed on telemetry for monitoring for hypotension/sepsis. Empiric intravenous antibiotics were continued pending cultures and his diet was advanced as tolerated. Mr. ___ remained inpatient until preliminary culture data was available and until he was afebrile for over 24 hours and there was noted trend improvement in his acute kidney injury. His creatinine had been elevated since admission and at the OSH on ___ his creatinine was 2.1. It uptrended to 2.8 even after the placement of the PCN so consult services were provided by nephrology for this acute kidney injury (presumed acute tubular necrosis). At discharge Mr. ___ pain was controlled with oral pain medications, he was tolerating a regular diet, ambulating without assistance, and voiding without difficulty. Mr. ___ was explicitly advised to follow up with nephrology as an outpatient and to report back to ___ daily for his intravenous antibiotics. Appointments and follow up appointments were secured and documented on his Discharge Worksheet. He was given explicit instructions to return to urology for follow up and for definitive stone management. Supplies and instructions for percutaneous nephrostomy care were provided by nursing and detailed on the Discharge Worksheet. All of his questions were answered in detail. Medications on Admission: NONE Discharge Medications: 1. Acetaminophen ___ mg PO Q6H:PRN pain, headache, fever 2. CeftriaXONE 1 gm IV Q24H RX *ceftriaxone 1 gram ONE gram IV Q24hrs Disp #*11 Vial Refills:*0 3. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg ONE capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*1 4. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain RX *oxycodone 5 mg ONE tablet(s) by mouth Q4hrs Disp #*40 Tablet Refills:*0 5. Senna 8.6 mg PO BID RX *sennosides [Senokot] 8.6 mg ONE tablet by mouth QD - BID Disp #*60 Tablet Refills:*0 6. Heparin Flush (10 units/ml) 2 mL IV DAILY and PRN, line flush 7. Sodium Chloride 0.9% Flush 10 mL IV DAILY and PRN, line flush Discharge Disposition: Home Discharge Diagnosis: acute kidney injury, flank pain, urinary tract infection, left obstructing nephrolithiasis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: -You will be discharged home with the PERCUTANEOUS NEPHROSTOMY (PCN) -You can expect to see occasional blood in your urine and to possibly experience some urgency and frequency over the next month -The kidney stone may or may not have been removed AND/or there may fragments/others still in the process of passing. -You may experience some pain associated with spasm of your ureter.; This is normal. Take the narcotic pain medication as prescribed if additional pain relief is needed. -PCNs/Ureteral stents MUST be removed or exchanged and therefore it is IMPERATIVE that you follow-up as directed. -Do not lift anything heavier than a phone book (10 pounds) -You may continue to periodically see small amounts of blood in your urine--this is normal and will gradually improve -Resume your pre-admission/home medications EXCEPT as noted. You should ALWAYS call to inform, review and discuss any medication changes and your post-operative course with your primary care doctor. HOLD ASPIRIN and aspirin containing products for one week unless otherwise advised. -IBUPROFEN (the ingredient of Advil, Motrin, etc.) may be taken even though you may also be taking Tylenol/Acetaminophen. You may alternate these medications for pain control. For pain control, try TYLENOL FIRST, then ibuprofen, and then take the narcotic pain medication as prescribed if additional pain relief is needed. -Ibuprofen should always be taken with food. Please discontinue taking and notify your doctor should you develop blood in your stool (dark, tarry stools) -Colace has been prescribed to avoid post surgical constipation and constipation related to narcotic pain medication. Discontinue if loose stool or diarrhea develops. Colace is a stool softener, NOT a laxative, and available over the counter. The generic name is DOCUSATE SODIUM. It is recommended that you use this medication. -Do not eat constipating foods for ___ weeks, drink plenty of fluids to keep hydrated -No vigorous physical activity or sports for 4 weeks and while PCN is in place. You should NOT drive while taking narcotic pain medication and while the PCN is in place. -Please refer to the provided nursing instructions and handout on PCN care, waste elimination, dressing changes. PERCUTANEOUS NEPHROSTOMY (PCN) TUBE INSTRUCTIONS FOR CARE---FOR FAMILY: Please leave PCN tube to external gravity drainage. Catheter flushing: If there are excessive blood clots or debris or thick urine within the connecting tubing, this can be gently flushed as needed to promote clearing. Use normal saline filled syringes provided by nursing. Change every 3 days, if soiled/saturated, as needed: Gently cleanse around the skin entry site of the catheter with gentle soap w/ warm water. Dry and apply gauze dressing. Catheter security: a) EVERYDAY you must check to be sure the catheter, the connecting tubing and the drainage bag are securely attached to the patient and are not kinked. b) If the catheter appears to be pulling "out", please notify Interventional Radiology. c) If the catheter pulls out, please notify Interventional Radiology within 8 hours. SAVE THE CATHETER for inspection--DO NOT throw it away. Call Interventional Radiology/Angio for ANY catheter related questions or problems. ___ or Fellow/Resident (pager# ___ Followup Instructions: ___
19980545-DS-14
19,980,545
21,585,596
DS
14
2179-01-04 00:00:00
2179-01-08 17:24:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Bactrim / Sprintec (___) Attending: ___. Chief Complaint: Chest pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ yo female recently admitted with bilateral pulmonary embolism (s/p dx and hospitalization ___ on coumadin who presents w/ acute onset CP. Reports awoke from sleep with left sideded CP, ___, pleuritic and constant. + difficulty taking deep breath, dry cough. No hemoptysis, no syncope. Took dilaudid 2 mg PO x2 and came to ED. Of note, had INR checked on ___ which was 7.4 and was instructed by PCP to discontinue lovenox and coumadin until ___ recheck. Has been off OCP since diagnosis. Only other med is ativan which was started recently for anxiety. The patient's PE was diagnosed at OSH, and patient had normal LENIs, and IVC was clean. No evidence of elevated BNP or Troponin. ECG was concerning for strain. Pt's lovenox and coumadin did overlap for greater than 5 days before discontinuation. . In the ED, initial vs were 98.1 115 130/85 19 99% 2L (100% on RA) Pt was found to be sinus tachy at 113. Bedside echo was performed and was w/o pericardial effusion or septal deviation; RV function appeared grossly normal. The patient was given 1 L NS . On arrival to the floor, patient reports feeling well with minimal pain after dilaudid, but still anxious. Past Medical History: Asthma GERD Bilateral pulmonary emboli without evidence of DVT in lower extremities or IVC treated with anticoagulation. Social History: ___ Family History: No family history of blood clots, or young relatives with unexplained early deaths. Physical Exam: Admission: Vitals: 98.2, 118/76, 76, 16, 100% RA GENERAL: NAD, awake and alert HEENT: AT/NC, EOMI, PERRLA, anicteric sclera, pink conjunctiva, patent nares, MMM, good dentition NECK: nontender and supple, no LAD, no JVD CARDIAC: RRR, nl S1 S2, no loud or wide split S2, ___ systolic murmur at the RUSB and LUSB, non harsh, non radiating LUNG: CTAB, no rales wheezes or rhonchi, no accessory muscle use ABDOMEN: +BS, soft, non-tender, non-distended, no rebound or guarding, no HSM, +aortic abdominal bruit EXT: warm and well-perfused, no cyanosis, clubbing or edema PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII tested and intact, strength ___ throughout, sensation grossly normal, gait intact Discharge: VSS, on ambulation O2 sat remained 100%, BP after exertion 102/60s No change in exam Pertinent Results: ___ 08:30AM WBC-5.5 RBC-5.38 HGB-15.3 HCT-45.1 MCV-84 MCH-28.5 MCHC-34.0 RDW-12.2 ___ 08:30AM NEUTS-56.8 ___ MONOS-6.7 EOS-2.5 BASOS-1.3 ___ 08:30AM PLT COUNT-372 ___ 08:30AM ___ PTT-55.1* ___ ___ 08:30AM GLUCOSE-95 UREA N-14 CREAT-0.7 SODIUM-141 POTASSIUM-3.4 CHLORIDE-104 TOTAL CO2-23 ANION GAP-17 ___ 09:15AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 09:15AM URINE UCG-NEGATIVE ___ 08:30AM cTropnT-<0.01 ___ 08:30AM proBNP-20 ___ 08:30AM TSH-3.7 Discharge Labs: ___ 08:30AM BLOOD ___ PTT-49.6* ___ Imaging: ___ CXRay: IMPRESSION: No acute intrathoracic process. Brief Hospital Course: ___ yo female with bilateral PE found two weeks ago in setting of OCP use but no other known risk factors who presents with severe pleuritic chest pain this morning with improvement with dilaudid. # Chest pain s/p PE: The patient was stable throughout her stay. On the floor, she had 100% O2 sat on room air with exertion and stable blood pressures with SBP>100. She had a normal appearing ECG on the floor aside from incomplete RBBB which is typically a normal variant in young healthy athletes, no evidence of right heart strain on informal echo in ED, normal trop and BNP. Notably, in the ED, the patient did have an abnormal ECG with sinus tachycardia and diffuse ST segment depression which was similar to her ECG on her initial presentation of PE about 1.5 weeks ago but this resolved on subsequent ECG as noted above. The patient had a normal appearing chest x ray. The etiology of the patient's pain is unclear, but could be from distal embolization of clot with possible infarct of small area of lung as severe pleuritic pain in PE is typical of an embolus that lodges peripherally near the innervation of pleural nerves, or the pain may be secondary to an inflammatory response as the body is resorbing her lung clot. Given the patient's stability lack of evidence of massive PE (no hemodynamic instability) or submassive PE (no elevated trop, BNP, or evidence of right heart strain), it was thought that continued anticoagulation would be the preferred approach over embolectomy or thrombolysis. It could be argued that in this otherwise healthy female with bilateral PEs, that thrombolysis would be reasonable to reduce the patient's chances of future pulmonary hypertension; however given how well and asymptomatic she appeared after the one episode of pain, it was thought best to manage conservatively. The patient's anticoagulation was held for supratherapeutic INR and she was scheduled to follow up with her PCP with instructions to recheck her INR. Given the clear reversible risk factor for her PE (OCPs) and lack of FHx of blood clots, no hypercoagulability workup was performed. The patient had been undergoing appropriate anticoagulation with >5 days of lovenox and discontinuation of LMWH only after therapeutic INR>24 hours. # Pain and Anxiety: Pt with significant anxiety regarding her pulmonary embolism. She was maintained on her outpatient regimen of dilaudid and ativan as needed. CODE: full COMMUNICATION Patient EMERGENCY CONTACT ___ (___) HCP? Y/N TRANSITIONAL: 1) Follow up INR with PCP for continued anticoagulation for at least 3 months 2) Counsel on safe sex practices as she will likely not use OCPs again Medications on Admission: 1. lorazepam 1 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for anxiety. 2. hydromorphone 2 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for pain. 3. Warfarin as directed Discharge Medications: 1. lorazepam 1 mg Tablet Sig: ___ Tablets PO Q6H (every 6 hours) as needed for anxiety. 2. hydromorphone 2 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for pain. 3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation. Disp:*60 Capsule(s)* Refills:*0* 4. Outpatient Lab Work Please have your INR drawn on ___ and faxed to ___, Dr. ___ Discharge Disposition: Home Discharge Diagnosis: Primary: Chest pain Secondary: Bilateral pulmonary embolism Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you. You were admitted for chest pain after your pulmonary embolism a couple of weeks ago. Your chest pain resolved after taking pain pills and your vital signs remained stable. Your ecg and lab tests were normal. Please STOP taking warfarin and lovenox until you see Dr. ___ on ___. Your last INR here on ___ was 4.0. It is likely that Dr. ___ like you to have your INR drawn again on ___. START Docusate sodium 100 mg BID for constipation Followup Instructions: ___
19981190-DS-6
19,981,190
24,364,972
DS
6
2111-07-31 00:00:00
2111-07-31 11:54:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: amoxicillin / Penicillins Attending: ___. Chief Complaint: Left thigh pain Major Surgical or Invasive Procedure: Open reduction internal fixation of left periprosthetic femur fracture History of Present Illness: ___ y/o female residing in ___ Place w/ history of dementia, CKD, lymphoma s/ chemotherapy, parkinsons disease with worsening balance problems and frequent falls over the last year, left hip hemiarthroplasty in ___ for a fall at ___ by Dr. ___ admission to ___ for subdural hematoma in ___ here by transfer from ___ after a mechanical fall and left periprosthetic spiral femoral neck fracture. Patient is unable to provide collateral history. Past Medical History: ___ Disease CKD Peripheral Neuropathy Anemia Lymphoma Social History: ___ Family History: non-contributory Physical Exam: Vitals: ___ 0408 Temp: 98.3 PO BP: 133/74 R Lying HR: 101 RR: 16 O2 sat: 93% O2 delivery: RA Dyspnea: 0 RASS: 0 Pain Score: Sleeping General: Well-appearing, breathing comfortably MSK: LLE: Primary dressing to left lateral thigh in place Mild warmth and erythema without marked ecchymosis, stable from serial exams Patient did not participate in motor/sensory exam WWP Pertinent Results: ___ 06:30AM BLOOD WBC-8.3 RBC-2.84* Hgb-8.7* Hct-26.5* MCV-93 MCH-30.6 MCHC-32.8 RDW-16.2* RDWSD-54.9* Plt ___ ___ 06:15AM BLOOD WBC-8.1 RBC-2.66* Hgb-8.2* Hct-25.4* MCV-96 MCH-30.8 MCHC-32.3 RDW-15.8* RDWSD-54.7* Plt ___ ___ 06:15AM BLOOD Glucose-92 UreaN-18 Creat-1.1 Na-143 K-4.1 Cl-106 HCO3-25 AnGap-12 Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a left periprosthetic femur fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for open reduction and internal fixation of left periprosthetic femur fracture, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The ___ hospital course was otherwise remarkable for transfusion of 2 units of packed red blood cells, but her hemoglobin had stabilized and the patient did not demonstrate signs of symptomatic anemia on discharge. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is touchdown weightbearing in the left lower extremity, and will be discharged on heparin for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: acetaminophen 325 mg capsule oral 2 capsule(s) Twice Daily amlodipine 5 mg tablet oral 1 tablet(s) Once Daily aspirin 81 mg tablet oral 1 tablet(s) Once Daily carbidopa ER 25 mg-levodopa 100 mg tablet,extended release oral 1 tablet extended release(s) Four times daily (9a, 12p, 1600, ___ metoprolol succinate ER 25 mg tablet,extended release 24 hr oral 1 tablet extended release 24 hr(s) Once Daily nitroglycerin 0.4 mg sublingual tablet sublingual 1 tablet, sublingual(s) Q5mins x3 doses) Discharge Medications: 1. Acetaminophen 650 mg PO Q6H RX *acetaminophen 325 mg 2 tablet(s) by mouth q6hr Disp #*80 Tablet Refills:*0 2. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation RX *bisacodyl [Correctol] 5 mg 2 tablet(s) by mouth once a day Disp #*60 Tablet Refills:*0 3. Calcium Carbonate 1250 mg PO TID RX *calcium carbonate 500 mg calcium (1,250 mg) 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*0 4. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 5. Heparin 5000 UNIT SC BID RX *heparin (porcine) 5,000 unit/mL 5000 units subcutaneous twice a day Disp #*56 Syringe Refills:*0 6. OxyCODONE (Immediate Release) 2.5 mg PO Q6H:PRN pain RX *oxycodone 5 mg 0.5 (One half) tablet(s) by mouth q6hr Disp #*30 Tablet Refills:*0 7. Senna 8.6 mg PO BID RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp #*60 Tablet Refills:*0 8. Vitamin D 800 UNIT PO DAILY RX *ergocalciferol (vitamin D2) 400 unit 2 tablet(s) by mouth once a day Disp #*60 Tablet Refills:*0 9. amLODIPine 5 mg PO DAILY 10. Carbidopa-Levodopa (___) 1 TAB PO QID 11. Metoprolol Succinate XL 25 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Left periprosthetic femur fracture Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: -Touchdown weightbearing to left lower extremity MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take heparin twice daily for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. -___ change the dressing to the thigh as needed. DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if you experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever > 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns THIS PATIENT IS EXPECTED TO REQUIRE <30 DAYS OF REHAB FOLLOW UP: Please follow up with your Orthopaedic Surgeon, Dr. ___. You will have follow up with ___, NP in the Orthopaedic Trauma Clinic 14 days post-operation for evaluation. Call ___ to schedule appointment upon discharge. Please follow up with your primary care doctor regarding this admission within ___ weeks and for and any new medications/refills. Physical Therapy: Touchdown weightbearing to the left lower extremity Treatments Frequency: Staples will remain in place for at least 2 weeks postoperatively. Incision may be left open to air unless actively draining. If draining, you may apply a gauze dressing secured with paper tape. You may shower and allow water to run over the wound, but please refrain from bathing for at least 4 weeks postoperatively Followup Instructions: ___
19981210-DS-27
19,981,210
27,159,051
DS
27
2146-11-30 00:00:00
2146-12-01 12:31:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Iodine-Iodine Containing / IV Dye, Iodine Containing Contrast Media Attending: ___ Chief Complaint: chest pain Major Surgical or Invasive Procedure: Cardiac catheterization History of Present Illness: ___ w CAD s/p 2 vessel CABG (LIMA-LAD, SVG-LPL) in ___, s/p ramus intermedius stent placement in ___, s/p AVR in ___, s/p pacemaker placement in ___, s/p PCI with BMS to LCx and angioplasty to ___ on ___, now presents with recurrent anginal chest pain. The patient reports that ___ chest pain started this afternoon when he was at home and at rest. It is left-sided and radiates to his neck. This is his typical anginal pain. He denies associated dyspnea, nausea, vomiting, and diaphoresis. He used nitro SL x3 at home without resolution and decided to return to the hospital for evaluation given his recent stent placement. Prior to this afternoon, he has felt in his normal state of health since discharge. He noted some minor chest irritation on ___ afternoon, and has seen no improvement or worsening of his dyspnea on exertion. In the ED, initial vitals were 97.5 62 150/70 22 97% 4LNC. He received 2 nitroglycerin SL tablets and morphine IV 5mg x4 for chest pain and dyspnea with eventual resolution. EKG showed more upright T-waves in V2-3 compared to prior on ___. Initial troponin was negative, although was only ___ hours after initiation of chest pain. Of note, at the time of his catheterization on ___, the patient had a thrombus that extended into the large ramus vessel requiring POBA with 30% residual occlusion. It was therefore thought likely that the patient's current chest pain was due to residual ramus disease. The cardiologist in the ED recommended admission for repeat PCI tomorrow. On the floor, the patient denies chest pain or dyspnea. He is breathing comfortably on room air. On review of systems he notes that he had an episode of indigestion (not chest pain) on ___ evening after dinner. He also is experiencing some cough and wheeze secondary to allergies. He sleeps with 2 pillows. He notes dyspnea on exertion when climbing a flight of stairs rapidly, but is able to tolerate working out regularly. He runs on a treadmill 30 minutes several times a week and does strength training. REVIEW OF SYSTEMS On review of systems, he denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, hemoptysis, black stools or red stools. He denies recent fevers, chills or rigors. He denies exertional buttock or calf pain. Cardiac review of systems is notable for absence of paroxysmal nocturnal dyspnea, ankle edema, palpitations, syncope or presyncope. All of the other review of systems were negative. Past Medical History: 1. CARDIAC RISK FACTORS: Diabetes (Borderline), Dyslipidemia, Hypertension 2. CARDIAC HISTORY: - AVR ___ (St ___ for bicuspid aortic valve, on coumadin - CABG: ___ (2 vessel: LIMA-LAD, SVG-LPL) - PERCUTANEOUS CORONARY INTERVENTIONS: ___ Tetra stent placed in ramus intermedius; ___ BMS to LCX and balloon angioplasty to the ramus - Tachy-brady syndrome s/p dual chamber PPM ___. OTHER PAST MEDICAL HISTORY: - Atrial fibrillation and atrial flutter previously on clonidine, dofetilide, dronedarone and now amiodarone. Warfarin for thromboembolic prophylaxis. S/P DCCV ___. - Mild diastolic dysfunction (EF 70% from ___ - GERD - Gout (reports had ankle swelling 3mos previously that he attributed to gout, not taking medications currently) - T2DM - GERD - asthma - MGUS IgM - iron-deficiency anemia - macular degeneration - s/p right cataract repair - osteopenia - tremor - trigger finger - erectile dysfunction - cervical radiculopathy Social History: ___ Family History: Father with MI at age ___ No h/o arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. Physical Exam: Admission exam: VS: 98.1 177/70 61 18 97% RA GENERAL: NAD. Alert and oriented x3. Mood, affect appropriate. HEENT: NC/AT. PERRL, EOMI, OP clear, MMM. NECK: Supple with no JVD. CARDIAC: RRR, nl S1, mechanical S2. ___ crescendo early systolic murmur best heard at the USB. No thrills, lifts. No S3 or S4. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. CTAB, no rales, wheezes or rhonchi. ABDOMEN: Soft, non-tender, non-distended. No HSM. EXTREMITIES: No cyanosis or clubbing. Trace pedal edema b/l. DP and ___ 2+ SKIN: Well healed scar over sternum. No stasis dermatitis, ulcers, scars, or xanthomas. Discharge exam: VS 133/64; 60; 18; 97%RA CARDIAC: RRR, nl S1, mechanical S2. ___ crescendo early systolic murmur best heard at the USB. No thrills, lifts. No S3 or S4. LUNGS: CTAB, no rales, wheezes or rhonchi. EXTREMITIES: Left wrist radial access without bleeding or hematoma Pertinent Results: ADMISSION LABS: ___ 04:47PM BLOOD WBC-11.9* RBC-4.79 Hgb-12.4* Hct-40.3 MCV-84 MCH-25.9* MCHC-30.8* RDW-17.5* Plt ___ ___ 04:47PM BLOOD Neuts-81.6* Lymphs-8.3* Monos-5.5 Eos-4.2* Baso-0.4 ___ 04:47PM BLOOD ___ PTT-33.8 ___ ___ 04:47PM BLOOD Glucose-205* UreaN-25* Creat-0.9 Na-138 K-4.3 Cl-104 HCO3-22 AnGap-16 CARDIAC ENZYMES: ___ 07:40AM BLOOD CK-MB-4 cTropnT-0.04* ___ 11:48PM BLOOD CK-MB-4 cTropnT-0.03* ___ 04:47PM BLOOD cTropnT-0.03* DISCHARGE LABS: ___ 07:40AM BLOOD WBC-9.4 RBC-4.23* Hgb-10.9* Hct-35.5* MCV-84 MCH-25.8* MCHC-30.8* RDW-17.4* Plt ___ ___ 08:26AM BLOOD ___ PTT-34.2 ___ ___ 07:40AM BLOOD Calcium-8.8 Phos-2.5* Mg-2.0 IMAGING: ___ CXR: IMPRESSION: No acute intrathoracic process. Cardiac cath ___: COMMENTS: 1. Selective coronary angiography of the left coronary artery was obtained via access through the left radial artery with a ___ Fr Glidesheath, using a ___ Fr XB 3.5 guide catheter. The LAD was known to be occluded from prior studies. The stent in the proximal circumflex was widely patent with a 30% distal stepdown. The mid-circumflex had a 40% stenosis. The ramus intermedius had a 30% stenosis at its origin. 2. The LIMA-LAD was known to be widely patent from the recent study, and hence was not engaged. The SVG-OM is known to be occluded, and partial filling of the distal segment of the vein graft could be seen in the images. The RCA is known to be non-dominant and was not engaged during the present study. 3. In view of the patient's symptoms we decided to interrogate the lesions in both circumflex, as well as in ramus branch by FFR study. This was performed using a Certus pressure wire with IV infusion of Adenosine. At maximal hyperemia the FFR value in Ramus was 0.88 (baseline 0.95), and in the circumflex was 0.87 (baseline 0.95). The values obtained indicated that none of the stenoses visualized in the circumflex and the ramus branches were hemodynamuically significant, and thus, failed to account for the patient's symptoms. FINAL DIAGNOSIS: 1. Patent stent in proximal circumflex and widely patent ramus intermedius (non-obstructive plaques only). 2. FFR interrogation of both ramus intermedius and circumflex coronary artery revealed no hemodynamically significant lesion. 3. Continuation of medical therapy. Brief Hospital Course: ___ y/o M w CAD s/p 2 vessel CABG (LIMA-LAD, SVG-LPL) in ___, s/p ramus intermedius stent placement in ___, s/p AVR in ___, s/p pacemaker placement in ___, s/p PCI with BMS to LCx and angioplasty to ramus on ___, now presents with recurrent chest pain. # Chest pain: The patient has known extensive CAD with multiple interventions including 2V CABG and several stent placements. The ramus intermedius was stented in ___, and during ___ PCI a thrombus was noted to partially occlude this large vessel. Balloon angioplasty of the ramus was performed but no new stent placed. Patient reports exertional chest pain relieved with SL nitroglycerin prior to ___ PCI. After ___ PCI, he started having chest pain at rest not relieved by SL nitroglycerin after ___ PCI, but sometimes no pain with exertion. EKG unchanged, CKMB 4, trop 0.03-0.04. Given his high risk, there was initial concern chest pain is angina due to ramus lesion. Initially started on nitroglycerin drip, morphine prn, and heparin drip (despite INR 2.3). Continued ASA, statin, Plavix. Repeat cardiac catheterization showed patent ramus and circumflex with FFR >0.8, so no intervention was indicated. Chest pain is unlikely cardiac in origin. Uptitrated Imdur from 60mg to 90mg daily as tolerated by BP. Plan to follow up with Dr. ___ on ___ as previously scheduled. # RHYTHM: Chronic atrial fibrillation and atrial flutter, s/p DCCV in ___ and pacemaker placement. Rhythm paced at 60 throughout hospitalization. Continued amiodarone and coumadin (see below). # PUMP: Mild symmetric left ventricular hypertrophy with mild diastolic dysfunction but preserved systolic function seen on last echo. # Anticoagulation: Currently anti-coagulated on coumadin for h/o AVR and atrial fibrillation. INR goal 2.5-3.5. INR on presentation on ___ was 2.3. Warfarin held on ___ due to plan for cardiac catheterization. INR on ___ was 2.4. Warfarin restarted on ___ post cath. Plan to recheck with Dr. ___ (___) on ___. # HTN: Well-controlled on home regimen. Continue diltiazem and Diovan. Uptitrated Imdur from 60mg to 90mg daily. # DM: No recent A1c in our system. Held metformin ___. Plan to restart on ___. # GERD: Continued omeprazole. # Asthma: Continue albuterol, mometasone, and Singulair. # BPH: ContinueD tamsulosin # Anemia: Continued ferrous sulfate # Macular degeneration: Continued olopatadine gtt, Preservision vitamins # Transitional issues: - code status: full - follow up with: - Dr. ___ ___ - INR check with Dr. ___ ___ - Medication changes: - restart Metformin on ___ - increase Imdur from 60mg to 90mg daily Medications on Admission: ALBUTEROL SULFATE 90 mcg 2 puff Q6H PRN SOB, wheeze AMIODARONE 100 mg daily ATORVASTATIN 40 mg daily CLOPIDOGREL 75 mg daily DILTIAZEM XL 120 mg BID ISOSORBIDE MONONITRATE 60 mg daily METFORMIN 500 mg daily MOMETASONE 110 mcg 2 puffs daily MONTELUKAST 10 mg daily NITROGLYCERIN 0.4 mg SL PRN chest pain OLOPATADINE 0.1 % 1 gtt per eye daily OMEPRAZOLE 20 mg BID TAMSULOSIN 0.4 mg daily TRIAZOLAM 0.125 mg QHS PRN sleep VALSARTAN 60 mg BID WARFARIN 5 mg daily ASPIRIN 81 mg daily CALCIUM CARBONATE-VITAMIN D3 500 mg-200 unit BID COENZYME Q10 50 mg daily FERROUS SULFATE 140 mg (45 mg iron) daily MULTIVITAMIN 1 tablet daily VIT C-VIT E-COPPER-ZNOX-LUTEIN [PRESERVISION] 226 mg-200 unit-5 mg-0.8 mg-34.8 mg 1 capsule daily Discharge Medications: 1. albuterol sulfate 90 mcg/actuation HFA Aerosol Inhaler Sig: Two (2) Inhalation every six (6) hours as needed for shortness of breath or wheezing. 2. amiodarone 200 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 4. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. diltiazem HCl 120 mg Capsule, Extended Release Sig: One (1) Capsule, Extended Release PO BID (2 times a day). 6. isosorbide mononitrate 30 mg Tablet Extended Release 24 hr Sig: Three (3) Tablet Extended Release 24 hr PO once a day. Disp:*90 Tablet Extended Release 24 hr(s)* Refills:*0* 7. metformin 500 mg Tablet Sig: One (1) Tablet PO once a day. 8. mometasone 110 mcg (30 doses) Aerosol Powdr Breath Activated Sig: Two (2) puffs Inhalation once a day. 9. montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 10. nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) Sublingual as directed as needed for chest pain: repeat every 5 minutes up to three times. 11. olopatadine 0.1 % Drops Sig: One (1) Ophthalmic daily (). 12. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO BID (2 times a day). 13. tamsulosin 0.4 mg Capsule, Ext Release 24 hr Sig: One (1) Capsule, Ext Release 24 hr PO HS (at bedtime). 14. triazolam 0.25 mg Tablet Sig: One (1) Tablet PO PRN (as needed) as needed for sleep. 15. valsartan 40 mg Tablet Sig: 1.5 Tablets PO BID (2 times a day). 16. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 17. warfarin 5 mg Tablet Sig: One (1) Tablet PO once a day. 18. Calcium 500 + D 500 mg(1,250mg) -200 unit Tablet Sig: One (1) Tablet PO twice a day. 19. ferrous sulfate 140 mg (45 mg iron) Tablet Extended Release Sig: One (1) Tablet Extended Release PO once a day. 20. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 21. PreserVision 226-200-5 mg-unit-mg Capsule Sig: One (1) Capsule PO once a day. 22. Outpatient Lab Work ___ on ___ Attention: Dr. ___. ___, ___ Phone: ___ Fax: ___ Discharge Disposition: Home Discharge Diagnosis: Atypical chest pain Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, It was a pleasure participating in your care at ___. You were admitted because you had chest and neck pain. You underwent cardiac catheterization, which showed that your heart vessels are not blocked. Your blood work and electrocardiogram also showed that you did not have a heart attack. We made the following changes to your medications: INCREASED Imdur from 60mg daily to 90mg daily HOLD Metformin till ___ Followup Instructions: ___
19981210-DS-29
19,981,210
26,790,133
DS
29
2148-07-10 00:00:00
2148-07-10 20:27:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Iodine-Iodine Containing / IV Dye, Iodine Containing Contrast Media Attending: ___. Chief Complaint: Chest Pain Major Surgical or Invasive Procedure: Cardiac catheterization ___ Cardiac catheterization ___ History of Present Illness: ___ with h/o CAD s/p 2v CABG (LIMA-LAD, SVG-LPL) in ___ and multiple stents, bicuspid aortic valve s/p AVR ___, atrial fibrillation/flutter, and tachy-brady syndrome s/p PPM placement in ___ presents with intermittent substernal chest pain since this morning. Pt. had been in his usual state of health until 06:00 in the monring of presentation (___). Pt. notes at that time his typical anginal chest pain at rest, specifically left sided chest pain with radiation to the left shoulder and jaw. Pt. also describes associated nausea and palpitations. Pt. took 3 sublingual nitro with minimal improvement in symptoms. He went back to sleep and woke up around 11:00 with substernal chest pressure that is new compared to typical CP. He took 3 more nitros with minimal improvement. Pt. then attended a ___ dinner at ___ and returned home. At 16:00, for continued pain, pt. took 3 more nitros and Dilt 60mg PO x1 with no improvement in pain. At this time, pt. called ambulance. En route, pt. reports no relief with 2 nitroglycerin sprays. He had 3 additional chewed baby aspirin for total of 325mg on day of presentation. Pt. denies any associated SOB/lightheadedness/dizzinessNo radiation to back. No shortness of breath. In the ED, initial vitals were: 97.6 74 132/68 18 99% 2L NC. EKG: AF @ 86, NA, NI, TWI v2-4 are c/w prior, new ST dep in v3-4. No STE. Rear leads w/o STE. Labs were notable for WBC 14.3 (85%N), INR 2.8, trop 0.32. Pt given morphine total of 4mg. Patient's presentation is concerning NSTEMI given his extensive history and ongoing pain. Pt continues have pain despite nitro gtt and dose of morphine. Pt given further morphine and nitro gtt uptitrate. His pain continuted but decreased to ___ and then ___. Spoke with patient's cardiologist and the cardiology fellow. Pt. received plavix-load (600mg) and start heparin gtt. Vitals on transfer: 64 137/59 20 96% RA. Pt.'s nitro drip was uptitrated and his CP resolved. On arrival to the floor, pt reports no ongoing chest pain at this time. Overall, he feels well. Continues to deny any palpitations/SOB/Cough/lightheadedhess/dizziness/orthopnea/PND. Past Medical History: 1. Coronary artery disease status post coronary artery bypass grafting in ___ (2-vessel: LIMA-LAD, SVG-LPL), PERCUTANEOUS CORONARY INTERVENTIONS ___ Tetra stent placed in ramus intermedius; ___ Bare metal stent to LCx and balloon angioplasty to ramus; ___ drug eluding stent placement x2 to ramus and LCx (bifurcation stenting), ___ POBA to ramus); ACS: NSTEMI ___ 2. Bicuspid aortic valve status ___ mechanical bileaflet prosthesis in ___ on warfarin 3. Tachy-brady syndrome status post dual chamber permanent pacemaker placement in ___ - Atrial fibrillation and atrial flutter on amiodarone – DC cardioversion ___ - Diastolic dysfunction (LVEF 70% in ___ - Diabetes - Dyslipidemia - Hypertension - Gastroesophageal reflux disease - IgM kappa monoclonal gammopathy - Asthma - Iron deficiency anemia - Macular degeneration - Osteopenia - Erectile Dysfunction - Tremor - Trigger finger - Cervical radiculopathy - Status post right cataract repair Social History: ___ Family History: Father with myocardial infarction at age ___. Mother died of natural causes at ___. No h/o arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: Admission physical VS: 98.1, 70, 138/61, 18, Sat 97% on RA General: NAD, comfortable, pleasant HEENT: NCAT, PERRL, EOMI Neck: supple, JVD 8cm at 45 degrees CV: regular rhythm, early systolic decrescendo murmur heard best at ___ increased on expiration Lungs: Mild bibasilar crackles bilaterally, otherwise lungs are clear Abdomen: protuberant, soft, NT/ND, BS+ Ext: WWP, trace to 1+ ___ pitting edema bilaterally, no clubinb/cyanosis, 2+ distal pulses bilaterally Neuro: moving all extremities grossly Discharge physical Tmax: 36.9 °C (98.5 °F) Tcurrent: 36.8 °C (98.2 °F) HR: 64 (64 - 81) bpm BP: 137/59(79) {120/51(69) - 156/79(89)} mmHg RR: 14 (10 - 26) insp/min SpO2: 97% General: NAD, comfortable, pleasant HEENT: NCAT, PERRL, EOMI Neck: supple, JVD 8cm at 45 degrees CV: regular rhythm, early systolic ejection murmur heard best at ___ increased on expiration Lungs: CTAB, no wheezes, rales, rhonci, or egophany Abdomen: protuberant, soft, NT/ND, BS+ Ext: WWP, no ___ edema, no clubbing/cyanosis, 2+ distal pulses bilaterally Neuro: moving all extremities grossly Pertinent Results: ADMISSION LABS: ___ 05:35AM BLOOD WBC-15.7* RBC-4.35* Hgb-12.4* Hct-39.1* MCV-90 MCH-28.4 MCHC-31.6 RDW-14.7 Plt ___ ___ 05:45PM BLOOD Neuts-85.1* Lymphs-5.9* Monos-6.4 Eos-2.1 Baso-0.4 ___ 05:35AM BLOOD ___ PTT-35.5 ___ ___ 05:35AM BLOOD Glucose-166* UreaN-23* Creat-1.1 Na-142 K-4.2 Cl-107 HCO3-26 AnGap-13 ___ 05:35AM BLOOD CK-MB-126* MB Indx-11.6* cTropnT-1.94* ___ 05:35AM BLOOD Calcium-8.7 Phos-2.6* Mg-2.1 NOTABLE LABS: ___ 05:35AM BLOOD WBC-15.7* RBC-4.35* Hgb-12.4* Hct-39.1* MCV-90 MCH-28.4 MCHC-31.6 RDW-14.7 Plt ___ ___ 08:15PM BLOOD Hct-39.1* Plt ___ ___ 02:05AM BLOOD WBC-20.5* RBC-4.21* Hgb-12.0* Hct-37.6* MCV-89 MCH-28.4 MCHC-31.8 RDW-14.5 Plt ___ ___ 05:15AM BLOOD WBC-28.1* RBC-4.15* Hgb-11.8* Hct-37.2* MCV-90 MCH-28.4 MCHC-31.6 RDW-14.5 Plt ___ ___ 05:15AM BLOOD Neuts-94.6* Lymphs-1.6* Monos-3.2 Eos-0.3 Baso-0.3 ___ 05:35AM BLOOD ___ PTT-35.5 ___ ___ 02:05AM BLOOD ___ PTT-33.2 ___ ___ 05:15AM BLOOD ___ PTT-31.9 ___ ___ 05:35AM BLOOD Glucose-166* UreaN-23* Creat-1.1 Na-142 K-4.2 Cl-107 HCO3-26 AnGap-13 ___ 02:05AM BLOOD Glucose-199* UreaN-21* Creat-0.9 Na-136 K-4.0 Cl-102 HCO3-25 AnGap-13 ___ 05:15AM BLOOD Glucose-187* UreaN-20 Creat-0.8 Na-138 K-4.4 Cl-103 HCO3-27 AnGap-12 ___ 11:55PM BLOOD CK(CPK)-1156* ___ 05:35AM BLOOD CK(CPK)-1082* ___ 08:15PM BLOOD CK(CPK)-718* ___ 05:45PM BLOOD CK-MB-79* MB Indx-12.2* ___ 05:45PM BLOOD cTropnT-0.32* ___ 11:55PM BLOOD CK-MB-151* MB Indx-13.1* cTropnT-1.56* ___ 05:35AM BLOOD CK-MB-126* MB Indx-11.6* cTropnT-1.94* ___ 08:15PM BLOOD CK-MB-62* MB Indx-8.6* cTropnT-1.82* ___ 02:05AM BLOOD CK-MB-39* MB Indx-8.4* cTropnT-1.27* ___ 11:18AM BLOOD CK-MB-28* cTropnT-0.91* ___ 05:35AM BLOOD Calcium-8.7 Phos-2.6* Mg-2.1 ___ 02:05AM BLOOD Calcium-8.7 Phos-2.1* Mg-2.0 ___ 05:15AM BLOOD Calcium-8.9 Phos-3.4 Mg-2.2 DISCHARGE LABS: ___ 04:58AM BLOOD WBC-22.9* RBC-3.99* Hgb-11.2* Hct-35.4* MCV-89 MCH-28.0 MCHC-31.6 RDW-14.7 Plt ___ ___ 04:58AM BLOOD ___ ___ 04:58AM BLOOD Glucose-128* UreaN-24* Creat-0.9 Na-138 K-3.8 Cl-101 HCO3-28 AnGap-13 ___ 04:58AM BLOOD Calcium-8.6 Phos-2.8 ___ Micro: None IMAGING: ___ CXR - IMPRESSION: No acute cardiopulmonary process. EKG: afib, 82, Q in III, TW flattening in precordial leads and inferior leads; compared to ___ EKGs voltage differs in V3-V5 and previous TWI are no longer seen in these leads 2D-ECHOCARDIOGRAM: ___: The left atrium is elongated. The estimated right atrial pressure is ___ mmHg. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. Overall left ventricular systolic function is low normal (LVEF = 50%) secondary to hypokinesis of the posterior and lateral walls. Right ventricular chamber size and free wall motion are normal. A bileaflet aortic valve prosthesis is present. The transaortic gradient is higher than expected for this type of prosthesis. Trace aortic regurgitation is seen. [The amount of regurgitation present is normal for this prosthetic aortic valve.] The mitral valve leaflets are mildly thickened. Mild (1+) mitral regurgitation is seen. There is borderline pulmonary artery systolic hypertension. There is no pericardial effusion. Compared with the prior study (images reviewed) of ___, resting posterior and lateral wall hypokinesis is now present. TTE ___: The left atrium is mildly dilated. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF 70%). Right ventricular chamber size and free wall motion are normal. A bileaflet aortic valve prosthesis is present. The transaortic gradient is higher than expected for this type of prosthesis. Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Mild (1+) mitral regurgitation is seen. There is borderline pulmonary artery systolic hypertension. There is no pericardial effusion. ETT with Stress TTE ___: TTE - Average functional exercise capacity. Ischemic ECG changes with 2D echocardiographic evidence of regional wall motion abnormalities at rest as detailed above. Worsening in wall motion abnormalities (akinesis rather than hypokinesis) of the same segments at achieved workload. Hypotensive response to stress. Mild aortic regurgitation, mild to moderate mitral regurgitation, and mild to moderate tricuspid regurgitation at rest. Well seated mechanic aortic prosthesis with slightly increased gradients (19mm valve). Moderate pulmonary artery systolic hypertension. Stress report - Marked significant EKG changes with ST elevation in aVR in the setting of baseline AV pacing and IVCD at peak exercise. Probable anginal type symptoms with a significant drop in systolic blood pressure. Average functional capacity. Echo report sent separately. CARDIAC CATH: ___: 1. Selective coronary angiography of this right dominant system revealed LAD, Ramus intermedius, SVG-OM occlusions. The site of the previous LMCA stent and the previous LCx stent was found to have no angiographically apparent flow limiting stenoses. Please see interventional addendum for full details. In shoft, the ramus intermedius was found to be occluded and was crossed with some difficulty. Angioplasty was performed with 2.0, 2.5, and 2.75 mm balloons and there was a residual 20% stenosis with normal flow. 2. Limited resting hemodynamics revealed normal systemic arterial pressure at 117/60. FINAL DIAGNOSIS: 1. Occlusion of the previously stented Ramus branch (ISR vs thrombosis) of undetermined age. 2. Successful POBA. 3. If recurrent symptoms, stenting would be possible from the femoral approach. Evidence of viability in this territory would be ideal prior to re-intervention. 4. DAPT minimum 1 month, ideally ___ year. Repeat Cath ___: Coronary angiography: right dominant LMCA: Widely patent. LAD: Occluded proximally LCX: There was a 20% stenosis in the proximal LCx at the prior stent sites. There was a ___ stenosis in the ramus branch at the site of POBA yesterday. There were two layers of prior stents in this region and incomplete balloon expansion consistent with vessel rigidity. RCA: Co-dominant/non dominant by prior cath SVG-LPL: Occluded on prior angiography LIMA-LAD: Widely patent. There was a 50-60% stenosis in the LAD just after the touchdown of the LIMA-LAD that is essentially unchanged from prior examination. The mid to distal LAD was a small-medium sized vessel. Interventional details There were no culprits for rest pain or EKG changes which would be consistent with small vessel disease. Maximal medical therapy will be pursued. Assessment & Recommendations 1.Three vessel coronary artery disease 2.Patent LIMA to the LAD with intermediate disease in the LAD 3.Patent ramus at the prior POBA site performed for in-stent restenosis 4.Occluded SVG to LPL by prior examination Previous Cath ___: Coronary angiography: right dominant LMCA: Distal 40% into Ramus and OM. LAD: Occluded ostially. Mild luminal irregularities after LIMA touchdown with serial 40% lesions. LCX: Ostial and proximal restenosis with 70% disease involving bifurcation with Ramus. RCA: Known small and nondominant. Not injected. LIMA-LAD: Widely patent. Ramus: Ostial 70% stenosis into previously placed stent. --> drug eluding stent placement x2 to ramus and LCx (bifurcation stenting) Brief Hospital Course: BRIEF SUMMARY STATEMENT: ___ w/ CAD s/p 2v CABG (LIMA-LAD, SVG-LPL) in ___ and multiple stents ___ Tetra stent ramus intermedius; ___ BMS to LCx and balloon angioplasty to ramus; ___ DES x2 to ramus and LCx (bifurcation stenting)), bicuspid aortic valve s/p ___ ___ AVR ___ on coumadin, atrial fibrillation/flutter on amiodarone, and tachy-brady syndrome s/p PPM placement in ___ presents with intermittent substernal chest pain x1d, trop leak of 0.32, and EKG w/ t-wave inversions V2-V4 with 1mm ST depressions V3-V4 c/w NSTEMI. The patient was placed on a nitro gtt for chest pain and BP control. Cath on ___ showed patent LMCA, LAD w/ proximal occlusion, occluded SVG->LPL (seen previously), and LCX Ramus w/ occlusion. Pt. had LCx Ramus balloon angioplasty performed for in-stent re-stenosis vs. thrombosis. Patient was sent back to the cath lab on ___ for persistent chest pain; no new culprit lesions were demonstrated, LIMA-LAD SVG remained patent. The patient did well post-cath and was continued on Plavix (no stents placed). Medical optimiziation was pursued, his Imdur was uptitrated from 60 to 120 mg PO QD. Because he is now on triple anticoagulant therapy, his goal INR for his mechanical valve should be 2.5-3.0. ACTIVE ISSUES: # NSTEMI: Pt presented with intermittent substernal CP associated with a troponin leak of 0.32 and EKG changes including t-wave inversions V2-V4 with 1mm ST depressions V3-V4 meeting criteria for NSTEMI. Pt's admission TIMI risk score of 6 placed the pt. in the high-risk category estimating his risk of all-cause mortality, new or recurrent MI, or severe recurrent ischemia requiring urgent revascularization in the next ___ days at 41%. Pt. received 600mg plavix load in the ED and was placed on a nitro drip. Heparin and coumadin were held in preparation for cath (INR 2.8). Pt. had TTE which revealed LVEF 50% secondary to hypokinesis of the posterior and lateral walls (new compared to prior TTE on ___ int he region of the rams with preserved function in the LAD territory) with a higher than expected transaortic gradient higher than expected for his type of prosthesis (chronic and stable). Pt. underwent cath on ___ which revealed showed patent LMCA, LAD w/ proximal occlusion, occluded SVG->LPL (seen previously), and LCX Ramus w/ occlusion. Pt. had LCx Ramus balloon angioplasty performed for in-stent re-stenosis vs. thrombosis. Patient was sent back to the cath lab on ___ for persistent chest pain; no new culprit lesions were demonstrated, LIMA-LAD SVG remained patent. Pt. remained chest pain free 24 hours prior to discharge. His medical regimen was continued with an increase of his imdur to 120mg Daily. # Leukocytosis: WBC count 14 on admission with neutrophil predominance thought to be ___ stress response to NSTEMI. His WBC count continued to increase in the setting of receiving methylprednisone for pre-allergy treatment of anticipated contrast for cath. WBC was downtrending at time of discharge. Throughout the hospital course, the pt. had no signs or symptoms of infection. CHRONIC ISSUES: # Afib/Aflutter: Stable. Continued on coumadin for goal INR 2.5-3.0, diltiazem, and amiodarone. # HTN: Stable. Pt's anti-hypertensives were initially held given titration of blood pressure with nitro drip. His imdur was increased at time of discharge while other home meds were continued at their previous doses. # T2DM: Stable. Placed on insulin sliding scale while in hospital. Discharged on home dose of metformin. # Asthma: Stable. Continued on regimen of memetasone inhaler and singulair. # GERD: Stable. Continued pantoprazole. # BPH: Stable. Continued tamsulosin. # Iron Deficiency Anemia: Stable. Continued ferrous sulfate. TRANSITIONAL ISSUES: # INR: At discharge, pt. with INR of 3.7 (up from 3.2 the day previous). Pt. will be taking 5mg coumadin ___, 6mg on ___, and will be rechecking his INR on ___. # Goal INR: Pt. with AVR with hx. afib/aflutter. Given this history and given that pt. is on triple anticoagulation therapy his optimal INR range should be between 2.5 to 3.0 (full therapeutic range 2.5 to 3.5) # Beta Blocker: Pt. had stated that he had not tolerated beta blockage in the past. As such, one was not initiated on this admission. # Leukocytosis: Pt. had significant leukocytosis in the setting of NSTEMI and pre-treatment with methylprednisone for contrast allergy prior to cath. Pt. WBC downtrending at discharge. Repeat CBC should be done to ensure return of normal WBC ___ days prior to discharge. # Atorvastatin: Pt's atorva was increased from 40mg to 80mg on discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Pantoprazole 40 mg PO Q24H 2. Calcium 500 + D (calcium carbonate-vitamin D3) 500 mg(1,250mg) -200 unit oral BID 3. Valsartan 60 mg PO BID 4. Amiodarone 100 mg PO DAILY 5. Diltiazem Extended-Release 120 mg PO BID 6. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 7. Aspirin 81 mg PO DAILY 8. coenzyme Q10 50 mg oral daily 9. Montelukast Sodium 10 mg PO DAILY 10. Ferrous Sulfate 325 mg PO DAILY 11. Clopidogrel 75 mg PO DAILY 12. Atorvastatin 40 mg PO HS 13. Tamsulosin 0.4 mg PO HS 14. MetFORMIN (Glucophage) 500 mg PO DAILY 15. Warfarin 6 mg PO 5X/WEEK (___) 16. Warfarin 7 mg PO 2X/WEEK (MO,WE) Discharge Medications: 1. Amiodarone 100 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO HS 4. Clopidogrel 75 mg PO DAILY 5. Diltiazem Extended-Release 120 mg PO BID 6. Isosorbide Mononitrate (Extended Release) 120 mg PO DAILY RX *isosorbide mononitrate 120 mg 1 tablet extended release 24 hr(s) by mouth Daily Disp #*90 Tablet Refills:*3 7. Montelukast Sodium 10 mg PO DAILY 8. Pantoprazole 40 mg PO Q24H 9. Tamsulosin 0.4 mg PO HS 10. Valsartan 60 mg PO BID 11. Warfarin 6 mg PO DAILY16 Starting ___ 12. Warfarin 5 mg PO ONCE Duration: 1 Dose For ___ 13. Nitroglycerin SL 0.4 mg SL PRN chest pain 14. Calcium 500 + D (calcium carbonate-vitamin D3) 500 mg(1,250mg) -200 unit oral BID 15. coenzyme Q10 50 mg ORAL DAILY 16. Ferrous Sulfate 325 mg PO DAILY 17. MetFORMIN (Glucophage) 500 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Primary Diagnoses: 1. Non-ST-segment elevation myocardial infarction (NSTEMI) Secondary Diagnsoes: 1. Coronary artery disease status post coronary artery bypass grafting in ___ (2-vessel: LIMA-LAD, SVG-LPL), PERCUTANEOUS CORONARY INTERVENTIONS ___ Tetra stent placed in ramus intermedius; ___ Bare metal stent to LCx and balloon angioplasty to ramus; ___ drug eluding stent placement x2 to ramus and LCx (bifurcation stenting), ___ POBA to ramus) 2. Bicuspid aortic valve status ___ mechanical bileaflet prosthesis in ___ on warfarin 3. Tachy-brady syndrome status post dual chamber permanent pacemaker placement in ___. Atrial fibrillation and atrial flutter on amiodarone 5. Diastolic dysfunction (LVEF 70% in ___ 6. Diabetes 7. Dyslipidemia 8. Hypertension 9. Gastroesophageal reflux disease 10. IgM kappa monoclonal gammopathy 11. Asthma 12. Iron deficiency anemia 13. Macular degeneration 14. Osteopenia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at the ___ ___. You were admitted to ___ with chest pain and found to have a heart attack (NSTEMI). You underwent cardiac catherization, which found an occluded artery. We opened this artery with a balloon (no stents were placed). We then treated you with medications. You had some persistent chest pain after this and had a repeat catheterization which showed no new or additional blockages. You had one episode of mild chest pain following this procedure but no additional chest pain. We continued you on a blood thinner medication that you will go home on (Plavix). We also increased increased your Imdur from 60 mg to 120 mg per day. Because you were started on a new blood thinner, you will need to have your INR monitored closely after discharge to make sure your blood is not too thin. You remained stable and were discharged home. Please follow-up with your PCP and your cardiologist. Thank you for allowing us to participate in your care. All the best, Your ___ Care Team Followup Instructions: ___
19981210-DS-31
19,981,210
25,095,273
DS
31
2149-01-17 00:00:00
2149-02-06 01:36:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Iodine-Iodine Containing / IV Dye, Iodine Containing Contrast Media Attending: ___. Chief Complaint: dyspnea Major Surgical or Invasive Procedure: -___: Right heart catheterization -___: Cardioversion History of Present Illness: Mr. ___ is a ___ year old gentleman with a past medical history significant for AVR, CAD s/p CABG and PCI with stent placement in proximal LCx and ramus, and asthma who presented to the ED with complaint of dyspnea. He was recently admitted in ___ for shortness of breath which was attributed to pneumonia. Since that hospitalization, he felt that his breathing never returned to baseline. Previously, he was able to do approximately 45 minutes of exercise on the treadmill however after his recent discharge he has only been able to get up to ___ minutes. His dyspnea on exertion failed to improve, and over the past several days he noted increasing shortness of breath and even some SOB at rest. He also endorses orthopnea (having to sleep on several pillows at night), abdominal distension, peripheral edema, and very slight weight gain (approximately 2lbs). ___ also notes that he had a failed cardioversion approximately 2 weeks ago as an outpatient and hasn't felt well since.Last echo in ___ showed mild global LV systolic dysfunction, 1+ MR. ___ does not wear O2 at home, reports compliance with medications. Denies any recent diet changes or salty meals. Started on lasix 2 weeks ago. In the ED, labs were notable for elevated BNP, supratherapeutic INR, and troponin 0.06. Exam with mild respiratory distress, +JVD, irregularly irregular. Crackles at bases bilaterally. ___ Pitting edema and ___ was admitted to the heart failure service. On the floor, ___ is comfortable. Not currently short of breath. ___ no chest pain, no current complaints. Pt does endorse a productive cough which is baseline for him with his asthma. Past Medical History: 1. CAD s/p CABG in ___ (2-vessel: LIMA-LAD, SVG-LPL), PCIs ___ Tetra stent placed in ramus intermedius; ___ Bare metal stent to LCx and balloon angioplasty to ramus; ___ ___ ___ x2 to ramus and LCx (bifurcation stenting), ___ POBA to ramus); ACS: NSTEMI ___. 2. Bicuspid aortic valve status ___ mechanical bileaflet prosthesis in ___ on warfarin 3. Tachy-brady syndrome status post dual chamber permanent pacemaker placement in ___ - Atrial fibrillation and atrial flutter on amiodarone s/p cardioversion ___, failed cardioversion ___ - Diastolic dysfunction (LVEF 70% in ___ - Diabetes - Dyslipidemia - Hypertension - Gastroesophageal reflux disease - IgM kappa monoclonal gammopathy - Asthma - Iron deficiency anemia - Macular degeneration - Osteopenia - Erectile Dysfunction - Tremor - Trigger finger - Cervical radiculopathy - Status post right cataract repair Social History: ___ Family History: Father with myocardial infarction at age ___. Mother died of natural causes at ___. No h/o arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION PHYSICAL EXAM ======================= General: friendly gentleman, conversant, resting comfortably in no acute distress HEENT: NC/AT, PERRL, MMM Neck: +JVD, supple full ROM CV: Regular rate, irregularly irregular rhythm. Nl S1, S2. soft systolic murmur. No rubs or gallops. Lungs: crackles at bases bilaterally, no wheezes Abdomen: Soft, moderately distended, non-TTP, bowel sounds present GU: No foley Ext: bilateral ___ pitting edema R>L Neuro: CN ___ intact. Motor function grossly normal, alert and oriented x3 Skin: no rashes DISCHARGE PHYSICAL EXAM ======================= Vitals: T 98.1, HR 76, BP 113/59, RR 16, 02 sat 95% RA Weight: 62.8<--69.3 General: sitting up in bed eating breakfast, NAD HEENT: MMM, OP clear Neck: JVD 8cm CV: RRR, +systolic murmur, mechanical valve Lungs: CTA b/l, no crackles or wheezes Abdomen: Soft, non-tender GU: No foley Ext: trace edema in ___ b/l Pertinent Results: ADMISSION LABS ============== ___ 11:32AM BLOOD WBC-10.3 RBC-3.64* Hgb-9.6* Hct-31.0* MCV-85 MCH-26.4* MCHC-31.0 RDW-16.0* Plt ___ ___ 11:32AM BLOOD Neuts-84.6* Lymphs-5.1* Monos-7.9 Eos-2.2 Baso-0.2 ___ 11:32AM BLOOD ___ PTT-35.4 ___ ___ 11:32AM BLOOD Plt ___ ___ 11:32AM BLOOD Glucose-181* UreaN-24* Creat-0.9 Na-143 K-3.8 Cl-108 HCO3-26 AnGap-13 ___ 11:32AM BLOOD proBNP-2420* ___ 11:32AM BLOOD cTropnT-0.06* ___ 11:32AM BLOOD Calcium-9.2 Phos-2.1* Mg-1.9 DISCHARGE LABS ============== ___ 07:05AM BLOOD WBC-11.9* RBC-4.28* Hgb-11.0* Hct-35.7* MCV-83 MCH-25.7* MCHC-30.8* RDW-15.3 Plt ___ ___ 07:05AM BLOOD ___ ___ 07:05AM BLOOD Glucose-123* UreaN-38* Creat-1.3* Na-140 K-4.1 Cl-99 HCO3-32 AnGap-13 ___ 07:05AM BLOOD Calcium-9.9 Phos-3.8 Mg-2.1 OTHER PERTINENT LABS ==================== ___ 11:12PM BLOOD CK-MB-4 cTropnT-0.10* ___ 06:40AM BLOOD CK-MB-5 cTropnT-0.07* ___ 06:40AM BLOOD TSH-<0.02* REPORTS ======= ___ CXR: Stable cardiomegaly, increased b/l pleural effusion, insterstitial pulmonary edema. ___ TTE: The left atrium is mildly dilated. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thicknesses are normal. The left ventricular cavity size is normal. Overall left ventricular systolic function is moderately depressed, with regional variation (LVEF = 35 %). [Intrinsic left ventricular systolic function is likely more depressed given the severity of valvular regurgitation.] Tissue Doppler imaging suggests an increased left ventricular filling pressure (PCWP>18mmHg). The right ventricular free wall thickness is normal. Right ventricular chamber size is normal. with severe global free wall hypokinesis. A bileaflet aortic valve prosthesis is present. The aortic valve prosthesis appears well seated, with normal leaflet/disc motion and transvalvular gradients. The mitral valve leaflets are mildly thickened. Moderate to severe (3+) mitral regurgitation is seen. [Due to acoustic shadowing, the severity of mitral regurgitation may be significantly UNDERestimated.] There is mild pulmonary artery systolic hypertension. There is no pericardial effusion. Compared with the prior study (images reviewed) of ___, biventricular systolic function is worse; mitral and tricuspid regurgitation is also worse. ___ REST THALLIUM STRESS: Moderate size, moderate severity defect seen in the left circumflex territory with some partial redistribution seen on 4 and 24 hour images. ___ Right heart cath: Hemodynamics: elevated filling pressures with moderate pulmonary hypertension Assessment & Recommendations 1. Elevated filling pressures with moderate pulmonary hypertension and hypoxemia. 2. Continue diuresis as per CHF team. Brief Hospital Course: ___ with h/o CAD s/p 2v CABG (LIMA-LAD, SVG-LPL) in ___ and multiple stents, bicuspid aortic valve s/p AVR ___, atrial fibrillation/flutter, and tachy-brady syndrome s/p PPM placement in ___ presented w/SOB found to have CHF exacerbation, now s/p successful cardioversion and diuresis. Has been in NSR since cardioversion. ACTIVE ISSUES ============= # Systolic and Diastolic HF: Pt reported increasing SOB in the setting of abdomen and ___ edema and slight weight gain. CXR showed pulmonary edema and bilateral pleural effusions which are increased from prior. Elevated BNP. Repeat TTE ___ with decreased EF from ___ (50% -> 35%), worsened TR and MR. ___ suspicion for low gradient low flow AS based on Dr. ___ ___. Right heart cath ___ significant for elevated filling pressures, with further diuresis recommended. Ddx for CHF includes CAD (Stress test with new defect with LCx territory), amiodarone toxicity. Afib also may have contributed; now in sinus s/p cardioversion. Pt remained volume overloaded so diuresis was continued and prior to discharge ___ was transtioned to PO torsemide (had been on lasix 20mg PO daily at home). # CAD: Last TTE showed left ventricular systolic function as low normal (LVEF = 50%) with mild global hypokinesis. Troponin 0.06 on admission labs, up to 0.10, down to ___ AM. Likely secondary to CHF exacerbation and not ACS. ___ did have an episode of chest discomfort ___ AM which he attributes to his afib/anxiety. Similar to his chronic episodes at home, and EKG unchanged. Likely represent chronic angina, pt reports episodes when HR>100. Repeat TTE with EF worsened to 35%. Restarted beta-blocker ___. Stress test ___ showed for moderate size, moderate severity defect seen in the left circumflex territory. Will hold off on cardiac cath for now, may reconsider outpatient. ___ was discharged on increased valsartan dose from 60mg (home) to 80mg. He was continued on home ASA/plavix, atorvastatin, imdur, and metoprolol as below. # Afib/Aflutter: CHADS 2 = 3 (HTN, age, DM). ___ on coumadin 5mg qd at home however INR supratherapeutic on admission so intially held. Of note, pt had recent cardioversion which failed to convert back to sinus rhythm. Pacer interrogation ___ significant for persistent AF since ___ with average V rates <100bpm, max V rate 137 bpm, and 34% V pacing since ___. Per EP recs, considering re-attempt at cardioversion now that he has received higher dose amiodarone x 1 month. INR down to 2.7 on ___ labs and warfarin restarted at home dose. Metoprolol restarted ___ at 12.5 qd (had been on previously then discontinued by ___ outpatient secondary to worsening asthma/COPD so had not been taking prior to admission), then uptitrated to 25mg qd ___. Now s/p successful cardioversion ___ AM. Rhythm remains regular. Home diltiazem discontinued ___. Metoprolol increased to 50mg qd on ___. On discharge, amiodarone dose decreased to 200mg qd. # Leukocytosis: pt with persistent leukocytosis, up to 13 on AM labs ___, ___ elevated at 12.6 ___. UA ___ without evidence for UTI. Pt without any symptoms or clinical signs of infection, likely a stress response. # Abdominal distension: Also present on ___ recent admission where he was fluid overloaded; attributed to volume overload at that time and reduced with diuresis. Now resolved with diuresis. CHRONIC ISSUES ============== # HTN: continued home regimen as above, with newly increased valsartan dose, and added metoprolol on this admission. # T2DM: held home metformin while inpatient, and ___ received sliding scale insulin. # Asthma: on home symbicort, albuterol PRN. Pt received Advair in house as symbicort not formulary and pt did not have his inhaler with him. # GERD: continued home pantoprazole # BPH: continued home tamsulosin TRANSITIONAL ISSUES =================== -___ being discharged home with ___ to help with medication changes, heart failure teaching -Will have labs drawn ___: INR, electrolytes that should be followed-up -TTE with significantly decreased EF since 6 weeks prior -Consider repeat TTE on an outpatient basis now that pt is diuresed -Multiple cardiac medication changes: please refer to sheet Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, sob 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO DAILY 4. Clopidogrel 75 mg PO DAILY 5. Diltiazem Extended-Release 120 mg PO BID 6. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 7. Montelukast 10 mg PO DAILY 8. Multivitamins 1 TAB PO DAILY 9. Nitroglycerin SL 0.4 mg SL PRN chest pain 10. Pantoprazole 40 mg PO Q24H 11. Tamsulosin 0.4 mg PO HS 12. TRIAzolam 0.125 mg PO HS:PRN insomnia 13. Valsartan 60 mg PO BID 14. coenzyme Q10 50 mg oral daily 15. MetFORMIN (Glucophage) 500 mg PO QHS 16. PreserVision Lutein (vit C-vit E-copper-ZnOx-lutein) 226-200-5-0.8 mg-unit-mg-mg oral daily 17. Amiodarone 300 mg PO DAILY 18. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation 2 puffs BID 19. Furosemide 20 mg PO DAILY 20. calcium carbonate-vitamin D3 500 mg(1,250mg) -200 unit oral BID 21. Warfarin 5 mg PO DAILY16 Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, sob 2. Amiodarone 200 mg PO DAILY RX *amiodarone 200 mg 1 tablet by mouth once a day Disp #*30 Tablet Refills:*0 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 80 mg PO DAILY 5. Clopidogrel 75 mg PO DAILY 6. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY 7. Montelukast 10 mg PO DAILY 8. Multivitamins 1 TAB PO DAILY 9. Pantoprazole 40 mg PO Q24H 10. Tamsulosin 0.4 mg PO HS 11. TRIAzolam 0.125 mg PO HS:PRN insomnia 12. Valsartan 80 mg PO BID RX *valsartan [Diovan] 80 mg 1 tablet by mouth twice a day Disp #*60 Tablet Refills:*0 13. Warfarin 5 mg PO DAILY16 14. Metoprolol Succinate XL 50 mg PO DAILY RX *metoprolol succinate 50 mg 1 tablet by mouth once a day Disp #*30 Tablet Refills:*0 15. Spironolactone 12.5 mg PO DAILY RX *spironolactone 25 mg 0.5 (One half) tablet by mouth once a day Disp #*15 Tablet Refills:*0 16. Torsemide 40 mg PO DAILY RX *torsemide 20 mg 2 tablets by mouth once a day Disp #*60 Tablet Refills:*0 17. calcium carbonate-vitamin D3 500 mg(1,250mg) -200 unit oral BID 18. coenzyme Q10 50 mg ORAL DAILY 19. MetFORMIN (Glucophage) 500 mg PO QHS 20. Nitroglycerin SL 0.4 mg SL PRN chest pain 21. PreserVision Lutein (vit C-vit E-copper-ZnOx-lutein) 226-200-5-0.8 mg-unit-mg-mg oral daily 22. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation INHALATION 2 PUFFS BID 23. Outpatient Lab Work Lab draw ___ -INR -Complete electrolyte panel Please fax results to: Dr. ___ ___ Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS ================= -Systolic and diastolic heart failure SECONDARY DIAGNOSES =================== -Coronary artery disease -Mitral regurgitation -Atrial fibrillation -Hypertension -Hyperlipidemia -Asthma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You came to ___ because you were having shortness of breath and leg and abdomen swelling consistent with heart failure exacerbation. You were also in atrial fibrillation. While here, you had an echocardiogram which showed decreased ejection fraction. You also had a right heart catheterization which confirmed fluid overload. You underwent cardioversion which successfully converted you out of atrial fibrillation, and you have been in normal sinus rhythm since. Now that the extra fluid has been diuresed off and you have been transitioned to oral diuretic medication you are ready to be discharged to continue your recovery at home with home visiting nurse service. You will need to have labs drawn on ___. This can be done either by the visiting nurse or at a lab. It is important that you continue to weigh yourself every morning, call MD if weight goes up more than 3 lbs. Continue to eat a sodium restricted (<2000mg) diet and take your medications as directed below. Thank you for allowing us to participate in your care. Followup Instructions: ___
19981210-DS-33
19,981,210
27,919,282
DS
33
2152-01-03 00:00:00
2152-01-03 16:35:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Iodine-Iodine Containing / IV Dye, Iodine Containing Contrast Media Attending: ___ Chief Complaint: Chest Pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ male with a past medical history of CAD with a very complex course including multiple stents, CHF, DM who presents with substernal chest pain. Chest pain occurred last night at rest. Took nitro and was able to sleep and then woke up with worsened chest pain and mild SOB. The pain improved after 3 nitroglycerin from a 6 out of 10 to 3 out of 10 and decided to go to ___. Trop neg there and CXR neg, received NTG and then xfer to ___ for further eval given complex cardiac history. Trop here negative. CP is now ___, attributes to taking his home medicines. Took full dose aspirin this morning. In the ___ initial vitals were: 98.0 76 131/76 14 96% RA EKG: paced Labs/studies notable for: trop < 0.01 Past Medical History: 1. CARDIAC RISK FACTORS - Diabetes - Hypertension - Dyslipidemia 2. CARDIAC HISTORY 1. Coronary artery disease s/p t CABG & PCI. - NSTEMI ___ s/p cath and POBA to Ramus stent, - recath showing patent stent. - extremely complicated anatomy unamenable to complete revascularization 2. Bicuspid aortic valve s/p aortic valve replacement ___ 3. Atrial fibrillation and atrial flutter - dronedarone and warfarin - amiodarone - PPM 4. Amiodarone therapy complicated with thyroiditis managed by endocrine service. 5. Mild diastolic dysfunction. 6. Cath for positive stress test in ___: 3 vessel cad - 60-70% proximal lesion in the LCx. - 30% in-stent restenosis of the ramus. - Patent LIMA->LAD. Totally occluded SVG->OM1. USA ___ CTO PCI of Ramus with PTCA alone 7. EF - 50%-55%. 3. OTHER PAST MEDICAL HISTORY - Diabetes mellitus. - Hypertension. - Dyslipidemia. - Iron deficiency anemia (previously on iron supplementation, discontinued ___. - History of a colon polyp. - Asthma. - Macular degeneration. - Osteopenia. Social History: ___ Family History: Father with myocardial infarction at age ___. Mother died of natural causes at ___. No h/o arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION EXAM: VS: afebrile BP 133/72 HR 75 RR 18 O2 SAT 97 RA GENERAL: WDWN M in NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with JVP non elevated CARDIAC: PMI located in ___ intercostal space, midclavicular line. RRR, systolic murmur, (+) click LUNGS:Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Distal pulses dopplerable DISCHARGE EXAM: - VITALS: 119 / 54R Lying 76 20 96 RA - I/Os: even - WEIGHT: 67.7 kg - WEIGHT ON ADMISSION: 67.1 - TELEMETRY: paced GENERAL: WDWN M comfortable in bed. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with JVP non elevated CARDIAC: PMI located in ___ intercostal space, midclavicular line. RRR, systolic murmur, (+) click LUNGS:Resp were unlabored, no accessory muscle use. Mild basilar crackles L>R ABDOMEN: Soft, NTND. EXTREMITIES: No c/c/e. Pertinent Results: ADMISSION LABS: ___ 12:55PM cTropnT-<0.01 ___ 05:24PM WBC-10.6* RBC-3.87* HGB-9.4* HCT-30.3* MCV-78* MCH-24.3* MCHC-31.0* RDW-18.6* RDWSD-51.9* ___ 05:24PM CALCIUM-9.5 PHOSPHATE-3.0 MAGNESIUM-2.1 ___ 05:24PM CK-MB-3 cTropnT-<0.01 ___ 05:24PM GLUCOSE-100 UREA N-26* CREAT-1.4* SODIUM-139 POTASSIUM-4.1 CHLORIDE-100 TOTAL CO2-28 ANION GAP-15 ECHO ___ The left atrial volume index is moderately increased. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. Overall left ventricular systolic function is low normal (LVEF = 50%) secondary to focal inferior posterior hypokinesis. Tissue Doppler imaging suggests an increased left ventricular filling pressure (PCWP>18mmHg). The right ventricular free wall thickness is normal. The right ventricular cavity is mildly dilated with normal free wall contractility. A bileaflet aortic valve prosthesis is present. The transaortic gradient is higher than expected for this type of prosthesis. Trace aortic regurgitation is seen. [The amount of regurgitation present is normal for this prosthetic aortic valve.] The mitral valve leaflets are mildly thickened. Mild (1+) mitral regurgitation is seen. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. Compared with the prior study (images reviewed) of ___, no major change. ___ CXR IMPRESSION: 1. Obscured right heart border may be secondary to atelectasis versus a consolidation. Recommend lateral view to further evaluate for a right middle lobe pneumonia. 2. Mild fluid overload new since the prior study. DISCHARGE LABS: ___ 07:55AM BLOOD WBC-11.1* RBC-4.62 Hgb-12.1* Hct-37.4* MCV-81* MCH-26.2 MCHC-32.4 RDW-20.2* RDWSD-56.4* Plt ___ ___ 08:20AM BLOOD Neuts-76* Bands-1 Lymphs-9* Monos-6 Eos-6 Baso-0 ___ Myelos-2* AbsNeut-8.78* AbsLymp-1.03* AbsMono-0.68 AbsEos-0.68* AbsBaso-0.00* ___ 07:55AM BLOOD Plt ___ ___ 07:55AM BLOOD Glucose-109* UreaN-31* Creat-1.6* Na-138 K-3.7 Cl-102 HCO3-23 AnGap-17 ___ 07:55AM BLOOD Calcium-9.4 Phos-2.7 Mg-2.3 ___ 08:40AM BLOOD TSH-12* Brief Hospital Course: ___ h/o CAD, HFpEF, AF s/p PPM, DM p/w chest pain and negative trops, ecg at baseline. - CORONARIES: s/p CTO of ramus stent - PUMP: 50 - RHYTHM: paced ACTIVE ISSUES: ================================== #Chest Pain/CAD: c/f unstable angina improves with nitrates. Given known inoperable CAD, attempted medical optimization. This was complicated by HAP that developed on ___. After hemodynamic stabilization and antibiotics, his discharge regimen was metop 37.5 mg daily, imdur 30 daily, ASA/Plavix, atorva 80, spirono 12.5, and torsemide 20 mg daily. TSH elevate to 12, likely from nonadherence. Should have recheck in 4 weeks and titrate as outpt #HAP: ___ with new URI symptoms congestion. CXR on ___ c/f RML PNA given new obscuring of R heart border. Hypotension on ___ out of proportion to patient's medication regimen c/f septic shock requiring approx. 12 hours of pressor support. He was fluid resuscitated and transfused 1u prbc for downtrending Hb and outpt provider goal of ___ 10. Micro data was unrevealing though MRSA swab negative. Vanc/cefepime started ___ and stopped on ___. Transitioned to Levofloxacin 750 mg po q48hrs based on renal clearance on ___. Will have last dose ___. Should be monitored closely for COPD exacerbation, which did not occur while inpt. #CHF/HTN: meds as above. euvolemic on discharge. DC weight 67.7 #Afib, PPM: CHADS-5 cont amio 100 mg daily, daily dose warfarin. INR on dc was 2.5. Given levoflox, ___ w/ 4 mg daily. Needs INR check ___ #Iron Deficiency Anemia: Patient with history of MUGS, iron deficient anemia with MCV 78 ferritin <20. Patient with history of colon polyps. Per outpatient PCP, concern for GI bleed, plan outpatient was EGD +/- colonoscopy; patient has negative guiaiac stools card from PCP and no bloody bowel movements while inpatient. In terms of MGUS, patient follows with Dr. ___, ___ visit ___ noted stability of IgM kappa MGUS. Per GI will do outpt scope given better outcomes and intermittent CP in house and no urgency to scope at this time. ___ with po iron and bid ppi CHRONIC/STABLE ISSUES: ================================== #COPD: stable on RA. cont inhalers - symbicort not on formulary will use advair, cont singulair. Patient refused advair throughout admission for throat irritation. #CKD: developed ___ after septic shock. improving and stable by discharge. #DM: appears no long on metformin. ISS #Hypothyroid: cont home synthroid 88mcg ___ 132 mcg). TSH 12, needs outpt med titration and f/u #GERD: cont ppi #BPH: cont Flomax #MGUS: stable, outpt f/u. #insomnia: hold benzo, offer ramelteon TRANSITIONAL ISSUES: - Please ensure outpt GI workup - Please titrate anti-angina and anti-hypertensives. Discharged on metop 37.5 mg daily, imdur 30 mg daily, spironolactone 12.5 mg daily, torsemide 20 mg daily - Please restart ___ when able - HAP: ___ on levoflox 750mg q48 hrs. QTC 476. Last dose ___ - INR: 2.5 on dc. 4 mg daily given levoflox. please recheck ___ and adjust prn - Please get BMP at next visit to assess renal function Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amiodarone 100 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Clopidogrel 75 mg PO DAILY 5. Isosorbide Mononitrate (Extended Release) 90 mg PO DAILY 6. Levothyroxine Sodium 88 mcg PO 6X/WEEK (___) 7. Levothyroxine Sodium 132 mcg PO 1X/WEEK (___) 8. Metoprolol Succinate XL 50 mg PO BID 9. Montelukast 10 mg PO DAILY 10. Multivitamins 1 TAB PO DAILY 11. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 12. Pantoprazole 40 mg PO Q24H 13. Tamsulosin 0.4 mg PO QHS 14. TRIAzolam 0.125 mg PO QHS:PRN insomnia 15. Valsartan 80 mg PO DAILY 16. Warfarin 5 mg PO DAILY16 17. albuterol sulfate 90 mcg/actuation inhalation Q4H:PRN 18. budesonide-formoterol 80-4.5 mcg/actuation inhalation BID 19. Spironolactone 12.5 mg PO DAILY 20. Torsemide 30 mg PO DAILY 21. ubidecarenone-omega 3-vit E ___ mg-mg-unit oral DAILY Discharge Medications: 1. Benzonatate 100 mg PO TID:PRN cough RX *benzonatate 100 mg 1 capsule(s) by mouth three times a day Disp #*30 Capsule Refills:*0 2. Cepacol (Sore Throat Lozenge) 2 LOZ PO Q2H:PRN sore throat RX *dextromethorphan-benzocaine [Cepacol Sorethroat-Cough] 5 mg-7.5 mg ___ lozenge(s) by mouth four times a day Disp #*32 Lozenge Refills:*0 3. GuaiFENesin ___ mL PO Q6H:PRN cough RX *guaifenesin 100 mg/5 mL 5 ml by mouth four times a day Refills:*0 4. Levofloxacin 750 mg PO Q48H RX *levofloxacin 750 mg 1 tablet(s) by mouth every other day Disp #*3 Tablet Refills:*0 5. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY RX *isosorbide mononitrate 30 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 6. Metoprolol Succinate XL 37.5 mg PO DAILY RX *metoprolol succinate 25 mg 1.5 tablet(s) by mouth daily Disp #*45 Tablet Refills:*0 7. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth twice a day Disp #*28 Tablet Refills:*0 8. Torsemide 20 mg PO DAILY RX *torsemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 9. albuterol sulfate 90 mcg/actuation inhalation Q4H:PRN 10. Amiodarone 100 mg PO DAILY 11. Aspirin 81 mg PO DAILY 12. Atorvastatin 80 mg PO QPM 13. budesonide-formoterol 80-4.5 mcg/actuation inhalation BID 14. Clopidogrel 75 mg PO DAILY 15. Levothyroxine Sodium 88 mcg PO 6X/WEEK (___) 16. Levothyroxine Sodium 132 mcg PO 1X/WEEK (___) 17. Montelukast 10 mg PO DAILY 18. Multivitamins 1 TAB PO DAILY 19. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 20. Spironolactone 12.5 mg PO DAILY 21. Tamsulosin 0.4 mg PO QHS 22. TRIAzolam 0.125 mg PO QHS:PRN insomnia 23. ubidecarenone-omega 3-vit E ___ mg-mg-unit oral DAILY 24. Warfarin 5 mg PO DAILY16 25. HELD- Valsartan 80 mg PO DAILY This medication was held. Do not restart Valsartan until you see your doctor in clinic for blood pressure check Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: Unstable angina HAP Secondary diagnoses: Iron deficiency anemia CAD Atrial fibrillation HTN COPD Diabetes Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure to take care of you at ___. WHY DID I HAVE TO STAY IN THE HOSPITAL? You had to stay in the hospital because of chest pain. You also had to stay in the hospital because of a pneumonia, aka lung infection. WHAT WAS DONE FOR ME? Your medications were adjusted for your chest pain. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? You should take your medications as prescribed. Please take your antibiotics (levofloxacin) at 8 pm on ___, ___, and ___ Please do not take valsartan until you see your regular doctors in ___ and discuss it with them. Please check your blood pressure every day and call your doctor if the systolic blood pressure (the top number) is LESS THAN 90. Please have an INR check on ___. Please follow up with your regular doctors. ___ yourself every morning, call MD if weight goes up more than 3 lbs. Sincerely, Your Medical Team Followup Instructions: ___
19982305-DS-10
19,982,305
28,629,030
DS
10
2161-05-14 00:00:00
2161-05-14 10:38:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: left hip pain Major Surgical or Invasive Procedure: Left hemiarthroplasty History of Present Illness: ___ year old female with history of hypertension (untreated) presents after slip and fall on the stairs with immediate right hip pain and inability to ambulate. Denies HS, LOC, pain elsewhere. Denies dizziness, SOB, CP or other syncopal symptoms. Patient is a community ambulatory and lives with daughter and other family. She is able to walk for grocery shopping and getting up and stairs on her own at baseline. Past Medical History: Hypertension Social History: ___ Family History: NC Physical Exam: LLE: Dressing intact Fires ___ SILT DPN/SPN Foot perfused, palp DP pulse Pertinent Results: ___ 01:29PM K+-4.0 ___ 12:40PM URINE HOURS-RANDOM ___ 12:40PM URINE UHOLD-HOLD ___ 12:40PM URINE COLOR-Yellow APPEAR-Hazy SP ___ ___ 12:40PM URINE BLOOD-SM NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-TR ___ 12:40PM URINE RBC-19* WBC-2 BACTERIA-FEW YEAST-NONE EPI-6 ___ 10:45AM GLUCOSE-126* UREA N-23* CREAT-0.8 SODIUM-137 POTASSIUM-5.7* CHLORIDE-102 TOTAL CO2-20* ANION GAP-21* ___ 10:45AM estGFR-Using this ___ 10:45AM CALCIUM-9.1 PHOSPHATE-3.4 MAGNESIUM-1.9 ___ 10:45AM WBC-11.2* RBC-4.41 HGB-14.3 HCT-42.8 MCV-97 MCH-32.4* MCHC-33.4 RDW-14.7 RDWSD-52.0* ___ 10:45AM NEUTS-81.7* LYMPHS-12.1* MONOS-5.4 EOS-0.1* BASOS-0.2 IM ___ AbsNeut-9.16*# AbsLymp-1.36 AbsMono-0.61 AbsEos-0.01* AbsBaso-0.02 ___ 10:45AM PLT COUNT-175 ___ 10:45AM ___ PTT-28.2 ___ Brief Hospital Course: Hospitalization Summary The patient presented to the emergency left femoral neck fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ after being preoperatively cleared by medical service, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The ___ hospital course was otherwise unremarkable.   At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is weight bearing as tolerated in the left lower extremity, and will be discharged on Lovenox for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: None Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H 2. Docusate Sodium 100 mg PO BID 3. Enoxaparin Sodium 40 mg SC DAILY RX *enoxaparin 40 mg/0.4 mL 40 mg SC daily Disp #*28 Syringe Refills:*0 4. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain RX *oxycodone 5 mg ___ tablet(s) by mouth every 4 hours Disp #*50 Tablet Refills:*0 Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Left femoral neck fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Weight bearing as tolerated MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take Lovenox daily for 4 weeks WOUND CARE: - You may shower. Please do not bathe or soak for 4 weeks. - Please change dressing every ___ days or more frequently if needed for drainage. DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if you experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever > 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns FOLLOW UP: Please follow up with ___ in the Orthopaedic Trauma Clinic ___ days post-operation for evaluation. Please call ___ to schedule appointment. Please follow up with your primary care doctor regarding this admission within ___ weeks and for and any new medications/refills. Followup Instructions: ___
19982483-DS-11
19,982,483
28,983,948
DS
11
2184-03-26 00:00:00
2184-03-28 12:32:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: R Shoulder pain Major Surgical or Invasive Procedure: ORIF R proximal humerus fracture History of Present Illness: ___ s/p mechanical fall this AM onto Right side in home bathroom hitting Right shoulder on toilet with immediate pain and swelling. Developed gradual onset of RUE parasthesias and later wrist extension weakness at ___, ___, transferred to ___ for evaluation. No loss of pulses or cool distal extremity, no open injuries. Endorses head strike without LOC, no neck/back pain, mild headache relieved with Tylenol. Past Medical History: Hypothyroid, hyperlipidemia. s/p hysterectomy, cholecystectomy, breast mass removal, abdominal lysis of adhesions Social History: ___ Family History: NC Physical Exam: 98.0 95 137/67 16 98% NAD, AAOx3 RUE - shoulder moderately swollen, tender, skin intact WWP distally, 2+ radial pulse Sensation diminished radial nerve distribution compared to left, median/ulnar/axillary intact Motor: shoulder exam limited by pain, triceps/biceps fire, ___+/5 wrist flexion, ___ finger flexion, ___ finger abduction. Pertinent Results: LABS: 11.6 > 37 < 292 INR 0.9 Electrolytes WNL U/A negative IMAGING: Xrays Right shoulder reviewed supine and standing films, notable for 3-part proximal humerus fracture with articular surface humeral head moderately intact, metaphyseal fracture, glenoid appears intact. Shaft medially displaced, Greater tuberosity superiorly displaced. Moderate reduction of angulation with gravity films. Brief Hospital Course: The patient was admitted to the orthopaedic surgery service on ___ with a R proximal humerus fracture. Patient was taken to the operating room and underwent ORIF R proximal humerus fracture. Patient tolerated the procedure without difficulty and was transferred to the PACU, then the floor in stable condition. Please see operative report for full details. Musculoskeletal: prior to operation, patient was ___. After procedure, patient's weight-bearing status was transitioned to ___ RUE, in sling at all times and orthoplast splint at all times. Throughout the hospitalization, patient worked with physical therapy. Neuro: post-operatively, patient's pain was controlled by morphine IV and was subsequently transitioned to oxycodone with good effect and adequate pain control. CV: The patient was stable from a cardiovascular standpoint; vital signs were routinely monitored. Hematology: The patient's HCT was stable and she did not require any blood transfusions during this hospitalization. Pulmonary: The patient was stable from a pulmonary standpoint; vital signs were routinely monitored. GI/GU: A po diet was tolerated well. Patient was also started on a bowel regimen to encourage bowel movement. Intake and output were closely monitored. ID: The patient received perioperative antibiotics. The patient's temperature was closely watched for signs of infection. Prophylaxis: The patient received aspirin during this stay, and was encouraged to get up and ambulate as early as possible. At the time of discharge on ___, POD #4, the patient was doing well, afebrile with stable vital signs, tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The incision was clean, dry, and intact without evidence of erythema or drainage; the extremity was NVI distally throughout. The patient was given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient will be continued on aspirin for DVT prophylaxis for 4 weeks post-operatively. All questions were answered prior to discharge and the patient expressed readiness for discharge. Medications on Admission: levothyroxine 100mcg, pravastatin, Vit D, MVI Discharge Medications: 1. Acetaminophen 650 mg PO Q6H 2. Aspirin 325 mg PO DAILY 3. Docusate Sodium 100 mg PO BID 4. Levothyroxine Sodium 100 mcg PO DAILY 5. Vitamin D 400 UNIT PO DAILY 6. Senna 1 TAB PO BID 7. Pravastatin 20 mg PO DAILY 8. OxycoDONE (Immediate Release) 2.5-5 mg PO Q4H:PRN Pain RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*60 Tablet Refills:*0 9. Multivitamins 1 CAP PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: R proximal humerus fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: ******SIGNS OF INFECTION******** - Please return to the emergency department or notify MD if you should experience severe pain, increased swelling, decreased sensation, difficulty with movement; fevers >101.5, chills, redness or drainage at the incision site; chest pain, shortness of breath or any other concerns. ********Wound Care******** - You can get the wound wet/take a shower starting from 3 days post-op. No baths or swimming for at least 4 weeks. Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. No dressing is needed if wound continues to be non-draining. ******WEIGHT-BEARING******* - Non weight bearing R upper extremity w/sling at all times, orthoplast cock-up wrist splint on at all times - No right shoulder Range of Motion, elbow/wrist/finger ROM ok ******MEDICATIONS*********** - Resume your pre-hospital medications. - You have been given medication for your pain control. Please do not operate heavy machinery or drink alcohol when taking this medication. As your pain improves please decrease the amount of pain medication. This medication can cause constipation, so you should drink ___ glasses of water daily and take a stool softener (colace) to prevent this side effect. - Medication refills cannot be written after 12 noon on ___. *****ANTICOAGULATION****** Take Aspirin 325mg PO daily for 4 weeks to prevent blood clots Physical Therapy: - NWB RUE w/sling at all times, orthoplast cock-up wrist splint at all times - no right shoulder ROM, elbow/wrist/finger ROM ok Treatments Frequency: Daily dressing change - dry sterile dressing overlay Followup Instructions: ___
19982539-DS-17
19,982,539
23,136,520
DS
17
2175-06-04 00:00:00
2175-06-04 12:40:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROSURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: R sided weakness, language difficulties Major Surgical or Invasive Procedure: ___ - Thrombectomy TICI IIb reperfusion ___ - Left hemicraniectomy for decompression ___ - PEG placement ___ - Right frontal EVD placement in OR ___ - Left wound washout and revision ___ - Removal of right frontal EVD ___ - Right VPS placement, ___ Strata History of Present Illness: Mr. ___ is a ___ yo man with history of poorly controlled HTN who presents as transfer from ___ with change in speech and right-sided weakness. Mr. ___ was LKW at 2300 ___ ___ when he was seen by his mother before going to bed. She heard a 'thump' at approx. 0200 and found him in the kitchen 'fumbling' in the sink. He said "I think I need some help, Mom". When she asked what was wrong, he said 'oatmeal' indicating he had dropped a bowl of oatmeal, leading to the thump. She helped him get dressed, and noted that he was dropping things out of his right hand. He was then taken to ___ at ___, where CTA reportedly showed M2 cutoff. Blood pressure on presentation was 208/101, HR 79. He was treated with IV labetalol 10 mg x3 then nicardipine gtt. He received ASA 325 at 0322. He was subsequently transferred for consideration of thrombectomy. Regarding his history, his mother states that he has known hypertension. He was recently experiencing severe headaches, went to his PCP, and was started on BP medications. Past Medical History: Hypertension Social History: ___ Family History: Father with hypertension and three strokes, CEA Mother with atrial myxoma and valve replacement Physical Exam: ADMISSION EXAM: ============== General: Awake, cooperative, NAD. HEENT: no scleral icterus, MMM, no oropharyngeal lesions. Pulmonary: Breathing comfortably, no tachypnea nor increased WOB Cardiac: RRR. Skin warm, well-perfused. Abdomen: soft, ND Extremities: Symmetric, no edema. Neurologic Examination: - Mental status: Awake, alert. No speech, occasional nonsyllabic vocalizations. Does not repeat even monosyllabic words. Follows some very simple commands (open/close eyes, look up) but opens mouth when asked to stick out tongue and holds up forefinger when asked to show thumbs up. Some perseveration. -Cranial Nerves: Gaze conjugate. Gaze rests to the left, crosses midline with VOR. R facial droop. - Motor: Normal bulk. Decreased tone R hemibody. RUE 2 at bi/tri, no movement distally. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA Gastroc L 5 ___ ___ 5 5 5 5 R 0 ___ 0 0 0 4 5 3 0 -DTRs: Bi Tri ___ Pat Ach Pec jerk Crossed Abductors L 2 2 2 1 R 0 2 2+ 2 Plantar response was flexor on the left, extensor on the right. -Sensory: Grimace to noxious R hemibody. Withdraws RLE from noxious. - Coordination: No dysmetria with finger to nose testing LUE. - Gait: unable to ambulate. DISCHARGE EXAM: ============== Opens eyes: [x]spontaneous [ ]to voice [ ]to noxious Orientation: [x]Nonverbal, patient with expressive aphasia, grunts Follows commands: [x]Simple [ ]Complex [ ]None Pupils: PERRL 4-3mm bilaterally EOM: Full throughout Speech Fluent: [ ]Yes [x]No - Expressive Aphasia Comprehension intact [x]Yes [ ]No Motor: LUE/LLE follows commands and moves purposely with ___ strength strength. RUE with no movement to noxious. RLE withdraws to noxious. Incision: Clean, dry and intact; closed with sutures and staples. Pertinent Results: Please see OMR for pertinent results Brief Hospital Course: #MCA infarct Pt presented w/ CTA showing L M2 cutoff. Underwent thrombectomy w/ TICI IIb reperfusion. He initially was transferred from PACU to ___ where he was found to have increased somnolence. Pt underwent stat CT which appeared stable and was transferred to NeuroICU. Upon arrival, pt's mentation appeared to improve. EEG was placed and was without seizure activity. On hospital day 2, he developed anisacoria secondary to cerebral edema and uncal herniation. Mannitol was started and his mental status improved. Mannitol was discontinued on ___ (within 48hrs) after Na >155 and sOsm>320. On ___, he developed an acute change with increasing somnulence and minimal responsiveness. STAT non-con head CT was obtained and he was found to have progression of cerebral edema with herniation. He was taken for STAT hemicraniectomy without complications. JP drain was removed on POD#2. He was extubated on ___. Once he was stable and transferred to to the ___. #Dyspgagia His swallowing was periodically evaluated and did not improve, therefore, a PEG tube was placed. He tolerated tube feeds. On ___, trials of nectar were initiated which the patient tolerated. #Seizure He had left arm seizure following hemicraniectomy and was started on Keppra 1g PO BID which should be taken as prescribed. #MRSA infection/External Hydrocephalus Hemicraniectomy incision had small amount of serous drainage and was closely monitored. Additional suture and staple was placed with improvement, however on ___ he was noted to have significant purulent, yellow drainage from craniectomy incision. Decision was made to place EVD for persistent CSF leak. He was taken to the OR for placement and given 1 unit platetes prior for recent Aspirin use. R frontal EVD was placed and wound was washed out. Pus was seen intraoperatively and cultures were sent. Please see operative report by Dr. ___ full details. He was transferred to the ___ for recovery and EVD was open to 10. Postop head CT showed expected surgical changes. Infectious disease was consulted and he was empirically started on Vancomycin and Cefepime ___. He was transferred to the ___ on Neurosurgery service. CSF culture grew MRSA and Cefepime was discontinued. Vanco was continued and adjusted per ID for therapeutic trough. He continued to have yellow drainage from incision. EVD height was lowered and tight head wrap was placed in attempt to divert flow. Unfortunately he continued to leak, and he was taken back to the OR on ___ for wound washout and revision with Dr. ___. Procedure was uncomplicated. For further procedure details, please see separately dictated operative report by Dr. ___ was extubated in the operating room and transported to the PACU for recovery. Once stable, he was transferred to the ___ for close neurological monitoring. Cultures were taken and eventually grew out MRSA. He was continued on Vancomycin per ID with dose adjusted according to trough. He underwent trial to wean EVD and incision began leaking. Patient was brought to the OR on ___ for VPS placement. The VPS was set to 1.0. He was extubated in the operating room and transferred to the PACU for recovery. He was later transferred to the ___ for close neurologic monitoring. Shunt adjusted to 2.0 on ___. Final ID plan is continue vancomycin until ___ then transition to doxycycline 100mg BID PO. Patient will follow up with ID outpatient. #Urinary Retention The patient's foley catheter was discontinued on ___. #Dispo Although physical therapy recommended rehab, his placement was complicated by the lack of a HCP. His mother elected to be the HCP but his placement required a guardian to be assigned. Guardianship was obtained and it was determined he would be medically ready for rehabilitation on ___. He was discharged to rehab on ___ in good condition with instructions for follow up. AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic Attack 1. Dysphagia screening before any PO intake? (X) Yes, confirmed done - () Not confirmed () No 2. DVT Prophylaxis administered? (X) Yes - () No 3. Antithrombotic therapy administered by end of hospital day 2? (X) Yes - () No 4. LDL documented? (X) Yes (LDL = 114) - () No 5. Intensive statin therapy administered? (simvastatin 80mg, simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, rosuvastatin 20mg or 40mg, for LDL > 70) () Yes - (x) No [if LDL >70, reason not given: held given bleeding risk [ ] Statin medication allergy [x ] Other reasons documented by physician/advanced practice nurse/physician ___ (physician/APN/PA) or pharmacist [ ] LDL-c less than 70 mg/dL ] 6. Smoking cessation counseling given? (x) Yes - () No [reason () non-smoker - () unable to participate] 7. Stroke education (personal modifiable risk factors, how to activate EMS for stroke, stroke warning signs and symptoms, prescribed medications, need for followup) given (verbally or written)? (x) Yes - () No 8. Assessment for rehabilitation or rehab services considered? (x) Yes - () No 9. Discharged on statin therapy? () Yes - x() No [if LDL >70, reason not given: [ ] Statin medication allergy [ x] Other reasons documented by physician/advanced practice nurse/physician ___ (physician/APN/PA) or pharmacist --> bleeding risk [ ] LDL-c less than 70 mg/dL 10. Discharged on antithrombotic therapy? () Yes [Type: (x) Antiplatelet - Aspirin 325() Anticoagulation] - () No 11. Discharged on oral anticoagulation for patients with atrial fibrillation/flutter? () Yes - () No - (x) N/A Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Metoprolol Tartrate 50 mg PO BID 2. lisinopril-hydrochlorothiazide ___ mg oral DAILY Discharge Medications: 1. Acetaminophen 650 mg PO Q4H:PRN Pain - Mild 2. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheezing 3. amLODIPine 10 mg PO DAILY 4. Aspirin 325 mg PO DAILY 5. Bisacodyl 10 mg PO/PR DAILY Constipation 6. Docusate Sodium 100 mg PO BID 7. FLUoxetine 20 mg PO DAILY 8. FoLIC Acid 1 mg PO DAILY 9. Heparin 5000 UNIT SC BID 10. Hydrochlorothiazide 50 mg PO DAILY 11. Ipratropium-Albuterol Neb 1 NEB NEB Q6H:PRN SOB/wheezing 12. Labetalol 300 mg PO Q6H 13. LevETIRAcetam 1000 mg PO Q12H 14. Multivitamins W/minerals 1 TAB PO DAILY 15. Nicotine Patch 21 mg TD DAILY 16. Nystatin Oral Suspension 5 mL PO QID oral thrush 17. OLANZapine (Disintegrating Tablet) 2.5 mg PO TID:PRN agitation 18. Thiamine 100 mg PO DAILY 19. TraMADol 25 mg PO Q6H:PRN Pain - Moderate 20. Vancomycin 1000 mg IV Q 12H Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Left MCA Infarct Uncal Herniation Hydrocephalus Wound Infection Dysphagia Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Surgery •You underwent a surgery called placement of a right VP shunt which is a ___ Strata Valve set to 2.0. •You underwent a surgery called a craniectomy. A portion of your skull was removed to allow your brain to swell. You must wear a helmet when out of bed at all times. •Please keep your sutures and staples along your incision dry until they are removed. •It is best to keep your incision open to air but it is ok to cover it when outside. •Call your surgeon if there are any signs of infection like redness, fever, or drainage. Activity •We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. •You make take leisurely walks and slowly increase your activity at your own pace once you are symptom free at rest. ___ try to do too much all at once. •No driving while taking any narcotic or sedating medication. •If you experienced a seizure while admitted, you are NOT allowed to drive by law. •No contact sports until cleared by your neurosurgeon. You should avoid contact sports for 6 months. Medications •Please do NOT take any blood thinning medication (Aspirin, Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon. •You have been discharged on Keppra (Levetiracetam) as you experienced a seizure during this hospitalization. This medication helps to prevent seizures. Please continue this medication as indicated on your discharge instruction. It is important that you take this medication consistently and on time. •You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. Infectious Disease Recommendations •You have been discharged on Vancomycin 1000 mg IV Q12H which will be continued through ___. At that time, you will need to be transitioned to Doxycycline 100mg PO BID. What You ___ Experience: •You may have difficulty paying attention, concentrating, and remembering new information. •Emotional and/or behavioral difficulties are common. •Feeling more tired, restlessness, irritability, and mood swings are also common. •You may also experience some ___ swelling around your face and eyes. This is normal after surgery and most noticeable on the second and third day of surgery. You apply ice or a cool or warm washcloth to your eyes to help with the swelling. The swelling will be its worse in the morning after laying flat from sleeping but decrease when up. •You may experience soreness with chewing. This is normal from the surgery and will improve with time. Softer foods may be easier during this time. •Constipation is common. Be sure to drink plenty of fluids and eat a high-fiber diet. If you are taking narcotics (prescription pain medications), try an over-the-counter stool softener. Headaches: •Headache is one of the most common symptoms after a brain bleed. •Most headaches are not dangerous but you should call your doctor if the headache gets worse, develop arm or leg weakness, increased sleepiness, and/or have nausea or vomiting with a headache. •Mild pain medications may be helpful with these headaches but avoid taking pain medications on a daily basis unless prescribed by your doctor. •There are other things that can be done to help with your headaches: avoid caffeine, get enough sleep, daily exercise, relaxation/ meditation, massage, acupuncture, heat or ice packs. When to Call Your Doctor at ___ for: •Severe pain, swelling, redness or drainage from the incision site •Fever greater than 101.5 degrees Fahrenheit •Nausea and/or vomiting •Extreme sleepiness and not being able to stay awake •Severe headaches not relieved by pain relievers •Seizures •Any new problems with your vision or ability to speak •Weakness or changes in sensation in your face, arms, or leg Call ___ and go to the nearest Emergency Room if you experience any of the following: •Sudden numbness or weakness in the face, arm, or leg •Sudden confusion or trouble speaking or understanding •Sudden trouble walking, dizziness, or loss of balance or coordination •Sudden severe headaches with no known reason Followup Instructions: ___
19982541-DS-12
19,982,541
20,860,014
DS
12
2148-12-02 00:00:00
2148-12-02 17:08:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: ___: Successful US-guided placement of ___ pigtail catheter into the gallbladder. History of Present Illness: Patient is a ___ male with a history of hypertension, stroke in ___, hyperlipidemia, question of MI in 1980s, who presents with several weeks of intermittent right upper quadrant abdominal pain. He reports he first had an episode of pain lasting 2 or 3 hours 3 weeks ago which resolved with Tylenol. He had a second episode of pain about a week ago, and today started having severe pain worse than his previous episodes that did not go away so he presented to ___ where he was found to have cholecystitis and a hepatic abscess. He was transferred to ___ for further management. He reports that since he received morphine he does not have any right upper quadrant abdominal pain, he denies fever/chills, nausea/vomiting, dyspnea or chest pain. He reports that he is lost approximately 40 pounds intentionally over the past 10 months. His last colonoscopy was ___ years ago and normal. He denies any blood in the stool. He has never had any abdominal surgeries. Past Medical History: Hypertension MI Hyperlipidemia Stroke Social History: ___ Family History: Non-contributory. Physical Exam: Physical Exam on Admission ___: Vitals: 101.3 86 130/62 16 99% RA GEN: A&Ox3, NAD HEENT: No scleral icterus, mucus membranes moist CV: RRR PULM: Breathing comfortably on room air ABD: Soft, nondistended, nontender, no rebound or guarding Ext: No ___ edema, ___ warm and well perfused Physical Exam on Discharge ___: VS: Temp 98.7 Oral BP 165/79 HR 76 RR 18 O2 Sat 94% RA GEN: NAD. A+Ox3. CV: Regular rate and rhythm Pulm: Lung sounds clear bilaterally Abd: Soft, large, non-tender. +BS. RLQ perc chole tube in place with bilious drainage. Dsg C/D/I. No erythema or hematoma noted. Ext: Warm, well-perfused. No pain or edema. Pertinent Results: Lab Values: ___ 05:30AM BLOOD WBC-6.5 RBC-3.83* Hgb-11.1* Hct-34.9* MCV-91 MCH-29.0 MCHC-31.8* RDW-13.8 RDWSD-46.2 Plt ___ ___ 06:02PM BLOOD Neuts-74.6* Lymphs-13.5* Monos-10.0 Eos-0.8* Baso-0.2 Im ___ AbsNeut-6.92* AbsLymp-1.25 AbsMono-0.93* AbsEos-0.07 AbsBaso-0.02 ___ 04:25AM BLOOD ___ ___ 05:30AM BLOOD Glucose-113* UreaN-12 Creat-1.4* Na-140 K-4.1 Cl-101 HCO3-26 AnGap-13 ___ 04:25AM BLOOD ALT-22 AST-15 AlkPhos-83 TotBili-0.4 ___ 05:30AM BLOOD Calcium-9.2 Phos-3.4 Mg-2.1 ___ 06:21PM BLOOD Lactate-0.7 Brief Hospital Course: Mr. ___ is a ___ year old male with a PMH significant for HTN, HLD, MI, and stroke (___), who presented to OSH and had CT imaging which showed acute cholecystitis and a hepatic abscess. He was transferred to ___ on ___ for further management. He was admitted to the Acute Care Surgery service and made NPO and started on IV fluids and IV antibiotics. The Interventional Radiology service was consulted for a percutaneous cholecystostomy, which was done on ___. Upon return to the floor, the patient was started on a clear liquid diet. The next day on HD1, he was advanced to a regular diet, which he was tolerating well. He was transitioned from IV antibiotics to PO antibiotics (Augmentin) on HD1 to finish a 10 day course. His abdominal pain had resolved. He was having bilious drainage from the percutaneous cholecystostomy tube. During this hospitalization, the patient voided without difficulty and was ambulating. The patient received subcutaneous heparin and venodyne boots were used during this stay. Nursing performed teaching with the patient on drain care and the patient verbalized understanding. At the time of discharge on ___, the patient was doing well. He was afebrile and vital signs were stable. The patient was discharged home with ___ services set up. Discharge teaching was completed and follow-up instructions were reviewed with reported understanding and agreement. He will follow up in the Acute Care Surgery clinic and with his PCP. Medications on Admission: 1. amLODIPine 5 mg PO DAILY 2. Chlorthalidone 25 mg PO DAILY 3. Labetalol 300 mg PO BID 4. Lisinopril 20 mg PO DAILY 5. Simvastatin 40 mg PO QPM Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever Please do not exceed 3gm in a 24 hour period. 2. Amoxicillin-Clavulanic Acid ___ mg PO Q12H End date ___. RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*18 Tablet Refills:*0 3. amLODIPine 5 mg PO DAILY 4. Chlorthalidone 25 mg PO DAILY 5. Labetalol 300 mg PO BID 6. Lisinopril 20 mg PO DAILY 7. Simvastatin 40 mg PO QPM Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Acute cholecystitis Intrahepatic abscess Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were transferred to ___ on ___ for evaluation of abdominal pain and were found to have acute cholecystitis (inflammation of your gallbladder) with an abscess in your liver. You were evaluated by the acute care surgery team and interventional radiology. You subsequently underwent placement of a percutaneous cholecystostomy tube. You tolerated this procedure well. You have since been tolerating a regular diet, ambulating, and your pain has resolved. You are now ready for discharge home with ___ services. Please follow the instructions below to continue your recovery: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon. Avoid driving or operating heavy machinery while taking pain medications. DRAIN CARE: *Please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody discharge, warm to touch, fever). *If the drain is connected to a collection container, please note color, consistency, and amount of fluid in the drain. Call the doctor, ___, or ___ nurse if the amount increases significantly or changes in character. Be sure to empty the drain frequently. Record the output, if instructed to do so. *Wash the area gently with warm, soapy water. *Keep the insertion site clean and dry otherwise. *Avoid swimming, baths, hot tubs; do not submerge yourself in water. *Make sure to keep the drain attached securely to your body to prevent pulling or dislocation. Followup Instructions: ___
19982872-DS-22
19,982,872
22,448,158
DS
22
2156-12-13 00:00:00
2156-12-14 06:12:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: abdominal pain Major Surgical or Invasive Procedure: None this hospitalization History of Present Illness: This is a ___ year-old Female with a PMH significant for hypertension, GERD, osteoarthritis and recurrent pharyngitis (scheduled for tonsillectomy next week) who presents with acute-onset abdominal pain for 3-days. . The patient notes the acute onset of sharp and stabbing abdominal pain in the umbilical region that began 3-days prior and was non-radiating and non-positional, but worse with movement. The pain is not relieved with Tylenol, Tums or Mylanta. She associates the pain with some loose, non-bloody and formed stools with nausea, but without emesis. She has had increased stool frequency in the last few days. She continues to pass flatus and is having BMs. She has no fevers or chills or back pain. She notes decreased interest in food over several days without significant unintentional weight loss. She denies dysuria or hematuria. No cough or URI symptoms. No sick contacts. She had a colonoscopy many years prior at ___. ___ which documented some internal hemorrhoids. . In the ED, initial VS 98.7 128 148/87 16 100% RA. Her exam was notable for diffuse abdominal pain, worse in the RUQ. Her laboratory studies were remarkable for a WBC 11.3 with neutrophilia of 78.4% without bandemia. Her LFTs and creatinine were normal. Lactate 1.8. She had a CT abdomen and pelvis that demonstrated 1.6-cm high density rounded structure along the transverse mesocolon with significant inflammatory changes (new since ___, concerning for a colonic diverticulum that appeared inflamed with concern for microperforation. She was evaluated by ___ surgery who felt there were no acute surgical indications. She received Zofran 4 mg IV x 1 and Morphine 4 mg IV x 1 for relief. . On arrival to the floor, she appears comfortable without complaints. Past Medical History: PAST MEDICAL & SURGICAL HISTORY: 1. Hypertension 2. Reflux esophagitis, GERD 3. Osteoarthritis 4. Recurrent pharyngitis (scheduled for tonsillectomy) 5. Fibromyalgia 6. Unexplained chronic anemia (likely iron deficiency anemia; work-up by Dr. ___ in ___ 7. s/p appendectomy ___ years prior) 8. s/p tubal ligation 9. s/p Cesarean section Social History: ___ Family History: Her mother had hypertension and died of a stroke. Her father also had hypertension. No malignancy history of note. Physical Exam: ADMISSION EXAM: . VITALS: 98.6 80 130/80 18 99% RA GENERAL: Appears in no acute distress. Alert and interactive. HEENT: Normocephalic, atraumatic. EOMI. PERRL. Nares clear. Mucous membranes moist. NECK: supple without lymphadenopathy. JVD not elevated. ___: Regular rate and rhythm, without murmurs, rubs or gallops. S1 and S2 normal. RESP: Clear to auscultation bilaterally without adventitious sounds. No wheezing, rhonchi or crackles. Stable inspiratory effort. ABD: soft, tender in the RLQ and epigastrum, non-distended, with normoactive bowel sounds. No palpable masses or peritoneal signs. No rebound tenderness or guarding. No CVA tenderness. EXTR: no cyanosis, clubbing or edema, 2+ peripheral pulses NEURO: CN II-XII intact throughout. Alert and oriented x 3. Strength ___ bilaterally, sensation grossly intact. Gait deferred. . DISCHARGE EXAM: . VITALS: 100.6 99.7 ___ 18 99% RA weight: 79.9 kg I/Os: 1160 / 300 | 700 GENERAL: Appears in no acute distress. Alert and interactive. HEENT: Normocephalic, atraumatic. EOMI. PERRL. Nares clear. Mucous membranes moist. NECK: supple without lymphadenopathy. JVD not elevated. ___: Regular rate and rhythm, without murmurs, rubs or gallops. S1 and S2 normal. RESP: Clear to auscultation bilaterally without adventitious sounds. No wheezing, rhonchi or crackles. Stable inspiratory effort. ABD: soft, minimally tender in the epigastrum to deep palpation, non-distended, with normoactive bowel sounds. No palpable masses or peritoneal signs. No rebound tenderness or guarding. No CVA tenderness. EXTR: no cyanosis, clubbing or edema, 2+ peripheral pulses NEURO: CN II-XII intact throughout. Alert and oriented x 3. Strength ___ bilaterally, sensation grossly intact. Gait deferred. Pertinent Results: ADMISSION LABS: . ___ 05:45AM BLOOD WBC-11.3* RBC-4.07* Hgb-12.1 Hct-33.4* MCV-82 MCH-29.6 MCHC-36.2* RDW-12.7 Plt ___ ___ 05:45AM BLOOD Neuts-78.4* Lymphs-17.7* Monos-3.1 Eos-0.4 Baso-0.3 ___ 05:45AM BLOOD Glucose-108* UreaN-15 Creat-0.9 Na-134 K-3.8 Cl-99 HCO3-23 AnGap-16 ___ 05:45AM BLOOD ALT-15 AST-16 AlkPhos-65 TotBili-0.6 ___ 05:45AM BLOOD Lipase-23 ___ 05:45AM BLOOD Albumin-4.4 Calcium-10.0 Phos-3.8 Mg-1.8 ___ 05:53AM BLOOD Lactate-1.8 . DISCHARGE LABS: . ___ 08:00AM BLOOD WBC-12.3* RBC-4.13* Hgb-12.3 Hct-34.6* MCV-84 MCH-29.8 MCHC-35.6* RDW-12.8 Plt ___ ___ 08:00AM BLOOD Glucose-104* UreaN-16 Creat-1.1 Na-135 K-3.7 Cl-98 HCO3-24 AnGap-17 ___ 08:00AM BLOOD Calcium-9.4 Phos-4.0 Mg-2.0 . URINALYSIS: None . MICROBIOLOGY DATA: ___ Blood cultures (x 2) - pending . IMAGING: ___ CT ABD & PELVIS WITH CO - 1.6 cm high-density rounded structure along transverse mesocolon with significant surrounding inflammatory changes, new since ___, in similar location to a previously seen transverse colonic diverticulum, suggestive of diverticulitis or appendagitis with an eroding fecalith with possible microperforation. An enhancing mass is felt less likely but cannot be excluded on this contrast-enhanced study, and could be further assessed with a limited non-contrast CT through this region in a few hours. Cholelithiasis without evidence to suggest cholecystitis. . ___ CT LIMITED ___ SCANS - Again demonstrated is a 1.6 cm high-density rounded structure along the transverse mesocolon with significant associated inflammatory changes, stable compared to prior study from 6:53 am the same day and new since ___. This mass is in a similar location to a previously seen transverse colon diverticulum and suggests diverticulitis or appendigitis with an eroding fecolith with microperforation. Brief Hospital Course: IMPRESSION: ___ with a PMH significant for HTN, GERD, osteoarthritis and recurrent pharyngitis who presents with 3-days of acute onset right upper quadrant abdominal pain found to have 1.6-cm diverticulum of the transverse mesocolon with inflammatory changes and concern for microperforation. . # TRANSVERSE MESOCOLON DIVERTICULITIS WITH ABDOMINAL PAIN - The patient presents with only a history of presumed gastritis associated with epigastric pain in ___ with CT imaging at that time that was reassuring. She now presented with 3 days of acute RUQ abdominal pain and a mild leukocytosis with shaking chills but fevers. A CT abdomen and pelvis demonstrated evidence of a transverse mesocolon diverticulum with surrounding inflammation. She was without clinical evidence of obstruction. After reviewing the imaging study, it was felt that a large 1.6-cm fecalith had impacted in the transverse colonic diverticulum resulting in inflammation and microperforation. We treated her with IV Ciprofloxacin and Flagyl and transitioned her to PO antibiotics once her pain improved. She was seen by Gastroenterology who felt she would require a colonoscopy as an outpatient once the inflammation subsides, with possible intervention. If this proves difficult, she will see Dr. ___ ___ surgery and discuss possible surgical intervention at a later time. Surgery felt there were no acute surgical indications on admission. Her exam improved with antibiotics, bowel rest and pain medication and she was discharged in stable condition. She was tolerating a liquid diet. She will remain on oral antibiotics for a total of 1-month. . # HYPERTENSION - Diagnosis of essential hypertension with outpatient blood pressures ranging from 120-140 mmHg systolic on recent clinic visits in late ___. Has been maintained on beta-blocker only. We continued her Atenolol 25 mg PO daily without issue. . # REFLUX ESOPHAGITIS, GERD - History of intermittent epigastric complaints with negative work-up. She has been utilizing a PPI and we continued Omeprazole 20 mg EC PO BID on admission. . TRANSITION OF CARE ISSUES: 1. Patient will continue on 1-month of oral antibiotics to be completed as an outpatient; Ciprofloxacin and Flagyl starting ___ and ending ___. 2. At the time of discharge, blood cultures from admission were without growth, but were still pending. 3. She has outpatient Gastroenterology and primary care physician ___ scheduled and will likely undergo colonoscopy following improvement in her symptoms and resolution of her inflammation, in the next ___ weeks. If there is unsuccessful endoscopic intervention to remove the impacted fecalith, she may require surgical consultation (which will need to be scheduled) as an outpatient to discuss possible partial colonic resection. Medications on Admission: HOME MEDICATIONS (confirmed with patient) 1. Atenolol 25 mg PO daily 2. Clobetasol 0.05% ointment applied to affected area at night 3. Fluticasone 50 mcg ___ sprays INH QHS 4. Omeprazole 20 mg EC PO BID Discharge Medications: 1. atenolol 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. clobetasol 0.05 % Ointment Sig: One (1) application Topical at bedtime: applied to affected areas. 3. fluticasone 50 mcg/actuation Spray, Suspension Sig: ___ sprays Nasal at bedtime. 4. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO BID (2 times a day). 5. metronidazole 500 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours) for 30 days: starting ___, ending ___. Disp:*90 Tablet(s)* Refills:*0* 6. ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 30 days: starting ___, ending ___. Disp:*60 Tablet(s)* Refills:*0* 7. oxycodone 5 mg Tablet Sig: ___ Tablets PO every ___ hours as needed for pain: AVOID taking this medication if you anticipate driving or if you are consuming alcohol. Disp:*25 Tablet(s)* Refills:*0* Discharge Disposition: Home Discharge Diagnosis: Primary Diagnoses: 1. Acute uncomplicated transverse colonic divericulitis . Secondary Diagnoses: 1. Hypertension 2. Reflux esophagitis, GERD 3. Osteoarthritis 4. Recurrent pharyngitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Patient Discharge Instructions: . You were admitted to the Internal Medicine service at ___ ___ on ___ regarding management of your abdominal pain. On CT imaging you were found to have a small outpouching or diverticulum of your transverse colon which was inflamed and likely infected. The Gastroenterology team felt you would best be managed with oral antibiotics and then you would undergo an outpatient colonoscopy following discharge. If they are unable to handle the issue via endoscopy, you will ___ with surgery for possible operative intervention in the future. Once your clinical exam improved, your pain was controlled and you were tolerating PO intake, you were discharged with oral antibiotics for 1-month. . Please call your doctor or go to the emergency department if: * You experience new chest pain, pressure, squeezing or tightness. * You develop new or worsening cough, shortness of breath, or wheezing. * You are vomiting and cannot keep down fluids, or your medications. * If you are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include: dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. * You see blood or dark/black material when you vomit, or have a bowel movement. * You experience burning when you urinate, have blood in your urine, or experience an unusual discharge. * Your pain is not improving within 12 hours or is not under control within 24 hours. * Your pain worsens or changes location. * You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. * You develop any other concerning symptoms. . CHANGES IN YOUR MEDICATION RECONCILIATION: . * Upon admission, we ADDED: START: Ciprofloxacin 500 mg by mouth twice daily for 30-days (started ___, ending ___ START: Flagyl (Metronidazole) 500 mg by mouth three times daily for 30-days (started ___, ending ___ START: Oxycodone 5 mg ___ tablets) by mouth every ___ hours, as needed for pain. AVOID taking this medication if you anticipate driving or if you are consuming alcohol. . * The following medications were DISCONTINUED on admission and you should NOT resume: NONE . * You should continue all of your other home medications as prescribed, unless otherwise directed above. Followup Instructions: ___
19982896-DS-22
19,982,896
23,285,325
DS
22
2157-07-27 00:00:00
2157-07-27 20:31:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: none History of Present Illness: The patient is a ___ year old female with a history of cholecystectomy who presents to the ED from home with abdominal pain. In early ___ she first developed RUQ/epigastric pain. She was found to have an elevated alkaline phosphatase and subsequent MRCP showed a small fluid-filled structure in the porta hepatis and a dilated cystic duct remnant. On ___ she underwent ERCP with sphincterotomy and spyglass cholangioscopy where filling defects were noted in the gallbladder neck although scope could not traverse a valve so not amenable to therapy. Following the procedure she was observed overnight and discharged home with minimal pain. The day prior to admission she developed severe epigastric pain. This was associated with nausea but no vomiting. No fevers or chills, no blood in stool, no jaundice. In the ED, initial vitals were:98.4 55 149/85 18 98% RA. Patient was given morphine and zofran. Currently abdominal pain is ___. Past Medical History: hypothyroid depression hypo-vitamin d esophagitis prior knee meniscal tear Social History: ___ Family History: Father with skin cancer Mother in good health in ___ Physical Exam: Vitals: T: 98.4 BP: 154/80 HR: 84 RR: 18 O2: 99%RA General: lying on left side, awake and alert, mild uncomfortable HEENT: dry mucus membranes Neck: no cervical LAD appreciated CV: S1, S2 regular rhythm, normal rate Lungs: CTA bilaterally, unlabored respirations Abdomen: soft, mild TTP epigastric, no rebound, no guarding GU: no foley Ext: no edema Neuro: alert, oriented to self, hospital, date, speech fluent, tongue midline Pertinent Results: ___ 04:40PM BLOOD WBC-8.3# RBC-4.69 Hgb-13.8 Hct-41.1 MCV-88 MCH-29.4 MCHC-33.5 RDW-13.0 Plt ___ ___ 04:40PM BLOOD Neuts-64.6 ___ Monos-6.4 Eos-1.0 Baso-0.6 ___ 04:40PM BLOOD Glucose-109* UreaN-12 Creat-0.8 Na-141 K-4.1 Cl-104 HCO3-25 AnGap-16 ___ 04:40PM BLOOD ALT-14 AST-18 AlkPhos-144* TotBili-0.5 ___ 04:40PM BLOOD Albumin-4.3 Calcium-9.8 Phos-3.7 Mg-1.9 ___ 04:40PM BLOOD Lipase-17 Final Report INDICATION: Cholecystectomy ___ years ago, abdominal pain, found to have stone in the cystic duct remnant/gallbladder neck. COMPARISON: Abdominal ultrasound on ___. TECHNIQUE: MDCT images were obtained through the abdomen first without IV contrast, and subsequently following the administration of IV contrast in the arterial and portal venous phases. Coronal and sagittal reformats were performed. FINDINGS: There is mild bibasilar dependent atelectasis. Visualized heart and pericardium are unremarkable. The liver is normal in contour and there are no focal hepatic lesions. There is no intrahepatic biliary duct dilatation. A clip is seen either within a seroma in the gallbladder fossa or in the remnant cystic duct which would be dilated. There is mild fat stranding adjacent to the gallbladder fossa. The pancreas is normal. The spleen is normal. The adrenal glands are normal. The kidneys are normal. No hydronephrosis. The visualized portions of the small and large bowel are unremarkable. The appendix is visualized and unremarkable. There is no free air. There is no mesenteric or retroperitoneal lymphadenopathy. CTA: The celiac artery and its major branches are patent. The SMA and its major branches are patent. The origin of the ___ is patent. The portal vein is patent. The aorta is normal in caliber. BONES: There is a hemangioma in the T12 vertebral body. There are mild-to-moderate degenerative changes of thoracolumbar spine. No suspicious osseous lesions. IMPRESSION: Findings consistent with inflammation of either a chronic seroma or remnant cystic duct with a surgical clip within the lumen of the structure. No stones are identified in the CBD. Brief Hospital Course: ___ year old female with a history of cholecystectomy who presents to the ED from home with abdominal pain found to have inlammatory changes consistent with cholecystitis of the remanant portion of her cystic duct. She had cholecysectomy performed ___ years ago. Earlier in ___ she underwent ERCP with sphincterotomy and spyglass evaluation of cystic duct but her pain recurred prompting this admission. Imaging during this admission included RUQ ultrasound and abdominal CT. The ultrasound showed 13mm stone in the cystic duct but I reviewed her abdominal CT with radiology and the finding on ultrasound more likely represents a prior surgical clip rather than stone based on appearance on CT. This area was deemed to be too small to target with ___ drainage. The pancreaetico-biliary surgery service consulted and with input from the ERCP team, we agreed that she will be treated with antibiotics for 10 days, have outpatient follow up with surgery and then elective cholecystectomy when her inflammation improves. Oral cipro/flagyl were started on ___ and should be continued for 10 days. She has follow up with Dr. ___ on ___. She was given instructions to take ibuprofen or percocet for RUQ pain. She was tolerating POs and had no pain prior to discharge. . #HYPOTHYROID: -continue dhome levothyroxine . #DEPRESSION: -continued home fluoxetine . #GERD: -continued home PPI Discharge Medications: 1. Fluoxetine 60 mg PO DAILY 2. Levothyroxine Sodium 75 mcg PO DAILY 3. Multivitamins 1 TAB PO DAILY 4. Omeprazole 20 mg PO DAILY 5. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4H:PRN pain RX *oxycodone-acetaminophen 5 mg-325 mg ___ tablet(s) by mouth every four (4) hours Disp #*24 Tablet Refills:*0 6. Vitamin D 800 UNIT PO DAILY 7. Ciprofloxacin HCl 500 mg PO Q12H Duration: 7 Days RX *ciprofloxacin 500 mg 1 tablet(s) by mouth twice a day Disp #*14 Tablet Refills:*0 8. Docusate Sodium 100 mg PO DAILY 9. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H RX *metronidazole 500 mg 1 tablet(s) by mouth three times a day Disp #*21 Tablet Refills:*0 10. Fish Oil (Omega 3) 1000 mg PO BID 11. Ibuprofen 600 mg PO Q8H:PRN pain over the counter Discharge Disposition: Home Discharge Diagnosis: acute cholecystitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: you were hospitalized with abdominal pain. CT of your abdomen showed cholecystitis of the remaining portion of your gall bladder. you will benefit from discussing removing the remaining portion of the gallbladder with Dr. ___. For now we recommend antibiotic treatment until you are ready for surgery. You will take two antibiotics for the next ___ days Followup Instructions: ___
19982989-DS-16
19,982,989
28,630,229
DS
16
2150-12-22 00:00:00
2150-12-22 13:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: morphine Attending: ___. Chief Complaint: dyspnea, hypoxia Major Surgical or Invasive Procedure: none History of Present Illness: HISTORY OF PRESENT ILLNESS: ============================ This is an ___ ___ gentleman with a history notable for HFpEF (EF 50% in ___, ?COPD, dementia, T2DM and BPH who presents from nursing home with dyspnea and hypoxia. Per the patient's daughter, Mr. ___ was diagnosed with a UTI at his nursing home one week prior to admission and was treated with antibiotics (cefpodoxime?). He also endorsed shortness of breath and cough during this week. On ___ his lasix was changed from 40 mg PO QD to 20 mg PO TID, and on ___ he received 40 mg PO BID. On ___ he became more short of breath and was noted to be sating 77-83% on RA. He received 3 stacked nebs without improvement in his oxygenation. EMS was called and they placed him on CPAP with improvement in his O2 sat and he was taken to the ___ ED. In the ED, - Initial Vitals: T 103.8, HR 83, BP 151/78, RR 20, 99% on CPAP - Exam: General: On a BiPAP, alert and oriented HEENT: Normal oropharynx, no exudates/erythema Cardiac: RRR , no chest tenderness Pulmonary: Diffuse crackles bilaterally. Abdominal/GI: Normal bowel sounds, no tenderness or masses Renal: No CVA tenderness MSK: No deformities or signs of trauma, no focal deficits noted. 3+ pitting edema up to the knees Neuro: Sensation intact upper and lower extremities, strength ___ upper and lower, no focal deficits noted, moving all extremities - Labs: - WBC 14.8 (90% N), Hgb 11.3, Plt 248 - AST 26, ALT 21, AP 169, Tbili 1.2, Alb 3.3 - Na 142, K 4.6, Cl 102, HCO3 19, BUN 34, Cr 1.8, Gluc 152, AGap 21 - proBNP 2263, trop <0.01 - Lactate 3.5 - VBG: pH 7.38, pCO2 48 - UA: Large Leuk, Nitr Pos, >182 WBC, Mod Bact - Imaging: - CXR: Lungs are low volume with increase in volume of bilateral pleural effusions right greater than left. Pulmonary edema has worsened. Consolidative opacities in both lower lobes right greater than left have also worsened. No pneumothorax. There is worsening pulmonary vascular congestion - Consults: N/A - Interventions: Placed on BiPAP ___ FiO2 50%, cefepime 2g, metronidazole 500 mg, 40mg IV Lasix ROS: Positives as per HPI; otherwise negative. Past Medical History: -BPH -Hypercholesterolemia. -Hypertension. -Head lesion after falling off a horse many years ago -Shoulder surgery status post motor vehicle accident -h/o prostate surgery -Olfactory groove Meningioma -T2DM -L hip replacement Social History: ___ Family History: Heart disease and lung cancer. Physical Exam: ADMISSION PHYSICAL EXAM ======================== VS: Reviewed in ___ GENERAL: Elderly man, agitated and picking at IV lines. HEENT: NCAT. MMM. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. LUNGS: Bilateral expiratory wheezes, bilateral crackles at lung bases. ABDOMEN: Normal bowels sounds, non distended, non-tender to palpation EXTREMITIES: Warm, 2+ edema in b/l lower extremities NEUROLOGIC: Moving all extremities spontaneously DISCHARGE PHYSICAL EXAM ======================== VS: WNL GENERAL: Alert, smiling sitting up in bed with no conversational dyspnea, very animated this AM EYES: Anicteric, PERRL ENT: Ears and nose without visible erythema, masses, or trauma. MMM CV: RRR, +S1, +S2, no S3/S4, no murmurs, unable to assess JVD given large neck radius RESP: B/L crackles tracking to lower lung fields. Breathing is non-labored GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. No HSM GU: Condom cath in place draining clear yellow urine. No suprapubic fullness or tenderness to palpation MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs, No ___ edema B/L SKIN: No rashes or ulcerations noted NEURO: A+O x 1.5 (identified hospital, his doctor and named family members not present, chronically unable to identify year/month/president) face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs PSYCH: pleasant, appropriate affect Pertinent Results: ___ 05:24PM ___ PO2-33* PCO2-43 PH-7.42 TOTAL CO2-29 BASE XS-2 ___ 05:24PM LACTATE-3.7* ___ 02:40PM LACTATE-5.8* ___ 10:09AM URINE HOURS-RANDOM CREAT-24 SODIUM-101 ___ 10:09AM URINE OSMOLAL-334 ___ 10:09AM URINE COLOR-Straw APPEAR-Hazy* SP ___ ___ 10:09AM URINE BLOOD-SM* NITRITE-POS* PROTEIN-30* GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-LG* ___ 10:09AM URINE RBC-6* WBC->182* BACTERIA-MOD* YEAST-NONE EPI-0 ___ 10:05AM ___ PO2-32* PCO2-48* PH-7.38 TOTAL CO2-29 BASE XS-1 INTUBATED-NOT INTUBA COMMENTS-PERIPHERAL ___ 10:05AM LACTATE-3.5* ___ 09:50AM GLUCOSE-152* UREA N-34* CREAT-1.8* SODIUM-142 POTASSIUM-4.6 CHLORIDE-102 TOTAL CO2-19* ANION GAP-21* ___ 09:50AM ALT(SGPT)-21 AST(SGOT)-26 ALK PHOS-169* TOT BILI-1.2 ___ 09:50AM LIPASE-12 ___ 09:50AM cTropnT-<0.01 ___ 09:50AM proBNP-2263* ___ 09:50AM ALBUMIN-3.3* CALCIUM-9.1 PHOSPHATE-4.2 MAGNESIUM-1.8 ___ 09:50AM WBC-14.8* RBC-3.91* HGB-11.3* HCT-38.4* MCV-98 MCH-28.9 MCHC-29.4* RDW-14.6 RDWSD-51.8* ___ 09:50AM NEUTS-89.7* LYMPHS-5.3* MONOS-3.8* EOS-0.2* BASOS-0.3 IM ___ AbsNeut-13.31* AbsLymp-0.78* AbsMono-0.57 AbsEos-0.03* AbsBaso-0.04 ___ 09:50AM PLT COUNT-248 IMAGING ======= CXR ___ Lungs are low volume with increase in volume of bilateral pleural effusions right greater than left. Pulmonary edema has worsened. Consolidative opacities in both lower lobes right greater than left have also worsened. No pneumothorax. There is worsening pulmonary vascular congestion Renal US ___. No evidence of stones or hydronephrosis. 2. Complex cystic structure at the left upper renal pole measuring 1.9 cm without evidence of internal vascularity, possibly representing a complex cyst but cannot exclude the possibility of an abscess. Reccomend follow-up with dedicated CT or MRI with contrast for further characterization. TTE ___ There is mild regional left ventricular systolic dysfunction with basal to mid infeiror wall hypokinesis (see schematic) and preserved/normal contractility of the remaining segments. The visually estimated left ventricular ejection fraction is 55%. Mild symmetric left ventricular hypertrophy with mild regional systolic dysfunction most consistent with single vessel coronary artery disease (PDA distribution). Moderate pulmonary hypertension. CXR (___) Bilateral pulmonary edema is mildly decreased. The pleural effusion with associated bibasilar atelectasis is unchanged, a superimposed focal consolidation cannot be excluded. Cardiomediastinal silhouette is stable. There is no pneumothorax. WBC: 8.5 <-- 11.3 <-- 14 <-- 20.7 Cr: 2.2 <-- 2.4 <-- 2.5 <-- 2.3 (B/L 1.8) HCO3: 31 <-- 28 <-- 29 <-- 30 <-- 22 Mg: 2.3 K: 4.0 Lac: 1.4 BNP: 2263 on admission VBG: pH 7.37, pCO2 55 UA: >182 WBC, Mod bacteria, +Nitrite, ___ BCx: Pending UCx: E Coli ESCHERICHIA COLI | AMPICILLIN------------ =>32 R AMPICILLIN/SULBACTAM-- 16 I CEFAZOLIN------------- =>64 R CEFTAZIDIME----------- 4 S CEFTRIAXONE----------- =>64 R CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ =>16 R TRIMETHOPRIM/SULFA---- <=1 S No prior positive UCx Brief Hospital Course: This is an ___ gentleman with a history notable for HFpEF (EF 50% in ___, ?COPD, dementia, T2DM and BPH who presents from nursing home with 1 week of dyspnea found to have crackles and edema on exam, CXR with pulmonary edema and elevated proBNP all consistent with a heart failure exacerbation and pneumonia. In addition, he has a dirty UA, leukocytosis, and fever suggestive of acute complicated UTI. ACUTE ISSUES ======================= # HFpEF exacerbation # Hypercarbic respiratory failure Patient presented with dyspnea (sating 77-83% on RA at nursing home) which improved on non-invasive ventilation. Was treated with BiPAP in MICU and improved rapidly with diuresis and antibiotics. Time course of improvement (<24 hours) c/w diuresis and not PNA treatment. Furthermore, denies any cough and no focal consolidation on CXR (obscured by pulm edema and effusions). Treating for HF exacerbation. TTE shows LVEF 55% with mild inferior wall hypokinesis, elevated PCWP (>18), moderate pulmonary artery systolic hypertension. Concern that home Lasix dose (40mg QD) was recently changed to 20mg TID which may be contributing to HF Exac. Likely trigger is UTI (treatment below) Pump - C/w Lasix 40mg PO QD with goal Net even. Given that patient is on RA and improving ___ c/w home 40mg PO Lasix QD - Chem should be checked at facility on ___ to ensure improvement of creatinine. If Cr > 2.3, then hold Lasix and hydrate orally for 48 hours. If Cr equal to 2.3, then decrease Lasix to 20mg PO QD. If Cr < 2.3 then continue with Lasix 40mg PO QD and resume home Metop Succ XL 200mg PO BID. - C/w home Isosorbide Mononitrate ER 30mg PO QD given SBP 150-170 - C/w home amlodipine 10mg PO QD - Incentive spirometry to stent open atelectatic alveoli in lower lung field due to shallow breathing Rhythm: NSR on ECG Ischemia: C/f CAD on TTE given mild inferior wall hypokinesis. Given neg trop and ECG w/o ischemic features, no concern for ACS event. Will empirically start atherosclerotic therapy - ASA 81mg QD - ___ year ASCVD risk 17.4%, started Atorva 40mg PO QD - Will need outpatient coronary angiogram pending patient/family preference # Acute complicated UTI # Leukocytosis Acute complicated E. Coli UTI sensitive to Bactrim and Macrobid. Given age > ___ and CrCl < ___, Macrobid is relatively contraindicated. Will start Bactrim knowing that this may artificially elevated serum Cr without changing CrCl. Given lack of productive cough, improving hypoxemia with diuresis, and no discrete focal consolidation on CXR, no need for empiric tx for PNA. Renal US with e/o renal cyst c/f abscess but given lack of fever, improving leukocytosis and clinical improvement with Abx, unlikely to be loculated abscess. - D/c Bactrim SS QD x 10 days (___) ___ on CKD (B/L Cr 1.8) Worsening chronologically with IV diuresis in ICU. Differential includes prerenal azotemia vs Type I CRS vs ATN. No e/o post-obstruction (renal US without hydro, bladder scan < 200cc). No e/o granular casts on ___. CKD likely ___ DM (A1c 7.0%). Improving with PO hydration on home Lasix 40mg PO QD. - C/w home 40mg PO Lasix - Encourage PO intake - Chem should be checked at facility on ___ to ensure improvement of creatinine. If Cr > 2.3, then hold Lasix and hydrate orally for 48 hours. If Cr equal to 2.3, then decrease Lasix to 20mg PO QD. If Cr < 2.3 then continue with Lasix 40mg PO QD and resume home Metop Succ XL 200mg PO BID given HR ___. # Long QT # Dementia # Delirium Combination of toxic metabolic encephalopathy ___ UTI and in-hospital delirium. Mentation improved dramatically with treatment of UTI. Suspect continued improvement with transfer to a familiar setting (namely his nursing facility) CHRONIC ISSUES ======================= # Anemia Iron studies, B12, folate all wnl in ___. Potentially ___ chronic cardiac or renal disease # Hypothyroidism Continued home levothyroxine # T2DM Continued home glargine with low dose ISS # Hypertension Continued home amlodipine, isosorbide mononitrate # BPH Continued home finasteride, tamsulosin To Do: [] Complete Bactrim Bactrim SS QD x 10 days (___) [] Chem should be checked at facility on ___ to ensure improvement of creatinine. If Cr > 2.3, then hold Lasix and hydrate orally for 48 hours. If Cr equal to 2.3, then decrease Lasix to 20mg PO QD. If Cr < 2.3 then continue with Lasix 40mg PO QD and resume home Metop Succ XL 200mg PO BID given HR ___. [] Once infection is complete and Cr and returned to baseline, consider outpatient cardiology evaluation for coronary angiogram to assess for CAD I spent 40 mins in discharge planning, coordination of care, and patient/family education. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Docusate Sodium 100 mg PO QHS 2. Tamsulosin 0.4 mg PO QHS 3. Polyethylene Glycol 17 g PO EVERY OTHER DAY 4. Levothyroxine Sodium 50 mcg PO DAILY 5. amLODIPine 10 mg PO DAILY 6. Multivitamins 1 TAB PO DAILY 7. Finasteride 5 mg PO DAILY 8. Furosemide 40 mg PO DAILY 9. Lactulose 30 mL PO DAILY 10. Vitamin D 400 UNIT PO DAILY 11. GuaiFENesin ___ mL PO BID 12. Metoprolol Succinate XL 200 mg PO BID 13. Senna 8.6 mg PO BID:PRN Constipation - First Line 14. melatonin 3 mg oral QHS 15. Glargine 9 Units Bedtime 16. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 40 mg PO QPM 3. Sulfameth/Trimethoprim SS 1 TAB PO BID Duration: 9 Days 4. Glargine 9 Units Bedtime 5. amLODIPine 10 mg PO DAILY 6. Docusate Sodium 100 mg PO QHS 7. Finasteride 5 mg PO DAILY 8. Furosemide 40 mg PO DAILY 9. GuaiFENesin ___ mL PO BID 10. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 11. Lactulose 30 mL PO DAILY 12. Levothyroxine Sodium 50 mcg PO DAILY 13. melatonin 3 mg oral QHS 14. Multivitamins 1 TAB PO DAILY 15. Polyethylene Glycol 17 g PO EVERY OTHER DAY 16. Senna 8.6 mg PO BID:PRN Constipation - First Line 17. Tamsulosin 0.4 mg PO QHS 18. Vitamin D 400 UNIT PO DAILY 19. HELD- Metoprolol Succinate XL 200 mg PO BID This medication was held. Do not restart Metoprolol Succinate XL until Pending repeat creatinine and potassium on ___, if stable or improving, can resume 20.Outpatient Lab Work Please check a chemistry on ___. If Creatinine >2.3, please hold Lasix for 48 hours and recheck creatinine. If Cr equal to 2.3, please decrease dose of Lasix to 20mg PO QD. If Cr <2.3, continue Lasix 40mg PO QD and resume home Metop (give SBP > 100, HR > 70). Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Complicated UTI Heart failure exacerbation Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Bedbound. Discharge Instructions: You were admitted for a urinary tract infection causing a heart failure exacerbation requiring an ICU admission to assist with your bleeding. Fortunately, with getting you to urinate more and placing you on correct antibiotics, we have been able to get you back to breathing room air. We will need to check your kidney function on ___ to make sure you are on the best dose of Lasix. Weigh yourself every morning, call your doctor if weight goes up more than 3 lbs. Followup Instructions: ___
19982989-DS-18
19,982,989
27,049,214
DS
18
2151-02-09 00:00:00
2151-02-11 13:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: morphine Attending: ___. Chief Complaint: chest pain, shortness of breath Major Surgical or Invasive Procedure: NONE History of Present Illness: ___ y/o M w/ HFpEF (HFpEF, EF 50% ___, possible COPD, CKD, dementia, T2DM, BPH, and recent admission for CHF exacerbation from ___ (discharge weight 70.2 kg (154.76 lb)) presenting from nursing facility with shortness of breath since this morning. He also endorses some chest pain. Further history is unavailable due to patient acuity. He arrives on BiPAP. In the ED, the patient was unable to be weaned off BiPAP and found to be in an acute heart failure exacerbation. - Initial vitals were: T97, BP 118-145/52-83, HR70s, RR low20s, Sat100% on BiPAP - Exam notable for: Bilateral peripheral edema. Scattered rales. Diminished at the right lower lung field. - Labs notable for: Hb 8.5, BUN 47, Cr 2.1 (baseline 2.1-2.3 per last admission), alk phos 173, trop 0.06, lactate 1.6, ___ 14416 (21,000 in previous admission) - Studies notable for: EKG Sinus rhythm with ventricular bigeminy - Patient was given: 40mg Lasix, then redosed with 80mg Lasix; Vanc+Zosyn, nitroglycerin SL On arrival to the CCU, patient continues on BiPAP and is overall confused. Family bedside and reports that the patient continues to experience shortness of breath although much less now that he has respiratory support. ROS: Positive per HPI. Remaining 10 point ROS reviewed and negative. Past Medical History: PAST MEDICAL HISTORY: 1. CARDIAC RISK FACTORS - DMII - Hypertension - Dyslipidemia 2. CARDIAC HISTORY - Coronaries: Unknown - HFpEF, EF 55% ___ (?46% on ___ - NSR 3. OTHER PAST MEDICAL HISTORY -BPH -Head lesion after falling off a horse many years ago -Shoulder surgery status post motor vehicle accident -h/o prostate surgery -Olfactory groove Meningioma -L hip replacement -Hypothyroidism Social History: ___ Family History: Per report, has family history of lung cancer and heart disease, but unclear what disease specifically or in whom. Physical Exam: ADMISSION PHYSICAL EXAM: ======================= PHYSICAL EXAMINATION: VS: afebrile BP: HR:70s Sat 100% on BiPAP GENERAL: Well developed, well nourished. On BiPAP. Oriented to person and place but not situation, somewhat confused. HEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI. NECK: Supple. JVP at earlobe at 65 degrees. CARDIAC: Normal rate, regular rhythm. No murmurs, rubs, or gallops. LUNGS: No chest wall deformities or tenderness. Respiration is labored with accessory muscle use. Scattered rales. Diminished at the right lower lung field. ABDOMEN: Soft, non-tender, non-distended. No palpable hepatomegaly or splenomegaly. EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or peripheral edema. SKIN: No significant lesions or rashes. PULSES: Distal pulses palpable and symmetric. NEURO: moves all extremities spontaneously without FND DISCHARGE PHYSICAL EXAM: ======================= GENERAL: Oriented x0. Delirious and agitated. HEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI. CARDIAC: Normal rate, regular rhythm. No murmurs, rubs, or gallops. LUNGS: CTAB. No chest wall deformities or tenderness. ABDOMEN: Soft, non-tender, non-distended. No palpable hepatomegaly or splenomegaly. EXTREMITIES: Warm, well perfused. No clubbing or cyanosis. Trace peripheral edema. SKIN: No significant lesions or rashes. PULSES: Distal pulses palpable and symmetric. NEURO: A&O x1. Pertinent Results: ADMISSION LABS: =============== ___ 10:18AM BLOOD WBC-8.2 RBC-3.02* Hgb-8.5* Hct-29.4* MCV-97 MCH-28.1 MCHC-28.9* RDW-17.3* RDWSD-62.2* Plt ___ ___ 10:18AM BLOOD Neuts-82.6* Lymphs-8.3* Monos-7.8 Eos-0.9* Baso-0.2 Im ___ AbsNeut-6.74* AbsLymp-0.68* AbsMono-0.64 AbsEos-0.07 AbsBaso-0.02 ___ 10:18AM BLOOD ___ PTT-34.2 ___ ___ 10:18AM BLOOD Glucose-137* UreaN-47* Creat-2.1* Na-139 K-4.6 Cl-101 HCO3-26 AnGap-12 ___ 10:18AM BLOOD ALT-18 AST-19 CK(CPK)-35* AlkPhos-173* TotBili-0.5 ___ 10:18AM BLOOD CK-MB-4 ___ ___ 10:18AM BLOOD Albumin-3.7 ___ 10:25AM BLOOD ___ pO2-23* pCO2-57* pH-7.30* calTCO2-29 Base XS--1 ___ 10:45AM BLOOD Type-ART PEEP-10 pO2-401* pCO2-47* pH-7.33* calTCO2-26 Base XS--1 Intubat-NOT INTUBA ___ 10:45AM BLOOD O2 Sat-98 ___ 01:42PM URINE Color-Straw Appear-Clear Sp ___ ___ 01:42PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG* ___ 01:42PM URINE RBC-1 WBC-7* Bacteri-NONE Yeast-NONE Epi-1 ___ 01:42PM URINE Mucous-RARE* PERTINENT LABS: ============== ___ 10:18AM BLOOD cTropnT-0.06* ___ 05:00PM BLOOD CK-MB-5 cTropnT-0.06* ___ 10:18AM BLOOD Lipase-16 ___ 10:25AM BLOOD Lactate-1.6 ___ 03:29PM BLOOD Lactate-1.4 DISCHARGE LABS: ============== ___ 07:53AM BLOOD WBC-6.7 RBC-3.20* Hgb-9.1* Hct-31.4* MCV-98 MCH-28.4 MCHC-29.0* RDW-16.3* RDWSD-58.0* Plt ___ ___ 05:34AM BLOOD ___ PTT-33.3 ___ ___ 07:53AM BLOOD Glucose-189* UreaN-43* Creat-2.4* Na-143 K-5.0 Cl-104 HCO3-24 AnGap-15 ___ 05:34AM BLOOD ALT-14 AST-33 ___ 05:46AM BLOOD ALT-15 AST-23 LD(LDH)-176 AlkPhos-155* TotBili-0.7 ___ 07:53AM BLOOD Calcium-8.6 Phos-2.8 Mg-2.5 RELEVANT MICRO: ============== ___ 1:42 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: YEAST. < 10,000 CFU/mL. ___ 10:18 am BLOOD CULTURE Blood Culture, Routine (Pending): No growth to date. ___ 10:39 am BLOOD CULTURE 2 OF 2. Blood Culture, Routine (Pending): No growth to date. RELEVANT IMAGING: ================= ___ Cardiac Pefusion Pharm FINDINGS: Left ventricular cavity size is normal There is considerable soft tissue attenuation especially on the rest images, limiting interpretation. Rest and stress perfusion images reveal a probable moderate fixed perfusion defect in the inferolateral wall. Gated images reveal normal wall motion. The calculated left ventricular ejection fraction is 55% IMPRESSION: Probable moderate fixed perfusion defect in the inferolateral wall. Soft tissue attenuation limits interpretation. ___ Stress (see above) INTERPRETATION: This ___ yo man with h/o HFpEF, CKD, possible COPD, and NIDDM was referred to the lab from the inpatient floor for evaluation of mild regional systolic dysfunction c/w CAD. The patient was administered 0.4 mg Regadenoson (Lexiscan) IV Bolus over 20 seconds. There were no reports of chest, back, neck, or arm discomforts during the study. In the setting of baseline STT abnormalities, the ST segments were uninterpretable for ischemia. Rhythm was sinus with rare isolated APBs and one VPB. There was an appropriate and heart rate response to the infusion. Post-MIBI, the Regadenoson was reversed with 60 mg Caffeine IV. IMPRESSION: No anginal type symptoms with uninterpretable EKG for ischemia. Nuclear report sent separately. ___ CT Head: FINDINGS: There is no evidence of infarction or hemorrhage. There is redemonstration of a hypodense extra-axial mass in the floor of the anterior cranial fossa with mild associated vasogenic edema measuring 3.7 x 3.2 cm, previously measuring 3.7 x 3.2 cm on prior study dated ___. There are bilateral periventricular and subcortical white matter hypodensities, nonspecific but compatible with sequelae of chronic small vessel ischemic disease. There is prominence of the ventricles and sulci suggestive of involutional changes. There is no evidence of fracture. There is mild mucosal thickening of the left ethmoid air cells. Otherwise, the visualized portion of the paranasal sinuses, mastoid air cells, and middle ear cavities are clear. The visualized portion of the orbits are unremarkable. IMPRESSION: 1. No acute intracranial process. 2. Stable olfactory groove meningioma, unchanged in size from prior study dated ___. ___ Renal Ultrasound: IMPRESSION: 1. No evidence of stones or hydronephrosis. 2. 1.4 cm cystic structure with thin avascular septations in the upper pole of the left kidney has decreased in size compared to prior, previously 1.9 cm. This likely represents a minimally complex cyst which requires no further follow-up, and is unlikely an abscess. ___ CXR: IMPRESSION: Cardiomegaly is severe, unchanged. Patient continues to be in interstitial pulmonary edema. Bilateral pleural effusion, large on the right and moderate on the left is unchanged. No pneumothorax. ___ TTE CONCLUSION: The left atrial volume index is normal. There is no evidence for an atrial septal defect by 2D/color Doppler. The estimated right atrial pressure is ___ mmHg. There is normal left ventricular wall thickness with a normal cavity size. There is a small area of regional left ventricular systolic dysfunction with hypokinesis of the inferoseptum, inferior, and inferolateral walls (see schematic) and preserved/normal contractility of the remaining segments. There is beat-to-beat variability in the left ventricular contractility due to the irregular rhythm. Quantitative biplane left ventricular ejection fraction is 46 % (normal 54-73%). Normal right ventricular cavity size with normal free wall motion. The aortic valve is not well seen. There is no aortic regurgitation. The mitral valve leaflets appear structurally normal with no mitral valve prolapse. There is mild [1+] mitral regurgitation. The pulmonic valve leaflets are not well seen. The tricuspid valve leaflets appear structurally normal. There is mild [1+] tricuspid regurgitation. There is mild pulmonary artery systolic hypertension. There is a trivial pericardial effusion. A right pleural effusion is present IMPRESSION: Suboptimal image quality. Normal left ventricular wall thickness and cavity size with mild regional systolic dysfunction c/w CAD. Normal right ventricular cavity size and systolic function. Mild mitral regurgitation. Mild tricuspid regurgitation. ___ CXR IMPRESSION: Moderate pulmonary edema worsened slightly since ___. Moderate right pleural effusion is changed in distribution, but probably not in overall volume. Moderate cardiomegaly unchanged. No pneumothorax. ___ EKG Sinus rhythm Ventricular bigeminy Compared with the previous tracing of ___, ventricular ectopic activity now present. ___ CXR IMPRESSION: Moderate right and probable small left pleural effusion. Significant atelectasis in the right middle and lower lobes. Congestion with probable mild edema. Brief Hospital Course: ___ with a history of HFpEF (HFpEF, EF ___, possible COPD, CKD, dementia, T2DM, BPH, and recent admission for CHF exacerbation from ___ presenting with shortness of breath from his nursing facility concerning for acute on chronic HFpEF exacerbation requiring CCU admission for BiPAP. Discharged euvolemic. TRANSITIONAL ISSUES ==================== Discharge wt: unknown Discharge Cr: ___: 2.4 (not at baseline) Discharge diuretic: torsemide 30mg PO daily [] discharged on torsemide 30 daily, may need titration to prevent future hospitalizations--please weight at ___ home daily and adjust diuretic accordingly [] can consider spiranolactone once patient's kidney function improves [] Consider ___ if renal function allows [] Ziopatch can be considered as an outpatient to assess if arrythmias are contributing to his presentation [] Would enforce daily weights at nursing home as well as 2g Na diet and 2L fluid restriction [] Patient has been having urinary retention during admission, needs f/u regarding this [] Patient discharged on Cr of 2.4 (somewhat above baseline), please recheck creatine ___ to ensure torsemide dose is appropriate [] needs f/u creatine in 1 week to assess for resolution of ___. [] Needs diet advanced as tolerated [] On olanzapine, need to monitor for medication adverse effects. [] Advance diet as tolerated [] Will need further evaluation for etiology of increased recent admissions for HF excerbation # CODE STATUS: Full (presumed) # CONTACT: ___ ___ (daughter) BRIEF HOSPITAL COURSE: ====================== ___ with a history of HFpEF (HFpEF, EF ___, possible COPD, CKD, dementia, T2DM, BPH, and recent admission for CHF exacerbation from ___ presenting with shortness of breath from his nursing facility concerning for acute on chronic HFpEF exacerbation requiring CCU admission for BiPAP. He was diuresed with Lasix IV, along with Lasix gtt. Transferred to the floor where IV diuresis was continued but then transitioned to POs. Held PO diuresis for a few days in setting of ___. Then discharged on torsemide 30 daily PO. His course was complicated by severe agitation in the setting of delirium and dementia, improved with Foley removal. # CORONARIES: unknown # PUMP: HFpEF, EF 50% ___ # RHYTHM: normal sinus rhythm ACUTE ISSUES: ============= # Acute on chronic HFpEF Exacerbation: Previous admission mid ___ for HFrEF exacerbation, now with similar presentation with SOB, chest pain, BNP elevation, small bump in trop, and stable ECG. He required CCU admission for BiPAP. He was diuresed with Lasix IV, along with Lasix drip then transferred to the floor where IV diuresis was continued but then transitioned to POs. Held PO diuresis for a few days in setting of ___. Then resumed. Discharged on torsemide 30 daily. His course was complicated by severe agitation in the setting of delirium and dementia. Also discharged on metoprolol 25 daily, isosorbide mononitrate 30, atrovostatin 80, ASA 81, and torsemide 30 daily. Discharge dry weight unknown and discharge creatinine of 2.4 (not baseline creatinine due to ___. Goals of care discussion held with daughter who continues to prefer pursuing aggressive care. # Hypoxemic respiratory failure # Potential PNA: Likely patient's dyspnea represents HF exacerbation. Less likely PNA in light of lack of fever, elevation of WBC, however pulmonary exam on admission revealed decreased diminished lung sounds at the right lower lung field, concerning for PNA. CXR in ED showed moderate right and probable small left pleural effusion along with significant atelectasis in the right middle and lower lobes and congestion with probable mild edema. He was given vancomycin/Zosyn in the ED, but these were discontinued on admission given low likelihood for infection. Improved oxygenation with diuresis. Approrpiate sats on RA at discharge. # Chronic Kidney Disease: Baseline Cr in the low 2's on last discharge, at baseline. Likely underlying CKD vs cardiorenal. Given acute volume overload state, seemed appropriate to continue diuretic and monitor renal function. Renal U/S ___ without evidence of obstructive process/hydro. # Hyperactive delirium # Dementia: Patient with underlying dementia complicated by delirium in the ICU. Tried to regulate sleep wake cycle with ramelteon qhs and Zyprexa standing, required IV antipsychotic doses intermittently. No signs of metabolic disturbance, infection, worsened hypoxia or hypercarbia as contributing factors. Likely worse ___ hospital stay. Delerium improved over hospitalization. #Nutritional Status Had mental status changes that required patient to be NPO for a few days but then transitioned back to a diet. Please advance as tolerated. CHRONIC/STABLE/RESOLVED ISSUES: =============================== # Hypothyroidism Patient continued on home levothyroxine 50mcg daily # BPH Patient continued home finasteride 5mg daily and home tamsulosin 0.4mg daily # T2DM Monitored Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Metoprolol Succinate XL 100 mg PO DAILY 2. amLODIPine 10 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 40 mg PO QPM 5. Docusate Sodium 100 mg PO QHS 6. Finasteride 5 mg PO DAILY 7. Furosemide 40 mg PO DAILY 8. Levothyroxine Sodium 50 mcg PO DAILY 9. Multivitamins 1 TAB PO DAILY 10. Tamsulosin 0.4 mg PO QHS 11. Vitamin D 400 UNIT PO DAILY 12. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY Discharge Medications: 1. OLANZapine 5 mg PO QHS delerium 2. Torsemide 30 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Metoprolol Succinate XL 25 mg PO DAILY 5. Aspirin 81 mg PO DAILY 6. Docusate Sodium 100 mg PO QHS 7. Finasteride 5 mg PO DAILY 8. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 9. Levothyroxine Sodium 50 mcg PO DAILY 10. Multivitamins 1 TAB PO DAILY 11. Tamsulosin 0.4 mg PO QHS 12. Vitamin D 400 UNIT PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS ================== Acute on Chronic HFpEF Exacerbation Hypoxemic hypercapnic respiratory failure SECONDARY DIAGNOSES ==================== Acute Delirium Dementia Poor nutrition Chronic Kidney Disease Benign Prostatic Hyperplasia Hypothyroidism Type 2 Diabetes Mellitus Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr ___, WHY WERE YOU ADMITTED TO THE HOSPITAL? - You were having shortness of breath WHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL? - You were placed on a breathing mask to help you breathe - You were treated with a water pill to help clear the fluid in your lungs that made it hard for you to breathe - You were given medications to treat your high blood pressure - You were seen by our specialists in geriatrics who recommended medications to help with your behavior disturbances at night WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - Take all of your medications as prescribed (listed below) - Follow up with your doctors as listed below - Weigh yourself every morning, seek medical attention if your weight goes up or down by more than 3 lbs in a day or 5 pounds in a week. - Seek medical attention if you have new or concerning symptoms or you develop swelling in your legs, abdominal distention, or shortness of breath at night. Please see below for more information on your hospitalization. It was a pleasure taking part in your care here at ___! We wish you all the best! - Your ___ Care Team Followup Instructions: ___
19983009-DS-20
19,983,009
26,466,419
DS
20
2142-09-09 00:00:00
2142-09-09 15:03:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Hypokalemia Major Surgical or Invasive Procedure: None History of Present Illness: ___ y/o male w/ history of pancreatic cancer (please see below for history and current regimen), diabetes presenting with hypokalemia. Patient reports intermittent hypokalemia in the past, usually during chemotherapy. Last chemo was about a month ago. K was 1.9 in clinic yesterday, and received 40 IV and 60 PO KCl. Patient has no vomiting, minimal intermittent diarrhea and has been eating regularly. No chest pain, shortness of breath or syncope. Patient was recently in ___ for daughter's wedding. In the ED, initial vitals were: 98.2 66 116/71 18 100% RA - Exam notable for: Lungs CTAB, Heart RRR, Abdomen soft, minimally tender. - Labs notable for: K of 2.0 initially, which repeated was 2.1 and then 2.4 after repletion. Mild LFT elevation and anemia (Hgb 10) - Imaging was notable for: - Patient was given: 60meq Kcl x 2, 40meq IV Kcl x1, Mg Sulf 2g, LR, Transfer vitals: 97.5 56 115/79 16 100% RA Upon arrival to the floor, patient reports he feels well. He has not had any recent weakness or numbess, No muscle pain. No CP, SOB, Abd pain. Notes some diarrhea, ___ times per day recently, not significantly watery. This is normal for him. No fevers/chills. Past Medical History: ONCOLOGIC HISTORY: ___ was initially diagnosed with acute pancreatitis in ___. Imaging raised concern for intraductal papillary mucinous neoplasm (IPMN), and he was followed with serial MRI. MRI ___ identified interval change in the configuration of his known pseudocyst. The study was repeated on ___ at which time an enhancing soft tissue abnormality was seen. Upper endoscopy then identified a large amount of mucus at the pylorus. Biopsy by FNA did not show carcinoma. On ___ he was taken to the operating room by Dr. ___ and underwent Whipple's pancreaticoduodenectomy. Pathology showed a 4.4 cm colloid carcinoma (mucinous noncystic carcinoma) arising from an intraductal IPMN. There was no lymphovascular/perineural invasion; 5 of 18 lymph nodes were involved. He was diagnosed with pT3N1Mx stage IIB mucinous noncystic carcinoma of the pancreas. He received six cycles of adjuvant gemcitabine under the care of Dr. ___, which completed in ___, followed by adjuvant radiation with concurrent capecitabine, which completed ___. He was then followed with surveillance imaging. CT in ___ identified a right upper lobe lung nodule for which he underwent CT-guided FNA. Cytology was suspicious for malignancy. He underwent repeat biopsy in ___ with similar results and was eventually taken to the operating room for VATS wedge resection ___. Pathology confirmed the finding of metastasis from his pancreatic colloid carcinoma. He initiated systemic chemotherapy with FOLFIRINOX ___. He completed 14 cycles as of ___ and then entered a treatment break. In ___ he developed peritoneal carcinomatosis with intra-abdominal ascites and a pulmonary embolism. He resumed cycle ___ FOLFIRINOX and completed an additional two cycles as of ___. Due to progression of peritoneal carcinomatosis he then transitioned to nab-paclitaxel/gemcitabine. He completed four cycles of this as of ___ at which time there was further disease progression. Initiated treatment with 5fu/Liposomal irrinotican and LCV on ___. CURRENT TREATMENT PLAN: Liposomal irinotecan/ ___ CI D1 and D15 OTHER PAST MEDICAL HISTORY: 1. Pancreatic colloid carcinoma, as detailed in the history of present illness. 2. Diabetes mellitus. 3. GERD. 4. Tuberculosis, for which he had isoniazid and rifampin. 5. Hyperlipidemia. 6. Chronic pancreatitis. 7. Anemia. 8. Umbilical hernia repair in ___. 9. Appendectomy in ___. Social History: ___ Family History: His mother with diabetes, passed in her early ___ of jaundice. Father with diabetes Physical Exam: ADMISSION PHYSICAL EXAM ===================== VITAL SIGNS: 97.9 126/78 52 18 100% RA GENERAL: Patient appears comfortable, in NAD HEENT: MMM, no scleral icterus, CN II-XII intact NECK: supple CARDIAC: RRR, no m/g/r, normal s1 and s2 LUNGS: CTAB, no w/c/r ABDOMEN: L side is firm with multiple masses. No significant tenderness. R side is soft. Normal bowel sounds, nondistended, EXTREMITIES: WWP, no ___ edema NEUROLOGIC: CNII-XII intact, upper and lower extremity strength SKIN: Port in place on R chest appears c/d/i DISCHARGE PHYSICAL EXAM ====================== VITAL SIGNS: 98.0 PO 122 / 81 L Standing 97 18 100 RA GENERAL: Patient appears comfortable, in NAD HEENT: MMM, no scleral icterus, CN II-XII intact NECK: supple CARDIAC: RRR, no m/r/g, normal s1 and s2 LUNGS: CTAB ABDOMEN: LUQ and LLQ are firm, rigid with palpable ill-defined masses. No significant tenderness. R side is soft. Normal bowel sounds, nondistended, EXTREMITIES: WWP, no ___ edema NEUROLOGIC: CNII-XII intact, upper and lower extremity strength SKIN: Port in place on R chest appears c/d/i Pertinent Results: ADMISSION LAB RESULTS ==================== ___ 11:10AM BLOOD WBC-8.1 RBC-4.73 Hgb-10.4* Hct-33.4* MCV-71* MCH-22.0* MCHC-31.1* RDW-19.6* RDWSD-49.1* Plt ___ ___ 11:10AM BLOOD UreaN-8 Creat-0.7 Na-142 K-1.9* Cl-95* HCO3-35* AnGap-14 ___ 11:10AM BLOOD ALT-54* AST-169* AlkPhos-100 TotBili-0.4 ___ 11:10AM BLOOD Albumin-3.0* Calcium-8.6 Phos-2.8 Mg-1.8 Iron-32* ___ 11:10AM BLOOD calTIBC-185* Ferritn-1427* TRF-142* ___ 11:10AM BLOOD CEA-4.8* DISCHARGE LAB RESULTS ==================== ___ 05:28AM BLOOD WBC-5.8 RBC-3.95* Hgb-8.8* Hct-28.3* MCV-72* MCH-22.3* MCHC-31.1* RDW-19.9* RDWSD-50.0* Plt ___ ___ 05:28AM BLOOD Glucose-78 UreaN-7 Creat-0.6 Na-138 K-3.6 Cl-103 HCO3-27 AnGap-12 ___ 05:28AM BLOOD Calcium-8.2* Phos-3.3 Mg-1.8 MICROBIOLOGY ============ ___ Stool culture: negative ___ C diff: negative IMAGING ======= ___ RUQ Ultrasound: 1. Pneumobilia without intrahepatic or extrahepatic biliary dilatation. 2. The patient is status post cholecystectomy. 3. Mild right-sided hydronephrosis, stable when compared to the CT from an outside facility on ___. 4. A heterogeneously hyperechoic ill-defined Mass is identified within the left upper quadrant adjacent to the spleen and does not demonstrate flow on color Doppler imaging. This is of unclear etiology and could represent a heterogeneous mass, hematoma or fluid collection. Further evaluation with contrast-enhanced imaging such as a multiphasic CT is recommended. ___ CT Chest, Abdomen, and Pelvis: 1. No intrahepatic or extrahepatic biliary duct dilation. There is pneumobilia. 2. Interval increase in the size and mass effect related to bulky soft tissue peritoneal and mesenteric masses from metastatic disease representing progression of metastatic carcinomatosis. 3. There are multiple new subcapsular splenic lesions and increase in size of the previously seen splenic lesions, due to progression of to metastatic disease. 4. Moderate right hydronephrosis and proximal to mid hydroureter with a delayed nephrogram. Hydronephrosis is not significantly changed from prior and is due to extrinsic mass effect on the ureter in the pelvis. Brief Hospital Course: ___ h/o stage IIB pancreatic colloid carcinoma with progressive disease in lung and peritoneum, who presents with hypokalemia secondary to diarrhea: # Hypokalemia: Patient with severe hypokalemia to 1.9 initially in setting of some recent diarrhea, and chemo 6 weeks ago. Likely a combination of diarrhea and chemotherapy effect, patient's K has been low in the past. Given slow response to repletion, likely significant whole body depletion. He was aggressively repleted with IV and PO potassium. He was discharged on PO Potassium 60 mEq daily, with close heme/onc follow-up. # Diarrhea: Patient with nonbloody diarrhea, formed stools, ___ times/day, likely contributing to symptoms. No associated infectious symptoms and C. diff negative. However does have recent travel history to ___. Stool cultures and O&P studies negative. He was give loperamide 2mg QID, which helped with his symptoms. # Elevated transaminases: Patient with transaminitis in a hepatocellular pattern with AST > ALT. Differential would include chemotherapy effect, disease progression, GI infection. Based on imaging findings disease progression is most likely. # Metastatic pancreatic colloid carcinoma: h/o stage IIB pancreatic colloid carcinoma with progressive disease in lung and peritoneum. Progressive on FOLFIRINOX, now on ___. Missed C3D1 due to current episode of hypokalemia. CT torso now with progressive disease. He was discharged with close heme/onc follow-up on ___. # DMII. Patient had several episodes of morning hypoglycemia. His Lantus was decreased to Lantus 8U at bedtime because of morning hypoglycemia. He was told to check his blood sugars every morning and call his PCP if blood sugars remained low. # HTN. Continued home lisinopril. # Pancreatic cancer/pancreatitis. Continued enzyme replacement. Continued lovenox prophylaxis. TRANSITIONAL ISSUES ==================== - Discharge K: 3.6 - Discharge potassium regimen: 60 mEq Potassium daily - CT torso with contrast done while inpatient showing progression of peritoneal and splenic disease - The patient's PO magnesium was held while he was an inpatient, and he was repleted with IV magnesium. PO magnesium was restarted at discharge knowing that it may worsen his diarrhea. Please continue to monitor. - Patient to follow up on ___ with his outpatient oncology team. He should have his potassium rechecked at that time. # CODE: Full code (confirmed) # CONTACT: ___ ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ondansetron 8 mg PO Q8H:PRN nausea 2. Lisinopril 2.5 mg PO DAILY 3. Magnesium Oxide 500 mg PO DAILY 4. Prochlorperazine 10 mg PO Q6H:PRN nausea 5. lipase-protease-amylase 20,000-68,000 -109,000 unit oral TID W/MEALS 6. Pegfilgrastim Onpro (On Body Injector) 6 mg SC Frequency is Unknown 7. Omeprazole 20 mg PO DAILY 8. Potassium Chloride 20 mEq PO DAILY 9. Vitamin D 1000 UNIT PO DAILY 10. Glargine 23 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 11. Enoxaparin Sodium 80 mg SC DAILY Start: Today - ___, First Dose: Next Routine Administration Time Discharge Medications: 1. LOPERamide 2 mg PO QID RX *loperamide [Anti-Diarrhea] 2 mg 2 mg by mouth four times per day Disp #*120 Tablet Refills:*0 2. Glargine 8 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 3. Potassium Chloride 60 mEq PO DAILY Hold for K > RX *potassium chloride 10 mEq 6 capsule(s) by mouth daily Disp #*180 Capsule Refills:*0 4. Enoxaparin Sodium 80 mg SC DAILY Start: ___, First Dose: Next Routine Administration Time 5. lipase-protease-amylase 20,000-68,000 -109,000 unit oral TID W/MEALS 6. Lisinopril 2.5 mg PO DAILY 7. Magnesium Oxide 500 mg PO DAILY 8. Omeprazole 20 mg PO DAILY 9. Ondansetron 8 mg PO Q8H:PRN nausea 10. Prochlorperazine 10 mg PO Q6H:PRN nausea 11. Vitamin D 1000 UNIT PO DAILY 12. HELD- Pegfilgrastim Onpro (On Body Injector) 6 mg SC Frequency is Unknown This medication was held. Do not restart Pegfilgrastim Onpro (On Body Injector) until you speak with oncologist Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: Diarrhea Hypokalemia Pancreatic cancer SECONDARY DIAGNOSIS: DMII GERD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___: You were hospitalized at ___. Why did you come to the hospital? ================================= You were admitted to ___ because your potassium was very low. You were also having diarrhea. What did we do for you? ======================= We gave you potassium both by IV and by mouth and your potassium slowly came back up. We did some stool studies to see if you had an infection causing diarrhea, and they have so far not showed an infection. What do you need to do? ======================= - Only take 8 Units of Lantus at bedtime since your blood sugars in the morning have been low. Check your blood sugar every morning, and decrease your bedtime Lantus dose if your blood sugars remain low. Call your primary care doctor if your sugars are low. - We have increased the amount of potassium that you should be taking at home as pills. You will follow up with your oncologist in clinic and discuss chemotherapy at that time. - Please get your potassium checked at your Heme/Onc appointment on ___. We wish you all the best! - Your ___ care team Followup Instructions: ___
19983009-DS-22
19,983,009
27,741,621
DS
22
2143-06-20 00:00:00
2143-06-20 19:26:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Failure to thrive Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ yo M with PMH of metastatic pancreatic colloid carcinoma admitted from the ED with persistent fatigue, weakness, and poor po intake and new diarrhea of two days duration. Patient hospitilazed ___ - ___ with weakness, fatigue and diarrhea. He was found to have ___ and concern for bowel obstruction and intestinal necrosis, and improved with supportive therapy. He was discharged to rehab ___ and received single agent nal-iri on ___. Per oncology, pt with persistent weakness and poor po appetite since before his last admission which continued at ___. His weight at ___ was down to 74 lbs from 93lbs on admission and he was initiated on mirtazapine and ranitidine. He was brought to the ED for failure to thrive and persistent diarrhea x2 days. In the ED, initial VS were pain 0, T 98.8, HR 97, BP 92/67, RR 18, O2 100%RA. Initial labs: Na 142, K 5.2, HCT 25, Cr 0.7, Ca 7.7, Mg 1.6, P 3.8, WBC 5.2, HCT 24.5, PLT 340. Lactate 1.2. Patient was given 1L NS prior to transfer. ED exam notable for: Constitutional - No Fever/chills, +FTT, decreased appetitie, weight loss Head / Eyes - No Diplopia ENT / Neck - No Epistaxis Chest/Respiratory - No Cough, No Dyspnea Cardiovascular - No Chest pain GI / Abdominal - No Black stool, No Bloody stool GU/Flank - No Dysuria Musc/Extr/Back - No Back pain, No Joint pain Skin - No Rash, No Diaphoresis Neuro - No Headache Imaging: No new imaging CT abd ___: "IMPRESSION: 1. Multiple dilated small and large bowel loops are identified. There is persistent stenosis of the sigmoid colon from the external compression caused by large pelvic masses, which is the likely the main site of bowel obstruction. 2. Pneumatosis intestinalis of the small bowel loops in the right abdomen is concerning for bowel ischemia and new from prior study. 3. Severe right hydronephrosis is new since ___, but similar compared to ___. 4. Multiple large peritoneal masses appear grossly similar to ___. Previously noted hepatic lesions are not demonstrated on this noncontrast exam." Patient received: -CTX 1g x1 -1 L D51/2NS -lisnopril 2.5mg -norepi started at 0.12 Consults: Oncology in ED Vitals on transfer: 80s/60s, HR ___, RR 12 100% RA Upon arrival to ___, pt reports feeling tired but "better." He denies fever/chills, CP, cough, dyspnea, abdominal pain, N/V, or dysuria. He reports limited appetite or fluid consumption for several days. PAST ONCOLOGIC HISTORY: As per last clinic note by Dr ___ was initially diagnosed with acute pancreatitis in ___. Imaging raised concern for intraductal papillary mucinous neoplasm (IPMN), and he was followed with serial MRI. MRI ___ identified interval change in the configuration of his known pseudocyst. The study was repeated on ___ at which time an enhancing soft tissue abnormality was seen. Upper endoscopy then identified a large amount of mucus at the pylorus. Biopsy by ___ did not show carcinoma. On ___ he was taken to the operating room by Dr. ___ and underwent ___'s pancreaticoduodenectomy. Pathology showed a 4.4 cm colloid carcinoma (mucinous noncystic carcinoma) arising from an intraductal IPMN. There was no lymphovascular/perineural invasion; 5 of 18 lymph nodes were involved. He was diagnosed with pT3N1Mx stage IIB mucinous noncystic carcinoma of the pancreas. He received six cycles of adjuvant gemcitabine under the care of Dr. ___, which completed in ___, followed by adjuvant radiation with concurrent capecitabine, which completed ___. He was then followed with surveillance imaging. CT in ___ identified a right upper lobe lung nodule for which he underwent CT-guided FNA. Cytology was suspicious for malignancy. He underwent repeat biopsy in ___ with similar results and was eventually taken to the operating room for VATS wedge resection ___. Pathology confirmed the finding of metastasis from his pancreatic colloid carcinoma. He initiated systemic chemotherapy with FOLFIRINOX ___. He completed 14 cycles as of ___ and then entered a treatment break. In ___ he developed peritoneal carcinomatosis with intra-abdominal ascites and a pulmonary embolism. He resumed cycle ___ FOLFIRINOX and completed an additional two cycles as of ___. Due to progression of peritoneal carcinomatosis he then transitioned to nab-paclitaxel/gemcitabine. He completed four cycles of this as of ___ at which time there was further disease progression. Mr. ___ initiated treatment with 5fu/nal-iri on ___. Snapshot analysis showed variants in ___ and p53" He was hopitilazed ___ - ___ with weakness, fatigue and diarrhea, found to have ___ and concern for bowel obstruction and intestinal necrosis. Improved with supportive therapy. Discharged to rehab ___. Received single agent nal-iri on ___ as he cannot receive ___ infusion at SNF. Past Medical History: 1. Pancreatic colloid carcinoma, as detailed in the history of present illness. 2. Diabetes mellitus. 3. GERD. 4. Tuberculosis, for which he had isoniazid and rifampin. 5. Hyperlipidemia. 6. Chronic pancreatitis. 7. Anemia. 8. Umbilical hernia repair in ___. 9. Appendectomy in ___. Social History: ___ Family History: His mother with diabetes, passed in her early ___ of jaundice. Father with diabetes Physical Exam: ADMISSION PHYISCAL EXAM: ============================== VS: 87/95, HR 93, RR 10, 100% on RA GENERAL: cachetic appearing, NAD EYES: Anicteric sclerea, PERLLA, EOMI, no chemosis ENT: clear OP, no JVD, no LAD CARDIOVASCULAR: RRR, no m/r/g, 2+ radial and DP pulses RESPIRATORY: CTAB, no crackles, wheezes, or rhonchi GASTROINTESTINAL: rock hard L quadrants, soft RUQ, scaphoid, large central palpable mass, nontender without rebound or guarding MUSKULOSKELATAL: Warm, well perfused extremities, 2+ pitting edema to mid tibia NEURO: Alert, oriented, CN II-XII intact, no focal deficits SKIN: stage 2 pressure injury coccyx, no additional rash or lesions DISCAHRGE PHYISCAL EXAM: ============================== VS: ___ 2343 Temp: 98.3 PO BP: 119/82 HR: 65 RR: 18 O2 sat: 97% O2 delivery: RA GENERAL: Cachectic appearing man, appears older than stated age, laying in bed in NAD EYES: Sclera anicteric HEENT: OP clear, MMM, no OP lesions LUNGS: CTAB - no wheezes, rhonchi, or rales CV: RRR, no m/r/g ABD: +BS, S, NT, +large central palpable mass that is stable in size EXT: Poor muscle bulk SKIN: warm, no rashes appreciated NEURO: AOx3, no facial asymmetry Pertinent Results: ADMISSION LABS: ============================= ___:12AM BLOOD WBC-5.2 RBC-2.91* Hgb-8.2* Hct-24.5* MCV-84 MCH-28.2 MCHC-33.5 RDW-16.1* RDWSD-48.7* Plt ___ ___ 12:12AM BLOOD Neuts-77.0* Lymphs-18.3* Monos-2.9* Eos-0.8* Baso-0.2 Im ___ AbsNeut-4.00 AbsLymp-0.95* AbsMono-0.15* AbsEos-0.04 AbsBaso-0.01 ___ 12:12AM BLOOD Glucose-94 UreaN-13 Creat-0.7 Na-142 K-5.2* Cl-107 HCO3-25 AnGap-10 ___ 12:12AM BLOOD Calcium-7.7* Phos-3.8 Mg-1.6 ___ 08:53PM BLOOD ___ pO2-47* pCO2-37 pH-7.37 calTCO2-22 Base XS--3 ___ 12:16AM BLOOD Lactate-1.2 K-4.6 DISCHARGE LABS: ============================== ___ 03:18AM BLOOD WBC-3.4* RBC-3.03* Hgb-8.5* Hct-26.1* MCV-86 MCH-28.1 MCHC-32.6 RDW-16.2* RDWSD-50.4* Plt ___ ___ 04:50AM BLOOD Neuts-50.6 ___ Monos-10.8 Eos-1.7 Baso-0.4 Im ___ AbsNeut-1.22* AbsLymp-0.86* AbsMono-0.26 AbsEos-0.04 AbsBaso-0.01 ___ 04:19AM BLOOD Hypochr-NORMAL Anisocy-NORMAL Poiklo-1+* Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL Ovalocy-1+* Target-1+* ___ 03:18AM BLOOD Glucose-102* UreaN-<3* Creat-0.3* Na-138 K-3.8 Cl-102 HCO3-30 AnGap-6* ___ 06:27AM BLOOD ALT-9 AST-13 LD(LDH)-189 AlkPhos-161* TotBili-0.2 ___ 03:18AM BLOOD Calcium-7.0* Phos-3.5 Mg-1.7 MICROBIOLOGY: ============================== ___ BLOOD CULTURE X2 - NEGATIVE ___ URINE CULTURE - ESCHERICHIA COLI | AMPICILLIN------------ =>32 R AMPICILLIN/SULBACTAM-- 16 I CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S ___ STOOL - C. DIFF - NEGATIVE ___ FECAL CULTURE - NEGATIVE FOR GNR, CAMPYLOBACTER, SALMONELLA, SHIGELLA IMAGING: ============================== ___ KUB IMPRESSION: Dilated air-filled loops of large and small bowel may reflect ileus or early/partial obstruction. Fecal material is visualized within the rectum and is noted to project over the descending colon as well. Brief Hospital Course: FICU COURSE ___ ============================= ASSESSMENT AND PLAN ==================== Mr. ___ is a ___ male with a past medical history of metastatic pancreatic colloid carcinoma admitted from the ED with hypotension in the setting of poor PO intake and new diarrhea of two days duration concerning for septic shock and severe hypovolemia. ACTIVE ISSUES ============= #Septic shock The patient presented with hypotension and leukocytosis with diarrhea x2 days. On arrival, he was noted to have a positive UA. Hence, his sepsis was thought to be from either a GI or urinary source. It was thought that severe hypovolemia was also contributing to his hypertension. His abdominal exam was similar to previous examinations based on a review of records and hence, his presentation was less likely to be from a perforation although there was concern given that he was found to have bowel necrosis during her recent hospitalization. He was started on norepinephrine in the ED with the goal of maintaining MAPs >60. Repeat abdominal imaging was not pursued as they were multiple, very recent imaging studies in our system. He was volume resuscitated with crystalloid and was continued on ceftriaxone and metronidazole for antibiotic coverage based on the concern of GI or urinary source. He was eventually weaned off norepinephrine on ___ and remained stable. At this time, he was thought to be stable enough to transfer to the medical floor for further care. #Diarrhea His diarrhea was attributed to irinotecan during his last admission and the offending agent had been discontinued as of ___. At that time, C. diff and stool cultures were all negative. His current diarrhea was not temporally associated with chemotherapy so there was concern for an infectious etiology. C. difficile and stool culture were sent. He was continued on metronidazole. He was given fluids and his electrolytes were repleted as needed. His C. difficile came back negative and he was started on loperamide for symptomatic relief. #UTI Upon presentation, the patient's UA was found to be positive for possible UTI. Urine cultures were sent for further evaluation. However, the patient remained asymptomatic. Of note, during his last admission, he failed a voiding trial and a foley was re-inserted after which he developed a leukocytosis with positive UA. UCx grew >100,000 E. coli and he was initiated on Ceftriaxone 2gm q24h (___). The foley was removed and his urinary retention resolved. At discharge, his leukocytosis had resolved and he was discharged on Bactrim DS BID for completion of a 7-day course (___). He was started on ceftriaxone based on previous data. # Metastatic pancreatic cancer # Chronic partial bowel obstruction The patient had known bulky peritoneal and mesenteric metastatic disease. A palliative care consult was placed to further assist the family. The patient's outpatient oncology team was notified of his current admission. He was continued on ondansetron and Compazine as needed. # Anorexia # Severe protein calorie malnutrition This was in the setting of progressive metastatic pancreatic cancer. A nutrition consult was placed and the patient was given Ensure 3 times daily. PO intake was also encouraged. CHRONIC ISSUES ============== # Diabetes The patient was noted to be hypoglycemic on arrival. His home doses of insulin were held in the setting. He was placed on an insulin sliding scale. # GERD His home omeprazole 20mg QHS was restarted. # History of PE He was continued on Lovenox 60mg daily (1.5mg/kg/day) per prior oncology recommendations. ========================================= OMED COURSE: ___ - ___ ========================================= Mr. ___ is a ___ male with history of metastatic pancreatic cancer admitted from the ED with hypotension in the setting of poor PO intake and diarrhea of two days duration concerning for septic shock from a urinary source and severe hypovolemia initially admitted to the ICU requiring multiple liters of IVF and pressors. He was subsequently called out to the oncology floor where he was observed prior to discharge with course complicated by relative hypotension. #s/p Septic Shock: #E. Coli UTI Hypotension and leukocytosis requiring temporary levophed support which resolved with aggressive fluid resuscitation. Likely from severe dehydration secondary to poor PO intake, diarrhea as well as possible contribution from UTI. He completed a 7 day course of ceftriaxone (last day ___. #Relative ___ on ___ to 70/40, asymptomatic in the setting of not receiving IV fluids. He was responsive to IVF and had stable blood pressures. He will require IV fluids at home to manage his blood pressure and he was also written for low dose midodrine 10 mg TID. #Diarrhea: Likely secondary to chemotherapy. Stool studies negative. Continued loperamide and provided supportive therapy with IVF and electrolyte repletion. # Severe Protein-Calorie Malnutrition: Secondary to progressive metastatic pancreatic cancer. Supplemental Ensure continued at discharge. # Metastatic Pancreatic Cancer: # Chronic Partial Bowel Obstruction: Known bulky peritoneal and mesenteric metastatic disease. He will follow-up with outpatient Oncology on ___. Zofran and Compazine were as needed # GERD: Held due to diarrhea, can restart home omeprazole 20mg as an outpatient. # Pulmonary Embolism: Continued home lovenox. Transitional Issues: [ ] He should receive 500 ml IVF BID [ ] Continue vitamin D 50,000 units qweek for 8 weeks ___, received 1 dose ___. Last dose ___ [ ] Sacral ulcer, stage II: please ensure that the patient is turned every couple of hours and that the area is closely monitored and cared for [ ] Consider restarting omeprazole. [ ] New Medications: Midodrine 10 mg PO TID, Neutra-Phos 2 PKT PO/NG TID, Potassium Chloride 40 mEq PO BID, Simethicone 40-80 mg PO/NG QID:PRN bloating [ ] Held Medications: None CODE: Full Code (confirmed) EMERGENCY CONTACT HCP: ___ (wife) ___ Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Ondansetron 8 mg PO Q8H:PRN nausea 2. Lisinopril 2.5 mg PO DAILY 3. Mirtazapine 15 mg PO QHS 4. Enoxaparin Sodium 60 mg SC DAILY Start: ___, First Dose: Next Routine Administration Time 5. Omeprazole 20 mg PO DAILY 6. sod phos di, mono-K phos mono ___ mg oral daily 7. Vitamin D 5000 UNIT PO DAILY 8. lipase-protease-amylase 20,000-68,000 -109,000 unit oral BID 9. Glargine 23 Units Bedtime 10. insulin lispro 100 unit/mL subcutaneous SSI 11. Potassium Chloride 60 mEq PO BID 12. Prochlorperazine 10 mg IV Q8H:PRN nausea Discharge Medications: 1. Midodrine 10 mg PO TID RX *midodrine 10 mg 1 tablet(s) by mouth three times per day Disp #*90 Tablet Refills:*0 2. Neutra-Phos 2 PKT PO TID RX *potassium, sodium phosphates [Phos-NaK] 280 mg-160 mg-250 mg 2 powder(s) by mouth three times per day Disp #*180 Packet Refills:*0 3. Potassium Chloride 40 mEq PO BID RX *potassium chloride 20 mEq 2 tablet(s) by mouth twice per day Disp #*120 Tablet Refills:*0 4. Enoxaparin Sodium 60 mg SC DAILY Start: ___, First Dose: Next Routine Administration Time 5. Famotidine 20 mg PO BID 6. LOPERamide 2 mg PO QID:PRN diarrhea RX *loperamide 2 mg 2 mg by mouth four times a day Disp #*30 Capsule Refills:*0 7. Magnesium Oxide 400 mg PO DAILY 8. Mirtazapine 15 mg PO QHS 9. Ondansetron 8 mg PO Q8H:PRN nausea 10. Prochlorperazine 10 mg IV Q8H:PRN nausea 11. sod phos di, mono-K phos mono ___ mg oral daily 12. Vitamin D ___ UNIT PO 1X/WEEK (___) 13. Zenpep (lipase-protease-amylase) 20,000-68,000 -109,000 unit oral TID W/MEALS 14.Hospital Bed Name: ___ Date of Birth: ___ Diagnosis: Metastatic Pancreatic Cancer, pain due to emaciation Length of Need: 99 15.Standard Manual Wheelchair Including seat abd back cushion, elevating leg rests, anti-tip and break extensions. Length = 13 months. Diagnosis: metastatic pancreatic carcinoma Discharge Disposition: Home With Service Facility: ___ ___: PRIMARY DIAGNOSIS: Sepsis from a urinary source Urinary tract infection SECONDARY DIAGNOSIS: Mucinous noncystic colloid carcinoma of the pancreas Irinotecan induced diarrhea Urinary retention Poor nutritional status, weakness Sacral ulcer, stage II History of pulmonary embolism Type II Diabetes Mellitus Hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, You were admitted to the hospital because you felt weak, were having diarrhea, your blood pressure was low and you had a urinary tract infection. You were initially admitted to the ICU due to the low blood pressure, but you were able to brought to the oncology floor once your blood pressure improved. We believe your diarrhea is from your irinotecan chemotherapy and we treated this with Imodium (loperamide). You also developed a bladder infection while you were in the hospital. You were treated with an IV antibiotic for 5 days. We discussed the best place for you to be discharged and after talking with your family, it seems that home with increased support will be the best. You will have a visiting nurse and IV fluids at home. It was truly a pleasure taking part in your care. We wish you all the best with your future health. Sincerely, The team at ___ Followup Instructions: ___
19983512-DS-14
19,983,512
23,377,766
DS
14
2141-08-24 00:00:00
2141-08-24 15:36:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: PODIATRY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Left ___ digit wound Major Surgical or Invasive Procedure: ___: L ___ digit I&D History of Present Illness: ___ PMH Sweet's Syndome & hypothyroid presented to ___ clinic today with left ___ toe with pain, edema, erythema and serous draining lesion. Per report, pt intially presented to ___ urgent care clinic yesterday. She states the symptoms first started on ___ and pt tried to treat herself with abx at home including Keflex ___ BID x2 days), PCN (x1 day) and Augmentin (x1 day). She relates worsening redness, edema and pain today in clinic. She states that she was recently on a cruise in ___ (___). She denies any trauma, but reports that she first noticed a lesion with a white tip ___. She states the redness has gotten worse in addition to the pain. She denies N/F/V/C, SOB, CP. Per report, a L foot stab incision and the lesion was de-roofed today in clinic expressing pus and was cultured. Pt. was not able to tolerate a full I&D and was referred to the ED for further evaluation. She was given one dose of Ceftriaxone 2g IV in office, started on Augmentin 875-125 mg BID. Past Medical History: sweet syndrome, eosinophilic esophagus, arthroscopic knee surgery, R knee reconstruction Social History: ___ Family History: Father- MI, DM, CKD; Mother- healthy; Grandmother- colon ___ Physical Exam: Admission PE: V:98 89 18 98% RA NAD, AOx3 RRR, no respiratory distress, soft non tender distress ___: ___: palpable, crt <3 sec, protective sensation intact. L foot ___ digit deviated laterally with dorsal PIPJ lesion, taught skin with surounding erythema extening to disal midfoot, hyperpigmentation, drainage, tender to palpation, active and passive ROM intact. Pertinent Results: Admission labs: ___ 04:23PM LACTATE-1.0 ___ 04:37PM ___ PTT-25.6 ___ ___ 04:37PM PLT SMR-NORMAL PLT COUNT-425 ___ 04:37PM HYPOCHROM-NORMAL ANISOCYT-NORMAL POIKILOCY-OCCASIONAL MACROCYT-NORMAL MICROCYT-NORMAL POLYCHROM-OCCASIONAL OVALOCYT-OCCASIONAL ___ 04:37PM NEUTS-79* BANDS-0 LYMPHS-15* MONOS-4 EOS-2 BASOS-0 ___ MYELOS-0 ___ 04:37PM WBC-12.1* RBC-4.77 HGB-13.3 HCT-41.2 MCV-87 MCH-27.9 MCHC-32.2 RDW-14.3 ___ 04:37PM estGFR-Using this ___ 04:37PM GLUCOSE-87 UREA N-9 CREAT-0.8 SODIUM-137 POTASSIUM-3.7 CHLORIDE-104 TOTAL CO2-24 ANION GAP-13 Discharge labs: ___ 07:45AM BLOOD WBC-11.8*# RBC-4.45 Hgb-12.3 Hct-38.4 MCV-86 MCH-27.7 MCHC-32.0 RDW-14.4 Plt ___ ___ 07:45AM BLOOD Glucose-93 UreaN-9 Creat-0.9 Na-139 K-3.8 Cl-100 HCO3-29 AnGap-14 ___ 07:45AM BLOOD Calcium-9.2 Phos-3.4 Mg-2.0 Brief Hospital Course: The patient presented to Emergency Room on ___. After thorough evaluation, it was deemed necessary to admit the patient to the podiatric surgery service and taken to the OR for a left ___ digit I&D. There were no adverse events in the operating room; please see the operative note for details. Afterwards, pt was taken to the PACU in stable condition, then transferred to the ward for observation. Post-operatively, the patient remained afebrile with stable vital signs; pain was well controlled with IV pain medication that was then transitioned into an entirly oral pain medication regimen on a PRN basis. The patient remained stable from both a cardiovascular and pulmonary standpoint. Urine output remained adequate throughout the hospitalization. The patient received subcutaneous heparin throughout admission. After four days on IV antibiotics, there was only minor improvement of the infection and derm was consulted in light of pt's history of Sweet's syndrome. Dermatology determined that the most likely etiology of the lesion is a Sweet's lesion and recommended she be discharged with clotrimazole cream BID applications. She was discharged on ___ ___ for assistance with dressing changes and will f/u with both dermatology and podiatry in ___ days. Medications on Admission: omeprazole, Luvox Discharge Medications: 1. Sulfameth/Trimethoprim DS 1 TAB PO BID RX *sulfamethoxazole-trimethoprim 800 mg-160 mg 1 tablet(s) by mouth twice a day Disp #*14 Tablet Refills:*0 2. Levothyroxine Sodium 50 mcg PO DAILY 3. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth q4-6h Disp #*30 Tablet Refills:*0 4. Clobetasol Propionate 0.05% Cream 1 Appl TP BID RX *clobetasol 0.05 % Apply to affected area twice a day Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Neutrophilic Dermatosis, left second digit Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: These are the discharge instructions for post-operative discharge instructions. Discharge Instructions: Please call your surgeon or return to the emergency department if you develop a fever greater than 101.5, severe increase in pain to operative site or pain unrelieved by your pain medication, nausea, vomiting, chills, foul smelling or colorful drainage from your incisions/wounds, redness or swelling around your incisions, or any other symptoms which are concerning to you. Diet: regular diet Medication Instructions: Resume your home medications. You will be starting some new medications: 1. You are being discharged on medications to treat the pain from your operation. These medications will make you drowsy and impair your ability to drive a motor vehicle or operate machinery safely. You MUST refrain from such activities while taking these medications. 2. Please, take your antibiotics as prescribed, it is critical for you to take them as prescribed and for the full course of the regimen. Wound Care: Please, apply clobetasol twice daily with xeroform on top and then dry,sterile dressing to cover. You may shower but please keep dressings clean, dry, and intact. Do not submerge your foot/leg in water. Please call the doctor or page the ___ pager, if you have increased pain, swelling, redness, or drainage to the operative sites. If you have any questions, please call the ___ clinic at ___. Followup Instructions: ___
19983512-DS-15
19,983,512
29,724,208
DS
15
2141-12-28 00:00:00
2141-12-28 15:13:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: vancomycin / Bactrim Attending: ___. Chief Complaint: Purulent, draining RLE wound with ___ Major Surgical or Invasive Procedure: ___: Local Kenalog injection (10mg) into RLE ___'s lesion ___: Local Kenalog injection (10mg) into RLE ___'s lesion History of Present Illness: Ms. ___ is a ___ with PMH significant for Sweet's syndrome (on periodic prednisone) who presented to the ___ ED with worsening pain and an expanding lesion on her lateral RLE. The lesion was located above the lateral malleolus and was a 4x5cm bulla with central eschar and surrounding warmth and erythema, which had been getting worse since ___. She had been seeing Derm 2x a week for this, and was on PO Cipro without improvement. The wound drained purulent, foul-smelling discharge. She had pain up her entire RLE. She had not noticed any other swelling. She had never had a lesion like this before. All other lesions were stable per patient. In the past, her lesions were not debrided as border disruption can cause spread of the lesion. She first noticed this lesion and was admitted to ___ ___ on ___. She was discharged on ___ on a prednisone taper (40mg daily with 10mg taper q2d). When she reached 20mg daily, she was seen at ___ on ___ with expansion and worsening of her lesion, her taper was elevated to 80mg daily. She noted continued worsening and on ___ was started on 64mg methylprednisone and Cipro. Despite this, she noted the lesion to grow significantly, turn black, and become purulent over the 2 days prior to admission. She stated that solumedrol is the only steroid that calms her Sweet's flares. Endorsed occasional night sweats and nausea. Denied fevers, chills, CP/SOB/palpitations, abdominal pain, hematemesis, V/C/D/melena/BRBPR, dysuria, numbness, tingling. Her last BM was 4 days prior to admission. In the ED initial vitals were: pain 10 99.5 87 122/82 16 100% RA She received IV Morphine 5mg x2, IV ketorolac 30mg, IV fentanyl 25mcg, IV methylpred 125mg, Zosyn 4.5g, IV Doxy 100mg Labs were notable for a WBC 17.5 with left shift, lactate 2.2 Upon transfer to the floor, vitals were: pain 7 97.9 79 102/56 17 99% RA Past Medical History: Sweet syndrome Eosinophilic esophagitis Hypothyroidism R knee arthroscopic surgery R knee open ACL reconstruction L ___ toe Sweet's lesion excision C-section Social History: ___ Family History: Father and grandmother with thyroid disease. Grandmother with colon ca. Extensive family history of heart disease. Physical Exam: Admission Physical Exam: Vitals: 98.2 76 138/72 18 98%RA pain 8 Wt: 120.9kg GENERAL: Patient comfortable in bed, appears stated age HEENT: NC/AT, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM, one lesion noted on the roof of her mouth with a purulent overlay NECK: nontender supple neck, no LAD, no JVD CARDIAC: RRR, nl S1,S2, no m/r/g LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: Soft, NT/ND, no HSM, BS+, no guarding or rebound tenderness. EXTREMITIES: WWP. 2+ ___ pulses. RLE 2+ pitting edema on dorsum of foot to 3 inches above ankle. No cyanosis or clubbing, moving all 4 extremities with purpose NEURO: A&Ox3. CN II-XII intact. Motor and sensation intact grossly in all 4 extremities. SKIN: RLE 4x5cm erythematous lesion with purulent discharge and necrotic eschar. Gauze dressing C/D/I. Circular healing lesions with overlying scab noted on L palm, LLE x 2, and RLE x 1, ranging from 1.5cm diameter to 3cm. Discharge Physical Exam: Vitals: 98.3 98.1 70 110/53 18 98% RA GENERAL: Patient comfortable in bed at rest, appears stated age HEENT: NC/AT, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM, one well-healing lesion noted on the roof of her mouth with a granulation tissue overlay NECK: nontender supple neck, no LAD, no JVD CARDIAC: RRR, nl S1,S2, no m/r/g LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: Soft, ND, mildly TTP in all quadrants, no HSM, BS+, no guarding or rebound tenderness. EXTREMITIES: WWP. 2+ ___ pulses. RLE trace edema on dorsum of foot to 3 inches above ankle. No cyanosis or clubbing, moving all 4 extremities with purpose. SILT S/S/SP/DP/T. ___ ___. NEURO: A&Ox3. CN II-XII intact. Motor and sensation intact grossly in all 4 extremities. SKIN: RLE 4x5cm erythematous lesion with purulent discharge and necrotic eschar. Improving erythema and edema compared to prior with less purulent discharge. Gauze dressing C/D/I. Circular healing lesions with overlying scab noted on L palm, LLE x 2, and RLE x 1, ranging from 1.5cm diameter to 3cm. Pertinent Results: Admission Labs: ___ 07:05AM WBC-17.5* RBC-4.31 HGB-11.9* HCT-37.8 MCV-88 MCH-27.6 MCHC-31.4 RDW-15.3 ___ 07:05AM NEUTS-80.3* LYMPHS-15.8* MONOS-3.5 EOS-0.3 BASOS-0.1 ___ 07:05AM ALT(SGPT)-19 AST(SGOT)-11 ALK PHOS-51 TOT BILI-0.3 ___ 07:05AM GLUCOSE-81 UREA N-18 CREAT-0.8 SODIUM-141 POTASSIUM-4.1 CHLORIDE-101 TOTAL CO2-29 ANION GAP-15 ___ 07:15AM LACTATE-2.2* During hospitalization: ___ 07:11AM BLOOD WBC-14.0* RBC-3.90* Hgb-10.9* Hct-33.8* MCV-87 MCH-27.8 MCHC-32.1 RDW-14.9 Plt ___ ___ 07:49AM BLOOD WBC-12.6* RBC-4.34 Hgb-12.0 Hct-37.9 MCV-87 MCH-27.6 MCHC-31.6 RDW-15.2 Plt ___ ___ 07:49AM BLOOD Triglyc-176* HDL-67 CHOL/HD-2.9 LDLcalc-93 Imaging: ___ R Tib/Fib AP/Lat: Soft tissue defect lateral to the distal fibular with no underlying osseous abnormality. Micro: Blood cultures -- no growth Brief Hospital Course: Ms. ___ is a ___ with PMH significant for Sweet's syndrome (on prednisone) who presented to the ___ ED with worsening pain and an expanding lesion on her lateral RLE, improved with IV steroids. # Leg lesion: Sweets vs Pyoderma Gangrenosum. Initially she was started on antibiotics in the ED but after careful evaluation by medicine and dermatology there was not felt to be a true infection, corroborated by the deep tissue sample negative culture despite superficial swab growing pseudomonas, so antibiotics were not continued. Dermatology injected kenalog x2 and recommended high dose IV steroids (125mg Methylpred daily) and discharge on 60mg prednisone twice daily with associated prophylactic medications (dapsone, vitamin D, calcium, PPI) at least until she seems dermatology in follow up ___, and likely for several weeks. She did have clear visible improvement in the leg lesion during her stay. Pain was severe and controlled with IV and PO narcotics. #Acute pain: from leg lesion. She was treated with opiates successfully (BID PO prior to discharge). She was instructed on use, especially with respect to benzodiazepine, which she had recently been taking at night priot to hospitalization to help her sleep (sleeplessness has been due to pain), to avoid over sedation. # Medication error: due to a POE ordering error, patient received 3x the intended dose of methylprednisolone on one night of her stay. She reported feeling somewhat "on edge" that morning, which was treated with ativan and trazodone for sleep, and fingersticks were monitored for 24 hours and were normal. An incident report was filed, and the patient was informed on the day of discovery. CHRONIC ISSUES: # Hypothyroidism - continued home levothyroxine # Eosinophilic esophagitis - continued home PPI Tranisitional issues: - Taper off pain meds and bowel regimen as symptoms allow - Continue dapsone and vitamin D/Calcium as long as on high dose steroids, taper per dermatology (TBD) Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Levothyroxine Sodium 50 mcg PO DAILY 2. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain 3. TraZODone 50 mg PO HS:PRN insomnia 4. Lorazepam 0.5 mg PO HS:PRN insomnia 5. Omeprazole 20 mg PO BID Discharge Medications: 1. Levothyroxine Sodium 50 mcg PO DAILY 2. Omeprazole 20 mg PO BID 3. TraZODone 50 mg PO HS:PRN insomnia 4. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every 6 hours Disp #*40 Tablet Refills:*0 5. Acetaminophen 650 mg PO Q8H pain 6. Dapsone 100 mg PO DAILY RX *dapsone 100 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 7. Polyethylene Glycol 17 g PO BID:PRN constipation take if no BM x1 day RX *polyethylene glycol 3350 17 gram/dose 17g powder(s) by mouth once or twice daily Disp #*238 Gram Gram Refills:*0 8. PredniSONE 60 mg PO BID You will continue at this dose until further instructed by dermatology. RX *prednisone 20 mg 3 tablet(s) by mouth twice a day Disp #*84 Tablet Refills:*0 9. Vitamin D 800 UNIT PO DAILY RX *ergocalciferol (vitamin D2) 400 unit 2 tablet(s) by mouth daily Disp #*60 Tablet Refills:*0 10. Calcium Carbonate 500 mg PO BID RX *calcium carbonate 500 mg calcium (1,250 mg) one tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 11. Clobetasol Propionate 0.05% Ointment 1 Appl TP BID RX *clobetasol 0.05 % apply to base of ankle wound twice a day Refills:*0 12. Lorazepam 0.5 mg PO Q8H:PRN anxiety/insomnia RX *lorazepam 0.5 mg one tab by mouth every 8 hours Disp #*20 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary: Sweet's syndrome-associated lesion vs. Pyoderma gangrenosum Secondary: Sweet's syndrome Hypothyroidism Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires crutches. Discharge Instructions: Dear ___, ___ was a pleasure taking care of you at the ___ ___. As you know, you were admitted to the inpatient Medicine service with a worsening lesion above your right ankle that had increased pain, redness, swelling despite oral steroid treatment. The Dermatologists saw you and thought this lesion could represent a flare of a Sweet's lesion or pyoderma gangrenosum. Per their recommendations, we started you on IV solumedrol to encourage healing. Though antibiotics were initially started in the Emergency Room, there was no concern for infection, and they were quickly stopped during your hospitalization. Your pain was controlled on medications, and your lesion improved significantly. A transition to oral steroids was made, and you were discharged home in stable condition with an improving lesion and close follow-up scheduled with Dermatology. Please review your medication list carefully as some other medications were also added to decrease your risk of side effects of high-dose steroids. We wish you the best of luck. Take care. Sincerely, Your ___ Team Followup Instructions: ___
19983512-DS-17
19,983,512
28,279,474
DS
17
2142-03-07 00:00:00
2142-03-09 22:07:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: vancomycin / Bactrim Attending: ___ Chief Complaint: Epigastric pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old woman with Sweet's syndrome, history of eosinophilic esophagitis, hypothyroidism, calculous cholecystitis s/p lap cholecystectomy 6 wks ago (___), on methylprednisolone, dapsone, and cyclosporine for Sweet syndrome presenting with acute on chronic abdominal pain. She was in her USOH on the night prior to presentation when she developed acute abdominal pain around 8pm. She was able to fall asleep but awoke again around 3am with severe abdominal pain. Pain is located in the epigastric region, and radiates bilaterally to the shoulders and upper back. Pain was constant and "unbearable" from 3am until around 8am when she arrived at the ___ ED. Abdominal pain has no clear exacerbating factors, and was not relieved with TUMS or omeprazole, or with changing positions, walking around, or lying down. No relation to food. Has been nauseated but no vomiting. Denies fevers, chills, diaphresis, diarrhea, constipation, chest pain, shortness of breath, palpitations, dysuria, although she notes urinary frequency with nocturia for several weeks. She states that her abdominal pain began around the time of her admission for cholecystitis in early ___, but has persisted following surgery. It occurs on a near-daily basis, and is usually present when she pushes in the epigastric area. She has had several exacerbations with severe abdominal pain, and it is at these times that the pain radiates to the back, although she states that this current episode is the worst so far. She also notes right sided shoulder pain felt in the anterior upper outer chest and radiating through the top of the acromioclavicular region into the scapula. This pain is sometimes exacerbated by movements and can be reproduced with palpation of the area. Of note, she reportedly had a negative abdominal CT scan 3 weeks ago, ordered by her PCP. In the ED, initial vitals were: T 97.5 HR86 BP 159/103 RR 16 SPO2 100%. Labs were notable WBC count 10.1, Hgb 11.6 (baseline ___, ALT 133, AST 191, Alk phos 107, Tbili 0.9, Dbili 0.6. Lipase 37. Chem 7 within normal limits except bicarb of 30. UA with small leukocyte esterase, few bacteria, 5 epithelial cells. Preliminary read of abdominal ultrasound was unremarkable. She was treated with Maalox, Donnatal, viscous lidocaine, zofran 4mg IV x 2, morphine 5mg IV x 3, and 1000mL normal saline. Vitals prior to transfer were T97.9 HR80 BP110/75 RR 18 SPO2 96% RA Review of systems: (+) Per HPI. Notes night sweats for several months, increasing lower extremity edemal, and weakness in her thighs since ___. Also notes moon facies and buffalo hump (-) Denies fever, chills, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies vomiting, diarrhea, constipation. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Past Medical History: PAST MEDICAL HISTORY: Sweet syndrome; dx'd age ___ Eosinophilic esophagitis Hypothyroidism Cholelithiasis/cholecystitis PAST SURGICAL HISTORY: Laparoscopic cholecystectomy ___ R knee arthroscopic surgery R knee open ACL reconstruction L ___ toe Sweet's lesion excision C-section Social History: ___ Family History: Father and grandmother with thyroid disease. Grandmother with colon cancer. Extensive family history of heart disease. Physical Exam: ADMISSION PHYSICAL EXAM: ================================= Vitals: T 98 BP 106/57, HR 80, RR 16, SPO2 97RA General: Alert, oriented, no acute distress, able to move and sit up in bed without difficulty HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-distended, bowel sounds present. Mild to moderate tenderness in the epigastrium without guarding. Very mild tenderness to deep palpation in the RLQ. No RUQ tenderness GU: No foley Ext: Warm, well perfused, 2+ pulses. 1+ nonpitting edema in bilateral lower extremities. R lateral ankle with approximately 5x5 cm2 ulcer with red-yellow fibrinous base and surrounding violaceous/grey erythema without rolled borders. Unable to appreciate undermined edges. Very tender MSK: No joint swelling, erythema, or increased warmth. Able to reproduce mild pain with palpation of soft tissue beneath AC joint anteriorly, and over several focal tender points on scapula and thoracic paraspinal muscles. Active and passive shoulder ROM intact, with mild pain with Neer impingement test on right. some reproduction of pain in right shoulder with empty can test. Able to perform ___, posterior lift-off, and resisted internal rotation without weakness/pain. Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, gait normal. DISCHARGE PHYSICAL EXAM: ================================ Vitals: T 97.8 BP 115/72, HR 77, RR 20, SPO2 98RA General: Alert, oriented, no acute distress, able to move and sit up in bed without difficulty HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-distended, bowel sounds present. Mild tenderness in the epigastrium, RUQ, and RLQ, no guarding Ext: Warm, well perfused, 2+ pulses. R lateral ankle with approximately 5x5 cm2 ulcer with red-yellow fibrinous base and surrounding violaceous/grey erythema without rolled borders. Unable to appreciate undermined edges. Very tender Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, gait normal. Pertinent Results: ADMISSION LABS: ======================================= ___ 09:15AM BLOOD WBC-10.1# RBC-3.67* Hgb-11.6* Hct-35.0* MCV-95 MCH-31.6 MCHC-33.1 RDW-13.7 Plt ___ ___ 09:15AM BLOOD Neuts-75.7* Lymphs-16.4* Monos-6.5 Eos-0.8 Baso-0.6 ___ 09:15AM BLOOD Glucose-105* UreaN-10 Creat-0.6 Na-141 K-4.0 Cl-102 HCO3-30 AnGap-13 ___ 09:15AM BLOOD ALT-133* AST-191* AlkPhos-107* TotBili-0.9 DirBili-0.6* IndBili-0.3 ___ 09:15AM BLOOD Lipase-37 ___ 09:15AM BLOOD Albumin-3.9 PERTINENT LABS: ======================================= ___ 05:15AM BLOOD WBC-9.5 RBC-3.49* Hgb-11.2* Hct-33.7* MCV-97 MCH-32.1* MCHC-33.2 RDW-13.7 Plt ___ ___ 05:15AM BLOOD Glucose-112* UreaN-7 Creat-0.7 Na-139 K-4.6 Cl-102 HCO3-30 AnGap-12 ___ 05:15AM BLOOD ALT-374* AST-251* AlkPhos-152* TotBili-0.6 ___ 05:15AM BLOOD Calcium-8.9 Phos-3.5 Mg-1.8 DISCHARGE LABS: ======================================= ___ 05:30AM BLOOD WBC-9.7 RBC-3.53* Hgb-11.2* Hct-33.6* MCV-95 MCH-31.8 MCHC-33.4 RDW-13.6 Plt ___ ___ 05:30AM BLOOD Glucose-100 UreaN-9 Creat-0.7 Na-138 K-3.8 Cl-101 HCO3-30 AnGap-11 ___ 05:30AM BLOOD ALT-221* AST-74* AlkPhos-125* TotBili-0.4 ___ 05:30AM BLOOD GGT-139* ___ 01:00PM BLOOD %HbA1c-4.4* eAG-80* STUDIES: ======================================= LIVER OR GALLBLADDER US ___ The liver is normal in echotexture, without focal lesions or intrahepatic biliary ductal dilatation. Main portal vein is patent with hepatopetal flow. The CBD measures 6 mm. The patient is status post cholecystectomy. Imaged portion of the pancreas appears within normal limits, without masses or pancreatic ductal dilation, with portions of the pancreatic tail obscured by overlying bowel gas. The spleen measures 12.2 cm, and is normal in echogenicity. The right kidney measures 10.7 cm. The left kidney measures 11.6 cm. Normal cortical echogenicity and corticomedullary differentiation is seen bilaterally. There is no evidence of masses, stones or hydronephrosis in the kidneys. Visualized portions of aorta and IVC are within normal limits. There is no ascites. IMPRESSION: Unremarkable abdominal ultrasonographic examination in this patient with prior cholecystectomy. MRCP (MR ABD ___ ___ Included views of the lung bases are clear. There is no pericardial pleural effusion. The heart size is normal. The liver parenchyma demonstrates mild heterogeneous on T1 weighted out of phase images in comparison to in phase sequences, denoting steatosis (series 12, image 13). Again seen arising from the caudate lobe is a well-circumscribed 14 mm lesion demonstrating high internal signal intensity on T2 weighted sequences, with peripheral nodular enhancement and centripedal enhancement on delayed sequences, most compatible with a hemangioma (series 4, image 18). A 4 mm segment III hepatic cyst is present (series 4, image 20). No concerning hepatic mass is detected. There is no intra or extrahepatic bile duct dilation. No peribiliary enhancement is detected. The patient is post cholecystectomy. The pancreas demonstrates normal signal intensity and bulk. A 3 mm cystic lesion within the pancreatic head is again seen, likely a tiny side branch IPMN (series 4, image 34). No concerning pancreatic lesion is detected. Pancreatic duct is normal in caliber. The spleen, adrenal glands, stomach, and intra-abdominal loops of small and large bowel are within normal limits. Arising from the posterior interpolar aspect of the left kidney is a well-circumscribed 6 mm hemorrhagic or proteinaceous cyst, denoted by a high internal signal intensity on T2 weighted sequences, intermediate signal intensity on T1 weighted precontrast images, without appreciable internal contrast enhancement (series 4, image 60, series 18, image 61). No concerning renal mass is detected. There is no collecting system obstruction. There is no mesenteric or retroperitoneal lymphadenopathy, and no free fluid. The abdominal aorta, celiac trunk, SMA, and renal arteries are patent and normal in caliber. A replaced left hepatic artery arises from the left gastric (series 16, image 31). There are no osseous lesions concerning for malignancy or infection. IMPRESSION: 1. No intra or extrahepatic bile duct dilation. No ductal stones. Post cholecystectomy. 2. Mild heterogeneous hepatic steatosis. 3. 3 mm cystic lesion within the pancreatic head is unchanged, likely a tiny side branch IPMN. ___ year followup recommended. 4. 14 mm caudate lobe hemangioma and 3 mm segment III hepatic cyst. No concerning hepatic mass. MICROBIOLOGY: ======================================= ___ 2:46 pm SEROLOGY/BLOOD VARICELLA-ZOSTER IgG SEROLOGY (Final ___: POSITIVE BY EIA. A positive IgG result generally indicates past exposure and/or immunity. ___ 2:46 pm Blood (CMV AB) CMV IgG ANTIBODY (Final ___: NEGATIVE FOR CMV IgG ANTIBODY BY EIA. <4 AU/ML. Reference Range: Negative < 4 AU/ml, Positive >= 6 AU/ml. CMV IgM ANTIBODY (Final ___: NEGATIVE FOR CMV IgM ANTIBODY BY EIA. INTERPRETATION: NO ANTIBODY DETECTED. Greatly elevated serum protein with IgG levels ___ mg/dl may cause interference with CMV IgM results. ___ 2:46 pm Immunology (CMV) CMV Viral Load (Final ___: CMV DNA not detected. Performed by Cobas Ampliprep / Cobas Taqman CMV Test. Linear range of quantification: 137 IU/mL - 9,100,000 IU/mL. Limit of detection 91 IU/mL. This test has been verified for use in the ___ patient population. Brief Hospital Course: ___ year old woman with history of Sweet's Syndrome on cyclosporine, methylprednisolone, and dapsone, cholecystitis s/p cholecystectomy in ___, and hypothyroidism presented with acute on chronic epigastric pain radiating to the back, with no clear etiology but improved symptoms at discharge. ACTIVE ISSUES: ============================ # Abdominal Pain The etiology of patient's abdominal pain was unclear. She had no alarm features such as vomiting, diarrhea, fevers, or severe pain, and labs revealed mild transaminitis and mildly elevated bilirubin, with normal WBC count, normal lipase, and normal urinalysis. Abdominal ultrasound was unrevealing, and per report recent CT scan was negative. On hospital day 2, ALT and AST increased to 374 and 251 respectively, indicative of hepatocellular injury. Hepatology was consulted, and recommended an MRCP, which only showed mild hepatic steatosis with no intra or extrahepatic bile duct dilatation. A further work up for auto-immune and infectious etiologies of hepatitis were pursued with many studies pending at the time of discharge. She had mild nausea, but no vomiting and was able to tolerate a regular diet without improvement or worsening of her pain. Pain was controlled initially with intravenous morphine but she was rapidly transitioned to oral tramadol and oxycodone as needed for breakthrough pain. Her symptoms improved to be tolerable, and she was discharged with close outpatient follow up for further evaluation. CHRONIC DIAGNOSES: ============================ # ___'s Syndrome Patient had a stable right lateral ankle wound, 5x5cm, consistent with pyoderma gangrenosum and likely manifestation of Sweet's Syndrome. There were no signs of superinfection. Wound was dressed daily with Adaptic nonadherent dressing. She was continued on dapsone 50mg daily and cyclosporine 100mg daily, which she reported taking at home. It was later clarified prior to discharge that she should have been taking cyclosporine 300 mg daily. She was admitted on a methylprednisolone taper, and was scheduled to transition from methylprednisolone 4mg PO daily to prednisone 5mg daily, but was continued on methylprednisolone 4mg daily until discharge, at which time she started the prednisone taper. # Hypothyroidism She was continued on home dose levothyroxine 150 mcg PO daily. # History of Eosinophilic Esophagitis She had no recent symptoms, and continued takin omeprazole 20mg PO BID. TRANSITIONAL ISSUES: ============================ - Patient currently taking only 100 mg cyclosporine daily (was prescribed 300 mg daily per her pharmacy and last Dermatology note dated ___ will need clarification of regimen with Dermatology regarding Sweet's Syndrome flare treatment. - Patient on last week of steroid taper for Sweet's flare, starting prednisone 5 mg PO daily tomorrow (___) for 7 days. - On MRCP, there was an unchanged in size, 3 mm cystic lesion within the pancreatic head, likely a tiny side branch IPMN. ___ year followup recommended. - Patient has a number of labs pending at discharge, including IgG levels, ___, AMA, anti-smooth muscle, ceruloplasmin, EBV viral load, Varicella IgM, HSV IgM and IgG, EBV VCA IgG and IgM, EBV EBNA IgG, and HCV viral load. - Pt will need LFTs trended at next outpt hepatology f/u appt Medications on Admission: 1. Dapsone 50 mg PO DAILY 2. Levothyroxine Sodium 150 mcg PO DAILY 3. Omeprazole 20 mg PO BID 4. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain 5. TraZODone 25 mg PO HS:PRN insomnia 6. Methylprednisolone 4 mg PO DAILY 7. CycloSPORINE (Sandimmune) 100 mg PO Q24H Discharge Medications: 1. Dapsone 50 mg PO DAILY 2. Levothyroxine Sodium 150 mcg PO DAILY 3. Omeprazole 20 mg PO BID 4. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*30 Capsule Refills:*0 5. PredniSONE 5 mg PO DAILY Duration: 7 Days RX *prednisone 5 mg 1 tablet(s) by mouth Daily Disp #*7 Tablet Refills:*0 6. Senna 8.6 mg PO BID RX *sennosides [senna] 8.6 mg 1 by mouth twice a day Disp #*30 Capsule Refills:*0 7. TraMADOL (Ultram) 50 mg PO Q4H:PRN pain RX *tramadol 50 mg 1 tablet(s) by mouth every four (4) hours Disp #*20 Tablet Refills:*0 8. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain RX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours Disp #*20 Tablet Refills:*0 9. DiCYCLOmine 10 mg PO BID RX *dicyclomine 10 mg 1 capsule(s) by mouth twice a day Disp #*30 Capsule Refills:*1 10. CycloSPORINE (Sandimmune) 100 mg PO Q24H Discharge Disposition: Home Discharge Diagnosis: Primary: Hepatitis (unknown etiology) Secondary: Sweet's Syndrome Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms ___, It was a pleasure meeting you and taking care of you during your hospitalization at ___. You were admitted to the hospital after an episode of severe abdominal pain. Testing revealed injury to the liver, of unknown cause, and we performed an extensive work up of potential causes. Many of the lab tests are still pending. We performed an MRI of your liver, which showed no clear etiology for your abdominal pain. It did show, however, a small cyst in your pancreas for which you'll need repeat imaging in ___ years and benign cysts in your liver, which do not require follow up. Fortunately, your abdominal pain improved, and we recommend follow up with your outpatient providers. It was a pleasure to take care of you during your stay. Please do no hesitate to contact us with any questions and concerns. Sincerely, Your ___ Medicine Team Followup Instructions: ___
19984491-DS-5
19,984,491
29,623,707
DS
5
2163-03-06 00:00:00
2163-03-06 14:14:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins Attending: ___ Chief Complaint: Subdural hematoma Major Surgical or Invasive Procedure: None History of Present Illness: ___ female who presents to ___ on ___ with a mild TBI s/p fall at home around 9 AM, hit head on nightstand, found to have SDH at OSH acute right sided 5mm SDH On Coumadin, INR was 2.8. Given vitamin K at OSH. INR on arrival here improved to 2.6. Per the patient family she has a history of PE/DVT and AVR thrombus. =================== Medicine accept note: Ms. ___ is an ___ yoF with PMH sig for dementia, DVT, PE, AVR thrombus, on warfarin, HTN, HLD, and proximal aortic dissection s/p AVR who presented from assisted living facility to ___ on ___ with a mild TBI s/p fall. Of note, pt has no known recent history of cardiac ischemia, syncopal episodes, orthostasis, epileptic activity, or falls. Of note, patients baseline mental status is AOx1, her functional status is independent with ADLs, no walker or cane needed, in fact she is a brisk walker. On the morning of ___, the pt was found conscious, with a head contusion, on the ground by the side of her bed by aids at her assisted living facility where she lives with her husband and her disabled son. She was lying, in pajamas, on her right hip. The fall was unwitnessed, but the aid attributed the pt's contusion to having hit her head on the nightstand. No bowel or bladder incontinence or evidence of tongue biting. Pt does not remember the fall, nor the preceding events, the fall was not witnessed. Per daughter report, pt has not mentioned any recent episodes of dizziness, chest pain, or shortness of breath, and noted no fever, chills, night sweats, nausea, or vomiting. Prior to fall, pt ambulated with ease, not using walker or cane, and ascended and descended stairs without assistance. Pt has had no known recent sick contacts, though moved to an assisted living facility two months ago, and no recent travel. She has poor fluid intake throughout the day, though eats three full meals per day at her facility. Per daughter, pt has significant baseline dementia, though is always oriented to self and location. Pt presented to OSH where she was found to have acute right sided 5mm SDH on Coumadin (INR 2.8), and she received vitamin K. CT C-spine and head performed. Upon presentation to ___ ED, pt had INR of 2.6. Chest (PA&LAT), ankle, and hip x-rays performed all unremarkable. Pt was monitored by the neurosurgical service and is planned for follow-up CT scan in two months. Warfarin was restarted on ___ because of INR of 2.0, and she was started on Keppra 500 mg BID x7 days (end date ___ for seizure prophylaxis. UA was taken and was positive for large nitrite and leuk, treatment for asymptomatic UTI initiated with TMP/SMX (day 1: ___. Pt was transferred to the medicine service for fall work-up. On ___, pt was AOx1, alert, conversational, and responded to commands appropriately. Pt denied dizziness, headache, blurry vision, chest pain, SOB, fever, chills, dysuria, or urinary urgency. Pt reports no ankle or hip pain or stiffness. Per daughter, pt is back to baseline. Past Medical History: Dementia, HLD, DVT, PE, thrombus, HTN, OA, s/p AVR on Coumadin AVR, bilateral Hip replacements Social History: ___ Family History: NC Physical Exam: Admission Physical exam: GCS:15 Gen: WD/WN, comfortable, NAD. HEENT: bruise and scrape over r eye, swollen Neck: supple Extrem: warm and well perfused Neuro: Mental Status: Awake, alert, cooperative with exam, normal affect, pleasantly confused (baseline) Orientation: Oriented to person only. Language: Speech is fluent with good comprehension. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 2 mm to 1.5 mm mm bilaterally. Visual fields are full to confrontation. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout. No pronator drift Sensation: Intact to light touch Handedness: Right Discharge physical exam: PE Vitals: Tmax=99.4 102-123/60-70 50-70 92-98%RA General: AOx2. Resting calmly. HEENT: Normocephalic, head, hair, scalp WNL. Ecchymosis with scrape over right eye. PERRLA. EOMI. MMM. No lesions on bucal mucosa, tongue, or lips. Neck: No LAD. No JVD. Lungs: Lungs clear do percussion posteriorly and clear to auscultation anteriorly and posteriorly. CV: RRR with nl S1 and S2. No rubs, murmurs, gallops. Abdomen: Abdomen non-tender to light and deep palpation in all 4 quadrants. Back: no CVA tenderness. No spinous process or paraspinal muscle pain. Ext: Warm and well-perfused. Tenderness to deep palpation on lateral aspect of dorsum of foot anterior to lateral malleolus. Neuro: CNs II-II in tact. Strength ___ throughout, ___ with R dorsiflexion. Light touch, vibration, and proprioception in tact throughout. Pertinent Results: =================== Admission labs: =================== ___ 01:28PM BLOOD WBC-5.6 RBC-4.37 Hgb-12.0 Hct-38.3 MCV-88 MCH-27.5 MCHC-31.3* RDW-14.2 RDWSD-45.9 Plt ___ ___ 01:28PM BLOOD Neuts-71.9* ___ Monos-5.7 Eos-0.9* Baso-0.7 Im ___ AbsNeut-4.01 AbsLymp-1.13* AbsMono-0.32 AbsEos-0.05 AbsBaso-0.04 ___ 01:28PM BLOOD ___ PTT-38.7* ___ =========== Micro =========== ___ 1:28 pm BLOOD CULTURE Blood Culture, Routine (Pending): ___ 2:55 pm URINE URINE CULTURE (Preliminary): ESCHERICHIA COLI. >100,000 CFU/mL. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ <=2 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S ============ Radiology: ============ ___ NCHCT (OSH) 5mm SDH CT Cervical Spine: negative Chest XR FINDINGS: PA and lateral views of the chest provided. Sternotomy wires are noted. Linear opacities in the bilateral lower lobes likely represent bibasilar atelectasis versus scarring. There are atherosclerotic calcifications involving the aortic arch and descending thoracic aorta. No radiopaque cardiac valve is seen. S-shaped curvature of the thoracolumbar spine is noted. IMPRESSION: 1. No radio opaque cardiac valve is seen. 2. Bibasilar atelectasis. ___ Ankle XRAY FINDINGS: No fracture, dislocation, or degenerative change is detected. The mortise is congruent on this non stress view. The tibial talar joint space is preserved and no talar dome osteochondral lesion is identified. No suspicious lytic or sclerotic lesion is identified. No soft tissue calcification or radiopaque foreign body is identified. MPRESSION: No acute fracture or dislocation of the right ankle ___ Hip XRAY The patient is status post bilateral total hip arthroplasties with evidence of revision on the right. There is no acute fracture or dislocation identified. Evaluation the sacrum is however obscured by overlying bowel. There are no gross degenerative changes. There is no suspicious lytic or sclerotic lesion. Vascular calcification is present as are calcifications over the right gluteal region likely reflective of injection granulomas. IMPRESSION: Status post bilateral total hip arthroplasties. No evidence of an acute fracture of the pelvis or right hip. =================== Discharge labs: =================== ___ 04:50AM BLOOD WBC-5.0 RBC-3.78* Hgb-10.4* Hct-32.7* MCV-87 MCH-27.5 MCHC-31.8* RDW-14.2 RDWSD-44.7 Plt ___ ___ 04:50AM BLOOD Neuts-60.3 ___ Monos-11.3 Eos-1.2 Baso-0.6 Im ___ AbsNeut-3.00 AbsLymp-1.30 AbsMono-0.56 AbsEos-0.06 AbsBaso-0.03 ___ 04:50AM BLOOD Plt ___ ___ 04:50AM BLOOD Glucose-91 UreaN-32* Creat-1.5* Na-135 K-3.4 Cl-97 HCO3-23 AnGap-18 ___ 04:50AM BLOOD Calcium-8.9 Phos-3.6 Mg-1.8 Brief Hospital Course: Ms. ___ is an ___ year old woman with past medical history of dementia (AOx1), deep vein thrombosis, pulmonary embolism, and aortic dissection with aortic valve replacement on warfarin who presented to ___ with a mild traumatic brain injury following a fall at her assisted living facility. The fall was not witnessed and she does not remember the fall or the preceding events. On head CT, patient was found to have an acute, right-sided 5mm subdural hematoma while on Coumadin, with an INR of 2.8. She received vitamin K, which reduced her INR to 2.6. She received chest, hip, and ankle x-rays, with no concerning findings obviated. Urinalysis was performed finding positive leukocyte esterase and nitrites, and urine culture was positive for gram negative rods. A three-day course of TMP-SMZ was initiated (end-date ___. Patient was monitored by neurosurgical service, and transferred to medicine for work-up of possible syncope. Telemetry and orthostatics were non-concerning. Fall was likely mechanical. #SDH: Unwitnessed fall ___ with no focal neurological deficit. NCHT ___ done in OSH showing 5mm SDH, corroborated by ___ radiology and neurosurgery. SDH was small/stable so no intervention required. Neurological exam was completely benign and remained that way during hospital stay with ___ strength bilaterally in all extremities, 2+ DTR and symmetric facial tone. Per daughter at bedside, pt remained cognitively at baseline. Of note, pt was given vitamin K at OSH and her INR reduced from 2.8 to 2.6 after administration. Warfarin was held ___ and then resumed at an average home dose of 5mg Warfarin on ___. Pt did well with q4H neuro checks and remained stable. Per neurology recommendations, patient was restarted on warfarin and started Keppra 500mg x 7 days (end date ___. Pt requires follow up with neurosurgery with Dr. ___ in clinic in 10 weeks with a repeat NCHCT at that time. #UTI: She had an abnormal urinalysis on admission and was prescribed a three day course of Bactrim, end date ___. Urine cultures grew pan-sensitive E.coli. No complaints of dysuria. #Fall: Given no recent history of syncope, orthostasis, chest pain, SOB or any other concerning symptoms, her episode may have been ___ to mechanical fall. Please refer to the accept note for more details for the event of the fall. Other etiologies of fall that are likely in this situation include AMS more than baseline ___ to infectious cause(UTI). Another cause may be orthostasis ___ to poor fluid intake per daughters report, though patient does not c/o symptoms and orthostatic vitals were negative. Cardiac etiology of valvular defect is unlikely as this did not occur during exertion. Arrythmia cannot but ruled out, but again is less likely given no history of prior syncope and pt did not declare herself on telemetry. Medication list reviewed and no recent changes and no drug interactions likely to precipitate this event. No loss of bowel or bladder control reduce likelihood of seizure. We believe fall was most likely mechanical. Consider work up with holter monitor and echo if patient has another episode. #Hip and ankle pain: Pt reported right hip and knee pain s/p fall due to impact of fall from standing. No fracture visualized on ankle or hip x-ray. Pt is able to bear weight on ankle and has no pain at base of the fifth metatarsal. No further imaging needed. Pain well controlled with Acetaminophen 650 mg PO:PRN. ___ Pt presented with Cr of 1.1 and Cr level peaked on ___ to 1.5. Per patients daughter, nurses and patient herself, she does not like to drink water and has to be reminded to drink frequently. Cr may also be falsely elevated secondary to Bactrim for UTI treatment. Trial of 500IV NS given over 2 hours on ___. Of note, HCTZ was discontinued secondary to creatinine elevation. SBP remained <160 per neurosurgery requests. Follow up with Cr levels on ___ and consider restarting HCTZ. Discharge orthostatic vitals negative on discharge after 500IV NS. #Code status: currently full code, per HC proxy. Daughter plans to discuss this further with other family members. CHRONIC ISSUES ============== #Dementia: Pt is at baseline per daughter. AOx1 (name, location [hospital], year ___. Can state days of week and months backward and spell WORLD backward. Pt was encouraged normal sleep-wake schedule to minimize likelihood of delirium #Hypercoagulability: s/p DVT x3, PE, AVR thrombosis, protein S deficiency . Continued warfarin at a changed dose of 5 mg PO q24. See above for more details. INR monitored by Dr. ___ ___ (PCP - ___. Followed by cardiology at ___ (Dr. ___ #HTN: Continued home amlodipine 2.5 mg PO q24, atenolol 50 mg PO q24, held HCTZ 25mg ___ iso elevated Cr. #HLD: Continued home atorvastatin 20mg PO q24 #Depression :Continued home citalopram 10mg TRANSITIONAL ISSUES: 1. Continue Levetiracetam 500mg PO BID for 7 days (end date: ___ 2. Monitor INR closely given that warfarin was stopped ___ then restarted ___ with changes to home dose. Home dose 4mg MTWThF, 8mg ___, changed to 5mg PO once daily. Next INR check on ___. Follow-up head CT in 2 months (Approx: ___ 4. Consider echo for possible cardiac etiology of fall 5. Recheck Cr level ___. Rise 1.1-->1.5 secondary to either prerenal etiology or falsely elevated iso Bactrim for UTI treatment. HCTZ held starting ___. Can resume once Cr back to baseline at 1.0-1.1. -Code Status: Full code, further discussion needed -Communication: ___ - daughter (___) Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. amLODIPine 2.5 mg PO DAILY 2. Hydrochlorothiazide 25 mg PO DAILY 3. Atenolol 50 mg PO BID 4. Vitamin D 1000 UNIT PO DAILY 5. FoLIC Acid 1 mg PO DAILY 6. Warfarin 4 mg PO 5X/WEEK (___) 7. Warfarin 2 mg PO 2X/WEEK (___) Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 2. Hydrocortisone ___. Cream 0.2% 1 Appl TP BID:PRN itching 3. LevETIRAcetam 500 mg PO BID Duration: 3 Days End date ___. Senna 17.2 mg PO QHS:PRN constipation 5. Warfarin 5 mg PO DAILY Please follow up with INR and change accordingly. 6. amLODIPine 2.5 mg PO DAILY 7. Atenolol 50 mg PO BID 8. Atorvastatin 20 mg PO QPM 9. FoLIC Acid 1 mg PO DAILY 10. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary diagnosis: xRight subdural hemorrhage without surgical intervention Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, You were admitted after you fell and hit your head while getting out of bed at the assisted living facility. You were taken to an outside hospital where they performed a head CT and found a small amount of bleeding around your brain. You were given vitamin K to reduce your likelihood of further bleeding. Upon transfer to ___, you received chest (PA&LAT), ankle, and hip x-rays, all of which showed no concerning findings such as fracture. You were monitored by the neurosurgical service, and were transferred to medicine to help determine the cause of your fall. While at the hospital, it was also found that you had a urinary tract infection and treatment with an antibiotic was started. You did very well, and got less confused and stronger as your hospital stay progressed. Discharge Instructions: -We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. -You may take leisurely walks and slowly increase your activity at your own pace once you are symptom free at rest. ___ try to do too much all at once. Medications -Your Coumadin was restarted while you were in the hospital. Please follow-up with your PCP (Dr. ___: ___ to closely monitor your INR. -You have been discharged on Keppra (Levetiracetam). This medication helps to prevent seizures. Please continue this medication as indicated in your discharge instructions. It is important that you take this medication consistently and on time. THIS MEDICATION IS FOR 7 DAYS ONLY, PLEASE STOP ON ___ AFTER THE EVENING DOSE. -You may use Acetaminophen (Tylenol) for minor discomfort. What You ___ Experience: -You may have difficulty paying attention, concentrating, and remembering new information. -Emotional and/or behavioral difficulties are common. -Feeling more tiredness, restlessness, irritability, and mood swings are also common. -Constipation is common. Be sure to drink plenty of fluids and eat a high-fiber diet. Headaches: -Headache is one of the most common symptom after a brain bleed. -Most headaches are not dangerous but you should call your doctor if the headache gets worse, develop arm or leg weakness, increased sleepiness, and/or have nausea or vomiting with a headache. -Mild pain medications may be helpful with these headaches but avoid taking pain medications on a daily basis unless prescribed by your doctor. -___ are other things that can be done to help with your headaches: avoid caffeine, get enough sleep, daily exercise, relaxation/ meditation, massage, acupuncture, heat or ice packs. When to Call Your Doctor at ___ for: -Fever greater than 101.5 degrees Fahrenheit -Nausea and/or vomiting -Extreme sleepiness and not being able to stay awake -Severe headaches not relieved by pain relievers -Seizures -Any new problems with your vision or ability to speak -Weakness or changes in sensation in your face, arms, or leg Call ___ and go to the nearest Emergency Room if you experience any of the following: -Sudden numbness or weakness in the face, arm, or leg -Sudden confusion or trouble speaking or understanding -Sudden trouble walking, dizziness, or loss of balance or coordination -Sudden severe headaches with no known reason We are wishing you all the best. Sincerely, Your ___ team Followup Instructions: ___
19984573-DS-18
19,984,573
29,579,818
DS
18
2113-02-16 00:00:00
2113-02-18 14:31:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: ___ Major Surgical or Invasive Procedure: None History of Present Illness: ___ single vehicle high speed ___ car vs pole with extensive damage to vehicle, ejected from car, +ETOH (145). Patient remembers entire event and reportedly had GCS 15 at scene. In the ED imaging showed grade II splenic lac and effusion of left knee without fracture. Past Medical History: PMH: none PSH: hernia as child MEDS AT HOME: none Allergies: NKDA Social History: ___ Family History: non contributory Physical Exam: Admitting exam Constitutional: Comfortable HEENT: Normocephalic, atraumatic, Extraocular muscles intact, Pupils equal, round and reactive to light left conjunctiva injection C. collar in place Chest: Clear to auscultation Cardiovascular: Regular Rate and Rhythm, Normal first and second heart sounds Abdominal: Soft, Nondistended tenderness in the left upper quadrant no rebound or guarding Extr/Back: No T. or L-spine tenderness +2 DP bilaterally tenderness over the patella with mild effusion of the left no pain with range of motion bilateral hips and ankles no pain with range of motion bilateral upper extremities Skin: Warm and dry scattered abrasions on the left side of his body Neuro: Speech fluent and x3 strength 5 out of 5 in the upper and lower extremities HEENT: Normocephalic, atraumatic, Extraocular muscles intact, Pupils equal, round and reactive to light left conjunctiva injection Chest: Clear to auscultation Cardiovascular: Regular Rate and Rhythm, Normal first and second heart sounds Abdominal: Soft, Nondistended, non-tender quadrant no rebound or guarding Extr/Back: Left knee effusion Neuro: Speech fluent and x3 strength 5 out of 5 in the upper and lower extremities Pertinent Results: ___ 12:47AM BLOOD WBC-10.3 RBC-4.70 Hgb-15.4 Hct-43.1 MCV-92 MCH-32.7* MCHC-35.6* RDW-11.8 Plt ___ ___ 04:10AM BLOOD WBC-12.9* RBC-4.21* Hgb-13.7* Hct-39.1* MCV-93 MCH-32.5* MCHC-35.0 RDW-12.4 Plt ___ ___ 07:42AM BLOOD Hct-38.1* ___ 01:39PM BLOOD Hct-35.8* ___ 08:00PM BLOOD WBC-7.9 RBC-4.09* Hgb-13.6* Hct-38.3* MCV-94 MCH-33.3* MCHC-35.7* RDW-12.0 Plt ___ ___ 06:25AM BLOOD WBC-7.3 RBC-3.94* Hgb-12.9* Hct-36.6* MCV-93 MCH-32.7* MCHC-35.2* RDW-12.3 Plt ___ ___ 04:10PM BLOOD WBC-7.1 RBC-4.22* Hgb-13.9* Hct-39.0* MCV-93 MCH-33.0* MCHC-35.7* RDW-11.9 Plt ___ ___ 05:40AM BLOOD Hct-40.5 ___ 12:47AM BLOOD UreaN-12 Creat-1.3* ___ 06:25AM BLOOD Glucose-85 UreaN-8 Creat-0.8 Na-138 K-3.5 Cl-101 HCO3-27 AnGap-14 ___ 04:10AM BLOOD ALT-34 AST-49* AlkPhos-47 TotBili-0.9 ___ 12:47AM BLOOD Lipase-95* ___ 12:47AM BLOOD ASA-NEG ___ Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 12:47AM BLOOD Glucose-95 Lactate-2.1* Na-144 K-3.6 Cl-103 calHCO3-28 CT C-spine Final Report INDICATION: High-speed motor vehicle crash; unrestrained driver. COMPARISONS: None. TECHNIQUE: Helical axial MDCT images were obtained through the cervical spine without the administration of IV contrast. Sagittal and coronal reformatted images were obtained and reviewed. FINDINGS: There is no fracture, subluxation, or thickening of the prevertebral soft tissues. Disc space heights are preserved. There are small central disc protrusions at C3-4 and C4-5, without evidence of significant spinal canal narrowing, though resolution of intraspinal detail on CT is limited. A small calcification is present in the nuchal ligament at C5. Numerous non-enlarged cervical lymph nodes are within normal limits in a patient of this age. There is mild pleural/parenchymal scarring at the imaged lung apices. IMPRESSION: No fracture or malalignment. CT torso IMPRESSION: 1. Grade 2 splenic laceration measuring 2 cm. Surrounding heterogeneity of the splenic parenchyma likely represents some additional parenchymal hematoma. There is no evidence of a subcapsular hematoma or perisplenic fluid. 2. Rounded opacity at the left base adjacent to the spleen is likely due to a tiny pulmonary contusion or a small focal region of atelectasis. 3. 5-mm right lower lobe pulmonary nodule. In the absence of specific risk factors, a followup CT is recommended at 12 months. If factors such as smoking exist, recommend a followup CT in 6 to 12 months. CT head No evidence of an acute intracranial injury. No fracture. Left knee xray - Small to moderate joint effusion. Brief Hospital Course: Given his splenic injury, Mr. ___ was admitted to the trauma ICU for monitoring and serial hematocrits. Imaging studies from the ED revealed CT c-spine negative, head CT negative. His pain was well-controlled and hematocrit remained stable. He was deemed stable for transfer to the surgical floor for additional monitoring. While on the floor, the paitent was complaining of left knee pain and having difficulty ambulation. Knee radiographs were negative for fracture. Pt was evaluated by physical therapy who gave him crutches with which he was able to ambulate without difficulty. He was given a referral for outpatient physical therapy. His hematocrits remained stable and his pain controlled. Pt was discharged with follow up. Medications on Admission: none Discharge Medications: 1. Outpatient Physical Therapy Evaluate and treat: Left Knee pain 2. Acetaminophen 1000 mg PO Q8H 3. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain ___ RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp #*15 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Spleen injury, Left knee injury Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital after a car wreck. You suffered an injury to your spleen. You were observed for in the ICU and onteh floor. Your blood counts were stable. You must not participate in any contact sports for atleast 6 weeks. You sustained an injury to your liver/spleen. You should go to the nearest Emergency department if you suddenly feel dizzy or lightheaded, as if you are going to pass out. These are signs that you may be having internal bleeding from your liver/spleen injury. Your liver/spleen injury will heal in time. It is important that you do not participate in any contact sports or any other activity for the next 6 weeks that may cause injury to your abdominal region. Avoid aspirin producs, NSAID's such as Advil, Motrin, Ibuprofen, Naprosyn, or Coumadin for at least ___ weeks unless otherwise directed as these can cause bleeding internally. Don't drive or operate heavy machinery while on oxycodone as it can make you sleepy. Followup Instructions: ___
19984710-DS-16
19,984,710
29,213,398
DS
16
2179-03-17 00:00:00
2179-03-17 08:12:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / amoxicillin / Augmentin / Keflex / erythromycin base / tramadol Attending: ___. Chief Complaint: abdominal pain Major Surgical or Invasive Procedure: endoscopy mild erythema in the lower esophagus consistent with mild esophagitis ___ A) Stomach: Lumen: Evidence of a previous Roux-en-Y Gastric Bypass was seen. Mucosa: Erythema and edema of the mucosa was noted in the stomach consistent with gastritis. Cold forceps biopsies were performed for histology at the stomach. Excavated Lesions A single non-bleeding 12 mm ulcer was found in the near gastro-jejunal anastamosis. Other A suture was seen. Duodenum: Other duodenum was not seen due to post surgical anatomy. The efferent and blind jejunal limbs were without abnormality. Impression: Mild erythema in the lower esophagus consistent with mild esophagitis ___ A) esophagitis Previous Roux-en-Y Gastric Bypass of the stomach Erythema and edema of the mucosa in the stomach (biopsy) Ulcer in the near gastro-jejunal anastamosis A suture was seen. Duodenum was not seen due to post surgical anatomy. The efferent and blind jejunal limbs were without abnormality. Otherwise normal EGD to post-anastamotic jejunal limbs Recommendations: - high dose BID PO PPI - no NSAID use - further care per inpatient team History of Present Illness: ___ with h/o gastric bypass surgery, active injection cocaine use, methadone maintenance treatment presentingwith ___ days of upper abdominal pain. Pain started without incident or trauma, progressed to become severe and has impaired appetite and oral intake. Pain is currently ___ and located above umbilicus and is non-radiating. She has not eaten meals for the past 5 days due to low appetite and pain. She did say eating improves pain. She had two episodes of hematemesis that were a teaspoon or less. She is passing flatus. She has not moved her bowels in this period. She was diagnosed with strep pharyngitis and prescribed clindamycin recently. She recently approx. 3 d ago binged on cocaine and shared a needle. She has had a mild cough without SOB, but productive of green phlegm for the past few days. She has also developed mid and lower back pain in this time without associated weakness. She has had fevers to 102 in the past week. ROS: She denies incontinence, dysuria, or hematuria. She last took methadone yesterday. 10pt ROS as per HPI In the ED she received analgesics, underwent CT abdomen that did not show bowel obstruction and had ___ surgery consultation. PMH: s/[ gastric bypass at ___ withj dr. ___ ___ years ago s/p ccy h/o lap surgery for sbo s/p bil oopheroectomy for chronic cysts h/o endometriosis h/o fibromyalgia h/o interstitial cystitis IBS s/p umbilical hernia repair sh; smokes ___ ppd, recently in drug/psych treatment at ___ in mid ___ for 10 days. active cocaine use, recently shared needle. homeless, no alcohol use. fh not pertinent for management of current chief complaint allergies: throat closes to amox, augmentin, penicillin, erythromycin, hives to Keflex meds last written on ___ for ___ pharmacy in ___ baclofen chlorpromazine docusate folic acid gabapentin gylcolax powder multivitamin prazosin sertraline sucralafate thiamine prescribed by ___ on ___: clindamycin Physical Exam: 97.9 108/70 74 fatigued but non toxic ctab rrr nmrg slight tenderness pain to percussion of mid upper back between scapula and midline lower back just above hips epigastric discomfort and pain to palpation, no rebound or guarding, no palpable organomegaly no suprapubic discomfort normal steady gait full ___ motor strength in all extremities calm and attentive, aox3, fluent speech symmetric facial features discharge avss aox3 calm and cooperative standing up and breathing easily conversant soft abdomen Pertinent Results: ___ 07:15AM BLOOD WBC-9.6 RBC-4.09 Hgb-11.3 Hct-35.1 MCV-86 MCH-27.6 MCHC-32.2 RDW-13.0 RDWSD-40.9 Plt ___ ___ 07:15AM BLOOD Glucose-89 UreaN-5* Creat-0.5 Na-142 K-4.8 Cl-102 HCO3-29 AnGap-11 ___ 08:40PM BLOOD ALT-18 AST-19 AlkPhos-115* TotBili-<0.2 ___ 08:40PM BLOOD Albumin-4.0 Iron-23* ___ 08:40PM BLOOD calTIBC-399 VitB12-327 Ferritn-19 TRF-307 ___ 07:15AM BLOOD 25VitD-38 ___ 09:05AM BLOOD CRP-6.6* ___ 09:05AM BLOOD HIV Ab-NEG ___ 09:05AM BLOOD HCV Ab-POS* HCV Viral Load Not Detected log10 IU/mL MRI spine 1. No evidence of infection orspinal cord compression in the thoracic or lumbar spine. 2. Minimal degenerative changes of the lumbar spine as described above. CXR IMPRESSION: Lungs are low volume with an ill-defined parenchymal opacity in the lingula concerning for pneumonia and posterior segment of the left upper lobe. Heart size is normal. Cardiomediastinal silhouette is unremarkable. There is no pleural effusion. No pneumothorax is seen Abdominal CT IMPRESSION: 1. No acute process within the abdomen or pelvis. Specifically, no small bowel obstruction. 2. Moderate stool burden from ascending to descending colon. 3. Unchanged splenomegaly. Brief Hospital Course: use, methadone maintenance treatment presenting with ___ days of upper abdominal pain found to have marginal ulcer on endoscopy performed on ___. Contributing factors to ulcer include past gastric bypass surgery and ongoing NSAID use (taken for dental pain). PPI BID Sucralafate. She was found to have low iron level and relatively low ferritin as well. Will treat with PO iron and vitamin C with awareness that absorption may be influenced by PPI and that it may exacerbate constipation. If she does not respond or tolerate, IV iron infusion would be a good option for her. Supplementing nutrition with MVI, thiamine, folate, B12. HCV VL detected, but unquantifiable. HIV VL negative Because she had back pain and active IVDU, we obtained imaging and MRI spine did not show evidence of osteomyelitis. CRP 6, ESR 29 Treating a diagnosed pneumonia (minimally symptomatic with cough but no hypoxia) with doxycycline 100mg BID for 7d, ___. Methadone maintenance: 150mg daily per patient receives at ___ ___, last dose given during admission on ___ transitional she will f/u with gi for repeat endoscopy f/u h. pylori serology f/u gi path biopsy f/u with her usual gastric bypass surgeon get referral to ___ treatment of hepatitis C Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Clindamycin 300 mg PO Q8H 2. Thiamine 100 mg PO DAILY 3. Sucralfate 1 gm PO QID 4. Sertraline 50 mg PO QHS 5. Prazosin 2 mg PO QHS 6. Multivitamins 1 TAB PO DAILY 7. Miralax (polyethylene glycol 3350) 17 gram oral DAILY:PRN 8. Docusate Sodium 100 mg PO BID 9. ChlorproMAZINE 50 mg PO Q4H:PRN agitation 10. Baclofen 10 mg PO TID 11. Methadone 150 mg PO DAILY Discharge Medications: 1. Ascorbic Acid ___ mg PO DAILY 2. Cyanocobalamin 250 mcg PO DAILY RX *cyanocobalamin (vitamin B-12) 250 mcg 1 lozenge(s) by mouth daily Disp #*100 Lozenge Refills:*0 3. Doxycycline Hyclate 100 mg PO Q12H RX *doxycycline hyclate 100 mg 1 tablet(s) by mouth twice a day Disp #*12 Tablet Refills:*0 4. Ferrous Sulfate 325 mg PO DAILY RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. FoLIC Acid 1 mg PO DAILY RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 6. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 7. Senna 8.6 mg PO BID:PRN Constipation 8. Baclofen 10 mg PO TID 9. Docusate Sodium 100 mg PO BID 10. Methadone 150 mg PO DAILY 11. Miralax (polyethylene glycol 3350) 17 gram oral DAILY:PRN 12. Multivitamins 1 TAB PO DAILY 13. Prazosin 2 mg PO QHS 14. Sertraline 50 mg PO QHS 15. Sucralfate 1 gm PO QID 16. Thiamine 100 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: marginal ulcer pneumonia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: you were hospitalized for evaluation of abdomoinal pain and had endoscopy that showed you had an ulcer in the stomach near the connection to the intestines. we recommend you take a proton pump inhibitor, pantoprazole for the next 8 weeks. you will require repeat endoscopy to schedule another look at this ulcer to see how it is healing. we are treating you with doxycycline an antibiotic to treat pneumonia. be aware it can cause photosensivity, and irritate the esophagus, so drink plenty of water with it and sit upright after taking it. we diagnosed low iron levels and recommend iron therapy. take iron ___ apart from the pantoprazole and take it with a vitamin c tablet or some orange juice Followup Instructions: ___
19984781-DS-19
19,984,781
23,944,999
DS
19
2165-06-06 00:00:00
2165-06-06 15:38:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Weakness Major Surgical or Invasive Procedure: None History of Present Illness: ___ woman with a history of hypertension, hypothyroidism, and insomnia , osteoarthritis, sjogrens syndromw who presents with weakness, abdominal discomfort and fever. Patient was in her usual state of health until ___ morning. She went out the grab coffee, started walking up her steps and felt significantly light headed, dizzy and very weak. She held on to her railing for support and very slowly made it up her 16 steps. Symptoms continued and worsened with activity. That night, generalize malaise continued, she checked her temperature at 101.5, she did not take anything and slept. ___, she went to visit her PCP, and needed support just to stand up. On ___ she also noticed worsening lower abdominal discomfort. Her PCP was very concerned for urosepsis so sent her to the ED. Of note, patient recently became very sexually active again for the first time in ___ years. She shares that since its been so long, at first it was not very comfortable and that she felt a UTI coming along. No dysuria, just lower abdominal discomfort/awareness. No spotting, malodorous discharge (though her sense of smell is not very good), increased discharge, back pain. Positive for constipation which has been chronic. Past Medical History: hypothyroidism, xerosis/eczema of the skin history of mosquito bite reactions eosinophilia fibromyalgia right hip greater trochanteric bursitis s/p right total hip replacement SJOGREN'S SYNDROME right knee osteoarthritis disc disease s/p discectomy postmenopausal/atrophic vaginitis L5/S1 disc disease/herniation s/p discectomy ___ (no hardware); p/w severe back pain following a fall; MRI ___ showed a large right sided disc herniation with free fragment formation of L5- S1 with some compromise of the thecal sac and the right sided neural foramen h/o erythema nodosum ___ years ago; developed while in ___. Seen by dermatologist but did not undergo etiologic evaluation HTN 6. h/o pneumonia x2; microbiologic etiology unknown IBS Raynaud's phenomenon Infertility hip osteoarthritis elbow fracture s/p fall ___ Social History: ___ Family History: Positive for diabetes, brother, osteoporosis father, and arthritis mother Physical ___: ADMISSION PHYSICAL EXAM: VS: 98.8 PO 132 / 74 L Lying 71 18 97 Ra GENERAL: NAD, smiling, conversing HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: supple, no LAD, no JVD HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, some TTP in lower quadrants/suprapubic superficially, more tender to deep palpation b/l, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing, or edema PULSES: 2+ DP pulses bilaterally NEURO: A&Ox3, moving all 4 extremities with purpose SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM: VS: 98.8 110 / 62 75 18 98 Ra GENERAL: NAD, smiling, conversing HEENT: mildly icteric sclera, pale conjunctiva, icterus under tongue HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, very mild discomfort with deep palpation of the lower abdomen NEURO: A&Ox3, moving all 4 extremities with purpose SKIN: warm and well perfused, diffuse macular rash on the back with papular rash on thighs Pertinent Results: ADMISSION LABS: ================ ___ 09:08PM URINE ___ ___ 09:08PM URINE ___ ___ 09:08PM URINE ___ ___ 09:08PM URINE ___ ___ 09:08PM URINE ___ SP ___ ___ 09:08PM URINE ___ ___ ___ ___ 09:08PM URINE RBC-<1 ___ ___ ___ 06:42PM ___ ___ 06:20PM ___ UREA ___ ___ TOTAL ___ ANION ___ ___ 06:20PM ___ this ___ 06:20PM ___ ___ 06:20PM ___ ___ ___ 06:20PM ___ ___ IM ___ ___ ___ 06:20PM PLT ___ DISCHARGE LABS: ================ ___ 04:50AM BLOOD ___ ___ Plt ___ ___ 04:50AM BLOOD ___ ___ ___ 04:50AM BLOOD ___ LD(___)-373* ___ ___ 04:50AM BLOOD ___ INTERVAL LABS: ============== ___ 04:10AM BLOOD Ret ___ Abs ___ ___ 04:10AM BLOOD ___ LD(LDH)-390* ___ ___ ___ 04:50AM BLOOD ___ LD(___)-447* ___ ___ 06:36AM BLOOD ___ LD(LDH)-455* ___ ___ 04:42AM BLOOD ___ LD(___)-418* ___ ___ 04:10AM BLOOD ___ cTropnT-<0.01 ___ 06:20PM BLOOD ___ ___ 04:10AM BLOOD ___ Hapto-<10* ___ ___ 04:10AM BLOOD ___ ___ 04:10AM BLOOD Free ___ ___ 04:10AM BLOOD ___ HAV ___ ___ 06:36AM BLOOD ___ ___ 04:50AM BLOOD ___ F ___ ___ ___ 01:15PM BLOOD HIV ___ ___ 04:10AM BLOOD HCV ___ ___ 03:50PM BLOOD HCV ___ DETECT URINE: ====== ___ 01:15AM URINE ___ ___ ___ 05:27AM URINE ___ ___ 09:08PM URINE ___ MICROBIOLOGY ============= ___ 4:42 am Blood (CMV AB) **FINAL REPORT ___ CMV IgG ANTIBODY (Final ___: NEGATIVE FOR CMV IgG ANTIBODY BY EIA. <4 AU/ML. Reference Range: Negative < 4 AU/ml, Positive >= 6 AU/ml. CMV IgM ANTIBODY (Final ___: NEGATIVE FOR CMV IgM ANTIBODY BY EIA. INTERPRETATION: NO ANTIBODY DETECTED. Greatly elevated serum protein with IgG levels ___ mg/dl may cause interference with CMV IgM results. ___ 4:50 am SEROLOGY/BLOOD TAKE FROM CHEM # ___ ___. **FINAL REPORT ___ MONOSPOT (Final ___: NEGATIVE by Latex Agglutination. ___ 4:10 am SEROLOGY/BLOOD ADDED DBIL ___. **FINAL REPORT ___ RAPID PLASMA REAGIN TEST (Final ___: NONREACTIVE. Reference Range: ___. ___ 2:29 am SWAB Source: Vaginal. **FINAL REPORT ___ SMEAR FOR BACTERIAL VAGINOSIS (Final ___: Indeterminate. Altered vaginal flora that does not meet criteria for diagnosis of bacterial vaginosis. If signs and/or symptoms persist, repeat testing may be warranted. Interpretive criteria have only been established for ___ women and ___ women on hormone replacement therapy. As low estrogen levels alter vaginal flora, results should be interpreted with caution in ___ women. Refer to the on line laboratory manual. Note, neither lactobacilli nor Gardnerella/Bacteroides/Mobiluncus morphotypes observed. The absence of these morphotypes likely represents normal flora in ___ women. YEAST VAGINITIS CULTURE (Final ___: NEGATIVE FOR YEAST. IMAGING: ======== ___ CT ABD & PELVIS WITH CO IMPRESSION: 1. No acute ___ or pelvic findings to correlate with patient's symptoms. 2. Extensive stool burden is visualized throughout the colon and rectum. 3. Narrowing of the proximal celiac axis which can be normal variant or potentially seen in median arcuate ligament syndrome, to be correlated clinically. ___ PELVIS U.S., TRANSVAGIN IMPRESSION: No free pelvic fluid. The ovaries are not visualized. ___ LIVER OR GALLBLADDER US IMPRESSION: Normal abdominal ultrasound with no focal findings to correlate with recent findings of transaminitis. Brief Hospital Course: Ms. ___ is an ___ female with a past medical history of osteoarthritis, diverticulosis, fibromyalgia, Raynaud's phenomenon who presented with fever, generalized weakness and abdominal pain. In the ED, abdominal pain was evaluated with a CT abdomen that revealed a high stool burden but was otherwise negative. Abdominal pain was initially treated with Doxycycline/Unasyn for suspicion of pelvic inflammatory disease that was ruled out with negative STI panel and TVUS, and improved bowel regimen. Labs on arrival were significant for anemia (9.7) and transaminitis. Her anemia was eventually found to be cold autoimmune hemolytic anemia with unclear trigger, with largely negative workup. Transaminitis also had unclear etiology and at discharge her LFTs were stable. Patient also had a diffuse macular rash on her back that improved with steroid cream and sarna lotion. At discharge cryoglobulins, ___, antismooth antibodies, SPEP, Mycoplasma antibodies and flow cytometry were pending. #Cold Autoimmune Hemolytic Anemia: Patient presented with a history of generalized fatigue with elevated LFTs. Direct Coomb's test was positive with negative IgG and 3+ C3 and positive cold agglutinins, indicative of cold autoimmune hemolytic anemia. Trigger for hemolysis is unclear, however, patient has a history of positive ___ and ___, with occasional h/o dry eyes and dry mouth. Patient also had decreased IgG and slight elevated IgM. RF positive. Hepatitis serology, HIV serology, CMV, monospot, RPR, STI panel negative. At discharge cryoglobulins, ___, antismooth antibodies, SPEP, Mycoplasma antibodies and flow cytometry were pending. She was treated with folic acid and B12, is responding appropriately (retic:7.9%) and did not approach transfusion threshold this hospitalization. #Transaminitis: Patient had elevated LFTs this hospitalization with unclear etiology, that stabilized and started to decrease at discharge. Infectious workup negative as above with blood cultures pending and negative UA and urine culture. Unlikely DILI given very short course of antibiotics. RUQ US without any obvious pathology. CMV negative. Possible autoimmune hepatitis with CMV viral load and antismooth antibodies pending at discharge. #Rash: Patient had diffuse itchy macular rash on her back with a papular rash on her thighs that proved with Triamcinolone Acetonide 0.1% Cream and Sarna Lotion. #Hypothyroidism: Patients thyroid function tests were within normal limits. Patient continued levothyroxine #HTN: Patient was continued HCTZ. #Depression: Patient was continued duloxetine TRANSITIONAL ISSUES: ===================== # Cold agglutinin hemolytic anemia. Will have follow up with primary care and hematology; pending results as above for investigation of etiology. #CODE: Full (presumed) #Name of health care proxy: ___ Relationship: Friend Phone number: ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. DULoxetine 60 mg PO DAILY 2. Levothyroxine Sodium 50 mcg PO DAILY 3. Hydrochlorothiazide 12.5 mg PO DAILY 4. Systane (propylene glycol) (peg ___ glycol) ___ % ophthalmic (eye) DAILY Discharge Medications: 1. Cyanocobalamin 50 mcg PO DAILY RX *cyanocobalamin (vitamin ___ [Vitamin ___ 50 mcg 1 tablet(s) by mouth DAILY Disp #*60 Tablet Refills:*0 2. FoLIC Acid 1 mg PO DAILY RX *folic acid 1 mg 1 tablet(s) by mouth DAILY Disp #*60 Tablet Refills:*0 3. Sarna Lotion 1 Appl TP BID RX ___ [Sarna ___ 0.5 %-0.5 % TP 1 Appl twice a ___ Refills:*0 4. Triamcinolone Acetonide 0.1% Cream 1 Appl TP TID RX *triamcinolone acetonide 0.1 % TP 1 Appl three times a ___ Refills:*0 5. DULoxetine 60 mg PO DAILY 6. Hydrochlorothiazide 12.5 mg PO DAILY 7. Levothyroxine Sodium 50 mcg PO DAILY 8. Systane (propylene glycol) (peg ___ glycol) ___ % ophthalmic (eye) DAILY Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: ================== 1. Cold autoimmune hemolytic anemia 2. transaminitis SECONDARY DIAGNOSIS =================== 1. Hypothyroidism 2. HTN 3. Depression Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You came to ___ because you experienced fever, fatigue and abdominal pain. Please see more details listed below about what happened while you were in the hospital and your instructions for what to do after leaving the hospital. It was a pleasure participating in your care. We wish you the best! Sincerely, Your ___ Care Team =================================== WHAT HAPPENED AT THE HOSPITAL? =================================== - You were evaluated for your abdominal pain and were ruled out for infection, and it was treated with a bowel regimen. - You fatigue and weakness was assessed and was determined to be secondary to an autoimmune condition (cold autoimmune hemolytic anemia. You were treated with medication (folic acid and vitamin B12). You were also evaluated for possible causes triggering this condition, however your workup was negative. ================================================== WHAT NEEDS TO HAPPEN WHEN YOU LEAVE THE HOSPITAL? ================================================== - Please, follow up with your primary care provider - ___, follow up with hematology Your ___ care team Followup Instructions: ___
19984875-DS-21
19,984,875
26,828,045
DS
21
2118-01-13 00:00:00
2118-01-13 16:41:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROSURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Left temporal ___ lesion Major Surgical or Invasive Procedure: ___ - Left craniotomy for resection of left temporal ___ lesion History of Present Illness: ___ is a ___ year old female with a history of lung cancer who presented to the Emergency Department on ___ with a new onset seizure. CT of the head concerning for a left temporal ___ lesion. The Neurosurgery Service was consulted for question of acute neurosurgical intervention. Patient was admitted to ___ further evaluation and management. Past Medical History: - arthritis - iron deficiency anemia - lung cancer status post lobectomy - panic disorder - status post hip replacement in ___ Social History: ___ Family History: Noncontributory Physical Exam: On Admission: ------------- Vital Signs: T 97.7F, HR 115, BP 133/70, RR 18, O2Sat 99% room air General: Elderly female laying on stretcher. Head, Eyes, Ears, Nose, Throat: Right periorbital ecchymosis and edema. Pupils equal, round, and reactive to light. Extraocular movements full. Lungs: No respiratory distress. Extremities: Warm and well perfused. Neurologic: Mental status: Awake and alert, follows simple commands. Orientation: Oriented to person only. Language: Nonfluent speech. Perseverative. Impaired naming. Cranial Nerves: I: Not tested. II: Pupils equally round and reactive to light, 3 to 2mm bilaterally. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout. No drift. Sensation: Intact to light touch. On Discharge: ------------- General: Vital Signs: T 98.1F, HR 74, BP 125/61, RR 16, O2Sat 96% room air Exam: Opens Eyes: [x]Spontaneous [ ]To voice [ ]To noxious Orientation: [x]Person [x]Place - With options [x]Time - With options Follows Commands: [ ]Simple [x]Complex [ ]None Pupils: Pupils equal, round, and reactive to light Extraocular Movements: [x]Full [ ]Restricted Face Symmetric: [x]Yes [ ]No Tongue Midline: [x]Yes [ ]No Drift: [ ]Yes [x]No Speech Fluent: [x]Yes [ ]No Comprehension Intact: [x]Yes [ ]No Motor: Trapezius Deltoid Biceps Triceps Grip Right5 5 5 5 5 Left 5 5 5 5 5 IP Quadriceps Hamstring AT ___ Gastrocnemius Right5 5 5 5 5 5 Left 4+* 4+* 4+* 5 5 5 *Pain limited. [x]Sensation intact to light touch Surgical Incision: [x]Clean, dry, intact [x]Staples Pertinent Results: Please see OMR for relevant laboratory and imaging results. Brief Hospital Course: ___ year old female with a left temporal ___ lesion. #Left Temporal ___ Lesion MRI of the ___ was obtained and confirmed the presence of a left temporal ___ lesion. Patient was started on Keppra to treat her seizures. She was also started on dexamethasone for cerebral edema. CT of the chest, abdomen, and pelvis did not reveal any areas of lung cancer recurrence or other metastases. Neuro Oncology and Radiation Oncology were consulted. Patient was taken to the operating room on ___ for a left craniotomy for resection of the left temporal ___ lesion. The procedure was uncomplicated and well tolerated. Tissue was sent for pathology. Patient was extubated in the operating room and recovered in the PACU. Patient was transferred to the step down unit postoperatively for close neurologic monitoring. Postoperative CT of the head showed expected postoperative changes and was negative for any acute intracranial hemorrhage. Postoperative MRI of the ___ also showed expected postoperative changes. Patient was eventually transferred to the floor. Patient was evaluated by Physical Therapy and Occupational Therapy, both of whom recommended rehabilitation. On ___, patient was neurologically stable. Patient was afebrile with stable vital signs, tolerating activity, tolerating a regular diet, voiding and stooling without difficulty, and her pain was well controlled with oral pain medications. She was discharged to ___ ___ in ___ on ___ in stable condition. She will follow-up in the ___ with Dr. ___ ___ days after surgery for staple removal. She will also follow-up in the ___ Tumor Clinic with Dr. ___ on ___ to determine further treatment. #History of Lung Cancer Medical Oncology was consulted given the patient's history of lung cancer. Patient will follow-up with Medical Oncology after discharge as an outpatient. #T4 Compression Fracture There was an age indeterminate T4 anterior compression deformity noted on CT of the chest. Patient does not have any tenderness to palpation. No activity restrictions or bracing indicated. #Left Lower Extremity Pain There was no acute fracture on x-ray of the left lower extremity, however there was a small knee joint effusion. Ultrasound of the left lower extremity was negative for deep vein thrombosis. Medications on Admission: - furosemide 20mg by mouth once daily - lorazepam 0.5mg by mouth three times daily - oxycodone 15mg by mouth Q6H as needed for pain Discharge Medications: 1. Acetaminophen 325-650 mg PO/NG Q6H:PRN Pain Do not exceed 3000mg in 24 hours. 2. Dexamethasone 2 mg PO/NG DAILY Duration: 1 Dose Please take on ___ at 08:00. This is dose # 5 of 5 tapered doses Tapered dose - DOWN 3. Dexamethasone 2 mg PO/NG Q12H Duration: 2 Doses Please take on ___ at 20:00 and ___ at 08:00. This is dose # 4 of 5 tapered doses Tapered dose - DOWN 4. Docusate Sodium 100 mg PO/NG BID:PRN Constipation While taking oxycodone. ___ discontinue once off oxycodone. Hold for loose stools. 5. Famotidine 20 mg PO/NG BID Duration: 5 Doses While taking dexamethasone. ___ discontinue once off dexamethasone. 6. Heparin 5000 UNIT SC BID ___ discontinue once patient is mobilizing adequately and consistently. 7. LevETIRAcetam 1000 mg PO BID 8. OxyCODONE (Immediate Release) ___ mg PO/NG Q6H:PRN Pain Duration: 7 Days Home medication is 15mg Q6H PRN pain. 9. Senna 17.2 mg PO/NG QHS:PRN Constipation While taking oxycodone. ___ discontinue once off oxycodone. Hold for loose stools. 10. Furosemide 20 mg PO/NG DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Left temporal ___ lesion Discharge Condition: Mental Status: Confused, sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory, requires assistance or aid, cane or walker. Discharge Instructions: Surgery: - You underwent surgery to remove a ___ lesion from your ___. - Please keep your incision dry until your staples are removed. - You may shower at this time, but keep your incision dry. - It is best to keep your incision open to air, but it is okay to cover it when outside. - Call your neurosurgeon if there are any signs of infection like fever, redness, or drainage. Activity: - We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. - You make take leisurely walks and slowly increase your activity at your own pace once you are symptom free at rest. ___ try to do too much all at once. - No driving while taking any narcotic or sedating medication. - If you experienced a seizure while admitted, you are NOT allowed to drive by law. - No contact sports until cleared by your neurosurgeon. You should avoid contact sports for six months. Medications: - Please do NOT take any blood thinning medication (aspirin, Coumadin, ibuprofen, Plavix, etc.) until cleared by your neurosurgeon. - You have been discharged on levetiracetam (Keppra). This medication helps to prevent seizures. Please continue this medication as indicated on your discharge instructions. It is important that you take this medication consistently and on time. - You may use acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. What You ___ Experience: - You may experience headaches and incisional pain. - You may also experience some postoperative swelling around your face and eyes. This is normal after surgery and most noticeable on the second and third day after surgery. You may apply ice or a cool or warm washcloth to help with the swelling. The swelling will be its worst in the morning after laying flat from sleeping, but will decrease when up. - You may experience soreness with chewing. This is normal from the surgery and will improve with time. Softer foods may be easier during this time. - Feeling more tired or restlessness is also common. - Constipation is common. Be sure to drink plenty of fluids and eat a high fiber diet. If you are taking narcotics (prescription pain medications), try an over the counter stool softener. When To Call Your Neurosurgeon At ___: - Severe pain, redness, swelling, or drainage from the incision site. - Fever greater than 101.5 degrees Fahrenheit. - Nausea or vomiting. - Extreme sleepiness or not being able to stay awake. - Severe headaches not relieved by pain relievers. - Seizures. - Any new problems with your vision or ability to speak. - Weakness or changes in sensation in your face, arms, or legs. Call ___ And Go To The Nearest Emergency Department If You Experience Any Of The Following: - Sudden numbness or weakness in the face, arms, or legs. - Sudden confusion or trouble speaking or understanding. - Sudden trouble walking, dizziness, or loss of balance or coordination. - Sudden severe headaches with no known reason. Followup Instructions: ___
19984875-DS-22
19,984,875
24,610,259
DS
22
2118-02-13 00:00:00
2118-02-13 19:41:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Sulfa (Sulfonamide Antibiotics) / latex Attending: ___. Chief Complaint: Per admitting Neurosurgery Team: Left posterior parietal mets Major Surgical or Invasive Procedure: None History of Present Illness: Per admitting Neurosurgery Team: ___ year old female with history of lung cancer and left posterior parietal mets to brain (s/p resection ___ presented to ___ with right-arm focal seizure, and word-finding difficulty. She received 10mg IV dexamethasone and underwent a NCHCT with increased edema. She was transferred to ___. Of note, the patient recently started Cyberknife on ___. She was admitted to the ___ for close neurologic monitoring. Past Medical History: Per admitting Neurosurgery Team: - arthritis - iron deficiency anemia - lung cancer status post lobectomy - panic disorder - status post hip replacement in ___ Social History: ___ Family History: Per admitting Neurosurgery Team: Noncontributory Physical Exam: Per admitting Neurosurgery Team: PHYSICAL EXAMINATION ON ADMISSION: =================================== Gen: alert, cachectic. Pupils: ___ EOMs: unable to formally assess, tracks examiner Extrem: Warm and well-perfused. RUE with notable focal sz activity Neuro: Mental status: Awake and alert, partially cooperative with exam Orientation: expressive aphasia, with fluent non-relevant speech. Unable to orient. Language: expressive aphasia, with fluent non-relevant. Some receptive language intact with intermittent ability to follow simple commands Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 2 to 1mm bilaterally. III, IV, VI: Extraocular movements unable to formally assess, tracks examiner. V, VII: Facial strength unable to formally assess, but no notable facial droop. VIII: Hearing intact to voice. XII: would not stick out tongue to command Motor: Right upper extremity with focal seizure activity. Right lower extremity withdraws to noxious. Left upper and left lower extremities assessed with confrontational motor exam, patient able to participate with simple commands and is 4+/5. Sensation: left-side intact to light touch PHYSICAL EXAMINATION ON DISCHARGE: ================================== VS: 97.9 128/76 70 18 98%RA GENERAL: Well-appearing lady, in no distress sitting in chair in solarium comfortably. HEENT: Anicteric, PERLL, Mucous membranes moist, oropharynx clear. CARDIAC: Regular rate and rhythm, no murmurs, rubs or gallops. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Non-distended, normal bowel sounds, soft, non-tender, no guarding, no palpable masses, no organomegaly. EXT: Warm, well perfused. No lower extremity edema. No erythema or tenderness. NEURO: Comprehensive aphasia but with linear thought process, mentating coherently. CN II-XII intact. Strength full throughout. Sensation to light touch intact. SKIN: No significant rashes. Pertinent Results: Please see OMR for pertinent lab and imaging results. Brief Hospital Course: Neurosurgery course: ##Brain lesion, metastatic lung carcinoma with cerebral edema The patient was admitted to the ___ on ___ with right upper extremity seizure activity. She underwent a CT of the head which showed edema. On ___, she underwent a MRI of the brain which revealed edema but no new lesions. On ___, the patient remained neurologically stable and it was determined she would be transferred to the ___ service on ___ to start Cyberknife treatment. Medical oncology course: Ms. ___ is a ___ year-old lady with metastatic NSCLC (s/p lobectomy, brain mets) c/b seizures s/p resection of R post temporal lobe mass (___) who presented with seizure and aphasia finding progression of residual disease seen on brain MRI, started on high dose steroids, uptitrated antiepileptics and received 5 fractions of SRS with significant improvement. . #Seizure disorder #Comprehensive aphasia #Encephalopathy #CNS metastatic disease #Cerebral edema Encephalopathy is likely post-ictal and resolved during the course of the admission. Aphasia and seizure episode possible triggered by edema in setting of progression of residual disease. With marked improvement in encephephalopathy and aphasia since ___ likely secondary to high-dose steroids, uptitrated levetiracetam. OT Received 5 fractions of SRS while in-house. OT recommended home with 24h care +ADL/IADL assistance which family was able to provide. Initially on dexamethasone 4mg q6h, tapered to 4mg q12h. Was started on dapson for PJP ppx and famotidine for PUD ppx. #Anxiety #Panic disorder Treated with BusPIRone 5 mg PO TID and LORazepam 1 mg PO/NG DAILY:PRN xrt to good effect. #Cancer associated chronic pain: Received intermittent tramadol 25 mg PO Q6H:PRN pain with minimal requirement by the end of the admission. #Metastatic NSCLC: With cerebral metastatic recurrence after lobectomy. Next steps in systemic treatment per Dr. ___ ___ ISSUES =================== 1. Started on dexamethasone 4mg q6h, tapered to 4mg q12h prior to discharge. Taper per Dr. ___. 2. Started on dapsone 100mg daily for PJP prophylaxis 40 minutes spent formulating and coordinating this patient's discharge plan. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 325-650 mg PO/NG Q6H:PRN Pain 2. Dexamethasone 2 mg PO/NG DAILY This is dose # 5 of 5 tapered doses Tapered dose - DOWN 3. Docusate Sodium 100 mg PO/NG BID:PRN Constipation 4. Furosemide 20 mg PO/NG DAILY 5. Famotidine 20 mg PO/NG BID 6. LevETIRAcetam 1000 mg PO BID 7. Senna 17.2 mg PO/NG QHS:PRN Constipation 8. Heparin 5000 UNIT SC BID 9. OxyCODONE (Immediate Release) ___ mg PO/NG Q6H:PRN Pain 10. Dexamethasone 2 mg PO/NG Q12H This is dose # 4 of 5 tapered doses Tapered dose - DOWN Discharge Medications: 1. Acetaminophen 325-650 mg PO Q6H:PRN Pain RX *acetaminophen 325 mg ___ capsule(s) by mouth four times a day Disp #*60 Capsule Refills:*0 2. Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line RX *bisacodyl 5 mg 2 tablet(s) by mouth daily Disp #*60 Tablet Refills:*0 3. BusPIRone 5 mg PO TID RX *buspirone 5 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*0 4. Dapsone 100 mg PO DAILY PJP ppx RX *dapsone 100 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 5. Docusate Sodium 100 mg PO BID:PRN Constipation RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*30 Capsule Refills:*0 6. Famotidine 20 mg PO BID RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 7. Dexamethasone 4 mg PO Q12H RX *dexamethasone [Decadron] 4 mg 1 tablet(s) by mouth twice a day Disp #*30 Tablet Refills:*0 8. LevETIRAcetam 1000 mg PO TID RX *levetiracetam [Keppra] 1,000 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*0 9. Senna 8.6 mg PO BID:PRN Constipation - First Line Reason for PRN duplicate override: Alternating agents for similar severity 10. Furosemide 20 mg PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Seizure disorder Secondary neoplasm of the brain, progression Vasogenic cerebral edema Wernicke's aphasia Non-small cell lung cancer Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, You were admitted for seizures due to growth in your brain tumor. You were started on steroids, anti-seizure medications and were given Cyberknife radiosurgery. You improved significantly. You are ready to continue recovering at home. It was a pleasure to take care of you. Your ___ Team Followup Instructions: ___
19985000-DS-17
19,985,000
25,310,042
DS
17
2169-07-13 00:00:00
2169-07-15 22:28:00
Name: ___ ___ No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Keflex / morphine / Dilaudid Attending: ___. Chief Complaint: diarrhea Major Surgical or Invasive Procedure: None History of Present Illness: Mrs. ___ is a ___ year old woman with history of Crohns disease s/p laparoscopic ileocecectomy in ___ and recent diagnosis of C.diff colitis on ___ who presents with worsening diarrhea and inability to keep herself fully hydrated. . Patient reports ___ bowel movement/day at baseline. She had previously been on ___ for her crohn's which had been stopped due to her pregnancy and breast feeding. She has been on ___ dose of prednisone since her deliver in ___. Currently taking 3mg prednisolone daily. Reports around ___ weeks ago she started having worsening diarrhea ___ along with abdominal crampying and fevers. She was found to have c-diff on ___ and started on PO vanc with improvment in abdominal pain and fevers. Continues to have non-bloody diarrhea. Reports feeling fatigued and not being able to keep herself hydrated at home. Able to take pos without nausea or vomiting. Last colonoscopy in ___ which showed ___ an erosion in the distal neoterminal ileum and anastomosis. Biopsies showed focal cyptitis at the end of the colon. Past Medical History: Crohn's disease of the terminal ileum and colon, mostly in the cecum and ascending colon. She is status post an ileocecectomy via laparoscopy ___ and had a Meckel's diverticulum removed at that same time Social History: ___ Family History: Father has ulcerative colitis. Mother healthy. Older brother healthy. Paternal grandmother has GI problems. Physical Exam: Admission Physical: VS - Temp 97.4F, BP 92/62, HR 85, R 18, O2-sat 98% RA GENERAL - well-appearing thin female, comfortable, appropriate HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear NECK - supple, no thyromegaly, no JVD, no carotid bruits LUNGS - CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART - PMI non-displaced, RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no rebound/guarding EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) SKIN - no rashes or lesions NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout . Discharge Physical Exam: VS - 97.8 90/50 81 100%RA GENERAL - appears fatigued but no acute distress HEENT - sclerae anicteric, dry mucous membranes, OP clear, no ulcers NECK - supple, no cervical or supraclavicular lymphadenopathy LUNGS - Unlabored breathing, clear to ausculattion bilaterally HEART - RRR, no MRG, nl S1-S2 ABDOMEN - +BS, soft, non-distedned, no tenderness to palpation. NO rebound or guarding. EXTREMITIES - warm and well perfused SKIN - no rashes or lesions NEURO - awake, A&Ox3 Pertinent Results: Pertinent Labs: ___ 04:34PM BLOOD WBC-13.4* RBC-4.85 Hgb-14.0 Hct-41.0 MCV-85 MCH-28.9 MCHC-34.2 RDW-13.0 Plt ___ ___ 05:24AM BLOOD WBC-9.7 RBC-3.81* Hgb-11.1* Hct-32.8* MCV-86 MCH-29.1 MCHC-33.8 RDW-13.3 Plt ___ ___ 04:34PM BLOOD Neuts-89.2* Lymphs-7.1* Monos-2.9 Eos-0.4 Baso-0.3 ___ 05:24AM BLOOD ESR-40* ___ 04:34PM BLOOD Glucose-80 UreaN-15 Creat-0.6 Na-136 K-3.9 Cl-100 HCO3-22 AnGap-18 ___ 05:27AM BLOOD Calcium-8.4 Phos-2.6* Mg-1.9 ___ 05:24AM BLOOD CRP-10.6* ___ 04:34PM URINE Color-Yellow Appear-Hazy Sp ___ ___ 04:34PM URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG Ketone-10 Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG ___ 04:34PM URINE RBC-4* WBC-3 Bacteri-NONE Yeast-NONE Epi-<1 ___ 04:34PM URINE CastGr-2* CastHy-3* ___ 04:34PM URINE UCG-NEGATIVE . ___ 2:33 am STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. ADDON REQUEST FOR CDT PER FAX BY ___ ON ___ @8AM. FECAL CULTURE (Final ___: NO SALMONELLA OR SHIGELLA FOUND. CAMPYLOBACTER CULTURE (Final ___: NO CAMPYLOBACTER FOUND. FECAL CULTURE - R/O VIBRIO (Pending): FECAL CULTURE - R/O YERSINIA (Final ___: NO YERSINIA FOUND. FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: NO E.COLI 0157:H7 FOUND. C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Illumigene DNA amplification assay. (Reference Range-Negative). . MRE: IMPRESSION: 1. Diffusely abnormal ileum with wall thickening and transmural enhancement. The features are not typical for active Crohn's disease and are more suggestive of infectious enteritis. 2. Normal appearing colon. Brief Hospital Course: ___ year old woman with history of Crohns disease s/p laparoscopic ileocecectomy in ___, who was started on po vancomycin on ___ for positive c-diff test who now presents with worsening diarrhea and inability to keep herself fully hydrated. . # Diarrhea - One week prior to admission she started having fevers, abdominal cramps and worsening diarrhea up to 15 times/day. She had positive c-diff on ___ at ___ and was started on po vancomycin. She presented to ___ with persistent watery diarrhea and volume depletion despite taking her po vancomycin. Repeat C-diff test and other stool studies during current hospital stay negative was negative. Patient had MR ___ with recommendation from GI consult team which did not reveal any evidence of active Crohns' flare but did suggest infectious enteritis. On the day of discharge she had 4 loose bowel movements and was tolerating her full diet. She was discharged on same dose of prednisolone to be tapered by her gastroenterologist. She will continue and complete treatment for c-diff on ___ with higher dose of po vancomycin. She was also restarted on her imodium. . #Crohns disease: Last colonoscopy done on ___ which showed signs of chronic active colitis. MR enterography did not show any signs of active Crohn's flare. She will continue on her current dose of prednisolone and follow up with her gastroenterologist for further care. . # Contact: ___ ___ # CODE: Full code . Transitions of care; - Patient will follow up with her gastroenterologist for further management of her Crohn's disease and for tapering down of her steroid. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Sertraline 75 mg PO QHS 2. Prenatal Vitamins 1 TAB PO DAILY Start: In am 3. prednisoLONE *NF* 3mg/1mL Oral daily 4. Loperamide 2 mg PO ___ TIMES A DAY Diarrhea Please take once a day to four times a day as needed for diarrhea 5. Cholestyramine 4 gm PO BID 6. Vancocin *NF* (vancomycin) 125 mg Oral QID Discharge Medications: 1. Prenatal Vitamins 1 TAB PO DAILY 2. Sertraline 75 mg PO QHS 3. Loperamide 2 mg PO ___ TIMES A DAY Diarrhea Please take once a day to four times a day as needed for diarrhea 4. Cholestyramine 4 gm PO BID 5. prednisoLONE *NF* 3mg/1mL Oral daily 6. Vancocin *NF* (vancomycin) 250 mg Oral QID Discharge Disposition: Home Discharge Diagnosis: 1. Diarrhea Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, it was a pleasure taking care of you during your hospitalization at ___. You were admitted because of worsening diarrhea and not being able to keep yourself hydrated. You were given intravenous fluids. You had MRI of your abdomen which did not show any signs of active crohn's disease. Your diarrhea was noted to imporve on the day of discharge. Please make a follow up appointment with your PCP and gastroenterologist for further care. You will be leaving on 250mg four times daily of po vancomycin to be taken until ___. Followup Instructions: ___
19985259-DS-4
19,985,259
23,988,340
DS
4
2129-12-23 00:00:00
2129-12-23 15:09:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: shellfish derived Attending: ___ Chief Complaint: dyspnea, LUQ abdominal pain, anxiety Major Surgical or Invasive Procedure: cardiac catheterization ___ ICD placement ___ History of Present Illness: Mr. ___ is a ___ year old gentleman with history of HTN, HLD, CAD, dilated CMY (EF 40-45% ___ presenting with dyspnea, abdominal pain and anxiety. Patient reported shortness of breath and ongoing LUQ, intermittent abdominal pain described as a "rolling sensation" that began 1 hour prior to presentation. He denies chest pain, shortness of breath, cough, nausea, vomiting, diarrhea, lower extremity swelling. Vitals on arrival: 97.0 74 136/84 18 98% RA Labs: notable for normal CBC with elevated MCV 100, bicarb 21, K 3.9, Mg 2.1, Cr 1.0, glucose 224, lactate 4.0, troponin T 0.02, normal coags. LFTs notable for normal alk phos and tbili, elevated AST 184 ALT 81. Imaging: CXR showed Interstitial opacities noted bilaterally suggestive of possible interstitial edema. Subsequent to arrival patient developed wide complex tachycardia with ECG showing monomorphic VT. He received adenosine 6mg, 12mg IV with no change. He was subsequently loaded with amiodarone 150mg x1 and started on gtt. Subsequently received metoprolol 5mg IV x1`, lidocaine 100mg IV x1, without conversion and subsequently hypotensive requiring cardioverted at 200J x1 with subsequent to normal sinus rhythm. At that time he was noted to have ECG with sinus rhythm, rate 75, normal axis, >1mm ST elevations in leads V1-V2, ST depressions in II, III, avF as well as V4-V6 concerning for anterior STEMI and CODE STEMI was called. Patient went to the cath lab where he was found to have LAD with small first diag with 70% stenosis not amenable to intervention. No other significant lesion noted. Patient had R radial access but was not able to engage catheter, subsequently R femoral access, sheath was pulled in the cath lab at the conclusion of the procedure. He received lidocaine gtt at 2mg/min, aspirin 325mg PO. On arrival to the CCU, patient reports feeling well, overwhelmed with ED course and frustrated that his pants were cut off. He denies chest pain, lightheadedness, shortness of breath. Abdominal discomfort has resolved. He refuses statin as he states it causes his muscles to ache. REVIEW OF SYSTEMS: (+) per HPI Cardiac review of systems is notable for absence of chest pain, dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, palpitations, syncope or presyncope. Denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, joint pains, cough, hemoptysis, black stools or red stools. Denies recent fevers, chills or rigors. Denies exertional buttock or calf pain. All If the other review of systems were negative. Past Medical History: HTN HLD CAD Dilated Cardiomyopathy diagnosed ___ at ___, (EF 40-45% ___ Social History: ___ Family History: Father CAD/PVD Mother diabetes, Died on hospice, dementia Sister ___ Cancer No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. Physical Exam: ADMISSION: VS: 98.7 74 139/71 26 94% on 4L Weight: 85kg (83.4kg at ___ ___ GEN: older gentleman lying flat in bed, anxious appearing but speaking in full sentences in NAD HEENT: PERRL, EOMI, no scleral icterus, MMM NECK: supple, JVP elevated at 10cmH20 CV: RRR, S1, S2 without appreciable m/r/g LUNGS: crackles at bilateral bases, no wheezes or rhonchi ABD: soft, non distended, non tender to palpation EXT: warm, well perfused, 1+ DP and ___ pulses bilaterally SKIN: warm, well perfused, no rashes, R groin with dressing in place, c/d/I no palpable thrill or audible bruit NEURO: axoxIII, CNII-XII grossly intact, gait not assessed DISCHARGE: VS: Tm98.0 123-153/55-69 ___ 18 97-100RA Weight: 80.1kg GENERAL: Well-appearing, alert, no NAD HEENT: NCAT. Sclera anicteric. PERRL, EOMI. MMM NECK: Supple with flat JVP CARDIAC: RRR, normal S1S2; no murmurs LUNGS: Resp were unlabored. No crackles, wheezes or rhonchi. Good air movement ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c. Trace ___ edema SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. Pertinent Results: ADMISSION: ================================ ___ 08:17PM BLOOD WBC-5.6 RBC-4.06* Hgb-14.0 Hct-40.7 MCV-100* MCH-34.5* MCHC-34.4 RDW-13.5 RDWSD-49.4* Plt ___ ___ 08:17PM BLOOD Neuts-52.5 ___ Monos-11.3 Eos-1.6 Baso-0.5 Im ___ AbsNeut-2.93 AbsLymp-1.88 AbsMono-0.63 AbsEos-0.09 AbsBaso-0.03 ___ 08:17PM BLOOD ___ PTT-25.9 ___ ___ 08:17PM BLOOD Glucose-224* UreaN-18 Creat-1.0 Na-133 K-7.4* Cl-100 HCO3-21* AnGap-19 ___ 08:17PM BLOOD ALT-81* AST-184* AlkPhos-50 TotBili-0.4 ___ 08:17PM BLOOD Lipase-56 ___ 08:17PM BLOOD cTropnT-0.02* ___ 08:17PM BLOOD Albumin-4.1 Calcium-8.8 Phos-3.1 Mg-2.1 ___ 08:17PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 08:30PM BLOOD Glucose-224* Lactate-4.0* Na-140 K-3.9 Cl-106 calHCO3-21 IMAGING/STUDIES: ================================ + CARDIAC CATH (___): Right dominant LMCA short without significant disease LAD 30% proximal ___ diagonal is small with 70% stenosis circumflex without significant disease ___ marginal very small with severe mid disease ___ marginal is large caliber without significant disease AV groove continues as a small vessel RCA is with 30% mid Right PDA is without significant disease Impressions: Branch vessel coronary artery disease Guideline directed medical therapy for CAD Admit to CCU for management of ventricular tachycardia + TTE ___ The left atrium is moderately dilated. Left ventricular wall thicknesses are normal. The left ventricular cavity is moderately dilated. Overall left ventricular systolic function is moderately depressed (LVEF=30- 35%) secondary to moderate global hypokinesis with akinesis of the lateral wall. No masses or thrombi are seen in the left ventricle. Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Mild to moderate (___) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Mild (1+) mitral regurgitation is seen. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. IMPRESSION: Suboptimal image quality requiring the use of contrast for better endocardial border definition. Moderately dilated left ventricular cavity with moderate global systolic dysfunction and regional involvement as described above. Mild-moderate aortic regurgitation. Mild mitral regurgitation. + Cardiac MRI ___ Please note that this report only pertains to extracardiac findings. There are no extracardiac findings. The entirety of this Cardiac MRI is reported separately in the Electronic Medical Record (OMR) - Cardiovascular Reports. PRELIMINARY RESULTS: suggestive of ischemic cardiomyopathy. LVEF 34%. LV end diastolic volume index: 139ml/m2 (severely increased). RVEF 68% (normal). There is transmural late gadolinium enhancement in the basal-distal anterior and anteroseptal walls, distal anterolateral wall, and apex and subendocardial (___) based LGE in the mid anterolateral wall most consistent with myocardial infarction ___ CXR In comparison with study of ___, there has been placement of a left subclavian pacer with leads extending to the right atrium and apex of the right ventricle. No postprocedure pneumothorax. The cardiac silhouette is again enlarged without definite vascular congestion or evidence of acute focal pneumonia. DISCHARGE: ================================ ___ 06:26AM BLOOD WBC-5.9 RBC-3.99* Hgb-13.8 Hct-40.8 MCV-102* MCH-34.6* MCHC-33.8 RDW-13.6 RDWSD-51.2* Plt ___ ___ 06:26AM BLOOD Glucose-116* UreaN-20 Creat-0.7 Na-137 K-4.8 Cl-104 HCO3-23 AnGap-15 ___ 06:26AM BLOOD Calcium-9.4 Phos-3.8 Mg-2.1 Brief Hospital Course: Mr. ___ is a ___ year old gentleman with history of HTN, HLD, CAD, dilated CMY (EF 40-45% ___ presented with dyspnea and left upper quadrant pain found to have sustained polymorphic ventricular tachycardia with subsequent ST elevations in setting of prolonged episode of sustained VT and adenosine administration. Admitted to CCU due to monomorphic VT. # CORONARIES: See cath report, ___ diag with 70% stenosis # PUMP: this admission - EF ___ # RHYTHM: normal sinus, previously wide complex tachycardia # VENTRICULAR TACHYCARDIA: Patient was found to be in wide complex tachycardia consistent with monomorphic VT. Patient was evaluated by EP who felt VT likely originating in the LV apical region secondary to scar and may be amenable to VT ablation. Stabilized on lidocaine gtt and remained stable off drip with continued episodes of non-sustained ventricular tachycardia. Increased home metoprolol XL to 50mg BID. Repeated discussions were had regarding VT ablation and/or antiarrhythmic medications. Mr. ___ was adamant about not doing either. He was also very resistant to ICD implant, but eventually agreed. He underwent ICD placement ___ without complications. # ACUTE DECOMPENSATED SYSTOLIC HEART FAILURE: LVEF 40-45% secondary to dilated cardiomyopathy per ___ records. Patient had previous workup at ___ that was reportedly negative for sarcoid, hemochromatosis, amyloid, HIV, syphilis, hypothyroidism. Now with new O2 requirement, CXR with increased vascular congestion and crackles on exam consistent with acute decompensated sCHF. Secondary to prolonged VT. Repeat TTE EF of ___, nml RV, no AS, mild to moderate AR, akinesis of the lateral wall of the LV. Global hypokinesis. Diuresed well with 80mg IV Lasix. Appeared euvolemic on physical exam, and ambulating on own without SOB. # CAD: Patient presented with VT, received adenosine x 2, after defibrillation and conversion to sinus rhythm had ST elevations in V1-V2, ST depressions in II, III, aVF concerning for anterior STEMI. Cardiac cath showed branch vessel CAD with 70% occlusion of ___ diag not amenable to intervention and no other significant CAD or evidence of acute plaque rupture. Medical management included aspirin, atorvastatin 20mg (pt refused higher dose due to myalgias), metoprolol, losartan. Cardiac MRI consistent with ischemic cardiomyopathy. CHRONIC ISSUES: #HTN: continued home losartan after achieving hemodynamic stability #HLD: Statin as above TRANSITIONAL ISSUES: -pt to complete 3 days of abx, 500mg TID Keflex (day 3 = ___ for post-ICD placement prophylaxis # Discharge weight: 80kg # Code: Full # Contact: son ___ ___, ex wife ___ ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Metoprolol Succinate XL 25 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Furosemide 20 mg PO DAILY 4. Losartan Potassium 100 mg PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Furosemide 20 mg PO DAILY 3. Losartan Potassium 100 mg PO DAILY 4. Metoprolol Succinate XL 50 mg PO BID RX *metoprolol succinate 50 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 5. Cephalexin 500 mg PO Q8H Duration: 1 Day RX *cephalexin 500 mg 1 capsule(s) by mouth three times a day Disp #*4 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Ventricular tachycardia due to ischemic cardiomyopathy, treated with ICD placement Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___. You were admitted to the Cardiac ICU for an abnormal heart beat. You required electric shock of your heart to regain a regular rhythm. To prevent this in the future, an ICD device was placed to help keep your heart in a regular rhythm. During your admission, you also had a imaging of your heart that showed scarring of your heart muscle likely due to a heart attack in the past. However, imaging of your heart did not show occlusions of the blood vessels around your heart. You are now doing well and are ready for discharge. Please continue to take your medications subscribed you to and follow-up with your cardiologist. We wish you the best of health, Your ___ Care Team Followup Instructions: ___
19985293-DS-15
19,985,293
21,731,208
DS
15
2184-08-25 00:00:00
2184-08-25 21:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: tramadol / lisinopril Attending: ___ Chief Complaint: Fever and chills Major Surgical or Invasive Procedure: PICC placement and removal History of Present Illness: ___ female with history of lap gastrojejunostomy in ___ for duodenal stricture, causing gastric outlet obstruction, nonresectable pancreatic cancer now on chemo, resultant biliary obstruction status post multiple draining stent placements by ___ (see below, but last on ___ had cholangiogram with balloon dilation and extenson of existing stent, and exchange of existing PTBD catheter), now presents with diaphoretic episodes, chills, and found to have bacteremia. History was obtained from the daughter/HCP. She reports that patient began having low-grade fevers five days prior to admission. She then developed intermittent chills for a few days, but no abdominal pain. She had her first day of chemotherapy (gemcitabine, C1D1 ___ the day prior to presentation. Routine blood cultures were drawn at her chemotherapy session, and they returned positive on ___. The family was notified to bring the patient to the ED. In the ED, initial vitals: T 97.8, HR 86, BP 124/58, 16, O2 94% RA - Exam notable for: normal mental status - Labs were notable for: WBC 8.4 -> 10.8, Hgb 7.5 -> 6.8, Plt 299, INR 1.1, Cr 1.1 -> 0.9, Mg 1.7, Albumin 2.7, Lactate 2.1 -> 1.4, UA normal, - Imaging: CXR showed patchy bibasilar opacities. CT demonstrated new air fluid collection near the lesser sac of the stomach concerning for contained duodenal perforation with abscess. She was evaluated by surgery who did not feel she was a surgical candidate. - Patient was given: 3.5L NS, Vancomycin, Cefepime, Oxycodone for pain She was initially going to be admitted to ___, but developed hypotension while getting a CT scan. She was fluid resuscitated and a right IJ line was placed. She was started on levophed (0.12) for low MAPs. She was given 1u pRBC transfusion for hgb 6.8, during which she had a blood transfusion reaction with rigors. Coombs was negative. She then spiked a fever to 104.8. Goals of care were discussed with the family, but no conclusion was reached. On arrival to the MICU, she was alert and oriented x3. She denied any abdominal pain or overall discomfort. She required increasing doses of lovophed at 0.3 mcg/kg/min to maintain MAP > 65. A 500 cc LR bolus was given. A goals of care conversation was had with the family, who determined that she would like to be DNR/DNI. Past Medical History: Locally advanced pancreatic adenocarcinoma diagnosed ___ Malignant CBD obstruction s/p PTBD HTN HLD Moderate AS Remote carotid endarterectomy Gastric outlet obstruction s/p gastrojejunostomy ___ Social History: ___ Family History: No known cancer is first degree relatives. Physical Exam: ADMISSION PHYSICAL EXAM ========================== VITALS: 98.8, HR 103, BP 113/60, RR 19, 95% RA GENERAL: Alert and oriented, lying in bed, denies pain HEENT: AT/NC, EOMI, PERRL NECK: nontender supple neck, no LAD, no JVD, right IJ pain CARDIAC: RRR, S1/S2, ___ systolic crescendo decrescendo murmur in the USB LUNG: CTA, no wheezes ABDOMEN: nondistended, +BS, nontender EXTREMITIES: WWP, no ___ edema PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact DISCHARGE PHYSICAL EXAM ========================== Vitlas: 97.8 106/71 86 18 97% RA General: alert, sitting in bed, no acute distress Neuro: oriented, moving all extremities Abd: soft, nontender throughout Pertinent Results: ADMISSION LABS ============================= ___ 08:39AM BLOOD WBC-7.3 RBC-2.89* Hgb-8.7* Hct-26.4* MCV-91 MCH-30.1 MCHC-33.0 RDW-14.0 RDWSD-47.6* Plt ___ ___ 11:30AM BLOOD Neuts-88* Bands-0 Lymphs-9* Monos-1* Eos-1 Baso-1 ___ Myelos-0 AbsNeut-7.39* AbsLymp-0.76* AbsMono-0.08* AbsEos-0.08 AbsBaso-0.08 ___ 11:30AM BLOOD ___ PTT-31.7 ___ ___ 08:39AM BLOOD UreaN-24* Creat-1.0 Na-131* K-3.5 Cl-94* HCO3-28 AnGap-13 ___ 08:39AM BLOOD ALT-15 AST-25 AlkPhos-178* TotBili-0.6 ___ 11:30AM BLOOD Albumin-2.7* Calcium-8.4 Phos-3.3 Mg-1.7 ___ 11:46AM BLOOD Lactate-2.1* DISCHARGE LAB ============================== ___ 06:10AM BLOOD WBC-8.0 RBC-3.60*# Hgb-10.6*# Hct-31.2*# MCV-87 MCH-29.4 MCHC-34.0 RDW-14.9 RDWSD-48.1* Plt ___ ___ 05:56AM BLOOD Glucose-65* UreaN-10 Creat-1.0 Na-133 K-3.5 Cl-100 HCO3-21* AnGap-16 MICROBIOLOGY ============================= ___ 12:01 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: ESCHERICHIA COLI. FINAL SENSITIVITIES. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ =>32 R AMPICILLIN/SULBACTAM-- 16 I CEFAZOLIN------------- 8 R CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- 8 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S ___ 4:25 am BLOOD CULTURE Source: Line-RIJ TLC. Blood Culture, Routine (Preliminary): LACTOBACILLUS SPECIES. Isolated from only one set in the previous five days. Anaerobic Bottle Gram Stain (Final ___: GRAM POSITIVE ROD(S). Reported to and read back by ___. (___) AT ___ ON ___. IMAGING ============================= CT abdomen/pelvis ___ IMPRESSION: 1. Interval development of an approximately 3.3 x 4.1 cm air and fluid collection anterior to the common hepatic artery within the lesser sac of the stomach, which likely represents a contained perforation/abscess originating from the stomach/duodenum, where the pancreatic mass is invading. 2. Chronically obstructed and distended gallbladder containing multiple small gallstones and sludge. New pericholecystic fluid is nonspecific and may be reactive to the adjacent inflammatory process. 3. Interval removal of right-sided PTBD, with mild right intrahepatic biliary ductal dilatation. Trace perihepatic fluid. 4. Interval increase in size of nonspecific hyperattenuating and soft tissue density rounded areas in the left rectus abdominus muscle possibly hematomas. metastatic implants would be unusual in this location, but cannot be completely excluded and attention to this region on follow-up imaging is recommended. 5. Small amount of pelvic free fluid. CXR ___ IMPRESSION: Patchy bibasilar opacities likely reflect atelectasis. Brief Hospital Course: Ms. ___ is an ___ female with history of lap gastrojejunostomy (___) for duodenal stricture causing gastric outlet obstruction, non-resectable pancreatic cancer now on chemo, biliary obstruction status post multiple draining stent placements by ___, who p/w septic shock and GNR bacteremia in the setting of a contained duodenal perforation. # Goals of care: Given patient's grave clinical status, a family meeting was held during which it was decided that the patient and her family would prefer to prioritize quality of life and discharge from hospital. Thus, patient was discharged home on hospice and confirmed DNR/DNI. # Septic shock: # GNR Bacteremia: Patient in septic shock secondary to GNR/GPR bacteremia in the setting of duodenal perforation and abscess, likely caused by pancreatic mass invasion. Initially on norepinephrine for hypotension, which was weaned. Per ID, treated with zosyn for coverage of intra-abdominal organisms. Blood cultures grew E. coli. Surgery was consulted but did not feel there were any surgical options at this time given that the perforation is contained. The patient's pain was well controlled on minimal IV dilaudid. Patient was kept NPO ___, but started on clears on ___ per surgery recommendations. Her diet was advanced to regular and it was well tolerated. Per ID, she was transitioned to PO levofloxacin and flagyl for an indefinite course. Will defer to hospice to help patient transition off antibiotics. # Anemia: Normocytic anemia with baseline hgb ___. Likely from ACD and malignancy. Hb droped to 6.5 and she was transfused 2 units to aid with weakness symptoms and improved to 10 at discharge. Family requested additional work-up for transfusions in the future, but this was discouraged given goals of care as above. # Pancreatic cancer: Diagnosed in ___. It is locally advanced and unresectable (encases vasculature). C1D1 of gemcitabine on ___. She has had numerous prior biliary stents, with the last PTBD exchange on ___. Per communications with outpatient oncologist, there is no plan for additional chemotherapy given infection and complications as noted above. > 30 minutes were spent on discharge care, planning, and coordination. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Cyanocobalamin 1000 mcg PO DAILY 2. Metoprolol Succinate XL 50 mg PO DAILY 3. Omeprazole 40 mg PO DAILY 4. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN BREAKTHROUGH PAIN 5. Vitamin D 1000 UNIT PO DAILY 6. Bisacodyl 10 mg PR QHS:PRN constipation 7. Docusate Sodium 100 mg PO BID 8. Polyethylene Glycol 17 g PO DAILY:PRN constipation 9. Senna 17.2 mg PO BID 10. calcium carbonate-vitamin D3 600 mg(1,500mg) -800 unit oral DAILY 11. Fish Oil (Omega 3) 1000 mg PO DAILY Discharge Medications: 1. Levofloxacin 500 mg PO Q48H RX *levofloxacin 500 mg 1 tablet(s) by mouth Q48H Disp #*14 Tablet Refills:*0 2. MetroNIDAZOLE 500 mg PO Q8H RX *metronidazole 500 mg 1 tablet(s) by mouth every eight (8) hours Disp #*60 Tablet Refills:*0 3. Bisacodyl 10 mg PR QHS:PRN constipation 4. Docusate Sodium 100 mg PO BID 5. Omeprazole 40 mg PO DAILY 6. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN BREAKTHROUGH PAIN RX *oxycodone 5 mg 1 tablet(s) by mouth Q4h:prn Disp #*10 Tablet Refills:*0 7. Polyethylene Glycol 17 g PO DAILY:PRN constipation 8. Senna 17.2 mg PO BID Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: pancreatic cancer duodenal perforation with abscess formation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms. ___, It was a pleasure caring for you during your stay at ___ ___. You were admitted for abdominal pain and a CT scan found that this was likely caused by a small perforation (a hole) in a part of your intestine. This hole caused an abscess (a collection of bacteria - an infection) because bacteria from the gut leaked into the surrounding area. You were treated with antibiotics. Fortunately, from your last CT scan, it appears as though the perforation (hole) seemed to close and nothing is leaking from your small intestines anymore. It is safe for you to eat. The abscess size is stable. Unfortunately, there is no further treatment for your cancer at this time given the many complications you have had. The surgeons evaluated you and your scans and did not think any operation would be beneficial. We are treating you with antibiotics, but this is more of a "Band-Aid" to hopefully prevent significant progression of the abscess, but it will not work forever. You should discuss with your hospice team when would be a good time to stop these antibiotics. You and your family discussed the treatment options with many of your providers in the hospital and you decided that it would be best to focus on the quality of your life rather than on treating these individual problems. We hope that you are comfortable at home and enjoy the remainder of your days with loved ones. The hospice team will help with this transition and help you manage your symptoms at home. Please take care, Your ___ Team Followup Instructions: ___
19985545-DS-15
19,985,545
26,220,192
DS
15
2138-11-18 00:00:00
2138-11-18 15:15:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: PSYCHIATRY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: depression, poor self-care Major Surgical or Invasive Procedure: none History of Present Illness: ___ y/o married M ___ police officer with h/o depression and anxiety, recent misuse of prescribed medications (opiates and benzodiazepine), also multiple myeloma diagnosed in ___ s/p BMT undergoing phase 1 clinical trial at ___, self-presenting w/ wife with reports of severe depression. Psychiatry consulted to assist with management and safety evaluation. CHIEF COMPLAINT: "Things seem to be getting worse in my life..." HISTORY OF PRESENT ILLNESS: Patient reports worsening depression over last few months, with more intese worsening over last two weeks, in setting of on-going cancer treatment for multiple myeloma, and multiple psychosocial stressors. Specifically, reports significant stress over two of his children (son and daughter) who are undergoing active substance treatment, with son who is former ___ dealing w/ Percocet dependence after multiple surgeries, and daughter w/ notable h/o sexual trauma from patient's father, depression, and ___ abuse in attempt to self-treat her depression. Patient reports he has grown increasingly "sick and tired" of how he is feeling, and that he has become "so depressed" that he spends almost his entire day in bed. Patient denies any suicidal ideation, intent, or plan, but states repeatedly that he wants his life to be "different," "happier," and "in a different place." Admits to taking excess medications every day for some time (weeks-months) in attempt to self-medicate the "stress" and "depression." Reports taking on average ___ oxycodone 30 mg tabs/day, and 2 oxycontin tabs bid (should be taking 1 tab bid). Also reports taking on average 8 tabs clonzaepam 0.5 mg/day (should be taking no more than ___. Patient admits he often does not know what he is taking, and states that is another reason he is here today. Reports wanting help for his depression and misuse of medications, expressing interest in hospitalization. Of note, patient reports he has not seen his psychiatrist in about a year, and never followed up w/ referrals to outpatient therapy. Reports completing intake w/ one therapist in community, but did not follow through because it was not a good fit. Refers to offers of support from friends and family that don't seem "sincere," and becomes tearful when discussing his on-going depressive symptoms. Admits to being extremely private at baseline. Expresses notable grief, concern, feelings of guilt over his children's struggles, and admits to worry over not wanting to be a burden to his wife. Wife (who is oncology nurse at ___ confirms history reported above. Confirms patient has not been getting out of bed to attend to basic self care, and will not shower/bathe, or change his clothes, and he is crying now every day. Reports patient rarely eats, such that he has lost a fair amount of weight over last few months (30 lbs). Denies acute safety concerns in terms of suicidality, but reports patient is severely depressed and managing his own medications, with no clear sense of what he is taking, such that he is often sedated in bed. Reports on-going marital stressors since before patient was diagnosed, with her serving as patient's only support. Reports patient is generally very private, and the fact that he was agreeable to come to ED today and is asking for hospitalization are "big cries for help." Past Medical History: PAST PSYCHIATRIC HISTORY: Diagnosis: h/o depression, anxiety Hospitalizations: none SA/SIB: none Harm to others: none Prior med trials: h/o sertraline in past, patient reports he did not find it to be helpful, no other trials of anti-depressants Treaters: previously saw psychiatrist Dr. ___ at ___ for many years, per OMR saw for ___ mins/twice monthly. Not seen in last year. Saw. Dr. ___ for psychiatric intake in ___ w/ no further follow up. Denies h/o therapy. PAST MEDICAL HISTORY: per OMR MULTIPLE MYELOMA pomalidomide, Velcade and Decadron therapy *S/P AUTOLOGOUS STEM CELL TRANSPLANT ACUTE RENAL FAILURE AUTO HPC, APHERESIS INFUSION GOUT STEM CELL COLLECTION STUDY ___ THERAPUTIC PLASMAPHERESIS Social History: SUBSTANCE ABUSE HISTORY: EtOH: denies use since multiple myeloma diagnosis in ___, previous heavy use, denies h/o withdrawal, DTs, detox treatment Illicits: denies, including IVDU, per OMR previous MJ use Tobacco: none FORENSIC HISTORY: ___ SOCIAL HISTORY: ___ Family History: FAMILY PSYCHIATRIC HISTORY: Father- depression, opiate abuse/dependence (Percocets), per OMR possible h/o ECT when psychiatrically hospitalized Sisters, brother- EtOH Son- opiate abuse/dependence (Percocets) Daughter- ___ abuse Multiple family members w/ h/o depression and anxiety. Denies h/o suicide. Physical Exam: ADMISSION PHYSICAL ___ Neuropsychiatric Examination: ROS: bilateral arm pain, diffuse body pain ___ MM, weakness, nonproductive cough, neck and occipital headache denies visual changes Numbness, , Seizures, Intolerance to heat/cold, , SOB, Chest pain, Abdominal pain, N/V, Diarrhea/Constipation, Melena/Hematechezia, Dysuria/Polyuria, Swelling PHYSICAL EXAMINATION: VS: BP: 122/72 HR: 68 temp: 97.8 resp:18 O2 sat: 100% on RA MENTAL STATUS EXAM: --appearance: ___ year old man wearing hospital gown, appears as stated age, lean with brusing on left elbow and right deltoid. --behavior/attitude guarded ; poor EC while discussing stressors, did make EC when discussing less personal issues of pain/medical history exhibited no PMR, PMA --speech: ___, low volume slow rate with paucity of speech \ --mood (in patient's words): " I'm depressed" --affect: blunted; appropriate to the context --thought content (describe): at times preservative on pain regimen --thought process: linear --perception: significant for without AH, VH, delusions, paranoia --SI/HI: significant for without SI with out intent, plan; no HI; --insight: fair --judgment: limited COGNITIVE EXAM: --orientation: alert to person, place, time, situation --attention/concentration: un able to recite MOYB, able to perform ___ backward --memory (apple, purple, honesty): immediate intact ___ delayed recall, --language: grossly intact --fund of knowledge: un able to recall the president on ___- said ___, knew president currently --similarities/analogies: understood analogy of "apples to oranges" PE: General: Well-nourished, in no distress. HEENT: Normocephalic. PERRL, EOMI. Oropharynx clear. Neck: Supple, trachea midline. No adenopathy or thyromegaly. Back: No significant deformity, Lungs: coarse rhonchi CV: Regular rate and rhythm; no murmurs/rubs/gallops; 2+ pedal pulses Abdomen: Soft, nontender, nondistended; no masses or organomegaly. Extremities: No clubbing, cyanosis, or edema. Skin: Warm and dry, bruising s/p fall on right deltoid/left elbow. Neurological: *Cranial Nerves- I: Not tested II: Pupils equally round and reactive to light bilaterally. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. *Motor- Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength diminished ___ throughout. No pronator drift. *Sensation- Intact to light touch *Reflexes- B T Pa intact *Coordination- Normal on finger-nose-finger, rapid alternating movements, heel to shin. Pertinent Results: ___ 03:55PM GLUCOSE-113* UREA N-7 CREAT-0.8 SODIUM-141 POTASSIUM-4.0 CHLORIDE-102 TOTAL CO2-26 ANION GAP-17 ___ 03:55PM CALCIUM-8.5 PHOSPHATE-4.4 MAGNESIUM-1.7 ___ 03:55PM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 03:55PM WBC-2.1* RBC-3.28* HGB-10.4* HCT-30.1* MCV-92 MCH-31.5 MCHC-34.5 RDW-14.3 ___ 03:55PM NEUTS-58.4 ___ MONOS-8.6 EOS-1.4 BASOS-1.4 ___ 03:55PM PLT COUNT-112* ___ CT head without contrast: 1. No acute intracranial process. If clinical concern for stroke or intracranial mass is high, MRI is more sensitive. 2. Aerosolized secretions in the right maxillary sinus may be infectious or inflammatory. Brief Hospital Course: 1. Psychiatric: Mr. ___ is a ___ year old man with multiple myeloma and gout admitted for depression with neurovegetative features and decreased self-care in the setting of ongoing narcotic dependence, strained relationships, and social stressers. Mr. ___ expressed strong motivation to decrease his pain medication and benzodiazepine doses, especially after talking with the pain consult team. His benzodiazepine dose was decreased from clonazepam 0.5mg TID to 0.5mg BID. His PRN opiate was decreased from 30mg QID to 25mg QID. His standing long-acting opiate (oxycontin 20mg BID) was discontinued over the course of two days, and Mr. ___ tolerated this well. He was given comfort medications, including dicyclomine, methocarbamol, and a clonidine patch, to assist with opitate withdrawal. Upon discharge, the plan is for Mr. ___ to attend a detoxification program to finish tapering down his opiates safely and comfortably and to determine how feasible a plan of coming off narcotics entirely is vs starting methadone or suboxone maintainance. He will continue to follow up with his outpatient psychiatrist and onclogist about this ongoing issue. Over the course of his hosptialization, the pain consult team was consulted and given the patients active addiction to opiates and unclear pain control needs at this time, were also in support of a detox. He will likely need pain control through time and they suggested consideration of methadone. They assisted with the taper of opiates to his current point and reccommned use of neurontin TID and clonidine weekly patch. They did not feel that the use of oxycontin and oxycodone through time would be safe management given the complexity of his presentation. For depression, Mr. ___ was started on effexor, which was titrated to 75mg daily. He was also started on seroquel for augementation of his antidepressant to assist with depression, severe anxiety, and rumination that appeared to be a factor even outside of his addiction. He tolerated the addition of these medications well. He is motivated for ongoing treatment of his depression given its comorbidity with his cancer diagnosis and addiction. He was motivated to begin therapy with his new therapist that was arranged by his psychiatrist prior to admission. His therapist is aware of his recent admission. He will also continue treatment with his psychiatrist, Dr. ___. After detox from his overuse/abuse of pain medications and benzos prior to coming to the hosptial, and initiation of treatment for his depression his neurovegetative features rapidly improved, and Mr. ___ actively engaged in aftercare planning. He was bright, social, slept and ate well, and tended to his hygiene. He was clearly future oriented, was free of suicidal ideation, plan or intent and denied ever being suicidal or having a suicide attempt. He expressed a commitment to life and motivation for sobriety for the good of himself and for his family. Despite family challanges, he identifies himself as a father, husband, and provider and this continues to keep him going in tough times. Over the course of his hospitalization contact was made with his wife and a meeting was held with his wife and their son. His wife was open to his return home and was supportive of his ongoing dual diagnosis treatment. Mr. ___ felt that his move to an apartment within the last few months was a big factor into his relapse has he felt alone and was again responsible for managing his own narcotic medications. When living at home his sister had been distributing and monitoring his narcotic pills. This remains something he is open to again. Over the course of his hosptialziation, his sister ___ phone ___ was contacted and if he requires having pain pills at home, she will assist in the distribution and coordination with her physicians as in the past. He is motivated to do what is needed to maintain sobriety and his functioning. Other contributors to his relapse recently included stress regarding his daughter who is pregnant, by someone who is also strugles with substance dependnece. Also one of his sons that lives at home with his wife is out of control with narcotic addiction and they have been actively working to section 35 him or remove him from the home. Mr. ___ is motivated to maintain his own sobriety as an example to his children and to reduce the amount of worry and stress on his wife who has been primarliy involved in the challanges with the children. Through out his admission, Mr. ___ was free of suicidal thoughts, was motivated for recovery and the future and worked well wiht his treatment team. He had capacity to make decisions for himself and had an awareness of his risk of relapse into depression and drug use. As an additional safety measure, Although Mr. ___ did not express suicidality, he recognized that given his history of depression and addiction disorder he was at an elevated risk from the general population of at some point having impulsive self injury. He agreed with the treatment team that he would keep his gun at work in a locked box, rather than at home. He owns a gun due to his profession as a ___. It was not felt that he was an acute risk to himself to the degree where removal of the gun from the home was indicated. In fact, threatening his identity as a police officer around this issue, would lead to further anxiety and feelings of being overwhelmed and would threaten his alliance clear motivation for help and recovery. This was discussed at length and consultation was sought regarding this issue from Dr. ___ who also evaluated the patient in the emergency room. Upon admission Mr. ___ demonstrated some cognitive impairment, particularly in attention. Possible etiologies included intoxication from the benzodiazepines and opiates he had been using at home, depression, or a chemotherapy side effect. His cognition appeared to improve considerably over the course of the hospital stay. However, a MOCA performed on ___ had a score of ___ and showed continuing deficits in attention, with poor digit repetition and errors on serial 7's, and language, both repetition and fluency. His cognition should be tracked closely in the outpatient setting with repeated cognitive screening over time and more in-depth neuropsychiatric testing should be considered. Mr. ___ outpatient psychiatrist, Dr. ___ ___ or cell phone ___, was in frequent communication by phone and included in treatment decisions. Likewise, his oncologist, Dr. ___, was consulted regarding tapering the opiate medications and his likley ongoing need for pain control in the future. At time of discharge, Mr ___ was anxious about the transfer to an ___ facility, but remained clearly future oriented and motivated to "do what it takes to get better." He expressed remorse for his pain medication seeking behaviors and misuse of prescription medications. He continued to reflect on his desire to improve his health and from a physical, mental, and addiction standpoint for the good of himself and his family. He appeared safe and appropriate for discharge from a locked ___ facility. He does not present as an acute danger to himself at this time and has been caring for himself appropriatley 2. Medical: #) Multiple myeloma: Per outpatient oncologist Dr. ___ medication changes were indicated, aside from stopping the prednisone 5mg which was deemed no longer necessary from a cancer perspective. However, he was restarted on prednisone when he had a flare of gout (see below) and will be discharged with a plan to continue the 5mg daily prednisone as he was taking prior to admission after he finishes the current prednisone taper. He will continue to follow up with Dr. ___ ___ further course of chemotherapy. He should be seen the day after discharge from detox. #) ___ esophagus: Mr. ___ was continued on Protonix 40mg bid. #) Gout: Mr. ___ suffered a flare in right ankle the day after his low-dose prednisone -- which he had been taking for multiple myeloma -- was discontinued. He was started on a prednisone taper from 30mg with 5mg decreases at 2-day intervals, with a plan to then continue 5mg daily prednisone chronically as prophylaxis. He was continued on his home Allopurinol ___ daily. Outpatient follow up with Dr. ___ was scheudled. 3. Safety: Maintained on 15 min checks as he was cooperative with treatment in hospital and denied sucidal ideation. He was maintained on fall precautions. While he initially presented as a risk to self outside of a structured environment due to poor self-care, his sleeping, eating, hygiene, and cognition all improved by the time of discharge. 4. Disposition: ___ facility Medications on Admission: Active Medication list as of ___: Medications - Prescription ACYCLOVIR - acyclovir 400 mg tablet. 1 Tablet(s) by mouth every eight (8) hours ALBUTEROL SULFATE - albuterol sulfate HFA 90 mcg/actuation Aerosol Inhaler. 2 puffs inhaled four times a day as needed for as needed for wheezing or shortness of breath ALLOPURINOL - allopurinol ___ mg tablet. 1 tablet(s) by mouth once a day 90 day supply CLONAZEPAM - clonazepam 0.5 mg disintegrating tablet. 1 tablet(s) by mouth three times a day - (Prescribed by Other Provider) DEXAMETHASONE - dexamethasone 4 mg tablet. 3 tablet(s) by mouth day after velcade ONDANSETRON - ondansetron 8 mg disintegrating tablet. 1 Tablet(s) by mouth every eight (8) hours as needed for nausea OXYCODONE - oxycodone 30 mg tablet. 1 tablet(s) by mouth - (Prescribed by Other Provider) OXYCODONE [OXYCONTIN] - OxyContin 20 mg tablet,extended release. 1 tablet(s) by mouth twice a day as needed for pain PANTOPRAZOLE - pantoprazole 40 mg tablet,delayed release. 1 Tablet(s) by mouth twice a day POTASSIUM CHLORIDE [KLOR-CON M20] - Klor-Con M20 mEq tablet,extended release. 2 tablet(s) by mouth once a day PREDNISONE - prednisone 5 mg tablet. 1 tablet(s) by mouth once a day 90 day supply PROCHLORPERAZINE MALEATE - prochlorperazine maleate 10 mg tablet. 1 Tablet(s) by mouth every eight (8) hours as needed for nausea ZOLPIDEM [AMBIEN] - Ambien 5 mg tablet. ___ tablet(s) by mouth at bedtime Medications - OTC ASPIRIN - aspirin 81 mg tablet,delayed release. 1 Tablet(s) by mouth once a day - (Prescribed by Other Provider) DOCUSATE SODIUM - docusate sodium 100 mg capsule. 1 capsule(s) by mouth twice a day as needed for constipation - (OTC) Discharge Medications: 1. Acyclovir 400 mg PO Q8H 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB/wheeze 3. Allopurinol ___ mg PO DAILY 4. Aspirin 81 mg PO DAILY 5. Clonidine Patch 0.1 mg/24 hr 1 PTCH TD QTUES 6. Docusate Sodium 100 mg PO BID 7. Gabapentin 300 mg PO TID 8. Pantoprazole 40 mg PO Q12H 9. Quetiapine Fumarate 50 mg PO QHS 10. Senna 1 TAB PO BID:PRN constipation 11. Venlafaxine XR 75 mg PO DAILY 12. Quetiapine Fumarate 25 mg PO BID:PRN severe anxiety 13. PredniSONE 5 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Axis I: Opioid dependence; Benzodiazepine dependence; Major Depression, recurrent; Cognitive Disorder NOS - intoxication vs mood related vs related to chemo Axis II: defer Axis III: multiple myeloma, gout Discharge Condition: MSE: Appearance: cooperative, appropriately groomed, showered, casually dressed Gait: walks steadily Tone: No evidence of stiffness or tremor Behavior: adequate eye contact, mild PMR Speech: soft volume, regular rate Mood: 'good' and later 'anxious' Affect: euthymic, fair to good range, congruent Thought Process: linear to direct questions Thought Content: no prominent delusions/paranoia. Help seeking. future oriented. Perceptions: denies Auditory/Visual/Somatic hallucinations. Does not appear to be responding to internal stim. Suicidality/Homicidality: patient continues to deny suicidal ideation plan, intent. Motivated for recovery. Insight/Judgment: improving/improving, both appear fair currently Discharge Instructions: During your admission at ___, you were diagnosed with depression and treatment included medication with venlafaxine. Please follow up with all outpatient appointments as listed. Please continue all medications as directed. Please avoid abusing alcohol and any drugs--whether prescription drugs or illegal drugs--as this can further worsen your medical and psychiatric illnesses. Please contact your outpatient psychiatrist or other providers if you have any concerns. Please call ___ or go to your nearest emergency room if you feel unsafe in any way and are unable to immediately reach your health care providers. It was a pleasure to have worked with you and we wish you the best of health. If you need to talk to a ___ Staff Member regarding issues of your hospitalization, please call ___. Followup Instructions: ___
19985545-DS-19
19,985,545
23,896,005
DS
19
2140-10-25 00:00:00
2140-10-25 16:36:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Sinus congestion. Shortness of Breath Major Surgical or Invasive Procedure: None History of Present Illness: ___ year-old man with past medical history of multiple myeloma (diagnosed ___ with IgG lambda multiple myeloma, Stage III by ___ at diagnosis, treated with lenalidomide/bortezomib/dexamethasone then clinical trial protocol ___ of dendritic cell/fusion vaccine followed by autologous hematopoietic stem cell transplantation, with day 0: ___, followed by treatment on clinical trial protocol ___ with pomalidomide/bortezomib/dexamethasone from ___ to ___, resumed pomalidomide/bortezomib/dexamethasone ___, most recently C5D1 on ___, with subsequent doses held because of ongoing dyspnea on exertion), hypertension, anxiety/depression, ___ esophagus, arthritis, gout, chronic back pain, and recent admissions for dyspnea on exertion of uncertain etiology, who presents with ongoing dyspnea on exertion, non-productive cough, myalgias, maxillary sinus pain, and diarrhea for the past day. His dyspnea on exertion, non-productive cough, and myalgias remain most concerning for a viral upper respiratory infectious process and/or maxillary sinusitis. However, other entities to consider in the differential diagnosis include obstructive/hypersensitivity lung disease (such as asthma), interstitial pneumonitis (less likely given normal lung parenchymal findings on recent chest CT), and medication effect of pomalidomide or bortezomib. Regarding his diarrhea, this is most likely related to antibiotics, specifically Augmentin. However, given his recent hospitalization and antibiosis, the possibility of C. difficile colitis or other infectious colitis must be evaluated. Past Medical History: PAST ONCOLOGIC HISTORY (per most recent onc note): diagnosed with stage III multiple myeloma in early ___. Treated with Velcade, Revlimid, and dexamethasone. He is now status post autologous stem cell transplant with stem cells reinfused on ___. Retarted on Revlimid and dexamethasone in ___. Treated on protocol ___ to include pomalidomide, dexamethasone and Velcade completing ___. CURRENT TREATMENT PLAN:Pomalyst PO for 14 days; Dex/velcade sc PAST MEDICAL HISTORY: MULTIPLE MYELOMA *S/P AUTOLOGOUS SC Tx ___ (see above) Anxiety/Depression GOUT Social History: SUBSTANCE ABUSE HISTORY: EtOH: denies use since multiple myeloma diagnosis in ___, previous heavy use, denies h/o withdrawal, DTs, detox treatment Illicits: denies, including IVDU, per OMR previous MJ use Tobacco: none FORENSIC HISTORY: ___ SOCIAL HISTORY: B/R in ___ and ___. Multiple sibling, father was ___ ___. Graduated from high school and completed ___ years at ___. Employed as ___ Officer ___ years. Remains employed, most recently in administrative capacity but has not worked in many months to last year. Married for almost ___ years, wife is ___ at ___. They have four adult children. W/ on-and-off separation from wife since just prior to multiple myeloma diagnosis in ___. (Pt had just moved out of the home prior to diagnosis in setting of planned separation, but moved back in w/ wife after diagnosis.) Most recently moved out again in ___, but moved back in w/ wife since ___ in setting of on-going cancer treatment. Notable on-going stressors related to son and daughter, both in active substance treatment. Daughter w/ notable h/o sexual trauma from patient's father, resulting in patient being mostly estranged from his family. Identifies as Catholic but not affiliated with church. Denies h/o trauma. Family History: FAMILY PSYCHIATRIC HISTORY: Father- depression, opiate abuse/dependence (Percocets), per OMR possible h/o ECT when psychiatrically hospitalized Sisters, brother- EtOH Son- opiate abuse/dependence (Percocets) Daughter- ___ abuse Multiple family members w/ h/o depression and anxiety. Denies h/o suicide. Physical Exam: Admission: Physical Examination: VS: T 97.6, HR 76, BP 132/76, RR 18, and SpO2 96% on room air Gen: Pleasant, thin, Caucasian man of normal build, in no acute distress, breathing comfortably HEENT: Mild pharyngeal inflammation with some post-nasal drip noted. Mild tenderness to palpation of bilateral maxillary sinuses. Cor: Regular rate and rhythm, S1S2 normal, no murmur/rub/gallops Pulm: Clear to auscultation bilaterally, no wheezes/rhonci/rales Abd: Soft, non-tender, non-distended. No hepato/splenomegaly Ext: Warm and well-perfused, no clubbing/cyanosis/edema Back: Slight tenderness to palpation in the right mid-scapular line at approximately the level of T12. Neuro: A/o x 3, strength/sensation grossly intact ECOG: 0 Karnofsky: 100 Discharge: Vitals: 97.5/98.2 120/74 69 20 99RA Gen: Pleasant, calm HEENT: No conjunctival pallor. No icterus. MMM. OP clear. LYMPH: No cervical or supraclav LAD CV: Normocardic, regular. Normal S1,S2. No MRG. LUNGS: CTAB. No wheezes, rales, or rhonchi. ABD: NABS. Soft, NT, ND. EXT: WWP. No ___ edema. SKIN: No rashes/lesions, petechiae/purpura ecchymoses. NEURO: A&Ox3. Pertinent Results: Admission: ___ 11:45AM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE ___ 11:43AM LACTATE-1.6 ___ 11:30AM GLUCOSE-93 UREA N-12 CREAT-1.0 SODIUM-143 POTASSIUM-3.9 CHLORIDE-106 TOTAL CO2-26 ANION GAP-15 ___ 11:30AM estGFR-Using this ___ 11:30AM ALT(SGPT)-12 AST(SGOT)-19 CK(CPK)-49 ALK PHOS-73 TOT BILI-0.3 ___ 11:30AM LIPASE-20 ___ 11:30AM cTropnT-<0.01 ___ 11:30AM proBNP-116 ___ 11:30AM ALBUMIN-4.3 CALCIUM-9.4 ___ 11:30AM IgG-445* IgA-43* IgM-50 ___ 11:30AM WBC-2.3* RBC-4.04* HGB-13.2* HCT-36.6* MCV-91 MCH-32.6* MCHC-36.0* RDW-14.2 ___ 11:30AM NEUTS-39.0* LYMPHS-50.2* MONOS-7.7 EOS-1.2 BASOS-1.8 ___ 11:30AM PLT COUNT-140* ___ 11:30AM ___ PTT-31.9 ___ Discharge: ___ 05:41AM BLOOD WBC-1.3* RBC-3.82* Hgb-12.3* Hct-34.0* MCV-89 MCH-32.4* MCHC-36.3* RDW-13.9 Plt ___ ___ 05:41AM BLOOD Neuts-64.7 ___ Monos-5.2 Eos-0.3 Baso-0.6 ___ 05:41AM BLOOD Plt ___ ___ 05:41AM BLOOD Glucose-146* UreaN-12 Creat-0.9 Na-140 K-4.3 Cl-104 HCO3-27 AnGap-13 ___ 05:41AM BLOOD ALT-12 AST-13 LD(LDH)-142 AlkPhos-60 TotBili-0.3 ___ 05:41AM BLOOD Calcium-8.7 Phos-3.0 Mg-1.8 Brief Hospital Course: #) Dyspnea on exertion, non-productive cough, myalgias, and maxillary sinus pain: Most likely secondary to viral upper respiratory infection vs. maxillary sinusitis. Other entities we considered included asthma, interstitial pneumonia (though unlikely as CT was negative). He was Flu negative with clear CXR. He was afebrile. His CRP was 4.9. He had a normal ECHO last admission with no signs of fluid overload or heart failure. His tnT is WLN making cardiac Amyloidosis unlikely. - Although afebrile, we re-broadened antibiotics to Ceftriaxone. - Albuterol/ipratropium nebulizer PRN dyspnea. - After subjective improvement in SOB after two days of IV CTX, we discharged home on Cefpodoxime. #) Diarrhea: resolved, most likely antibiotic associated. - Held Augmentin - Checked stool C. difficile DNA amplification. #) Multiple myeloma, complicated by hypogammaglobulinemia: Disease presently well-controlled, based on recent serum free light chain assay from ___. - Repeated quantitative immunoglobulins, which showed low IgG; we administered IVIg while in house. - Continued to hold pomalidomide, bortezomib, and dexamethasone. His WBC was low and we suspect it is d/t to chemo. We advised to continue holding his chemo on discharge and follow up with Dr. ___ to determine when to restart. - We Continued acyclovir and Bactrim for prophylaxis. - Continued aspirin. #) Anxiety/depression: - Continued venlafaxine - Continued clonazepam #) Chronic back pain - Continued lidocaine patch, gabapentin, and oxycodone. #) Fluid/electrolytes/nutrition: - Regular diet #) DVT prophylaxis: - Enoxaparin 30 mg q12h, given normal renal function. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q8H 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, dyspnea 3. Amoxicillin-Clavulanic Acid ___ mg PO Q12H 4. Aspirin 81 mg PO DAILY 5. Azithromycin 250 mg PO Q24H 6. ClonazePAM 0.5 mg PO TID:PRN anxiety 7. Gabapentin 600 mg PO TID 8. Lidocaine 5% Patch 2 PTCH TD QAM 9. Omeprazole 40 mg PO DAILY 10. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN PRN pain 11. Pseudoephedrine 60 mg PO Q6H:PRN confgestion 12. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 13. Acetaminophen 650 mg PO Q6H:PRN Pain 14. Venlafaxine 225 mg PO DAILY 15. Zolpidem Tartrate 5 mg PO QHS:PRN insomnia Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain 2. Acyclovir 400 mg PO Q8H 3. ClonazePAM 0.5 mg PO TID:PRN anxiety 4. Gabapentin 600 mg PO TID 5. Lidocaine 5% Patch 2 PTCH TD QAM 6. Omeprazole 40 mg PO DAILY 7. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN PRN pain RX *oxycodone [Oxecta] 5 mg 1 tablet(s) by mouth Q6H:PRN Disp #*12 Tablet Refills:*0 8. Pseudoephedrine 60 mg PO Q6H:PRN confgestion 9. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 10. Venlafaxine 225 mg PO DAILY 11. Zolpidem Tartrate 5 mg PO QHS:PRN insomnia RX *zolpidem [Ambien] 5 mg 1 tablet(s) by mouth QHS:PRN Disp #*3 Tablet Refills:*0 12. Docusate Sodium 100 mg PO BID 13. Guaifenesin ___ mL PO Q6H:PRN cough/congestion RX *guaifenesin 600 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*14 Tablet Refills:*0 14. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, dyspnea 15. Cefpodoxime Proxetil 200 mg PO Q12H Duration: 7 Days RX *cefpodoxime 200 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*14 Tablet Refills:*0 16. Aspirin 81 mg PO DAILY 1. Acetaminophen 650 mg PO Q6H:PRN Pain 2. Acyclovir 400 mg PO Q8H 3. ClonazePAM 0.5 mg PO TID:PRN anxiety 4. Gabapentin 600 mg PO TID 5. Lidocaine 5% Patch 2 PTCH TD QAM 6. Omeprazole 40 mg PO DAILY 7. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN PRN pain RX *oxycodone [Oxecta] 5 mg 1 tablet(s) by mouth Q6H:PRN Disp #*12 Tablet Refills:*0 8. Pseudoephedrine 60 mg PO Q6H:PRN confgestion 9. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 10. Venlafaxine 225 mg PO DAILY 11. Zolpidem Tartrate 5 mg PO QHS:PRN insomnia RX *zolpidem [Ambien] 5 mg 1 tablet(s) by mouth QHS:PRN Disp #*3 Tablet Refills:*0 12. Docusate Sodium 100 mg PO BID 13. Guaifenesin ___ mL PO Q6H:PRN cough/congestion RX *guaifenesin 600 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*14 Tablet Refills:*0 14. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing, dyspnea RX *albuterol sulfate [Proventil HFA] 90 mcg 2 puff Q6H:PRN Disp #*1 Inhaler Refills:*0 15. Cefpodoxime Proxetil 200 mg PO Q12H Duration: 7 Days RX *cefpodoxime 200 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*14 Tablet Refills:*0 16. Aspirin 81 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Viral Upper Respiratory Infection Sinusitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You came to us with shortness of breath and nasal congestion. We tested you again for Flu, which was negative and our workup shows most likely a viral process. However, one can develop bacterial infections at the same time, so we started you on IV antibiotics. We gave you breathing treatments to help open your lungs and help you breath. You improved on the IV antibitoics so are discharging you home with oral antibitoics to take. It was a pleasure taking care of you. Sincerely, Your ___ team. Followup Instructions: ___
19985545-DS-25
19,985,545
21,516,111
DS
25
2144-08-25 00:00:00
2144-08-25 20:13:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: nausea, vomiting, diarrhea Major Surgical or Invasive Procedure: Intubated ___ Extubated ___ ___ LP ___ LP ___ Bone marrow biopsy ___ History of Present Illness: ___ with h/o multiple myeloma c/b recent spinal lesions s/p radiation with recent initiation of clinical trial drug regimen on ___ (___; ___ and history of opiate withdrawal with recent decrease in outpatient pain medication regimen who presented to the ED on ___ with c/o nausea, vomiting and diarrhea. Shortly after receiving clinical trial medications, patient developed profuse non-bloody, non-bilious vomiting and non-bloody diarrhea. Patient called EMS given concern for symptoms; when EMS arrived they had difficulty obtaining an SpO2, with the highest recorded level in the ___ with poor waveform. En route to the emergency department, patient developed a sharp, periumbilical abdominal pain. He otherwise noted subjective chills and dysuria, but denied any fever, chest pain, SOB, melena, or BRBPR. In the ED, - Initial Vitals: T 98.0 HR 108 BP 96/53 RR 18 SpO2 76% 4L NC - Exam: Mottled skin, appears chronically ill RRR, no murmur, no JVD Decreased breath sounds in LLL, no wheezing or crackles Abdomen soft, no focal tenderness, no rebound or guarding Skin warm and dry - Labs: WBC 6.4 Hg 13.3 Plt 67 D-dimer 1718 Fibrinogen 546 INR 1.4 LDH 656 Uric Acid 10.0 K 3.1 Cr 1.5 (baseline 0.9) HCO3 21 AG 20 VBG @ ___: 7.42 | 42 Lactate 4.0 VBG @ 0000: 7.58 | 26 Lactate 1.4 Trop < 0.01 AST 50 ALT 79 ALP 100 Tbili 1.5 - Imaging: CTA CHEST: 1. No evidence of pulmonary embolism. 2. Fluid throughout all visualized bowel loops with diffuse bowel wall hyperemia, likely reflecting diffuse enteritis, likely infectious or inflammatory. No bowel wall thickening. 3. New ground-glass opacities within the lower lobes bilaterally, compatible with infection. 4. Mild bladder wall thickening anteriorly, which should be correlated with urinalysis for evidence of cystitis. 5. Known osseous myeloma lesions are better visualized on prior examinations. Soft tissue within the spinal canal at the level of L3 is re-demonstrated, but better evaluated on the MR ___ dated ___. 6. Large hiatal hernia. ___ IMAGING PRELIM READS:**** CT ___ WITHOUT CONTRAST: No acute intracranial abnormality. CTA ___: The vessels of the circle of ___ and their principal intracranial branches appear normal without stenosis, occlusion, or aneurysm formation. The dural venous sinuses are patent. CTA NECK: There are atherosclerotic calcifications of the bilateral carotid bifurcations, without evidence of internal carotid stenosis by NASCET criteria. The vertebral arteries and their major branches appear normal with no evidence of stenosis or occlusion. PERFUSION: No evidence of abnormal perfusion. - Consults: Code Stroke: low suspicion for stroke given no evidence large territory infarct/bleed on CT and non-localizing exam. Recommended - MRI Brain w/ and ___ contrast, LP for CSF gram stain/culture, cell count, protein, glucose, HSV PCR, Cryptococcus antigen, flow cytometry, cytology and CSF Hold.Recommend empiric treatment with meningitic dosing of vanc/CTX and acyclovir. Neurology Consult service will follow along. - Interventions: ___ 22:05 IVF LR ( 1000 mL ordered) ___ 23:49 IV CefePIME 2 g ___ 00:33 IVF LR ( 1000 mL ordered) ___ 00:33 IV Vancomycin (1500 mg ordered) Central venous line placed in ED. LP deferred iso thrombocytopenia and agitation. In the unit, patient was agitated and attempting to remove clothing, screaming at staff for help. He was unable to communicate when asked ROS questions and did not fully participate in examination. Received 5 mg IV Haldol, placed on CIWA, reinitiated on opiates to minimize risk of withdrawal, initiated on IVF, administered morphine IV x2 in s/o likely withdrawal and ordered for stat TLS labs. Past Medical History: Multiple myeloma s/p autologous stem cell transplant, radiation Orthostatic hypotension Opiate withdrawal w/ substance use disorder Depression Gout Social History: ___ Family History: paternal grandmother was institutionalized. Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VS: T 99.7 HR 63 BP 134/53 RR 23 SPO2 100% GEN: ___ yo M, sitting up in bed, repeatedly screaming out "god help please" and trying to get out of bed. EYES: Pupils equal round reactive and dilated at 5 mm HENNT: Poor dentition CV: RRR no M/R/G RESP: No increased work of breathing. Decreased basilar breath sounds. No crackles, rhonchi. GI: Non-distended. Voluntary guarding. Soft with patient unable to communicate if pain to palpation. MSK: No peripheral edema. SKIN: Petechiae over bilateral legs. NEURO: Unable to follow commands. AAOx0 PSYCH: Agitated. DISCHARGE PHYSICAL EXAM: ======================== Vitals:24 HR Data (last updated ___ @ 651) Temp: 98.0 (Tm 98.3), BP: 130/80 (102-177/67-102), HR: 104 (79-113), RR: 18, O2 sat: 97% (96-99), O2 delivery: Ra, Wt: 137.2 lb/62.23 kg Gen: sitting up in bed, alert and interactive, in no acute distress CV: regular rhythm, tachycardic, no m/g/r LUNGS: CTAB, breathing comfortably on room air ABD: soft, nontender, nondistended EXT: warm and well-perfused, no ___ edema. NEURO: alert, grossly oriented, ___ strength on ankle dorsiflexion and plantarflexion bilaterally Pertinent Results: ADMISSION LABS: =============== ___ 09:31PM BLOOD WBC-6.4 RBC-4.23* Hgb-13.3* Hct-38.6* MCV-91 MCH-31.4 MCHC-34.5 RDW-13.2 RDWSD-41.1 Plt Ct-67* ___ 09:31PM BLOOD Neuts-81.9* Lymphs-10.9* Monos-4.1* Eos-0.2* Baso-0.2 Im ___ AbsNeut-5.25 AbsLymp-0.70* AbsMono-0.26 AbsEos-0.01* AbsBaso-0.01 ___ 09:31PM BLOOD ___ PTT-29.0 ___ ___ 09:31PM BLOOD ___ D-Dimer-1718* ___ 09:31PM BLOOD Glucose-114* UreaN-19 Creat-1.5* Na-142 K-3.1* Cl-101 HCO3-21* AnGap-20* ___ 09:31PM BLOOD Albumin-4.2 Calcium-9.7 Phos-2.4* Mg-1.9 UricAcd-10.0* ___ 09:31PM BLOOD ALT-50* AST-79* LD(LDH)-656* AlkPhos-100 TotBili-1.5 ___ 09:31PM BLOOD Lipase-22 ___ 09:31PM BLOOD cTropnT-<0.01 ___ 09:31PM BLOOD ASA-NEG Acetmnp-NEG Tricycl-NEG ___ 09:42PM BLOOD ___ pO2-19* pCO2-42 pH-7.42 calTCO2-28 Base XS-1 ___ 09:42PM BLOOD Lactate-4.0* Na-140 K-3.1* PERTINENT LABS/MICRO/IMAGING: ============================= ___ 11:19AM BLOOD Osmolal-272* ___ 06:43AM URINE Osmolal-522 ___ 06:43AM URINE Hours-RANDOM Na-127 ___ 06:14AM BLOOD Osmolal-269* ___ 03:16PM URINE Osmolal-415 ___ 03:16PM URINE Hours-RANDOM Na-146 ___ 12:00PM BLOOD TSH-3.8 ___ 06:35AM BLOOD Cortsol-17.4 ___ 07:07AM BLOOD Cortsol-25.5* ___ 07:44AM BLOOD Cortsol-29.5* ___ 06:35 ACTH - FROZEN Test Result Reference Range/Units ACTH, PLASMA 21 ___ pg/mL ___ 12:40PM BLOOD CK-MB-3 cTropnT-<0.01 ___ 02:49AM BLOOD cTropnT-0.02* ___ 01:57AM BLOOD cTropnT-<0.01 ___ 12:00AM BLOOD PEP-NO MONOCLO FreeKap-1.0* FreeLam-0.9* Fr K/L-1.1 IgG-394* IgA-18* IgM-22* IFE-NO MONOCLO ___ 00:00 VitB12 155* Folate 4 ___ 12:07 Osmolal 281 MICRO: -------- ___ 10:20 am URINE Source: Catheter. URINE CULTURE (Final ___: NO GROWTH. ___ 2:41 am BLOOD CULTURE Source: Venipuncture. Blood Culture, Routine (Final ___: NO GROWTH. ___ 2:42 am BLOOD CULTURE Source: Venipuncture. Blood Culture, Routine (Final ___: STAPHYLOCOCCUS, COAGULASE NEGATIVE. Isolated from only one set in the previous five days. SENSITIVITIES PERFORMED ON REQUEST.. Aerobic Bottle Gram Stain (Final ___: Reported to and read back by ___. ___ ON ___ AT 0115. GRAM POSITIVE COCCI IN CLUSTERS. ___ 9:29 pm STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. CDT ADDED ON ___ AT 0035. FECAL CULTURE (Final ___: NO ENTERIC GRAM NEGATIVE RODS FOUND. NO SALMONELLA OR SHIGELLA FOUND. CAMPYLOBACTER CULTURE (Final ___: NO CAMPYLOBACTER FOUND. OVA + PARASITES (Final ___: NO OVA AND PARASITES SEEN. This test does not reliably detect Cryptosporidium, Cyclospora or Microsporidium. While most cases of Giardia are detected by routine O+P, the Giardia antigen test may enhance detection when organisms are rare. Cryptosporidium/Giardia (DFA) (Final ___: NO CRYPTOSPORIDIUM OR GIARDIA SEEN. C. difficile PCR (Final ___: NEGATIVE. (Reference Range-Negative). ___ 12:45 pm BLOOD CULTURE Blood Culture, Routine (Final ___: NO GROWTH. ___ 11:20 pm BLOOD CULTURE Source: Line-cvl. Blood Culture, Routine (Final ___: NO GROWTH. ___ 2:22 pm URINE Source: ___. URINE CULTURE (Final ___: NO GROWTH. ___ 4:02 pm CATHETER TIP-IV Source: central line. WOUND CULTURE (Final ___: No significant growth. ___ 12:34 am BLOOD CULTURE Source: Line-right IJ. Blood Culture, Routine (Final ___: NO GROWTH. ___ 12:34 am BLOOD CULTURE Source: Venipuncture. Blood Culture, Routine (Final ___: NO GROWTH. ___ 9:31 am URINE Source: Catheter. URINE CULTURE (Final ___: NO GROWTH. ___ 05:14PM CEREBROSPINAL FLUID (CSF) TNC-99* ___ Polys-73 ___ ___ 05:14PM CEREBROSPINAL FLUID (CSF) TotProt-___* Glucose-78 ___ 5:14 pm CSF;SPINAL FLUID SOURCE: LP. GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE (Final ___: NO GROWTH. ___ 04:20PM CEREBROSPINAL FLUID (CSF) TNC-11* ___ Polys-9 ___ ___ 04:20PM CEREBROSPINAL FLUID (CSF) TotProt-255* Glucose-108 ___ 4:18 pm CSF;SPINAL FLUID Source: LP TUBE #3. GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE (Final ___: NO GROWTH. IMAGING: --------- CXR ___: No acute cardiopulmonary abnormality. Moderate-sized hiatal hernia. CTA ___ AND NECK ___: 1. No acute intracranial abnormality by unenhanced ___ CT. No hemorrhage. 2. No large vessel occlusion. Minimal narrowing, left cavernous ICA. Otherwise, unremarkable circle of ___. 3. 55 mL volume of elevated MTT, primarily left temporal lobe. No evidence of abnormal cerebral blood flow or cerebral blood volume. No evidence of infarct core. 4. Calcified atherosclerotic plaque causes 18% proximal right ICA luminal narrowing by NASCET criteria. Mild narrowing, bilateral ECA origins. Otherwise, widely patent cervical vertebral and carotid arteries. No left ICA narrowing. 5. Lytic lesions in the right clavicle and humerus, unchanged in size, previously FDG avid on PET-CT from ___, better evaluated on that study. 6. Ground-glass opacity in the superior segment, left lower lobe, better evaluated on same-day CTA chest. CTA CHEST AND CT ABDOMEN ___: 1. No evidence of pulmonary embolism. 2. Fluid throughout all visualized bowel loops with diffuse bowel wall hyperemia, likely reflecting diffuse enteritis, likely infectious or inflammatory. No bowel wall thickening. 3. New ground-glass opacities within the lower lobes bilaterally, compatible with infection. 4. Mild bladder wall thickening anteriorly, which should be correlated with urinalysis for evidence of cystitis. 5. Known osseous myeloma lesions are better visualized on prior examinations. Soft tissue within the spinal canal at the level of L3 is re-demonstrated, but better evaluated on the MR ___ dated ___. ___. Large hiatal hernia. EEG ___: This continuous ICU monitoring study was abnormal due to 1) attenuation and continuous focal slowing in the left hemisphere, indicative of focal cerebral dysfunction. 2) Generalized background slowing suggestive of a mild encephalopathy, non-specific in etiology, however toxic metabolic disturbances, infection, or medication effect are possible causes. There were no push button events. There were no electrographic seizures or epileptiform discharges. CT ___ WITHOUT CONTRAST ___: 1. No acute intracranial abnormality. 2. Bilateral periventricular and subcortical hypodensities that are most likely related to chronic small vessel ischemia. MR ___ WITHOUT CONTRAST ___: 1. No acute intracranial abnormality. 2. Chronic findings include global parenchymal volume loss and mild changes of chronic white matter microangiopathy. EEG ___: This continuous ICU monitoring study was abnormal due to: Near continuous focal slowing in the left temporal and parasagittal regions suggestive of focal cerebral dysfunction. There were no push button events. There were no electrographic seizures or epileptiform discharges. Compared to the previous day there was no significant change. CHEST X RAY ___: Probable mild bronchitis lung bases again noted. Hazy opacity left lung base appears slightly improved. CXR ___: No evidence of pneumonia or pleural effusion. TTE ___: The left atrial volume index is mildly increased. The inferior vena cava diateter is normal. There is normal left ventricular wall thickness with a normal cavity size. There is normal regional and global left ventricular systolic function. Quantitative biplane left ventricular ejection fraction is 57 %. There is no resting left ventricular outflow tract gradient. Tissue Doppler suggests an increased left ventricular filling pressure (PCWP greater than 18mmHg). Normal right ventricular cavity size with normal free wall motion. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. The aortic arch is mildly dilated. The aortic valve leaflets (?#) are mildly thickened. There is mild aortic valve stenosis (valve area 1.5-1.9 cm2). There is no aortic regurgitation. The mitral valve leaflets are mildly thickened with no mitral valve prolapse. There is moderate mitral annular calcification. There is trivial mitral regurgitation. The tricuspid valve leaflets appear structurally normal. There is physiologic tricuspid regurgitation. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. IMPRESSION: Normal biventricular function. Mildly thickened aortic valve leaflets with mild AS. Mildly thickened mitral valve leaflets with moderate MAC. Trivial MR. ___ ___: 1. No acute intracranial abnormality. Please note MRI of the brain is more sensitive for the detection of acute infarct. 2. Atrophy, probable small vessel ischemic changes, and atherosclerotic vascular disease as described. EEG ___: This is an abnormal ICU EEG study because of diffuse slowing of background with periods of diffuse voltage attenuation indicative of moderate- severe encephalopathy, which is nonspecific as to etiology. Frontal rhythmic delta activity is a nonspecific finding that can be seen with diffuse encephalopathies as well as structural disorders involving deep midline structure or increased intracranial pressure. There are no epileptiform discharges or electrographic changes. CTA ___ ___: 1. No evidence of mass, hemorrhage or infarction. 2. The major arteries the ___ and neck are patent. 3. Partially imaged left lower lobe collapse. Difficult to exclude pneumonia in the appropriate clinical setting. Please see report for subsequent chest radiograph dated ___. EEG ___: This is an abnormal ICU EEG study because of diffuse slowing of the background indicative of mild-moderate encephalopathy, which is nonspecific as to etiology. Frontal rhythmic delta activity is a nonspecific finding that can be seen with diffuse encephalopathies as well as structural disorders involving deep midline structure or increased intracranial pressure. There are no epileptiform discharges or electrographic changes. Compared to the prior day's recording, there is improvement in background. MR ___ contrast ___: No acute infarction or evidence of other acute intracranial abnormalities. EEG ___: This is an abnormal ICU EEG study because of diffuse slowing of background indicative of mild-moderate encephalopathy, which is nonspecific as to etiology. Frontal rhythmic delta activity is a nonspecific finding that can be seen with diffuse encephalopathies as well as structural disorders involving deep midline structure or increased intracranial pressure. There are no epileptiform discharges or electrographic changes. Compared to the prior day's recording, there is no significant change. MR ___/ and ___ contrast ___: 1. Multiple T2 hyperintense, T1 hypointense enhancing lesions throughout the thoracic and lumbar ___ are consistent with clinical history of multiple myeloma. Dominant lesion in the L3 vertebral body has slightly decreased in size compared to prior exam with resolution of the soft tissue component. 2. Subtle enhancement of the cauda equina nerve roots on the left at the level of L2 are new compared to prior exam concerning for leptomeningeal metastatic infiltration. 3. Multilevel degenerative disc disease in the cervical ___, most pronounced at C4-C5 with moderate spinal canal narrowing. 4. Multilevel degenerative disc disease in the lumbar ___, most pronounced at L3-L4 with moderate spinal canal narrowing and moderate right spinal canal narrowing. 5. Small bilateral pleural effusions with consolidations in the dependent portions of the lungs are consistent with worsening pleural-parenchymal disease. CXR ___: Comparison to ___. Resolution of a pre-existing left pleural effusion. Stable normal size of the cardiac silhouette. No pulmonary edema, no pneumonia, no pleural effusions. Stable correct position of a right internal jugular vein catheter. A previous left lower lobe consolidation is still visualized. The consolidation shows air inclusion and could correspond to the hiatal hernia, documented on the CT examination from ___. No pleural effusions. No pulmonary edema. MRI ___ w/ and ___ contrast ___: 1. Multiple T2 hyperintense, T1 hypointense enhancing lesions throughout the lumbar ___ are consistent with clinical history of multiple myeloma, similar compared to prior exam. 2. Increasing subtle enhancement of the cauda equina nerve roots are concerning for worsening leptomeningeal metastatic infiltration. 3. Moderate to severe spinal canal narrowing at L3-L4 appears minimally progressed. DISCHARGE LABS: =============== ___ CBC: 2.4>10.3/30.4<93 ANC 1.26 ___ Coags: ___ 11.0, PTT 31.2, INR 1.0 ___ BMP: 136/3.9 | ___ | ___ < 109 Ca 9.0, Phos 4.1, Mg 2.0 ___ LFTs: ALT 15, AST 10, AlkP 82, tBili 0.6 Brief Hospital Course: PATIENT SUMMARY: ================ ___ with history of multiple myeloma c/b recent spinal lesions s/p radiation with recent initiation of Ninlaro ___ (held on admission), also with history of opiate/benzo use and withdrawal, who presented to the ED on ___ with c/o nausea, vomiting, diarrhea, AMS with aphasia in the setting of taking an extra dose of Ninlaro. Stroke workup and EEG negative, treated empirically for meningoencephalitis and mental status back to baseline within 24 hours (though also in setting of holding sedating meds). Course c/b persistent thrombocytopenia refractory to transfusion, persistent pain requiring narcotics, orthostatic hypotension on midodrine, and hyponatremia. Patient had unresponsive/hypoxic/hypotensive episode on ___ required intubation and transfer to the ICU, with ICU course c/b intermittent hypotensive/unresponsive episodes, Afib with RVR, and agitation. Stabilized and transferred back to the floor with ongoing severe orthostasis and pain, now under better control. Also found to have possible leptomeningeal involvement on MRI ___ discharged on dexamethasone. ACUTE ISSUES: ============= #AMS: #Aphasia: Per daughter, patient had been intermittently confused since ___. Patient then developed acute change in mental status in ED, with inability to follow commands and word finding difficulties/word salad. Given concern for stroke, code stroke called. NIHSS 4. No evidence of hemorrhage or large territory infarct on ___. No new abnormalities noted on MRI, and CTA ___ without significant stenosis. Neuro with low suspicion for stroke as exam did not localize to a particular vascular territory. EEG showed no epileptiform activity. He was started on empiric treatment for meningoencephalitis with vanc/ceftriaxone/acyclovir/ampicillin while awaiting LP. Unfortunately LP could not initially be done due to thrombocytopenia that did not improve with transfusions. Antibiotics were discontinued on ___ after about 5 days of treatment given low suspicion for infection. Unclear what caused the acute change in mental status/word finding difficulties. Potentially related to the Ninlaro, as patient reports taking two pills instead of one, however nothing like this has been reported in the literature. He was monitored off antibiotics. LP was able to be done later in hospital course, which was negative for infection. He did have further episodes of AMS/unresponsiveness during hospitalization (see below) which subsequently improved. # Unresponsive episodes: # Hypotension: # Fever: Starting on ___, patient had numerous unresponsive episodes. During these, he did not respond to voice or sternal rub, SBP was low in 60-80s and HRs were high normal. Basic labs were checked and no clear etiology was found. There was no evidence of infection. Differential diagnosis included primary neurologic process such as autonomic dysreflexia secondary to spinal radiation vs. multiple myeloma meningeal involvement vs. metastasis to the ___. These episodes were felt to be less likely due to drug overdose as narcan did not help, though could have still been benzo OD given he was found to have pill bottle in his room earlier in his course. During the first episode, the patient was intubated due to agonal breathing and transferred to the ICU. He was then extubated and continued to have unresponsive episodes. EEG showed no seizures. MRI showed no acute infarcts or evidence of prior. Infectious workup was unremarkable. LP done by ___ on ___ was traumatic but unrevealing. He was then transferred back to the floors. Repeat LP by Dr. ___ ___ showed no evidence of myeloma, though repeat MRI ___ showed increasing enhancement around the cauda equina concerning for leptomeningeal involvement and he was started on dexamethasone. Overall etiology of these episodes is still unclear at this point, though the thought is that there is an element of autonomic dysfunction secondary to prior myeloma treatment, and now possibly and element of leptomeningeal involvement. #Orthostatic hypotension: On ___ patient noted to be hypotensive to SBP 99 (from SBP 140s a few hours earlier) and on manual repeat SBP 80. HR ___, no hypoxia, asymptomatic. Positive orthostatic vitals. Orthostasis did not improve with IVF so unlikely due to hypovolemia. Sepsis workup negative. No medications on list that lead to hypotension. ___ stim negative for adrenal insufficiency. Likely due to autonomic dysfunction in the setting of Velcade/Ninlaro treatment. Started on midodrine 5mg TID, which was downtitrated to 2.5mg BID given supine hypertension. #Multiple myeloma: #Pancytopenia: Pt with relapsed multiple myeloma diagnosed in ___ c/b ___ lesions s/p radiation. Recent ___ PET/CT c/f disease progression with decision to move forward with triple therapy with ninlaro, dexamethasone, and revlimid as part of a clinical trial at ___ in the s/o multiple failed prior treatments. Received first dose of Ninlaro at 8mg (initial starting dose usually 4 mg) on ___ with plan to initiate revlimid if well tolerated at a later date. He reported taking an extra dose of Ninlaro prior to admission. He was noted to have worsening pancytopenia, especially thrombocytopenia, which was though to be due to the Ninlaro. Thrombocytopenia was minimally responsive to transfusions, and IVIG/hydrocortisone also had minimal effect. Counts uptrended and plateaued. Bone marrow biopsy done ___ which showed no disease. LP was also done on ___ due to c/f leptomeningeal involvement on MRI ___, and this also showed no evidence of myeloma on cytology (specimen inadequate for flow). However MRI ___ did show enhancement of cauda equina which was thought to more likely represent leptomeningeal involvement, though could be arachnoiditis due to radiation. He was started on dexamethasone and will follow up with Dr. ___ Dr. ___ for further workup. He was seen by radiation oncology and they did not feel that he was a candidate for further radiation should this represent disease. #DOE, improved: Patient complaining of increased SOB on exertion since hospitalization. Lungs clear, no peripheral edema. TTE done earlier in the hospitalization without any e/o heart failure. Consider deconditioning vs. symptomatic anemia vs. cardiopulm etiology. Improved after pRBC transfusion. Continued to work with ___ while inpatient. #Afib with RVR, resolved: Symptomatic AFib with RVR in the ICU without a known history although prior EKGs have shown frequent ectopy with PVCs and PACs. Unclear trigger without obvious signs of infection or ACS. There was concern for autonomic dysfunction and any adrenergic stimuli could be responsible. Reverted to sinus on diltiazem. Remained in NSR off nodal agents. #Hyponatremia, resolved: Na noted to be 130 (had downtrended daily), asymptomatic. Serum osm 269 with urine osm and urine Na elevated which would be consistent with SIADH picture. Had been on IVF and received boluses, so less likely hypovolemic hyponatremia. No renal failure, diuretic use, peripheral edema or ascites. ___ stim and TSH wnl. Placed on fluid restriction 1200cc. After he returned to the floor from the ICU, fluid restriction lifted and Na remained within normal range. #Diarrhea, resolved: #Enteritis: #Hypokalemia: CT scan with diffuse bowel wall hyperemia. Likely infectious vs. inflammatory in the setting of recent medication introduction. C.Diff negative and stool cultures negative. Symptomatic treatment with loperamide. Also may be element of opioid withdrawal. Resolved about a week into hospitalization. CHRONIC ISSUES: =============== #Chronic pain: #Opiate use: #Benzodiazepine use: Patient on significant opiate regimen (oxycodone, morphine) as outpatient with recent decrease in opiate dosing (oxycodone 10 mg TID to 5 mg TID) on ___ and history of withdrawal in the past per daughter. On initial exam, patient with pupillary dilation and recent complaints of diarrhea, concerning for possible withdrawal. Patient also on significant benzodiazepine regimen as outpatient with patient completing medications prior to end of prescription in recent past per family members. During this hospitalization, found to have empty Klonapin bottle and bottle with 2 pills of ambien. Reports he last took pills 2 days prior to being found. He continued to report severe pain while on oxycodone 10mg TID, so his regimen was changed to oxycodone 15mg q4h prn which he was taking consistently. Klonapin was decreased from 1mg TID to BID. Pain management intermittently followed and then palliative care came on board to help optimize pain regimen. He was ultimately discharged on oxycontin 20mg q12h, oxycodone 5 mg PO q4h prn BTP, gabapentin 800mg/800mg/1200mg, cymbalta 40mg. He was also discharged on dexamethasone for presumed cord irritation symptoms. #Insomnia: #Anxiety: #Agitation: Patient with hx of anxiety and insomnia, multiple prior psych admissions, most recently ___, who is now complaining of worsening insomnia and anxiety. Normally takes Ambien and Klonapin 1mg TID at home. Tried on various regimens inpatient, including ramelteon, zyprexa, and trazodone. Tried ambien, however patient had episode of sleepwalking where he felt like he was in a dream. Required Haldol for agitation in the ICU. Was placed on Olanzapine standing and PRN with some improvement in mood and agitation, which was d/c-ed when the above changes were made to regimen. Psychiatry was briefly involved in medication management. TRANSITIONAL ISSUES: =================== [ ] Discharged on dexamethasone 4mg PO q8h. Up- or down-titrate as appropriate. [ ] Will require follow-up with Dr. ___ further workup/treatment of possible leptomeningeal involvement on MRI. [ ] Follow-up orthostatic hypotension/autonomic dysfunction. Can consider up-titrating midodrine (currently on 2.5mg BID) however be mindful of supine hypertension. Can also consider addition of fludrocort. Would likely benefit from ___ clinic follow-up. [ ] Given frequent PVCs, PACs, and episode of Afib in the ICU, may consider outpatient Holter monitor. [ ] Would benefit from follow-up with palliative care for help with analgesic management given history of opioid use disorder and chronic pain. The ___ care team ___ MD) is currently working on scheduling this appointment. [ ] Patient qualifies for home ___ and OT per inpatient team recs. CODE: Full EMERGENCY CONTACT HCP: ___, daughter This patient was prescribed, or continued on, an opioid pain medication at the time of discharge (please see the attached medication list for details). As part of our safe opioid prescribing process, all patients are provided with an opioid risks and treatment resource education sheet and encouraged to discuss this therapy with their outpatient providers to determine if opioid pain medication is still indicated. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. OxyCODONE (Immediate Release) 5 mg PO TID 2. Doxepin HCl 100 mg PO HS 3. ClonazePAM 1 mg PO TID 4. Morphine SR (MS ___ 60 mg PO Q12H 5. Zolpidem Tartrate 12.5 mg PO QHS 6. Promethazine 25 mg PO Q6H:PRN Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H RX *acetaminophen 500 mg 2 tablet(s) by mouth every eight (8) hours Disp #*84 Tablet Refills:*0 2. Acyclovir 400 mg PO Q12H RX *acyclovir 400 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*60 Tablet Refills:*0 3. Atovaquone Suspension 1500 mg PO DAILY RX *atovaquone 750 mg/5 mL 1500 mg by mouth daily Refills:*0 4. Bengay Cream 1 Appl TP BID:PRN knee pain RX *menthol [Bengay Cold Therapy] 5 % Apply to painful areas twice a day Refills:*0 5. Cyanocobalamin 1000 mcg PO DAILY RX *cyanocobalamin (vitamin B-12) 1,000 mcg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 6. Dexamethasone 4 mg PO Q8H RX *dexamethasone 4 mg 1 tablet(s) by mouth every eight hours Disp #*90 Tablet Refills:*0 7. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 8. DULoxetine 40 mg PO DAILY RX *duloxetine 40 mg 1 capsule(s) by mouth daily Disp #*30 Capsule Refills:*0 9. FoLIC Acid 1 mg PO DAILY RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 10. Gabapentin ___ mg PO TID Please take 800mg at 8am, 800mg at 3pm, and 1200mg at 11pm. RX *gabapentin 800 mg ___ tablet(s) by mouth three times a day Disp #*105 Tablet Refills:*0 11. Midodrine 2.5 mg PO BID Please check BP in AM. If SBP > 150, please hold both daily doses and recheck the next morning. RX *midodrine 2.5 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 12. OxyCODONE SR (OxyconTIN) 20 mg PO Q12H RX *oxycodone 20 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*14 Tablet Refills:*0 13. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First Line RX *polyethylene glycol 3350 17 gram 1 powder(s) by mouth daily Disp #*30 Packet Refills:*0 14. Senna 8.6 mg PO BID RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp #*60 Tablet Refills:*0 15. ClonazePAM 1 mg PO BID RX *clonazepam 1 mg 1 tablet(s) by mouth twice a day Disp #*14 Tablet Refills:*0 16. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth every four hours Disp #*20 Tablet Refills:*0 17. Promethazine 25 mg PO Q6H:PRN RX *promethazine 25 mg 1 tablet by mouth every six (6) hours Disp #*20 Tablet Refills:*0 18. HELD- Doxepin HCl 100 mg PO HS This medication was held. Do not restart Doxepin HCl until you speak with your doctor. 19. HELD- Morphine SR (MS ___ 60 mg PO Q12H This medication was held. Do not restart Morphine SR (MS ___ until you speak with your doctor. 20. HELD- Zolpidem Tartrate 12.5 mg PO QHS This medication was held. Do not restart Zolpidem Tartrate until you speak with your doctor. Discharge Disposition: Home Discharge Diagnosis: PRIMARY: -Altered mental status/aphasia -Unresponsive episodes -Orthostatic hypotension SECONDARY: -Multiple myeloma -Pancytopenia -Chronic pain/neuropathic pain -Atrial fibrillation -Agitation -Hyponatremia -Diarrhea Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___. WHY WAS I ADMITTED TO THE HOSPITAL? You were admitted to the hospital because you were vomiting and having diarrhea, and you were feeling more confused. You were initially admitted to the ICU, then transferred to the floor once you were feeling better. WHAT HAPPENED WHILE I WAS IN THE HOSPITAL? -In the emergency room, you were unable to speak normally. Imaging of your ___ was done, which did not show any stroke. You also had an EEG which did not show any seizures. You were given antibiotics to treat a possible infection. -No infectious cause of your diarrhea was found. It was probably due to the extra chemotherapy medication that you took. Your diarrhea improved. -Your platelets became low, so you were given a few platelet transfusions as well as some medications to try to increase your platelets. -You were seen by the psychiatry team to help manage medications for your insomnia. You were also seen by the pain management team to help manage your pain, and you were started on gabapentin. You were later seen by palliative care who optimized your pain regimen. -You had frequent episodes of low blood pressure, mostly upon sitting or standing, so you were started on a medication (midodrine) to help with this. -You had an episode where you became unresponsive and your oxygenation level was low, so you were intubated and transferred back to the ICU. In the ICU you continued to have a few episodes where your blood pressure dropped. You also were noted to have an irregular and fast heart rhythm which resolved with medications. -You had a lumbar puncture and bone marrow biopsy which did not show myeloma in the spinal fluid or bone marrow. However, you had an MRI of your ___ which showed findings that could be consistent with myeloma of the ___. You were then started on steroids and you will need to follow up with Dr. ___ Dr. ___ for further workup. WHAT SHOULD I DO WHEN I LEAVE THE HOSPITAL? -Continue to take all of your medications as prescribed. -Have your sister check your BP every morning. If the systolic BP is greater than 150, hold your midodrine doses for that day. -Please attend all ___ clinic appointments. -The inpatient physical and occupational therapy teams evaluated you and you qualify for home physical therapy (___) and occupational therapy (OT), which can be set up. -If you develop sudden weakness in your legs, worsening numbness/tingling, or you feel you cannot control your urination or defecation, please immediately go to the ED. We wish you all the best, Your ___ Care Team Followup Instructions: ___
19985545-DS-27
19,985,545
29,375,845
DS
27
2144-10-14 00:00:00
2144-10-14 18:41:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Fall Major Surgical or Invasive Procedure: None History of Present Illness: ___ yo M with history of multiple myeloma, anxiety, and orthostatic hypotension presenting with weakness, lightheadedness, shortness of breath, decreased intake by mouth, and weight loss. He had 2 falls today ___ when getting up from the bed and walking to the bathroom. He reports feeling dizzy with SOB, denies palpitations/CP. He fell on his back denies headstrike. He then tried to get back up and fell again. He denies LOC. Over the past 2 wks he had has progressive SOB. He reports that 4 wks ago he was able to walk over a block, but now is unable to walk more than a few steps before feeling SOB. Denies any cough, sputum production, hemoptysis, congestion. He reports that SOB was not present during his last admission. Pt reports he sleeps with 4 pillows but is able to lay flat w/o dyspnea, denies PND. He also mentions that for the past 3 days he has had minimal oral intake due to lack of appetite. He reports 6lbs unintentional wt loss since discharge. Denies n/v/diarrhea. Mentioned that his appetite has been low since about ___. Of note, was recently admitted at ___ ___ with similar symptoms of dizziness, poor oral intake and fall. It was that that his falls were due to orthostatic hypotension which was treated with midodrine, compression stockings and salt tabs. It was also thought that the medications could also be contributing and a taper was started. He was also instructed to f/u with ___ clinic w/Dr ___ reports that his appointment was scheduled for today ___ but he presented to the ED for the fall. Last saw Dr. ___ on ___ after discharge, pt reported worsening neuropathy in setting of decreased gabapentin. At that time it seemed that his MM did not require immediate therapy as recent evaluation w/o clear evidence of disease. In the ED: - Initial vital signs were notable for: afeb, 110, 116/73, 18 95% RA, lowest BP 81/55 - Exam notable for: oral thrush, tachycardic. - Labs were notable for: 142 | 106 | 16 / \ 11.1 / ----------- 124 5.5 --- 111 3.9 | 22 | 1.2 \ / 31.5 \ Ca 9 | Mg 2 |Phos 2.4 ___ 12 |PTT 23.1 | INR 1.1 Lactate 3.2 Blood cultures pending - Studies performed include: CXR, CT Head - Patient was given: 1L IVF - Consults: None Vitals on transfer: 98.4 91 118/69 18 99% RA Upon arrival to the floor, pt reports that he is hungry and would like a diet so that he can order food. He reports that his symptoms are similar to his last admission but the SOB is new, again he emphasized that he is unable to ambulate more than a few steps before feeling SOB. Again denies fever, chills, n/v, diarrhea, dysuria, cough, palpitations, CP, orthopnea, PND, leg swelling. Also mentioned that his sister, who he lives with had a cold last week. Past Medical History: Multiple myeloma s/p autologous stem cell transplant ___, radiation Orthostatic hypotension Opiate withdrawal w/ substance use disorder Depression Gout Social History: ___ Family History: paternal grandmother was institutionalized. Physical Exam: ADMISSION PHYSICAL EXAM: ====================== Vitals: 24 HR Data (last updated ___ @ 1731) Temp: 98.1 (Tm 98.1), BP: 115/77, HR: 94, RR: 20, O2 sat: 100%, O2 delivery: Ra, Wt: 129 lb/58.51 kg Gen: Cachectic, Lying in bed. NAD HEENT: PERRLA, EOMI, pupils 4mm. No conjunctival pallor. No icterus. Dry MM. No visible thrush. NECK: JVP wnl, no hepatojugular reflux LYMPH: No cervical or supraclav LAD CV: Tachycardic, irregular rhythm. No MRG. LUNGS: No incr WOB. reduced air movement B/L. No wheezes, rales, or rhonchi. When standing pt becomes dyspneic ABD: ND, nl bowel sounds, NT, no HSM. EXT: WWP. No ___ edema. SKIN: No rashes/lesions, petechiae/purpura ecchymoses. NEURO: AOx3. CN ___ intact. Full strength in upper and lower extremities DISCHARGE PHYSICAL EXAM: ====================== Gen: Cachectic, Lying in bed. NAD HEENT: PERRLA, EOMI, No conjunctival pallor. No icterus. Dry MM. No visible thrush. NECK: JVP present about mid neck LYMPH: No cervical or supraclav LAD CV: regular rhythm . No MRG. LUNGS: No incr WOB. CTAB. No wheezes, rales, or rhonchi. ABD: thin,ND, nl bowel sounds, NT, no HSM. EXT: WWP. No ___ edema. SKIN: No rashes/lesions, petechiae/purpura ecchymoses. NEURO: AOx3. CN ___ intact. Full strength in upper and lower extremities GU: normal appearing genitalia. Testes w/o edema or erythema. L testicle tender, no palpable masses. Unable to appreciate inguinal hernia. R testicle normal Pertinent Results: ADMISSION LABS: ============== ___ 07:35PM ALT(SGPT)-6 AST(SGOT)-7 LD(LDH)-160 ALK PHOS-47 TOT BILI-1.3 ___ 07:35PM TOT PROT-5.1* ALBUMIN-3.9 GLOBULIN-1.2* ___ 07:35PM PEP-HYPOGAMMAG Free K-1.5* Free ___ Fr K/L-0.25* IgG-292* IgA-16* IgM-12* ___ 07:35PM D-DIMER-824* ___ 03:06PM ___ COMMENTS-GREEN TOP ___ 03:06PM LACTATE-1.4 ___ 10:39AM ___ COMMENTS-GREEN TOP ___ 10:39AM LACTATE-3.2* ___ 10:32AM GLUCOSE-124* UREA N-16 CREAT-1.2 SODIUM-142 POTASSIUM-3.9 CHLORIDE-106 TOTAL CO2-22 ANION GAP-14 ___ 10:32AM estGFR-Using this ___ 10:32AM CALCIUM-9.0 PHOSPHATE-2.4* MAGNESIUM-2.0 ___ 10:32AM ASA-NEG ACETMNPHN-NEG tricyclic-NEG ___ 10:32AM WBC-5.5 RBC-3.30* HGB-11.1* HCT-31.5* MCV-96 MCH-33.6* MCHC-35.2 RDW-14.3 RDWSD-48.4* ___ 10:32AM NEUTS-56.5 ___ MONOS-11.7 EOS-0.2* BASOS-0.6 IM ___ AbsNeut-3.08 AbsLymp-1.65 AbsMono-0.64 AbsEos-0.01* AbsBaso-0.03 ___ 10:32AM ___ PTT-23.1* ___ ___ 10:32AM PLT COUNT-111* DISCHARGE LABS: =============== ___ 06:40AM BLOOD WBC-2.8* RBC-2.58* Hgb-8.7* Hct-26.3* MCV-102* MCH-33.7* MCHC-33.1 RDW-14.3 RDWSD-51.5* Plt Ct-63* ___ 06:00AM BLOOD Neuts-49.3 ___ Monos-13.0 Eos-0.5* Baso-0.5 Im ___ AbsNeut-1.02* AbsLymp-0.74* AbsMono-0.27 AbsEos-0.01* AbsBaso-0.01 ___ 06:40AM BLOOD Plt Ct-63* ___ 06:35AM BLOOD ___ PTT-UNABLE TO ___ ___ 07:35PM BLOOD D-Dimer-824* ___ 06:40AM BLOOD Glucose-86 UreaN-17 Creat-0.7 Na-142 K-4.6 Cl-104 HCO3-30 AnGap-8* ___ 06:40AM BLOOD ALT-7 AST-9 LD(LDH)-156 AlkPhos-52 TotBili-0.5 ___ 06:40AM BLOOD Albumin-3.5 Calcium-8.6 Phos-4.3 Mg-2.0 ___ 06:15AM BLOOD VitB12-450 Folate-13 Hapto-<10* ___ 03:20PM BLOOD calTIBC-222* Ferritn-370 TRF-171* ___ 03:40PM BLOOD %HbA1c-4.4 eAG-80 ___ 06:00AM BLOOD 25VitD-21* ___ 06:00AM BLOOD Cortsol-1.6* ___ 07:35PM BLOOD PEP-HYPOGAMMAG FreeKap-1.5* FreeLam-5.9 Fr K/L-0.25* IgG-292* IgA-16* IgM-12* ___ 10:32AM BLOOD ASA-NEG Acetmnp-NEG Tricycl-NEG ___ 03:40PM BLOOD tTG-IgA-0 ___ 10:39AM BLOOD Lactate-3.2* ___ 03:06PM BLOOD Lactate-1.4 ___ 03:40PM BLOOD HVY MTL (WHLE BLD NVY/EDTA)-Test IMAGING: ======== CXR ___: IMPRESSION: No acute intrathoracic process. CT Head ___: IMPRESSION:1. No acute intracranial process. No fracture. TTE ___: EF 60-65% suboptimal study, no change obvious change from prior MRI spine ___: IMPRESSION: 1. Study is moderately degraded by motion. 2. No definite evidence of fracture. 3. Scattered myelomatous lesions are unchanged. 4. Within limits of study, no definite new or enlarging myomatous lesions identified. 5. Previously seen enhancement of the cauda equina nerve roots is less conspicuous. 6. Grossly stable multilevel thoracic and lumbar spondylosis compared to 3 weeks prior thoracic and lumbar spine contrast MRI as described, again most pronounced at L3-4 where there is mild-to-moderate vertebral canal, moderate left and severe right neural foraminal narrowing. 7. Limited imaging of the lungs suggests bilateral scarring and probable dependent atelectasis. If concern for lung opacities, consider dedicated chest imaging for further evaluation. Sniff test ___: IMPRESSION: No evidence of diaphragmatic paralysis. PFTS: ___ FEV1/FVC: 62% DsbHb 83% MIP 44% MEP 33% Scrotal U/S ___: IMPRESSION: 1. Heterogeneous echotexture of the right testis without evidence of focal mass or abnormal vascularity. Findings may reflect sequelae of prior injury. 2. Otherwise normal scrotal ultrasound. MICROBIOLOGY: ============= ___ 3:40 pm Blood (LYME) Lyme IgG (Pending): Lyme IgM (Pending): __________________________________________________________ ___ 5:42 am URINE Source: Catheter. **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. __________________________________________________________ ___ 10:32 am BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. Brief Hospital Course: ___ with multiple myeloma presents with progressive dyspnea, failure to thrive, dizziness and mechanical falls after recent hospitalization for similar symptoms. TRANSITIONAL ISSUES: ================== [] New Meds: Fludrocortisone 0.1mg PO Daily for orthostatic hypotension Naloxone Inhaler for opioid overdose Prednisone 10mg PO daily WILL NEED TAPER ONLY GIVEN 7DAY Rx Multivitamins with minerals daily Vitamin D3 2000U daily [] Stopped/Held Meds: Dexamethasone Midodrine [] Discharge weight: 62 kg [] Consider ADDRESSING POLYPHARMACY to help reduce the risk of falls: patient on multiple psych/sedating medications as well as opioid/pain medications [] f/u orthostatic blood pressure and symptoms consider uptitrating Fludrocortisone to 0.2mg daily [] Continue to wear thigh high compression stockings [] F/u weights for adequate oral intake, encourage fluid intake ___ daily [] Discharge Creatinine: 0.7 [] Continue BM regimen as on chronic opioids [] Only new medication Rx's were provided, no opioid, psych, sleep prescriptions were provided as pt should have enough at home after reviewing fill history and time in hospital FOLLOW UP APPOINTMENTS: [] F/u with urology: Dr. ___ will coordinate f/u for urinary retention and bladder training [] f/u with ___ clinic: Request placed for Dr. ___, ___ will f/u on HBA1c, B1, B6, ___, Ro, La, ACE, heavy metals, tTG IgA, lyme, HIV, urine PBG, BNP [] f/u with palliative care: Dr. ___ ___ 9am [] f/u PCP: Dr. ___ ___ 10AM ACTIVE ISSUES: ============= #POLYPHARMACY: Pt is on many medications that may be contributing to his recurrent falls which include Clonazepam, gabapentin, oxycodone, oxycontin, tramadol, zolpidem, and mirtazepapine. We would highly suggest that his polypharmacy burden be reduced given recurrent admissions. #dyspnea: Pt with 4wk hx of dyspnea that has been progressively worsening now he can only take a couple steps. Modified Wells score 2.5/unlikely. CXR clear. Denies hemoptysis. On exam Tachy, with reduced air movement. Dyspnea upon standing. CTA negative for PE. Monitored on Tele which was NSR. PFTs were done showing obstructive pattern with reduced MIP. Sniff test nl diaphragm movement. Pulmonology was consulted. Dyspnea improved with IVF and nutrition, thus it was thought to be secondary to underlying orthostatic hypotension. This improved prior to discharge #Falls #Orthostatic hypotension Pt has long hx of falls which are likely multifactorial: orthostatic hypotension, polypharmacy (including opioids), non-compliance with walker, and possible large fiber sensory neuropathy. Pt with hx of orthostatic hypotension. Recently has also had poor PO intake which may further exacerbate orthostatic hypotension. Other possibilities include adrenal insufficiency, POEMS syndrome, autonomic dysfunction ___ Parkinsonism (no signs/symptoms). Was instructed to f/u with Dr ___ ___ clinic. Neurology was consulted and suggested a panel of labs for small fiber polyneuropathy, most of which are pending, we have requested f/u with Dr. ___ will f/u on the labs. We continued compression stockings. Stopped home midodrine and started Fludrocortisone 0.1 mg po daily for orthostatic hypotension in the hopes of better home compliance. #urinary retention #testicular pain During admission pt had intermittent urinary retention requiring straight catheterization. Urology was consulted, they recommended foley placement and will f/u with him as an outpatient for straight cath education and urodynamic testing. MRI was done to evaluate his thoracic and lumbar spine which revealed no change in known lesions. Pt then complained of testicular pain, testicular U/S was reassuring and it was likely due to tension on foley, this resolved when foley was addressed. #Multiple Myeloma MM studies were stable. He was admitted on dexamethasone 2mg po daily and was transitioned to prednisone 10mg PO daily. He continued home acyclovir, atovaquone and omeprazole. #FFT #severe MALNUTRITION: Likely multifactorial given multiple chronic issues outlined above. As well as psychosocial stressors at home. Psych was consulted and helped to clarify medications. Palliative was consulted as they followed him during the last admission. Nutrition was consulted. We continued B12, folate, and MVI. GI was consulted and suggested stool elastase and calprotectin both remain pending. SW was consulted to help with resources. ___ (resolved): Creatine on admission was 1.2 with rehydration decreased to 0.5, suggesting it was likely pre-renal in setting of poor PO intake. Urine culture was negative. PO intake was encouraged. Creatinine upon discharge was #CHRONIC MALIGNANCY ASSOCIATED PAIN #Opiate use Per OMR, Management previously complicated by history of opiate misuse. Recently transitioned from morphine to oxycodone. Stable pain in knees and back. Has narcotic contract with ___, however this was discontinued due to violation on ___. Has been Rx OxyCONTIN and Oxycodone by Dr. ___ filled ___ with one month supply. Serum and urine tox screen were as expected. No prescriptions for controlled substances were provided on discharge. Home oxyCONTIN, oxycodone, lorazepam were continued as inpatient. Please consider reducing opioid medications as may contribute to fall risk. Also on discharge was given inhaled naloxone as a precaution for opioid overdose. #pancytopenia #thrombocytopenia #anemia On arrival counts were low normal, however with IVF counts decreased and remained low. Unclear etiology but counts were stable. MM may be contributing however MM labs do not suggest active disease. There was was appears to be a spurious low platelet count to 15, upon repeat was back up to 57, HIT abs were checked and were negative. Smear was also done, no schistocytes were seen. #hypophos was repleted per scale #Thrush Pt reports 2 wks of stomach pain, denies odynophagia. On exam no oral thrush. Pt may continue home nystatin as needed. #lactic acidosis (Resolved) Likely secondary to hypovolemia as improved with IVF CHRONIC ISSUES: ============== #DEPRESSION: Continued home clonazepam BID (pt reports he takes it TID), home gabapentin, home Escitalopram and mirtaz #insomnia: continued home ?tramadol, home zolpidem # CODE: Presumed Full # EMERGENCY CONTACT: Name of health care proxy: ___ Relationship: daughter Phone number: ___ Alternate HCP: ___ (son) ___ This patient was prescribed, or continued on, an opioid pain medication at the time of discharge (please see the attached medication list for details). As part of our safe opioid prescribing process, all patients are provided with an opioid risks and treatment resource education sheet and encouraged to discuss this therapy with their outpatient providers to determine if opioid pain medication is still indicated. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 1000 mg PO Q8H 2. Acyclovir 400 mg PO Q12H 3. Atovaquone Suspension 1500 mg PO DAILY 4. Bengay Cream 1 Appl TP BID:PRN knee pain 5. ClonazePAM 1 mg PO BID 6. Cyanocobalamin 1000 mcg PO DAILY 7. Dexamethasone 2 mg PO DAILY 8. Docusate Sodium 100 mg PO BID 9. FoLIC Acid 1 mg PO DAILY 10. Gabapentin 600 mg PO BID 11. Gabapentin 900 mg PO QHS 12. Midodrine 5 mg PO TID 13. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Moderate 14. OxyCODONE SR (OxyconTIN) 10 mg PO Q12H 15. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First Line 16. Senna 8.6 mg PO BID 17. Nystatin Oral Suspension 10 mL PO QID:PRN thrush 18. Omeprazole 40 mg PO DAILY 19. Sodium Chloride 2 gm PO TID W/MEALS 20. Ondansetron 4 mg PO Q8H:PRN Nausea/Vomiting - First Line 21. TraMADol 50 mg PO QHS 22. Escitalopram Oxalate 20 mg PO DAILY 23. Mirtazapine 15 mg PO QHS 24. Zolpidem Tartrate 12.5 mg PO QHS Discharge Medications: 1. Fludrocortisone Acetate 0.1 mg PO DAILY RX *fludrocortisone 0.1 mg 1 tablet(s) by mouth daily in the morning Disp #*30 Tablet Refills:*0 2. Multivitamins W/minerals 1 TAB PO DAILY RX *multivitamin,tx-minerals [Vitamins and Minerals] 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 3. Naloxone Nasal Spray 4 mg IH ONCE MR1 opioid overdose Duration: 1 Dose RX *naloxone [Narcan] 4 mg/actuation 1 spray nasal spray once Disp #*1 Spray Refills:*0 4. PredniSONE 10 mg PO DAILY RX *prednisone 5 mg 2 tablet(s) by mouth daily Disp #*20 Tablet Refills:*0 5. Vitamin D3 (cholecalciferol (vitamin D3)) 2,000 unit oral DAILY RX *cholecalciferol (vitamin D3) 2,000 unit 1 capsule(s) by mouth daily Disp #*30 Capsule Refills:*0 6. Acetaminophen 1000 mg PO Q8H 7. Acyclovir 400 mg PO Q12H 8. Atovaquone Suspension 1500 mg PO DAILY 9. Bengay Cream 1 Appl TP BID:PRN knee pain 10. ClonazePAM 1 mg PO BID 11. Cyanocobalamin 1000 mcg PO DAILY 12. Docusate Sodium 100 mg PO BID 13. Escitalopram Oxalate 20 mg PO DAILY 14. FoLIC Acid 1 mg PO DAILY 15. Gabapentin 900 mg PO QHS 16. Gabapentin 600 mg PO BID 17. Mirtazapine 15 mg PO QHS 18. Nystatin Oral Suspension 10 mL PO QID:PRN thrush 19. Omeprazole 40 mg PO DAILY 20. Ondansetron 4 mg PO Q8H:PRN Nausea/Vomiting - First Line 21. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Moderate 22. OxyCODONE SR (OxyconTIN) 10 mg PO Q12H 23. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First Line 24. Senna 8.6 mg PO BID 25. Sodium Chloride 2 gm PO TID W/MEALS 26. TraMADol 50 mg PO QHS 27. Zolpidem Tartrate 12.5 mg PO QHS Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS: ================= Orthostatic hypotension SECONDARY DIAGNOSIS: =================== Failure to thrive malnutrition acute kidney injury urinary retention dyspnea without hypoxia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr ___, It was a privilege caring for you at ___. Please see below for more information on your hospitalization. WHY WERE YOU ADMITTED TO THE HOSPITAL? - You fell, lost weight, had low blood pressure, and was short of breath WHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL? - We gave you fluid through your IV for hydration - We made sure you were eating 3 meals a day - We had neurology see you they recommended some lab testing and the results are pending, you will follow up with Dr. ___ in the ___ clinic to follow up on those results. - We had urology see you because you were having difficulty urinating, we placed a foley to drain your bladder. You will follow up with urology as an outpatient they will come up with a plan regarding the foley - We had our pulmonology (lung) doctors ___ for your shortness of breath, we did imaging and testing which came back reassuring. - We monitored your orthostatic blood pressures and your symptoms. Similar to prior hospital admissions your blood pressure dropped when you stood up, when you first arrived you would become dizzy and short of breath. This improved but you were still orthostatic after you were hydrated and well fed. - You complained of testicular pain we did an ultrasound which was normal - We had psychiatry see you to help us with your medications. WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - Take all of your medications as prescribed (listed below) We ARE VERY CONCERNED ABOUT YOUR MEDICATION LIST. There are multiple medications that you take that may be contributing you your recurrent falls. It would be beneficial to reduce the amount of sedating medications that you take. - Follow up with your doctors as listed below - Seek medical attention if you have new or concerning symptoms of falls, dizziness, or shortness of breath. It was a pleasure taking part in your care here at ___! We wish you all the best! - Your ___ Care Team Followup Instructions: ___
19985545-DS-29
19,985,545
23,469,336
DS
29
2145-07-21 00:00:00
2145-07-21 15:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: nausea, vomiting, diarrhea and subacute SOB Major Surgical or Invasive Procedure: none History of Present Illness: HISTORY OF PRESENTING ILLNESS: Mr. ___ is a ___ year old M admitted for dyspnea, n/v, and abdominal pain found to have ___, pancytopenia and klebsiella bacteremia. His PMH is significant for multiple myeloma s/p auto SCT in ___, afib, asthma, depression, substance abuse in remission, orthostatic hypotension, and other co-morbidities. He was in his usual state of health until approximately two weeks prior to admission when he began to feel more SOB. This was on exertion and began to become more prominent. No CP, leg swelling, fevers or chills. Notably, he has been having exertional dyspnea episodically since approximately ___. He has seen Pulmonology and Cardiology as well as Hem/Onc. Studies have included PFTs, TTE, EKG, and routine imaging with no definitive cause found. Per Pulm, suspicion for deconditioning. Infectious workup on admission showed pan-sensitive klebsiella bacteremia and pseudomonas aeruginosa UTI. Past Medical History: [ONCOLOGIC & TREATMENT HISTORY]: Per primary hemoncologist Dr. ___: Diagnosed with multiple myeloma in acute renal failure in ___. He was found to be anemic with a hemoglobin of 7 to 9.9 with splenomegaly seen on CT of the abdomen. Bone marrow biopsy and aspirate on ___ showed that CD138 positive cells replaced 90% of his marrow with abnormal plasma cells seen. Cytogenetics showed a normal male karyotype and skeletal survey done on ___ showed degenerative disease in the cervical and lumbar spine and a question of a ___ versus a lytic lesion in the frontal skull. He had an elevated serum free lambda of 1140 mg/L, beta 2 of 10, IgG of 2.3 g/dL, calcium of 10.1, creatinine of 1.18 and albumin of 3.6. However, over the span of ___ weeks he developed renal failure and ultimately was admitted for plasmapheresis and Velcade. TREATMENT HISTORY: --___: Cycle 1 Plasmapheresis + Velcade Cycle 2 Velcade + Dexamethasone(severe neuropathy) Cycle 3 - 5 Revlimid/Dexamethasone --___: High Dose Cytoxan for Mobilization --___: Autologous Stem cell Transplant --Treated on Protocol ___ vaccination with DC/Tumor fusion vaccine in patients with multiple myeloma --___: Completed ___ fusion vaccines --___: Found modest rise in paraprotein. Started on Revlimid but tolerated poorly due to nausea and loose stools and ultimately stopped in ___. --Slow rising paraprotien over the following year --___: Started on Protocol ___ A Phase I multicenter, open label, dose-escalation to determine the maximum tolerated dose for the combination of Pomalidamide, Velcade and low dose dexamethasone in subject with relapsed or refractory multiple myeloma. --Lost to follow up for one year, re-presented in ___ with a rising light chain. M protein was found to be 780 with a max of 1110 and a free light chain of 270. His free lambda did rise to as high as 447 in ___ prior to initiating treatment. --___: Placed back on pomalidomide at 4 mg daily; decreased to 2mg due to cytopenias. --___: Found to have a small rise in his light chain, and SPEP revealed a monoclonal protein of 910 and a free light chain of 293. Reinitiated treatment with Velcade and dexamethasone and increased the pomalidomide to 3 mg daily. --Received four cycles of Velcade, pomalidomide and dexamethasone with great disease control, then placed on pomalidomide maintenance for close to ___ years. Dose was decreased from 3mg to 2mg ___ due to fatigue and nausea. --___: Presented with right sacral pain unrelieved by Tylenol. Pelvic and lumbar sacral MRI obtained. Clear progression of disease including L3 and L5 lesions. --___: Daratumumab added to current pomalidomide treatment. --Treatment plan: Daratumumab 16 mg/kg weekly for 8 weeks Pomalidomide 2 mg p.o. daily for 21 out of 28 days will increase to 3 mg next cycle Dexamethasone 20 mg p.o. day of and day following Daratumumab ___: Week 2 ___ ___: Week 3 ___ ___: Week 4 ___ ___: Week 5 ___ ___: Week 6 ___ ___: Week 7 ___ ___: Week 8 ___ (Dexamethasone decreased to 10 mg on day of ___ and ___ 4 mg on following 2 days) ___: Treatment held and admitted for respiratory work up ___: Started Daratumumab/Dexamethasone alone ___: T7-T8 lesions. RT therapy started ___: Retuned to Daratumumab Monthly ___: Pet shows progression of disease. RT to L spine and femur ___: started Ninlaro/Dex but accidently took two Ninlaro pills in two subsequent days. Admitted for MS changes. ___: PET CT shows interval resolution uptake in the bones, now demonstrating background uptake. No new suspicious uptake. ___ 2. Mild uptake along the thoracic esophagus, likely representing mild esophagitis secondary to hiatal hernia. Problems (Last Verified ___ by ___: *S/P AUTOLOGOUS STEM CELL TRANSPLANT ACUTE RENAL FAILURE AUTO HPC, APHERESIS INFUSION GOUT MULTIPLE MYELOMA STEM CELL COLLECTION STUDY ___ THERAPUTIC PLASMAPHERESIS MULTIPLE MYELOMA DEPRESSION ADVANCE CARE PLANNING BACK PAIN ASTHMA NARCOTICS AGREEMENT DYSPNEA Social History: ___ Family History: paternal grandmother was institutionalized. Physical Exam: ADMISSION PHYSICAL EXAMINATION ============================ General: Sitting upright, in no acute distress Skin: No obvious rashes/lesions, pale HENT: Normocephalic, atraumatic. Oropharynx clear with moist mucous membranes, no lesions Eyes: Extraocular movements intact, non-injected, no scleral icterus. Lymph: No palpable cervical, submandibular, or supraclavicular lymphadenopathy. CV: Regular rate and rhythm, S1, S2, systolic murmur noted, no audible rubs, ___ Resp: CTAB with diminishment in bases, no inc WOB Abd: Bowel sounds present, soft, nondistended. Tender in RUQ and LUQ to deep palpation. No palpable hepatosplenomegaly Extremities: Warm, without edema Neuro: Grossly normal, moving all limbs Psych: Alert & oriented to conversation, euthymic, appropriately conversant ECOG performance status: 2 DISCHARGE PHYSICAL EXAMINATION =================================== 24 HR Data (last updated ___ @ 1114) Temp: 97.8 (Tm 98.4), BP: 144/81 (134-175/69-91), HR: 60 (55-73), RR: 20 (___), O2 sat: 98% (97-98), O2 delivery: RA, Wt: 161.4 lb/73.21 kg GEN: A&Ox3, NAD HEENT: MMM, no OP lesions, no cervical, supraclavicular lymphadenopathy. CV: Irregularly irregular sometimes but currently in sinus bradycardia. No murmurs, rubs or gallops PULM: non-labored, fine crackles at bases. No rhonchi or wheezing ABD: BS+, soft, NT/ND, no masses or hepatosplenomegaly. No rebound or guarding. MUSC: No edema or tremors SKIN: Dry. Pink papules with concave yellow center noted on right chest. No other lesions ACCESS: PIV C/D/I Pertinent Results: ADMISSION LABS ====================== ___ 08:54PM URINE HOURS-RANDOM TOT PROT-9 ___ 08:54PM URINE U-PEP-ALBUMIN IS ___ 08:54PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 08:54PM URINE BLOOD-SM* NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-LG* ___ 08:54PM URINE RBC-1 WBC-33* BACTERIA-FEW* YEAST-NONE EPI-<1 TRANS EPI-<1 ___ 07:11PM LIPASE-31 ___ 07:11PM TOT PROT-6.3* ___ 07:11PM PEP-ABNORMAL B Free K-19.4 Free L-76.7* Fr K/L-0.25* b2micro-6.5* ___ 10:58AM cTropnT-<0.01 ___ 07:55AM OTHER BODY FLUID FluAPCR-NEG FluBPCR-NEG ___ 07:52AM ___ PTT-34.2 ___ ___ 07:52AM D-DIMER-871* ___ 07:29AM GLUCOSE-83 UREA N-24* CREAT-1.8* SODIUM-136 POTASSIUM-3.4* CHLORIDE-101 TOTAL CO2-20* ANION GAP-15 ___ 07:29AM estGFR-Using this ___ 07:29AM ALT(SGPT)-14 AST(SGOT)-29 ALK PHOS-70 TOT BILI-0.5 ___ 07:29AM LIPASE-17 ___ 07:29AM proBNP-670* ___ 07:29AM cTropnT-<0.01 ___ 07:29AM ALBUMIN-3.8 CALCIUM-8.0* PHOSPHATE-3.4 MAGNESIUM-1.8 ___ 07:29AM WBC-1.4* RBC-3.12* HGB-10.0* HCT-29.8* MCV-96 MCH-32.1* MCHC-33.6 RDW-14.2 RDWSD-49.2* ___ 07:29AM NEUTS-32.4* ___ MONOS-33.1* EOS-0.0* BASOS-0.0 IM ___ AbsNeut-0.45* AbsLymp-0.47* AbsMono-0.46 AbsEos-0.00* AbsBaso-0.00* ___ 07:29AM PLT COUNT-58* IMAGING STUDIES ============================ ___ CT abd/pelv IMPRESSION: No acute intra-abdominal pathology to account for patient's symptoms, within the limitations of this unenhanced scan. ___ RUQ U/S IMPRESSION: No cholelithiasis or evidence of acute cholecystitis. No biliary ductal dilatation. "Laboratory pulmonary function tests from ___ show total lung capacity 7.4 (107% predicted and residual volume 3.5 (138% predicted with an RV/TLC of 130% predicted. Slow vital capacity is 88% predicted and forced vital capacity is 3.96 (91% predicted). FEV1 to vital capacity ratio is 74% (99% predicted). Diffusing capacity is 16.8 (66% predicted) DL divided by alveolar volume is 2.9 (77% predicted)." DISCHARGE LABS ___ 07:10AM BLOOD WBC: 2.9* RBC: 2.76* Hgb: 8.6* Hct: 27.1* MCV: 98 MCH: 31.2 MCHC: 31.7* RDW: 15.3 RDWSD: 49.2* Plt Ct: 57* ___ 07:10AM BLOOD Neuts: 48.9 Lymphs: ___ Monos: 16.0* Eos: 0.7* Baso: 0.7 Im ___: 3.1* AbsNeut: 1.44* AbsLymp: 0.90* AbsMono: 0.47 AbsEos: 0.02* AbsBaso: 0.02 ___ 07:10AM BLOOD Glucose: 88 UreaN: 13 Creat: 0.8 Na: 145 K: 4.2 Cl: 106 HCO3: 29 AnGap: 10 ___ 07:10AM BLOOD ALT: 8 AST: 12 LD(LDH): 204 AlkPhos: 53 TotBili: 0.5 ___ 07:10AM BLOOD Calcium: 8.6 Phos: 3.7 Mg: 1.9 ___ 9:00 BLOOD CULTURE: KLEBSIELLA PNEUMONIAE. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ KLEBSIELLA PNEUMONIAE | AMPICILLIN/SULBACTAM-- 4 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S CTA ___: 1. No evidence of pulmonary embolism centrally through the segmental pulmonary arteries. Evaluation of the subsegmental pulmonary arteries is limited due to timing of the contrast bolus. 2. Trace right nonhemorrhagic pleural effusion is new from prior. 3. Stable to slightly improved diffuse bronchial wall thickening. 4. Stable right upper lobe 4 mm pulmonary nodule. 5. Severe coronary artery and mitral annular calcifications. 6. Moderate hiatal hernia and patulous esophagus, which may predispose to aspiration. bil LENIs ___: No evidence of deep venous thrombosis in the right or left lower extremity veins. CT chest ___: No evidence of pneumonia in the present examination. Stable right upper lobe 4 mm nodule (5:34). Moderate bronchial wall thickening reflecting chronic bronchitis. Severe coronary artery atherosclerotic disease. Severe mitral annulus calcification. ___: CT abd/pelvis 1. No acute intra-abdominal pathology to account for patient's symptoms, within the limitations of this unenhanced scan. Brief Hospital Course: ASSESSMENT AND PLAN: Mr. ___ is a ___ year old male admitted with dyspnea, N/V/D, and abdominal pain found to have ___, pancytopenia as well as klebsiella bacteremia and pseudomonas UTI. His PMH is significant for MM (s/p auto SC in ___, afib, asthma, depression, substance abuse in remission, orthostatic hypotension, and other comorbidities. Acute Conditions ======================== #Bacteremia (Klebsiella Pneumoniae): #UTI (Pseudomonas Aeruginosa, initial culture < 100K): Presented with SOB, N/V/D and abdominal discomfort. CT Torso and CXR ___ without evidence of infection. Blood culture (___) grew GNR. Started on cefepime while awaiting culture data - which showed klebsiella. Additionally, UA showed 33 WBC with culture growing pseudomonas A. Of note, patient left ___ with PIV which may have been likely source of bacteremia but source of UTI is unclear (imaging did not show enlarged prostate, recent PSA ___ = 0.6). He did have urinary symptoms (urgency and dysuria on presentation) but since these have resolved. -PIV Culture No growth -Repeat UA improved and Ucx without growth -Cefepime (___) x7 days then transitioned to Ciprofloxacin x7 days ___ - ___ with plan for a 14 day course per ID -Surveillance cultures NGTD -ID signed off #Multiple Myeloma: #Pancytopenia (Improving): Diagnosed in ___ with anemia, ___ showing CD138 cells in 90% of marrow with abnormal plasma cells. He is status post plasmapharesis, velcade, auto transplant, ___, and other therapies with his last treatment being in ___. His counts the day of admission showed pancytopenia with neutropenia and a Cr of 1.8. His recent numbers over the past few months when trended (see above) showed a worsening free kappa/lambda since ___ with rising IgG. His ___ SPEP was deemed monoclonal. Given this change, plan was to obtain PET scan to further evaluate whether he has evidence of disease progression. Unclear if his pancytopenia is related to progression of disease or infection (counts improving now so presume likely infection related). Received x1 dose of GSCF on ___. Has mild LDH elevation which may be due to counts recovery/recent GSCF. Free Lamdba trending up modestly. Bone marrow biopsy done ___ (results pending). -Continue infectious prophylaxis: acyclovir -Transfuse if plts < 10 and/or hgb < 7 -B12 & folate normal; F/U zinc & copper -Plan for PET scan ___ outpatient. - follow up bone marrow bx results. #Asthma: #AS: #DOE/SOB: Improving overall since admission but persists. His SOB is subacute, has been ongoing episodically with exertion since approximately ___. He has had workup with cardiology, pulmonary, and hem/Onc with PFTs, TTE, EKG, and myeloma restaging. Overall, he has known asthma and AS; however, his other studies do not point to a clear cause. Per Pulmonary, concern raised for deconditioning. As suspicion for myeloma recurrence looms, his SOB may be a constitutional symptom reflecting brewing underlying disease. EKG and troponins are appropriate. CXR x2 without evidence of infection. No evidence of clot on CTA or LENIs. Of note, patient has been recently on apixaban (~ 2 weeks) as part of afib management but this has been on hold in s/o TCP. -Consider restarting apixaban if plts remains > 50K. -Continue supportive care #Epigastric & Chest Pain: Largely resolved but occasionally reports symptoms. Chest pain is sharp in intensity but does not refer elsewhere. No worsening of SOB or hypoxia. No exacerbating factors. Suspect GERD related. Current cardiac workup negative (no new arrhythmias, cardiac enzymes flat and repeat chest imaging without acute pulmonary infection). Improved with H2 blocker and continues on home PPI. -Remains on telemetry -Trend examination ___ (Resolved): #Abdominal Pain (Resolved): #N/V/D (Largely resolved): Resolved since admission but with recrudescence of diarrhea on ___ (? due to IV ABX). On admission, BUN/Cr = ___ was above his usual of 0.9 significantly. His bicarb is low reflecting metabolic acidosis. Previous values from ___ show a rising trend: Cr 0.9 on ___ and Cr 1.2 on ___. Thus, this has been a protracted process again, consistent with multiple myeloma. Contribution may also be from vomiting and diarrhea; Notably, RUQ U/S and CT A/P did not reveal abnormality so fundamental reason for his GI symptoms is unclear. ___ resolved with IVF. Overall stool studies have been unrevealing. -Repeat stool studies if persists -Loperamide prn -IVF prn -Lipase normal #Atrial Fibrillation with RVR: History of a-fib (on metoprolol ER 25mg). Held apixaban in setting of low plts. On telemetry and had been in NSR until ___ when he was in afib with rvr (rates in 170s, no recurrence since then). He was asymptomatic and maintaining BPs. -Continue metoprolol -Continue telemetry -Holding apixaban as above #Hypertension: Improved. SBPs ranging between 150-170s since admission, asymptomatic. Besides BB (metoprolol) for rate control in s/o known afib, patient is not on anti-HTNs. Unclear exacerbating factor at this point but will hold off on initiating new regimen. -Monitor and trend BPs #Hypophosphatemia: Suspect ___ decreased PO intake, repleting prn Chronic/Stable/Resolved Conditions ========================================== #Substance Use Disorder: #Depression: Has had issues in the past with improper use of benzodiazepines and opiates. Follows OSH Psychiatry and states he has been in remission for months. -Continue clonazepam as 1mg QID -Continue home escitalopram -Takes cannabinoid at home - but holding inpatient -B12 & folate normal as above #Lesion on Chest: #History of Basal Cell: Patient has lesion on chest which should be biopsied. However, given low counts, we will hold but will likely pursue dermatology follow up (could be done as an outpatient). #Orthostatic Hypotension: Continues florinef. -Hold off on daily orthostatic VS as stable -Held midodrine as he only takes it PRN. Transitional Issues ======================== [ ] Bone marrow biopsy results pending [ ] Stable right upper lobe 4 mm nodule [ ] follow up with cardiology [ ] consider restarting anticoagulation depending on platelet count. [ ] Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 1000 mg PO Q8H 2. Acyclovir 400 mg PO Q12H 3. ClonazePAM 1 mg PO BID 4. Cyanocobalamin 1000 mcg PO DAILY 5. Escitalopram Oxalate 20 mg PO DAILY 6. Fludrocortisone Acetate 0.2 mg PO DAILY 7. FoLIC Acid 1 mg PO DAILY 8. Gabapentin 900 mg PO QHS 9. Gabapentin 600 mg PO BID 10. Multivitamins W/minerals 1 TAB PO DAILY 11. Omeprazole 40 mg PO DAILY 12. PredniSONE 10 mg PO DAILY 13. Zolpidem Tartrate ___ mg PO QHS:PRN sleep 14. Naloxone Nasal Spray 4 mg IH ONCE MR1 opioid overdose 15. Vitamin D3 (cholecalciferol (vitamin D3)) 2,000 unit oral DAILY 16. Midodrine 2.5 mg PO TID Discharge Medications: 1. Ciprofloxacin HCl 500 mg PO Q12H Continue as ordered until ___ 2. Acetaminophen 325-650 mg PO Q4H:PRN Pain - Mild 3. ClonazePAM 1 mg PO QID:PRN anxiety 4. Acyclovir 400 mg PO Q12H 5. Cyanocobalamin 1000 mcg PO DAILY 6. Escitalopram Oxalate 20 mg PO DAILY 7. Fludrocortisone Acetate 0.2 mg PO DAILY 8. FoLIC Acid 1 mg PO DAILY 9. Gabapentin 900 mg PO QHS 10. Gabapentin 600 mg PO BID 11. Midodrine 2.5 mg PO TID:PRN orthostasis 12. Multivitamins W/minerals 1 TAB PO DAILY 13. Naloxone Nasal Spray 4 mg IH ONCE MR1 opioid overdose 14. Omeprazole 40 mg PO DAILY 15. PredniSONE 7.5 mg PO DAILY 16. Vitamin D3 (cholecalciferol (vitamin D3)) 2,000 unit oral DAILY 17. Zolpidem Tartrate ___ mg PO QHS:PRN sleep 18. HELD- Apixaban 5 mg PO BID This medication was held. Do not restart Apixaban until instructed to restart by your healthcare provider (due to low platelet count). Discharge Disposition: Home Discharge Diagnosis: Primary Diagnoses ===================== Klebsiella Bacteremia Pseudomonas UTI Dyspnea without Hypoxia Hypertension Secondary Diagnoses =========================== Multiple Myeloma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, You were admitted due to worsening shortness of breath, nausea, vomiting and diarrhea. Extensive workup showed infection in your blood and urine which were treated with IV antibiotics. You will complete treatment for your infections with oral antibiotics, ciprofloxacin. Please continue to take all of your medications as prescribed. Your appointment with Dr. ___ is as listed below. It was an absolute pleasure taking care of you. Sincerely, Your ___ TEAM Followup Instructions: ___
19986107-DS-20
19,986,107
27,203,962
DS
20
2171-06-29 00:00:00
2171-07-14 12:18:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: LUQ pain Major Surgical or Invasive Procedure: ___: Gel-Foam embolization of the left gastric artery. ___: Upper endoscopy History of Present Illness: ___ PMHx for alcoholism, DM, vasculitis and a remote hx of a rupture splenic artery pseudoaneurysm that was embolized ___ who was admitted from OSH with concerns for hemoperitoneum. Of significance, patient was seen by the surgical service in ___, for an acute onset of UGI bleed, with subsequent findings significant for ruptured pseudoaneurysm into the lesser sac of the stomach. CT scan back in ___ characterized two splenic ( proximal, distal) aneurysms. The proximal pseudoaneurysm that was ruptured was coiled. Patient did have a prolonged hospital course, but was eventually discharged in stable condition. Patient now states that she has been complaining of significant " bilateral rib pain" since ___ that have progressed. She now complains of colicky sharp left upper quadrant abdominal pain, as well as difficulty with PO intake. She states that she hasn't passed gas for ___ days. Denies fevers, BRBPR or UGB. She went to OSH where she was scanned, and was found to have a three pockets of hemoperitoneum, perihepatic, pelvic, and near the stomach. Past Medical History: PAST MEDICAL HISTORY: Autoimmune hepatitis Vasculitis HTN IBS Depression DM Alcoholism Migraines . PAST PSYCHITATRIC HISTORY: Pt sees a psychiatrist and a therapist for likely depression, with possibility of mania, per patient report. This is to be confirmed with her Psychiatrist (Dr ___ and therapist (Dr ___. She denies ever being hospitalized for such depressions. She states that she has contemplated suicide but has bot been really serious about it. She has poor sleep, treated with sleeping medicines, and feels guilty about not feeling good and letting her family down by not taking care of herself. Her mother's death ___ years ago, remains a source of her depression. Social History: SOCIAL HISTORY: Pt is older of two children, describes happy childhood. Denies abuse. One year of college. Works as a ___ for the fourth grade. Married with ___ old twins and is happy that she has coinciding holidays with them. SUBSTANCE USE: -Denies tobacco. -History of ETOH abuse though claims sobriety from ETOH for past ___ years. Used -to drink 1 qt whisky qday x years; denies ___. + blackouts, no seizures, no severe withdrawal. History of 2 detoxes at least, including ___ in ___. -History of fairly heavy marijuana use x years between ages ___ -History of heavy daily cocaine use x years between ages ___ -Denies IVDU Family History: FAMILY PSYCHIATRIC HISTORY: Sister and Grandmother diagnosed with depression. Her grandmother had been hospitalized for this. Physical Exam: Admission Physical exam: Vitals: Stable General: AAOx3 Cardiac: Normal S1, S2 Respiratory: Breathing comfortably on room air Abdomen: Soft, distended, tenderness in LUQ, mid tenderness RUQ. No rebound or guarding. No signs of peritonitis. Skin: No lesions Discharge Physical Exam: VS: 98.2, 99, 171/87, 18, 98% GEN: AA&O x 3, NAD, calm, cooperative. HEENT: (-)LAD, mucous membranes moist, trachea midline, EOMI, PERRL. CHEST: Clear to auscultation bilaterally, (-) cyanosis. ABDOMEN: (+) BS x 4 quadrants, soft, mildly tender to palpation EXTREMITIES: Warm, well perfused, pulses palpable, (-) edema Pertinent Results: ___ 03:15PM BLOOD Hct-29.9* ___ 03:11AM BLOOD WBC-11.2* RBC-2.88* Hgb-9.0* Hct-28.1* MCV-98 MCH-31.3 MCHC-32.0 RDW-12.9 RDWSD-45.1 Plt ___ ___ 07:22PM BLOOD WBC-11.5* RBC-2.76* Hgb-8.9* Hct-26.9* MCV-98 MCH-32.2* MCHC-33.1 RDW-12.9 RDWSD-45.0 Plt ___ ___ 05:10PM BLOOD WBC-11.7* RBC-2.72* Hgb-8.8* Hct-26.5* MCV-97 MCH-32.4* MCHC-33.2 RDW-12.9 RDWSD-45.2 Plt ___ ___ 12:50PM BLOOD WBC-12.7* RBC-2.80* Hgb-8.8* Hct-27.2* MCV-97 MCH-31.4 MCHC-32.4 RDW-12.9 RDWSD-45.2 Plt ___ ___ 11:06PM BLOOD WBC-10.3* RBC-2.55* Hgb-8.1* Hct-25.2* MCV-99* MCH-31.8 MCHC-32.1 RDW-13.0 RDWSD-46.2 Plt ___ ___ 07:44PM BLOOD WBC-11.0* RBC-2.36* Hgb-7.6* Hct-23.3* MCV-99* MCH-32.2* MCHC-32.6 RDW-12.9 RDWSD-45.1 Plt ___ ___ 02:27PM BLOOD WBC-13.3* RBC-2.66* Hgb-8.4* Hct-26.2* MCV-99* MCH-31.6 MCHC-32.1 RDW-12.8 RDWSD-45.3 Plt ___ ___ 05:26AM BLOOD WBC-9.9 RBC-2.97* Hgb-9.4* Hct-29.0* MCV-98 MCH-31.6 MCHC-32.4 RDW-12.8 RDWSD-45.2 Plt ___ Imaging: ___ CT A/P: 1. No evidence of aneurysm, pseudoaneurysm or active extravasation. 2. Small volume hemoperitoneum in the upper abdomen and pelvis, little changed from the outside hospital CT performed several hours earlier. 3. More localized fluid with surrounding stranding along the greater curvature of the stomach, raising the possibility that the source of bleeding is from the gastroepiploic territory. However, an underlying lesion cannot be excluded, and an MRI is recommended for further evaluation when clinically appropriate. ___ MESENTERIC ARTERIOGRAM: Abnormal appearance of the left gastric artery treated with Gel-Foam embolization. Otherwise, normal arteriograms of the celiac, gastroduodenal artery, gastroepiploic artery, and superior mesenteric artery, without active extravasation. ___ MRI Abdomen: 1. Limited exam due to the artifact from splenic artery embolization coils. Diffusion, and pre and post contrast sequences cannot be used to assess for tumor given this artifact. However, no obvious signal abnormality or other finding is seen in the gastric wall on other T1 or T2 weighted sequences. 2. Similar appearance of hematoma along the greater curvature of the stomach, intimately associated with the gastric wall, again raising the possibility of a gastroepiploic artery or gastric wall vascular abnormality as the etiology of this finding. 3. Main pancreatic ductal dilation to 6 mm without extrahepatic or intrahepatic biliary dilation. A ___ at the ampulla or ampullary stenosis is not excluded. 4. Bibasilar atelectasis, right greater than left. 5. 4 mm gallbladder polyp. No specific follow-up is needed for this finding. Brief Hospital Course: Ms. ___ was admitted to spontaneous hemoperitoneum with unknown etiology. CTA did not reveal any extravasation. ___ was consulted and an angiogram was performed. They did not see any extravasation but noted the left gastric to be abnormal in appearance. The left gastric was then gel-foam embolized given it's abnormal appearance. An MRI was obtained to rule out any gastric masses. It revealed a possibly abnormal gastric wall and a possibly stenotic ampulla. Given these findings GI was consulted. During this time, she was admitted to the ICU with the following course. Neuro: Her pain was controlled with IV and then subsequently PO pain medication. CV: hemodynamics were monitored closely. She was intermittently tachycardic upon arrival which shortly resolved. Resp: She remained stable on room air GI: Please see above imaging and intervention course. Her diet was advanced once her Hcts were stable. GU: UOP was adequate with a foley in place Heme: Serial hematocrits were obtained without need for transfusions. ID: no acute issues She was stable for transfer to the floor on ___. Hematocrit was stable and subcutaneous heparin was restarted for DVT prophylaxis. On HD5 the patient was triggered for hypotension, hypoxia, and downtrending hematocrit. Repeat CT of abdomen / pelvis showed mild interval decrease in the amount of small volume hemoperitoneum. Chest xray and cardiac enzymes were normal. The following day the hematocrit came up on its own. GI was consulted for endoscopic evaluation to rule out a gastric malignancy that may have led to her bleed. on HD7, the patient underwent an EGD, which was normal and showed no findings to explain the bleeding. Pain was well controlled. Diet was progressively advanced as tolerated to a regular diet with good tolerability. The patient voided without problem. During this hospitalization, the patient ambulated early and frequently, was adherent with respiratory toilet and incentive spirometry, and actively participated in the plan of care. The patient received subcutaneous heparin and venodyne boots were used during this stay. . At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient was discharged home without services. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. TraZODone 200 mg PO QHS:PRN insomnia 2. Verapamil 360 mg PO Q12H 3. Venlafaxine XR 150 mg PO DAILY 4. PredniSONE 7 mg PO DAILY 5. Metoclopramide 10 mg PO DAILY 6. Pramipexole 1 mg PO QHS 7. Omeprazole 20 mg PO BID 8. MethylPHENIDATE (Ritalin) 20 mg PO TID 9. NovoLIN 70/30 (insulin NPH and regular human) 8 units subcutaneous DAILY 10. Gabapentin 1200 mg PO BID 11. Fluticasone Propionate NASAL 2 SPRY NU DAILY 12. Fluoxetine 20 mg PO DAILY 13. Celebrex ___ mg oral BID 14. Atenolol 25 mg PO DAILY Discharge Medications: 1. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp #*20 Tablet Refills:*0 2. NovoLIN 70/30 (insulin NPH and regular human) 8 units subcutaneous DAILY 3. Celebrex ___ mg oral BID 4. Senna 8.6 mg PO BID 5. Atenolol 25 mg PO DAILY 6. Fluoxetine 20 mg PO DAILY 7. Fluticasone Propionate NASAL 2 SPRY NU DAILY 8. Gabapentin 1200 mg PO BID 9. MethylPHENIDATE (Ritalin) 20 mg PO TID 10. Metoclopramide 10 mg PO DAILY 11. Omeprazole 20 mg PO BID 12. Pramipexole 1 mg PO QHS 13. PredniSONE 7 mg PO DAILY 14. TraZODone 200 mg PO QHS:PRN insomnia 15. Venlafaxine XR 150 mg PO DAILY 16. Verapamil 360 mg PO Q12H 17. Bisacodyl 10 mg PO/PR DAILY:PRN constipation 18. Docusate Sodium 100 mg PO BID Discharge Disposition: Home Discharge Diagnosis: Hemoperitoneum Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were transferred to ___ with complaints of abdominal pain and CT imaging concerning for blood in your peritoneum but did not show any active bleeding. You were admitted for close monitoring for any sign of continued bleeding. Your hematocrit and vital signs have been stable and you did not require any blood transfusions or interventional procedure to stop the bleeding. The Gastroenterology doctors were ___, and they performed an endoscopic exam of your stomach, which showed no findings on EGD to explain the bleeding. You are now tolerating a regular diet and your pain is improved. You are ready to be discharged home to continue your recovery. Please note the following discharge instructions: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Followup Instructions: ___
19986183-DS-12
19,986,183
28,820,683
DS
12
2193-08-12 00:00:00
2193-08-22 08:58:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Codeine / pseudoephedrine Attending: ___ Chief Complaint: Hyperglycemia Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ female with past medical history notable for Type 1 DM and NHL who presented with hyperglycemia in the setting of taking steroids. Patient states it all began ~ 2 weeks prior to admission where she noticed LLE>RLE. She was sent to ___ where significant workup was done to rule out PE (with CTA and LENIs). It was concluded she had no clot, however she was found to have worsening of her Non-Hodgkin's lymphoma. Her oncologist prescribed dexamethasone for 4 days which she started taking 2 days prior to admission (with plan for initiation of rituximab in 1 week - ___. Both patient and providers were aware of hyperglycemia and thus she was closely monitoring her sugars. Of note patient is very knowledgeable about her sugars and diabetes management. She uses an insulin pump with Humalog and noticed elevated sugars as expected. However when sugars started being uncontrolled and instructions by phone from ___ did not resolve them (with basal insulin adjustment), she presented to the emergency room. She denies any symptoms except a cough for the past month. She denies dizziness, increased urinary frequency, chest pain, N/v/Diarrhea In the ED - Initial vitals: 96.6 74 110/66 16 100% on RA - Labs: + WBC 13.4 Hgb 10.8 Plt 267 + Na 123, K 6.5 (hemolyzed) creatinine 1.2 - Imaging: Cxray with no findings - Patient was given ceftriaxone for a question of UTI and regular insulin 10units, followed by 8 units humalog Transfer vitals HR 77 BP 126/93 RR 16 98% on RA. Patient's ___ on arrival to the floor is ~ 180 Past Medical History: - Type I DM (on insulin pump) - Non-Hodgkin's Lymphoma (diagnosed ___ and never treated) - Hyperlipidemia - Hypertension Social History: ___ Family History: Reviewed and found to be not relevant to this illness/reason for hospitalization. Physical Exam: Admission physical exam: VITALS: Afebrile and vital signs stable (see eFlowsheet) GENERAL: Alert and in no apparent distress EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate, oral mucosa is dry CV: Heart regular, no murmur, no S3, no S4. No JVD. RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. No HSM. Insulin pump attached to RLQ - area is clean with no erythema GU: No suprapubic fullness or tenderness to palpation MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs, 2+ BLE with LLE>RLE NEURO: Alert, oriented, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs, sensation to light touch grossly intact throughout PSYCH: pleasant, appropriate affect Discharge physical exam: ___ 0818 Temp: 98.5 PO BP: 107/58 HR: 93 RR: 18 O2 sat: 99% O2 delivery: Ra GENERAL: Alert and in no apparent distress EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate, oral mucosa is dry CV: Heart regular, no murmur, no S3, no S4. No JVD. RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. No HSM. Insulin pump attached to RLQ - area is clean with no erythema GU: No suprapubic fullness or tenderness to palpation MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs, 3+ BLE with LLE>RLE NEURO: Alert, oriented, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs, sensation to light touch grossly intact throughout PSYCH: pleasant, appropriate affect Pertinent Results: Admission labs =============== ___ 04:17AM BLOOD WBC-13.4* RBC-4.03 Hgb-10.8* Hct-32.6* MCV-81* MCH-26.8 MCHC-33.1 RDW-13.8 RDWSD-40.4 Plt ___ ___ 04:17AM BLOOD Glucose-441* UreaN-45* Creat-1.2* Na-123* K-6.5* Cl-87* HCO3-19* AnGap-17 ___ 04:17AM BLOOD Calcium-12.2* Phos-4.6* Mg-1.6 ___ 05:55AM BLOOD 25VitD-10* ___ 06:42AM BLOOD PTH-20 ___ 05:55AM BLOOD PEP-NO MONOCLO IgG-628* IgA-90 IgM-31* IFE-NO MONOCLO Discharge labs ================ ___ 05:55AM BLOOD WBC-6.6 RBC-3.93 Hgb-10.6* Hct-31.8* MCV-81* MCH-27.0 MCHC-33.3 RDW-14.2 RDWSD-41.3 Plt ___ ___ 05:55AM BLOOD Glucose-60* UreaN-37* Creat-1.0 Na-140 K-4.0 Cl-103 HCO3-23 AnGap-14 ___ 05:55AM BLOOD TotProt-4.8* Albumin-2.9* Globuln-1.9* Calcium-12.4* Phos-4.3 Mg-1.8 ___ 04:31AM BLOOD Lactate-2.1* K-4.2 Brief Hospital Course: Ms. ___ is a ___ female with past medical history notable for Type 1 DM and NHL who presented with hyperglycemia in the setting of taking steroids. ACUTE/ACTIVE PROBLEMS: # Hyperglycemia: # Type 1 DM: Patient with Type I DM and presenting with elevated sugars in the setting of taking dexamethasone for treatment of advancing NHL. No evidence of DKA currently. Patient uses an insulin pump and very experienced with its use, and given ability to manage her own sugars with well controlled numbers we continued to use the pump with her direction and ___ support. No evidence of infection. No chest pain/cardiac symptoms. # Hyponatremia: Resolved/ likely in the setting of high sugars. Na was 123 on admission but corrected for sugars was ~130. Discharge Na was 140 # Hypercalcemia: Currently asymptomatic and stable. We reviewed ___ records where her last calcium in ___ was ~10.1. This is likely new in the setting of malignancy. In order not to anchor on that, work up done to rule out other etiologies (workup pending at the time of discharge): PTH, Vitamin D, SPEP and UPEP given trace anemia. Patient educated to avoid factors that can aggravate hypercalcemia, including thiazide diuretics, volume depletion (to drink ___ glasses of water daily given risk of dehydration in the setting of diabetes, avoid high calcium diet (>1000 mg/day). # Leukocytosis: Resolved. No evidence of infection despite intermittent cough for ~ 1 month (patient states was treated for Pneumonia ~ 1 month ago). Leukocytosis likely due to steroids. # NHL: Significantly advanced per patient report and CT image records patient presented. LLE>RLE worked up and DVT ruled out at ___ ~ 2 weeks earlier with suspicion for malignancy as etiology. TRANSITIONAL ISSUES ====================== - F/u on workup sent for hypercalcemia - Continue to monitor calcium as outpatient and ensure it is mild or moderate >30 minutes spent on discharge planning and coordination Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Dexamethasone 4 mg PO DAILY 2. Probiotic (B. coagulans) (Bacillus coagulans) 10 billion cell oral DAILY 3. Insulin Pump SC (Self Administering Medication)Insulin Lispro (Humalog) Target glucose: 80-180 4. Simvastatin 20 mg PO QPM 5. Aspirin EC 81 mg PO DAILY Discharge Medications: 1. Insulin SC Sliding Scale Insulin SC Sliding Scale using HUM Insulin 2. Aspirin EC 81 mg PO DAILY 3. Probiotic (B. coagulans) (Bacillus coagulans) 10 billion cell oral DAILY 4. Simvastatin 20 mg PO QPM Discharge Disposition: Home Discharge Diagnosis: Hyperglycemia Hypercalcemia Hyponatremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Miss ___, ___ were admitted due to uncontrolled sugar in the setting of taking steroids. ___ improved significantly managing your sugars with your insulin pump. Please DO NOT take anymore steroids and follow up with your doctor. Your calcium levels were also found to be moderately elevated. ___ had no symptoms and ___ were also hydrated significantly in the hospital. We sent labs to understand what caused this (which were pending by discharge) though we also suspect the Lymphoma could be the cause. Please follow up with your doctor to ensure your calcium levels are rechecked. It was a pleasure being part of your team Your ___ team Followup Instructions: ___
19986230-DS-16
19,986,230
21,266,234
DS
16
2188-12-16 00:00:00
2188-12-18 22:14:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: UROLOGY Allergies: Oxycodone / Naprosyn Attending: ___. Chief Complaint: L flank pain Major Surgical or Invasive Procedure: cystoscopy, L ureteral stent History of Present Illness: This is a ___ year old female who presents with right lower quadrant pain. She reports sudden onset of RLQ pain starting 2 days ago that radiated to her right flank. This was associated with nausea, emesis x1, and chills. Denies dysuria, hematuria, fevers. She denies history of nephrolithiasis. Past Medical History: PGynHx: No abl paps, regular menses until ___, no STIs PObHx: G5P4, 1 TAB PMH: Reported no current medical issues, though in reports found notes re. ___ right breast granular cell tumor found on bx but no f/u from pt. Also h/o back pain. PSH: ___ - laparoscopically assisted vaginal hysterectomy with cystoscopy ___: Operative hysteroscopy with myomectomy and endometrial ablation with rollerball ___: R breast bx Social History: ___ Family History: FamHx: no breast, gyn, colon malignancy. + fam history of fibroids. Physical Exam: On discharge: NAD No cardiopulmonary distress Abd soft nt nd Pertinent Results: ___ 06:15AM BLOOD WBC-7.4 RBC-4.35 Hgb-11.8 Hct-37.8 MCV-87 MCH-27.1 MCHC-31.2* RDW-15.6* RDWSD-49.5* Plt Ct-94* ___ 06:15AM BLOOD Glucose-110* UreaN-11 Creat-1.1 Na-142 K-3.8 Cl-108 HCO3-21* AnGap-13 Brief Hospital Course: This is a ___ yF who presented with obstructive uropathy and SIRS (fevers, leukocytosis) due to a L ureteral calculus. She underwent a cystoscopy, R ureteral stent placement by Dr. ___ on ___. Post-operatively, the patient's hospitalization stay involved treating septicemia (Proteus, pan-sensitive) that grew in her blood on presentation. She stayed until ___ when she de-effervesced. Her Foley was removed prior to discharge. When it was demonstrated that she was afebrile x 24 hours on oral therapy and voiding without issues, she was discharged on ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 10 mg PO DAILY Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever Reason for PRN duplicate override: Alternating agents for similar severity 2. Ibuprofen 600 mg PO Q8H:PRN pain/fever 3. Polyethylene Glycol 17 g PO DAILY:PRN constipation 4. Sulfameth/Trimethoprim DS 1 TAB PO BID RX *sulfamethoxazole-trimethoprim 800 mg-160 mg 1 tablet(s) by mouth twice a day Disp #*22 Tablet Refills:*0 5. Tamsulosin 0.4 mg PO DAILY RX *tamsulosin 0.4 mg 1 capsule(s) by mouth daily Disp #*30 Capsule Refills:*1 6. TraMADol 50-100 mg PO Q4H:PRN BREAKTHROUGH PAIN RX *tramadol 50 mg 1 tablet(s) by mouth every six (6) hours Disp #*15 Tablet Refills:*0 7. Lisinopril 10 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Urosepsis secondary to obstructed ureteral stone Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Take antibiotic as prescribed for 11 days. Drink 8 or more glasses of water daily. Go to emergency room if you develop any of the following: fevers nausea/vomiting leading to inability to tolerate fluids worsening pain persistent shakes and chills The urology office phone number is ___. Call office on ___ to confirm your surgery date. Followup Instructions: ___
19986309-DS-19
19,986,309
21,193,364
DS
19
2117-06-01 00:00:00
2117-06-01 15:23:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Left sided weakness and tingling Major Surgical or Invasive Procedure: None History of Present Illness: ___ is an ___ yo right handed man with a history of metastatic SCLC with solitary left cerebellar brain met s/p gamma knife radiosurgery in ___ (gets care at ___) who presents with transient left arm weakness, as well as abnormal sensation in his face. The day of presentation he tried to pick up a glass of juice with his left hand at around 6:30 pm but found he was unable. He could reach to the glass and wrap his fingers around it, but couldn't bring it to his mouth. He denies having shaking in his arm. At the same time his left face began to "feel funny" like a swollen numb feeling. The arm was weak for ___ minutes. The left face was numb for ~7 minutes. Then, the sensation he had on his left face moved to his right face. He walked to the kitchen and told his daughter about his symptoms, who called an ambulance. He was taken to ___ where ___ was read as having a SAH vs. laminar necrosis with edema in the right parietal cortex. He was transferred to ___ for neurology evaluation. He denied trouble talking or walking. He doesn't know if his face was drooping. This morning, he feels back to normal apart from a mild headache, though this is similar to his chronic headaches which are a pressure like sensation in his forehead bilaterally. He gets care at ___ for "brain cancer and lung cancer". He's had radiation treatment for the brain cancer. He doesn't know what type of cancer it is, but denies it being a metastasis from his lung cancer. He says he was treated for his cancer ___ years ago and he's been told he is currently cancer free. Review of Systems: + for recent cough w/ SOB, chronic dizziness, chronic memory problems, and headache; The pt denies loss of vision, blurred vision, diplopia, dysarthria, dysphagia, lightheadedness, tinnitus or new hearing difficulty. Denies difficulties producing or comprehending speech. No bowel or bladder incontinence or retention. Denies new difficulty with gait. The pt denies recent fever or chills. Denies chest pain or palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies rash. Past Medical History: -metastatic small cell lung cancer diagnosed ___ - s/p chemo and radiation (___, metastatic to L1, adrenal gland, and brain -solitary brain met to left cerebellum s/p gamma knife radiosurgery ___ -diabetes -HLD -hypothyroidism -HTN Social History: ___ Family History: history of cancer in family Physical Exam: Admission Exam: Vitals: 97.1 69 136/77 15 96% RA General: Awake, cooperative, NAD. HEENT: NC/AT Neck: Supple. Pulmonary: breathing comfortably on RA CV: RRR Abdomen: soft, nondistended Extremities: no edema, warm Skin: no rashes or lesions noted. Neuro: -Mental Status: Awake, not oriented to ___ but knows he's in a hospital. Has difficulty relating details of his medical history. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt. was able to name both high and low frequency objects. Speech was not dysarthric. Able to follow both midline and appendicular commands. Inattentive, unable to name ___ backward (stuck at ___. There was no evidence of neglect. -Cranial Nerves: I: Olfaction not tested. II: in light: left pupil 3.5->2.5, right 2.5->1.5mm; pupillary asymmetry is more pronounced in the dark. VFF to confrontation with finger counting. III, IV, VI: EOMI without nystagmus. slightly smaller palpebral fissure on right V: Facial sensation intact to light touch and pin in all distributions VII: Subtle decreased activation of left lower face with flattening of the NLF. VIII: hard of hearing. IX, X: Palate elevates symmetrically. XI: full strength in trapezii bilaterally. XII: Tongue protrudes in midline -Motor: Normal bulk throughout. No pronator drift bilaterally. No tremor noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L ___ ___ ___ 5 5 5 5 5 R ___ ___ ___ 5 5 5 5 5 -DTRs: ___ Tri ___ Pat Ach L 1 tr tr 1+ 0 R 1 tr tr 1+ 0 - Toes were downgoing bilaterally. -Sensory: left arm and leg with 50% pinprick sensation compared to right. Decreased temperature sensation in left arm. Temperature gradient in the legs. Vibration absent in the feet. -Coordination: ?subtle dysmetria on FNF bilaterally. Rapid alternating movements are slower on the left. -Gait: Good initiation. Narrow-based, normal stride, appears mildly unsteady. Romberg absent but with subjective unsteadiness. Discharge Exam: Vitals: 97.9 155/95 66 17 98% RA General: Awake, cooperative, NAD. HEENT: NC/AT Neck: Supple. Pulmonary: breathing comfortably on RA CV: RRR Abdomen: soft, nondistended Extremities: no edema, warm Skin: no rashes or lesions noted. Neuro: -Mental Status: Awake, initially not oriented to date, but recalled that it was ___ and ___ is fluent with intact repetition and comprehension. Normal prosody. Pt. was able to name high but not low frequency objects ("pen" but not "tip", "glasses" but not "lens"). Speech was not dysarthric. Able to follow both midline and appendicular commands. Inattentive, unable to name ___ backward (stuck at ___. There was no evidence of neglect. -Cranial Nerves: I: Olfaction not tested. II: in light: left pupil 3->2, right 2->1mm; pupillary asymmetry is more pronounced in the dark. VFF to confrontation with finger counting. III, IV, VI: EOMI without nystagmus. slightly smaller palpebral fissure on right (pseudoptosis, R eye inverse ptosis) V: Facial sensation intact to light touch and pin in all distributions VII: face symmetrical with mild flattening of NLF on left VIII: hard of hearing. IX, X: Palate elevates symmetrically. XI: full strength in trapezii bilaterally. XII: Tongue protrudes in midline -Motor: Normal bulk throughout. No pronator drift bilaterally. No tremor noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L ___ ___ ___ 5 5 5 5 5 R ___ ___ ___ 5 5 5 5 5 -DTRs: ___ Tri ___ Pat Ach L 1 tr tr 1+ 0 R 1 tr tr 1+ 0 - Toes were downgoing bilaterally. -Sensory: intact to light touch throughout -Coordination: subtle dysmetria on FNF bilaterally with pass-pointing. Pertinent Results: OSH Labs: Na 143 K 4.6 Cl 103 Glu 90 bicarb 28 Cr 1.2 BUN 18 ALT 10 AST 17 trop <0.01 WBC 4.6 Hb 13.1 ___ 12.8 INR 1.15 PTT 31.6 Admission Labs ___ @12:15am: WBC-3.3* RBC-3.84* Hgb-12.9* Hct-38.5* MCV-100* MCH-33.6* MCHC-33.5 RDW-12.7 RDWSD-46.8* Plt Ct-72* Neuts-47.3 ___ Monos-10.1 Eos-1.8 Baso-0.6 Im ___ AbsNeut-1.55* AbsLymp-1.31 AbsMono-0.33 AbsEos-0.06 AbsBaso-0.02 ___ PTT-30.4 ___ Glucose-92 UreaN-18 Creat-1.0 Na-139 K-4.1 Cl-103 HCO3-24 AnGap-16 Discharge Labs ___ @07:45am WBC-3.9* RBC-3.96* Hgb-13.2* Hct-39.6* MCV-100* MCH-33.3* MCHC-33.3 RDW-12.4 RDWSD-46.4* Plt ___ Glucose-80 UreaN-15 Creat-0.9 Na-141 K-3.7 Cl-105 HCO3-25 AnGap-15 Calcium-9.1 Phos-2.7 Mg-1.6 Images: NCHCT ___ - ___ PRIMARY READ: ribbon-like high density in the right parietal lobe superiorly with surrounding mild intra-axial edema. Finding is nonspecific may be secondary to small subarachnoid hemorrhage or possibly laminar necrosis secondary to recent infarct in this area. - ___ SECOND READ: 1. Right frontal subarachnoid hemorrhage. 2. Reported brain tumor not visualized on this non-contrast enhanced study and review of prior imaging is recommended. CTA HEAD & CTA NECK: WET READ ___ Non con head: Stable to perhaps minimal increase in right frontal subarachnoid hemorrhage. Otherwise no significant change from prior. CTA: Final read pending 3D recons. The carotid and vertebral arteries and their major intracranial branches are patent with no aneurysm greater than 3mm, high-grade stenosis or other vascular abnormality. Numerous pulmonary nodules bilaterally. Comparison with prior imaging would be helpful to evaluate stability. MR HEAD W & W/OUT CONTRAST: ___ 1. Sulcal FLAIR hyperintensity and leptomeningeal enhancement involving the right central, precentral and superior frontal sulci. Additional focus of leptomeningeal enhancement at the left frontal superior gyrus. Findings may represent reactive changes secondary to subarachnoid hemorrhage versus leptomeningeal carcinomatosis, given clinical history of lung cancer. Consider correlation with CSF cytology and/or follow up imaging to characterize the evolution of these findings. 2. Extensive bilateral cortical siderosis consistent with prior subarachnoid hemorrhages. 3. No discrete parenchymal lesion. CXR PA & LAT: ___ The lungs are mildly hyperinflated. The cardiomediastinal contour is within normal limits. The heart is not enlarged. There is a slightly prominent epicardial fat pad along the right heart border. No consolidation, pneumothorax or pleural effusion seen. There are moderately severe multilevel degenerative changes in the thoracic spine. Brief Hospital Course: ___ is an ___ yo R-handed man with a history of metastatic SCLC (with a single cerebellar met s/p knife radiosurgery) who presented to OSH with transient left arm weakness, as well as left followed by right face numbness. A ___ at ___ demonstrated a right frontal convexal subarachnoid hemorrhage, which may have prompted a seizure leading to his transient symptoms. The etiology of his SAH is unclear; the differential includes metastatic lesion from his known expanding primary lung cancer (no current evidence of MRI), amyloidosis (no evidence on MRI), AVM (no evidence on CTA), traumatic (no history but patient poor historian), aneurysm (not seen on CTA), or RCVS. Upon admission to ___, all of his labs were within normal limits; he was given Keppra 1000mg PO for seizure prophylaxis. A CTA of the head and neck showed no aneurysms with patent carotid and vertebral arteries. An MRI did not show any discrete masses or evidence of amyloid. It did show sulcal FLAIR hyperintensity and leptomeningeal enhancement involving the right central, precentral and superior frontal sulci. Additional focus of leptomeningeal enhancement at the left frontal superior gyrus. This could be consistent with reactive changes secondary to SAH versus leptomeningeal carinomatosis. The MRI also showed evidence of extensive bilateral sidersosis from prior SAHs. He improved over the course of his admission, and his neurological exam was unremarkable the day after admission. He was discharged home on 1g Keppra BID with plans to follow-up with his oncologist at ___ for further workup regarding the etiology of his SAH including outpatient LP once SAH resorbs and plans to have his PCP refer him to a neurologist for outpatient titration of Keppra. Transitional Issues: -Spoke with outpatient ___ on-call oncologist, Dr. ___ agreed to pursue further work-up for etiology of ___ as outpatient - Will need to follow-up with oncologist, Dr. ___ evidence of mass or amyloid on MRI - Will need outpatient referral by PCP to neurologist in home network for titration of Keppra; currently on 1g Keppra BID due to concern for seizure - Will need outpatient monitoring of blood pressure (goal BP<140/90) -CTA final read pending (wet read only) -Numerous pulmonary nodules on CTA Medications on Admission: The Preadmission Medication list is accurate and complete. 1. MetFORMIN (Glucophage) 750 mg PO TID 2. Pioglitazone 15 mg PO DAILY 3. Atorvastatin 20 mg PO QPM 4. Levothyroxine Sodium 25 mcg PO DAILY 5. Lisinopril 10 mg PO DAILY Discharge Medications: 1. Atorvastatin 20 mg PO QPM 2. Levothyroxine Sodium 25 mcg PO DAILY 3. Lisinopril 10 mg PO DAILY 4. Pioglitazone 15 mg PO DAILY 5. LeVETiracetam 1000 mg PO BID RX *levetiracetam 1,000 mg 1 tablet(s) by mouth twice daily Disp #*30 Tablet Refills:*2 6. MetFORMIN (Glucophage) 750 mg PO TID Discharge Disposition: Home Discharge Diagnosis: Subarachnoid hemorrhage Discharge Condition: Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Mental Status: Confused - sometimes. Discharge Instructions: Dear Mr. ___, You were admitted with a brain bleed ("subarachnoid hemorrhage"). There was no evidence of a new mass on your MRI. It will be important for you to buy a blood pressure cuff and measure your blood pressure once daily at home and keep a diary of blood pressures. Bring this diary to your primary care doctor. Your goal blood pressure should be less than 140 for the top number and less than 90 for the bottom number. We are concerned that your symptoms may have been due to a seizure due to irritation of your brain by the blood. We have started you on a seizure medication (Keppra); you will need to take 1 gram twice a day. We spoke with the on-call oncologist at the office at ___ that follows you for your cancer. It will be very important that you call them to make a follow-up appointment due to the growing cancer in your lungs and for further work-up to make sure you do not have a new mass in your brain. It was a pleasure meeting you! Your ___ Neurology Team Followup Instructions: ___
19986341-DS-19
19,986,341
25,942,220
DS
19
2169-10-20 00:00:00
2169-10-20 21:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Shortness of breath Major Surgical or Invasive Procedure: Pericardiocentesis History of Present Illness: ___ with PMHx aortic stenosis s/p AVR(#23MM Magna Ease) and coronary artery disease s/p coronary artery bypass graft x 2 (LIMA-LAD, SVG-D) ___, alcohol use disorder, T2DM, gout, HLD, HTN, a-fib on apixiban admitted to the CCU for management of pericardial tamponade and cardiogenic shock. He presented with 1 day of significant shortness of breath, inability to lay flat and extreme weakness. The patient denies any chest pain or abdominal pain. He also has hyperglycemia and metabolic acidosis concerning for DKA. Bedside ultrasound showed a large pericardial effusion with significant right ventricular collapse consistent with pericardial tamponade. The patient received K-Centra. In the ED, - Initial vitals were: 96.0 100 ___ 95% 2L NC - Labs notable for: -H/H 12.1/41.8, WBC 15.0, plt 239 -Na 128, BUN 22, Cr 1.7, glucose 390 -___ 19.9, PTT 27.1, INR 1.8 -Trop-T < 0.01 -VBG 7.18/42 - Studies notable for: CXR: Low lung volumes with mild retrocardiac atelectasis and trace left pleural effusion. Possible mild pulmonary vascular congestion without frank pulmonary edema. - Patient was given: IV Kcentra, 1L NS Bedside ECHO performed by cardiology fellow notable for large pericardial effusion. Patient subsequently taken to the cath lab for emergent pericardiocentesis. Per procedural report, "The pericardial space was accessed from the subxiphoid approach with echocardiographic and fluoroscopic guidance. The initial mean pericardial pressure was 35 mm Hg with an amber fluid dripping back. After removal of 865 mL of dark amber (slightly reddish brown fluid: 60+60+20 mL in syringes, 725 in vacuum bottle), the pericardial effusion was minimal on echocardiogram with marked symptomatic improvement and closing pericardial pressure of 3 mm Hg. The pericardial drainage catheter was secured in place." On arrival to the CCU, the patient feels much improved and was sitting comfortably in bed. He denied any dizziness, LH, CP, SOB, abdominal pain, n/v/d, or urinary symptoms. ROS: Positive per HPI. Remaining 10 point ROS reviewed and negative. Past Medical History: Alcohol Abuse Aortic Stenosis Diabetes Mellitus Type II Gout Hyperlipidemia Hypertension Social History: ___ Family History: No family history of heart disease Physical Exam: ADMISSION EXAM: =============== VS: Reviewed in MetaVision GENERAL: Well developed, well nourished in NAD. Oriented x3. Mood, affect appropriate. HEENT: Sclera anicteric. PERRL. EOMI. NECK: Supple. JVP 10 at 60 degrees. CARDIAC: rrr, ___ holo-systolic murmur, no g/r CHEST: Healing sternotomy scar; mild-moderate bibasilar crackles, no wheeze. ABDOMEN: NTND, bowel sounds present EXTREMITIES: WWP, no pitting edema SKIN: No significant lesions or rashes. PULSES: Distal pulses palpable and symmetric. NEURO: CNII-XII intact DISCHARGE LABS: =============== 24 HR Data (last updated ___ @ 316) Temp: 98.0 (Tm 98.8), BP: 147/83 (123-147/62-88), HR: 97 (75-97), RR: 18, O2 sat: 96% (96-99), O2 delivery: Ra GENERAL: Well developed, well nourished in NAD. Oriented x3. Mood, affect appropriate. HEENT: Sclera anicteric. PERRL. EOMI. NECK: Supple. JVP 8 at 60 degrees. CARDIAC: rrr, ___ holo-systolic murmur, no g/r CHEST: Healing sternotomy scar; mild-moderate bibasilar crackles, no wheeze. ABDOMEN: NTND, bowel sounds present EXTREMITIES: WWP, no pitting edema SKIN: No significant lesions or rashes. PULSES: Distal pulses palpable and symmetric. NEURO: CNII-XII intact Pertinent Results: ADMISSION LABS ============== ___ 06:55PM BLOOD WBC-15.0* RBC-5.92 Hgb-12.1* Hct-41.8 MCV-71* MCH-20.4* MCHC-28.9* RDW-18.6* RDWSD-42.3 Plt ___ ___ 06:55PM BLOOD Neuts-72.0* ___ Monos-4.6* Eos-0.2* Baso-0.9 NRBC-0.2* Im ___ AbsNeut-10.78* AbsLymp-3.18 AbsMono-0.69 AbsEos-0.03* AbsBaso-0.13* ___ 06:55PM BLOOD ___ PTT-27.1 ___ ___ 06:55PM BLOOD Glucose-390* UreaN-22* Creat-1.7* Na-128* K-7.5* Cl-95* HCO3-11* AnGap-22* ___ 01:52AM BLOOD ALT-261* AST-186* AlkPhos-76 TotBili-0.5 ___ 06:55PM BLOOD cTropnT-<0.01 ___ 10:01PM BLOOD Calcium-8.6 Phos-5.8* Mg-1.7 ___ 07:05PM BLOOD Lactate-9.2* DISCHARGE LABS ============== ___ 07:27AM BLOOD WBC-7.7 RBC-5.92 Hgb-12.0* Hct-40.5 MCV-68* MCH-20.3* MCHC-29.6* RDW-17.3* RDWSD-38.7 Plt ___ ___ 07:27AM BLOOD Glucose-239* UreaN-19 Creat-0.9 Na-136 K-4.6 Cl-100 HCO3-22 AnGap-14 ___ 06:55AM BLOOD ALT-182* AST-25 AlkPhos-102 TotBili-0.5 ___ 07:27AM BLOOD Calcium-9.8 Phos-4.1 Mg-1.9 PERTINENT LABS ============== ___ 05:06AM BLOOD CK-MB-2 cTropnT-0.05* ___ 06:55PM BLOOD Beta-OH-0.2 ___ 05:06AM BLOOD HBsAg-NEG HBsAb-POS HBcAb-POS* HAV Ab-POS* ___ 06:27AM BLOOD CRP-18.7* ___ 05:06AM BLOOD HCV Ab-NEG ___ 10:19PM BLOOD Lactate-5.8* ___ 02:14AM BLOOD Lactate-2.8* ___ 12:19PM BLOOD Lactate-1.3 ___ 05:06AM BLOOD HBsAg-NEG HBsAb-POS HBcAb-POS* HAV Ab-POS* ___ 02:56PM BLOOD IgM HAV-NEG ___ 06:27AM BLOOD HBV VL-NOT DETECT HCV VL-NOT DETECT ___ 05:06AM BLOOD HCV Ab-NEG IMAGING ======= CXR - ___ Low lung volumes with mild retrocardiac atelectasis and trace left pleural effusion. Possible mild pulmonary vascular congestion without frank pulmonary edema. TTE - ___ EF > 60%. Well seated, normal functioning bioprosthetic AVR with normal gradient and no aortic regurgitation. Normal left ventricular wall thickness and biventricular cavity sizes and regional/global systolic function. Small circumferential pericardial effusion without echocardiographic evidence for tamponade physiology. Compared with the prior TTE (images reviewed) of ___ , the pericardial effusion is now slightly larger but remains small and without echo evidence of hemodynamic compromise. CXR - ___ In comparison with the study of ___, following pericardiocentesis the cardiac silhouette is now essentially within normal limits. Pericardial drain is in place. Blunting of the left costophrenic angle is consistent with pleural fluid. No evidence of appreciable vascular congestion or acute focal pneumonia. RUQUS - ___ 1. Echogenic liver consistent with steatosis. Other forms of liver disease and more advanced liver disease including steatohepatitis or significant hepatic fibrosis/cirrhosis cannot be excluded on this study. 2. Mild splenomegaly. 3. Cholelithiasis. Focused TTE - ___ The estimated right atrial pressure is ___ mmHg. There is suboptimal image quality to assess regional left ventricular function. Overall left ventricular systolic function is normal. The visually estimated left ventricular ejection fraction is 60%. Normal right ventricular cavity size with depressed free wall motion. The mitral valve leaflets are mildly thickened. There is moderate mitral annular calcification. Due to acoustic shadowing, the severity of mitral regurgitation could be UNDERestimated. There is a small posterior pericardial effusion. The effusion is echo dense, c/w blood, inflammation or other cellular elements. There are no 2D or Doppler echocardiographic evidence of tamponade. Compared with the prior TTE (images reviewed) of ___, there is no obvious change, but the suboptimal image quality of the studies precludes definitive comparison. CT abdomen/pelvis without contrast - ___ 1. Punctate, subpleural nodules in the right lower lobe are nonspecific, but likely infectious versus inflammatory in etiology. 2. Trace residual pericardial effusion with a pericardial drain in situ. 3. Incidentally noted are multiple healing right-sided rib fractures. TTE - ___ Small posterior loculated pericardial effusion without tampoande. Compared with the prior TTE ___ , small posterior effusion not echolucent. Appears slightly larger (see apical 4 and apical long axis views). MICRO ===== PERICARDIAL FUID. **FINAL REPORT ___ GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method, please refer to hematology for a quantitative white blood cell count, if applicable. FLUID CULTURE (Final ___: NO GROWTH. ANAEROBIC CULTURE (Final ___: NO GROWTH. URINE CULTURE (Final ___: NO GROWTH. Blood Culture, Routine (Final ___: NO GROWTH. PATH ==== Pericardial fluid - ___: NEGATIVE FOR MALIGNANT CELLS. Predominantly lymphocytes, with scattered admixed reactive mesothelial cells. Brief Hospital Course: ___ with PMHx aortic stenosis s/p AVR(#23MM Magna Ease) and coronary artery disease s/p coronary artery bypass graft x 2 (LIMA-LAD, SVG-D) ___, alcohol use disorder, T2DM, gout, HLD, HTN, a-fib on apixiban admitted to the CCU for management of pericardial tamponade and cardiogenic shock. ACUTE ISSUES ============ # Pericardial effusion w/ effusoconstrictive physiology Patient presented to ED on ___ with 1-month cough and 2-day worsening dyspnea on exertion. Bedside TTE in the ED showed large effusion with normal global LV function and signs of RV collapse. Had an emergent pericardiocentesis with mean pericardial opening pressures of 35 mmHg and closing pressures of 3 mm Hg. 875 mL of dark amber fluid was removed and a pericardial drainage catheter was secured in place. He was transferred to the CCU where he continued to be monitored. The drainage catheter was removed on ___ after 24-hour collection was <50cc. Pericardial fluid fluid cell count, chemistry, cytology, culture was c/w post surgical/inflammatory pericardial effusion. CRP was 18.7. Patient was started on colchicine 0.6mg BID for 3 months (End date ___. The patient's apixaban was held at discharge. Would consider restarting after repeating TTE in 1 week. #Post surgical cough #Dysphonia Patient has noticed a chronic cough after his CABG. Despite being euvolemic, the patient continues to have a cough. CT Chest was done without evidence of cause. The patient was started on cough suppressants and had a SNIFF test given L diaphragm was slightly elevated on CXR. This showed no evidence diaphragmatic weakness. He was started on pantoprazole for empiric treatment of GERD. Planned for ENT referral as an outpatient. # Lactic acidosis # Hypotensive shock Pt presented with lactic acidosis to 9.2 which down-trended to 2.8; pH of 7.18 and PCO2 42, Bicarbonate of 16. Labs were initially concerning for DKA given FBG of 390 so pt was placed on insulin gtt which was weaned to SSI after urine ketones and serum beta-hydroxybutyrate resulted negative. Lactic acidosis likely in the setting of poor cadiac perfusion d/t tamponade physiology which responded to therapeutic pericardiocentesis. # ___ Cr baseline 0.9-1.2; peak 1.7, down-trended to 0.9. Likely pre-renal given hypoperfusion iso tamponade. Cr on discharge 0.9 # Paroxysmal AF Metoprolol succinate was held initially iso temponade and hypotension. Patient had one episode of afib with RVR and was started on metoprolol tartrate that was consolidated to metoprolol succinate 100mg daily. Apixaban was held initially due to concerns that the pericardial effusion was hemorrhagic. Patient was discharged on metop succinate 100mg daily and held apixaban 5mg BID. # Transaminitits (improving): on ___, ALT was 542 and AST of 187 with normal total Bilirubin. No clear etiology; however, this coincidenced with starting colchicine. RUQUS showed hepatic steatosis without obstruction. Hep. B serology showed immunity due to previous infection. Hep B viral load was pending. Hep A antibodies were negative and Hep C antibodies were negative. Atorvastatin was switched to Crestor 20mg. LFTs came down. On discharge, ALT was 182 and AST was 25. #Gout Flare Pt had gout flare in R second PIP joint on ___, was given three days of PO prednisone 20 mg. CHRONIC ISSUES ============== #NIDDM The patient was placed on insulin sliding scale while inpatient. His home oral regimen was continued on discharged. Would consider switching to SGLT2 for cardiovascular benefit. - home Amaryl (glimepiride); pt not taking - home Januvia (SITagliptin) 100 mg oral daily - home MetFORMIN (Glucophage) 500 mg PO BID #Aortic Stenosis s/p Aortic valve replacement #Coronary Artery Disease s/p coronary artery bypass graft x 2 - Cont ASA 81. - Cont Atorvastatin 40mg qHS TRANSITIONAL ISSUES [] repeat CRP after treatment. CRP was 18.7 while inpatient [] Will need repeat echo in ___ weeks to ensure no reaccumulation. Would consider restarting apixaban if stable. [] Consider switching from glimepiride to SGLT2 given cardiovascular benefit [] Ensure ENT follow up for chronic cough [] f/u HBV and HCV VL #CODE: Full code (confirmed) #CONTACT/HCP: ___ (wife) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 40 mg PO QPM 3. GuaiFENesin ER 1200 mg PO Q12H 4. Ranitidine 150 mg PO DAILY 5. Senna 17.2 mg PO QHS 6. TraMADol 50 mg PO Q6H:PRN Pain - Moderate 7. Apixaban 5 mg PO BID 8. Amaryl (glimepiride) 4 mg oral BID 9. Januvia (SITagliptin) 100 mg oral DAILY 10. Losartan Potassium 25 mg PO DAILY 11. MetFORMIN (Glucophage) 500 mg PO BID 12. FoLIC Acid 1 mg PO DAILY 13. Thiamine 100 mg PO DAILY 14. TraZODone 25 mg PO QHS:PRN insomnia 15. Furosemide 40 mg PO DAILY 16. Metoprolol Succinate XL 100 mg PO DAILY Discharge Medications: 1. Colchicine 0.6 mg PO BID RX *colchicine 0.6 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*2 2. GuaiFENesin-Dextromethorphan ___ mL PO Q6H Cough 3. Pantoprazole 40 mg PO Q24H 4. Rosuvastatin Calcium 20 mg PO QPM RX *rosuvastatin 20 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*3 5. Amaryl (glimepiride) 4 mg oral BID 6. Aspirin 81 mg PO DAILY 7. FoLIC Acid 1 mg PO DAILY 8. GuaiFENesin ER 1200 mg PO Q12H 9. Januvia (SITagliptin) 100 mg oral DAILY 10. Losartan Potassium 25 mg PO DAILY 11. MetFORMIN (Glucophage) 500 mg PO BID 12. Metoprolol Succinate XL 100 mg PO DAILY 13. Ranitidine 150 mg PO DAILY 14. Senna 17.2 mg PO QHS 15. Thiamine 100 mg PO DAILY 16. TraMADol 50 mg PO Q6H:PRN Pain - Moderate 17. TraZODone 25 mg PO QHS:PRN insomnia 18. HELD- Apixaban 5 mg PO BID This medication was held. Do not restart Apixaban until you see your cardiologist 19. HELD- Furosemide 40 mg PO DAILY Duration: 7 Days This medication was held. Do not restart Furosemide until you are told to by your heart doctor Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS: ================== Pericardial Effusion with tamponade physiology SECONDARY DIAGNOSES: ==================== Atrial fibrillation Chronic cough transaminitis Gout Type 2 diabetes mellitus Acute kidney injury Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___. WHY WAS I IN THE HOSPITAL? - You were admitted to the hospital because you were having trouble breathing. WHAT WAS DONE IN THE HOSPITAL? - You had an ultrasound of your heart. This showed that there was a collection of fluid surrounding your heart. - You had a procedure called a pericardiocentesis to remove the extra fluid surrounding your heart. WHAT SHOULD I DO WHEN I LEAVE THE HOSPITAL? - Continue to take all your medications as prescribed. - Make sure to follow-up with your heart doctor and primary care doctor. We wish you the best! Your ___ Care Team Followup Instructions: ___
19986589-DS-25
19,986,589
27,690,011
DS
25
2192-02-21 00:00:00
2192-02-21 18:05:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Chest Pain Major Surgical or Invasive Procedure: ___ Cardiac Cath History of Present Illness: ___ y.o. male w/ h/o CAD w/anomalous RCA, prior NSTEMI w/BMS to anomalous RC and CABG w/SVG to anomalous dRCA ___ and s/p PCI ___ with DES to distal OM1 on ASA and plavix, DM2, HTN, and HLD presenting with chest pain. He says he has been having chest pain intermittently since discharge that he describes as sharp stabbing pains. He has been taking SL nitro which improved his pain except for today. This morning the patient developed substernal CP at rest that lasted 10 secs. At 4 ___ he developed L sided chest pressure ___ at rest that was non-radiating and worsened with talking and got better with resting. The pain was also associated with lightheadness and he said it felt like pressure/squeezing. He tried NTG x3 and full-dose ASA with slight improvement. Denies nausea, vomiting, diaphoresis, abdominal pain, SOB. Initial reports from EMS was that the patient had ST depressions on EKG. He was discharged to rehab ___ after undergoing PCI. He saw his cardiologist on ___ as an outpatient at which point he reported frequent presyncopal episodes with standing and reported that his blood pressure has been low. His lisinopril was stopped by the rehab but his symptoms continued. Dr. ___ his metoprolol and Imdur dosing. In the ED... - Initial vitals: 96.9F, BP 120/80, RR 16, 100% on RA - EKG: Slight horizontal flattening of inferior leads, otherwise not significantly changed from prior - Labs/studies notable for: Trop neg x1 - Patient was given: SL nitro x2 - Vitals on transfer: HR 81, BP 98/59, RR 25, 95% on RA On the floor he reports that his chest pain improved from ___ to ___ since receiving 2 SL nitro in the ED. He said the pain never went away completely. He received a ___ SL nitro during the interview with ultimate resolution of chest pain. He reports that he was feeling lightheaded at his rehab when getting up to be washed and reports that his SBP was as low as 74 during these episodes. He says that once his Imdur and metoprolol doses were reduced he noticed improvement in those symptoms. Past Medical History: 1. CARDIAC RISK FACTORS - Diabetes (+) - Hypertension (+) - Dyslipidemia (+) 2. CARDIAC HISTORY - CABG: ___ - PERCUTANEOUS CORONARY INTERVENTIONS: ___ (BMS to proximal anomalous RCA), ___ - PACING/ICD: None 3. OTHER PAST MEDICAL HISTORY - Osteoarthritis - Constipation Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION PHYSICAL EXAMINATION: ===================== VS: 97.4F, 122/78, HR 81, RR 18, 96% on RA GENERAL: Sitting on the edge of the bed, in no acute distress HEENT: AT/NC, anicteric sclera, MMM NECK: supple, no LAD CV: RRR, S1/S2, no murmurs, gallops, or rubs CHEST: pain not reproducible to palpation PULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles GI: abdomen soft, nondistended, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing, or edema PULSES: 2+ radial pulses bilaterally NEURO: Alert, moving all 4 extremities with purpose, face symmetric DISCHARGE PHYSICAL EXAM: VS: 24 HR Data (last updated ___ @ 828) Temp: 98.6 (Tm 98.7), BP: 106/62 (103-128/62-80), HR: 84 (79-94), RR: 17 (___), O2 sat: 96% (94-100) GENERAL: Sitting on the edge of the bed, in some pain. HEENT: AT/NC, anicteric sclera, MMM NECK: supple, no LAD CV: NR, RR. Nl S1, S2. No m/r/g. CHEST: Pain not reproducible to palpation PULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles GI: abdomen soft, nondistended, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing, or edema PULSES: 2+ radial pulses bilaterally NEURO: Alert, moving all 4 extremities with purpose, face symmetric Pertinent Results: ADMISSION/PERTINENT LABS ======================== ___ 06:43PM BLOOD WBC-5.0 RBC-4.38* Hgb-13.4* Hct-40.5 MCV-93 MCH-30.6 MCHC-33.1 RDW-12.8 RDWSD-43.8 Plt ___ ___ 06:35AM BLOOD WBC-3.9* RBC-4.28* Hgb-12.9* Hct-39.7* MCV-93 MCH-30.1 MCHC-32.5 RDW-13.0 RDWSD-44.2 Plt ___ ___ 06:43PM BLOOD Neuts-56.3 ___ Monos-8.5 Eos-3.0 Baso-0.6 Im ___ AbsNeut-2.83 AbsLymp-1.57 AbsMono-0.43 AbsEos-0.15 AbsBaso-0.03 ___ 06:43PM BLOOD ___ PTT-26.8 ___ ___ 06:35AM BLOOD Glucose-173* UreaN-14 Creat-0.7 Na-140 K-4.4 Cl-103 HCO3-25 AnGap-12 ___ 06:43PM BLOOD cTropnT-<0.01 ___ 12:58AM BLOOD CK-MB-2 cTropnT-<0.01 ___ 08:31AM BLOOD CK-MB-2 cTropnT-<0.01 ___ 06:35AM BLOOD Calcium-9.3 Phos-4.0 Mg-2.0 STUDIES ======= Cath ___ LM: The left main coronary artery had mild plaquing. LAD: The left anterior descending coronary artery had an ostial 30% stenosis. The mid LAD had a slightly hazy 30% stenosis unchanged from prior angiogram. The distal LAD wrapped well around the apex. Flow in the LAD was delayed and pulsatile, consistent with microvascular dysfunction. Circ: The circumflex coronary artery had a near ostial 20% plaque. The retroflexed OM1 had an origin 40% stenosis. The mid OM1 was angulated with some dynamic bending during systole. The angulated OM2 had mild proximal plaquing. The AV groove CX was retroflexed after OM2 with mild plaquing before supplying 2 LPLs. Flow in OMs and LPLs was delayed, consistent with microvascular dysfunction. RCA: The right coronary artery arose anomalously adjacent to the LMCA and had mild luminal irregularities. The proximal stent had mild in-stent restenosis. There was competitive flow in the mid RCA from the SVG. SVG-RCA: The saphenous vein graft to the distal RCA had luminal irregularities. There was antegrade perfusion into the RPDA and retrograde perfusion into the native mid RCA. Complications: There were no clinically significant complications. Findings 1. Stable native coronary atherosclerosis with patent recent OM1 stent and mild restenosis of the prior stent in the anomalous RCA arising adjacent to the LMCA. 2. Patent SVG-distal RCA. 3. Diffuse slow pulsatile flow consistent with microvascular dysfunction. Brief Hospital Course: Mr. ___ is a ___ year-old man w/ h/o CAD w/anomalous RCA, prior NSTEMI w/BMS to anomalous RC and CABG w/SVG to anomalous dRCA ___ and s/p PCI ___ with DES to distal OM1 on ASA and plavix, DM2, HTN, and HLD presenting with chest pain. # CORONARIES: Patent SVG-distal RCA, patent recent OM1 stent and mild restenosis of prior stent in anomalous RCA arising adjacent to LMCA, diffuse slow pulsatile flow consistent with microvascular dysfunction, # PUMP: EF 55% # RHYTHM: NSR ACTIVE ISSUES ============= # Unstable Angina # CAD H/o DES to OM1 last month, with remainder of vessels relatively patent. Had decreased Imdur and Metoprolol I/s/o presyncope at last visit with Dr. ___. Presented with multiple intermittent episodes of CP, initially atypical and mostly stabbing, then progressive to more of a pressure sensation, which responded to NTG. Trops negative x3. EKGs unchanged. Started on NTG drip due to persistent pain. Underwent cath via RRA with no evidence of new/progressive disease and all grafts and vessels similarly patent to prior study in ___. Increased imdur to 30mg. Continued on ASA, Plavix, Metoprolol, Atorvastatin. # Pre-syncope Reports several episodes at rehab of orthostasis and pre-syncope and reports low systolic blood pressures. His lisinopril was discontinued but symptoms persisted. Imdur and metroprolol doses were reduced at recent outpatient cardiology visit as above and since then symptoms have resolved. Orthostatics here negative. Increased imdur without recurrence in symptoms. CHRONIC ISSUES ============== # Type 2 diabetes On lantus, metformin, byetta, and glipizide as an outpatient. A1c 10.1% in ___ and since then has been started on insulin. Continued on Lantus and ISS. # Severe osteoarthritis of bilateral knee status post replacement Wheelchair bound. Continued lidocaine patches, APAP, tramadol, gabapentin. TRANSITIONAL ISSUES =================== [ ] Increased Imdur due to persistent CP though most likely small-vessel I/s/o no intervenable lesions on cath. Monitor for presyncope/syncopal symptoms. [ ] ___ likely continue with some CP; can take SL nitroglycerin for pain that lasts more than a few seconds. If pain persists despite SL nitro, should come to ED for evaluation. [ ] Patient brought up desire for surgery for OA of knees. Discussed that orthopedics can communicate with Dr. ___ ___ regarding ___ risk evaluation. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 5. GlipiZIDE 10 mg PO BID 6. Lidocaine 5% Patch 1 PTCH TD QAM 7. Metoprolol Succinate XL 25 mg PO DAILY 8. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 9. Clopidogrel 75 mg PO DAILY to prevent stent thrombosis 10. Isosorbide Mononitrate (Extended Release) 15 mg PO DAILY 11. Byetta (exenatide) 10 mcg/dose(250 mcg/mL) 2.4 mL subcutaneous BID 12. MetFORMIN (Glucophage) 1000 mg PO BID 13. Milk of Magnesia 30 mL PO QHS:PRN Constipation - First Line 14. Multivitamins 1 TAB PO DAILY 15. Gabapentin 300 mg PO TID 16. melatonin 3 mg oral QHS 17. Glargine 18 Units Bedtime 18. TraMADol 75 mg PO Q6H:PRN Pain - Moderate 19. Senna 17.2 mg PO DAILY Discharge Medications: 1. Glargine 18 Units Bedtime 2. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 3. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 4. Aspirin 81 mg PO DAILY 5. Atorvastatin 80 mg PO QPM 6. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 7. Byetta (exenatide) 10 mcg/dose(250 mcg/mL) 2.4 mL subcutaneous BID 8. Clopidogrel 75 mg PO DAILY to prevent stent thrombosis 9. Gabapentin 300 mg PO TID 10. GlipiZIDE 10 mg PO BID 11. Lidocaine 5% Patch 1 PTCH TD QAM 12. melatonin 3 mg oral QHS 13. MetFORMIN (Glucophage) 1000 mg PO BID 14. Metoprolol Succinate XL 25 mg PO DAILY 15. Milk of Magnesia 30 mL PO QHS:PRN Constipation - First Line 16. Multivitamins 1 TAB PO DAILY 17. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 18. Senna 17.2 mg PO DAILY 19. TraMADol 75 mg PO Q6H:PRN Pain - Moderate RX *tramadol 50 mg 1.5 tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills:*0 Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Unstable Angina Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. WHY WAS I ADMITTED TO THE HOSPITAL? - You were admitted to the hospital because you were having chest pain. WHAT HAPPENED WHILE I WAS IN THE HOSPITAL? - We gave you medicine to treat your chest pain. - We did a cardiac catheterization to look at the stents and the blood vessels in your heart, which showed no new disease. - We changed your medications to try and reduce the frequency of your chest pain. WHAT SHOULD I DO WHEN I GO HOME? - You should continue to take your medications as prescribed. - You should attend the appointments listed below. We wish you the best! Your ___ Care Team Followup Instructions: ___
19986589-DS-27
19,986,589
20,368,763
DS
27
2192-03-18 00:00:00
2192-03-18 15:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Chest Pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old man with PMH notable for CAD s/p CABG, BMS and DES as well as DM and HTN. ___ has had four admissions since ___ with complaints of chest pain. He underwent a PCI to OM1 with DES in ___. He underwent angiography again on ___ which showed stable nonobstructive CAD with evidence of diffuse microvascular disease. At discharge ___, added amlodipine, increased isosorbide from 15mg to 30mg and added protonix. He again presents with c/o CP. Per EMS report, was distraught and crying in the ambulance. He was admitted through the ED to rule out for MI. Past Medical History: 1. CARDIAC RISK FACTORS - Diabetes (+) - Hypertension (+) - Dyslipidemia (+) 2. CARDIAC HISTORY - CABG: ___ - PERCUTANEOUS CORONARY INTERVENTIONS: ___ (BMS to proximal anomalous RCA), ___ - PACING/ICD: None 3. OTHER PAST MEDICAL HISTORY - Osteoarthritis - Constipation Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: Admission exam: Physical Examination: General: chronically ill appearing man looking older than stated age sitting up in bed in NAD Neuro: alert and oriented w/o focal deficit, speech clear and coherent Cardiac: RRR, no M/R/G Lungs: diminished bilat, breathing regular and unlabored Abd: +BS, soft NT ND Extremities: Warm and dry w/o edema, +2 palpable peripheral pulses. Bilateral knees with long scars because of BKA. No obvious swelling or tenderness to palpation. Admission weight:109.2 kg Discharge exam: VS: 97.9, 112/73-118/73, HR 64-98, RR 16, 02 sat 96% RA WEIGHT: 108.9 kg I/O: 120/1000cc TELEMETRY: SR 70's, no alarms per telemetry review Physical Examination: Gen: Patient is comfortable, in no acute distress. HEENT: Face symmetrical, trachea midline. Neuro: A/Ox3. Speaking in complete, coherent sentences. No face, arm, or leg weakness. Pulm: Breathing unlabored. Breath sounds clear bilaterally. Cardiac: No JVD. No thrills or bruits heard on carotids bilaterally. S1, S2 RRR. No splitting of heart sounds, murmurs, S3, S4 or friction rubs heard. Vasc: No edema noted in bilateral upper or lower extremities. No pigmentation changes noted in bilateral upper or lower extremities. Skin dry, warm. Bilateral radial, ___ pulses palpable 2+. Abd: Rounded, soft, non-tender. Diagnostic studies: CXR ___: No focal consolidations. No pneumothorax. Pertinent Results: ___ 07:27PM cTropnT-<0.01 ___ 11:11AM cTropnT-<0.01 ___ 05:00AM cTropnT-<0.01 ___ 04:45AM cTropnT-<0.01 proBNP-47 ___ 11:11AM GLUCOSE-165* UREA N-10 CREAT-0.8 SODIUM-141 POTASSIUM-3.9 CHLORIDE-100 TOTAL CO2-28 ANION GAP-13 Brief Hospital Course: Mr. ___ is an ___ gentleman with a history of coronary artery disease status post CABG and multiple PCI's, hypertension, hyperlipidemia, type 2 diabetes who has had multiple admissions for chest pain in recent months. He resides at the ___ in ___, ___ due to chronic disability and being wheelchair-bound at this time. His last cardiac catheterization was in ___ showing stable CAD and chest pain thought to be secondary to micro vascular disease. On ___, he was residing at the rehab when he was anxious and upset and reports a delay in response to complaints of chest pain. He then called ___ himself and was brought to the emergency department by EMS. His troponins were negative x5 with no new EKG changes. We increased his metoprolol succinate to 50 mg daily as his heart rate was initially in the ___, which he has tolerated well. On day of discharge his heart rate was 60-80. We did not increase isosorbide mononitrate due to blood pressure; he has been running SBP 112-118. That might be a consideration in the future if his blood pressure is higher and he tolerates the increased dose of beta-blocker. We also considered introducing Ranexa but felt he may benefit from maximizing beta blockade (goal HR 60 bpm as BP tolerates) and having his anxiety managed first and see if that helps decrease chest pain. He had a few transient episodes of chest pain in the setting of anxiety and in the absence of EKG changes while admitted. He was given Ativan 0.5 mg on 2 separate occasions which was very effective and chest pain resolved without any further intervention. He admits to high anxiety and stress being a trigger for his multiple episodes of chest pain requiring hospital admission. He is anxious about his disability, being wheelchair-bound, and needing knee surgery which he reportedly has not been cleared to undergo. He is willing to follow-up with his PCP and willing to trial medication in attempt to better manage his anxiety which seems to be consistently a trigger for these chest pain episodes. For now, we will prescribe Ativan 0.5 mg up to twice daily for anxiety. He was instructed not to drive while taking this medication. (He is currently wheelchair-bound and in a long-term care facility so this should not impact him at this time.) We requested that the rehab make a hospital follow-up appointment with his PCP ___ 1 week of discharge to address ongoing anxiety and stress. We are hopeful that managing this will decrease his episodes of chest pain. He may also benefit from additional support services such as social work. For cardiac medications, he will continue atorvastatin, Plavix, aspirin, isosorbide, metoprolol succinate, amlodipine and as needed nitro. He may benefit from an ACE given prior NSTEMI with hypertension and diabetes, though we will not start it now given recent reported orthostasis prior to this hospitalization and soft BP. He has a follow-up appointment with Dr. ___ who is his primary cardiologist in ___ and continues to be followed by orthopedics for his ongoing knee issue. Also to note, there was some report of pyuria prior to admission and reportedly was ordered for Cipro at the rehab but never took it. A urine culture done here this admission was negative for growth . He was afebrile and had no urinary complaints and did not get any antibiotics during this admission. He is voiding without difficulty. We will discharge him back to rehab today via chair car. >30 minutes spent on discharge planning/coordination of care. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 2. Gabapentin 300 mg PO TID 3. Metoprolol Succinate XL 25 mg PO DAILY 4. MetFORMIN (Glucophage) 1000 mg PO BID 5. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 6. Docusate Sodium 100 mg PO BID 7. Polyethylene Glycol 17 g PO BID:PRN Constipation - Third Line 8. amLODIPine 5 mg PO DAILY 9. Atorvastatin 80 mg PO QPM 10. exenatide 10 mcg/dose(250 mcg/mL) 2.4 mL subcutaneous BID 11. Glargine 18 Units Bedtime 12. Senna 17.2 mg PO QHS:PRN Constipation - First Line 13. Multivitamins 1 TAB PO DAILY 14. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 15. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 16. TraMADol 75 mg PO Q6H:PRN Pain - Moderate 17. melatonin 3 mg oral HS 18. Clopidogrel 75 mg PO DAILY 19. Pantoprazole 40 mg PO Q24H 20. Aspirin 81 mg PO DAILY 21. Tamsulosin 0.4 mg PO QHS 22. GlipiZIDE 10 mg PO BID Discharge Medications: 1. LORazepam 0.5 mg PO Q12H:PRN anxiety RX *lorazepam 0.5 mg 1 tablet by mouth every twelve (12) hours Disp #*30 Tablet Refills:*0 2. Metoprolol Succinate XL 50 mg PO DAILY RX *metoprolol succinate 50 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 3. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 4. amLODIPine 5 mg PO DAILY 5. Aspirin 81 mg PO DAILY 6. Atorvastatin 80 mg PO QPM 7. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 8. Clopidogrel 75 mg PO DAILY 9. Docusate Sodium 100 mg PO BID 10. exenatide 10 mcg/dose(250 mcg/mL) 2.4 mL subcutaneous BID 11. Gabapentin 300 mg PO TID 12. GlipiZIDE 10 mg PO BID 13. Glargine 18 Units Bedtime 14. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 15. melatonin 3 mg oral HS 16. MetFORMIN (Glucophage) 1000 mg PO BID 17. Multivitamins 1 TAB PO DAILY 18. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 19. Pantoprazole 40 mg PO Q24H 20. Polyethylene Glycol 17 g PO BID:PRN Constipation - Third Line 21. Senna 17.2 mg PO QHS:PRN Constipation - First Line 22. Tamsulosin 0.4 mg PO QHS 23. TraMADol 75 mg PO Q6H:PRN Pain - Moderate Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Chest pain, coronary microvascular disease Discharge Condition: See discharge summary Discharge Instructions: You were admitted to ___ with chest pain. You EKG and blood work showed that you did not have a heart attack. You had a recent cardiac catheterization in ___ during prior admission which showed stable coronary arteries. It is felt that you have "microvascular" disease which involves the very small branches off the main coronary arteries. We have optimized your medical management to treat this and attempt to prevent chest pain. There also appears to be a component of stress/anxiety which precipitates the chest pain episodes. You were given a dose of Ativan during one of your episodes here at the hospital which worked well to decrease the stress and the chest pain resolved at that time without further intervention. We request that you see your PCP within one week of discharge in order to discuss medication options and perhaps start on something daily to help decrease your baseline anxiety. If your stress/anxiety was better managed, it may decrease your episodes of chest pain. Meanwhile we have prescribed Ativan/Lorazepam 0.5mg by mouth to take up to twice daily as needed for anxiety. PLEASE ONLY TAKE WHEN NEEDED TO MANAGE ACUTE ANXIETY. YOU CAN NOT DRIVE WHILE TAKING THIS MEDICATION. You should continue your current medications with the following changes: 1. Increase Metoprolol Succinate to 50mg daily 2. Start Ativan (Lorazepam) 0.5mg every 12 hours AS NEEDED for anxiety. If you have any urgent questions that are related to your recovery from your hospitalization or are experiencing any symptoms that are concerning to you and you think you may need to return to the hospital, please call the ___ HeartLine at ___ to speak to a cardiologist or cardiac nurse practitioner. You will follow-up with PCP within one week of hospital discharge. We have asked the rehab to scheduled this appointment and necessary transportation to and from. You will follow-up with your cardiologist as scheduled below. It has been a pleasure to have participated in your care and we wish you the best with your health! Your ___ Cardiac Care Team Followup Instructions: ___
19986589-DS-28
19,986,589
21,321,609
DS
28
2192-05-30 00:00:00
2192-05-31 07:50:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: chest pain Major Surgical or Invasive Procedure: none History of Present Illness: Mr. ___ is a ___ male with history of CAD s/p CABG, Type II diabetes, hypertension, and chronic knee pain, who presents from rehab with chest pain. Patient states at rehab he had to use the bathroom and called for assistance, but nobody would come to help him. He then called ___. EMS helped him to the restroom. During this interaction he developed sudden-onset moderate chest pain, which he describes as a left-sided heaviness, that then radiated to the right side. This is in the setting of coronary artery disease and is typical for his episodes of angina. He was therefore brought to the ED. Denies any associated shortness of breath, cough, fever, diaphoresis, nausea, vomiting. Denies abdominal pain. Denies dizziness or lightheadedness. Patient states that his typical chest pain will start on the left side. He will often try SL nitro at this point, which most often relieves the pain. However, at times it does not and radiates to the right side and will become squeezing. He states that this happened a lot in ___ and ___, but has been doing better. He feels that it is triggered by stress. Regarding his UTI, he notes that had he has had two urinary tract infections this past month. The one he is being treated for now he did not have any symptoms, but it was found on testing. Regarding his knee pain, he notes that he both knees hurt, especially the left, which will buckle sometimes, causing him to fall. This was worse after knee replacements ___ years ago. Uses a wheelchair. He has discussed an operation to help repair his knees, but states that his cardiologist doesn't feel that a surgery would be safe until can go a year without a cardiac event. He states that being in rehab has been very difficult. He notes that he is there with many people who are much older than him, and this has taken a mental toll. He has seen many things that have made him uncomfortable and feel that the care he gets is often very poor. He also struggles with the idea of being stuck in a wheelchair at a rehab at such a young age. He also reports that he used to see Dr ___, who is now at ___. Would like to see her again, previously limited by insurance. On review of records, patient has had around five admissions since ___ with chest pain, and several additional ED visits. He underwent a PCI to OM1 with DES in ___. He underwent angiography again on ___ which showed stable nonobstructive CAD with evidence of diffuse microvascular disease. He most recently underwent a nuclear stress on ___ which was normal. In the ED: Initial vital signs were notable for: T 97, HR 95, BP 133/86, RR 20, 97% RA Exam notable for: well-appearing on exam. He has tenderness to palpation of the anterior chest wall. He is breathing comfortably on room air and lungs are clear to auscultation. Radial pulses intact. Abdomen soft and nontender. Labs were notable for: - CBC: WBC 4.8, hgb 12.9, plt 354 - Lytes: 139 / 103 / 11 AGap=12 -------------- 242 4.4 \ 24 \ 0.8 - trop <0.01 x2 Studies performed include: CXR with no acute intrathoracic process. Patient was given: ___ 06:40 IV Ketorolac 15 mg ___ 08:02 PO/NG amLODIPine 5 mg ___ 08:02 PO/NG Clopidogrel 75 mg ___ 08:02 PO/NG Gabapentin 300 mg ___ 08:02 PO Isosorbide Mononitrate (Extended Release) 30 mg ___ 08:02 PO Metoprolol Succinate XL 25 mg ___ 08:02 PO Pantoprazole 40 mg ___ 08:03 SC Insulin 2 Units ___ 08:04 PO/NG Aspirin 81 mg ___ 08:04 PO TraMADol 75 mg ___ 15:19 PO/NG Gabapentin 300 mg ___ 17:08 SC Insulin 6 Units ___ 18:10 PO TraMADol 75 mg Plan was initially for patient to return to rehab. However, he declined to go with plan to go to Motel. After multiple discussions with ___, CM, SW, plan to admit patient to medicine for further physical therapy and discuss returning to rehab. Patient amenable with this plan. Vitals on transfer: T 98.3, HR 81, BP 134/70, RR 18, 95% RA Upon arrival to the floor, patient recounts history as above. He has no chest pain now. ROS: Pertinent positives and negatives as noted in the HPI. All other systems were reviewed and are negative. Past Medical History: 1. CARDIAC RISK FACTORS - Diabetes (+) - Hypertension (+) - Dyslipidemia (+) 2. CARDIAC HISTORY - CABG: ___ - PERCUTANEOUS CORONARY INTERVENTIONS: ___ (BMS to proximal anomalous RCA), ___ - PACING/ICD: None 3. OTHER PAST MEDICAL HISTORY - Osteoarthritis - Constipation Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION EXAM: ==================== VITALS: T 98.2, HR 79, BP 120/70, RR 18, 99% RA GENERAL: Alert and in no apparent distress EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate CV: Heart regular, no murmur, no S3, no S4. No JVD. RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. No HSM GU: No suprapubic fullness or tenderness to palpation MSK: Neck supple, moves all extremities. Lower extremities with knee pain to flexion and extension SKIN: No rashes or ulcerations noted NEURO: Alert, oriented, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs, sensation to light touch grossly intact throughout PSYCH: pleasant, appropriate affect DISCHARGE EXAM: ==================== GENERAL: Alert and in no apparent distress, sitting up in CHAIR EYES: Anicteric, pupils equally round CV: RRR no m/r/g LUNGS: CTAB ABD: obese, normal bowel sounds. NEURO: Alert, oriented, face symmetric, speech fluent PSYCH: Calm Pertinent Results: ADMISSION LABS: ___ 12:14AM BLOOD WBC-4.8 RBC-4.50* Hgb-12.9* Hct-40.8 MCV-91 MCH-28.7 MCHC-31.6* RDW-12.4 RDWSD-41.1 Plt ___ ___ 12:14AM BLOOD Neuts-53.8 ___ Monos-7.6 Eos-3.1 Baso-1.0 Im ___ AbsNeut-2.60 AbsLymp-1.66 AbsMono-0.37 AbsEos-0.15 AbsBaso-0.05 ___ 12:14AM BLOOD Glucose-242* UreaN-11 Creat-0.8 Na-139 K-4.4 Cl-103 HCO3-24 AnGap-12 ___ 12:14AM BLOOD cTropnT-<0.01 ___ 03:24AM BLOOD cTropnT-<0.01 ___ 03:24AM BLOOD cTropnT-<0.01 ====================================== EXAMINATION: CHEST (PA AND LAT) INDICATION: History: ___ with chest pain// eval pna COMPARISON: Chest radiograph ___ FINDINGS: AP and lateral views of the chest. Mid sternotomy wires are again seen and appear similarly positioned. Low lung volumes bilaterally, particularly on the right where there is unstable right hemidiaphragm elevation. No areas of focal consolidation, pulmonary edema, pneumothorax or pericardial effusion. Cardiac size is normal. IMPRESSION: No acute intrathoracic process. Brief Hospital Course: Mr. ___ is a ___ male with history of CAD s/p CABG, type II diabetes, hypertension, and chronic knee pain, who presents from rehab with recurrent chest pain with negative workup for acute cardiac cause, admitted as declined to return to nursing facility. Patient was ultimately discharged to a hotel as patient refused to return to prior SAR. # Coronary artery disease/Microvascular coronary disease: # Chest Pain: # Chronic stable angina: Patient with significant history of CAD and what is felt to be angina from microvascular disease. Multiple troponins negative and EKG without ischemic changes. No chest pain since arrival, and extensive recent workup, including nuclear stress last month. This was thought to be exacerbated by anxiety. patient also complained of pleuritic chest pain and lightheadedness and underwent a CT chest that was negative. # Osteoarthritis: # Knee pain: Patient is unable to ambulate as knees buckle, which has currently left him wheelchair-bound and previously in rehab. This is reportedly due to prior failed knee surgery. Plan for eventual surgery, though first would need to be improved from a cardiac standpoint. Discharged with wheelchair and bedside commode. #UTI -previously treated with cefpodoxime for a Klebsiella UTI, patient unaware if he received the antibiotics as he was in rehab. UA suggestive of infection. Culture pending at discharge. Given Cipro for 10day course. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lidocaine 5% Patch 1 PTCH TD QAM 2. LORazepam 0.5 mg PO BID:PRN anxiety 3. Clopidogrel 75 mg PO DAILY 4. Metoprolol Succinate XL 50 mg PO DAILY 5. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 6. Atorvastatin 80 mg PO QPM 7. amLODIPine 5 mg PO DAILY 8. Pantoprazole 40 mg PO Q24H 9. melatonin 3 mg oral QHS 10. Tamsulosin 0.4 mg PO QHS 11. Glargine 18 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 12. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain 13. Polyethylene Glycol 17 g PO BID:PRN Constipation - Third Line 14. Gabapentin 300 mg PO TID 15. Byetta (exenatide) 10 mcg/dose(250 mcg/mL) 2.4 mL subcutaneous BID 16. GlipiZIDE 10 mg PO BID 17. TraMADol 75 mg PO Q6H:PRN Pain - Moderate 18. Milk of Magnesia 30 mL PO Q12H:PRN Constipation - Second Line 19. Cefpodoxime Proxetil 100 mg PO Q12H 20. MetFORMIN (Glucophage) 1000 mg PO BID 21. Acetaminophen 975 mg PO Q6H:PRN Pain - Mild/Fever 22. Aspirin 81 mg PO DAILY 23. Multivitamins 1 TAB PO DAILY 24. Senna 17.2 mg PO QHS 25. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 26. Mylanta 30 ml oral Q4H:PRN dyspepsia Discharge Medications: 1. Ciprofloxacin HCl 750 mg PO Q12H urinary tract infection RX *ciprofloxacin HCl 750 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*20 Tablet Refills:*0 2. Acetaminophen 650 mg PO Q8H:PRN Pain - Mild/Fever RX *acetaminophen [8HR Muscle Aches-Pain] 650 mg 1 tablet(s) by mouth q8 Disp #*30 Tablet Refills:*0 3. Glargine 18 Units Bedtime Insulin SC Sliding Scale using HUM Insulin RX *blood sugar diagnostic [Blood Glucose Test] use for blood sugar monioring 4x dialy Disp #*200 Strip Refills:*0 RX *insulin glargine [Lantus Solostar U-100 Insulin] 100 unit/mL (3 mL) ___ Units before BED; Disp #*3 Syringe Refills:*0 RX *blood-glucose meter [Blood Glucose Monitoring] blood sugar monitoring 4X day Disp #*1 Kit Refills:*0 RX *lancets [BD Microtainer Lancet] 30 gauge use for glucose monitoring Disp #*200 Each Refills:*0 4. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 81 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 5. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 tablet(s) by mouth qpm Disp #*30 Tablet Refills:*0 6. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 7. Byetta (exenatide) 10 mcg/dose(250 mcg/mL) 2.4 mL subcutaneous BID RX *exenatide [Byetta] 10 mcg/0.04 mL per dose (250 mcg/mL) 2.4 mL 10 mcg twice a day Disp #*1 Syringe Refills:*0 8. Clopidogrel 75 mg PO DAILY RX *clopidogrel 75 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 9. Gabapentin 300 mg PO TID RX *gabapentin 300 mg 1 capsule(s) by mouth three times a day Disp #*90 Capsule Refills:*0 10. GlipiZIDE 10 mg PO BID diabetes RX *glipizide 10 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 11. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY RX *isosorbide mononitrate 30 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 12. Lidocaine 5% Patch 1 PTCH TD QAM 13. LORazepam 0.5 mg PO BID:PRN anxiety RX *lorazepam [Ativan] 0.5 mg 1 tablet(s) by mouth twice a day Disp #*10 Tablet Refills:*0 14. melatonin 3 mg oral QHS 15. MetFORMIN (Glucophage) 1000 mg PO BID RX *metformin [Fortamet] 1,000 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 16. Metoprolol Succinate XL 50 mg PO DAILY RX *metoprolol succinate [Kapspargo Sprinkle] 50 mg 1 capsule(s) by mouth once a day Disp #*30 Capsule Refills:*0 17. Milk of Magnesia 30 mL PO Q12H:PRN Constipation - Second Line 18. Multivitamins 1 TAB PO DAILY 19. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain RX *nitroglycerin 0.4 mg 1 tablet(s) sublingually q5min Disp #*15 Tablet Refills:*0 20. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth q24h Disp #*30 Tablet Refills:*0 21. Tamsulosin 0.4 mg PO QHS RX *tamsulosin [Flomax] 0.4 mg 1 capsule(s) by mouth at bedtime Disp #*30 Capsule Refills:*0 22. TraMADol 75 mg PO Q6H:PRN Pain - Moderate RX *tramadol [Ultram] 50 mg 1.5 tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills:*0 23.bedside Commode Drop arm, no diagnosis: ambulatory dysfunction physical function: good length of need: 13 months 24.Standard Manual Wheelchair Standard Manual Wheelchair, Seat and back cushion, Elevating leg rests, Anti tip and brake extensions Dx: Ambulatory dysfunction Px: good ___ 13 months Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Diabetes, type II Coronary artery disease Anxiety Knee osteoarthritis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Mr. ___, You were admitted to the hospital for chest discomfort and anxiety while at rehab. We made adjustments in your blood pressure regimen to help in case the chest pain was due to heart disease. We also adjusted your insulin regimen since you had elevated blood sugars. You should continue your home regimen at discharge. Your urine studies revealed elevation in WBC concerning for a urinary tract infection. You are prescribed 10 days of Ciprofloxacin antibiotics. Followup Instructions: ___